Clustering O 0 0.11730263382196426
of O 0 0.03831811621785164
missense O 0 0.12547773122787476
mutations O 0 0.031545162200927734
in O 0 0.014342340640723705
the O 0 0.04025042802095413
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 0.03176639974117279
in O 0 0.011678635142743587
a O 0 0.022171229124069214
sporadic B-Disease 1 0.9848122596740723
T I-Disease 1 0.9999996423721313
- I-Disease 1 0.9999997615814209
cell I-Disease 1 0.9996583461761475
leukaemia I-Disease 1 0.9999991655349731
. O 0 0.06363954395055771

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
telangiectasia I-Disease 1 0.9999996423721313
( O 0 0.045130256563425064
A B-Disease 1 0.9999345541000366
- I-Disease 1 1.0
T I-Disease 1 0.9999996423721313
) O 0 0.0129020344465971
is O 0 0.007632668595761061
a O 0 0.015103715471923351
recessive B-Disease 1 0.9998801946640015
multi I-Disease 1 0.9999996423721313
- I-Disease 1 1.0
system I-Disease 1 0.9999681711196899
disorder I-Disease 1 1.0
caused O 1 0.9988775849342346
by O 0 0.023709729313850403
mutations O 0 0.02049039863049984
in O 0 0.009569436311721802
the O 0 0.016044460237026215
ATM O 0 0.19243375957012177
gene O 0 0.020258145406842232
at O 0 0.020467150956392288
11q22 O 1 0.9984762072563171
- O 1 0.999987006187439
q23 O 1 0.9999408721923828
( O 0 0.04311046376824379
ref O 1 0.998623251914978
. O 0 0.021298697218298912
3 O 0 0.034956589341163635
) O 0 0.02810753881931305
. O 0 0.030598636716604233

The O 0 0.050049763172864914
risk O 0 0.2981584966182709
of O 0 0.4605237543582916
cancer B-Disease 1 1.0
, O 0 0.20794259011745453
especially O 1 0.8611663579940796
lymphoid B-Disease 1 1.0
neoplasias I-Disease 1 0.9999970197677612
, O 0 0.020940598100423813
is O 0 0.014335413463413715
substantially O 0 0.02404542826116085
elevated O 1 0.7054786682128906
in O 0 0.014952843077480793
A B-Disease 1 0.9998892545700073
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9999580383300781
and O 0 0.015955273061990738
has O 0 0.014462791383266449
long O 0 0.01914512924849987
been O 0 0.015154721215367317
associated O 0 0.021651780232787132
with O 0 0.03560560941696167
chromosomal O 1 0.9999991655349731
instability O 1 0.9999990463256836
. O 0 0.08945727348327637

By O 0 0.05011935532093048
analysing O 1 0.8187254667282104
tumour B-Disease 1 0.9999998807907104
DNA O 0 0.04867203161120415
from O 0 0.021184682846069336
patients O 0 0.16798238456249237
with O 0 0.01771332509815693
sporadic B-Disease 1 0.9859520196914673
T I-Disease 1 0.9999991655349731
- I-Disease 1 0.9999935626983643
cell I-Disease 1 0.9089764952659607
prolymphocytic I-Disease 1 0.9999954700469971
leukaemia I-Disease 1 1.0
( O 1 0.9320216774940491
T B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999997615814209
PLL I-Disease 1 0.9999991655349731
) O 0 0.021285826340317726
, O 0 0.01331042218953371
a O 0 0.01975858025252819
rare O 0 0.05369659885764122
clonal B-Disease 1 0.9999904632568359
malignancy I-Disease 1 0.9999995231628418
with O 0 0.019468961283564568
similarities O 0 0.018415849655866623
to O 0 0.01171012595295906
a O 0 0.019885774701833725
mature B-Disease 1 0.9324414730072021
T I-Disease 1 0.9999980926513672
- I-Disease 1 0.9999992847442627
cell I-Disease 1 0.9983519315719604
leukaemia I-Disease 1 0.9999997615814209
seen O 0 0.020560113713145256
in O 0 0.01436666864901781
A B-Disease 1 0.9999003410339355
- I-Disease 1 1.0
T I-Disease 1 0.9999995231628418
, O 0 0.014351174235343933
we O 0 0.009141302667558193
demonstrate O 0 0.015274541452527046
a O 0 0.01322625670582056
high O 0 0.020511066541075706
frequency O 0 0.019603708758950233
of O 0 0.01918112486600876
ATM O 1 0.6111893653869629
mutations O 0 0.0377022884786129
in O 0 0.029992597177624702
T B-Disease 1 0.9999896287918091
- I-Disease 1 0.9999914169311523
PLL I-Disease 1 0.9997970461845398
. O 0 0.06319689005613327

In O 0 0.034702904522418976
marked O 0 0.047179825603961945
contrast O 0 0.027567101642489433
to O 0 0.01611458882689476
the O 0 0.02270241640508175
ATM O 1 0.8178656697273254
mutation O 0 0.0330500565469265
pattern O 0 0.02385104075074196
in O 0 0.014022085815668106
A B-Disease 1 0.998928964138031
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999949932098389
, O 0 0.015826543793082237
the O 0 0.014652000740170479
most O 0 0.013699518516659737
frequent O 0 0.03220989555120468
nucleotide O 0 0.030881425365805626
changes O 0 0.013396787457168102
in O 0 0.012728830799460411
this O 0 0.02064390480518341
leukaemia B-Disease 1 0.9999997615814209
were O 0 0.036420516669750214
missense O 1 0.9866282939910889
mutations O 0 0.07592349499464035
. O 0 0.04598866030573845

These O 0 0.0250619575381279
clustered O 0 0.056386783719062805
in O 0 0.015361099503934383
the O 0 0.016717152670025826
region O 0 0.021797940135002136
corresponding O 0 0.01726178452372551
to O 0 0.01325136050581932
the O 0 0.023153161630034447
kinase O 1 0.9988307356834412
domain O 0 0.03308175876736641
, O 0 0.01143129263073206
which O 0 0.0077700079418718815
is O 0 0.008550683036446571
highly O 0 0.014457830227911472
conserved O 0 0.017496872693300247
in O 0 0.013456571847200394
ATM O 1 0.9902820587158203
- O 1 0.9996479749679565
related O 0 0.023270169273018837
proteins O 0 0.019477607682347298
in O 0 0.015329930931329727
mouse O 0 0.056758709251880646
, O 0 0.029995037242770195
yeast O 0 0.10714033991098404
and O 0 0.035193514078855515
Drosophila O 0 0.10484500974416733
. O 0 0.04436032474040985

The O 0 0.04793250560760498
resulting O 0 0.059034161269664764
amino O 0 0.09431872516870499
- O 1 0.9999946355819702
acid O 0 0.3985210061073303
substitutions O 0 0.03785606846213341
are O 0 0.008791209198534489
predicted O 0 0.022134138271212578
to O 0 0.016082962974905968
interfere O 0 0.04181447997689247
with O 0 0.023683184757828712
ATP O 1 0.9999562501907349
binding O 0 0.049566734582185745
or O 0 0.028232548385858536
substrate O 0 0.07245639711618423
recognition O 0 0.050766702741384506
. O 0 0.042217548936605453

Two O 0 0.016757119446992874
of O 0 0.022521428763866425
seventeen O 0 0.0721057876944542
mutated O 1 0.9964606165885925
T B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999982118606567
PLL I-Disease 1 0.9999730587005615
samples O 0 0.026265032589435577
had O 0 0.012828650884330273
a O 0 0.011932797729969025
previously O 0 0.015667017549276352
reported O 0 0.0236977469176054
A B-Disease 1 0.9953709244728088
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999979734420776
allele O 0 0.1258324831724167
. O 0 0.047332003712654114

In O 0 0.033151041716337204
contrast O 0 0.03836379200220108
, O 0 0.020585516467690468
no O 0 0.017325300723314285
mutations O 0 0.0209353007376194
were O 0 0.00880973506718874
detected O 0 0.018331069499254227
in O 0 0.009977610781788826
the O 0 0.021473808214068413
p53 O 1 0.9957784414291382
gene O 0 0.022483164444565773
, O 0 0.011304997839033604
suggesting O 0 0.014302005060017109
that O 0 0.008876311592757702
this O 0 0.021440651267766953
tumour B-Disease 1 1.0
suppressor O 1 0.9999997615814209
is O 0 0.020404107868671417
not O 0 0.010934480465948582
frequently O 0 0.01637294888496399
altered O 0 0.01997736468911171
in O 0 0.015628984197974205
this O 0 0.026919707655906677
leukaemia B-Disease 1 0.9999998807907104
. O 0 0.05923929437994957

Occasional O 0 0.12032642960548401
missense O 1 0.9194939732551575
mutations O 0 0.04865385591983795
in O 0 0.020363401621580124
ATM O 0 0.1986178159713745
were O 0 0.010676367208361626
also O 0 0.009957953356206417
found O 0 0.010827979072928429
in O 0 0.017157642170786858
tumour B-Disease 1 1.0
DNA O 0 0.03016510047018528
from O 0 0.01603422500193119
patients O 0 0.04834958165884018
with O 0 0.01812206394970417
B B-Disease 1 0.9999868869781494
- I-Disease 1 0.9999856948852539
cell I-Disease 0 0.07701161503791809
non I-Disease 1 0.978425145149231
- I-Disease 1 1.0
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 1.0
( O 0 0.28529301285743713
B B-Disease 1 0.9999909400939941
- I-Disease 1 0.9999498128890991
NHL I-Disease 0 0.2728272080421448
) O 0 0.013117850758135319
and O 0 0.010859777219593525
a O 0 0.02411026880145073
B B-Disease 1 0.9999728202819824
- I-Disease 1 0.9999912977218628
NHL I-Disease 1 0.9917910099029541
cell O 0 0.07564572989940643
line O 0 0.0579090341925621
. O 0 0.03621157631278038

The O 0 0.032538656145334244
evidence O 0 0.01889999955892563
of O 0 0.014276302419602871
a O 0 0.015220548957586288
significant O 0 0.011058623902499676
proportion O 0 0.015837540850043297
of O 0 0.013177207671105862
loss O 1 0.7388341426849365
- O 1 0.9999871253967285
of O 0 0.1008983850479126
- O 1 0.9999995231628418
function O 0 0.025953255593776703
mutations O 0 0.019975805655121803
and O 0 0.010473157279193401
a O 0 0.014600183814764023
complete O 0 0.0200845655053854
absence O 0 0.025765173137187958
of O 0 0.01612730324268341
the O 0 0.018703095614910126
normal O 0 0.022817429155111313
copy O 0 0.025892140343785286
of O 0 0.016844628378748894
ATM O 0 0.043848004192113876
in O 0 0.007893014699220657
the O 0 0.010623487643897533
majority O 0 0.015175501815974712
of O 0 0.025228189304471016
mutated O 1 0.9996391534805298
tumours B-Disease 1 1.0
establishes O 1 0.999991774559021
somatic O 1 0.9999771118164062
inactivation O 1 0.9999525547027588
of O 0 0.02058550715446472
this O 0 0.011590586043894291
gene O 0 0.01515440084040165
in O 0 0.008500107564032078
the O 0 0.01765133999288082
pathogenesis O 1 0.9993168115615845
of O 0 0.028495190665125847
sporadic B-Disease 1 0.9999431371688843
T I-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
PLL I-Disease 1 0.9999922513961792
and O 0 0.022379755973815918
suggests O 0 0.022124426439404488
that O 0 0.011252950876951218
ATM O 0 0.0569850318133831
acts O 0 0.026372751221060753
as O 0 0.025695987045764923
a O 1 0.5857745409011841
tumour B-Disease 1 1.0
suppressor O 1 0.9999984502792358
. O 0 0.07474187761545181

As O 0 0.03477664664387703
constitutional O 0 0.048500921577215195
DNA O 0 0.034253641963005066
was O 0 0.02158620022237301
not O 0 0.009976719506084919
available O 0 0.009461237117648125
, O 0 0.009882467798888683
a O 0 0.020498480647802353
putative O 1 0.9760860204696655
hereditary O 1 0.9999972581863403
predisposition O 1 0.999998927116394
to O 1 0.9725436568260193
T B-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.9999969005584717
will O 0 0.02316468581557274
require O 0 0.019827863201498985
further O 0 0.020475206896662712
investigation O 0 0.03944939002394676
. O 0 0.022938555106520653
. O 0 0.035131264477968216

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.999261200428009
kinase O 1 0.999210000038147
is O 0 0.02047405019402504
involved O 0 0.014401307329535484
in O 0 0.009437412954866886
the O 0 0.015194171108305454
modulation O 0 0.030021948739886284
of O 0 0.01616714894771576
the O 0 0.035582639276981354
Ca2 O 1 0.9999977350234985
+ O 1 0.9997990727424622
homeostasis O 1 0.9999828338623047
in O 0 0.16352267563343048
skeletal O 1 1.0
muscle O 1 0.9999997615814209
cells O 1 0.8858159780502319
. O 0 0.04933186620473862

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999805688858032
DM B-Disease 1 1.0
) O 0 0.026290269568562508
, O 0 0.01346354279667139
the O 0 0.014134719967842102
most O 0 0.0189084280282259
prevalent O 1 0.999998927116394
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9926292896270752
adults O 1 0.995410144329071
, O 0 0.020807906985282898
is O 0 0.014466195367276669
caused O 0 0.025570891797542572
by O 0 0.01755530573427677
( O 0 0.030314283445477486
CTG O 1 0.999997615814209
) O 0 0.02439751662313938
n O 0 0.05641518533229828
- O 1 0.9220856428146362
repeat O 0 0.039870891720056534
expansion O 0 0.02456057444214821
in O 0 0.010161222890019417
a O 0 0.0167191531509161
gene O 0 0.01956995576620102
encoding O 0 0.01880529709160328
a O 0 0.022132011130452156
protein O 0 0.03760887682437897
kinase O 1 0.7590621113777161
( O 0 0.049556318670511246
DM B-Disease 1 1.0
protein O 0 0.09905914962291718
kinase O 1 0.995913565158844
; O 0 0.02949102781713009
DMPK O 1 0.9998884201049805
) O 0 0.021614879369735718
and O 0 0.015175546519458294
involves O 0 0.0221536997705698
changes O 0 0.01567661017179489
in O 0 0.021407902240753174
cytoarchitecture O 1 0.9999028444290161
and O 0 0.05280784144997597
ion O 1 0.9996811151504517
homeostasis O 1 0.9995580315589905
. O 0 0.05781345069408417

To O 0 0.04167350381612778
obtain O 0 0.04022672772407532
clues O 0 0.03217631205916405
to O 0 0.014632518403232098
the O 0 0.01765517145395279
normal O 0 0.023141389712691307
biological O 0 0.022507794201374054
role O 0 0.024442411959171295
of O 0 0.022435225546360016
DMPK O 1 0.9999819993972778
in O 0 0.02770920842885971
cellular O 1 0.9580995440483093
ion O 1 0.9998730421066284
homeostasis O 1 0.9998595714569092
, O 0 0.016542568802833557
we O 0 0.00784141942858696
have O 0 0.005114622414112091
compared O 0 0.010816182009875774
the O 0 0.01826363056898117
resting O 1 0.9987137317657471
[ O 1 0.9567172527313232
Ca2 O 1 0.9999872446060181
+ O 1 0.9961684346199036
] O 0 0.05380821228027344
i O 0 0.020547950640320778
, O 0 0.011262185871601105
the O 0 0.013264046981930733
amplitude O 0 0.029245471581816673
and O 0 0.011581990867853165
shape O 0 0.019706880673766136
of O 0 0.02448943257331848
depolarization O 1 0.9999995231628418
- O 1 1.0
induced O 1 0.9999998807907104
Ca2 O 1 0.9999997615814209
+ O 1 0.9997408986091614
transients O 1 0.9902932643890381
, O 0 0.016155622899532318
and O 0 0.010108038783073425
the O 0 0.010609217919409275
content O 0 0.011529051698744297
of O 0 0.01631566695868969
ATP O 1 0.9999887943267822
- O 1 0.9999911785125732
driven O 0 0.2049463391304016
ion O 0 0.3734699785709381
pumps O 0 0.057764098048210144
in O 0 0.021188242360949516
cultured O 1 0.9997753500938416
skeletal O 1 0.9999990463256836
muscle O 1 0.9999152421951294
cells O 0 0.031016124412417412
of O 0 0.02019270323216915
wild O 0 0.038358837366104126
- O 1 0.9999576807022095
type O 0 0.032610975205898285
and O 0 0.02080426551401615
DMPK O 1 0.9999547004699707
[ O 1 0.9073398113250732
- O 1 0.9999982118606567
/ O 1 0.9999953508377075
- O 1 0.9999955892562866
] O 0 0.275265097618103
knockout O 1 0.9035571217536926
mice O 0 0.07707903534173965
. O 0 0.044061511754989624

In O 0 0.03293674439191818
vitro O 0 0.24037498235702515
- O 1 0.9995488524436951
differentiated O 1 0.9039706587791443
DMPK O 1 0.9999589920043945
[ O 1 0.9113690257072449
- O 1 0.9999982118606567
/ O 1 0.9999834299087524
- O 1 0.9999891519546509
] O 0 0.07208884507417679
myotubes O 1 0.893966794013977
exhibit O 0 0.030863197520375252
a O 0 0.020409703254699707
higher O 0 0.023936303332448006
resting O 1 0.9977388381958008
[ O 1 0.9471030235290527
Ca2 O 1 0.9999927282333374
+ O 1 0.9979045391082764
] O 0 0.04721570014953613
i O 0 0.01779916323721409
than O 0 0.0075058056972920895
do O 0 0.010333149693906307
wild O 0 0.026767155155539513
- O 1 0.9999476671218872
type O 1 0.5585893392562866
myotubes O 1 0.9987955093383789
because O 0 0.013276411220431328
of O 0 0.01190663781017065
an O 0 0.013645150698721409
altered O 0 0.019936153665184975
open O 0 0.01675194315612316
probability O 0 0.012848920188844204
of O 0 0.014181442558765411
voltage O 0 0.30325570702552795
- O 1 0.9996438026428223
dependent O 0 0.04487735405564308
l O 1 0.9837749004364014
- O 1 0.9999004602432251
type O 1 0.8751990795135498
Ca2 O 1 0.9999037981033325
+ O 1 0.819392204284668
and O 0 0.040594104677438736
Na O 1 0.9999728202819824
+ O 0 0.1497354805469513
channels O 0 0.04707995057106018
. O 0 0.03580072149634361

The O 0 0.06642555445432663
mutant O 0 0.192035973072052
myotubes O 1 0.9903851747512817
exhibit O 0 0.06502339988946915
smaller O 0 0.029121659696102142
and O 0 0.02674091048538685
slower O 0 0.06532051414251328
Ca2 O 1 0.9998250603675842
+ O 0 0.11974819749593735
responses O 0 0.030644915997982025
upon O 0 0.027461450546979904
triggering O 0 0.06927656382322311
by O 0 0.030465615913271904
acetylcholine O 1 0.9993890523910522
or O 0 0.027193546295166016
high O 1 0.8191074728965759
external O 1 0.954314649105072
K O 1 0.9998486042022705
+ O 1 0.6836062669754028
. O 0 0.0428457111120224

In O 0 0.03510840982198715
addition O 0 0.03084000200033188
, O 0 0.01888778619468212
we O 0 0.01268231775611639
observed O 0 0.014864061027765274
that O 0 0.00994934607297182
these O 0 0.01605617068707943
Ca2 O 1 0.9998912811279297
+ O 1 0.9984742999076843
transients O 1 0.9985905289649963
partially O 0 0.04991665855050087
result O 0 0.015929417684674263
from O 0 0.011625927872955799
an O 0 0.01429684367030859
influx O 0 0.044345173984766006
of O 0 0.029258321970701218
extracellular O 1 0.9999604225158691
Ca2 O 1 0.999967098236084
+ O 0 0.05829647555947304
through O 0 0.015038221143186092
the O 0 0.023176496848464012
l O 1 0.9996275901794434
- O 1 0.9999982118606567
type O 1 0.9956634640693665
Ca2 O 1 0.9999322891235352
+ O 0 0.24237331748008728
channel O 0 0.055057063698768616
. O 0 0.03572814539074898

Neither O 0 0.06000491604208946
the O 0 0.026846611872315407
content O 0 0.021350611001253128
nor O 0 0.02083621919155121
the O 0 0.013132124207913876
activity O 0 0.018731769174337387
of O 0 0.027328429743647575
Na O 1 0.9999986886978149
+ O 1 0.999053418636322
/ O 1 0.9996825456619263
K O 1 0.9976682066917419
+ O 1 0.82535320520401
ATPase O 1 0.9863563776016235
and O 0 0.03886363282799721
sarcoplasmic O 1 0.9999852180480957
reticulum O 1 0.9999936819076538
Ca2 O 1 0.999998927116394
+ O 1 0.9999948740005493
- O 1 0.9999991655349731
ATPase O 1 0.9990642666816711
are O 0 0.013327003456652164
affected O 0 0.028309732675552368
by O 0 0.03161904588341713
DMPK O 1 0.9999568462371826
absence O 1 0.8461737036705017
. O 0 0.055594973266124725

In O 0 0.03488083928823471
conclusion O 0 0.038255851715803146
, O 0 0.020088929682970047
our O 0 0.021180540323257446
data O 0 0.01212388090789318
suggest O 0 0.015349621884524822
that O 0 0.012097672559320927
DMPK O 1 0.9995629191398621
is O 0 0.01886025071144104
involved O 0 0.01628050208091736
in O 0 0.015928911045193672
modulating O 1 0.7523011565208435
the O 0 0.019442928954958916
initial O 0 0.022641757503151894
events O 0 0.013126199133694172
of O 0 0.019336411729454994
excitation O 1 0.9980840682983398
- O 1 0.9999990463256836
contraction O 1 0.9967136383056641
coupling O 1 0.9822555780410767
in O 0 0.04658512398600578
skeletal O 1 0.9999994039535522
muscle O 1 0.9999756813049316
. O 0 0.041053447872400284
. O 0 0.04562639445066452

Constitutional O 0 0.14335006475448608
RB1 O 1 0.9999988079071045
- O 1 0.999994158744812
gene O 0 0.07841053605079651
mutations O 0 0.03874964267015457
in O 0 0.020061733201146126
patients O 1 0.9854787588119507
with O 0 0.029818333685398102
isolated O 1 0.9996325969696045
unilateral B-Disease 1 0.999953031539917
retinoblastoma I-Disease 1 0.9999998807907104
. O 0 0.08032295852899551

In O 0 0.029372379183769226
most O 0 0.024230023846030235
patients O 0 0.43631452322006226
with O 0 0.020577311515808105
isolated O 1 0.9929311275482178
unilateral B-Disease 1 0.9999430179595947
retinoblastoma I-Disease 1 1.0
, O 1 0.9996170997619629
tumor B-Disease 1 1.0
development O 0 0.042667608708143234
is O 0 0.018779993057250977
initiated O 0 0.05742901936173439
by O 0 0.024065198376774788
somatic O 1 0.9923954010009766
inactivation O 1 0.9993917942047119
of O 0 0.021999677643179893
both O 0 0.019632168114185333
alleles O 0 0.04243830591440201
of O 0 0.026083065196871758
the O 0 0.16684052348136902
RB1 O 1 0.9999995231628418
gene O 0 0.070166677236557
. O 0 0.044567808508872986

However O 0 0.029880346730351448
, O 0 0.016879355534911156
some O 0 0.009574390947818756
of O 0 0.017620470374822617
these O 0 0.017612161114811897
patients O 1 0.9964595437049866
can O 0 0.02927166223526001
transmit O 1 0.9763192534446716
retinoblastoma B-Disease 1 0.9999996423721313
predisposition O 1 0.9999834299087524
to O 0 0.03306291997432709
their O 0 0.028082145377993584
offspring O 0 0.39082926511764526
. O 0 0.04668243229389191

To O 0 0.029487116262316704
determine O 0 0.020684590563178062
the O 0 0.017929144203662872
frequency O 0 0.01867206208407879
and O 0 0.011345394887030125
nature O 0 0.013682647608220577
of O 0 0.015610705129802227
constitutional O 0 0.39261966943740845
RB1 O 1 1.0
- O 1 0.9999997615814209
gene O 0 0.06945385783910751
mutations O 0 0.02579423226416111
in O 0 0.014042696915566921
patients O 0 0.23336878418922424
with O 0 0.017481442540884018
isolated O 1 0.9867621064186096
unilateral B-Disease 1 0.9998964071273804
retinoblastoma I-Disease 1 0.9999998807907104
, O 0 0.02293814904987812
we O 0 0.01189142744988203
analyzed O 0 0.019081560894846916
DNA O 0 0.022336257621645927
from O 0 0.02327272854745388
peripheral O 1 0.9999632835388184
blood O 1 0.9993226528167725
and O 0 0.038767796009778976
from O 1 0.9552116990089417
tumor B-Disease 1 1.0
tissue O 1 0.9998898506164551
. O 0 0.05969151854515076

The O 0 0.03495873883366585
analysis O 0 0.019074054434895515
of O 0 0.028832754120230675
tumors B-Disease 1 0.9999978542327881
from O 0 0.023829784244298935
54 O 0 0.05641726031899452
( O 0 0.0227801650762558
71 O 0 0.040925052016973495
% O 0 0.01777656190097332
) O 0 0.012113355100154877
of O 0 0.016337094828486443
76 O 0 0.12639255821704865
informative O 0 0.24514032900333405
patients O 1 0.8092186450958252
showed O 0 0.021983608603477478
loss O 0 0.02511931210756302
of O 0 0.022066956385970116
constitutional O 1 0.5823887586593628
heterozygosity O 1 0.9999996423721313
( O 1 0.9967309236526489
LOH O 1 1.0
) O 0 0.04095394164323807
at O 0 0.04243316128849983
intragenic O 1 0.9974411725997925
loci O 0 0.12097413837909698
. O 0 0.05574476718902588

Three O 0 0.029335061088204384
of O 0 0.03902074694633484
13 O 0 0.07752258330583572
uninformative O 1 0.9999597072601318
patients O 1 0.9975665807723999
had O 0 0.04676036536693573
constitutional O 0 0.09389570355415344
deletions O 1 0.572488009929657
. O 0 0.05760728195309639

For O 0 0.03719908744096756
39 O 0 0.04624713212251663
randomly O 0 0.03397929295897484
selected O 0 0.042791325598955154
tumors B-Disease 1 0.9999635219573975
, O 0 0.03137120231986046
SSCP O 1 0.9999821186065674
, O 0 0.04174695909023285
hetero O 1 0.9999988079071045
- O 1 0.999998927116394
duplex O 1 0.9998931884765625
analysis O 0 0.023067636415362358
, O 0 0.018619900569319725
sequencing O 0 0.026938483119010925
, O 0 0.014416354708373547
and O 0 0.015440157614648342
Southern O 0 0.0429636687040329
blot O 1 0.99580979347229
analysis O 0 0.01651071570813656
were O 0 0.010781281627714634
used O 0 0.012879899702966213
to O 0 0.019555889070034027
identify O 0 0.04000554978847504
mutations O 0 0.05030711367726326
. O 0 0.03685898333787918

Mutations O 0 0.06751246750354767
were O 0 0.01902749203145504
detected O 0 0.030456433072686195
in O 0 0.014420493505895138
21 O 0 0.0270075760781765
( O 0 0.021267035976052284
91 O 0 0.04059115797281265
% O 0 0.017357055097818375
) O 0 0.013850230723619461
of O 0 0.022058693692088127
23 O 0 0.4117222726345062
tumors B-Disease 1 0.9999996423721313
with O 1 0.7471241354942322
LOH O 1 1.0
. O 0 0.07728714495897293

In O 0 0.03594140335917473
6 O 0 0.04334961995482445
( O 0 0.023180754855275154
38 O 0 0.02762605808675289
% O 0 0.015179864130914211
) O 0 0.011401142925024033
of O 0 0.01446071732789278
16 O 0 0.04099753126502037
tumors B-Disease 1 0.9999998807907104
without O 0 0.39510616660118103
LOH O 1 1.0
, O 0 0.022564483806490898
one O 0 0.018146635964512825
mutation O 0 0.03301326185464859
was O 0 0.02411440946161747
detected O 0 0.027418367564678192
, O 0 0.01045754924416542
and O 0 0.009481148794293404
in O 0 0.009783589281141758
9 O 0 0.02304408885538578
( O 0 0.015187222510576248
56 O 0 0.023244651034474373
% O 0 0.0121997632086277
) O 0 0.009570322930812836
of O 0 0.013706665486097336
the O 0 0.05414905399084091
tumors B-Disease 1 1.0
without O 1 0.9252564311027527
LOH O 1 1.0
, O 0 0.033558622002601624
both O 0 0.021562177687883377
mutations O 0 0.03379383683204651
were O 0 0.01693127118051052
found O 0 0.024196427315473557
. O 0 0.030881747603416443

Thus O 0 0.03428163006901741
, O 0 0.016520783305168152
a O 0 0.013382116332650185
total O 0 0.012142181396484375
of O 0 0.014750232920050621
45 O 0 0.02492782473564148
mutations O 0 0.021286100149154663
were O 0 0.010041601955890656
identified O 0 0.01910974830389023
in O 0 0.019589398056268692
tumors B-Disease 1 0.9999924898147583
of O 0 0.051247186958789825
36 O 1 0.8416566252708435
patients O 1 0.9998020529747009
. O 0 0.054368000477552414

Thirty O 0 0.07039050757884979
- O 0 0.4468117952346802
nine O 0 0.016751809045672417
of O 0 0.014717171899974346
the O 0 0.02137763425707817
mutations O 0 0.03702394664287567
- O 1 0.9946081638336182
including O 0 0.013079379685223103
34 O 0 0.025411952286958694
small O 0 0.018097756430506706
mutations O 0 0.02259603515267372
, O 0 0.01164819486439228
2 O 0 0.018999747931957245
large O 0 0.01955575682222843
structural O 1 0.6424546837806702
alterations O 0 0.38993924856185913
, O 0 0.015409409068524837
and O 0 0.01641380600631237
hypermethylation O 1 0.9998983144760132
in O 0 0.020853029564023018
3 O 1 0.8275805711746216
tumors O 1 1.0
- O 1 0.999975323677063
were O 0 0.011728516779839993
not O 0 0.010352003388106823
detected O 0 0.01905924640595913
in O 0 0.009917382150888443
the O 0 0.023039186373353004
corresponding O 0 0.06407888978719711
peripheral O 1 0.9999986886978149
blood O 1 0.9998633861541748
DNA O 0 0.07244546711444855
. O 0 0.04274526983499527

In O 0 0.03432518243789673
6 O 0 0.04237871989607811
( O 0 0.024521296843886375
17 O 0 0.024444889277219772
% O 0 0.015298226848244667
) O 0 0.009598929435014725
of O 0 0.009478055872023106
the O 0 0.015428759157657623
36 O 0 0.03327907249331474
patients O 1 0.9930693507194519
, O 0 0.015110829845070839
a O 0 0.022011181339621544
mutation O 0 0.08726179599761963
was O 0 0.02104746364057064
detected O 0 0.019433455541729927
in O 0 0.008292586542665958
constitutional O 0 0.022613901644945145
DNA O 0 0.020583076402544975
, O 0 0.009709144942462444
and O 0 0.008086930960416794
1 O 0 0.013697760179638863
of O 0 0.01129105407744646
these O 0 0.0101867550984025
mutations O 0 0.023032622411847115
is O 0 0.013516250997781754
known O 0 0.01721915975213051
to O 0 0.012596710585057735
be O 0 0.011153939180076122
associated O 0 0.017718123272061348
with O 0 0.020110026001930237
reduced O 0 0.059403687715530396
expressivity O 1 0.9994906187057495
. O 0 0.060231711715459824

The O 0 0.0345616415143013
presence O 0 0.02981007844209671
of O 0 0.017969472333788872
a O 0 0.02259167470037937
constitutional O 0 0.050748344510793686
mutation O 0 0.250500351190567
was O 0 0.023244304582476616
not O 0 0.010814860463142395
associated O 0 0.013209694065153599
with O 0 0.009586126543581486
an O 0 0.013614095747470856
early O 0 0.02380308322608471
age O 0 0.03975202143192291
at O 0 0.08144894987344742
treatment O 1 0.999897837638855
. O 0 0.05518760159611702

In O 0 0.035603128373622894
1 O 0 0.05397462099790573
patient O 1 0.9975762963294983
, O 0 0.039024464786052704
somatic O 1 0.9993477463722229
mosaicism O 1 0.9999768733978271
was O 0 0.0400627925992012
demonstrated O 0 0.028923816978931427
by O 0 0.0161543358117342
molecular O 0 0.018043603748083115
analysis O 0 0.009862946346402168
of O 0 0.013293381780385971
DNA O 0 0.022909015417099
and O 0 0.019003301858901978
RNA O 0 0.06102714687585831
from O 0 0.03962818533182144
peripheral O 1 0.9999957084655762
blood O 1 0.9996250867843628
. O 0 0.05139019340276718

In O 0 0.03967425972223282
2 O 0 0.048836849629879
patients O 0 0.06659375131130219
without O 0 0.01663176715373993
a O 0 0.027461152523756027
detectable O 1 0.9036036133766174
mutation O 0 0.07902239263057709
in O 0 0.02611120231449604
peripheral O 1 0.9999997615814209
blood O 1 0.9999927282333374
, O 0 0.34614500403404236
mosaicism O 1 0.9999923706054688
was O 0 0.028523365035653114
suggested O 0 0.017099257558584213
because O 0 0.00943602155894041
1 O 0 0.01227192860096693
of O 0 0.009966862387955189
the O 0 0.02123618870973587
patients O 1 0.9999793767929077
showed O 1 0.9999723434448242
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.026277486234903336
the O 0 0.021069291979074478
other O 0 0.013884942047297955
later O 0 0.02615739032626152
developed O 0 0.04114021733403206
bilateral B-Disease 1 0.983472466468811
retinoblastoma I-Disease 1 0.9999990463256836
. O 0 0.06753960251808167

In O 0 0.03303074464201927
conclusion O 0 0.03653227910399437
, O 0 0.02023165114223957
our O 0 0.01897086389362812
results O 0 0.01297574769705534
emphasize O 0 0.02877109870314598
that O 0 0.008995266631245613
the O 0 0.019073868170380592
manifestation O 1 0.998390793800354
and O 0 0.029442084953188896
transmissibility O 1 0.9999970197677612
of O 0 0.49126556515693665
retinoblastoma B-Disease 1 0.9999994039535522
depend O 0 0.02440081536769867
on O 0 0.014072410762310028
the O 0 0.012666999362409115
nature O 0 0.012259559705853462
of O 0 0.009712410159409046
the O 0 0.014148521237075329
first O 0 0.020075011998414993
mutation O 0 0.030188478529453278
, O 0 0.010065482929348946
its O 0 0.009617841802537441
time O 0 0.008827874436974525
in O 0 0.009486466646194458
development O 0 0.01603776030242443
, O 0 0.011063835583627224
and O 0 0.008752129040658474
the O 0 0.010115413926541805
number O 0 0.008534294553101063
and O 0 0.009712805040180683
types O 0 0.013431848958134651
of O 0 0.02330702915787697
cells O 0 0.463858038187027
that O 0 0.01152013149112463
are O 0 0.0095297209918499
affected O 0 0.02617805264890194
. O 0 0.02232993021607399
. O 0 0.03306623175740242

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.3503047823905945
the I-Disease 1 0.5005026459693909
fifth I-Disease 1 0.9999111890792847
component I-Disease 1 0.8965854048728943
of I-Disease 0 0.027926163747906685
complement I-Disease 0 0.21671167016029358
in O 0 0.025432389229536057
man O 0 0.15794014930725098
. O 0 0.038479916751384735

I O 0 0.15800051391124725
. O 0 0.07158461958169937

Clinical O 1 0.9982138872146606
, O 0 0.05294276773929596
immunochemical O 1 0.9998575448989868
, O 0 0.03252972662448883
and O 0 0.02647511288523674
family O 0 0.05177390202879906
studies O 0 0.0327945351600647
. O 0 0.036941319704055786

The O 0 0.03020799160003662
first O 0 0.02259049564599991
recognized O 0 0.03088107518851757
human O 0 0.03501921519637108
kindred O 1 0.9999988079071045
with O 1 0.9522489905357361
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9151549935340881
the I-Disease 1 0.5809613466262817
fifth I-Disease 1 0.9998175501823425
component I-Disease 1 0.8945139050483704
of I-Disease 0 0.025062626227736473
complement I-Disease 1 0.9986977577209473
( O 0 0.4832923412322998
C5 O 1 0.9999990463256836
) O 0 0.02599150873720646
is O 0 0.0214585792273283
described O 0 0.0399729423224926
. O 0 0.03414444625377655

The O 0 0.054091788828372955
proband O 1 0.501893162727356
, O 0 0.020607227459549904
a O 0 0.019125033169984818
20 O 0 0.021560031920671463
- O 1 0.982488214969635
year O 0 0.017967116087675095
- O 1 0.9983962178230286
old O 0 0.04046304151415825
black O 0 0.05364951118826866
female O 1 0.6647093892097473
with O 1 0.9967142343521118
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999277591705322
age O 1 0.9556536078453064
11 O 0 0.03475799784064293
, O 0 0.024972906336188316
lacked O 1 0.9982860684394836
serum O 1 1.0
hemolytic O 1 1.0
complement O 1 0.9998276233673096
activity O 0 0.05478634685277939
, O 0 0.02475089393556118
even O 0 0.024571452289819717
during O 0 0.04984398931264877
remission O 1 0.9999628067016602
. O 0 0.06503603607416153

C5 O 1 0.9999256134033203
was O 0 0.09745900332927704
undetectable O 1 0.9993211030960083
in O 0 0.028190936893224716
her O 0 0.21539074182510376
serum O 1 0.999667763710022
by O 0 0.027639375999569893
both O 0 0.03157305717468262
immunodiffusion O 1 0.999969482421875
and O 0 0.3896315097808838
hemolytic O 1 1.0
assays O 1 0.6623805165290833
. O 0 0.06459695100784302

Other O 0 0.03435777127742767
complement O 0 0.05779922381043434
components O 0 0.026336638256907463
were O 0 0.010655487887561321
normal O 0 0.020936651155352592
during O 0 0.028500761836767197
remission O 1 0.9999995231628418
of O 1 0.9997003078460693
lupus O 1 1.0
, O 0 0.3449473977088928
but O 0 0.0334741435945034
C1 O 1 1.0
, O 0 0.051399435847997665
C4 O 1 0.9999960660934448
, O 0 0.04074752703309059
C2 O 1 0.9999996423721313
, O 0 0.026264864951372147
and O 0 0.03452630341053009
C3 O 1 0.9999998807907104
levels O 0 0.06741645187139511
fell O 1 0.9161832928657532
during O 0 0.09869246184825897
exacerbations O 1 0.9999890327453613
. O 0 0.07397980988025665

A O 0 0.05686822161078453
younger O 0 0.056669920682907104
half O 0 0.038823939859867096
- O 1 0.9999493360519409
sister O 1 0.6944038271903992
, O 0 0.015346336178481579
who O 0 0.016456162557005882
had O 0 0.016201891005039215
no O 0 0.02598748356103897
underlying O 1 0.9999973773956299
disease O 1 1.0
, O 1 0.5537131428718567
was O 0 0.3465946614742279
also O 0 0.011224432848393917
found O 0 0.009649433195590973
to O 0 0.014060823246836662
lack O 0 0.04680196940898895
immunochemically O 1 0.9999945163726807
detectable O 1 0.9999741315841675
C5 O 1 0.9999916553497314
. O 0 0.05719305947422981

By O 0 0.08852262049913406
hemolytic O 1 1.0
assay O 1 0.9992590546607971
, O 0 0.03165958449244499
she O 0 0.025309104472398758
exhibited O 0 0.03812215477228165
1 O 0 0.035385169088840485
- O 1 0.9961583018302917
2 O 0 0.01628977432847023
% O 0 0.008812458254396915
of O 0 0.009639168158173561
the O 0 0.01875675469636917
normal O 0 0.1359906643629074
serum O 1 0.9999992847442627
C5 O 1 0.9999996423721313
level O 0 0.035011548548936844
and O 0 0.020027166232466698
normal O 0 0.028632210567593575
concentrations O 0 0.038868408650159836
of O 0 0.020639125257730484
other O 0 0.01832844316959381
complement O 0 0.08699025213718414
components O 0 0.048719216138124466
. O 0 0.04008930176496506

C5 O 1 0.999966025352478
levels O 0 0.03916728124022484
of O 0 0.019701169803738594
other O 0 0.01309586875140667
family O 0 0.02220718190073967
members O 0 0.014080495573580265
were O 0 0.008868160657584667
either O 0 0.011996232904493809
normal O 0 0.015843665227293968
or O 0 0.01002404186874628
approximately O 0 0.011487359181046486
half O 0 0.02092815563082695
- O 1 0.9997573494911194
normal O 0 0.023488027974963188
, O 0 0.014918985776603222
consistent O 0 0.025235839188098907
with O 0 0.02137264795601368
autosomal O 1 0.99981290102005
codominant O 1 0.9999583959579468
inheritance O 0 0.2847974896430969
of O 0 0.022893650457262993
the O 0 0.038682788610458374
gene O 0 0.3621862828731537
determining O 1 0.9979666471481323
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.12707717716693878

Normal O 1 0.9608739018440247
hemolytic O 1 1.0
titers O 1 0.9998347759246826
were O 0 0.0240225438028574
restored O 0 0.04607703909277916
to O 0 0.014622580260038376
both O 0 0.016908397898077965
homozygous O 1 0.6346063017845154
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999996423721313
( O 0 0.12602056562900543
C5D B-Disease 1 0.9999995231628418
) O 0 0.03199930116534233
sera O 1 0.9781270027160645
by O 0 0.014634705148637295
addition O 0 0.014883394353091717
of O 0 0.021069897338747978
highly O 0 0.14851081371307373
purified O 1 0.9997236132621765
human O 0 0.32681477069854736
C5 O 1 0.9999748468399048
. O 0 0.059009943157434464

In O 0 0.038104381412267685
specific O 0 0.04739770293235779
C5 O 1 0.9999996423721313
titrations O 1 0.9998306035995483
, O 0 0.02359621599316597
however O 0 0.014055292122066021
, O 0 0.012357877567410469
it O 0 0.00835467129945755
was O 0 0.017022274434566498
noted O 0 0.013766473159193993
that O 0 0.0077516804449260235
when O 0 0.011229132302105427
limited O 0 0.013023601844906807
amounts O 0 0.013557842932641506
of O 0 0.024389222264289856
C5 O 1 0.9999216794967651
were O 0 0.017687710002064705
assayed O 0 0.05114644765853882
in O 0 0.010966178961098194
the O 0 0.013422728516161442
presence O 0 0.02008601278066635
of O 0 0.01928228698670864
low O 0 0.043635863810777664
dilutions O 1 0.9967341423034668
of O 0 0.02908831462264061
either O 0 0.044958870857954025
C5D B-Disease 1 1.0
serum O 1 0.999998927116394
, O 0 0.03308923915028572
curving O 0 0.2582318186759949
rather O 0 0.015162280760705471
than O 0 0.010824696160852909
linear O 0 0.035005249083042145
dose O 1 0.9998165965080261
- O 1 0.9999716281890869
response O 0 0.030386988073587418
plots O 0 0.026938458904623985
were O 0 0.010190645232796669
consistently O 0 0.027363667264580727
obtained O 0 0.019031358882784843
, O 0 0.01714460365474224
suggesting O 0 0.024833599105477333
some O 0 0.015801778063178062
inhibitory O 0 0.1303238421678543
effect O 0 0.04238651320338249
. O 0 0.03910920396447182

Further O 0 0.04088503122329712
studies O 0 0.022948216646909714
suggested O 0 0.021280568093061447
that O 0 0.011528008617460728
low O 0 0.03374435752630234
dilutions O 1 0.8581714630126953
of O 0 0.04289666563272476
C5D B-Disease 1 1.0
serum O 1 0.9999934434890747
contain O 0 0.03300991281867027
a O 0 0.032995790243148804
factor O 1 0.7362148761749268
( O 0 0.023703422397375107
or O 0 0.01759987138211727
factors O 0 0.016920574009418488
) O 0 0.014914271421730518
interfering O 0 0.030753055587410927
at O 0 0.012747041881084442
some O 0 0.006817908026278019
step O 0 0.01727902889251709
in O 0 0.010932402685284615
the O 0 0.02977328561246395
hemolytic O 1 1.0
assay O 1 0.9992708563804626
of O 0 0.4732687771320343
C5 O 1 0.9999990463256836
, O 0 0.020305851474404335
rather O 0 0.009954612702131271
than O 0 0.008096391335129738
a O 0 0.02181333489716053
true O 0 0.06517507135868073
C5 O 1 0.9999991655349731
inhibitor O 1 0.999990701675415
or O 0 0.052851270884275436
inactivator O 1 0.9988429546356201
. O 0 0.05548784136772156

Of O 0 0.054902318865060806
clinical O 1 0.9474098086357117
interest O 0 0.02308589033782482
are O 0 0.010941330343484879
( O 0 0.015864526852965355
a O 0 0.014572660438716412
) O 0 0.011045840568840504
the O 0 0.011604665778577328
documentation O 0 0.029507605358958244
of O 0 0.03806759789586067
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999786615371704
vasculitis B-Disease 1 1.0
, O 1 0.9995644688606262
and O 1 0.9999282360076904
arthritis B-Disease 1 1.0
in O 0 0.15188200771808624
an O 0 0.05391022190451622
individual O 0 0.025630967691540718
lacking O 1 0.9995468258857727
C5 O 1 0.9999998807907104
( O 0 0.01871604472398758
and O 0 0.010938374325633049
its O 0 0.01698400266468525
biologic O 1 0.9999631643295288
functions O 0 0.01875988207757473
) O 0 0.014750232920050621
, O 0 0.013241923414170742
and O 0 0.013377785682678223
( O 0 0.021755272522568703
b O 1 0.5387147665023804
) O 0 0.012551868334412575
a O 0 0.014584277756512165
remarkable O 0 0.029904143884778023
propensity O 1 0.99830162525177
to O 1 0.5562484264373779
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.055420178920030594
the O 1 0.7075410485267639
proband O 1 0.9999979734420776
, O 0 0.018036549910902977
even O 0 0.01000763475894928
during O 0 0.013105509802699089
periods O 0 0.018618375062942505
of O 0 0.017752589657902718
low O 1 0.9254593849182129
- O 1 0.9999948740005493
dose O 1 0.9719449281692505
or O 0 0.019255761057138443
alternate O 0 0.04306892305612564
- O 1 0.9999567270278931
day O 1 0.8879634141921997
corticosteroid O 1 0.9999995231628418
therapy O 1 0.9999583959579468
. O 0 0.05408703535795212

Other O 0 0.031007736921310425
observations O 0 0.02779044210910797
indicate O 0 0.016638774424791336
that O 0 0.008387446403503418
the O 0 0.01926005631685257
C5D B-Disease 1 0.9999821186065674
state O 0 0.018120622262358665
is O 0 0.017279095947742462
compatible O 0 0.035156816244125366
with O 0 0.021194515749812126
normal O 0 0.18911898136138916
coagulation O 1 0.9999986886978149
function O 0 0.028844662010669708
and O 0 0.013925314880907536
the O 0 0.01693262718617916
capacity O 0 0.020508890971541405
to O 0 0.017308924347162247
mount O 1 0.8626980781555176
a O 0 0.06313946843147278
neutrophilic O 1 0.9999998807907104
leukocytosis O 1 0.9999998807907104
during O 1 0.9999384880065918
pyogenic B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.05693522468209267
. O 0 0.04893117770552635

Susceptibility O 1 0.9996618032455444
to O 1 0.8971242904663086
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.4025920629501343
twins O 1 0.9978190660476685
: O 0 0.020151041448116302
the O 0 0.013889892026782036
role O 0 0.020957281813025475
of O 0 0.017782703042030334
genes O 0 0.0261602234095335
, O 0 0.11283453553915024
HLA O 1 1.0
, O 0 0.024737440049648285
and O 0 0.020025620236992836
the O 0 0.02797575853765011
environment O 0 0.04870026558637619
. O 0 0.03743996098637581

OBJECTIVE O 0 0.09450116008520126
To O 0 0.025504127144813538
determine O 0 0.01625148393213749
the O 0 0.01713704504072666
relative O 0 0.030645227059721947
effects O 0 0.027003193274140358
of O 0 0.020648052915930748
genetic O 0 0.031123735010623932
and O 0 0.018204176798462868
environmental O 0 0.038997042924165726
factors O 0 0.01786143146455288
in O 0 0.017613183706998825
susceptibility O 1 0.9999738931655884
to O 1 0.9998158812522888
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999725818634033
AS B-Disease 1 0.9999172687530518
) O 0 0.041728533804416656
. O 0 0.03720089793205261

METHODS O 0 0.06651291251182556
Twins O 0 0.08537580817937851
with O 0 0.020871514454483986
AS B-Disease 0 0.035159192979335785
were O 0 0.010092581622302532
identified O 0 0.012249741703271866
from O 0 0.007387669291347265
the O 0 0.011918829753994942
Royal O 0 0.11986377835273743
National O 1 0.894520103931427
Hospital O 1 1.0
for O 1 0.9999233484268188
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9963094592094421
. O 0 0.059938278049230576

Clinical O 1 0.9944456815719604
and O 0 0.05319426953792572
radiographic O 1 0.9997418522834778
examinations O 1 0.6402190327644348
were O 0 0.017310718074440956
performed O 0 0.0270867720246315
to O 0 0.01795535907149315
establish O 0 0.11904008686542511
diagnoses O 1 0.9999996423721313
, O 1 0.6130154728889465
and O 1 0.9900250434875488
disease O 1 1.0
severity O 1 0.9999992847442627
was O 1 0.9846409559249878
assessed O 0 0.0357314832508564
using O 0 0.01240268163383007
a O 0 0.017597371712327003
combination O 0 0.029369613155722618
of O 0 0.02437266707420349
validated O 0 0.07204251736402512
scoring O 0 0.04711909219622612
systems O 0 0.05664888396859169
. O 0 0.04071112349629402

HLA O 1 0.9999967813491821
typing O 0 0.11081311851739883
for O 0 0.045472100377082825
HLA O 1 0.9999998807907104
- O 1 0.9999490976333618
B27 O 1 0.9981720447540283
, O 0 0.04644189774990082
HLA O 1 1.0
- O 1 0.9999862909317017
B60 O 1 0.9973189234733582
, O 0 0.02294064499437809
and O 0 0.0295603945851326
HLA O 1 1.0
- O 1 0.9999991655349731
DR1 O 1 0.9999760389328003
was O 0 0.032439686357975006
performed O 0 0.027516651898622513
by O 0 0.01869996264576912
polymerase O 1 0.5174423456192017
chain O 0 0.04441456124186516
reaction O 0 0.02578636072576046
with O 0 0.014678123407065868
sequence O 0 0.025869792327284813
- O 1 0.9672616720199585
specific O 0 0.018685337156057358
primers O 0 0.07332876324653625
, O 0 0.020318517461419106
and O 0 0.023595508188009262
zygosity O 1 0.9945564270019531
was O 0 0.04335746914148331
assessed O 0 0.046989310532808304
using O 0 0.029495468363165855
microsatellite O 0 0.3908644914627075
markers O 0 0.0935983955860138
. O 0 0.047169942408800125

Genetic O 0 0.07269040495157242
and O 0 0.03115931525826454
environmental O 0 0.047228436917066574
variance O 0 0.039855144917964935
components O 0 0.02163628116250038
were O 0 0.00891727302223444
assessed O 0 0.017570042982697487
with O 0 0.010651339776813984
the O 0 0.019403038546442986
program O 0 0.0477980338037014
Mx O 1 0.9999854564666748
, O 0 0.01540331169962883
using O 0 0.008419588208198547
data O 0 0.007022513542324305
from O 0 0.007492780219763517
this O 0 0.0063038659282028675
and O 0 0.008314819075167179
previous O 0 0.014109333977103233
studies O 0 0.010937445797026157
of O 0 0.017904654145240784
twins O 1 0.9903196096420288
with O 0 0.030931176617741585
AS B-Disease 1 0.9437384605407715
. O 0 0.04568515345454216

RESULTS O 0 0.03163007274270058
Six O 0 0.019395427778363228
of O 0 0.021575424820184708
8 O 0 0.04740240052342415
monozygotic O 1 0.9985697269439697
( O 0 0.10231781750917435
MZ O 1 0.9999997615814209
) O 0 0.036872539669275284
twin O 0 0.3783251941204071
pairs O 0 0.028852000832557678
were O 0 0.024026798084378242
disease O 1 0.9999984502792358
concordant O 1 0.9999573230743408
, O 0 0.023438306525349617
compared O 0 0.014819341711699963
with O 0 0.010289271362125874
4 O 0 0.016286641359329224
of O 0 0.013677018694579601
15 O 0 0.027400819584727287
B27 O 1 0.9977061748504639
- O 1 0.9988157749176025
positive O 0 0.039777424186468124
dizygotic O 1 0.9983463287353516
( O 0 0.05225294083356857
DZ O 1 0.9999986886978149
) O 0 0.033319562673568726
twin O 0 0.1306888908147812
pairs O 0 0.026050612330436707
( O 0 0.022221142426133156
27 O 0 0.02671235240995884
% O 0 0.015624496154487133
) O 0 0.011751444078981876
and O 0 0.009386088699102402
4 O 0 0.01610889658331871
of O 0 0.017192494124174118
32 O 0 0.050157539546489716
DZ O 1 0.9999985694885254
twin O 1 0.9862500429153442
pairs O 0 0.030432485044002533
overall O 0 0.03541161119937897
( O 0 0.021169837564229965
12 O 0 0.021296780556440353
. O 0 0.014274874702095985
5 O 0 0.025895724073052406
% O 0 0.02379564568400383
) O 0 0.024508774280548096
. O 0 0.031093815341591835

Nonsignificant O 1 0.998019814491272
increases O 0 0.04782125726342201
in O 0 0.016071364283561707
similarity O 0 0.020817965269088745
with O 0 0.011738668195903301
regard O 0 0.020036375150084496
to O 0 0.014365541748702526
age O 0 0.057056307792663574
at O 1 0.9995385408401489
disease O 1 1.0
onset O 1 1.0
and O 0 0.020252296701073647
all O 0 0.011557342484593391
of O 0 0.021554075181484222
the O 1 0.9965554475784302
disease O 1 1.0
severity O 1 0.999997615814209
scores O 0 0.048154424875974655
assessed O 0 0.02515633963048458
were O 0 0.009434444829821587
noted O 0 0.015385092236101627
in O 0 0.017849557101726532
disease O 1 0.9999991655349731
- O 1 0.9999997615814209
concordant O 1 0.9999969005584717
MZ O 1 1.0
twins O 1 0.9134287238121033
compared O 0 0.03225408121943474
with O 0 0.032066430896520615
concordant O 1 0.9999710321426392
DZ O 1 0.9999998807907104
twins O 1 0.9944702386856079
. O 0 0.061034370213747025

HLA O 1 0.9999997615814209
- O 1 0.9999711513519287
B27 O 1 0.9986146688461304
and O 0 0.03346748650074005
B60 O 1 0.8951876163482666
were O 0 0.012695232406258583
associated O 0 0.015548434108495712
with O 0 0.013605238869786263
the O 0 0.32191550731658936
disease O 1 0.9999997615814209
in O 0 0.030626460909843445
probands O 1 0.9999915361404419
, O 0 0.016229473054409027
and O 0 0.010493031702935696
the O 0 0.012595252133905888
rate O 0 0.017791327089071274
of O 0 0.0260686744004488
disease O 1 0.9999991655349731
concordance O 1 0.9999797344207764
was O 0 0.08730527758598328
significantly O 0 0.02192259579896927
increased O 0 0.01974431611597538
among O 0 0.03525467962026596
DZ O 1 0.9999997615814209
twin O 1 0.9808201193809509
pairs O 0 0.01984352432191372
in O 0 0.00910671055316925
which O 0 0.008642837405204773
the O 0 0.01812150329351425
co O 1 0.9998315572738647
- O 1 0.9999977350234985
twin O 1 0.9964926838874817
was O 0 0.029909804463386536
positive O 0 0.02099999226629734
for O 0 0.01584940031170845
both O 0 0.024282410740852356
B27 O 1 0.9995900988578796
and O 0 0.04988405853509903
DR1 O 1 0.9998319149017334
. O 0 0.056291043758392334

Additive O 1 0.9538904428482056
genetic O 0 0.0693482905626297
effects O 0 0.03797714784741402
were O 0 0.013589933514595032
estimated O 0 0.018367396667599678
to O 0 0.015531489625573158
contribute O 0 0.027051398530602455
97 O 0 0.043549586087465286
% O 0 0.014212239533662796
of O 0 0.014414898119866848
the O 0 0.020557723939418793
population O 0 0.02560986764729023
variance O 0 0.05083738639950752
. O 0 0.0383262000977993

CONCLUSION O 0 0.18434496223926544
Susceptibility O 1 0.9969651103019714
to O 0 0.027045726776123047
AS B-Disease 0 0.3679591119289398
is O 0 0.01602189801633358
largely O 0 0.020830003544688225
genetically O 0 0.02013426274061203
determined O 0 0.01871693693101406
, O 0 0.011720339767634869
and O 0 0.009641926735639572
the O 0 0.013987177051603794
environmental O 0 0.047860149294137955
trigger O 1 0.9094218611717224
for O 0 0.017695778980851173
the O 1 0.9779798984527588
disease O 1 1.0
is O 0 0.1850513517856598
probably O 0 0.044340599328279495
ubiquitous O 0 0.4991919696331024
. O 0 0.04153227433562279

HLA O 1 1.0
- O 1 0.9999911785125732
B27 O 1 0.9849207997322083
accounts O 0 0.019134441390633583
for O 0 0.01047045923769474
a O 0 0.014781936071813107
minority O 0 0.022309010848402977
of O 0 0.015516769140958786
the O 0 0.022906845435500145
overall O 1 0.875989556312561
genetic O 1 0.5009616613388062
susceptibility O 1 0.9997876286506653
to O 0 0.03285810351371765
AS B-Disease 1 0.9167892336845398
. O 0 0.039954908192157745

Cell O 0 0.18542852997779846
cycle O 0 0.09610700607299805
- O 1 0.997875452041626
dependent O 0 0.04812191426753998
colocalization O 1 0.6539667248725891
of O 0 0.03334968164563179
BARD1 O 1 0.9999980926513672
and O 0 0.05659990385174751
BRCA1 O 1 0.999969482421875
proteins O 0 0.033962562680244446
in O 0 0.018628964200615883
discrete O 0 0.049103837460279465
nuclear O 0 0.06374363601207733
domains O 0 0.0658097118139267
. O 0 0.04022480547428131

Germ O 1 0.9999842643737793
- O 1 0.9995837807655334
line O 0 0.049239568412303925
mutations O 0 0.02669925056397915
of O 0 0.01717677339911461
the O 0 0.034712210297584534
BRCA1 O 1 0.9999961853027344
gene O 0 0.048055559396743774
predispose O 0 0.45566901564598083
women O 0 0.019208360463380814
to O 0 0.014514223672449589
early O 0 0.030315237119793892
- O 1 0.9999998807907104
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 1 0.705551266670227
compromising O 1 0.9992722868919373
the O 0 0.030723001807928085
genes O 0 0.03000178001821041
presumptive O 1 0.9998546838760376
function O 0 0.027609623968601227
as O 0 0.024335622787475586
a O 1 0.5420043468475342
tumor B-Disease 1 1.0
suppressor O 1 0.9999960660934448
. O 0 0.06449650973081589

Although O 0 0.03279021754860878
the O 0 0.032438766211271286
biochemical O 0 0.05653220787644386
properties O 0 0.034793704748153687
of O 0 0.041348397731781006
BRCA1 O 1 0.9999991655349731
polypeptides O 0 0.40515071153640747
are O 0 0.010351969860494137
not O 0 0.010683773085474968
understood O 0 0.020995624363422394
, O 0 0.011771772056818008
their O 0 0.011914589442312717
expression O 0 0.025356115773320198
pattern O 0 0.031243853271007538
and O 0 0.022911449894309044
subcellular O 0 0.12522032856941223
localization O 0 0.056689873337745667
suggest O 0 0.017052436247467995
a O 0 0.01616596430540085
role O 0 0.027796614915132523
in O 0 0.020873814821243286
cell O 1 0.9716141819953918
- O 1 0.9999786615371704
cycle O 0 0.07279551029205322
regulation O 0 0.052937813103199005
. O 0 0.036814745515584946

When O 0 0.0754459872841835
resting O 1 0.9999794960021973
cells O 0 0.09351202100515366
are O 0 0.016371259465813637
induced O 1 0.9965776801109314
to O 0 0.02447509951889515
proliferate O 1 0.7126413583755493
, O 0 0.016640866175293922
the O 0 0.016847029328346252
steady O 0 0.13882580399513245
- O 1 0.946016252040863
state O 0 0.011498773470520973
levels O 0 0.015947652980685234
of O 0 0.01869949884712696
BRCA1 O 1 0.992350161075592
increase O 0 0.016621282324194908
in O 0 0.014896088279783726
late O 0 0.048166342079639435
G1 O 1 0.9999281167984009
and O 0 0.018924975767731667
reach O 0 0.022589897736907005
a O 0 0.019938578829169273
maximum O 0 0.030022839084267616
during O 0 0.0441877543926239
S O 1 0.9992634654045105
phase O 0 0.1947023868560791
. O 0 0.04813816770911217

Moreover O 0 0.058930136263370514
, O 0 0.023610718548297882
in O 0 0.023548675701022148
S O 1 0.999840497970581
phase O 1 0.99483323097229
cells O 0 0.06362830847501755
, O 0 0.039343249052762985
BRCA1 O 1 0.9996011853218079
polypeptides O 0 0.07949749380350113
are O 0 0.01653807982802391
hyperphosphorylated O 1 0.9513363242149353
and O 0 0.024968110024929047
accumulate O 0 0.05440543591976166
into O 0 0.024195363745093346
discrete O 0 0.043934110552072525
subnuclear O 1 0.9951397180557251
foci O 1 0.9987573623657227
termed O 1 0.9572966694831848
" O 0 0.08527446538209915
BRCA1 O 1 0.998675525188446
nuclear O 0 0.09208858758211136
dots O 0 0.10855521261692047
. O 0 0.0511707067489624

" O 0 0.10825478285551071
BRCA1 O 1 0.9998236298561096
associates O 1 0.7453434467315674
in O 0 0.02493654005229473
vivo O 0 0.07597445696592331
with O 0 0.02015514299273491
a O 0 0.03484397009015083
structurally O 1 0.865071713924408
related O 0 0.04554823040962219
protein O 0 0.0548960380256176
termed O 1 0.5217251777648926
BARD1 O 1 0.9998170733451843
. O 0 0.06606262922286987

Here O 0 0.03733604773879051
we O 0 0.01719292625784874
show O 0 0.014836791902780533
that O 0 0.008040991611778736
the O 0 0.015332147479057312
steady O 0 0.050290580838918686
- O 1 0.855151891708374
state O 0 0.013717795722186565
levels O 0 0.017316941171884537
of O 0 0.02006893791258335
BARD1 O 1 0.9999886751174927
, O 0 0.018007032573223114
unlike O 0 0.018321171402931213
those O 0 0.01092962734401226
of O 0 0.027030836790800095
BRCA1 O 1 0.9999880790710449
, O 0 0.022349873557686806
remain O 0 0.02564859203994274
relatively O 0 0.02240830473601818
constant O 0 0.03957227244973183
during O 0 0.055852461606264114
cell O 1 0.9926261305809021
cycle O 1 0.8765203952789307
progression O 1 0.9983670115470886
. O 0 0.05666881054639816

However O 0 0.040889594703912735
, O 0 0.03463571146130562
immunostaining O 1 0.9590913653373718
revealed O 0 0.03872096166014671
that O 0 0.019515885040163994
BARD1 O 1 0.9992443323135376
resides O 0 0.07942212373018265
within O 0 0.03392738103866577
BRCA1 O 1 0.9975095987319946
nuclear O 0 0.054201480001211166
dots O 0 0.05283379182219505
during O 0 0.031236102804541588
S O 1 0.9723064303398132
phase O 0 0.03962972015142441
of O 0 0.018916187807917595
the O 0 0.03199712187051773
cell O 1 0.9862039089202881
cycle O 0 0.047889482229948044
, O 0 0.01510065607726574
but O 0 0.009471920318901539
not O 0 0.008534007705748081
during O 0 0.021415524184703827
the O 0 0.03705151006579399
G1 O 1 0.9999887943267822
phase O 1 0.5129054188728333
. O 0 0.04920109733939171

Nevertheless O 0 0.09746959805488586
, O 0 0.05932501703500748
BARD1 O 1 0.9999774694442749
polypeptides O 0 0.0906166285276413
are O 0 0.012216991744935513
found O 0 0.011688568629324436
exclusively O 0 0.01511028315871954
in O 0 0.00866504292935133
the O 0 0.014009750448167324
nuclear O 0 0.022172383964061737
fractions O 0 0.019872626289725304
of O 0 0.012360827066004276
both O 0 0.017125554382801056
G1 O 1 0.9999957084655762
- O 1 0.9999464750289917
and O 0 0.02843169867992401
S O 1 0.9999935626983643
- O 1 0.9999938011169434
phase O 1 0.9823251962661743
cells O 0 0.05622532218694687
. O 0 0.04099523648619652

Therefore O 0 0.05179258808493614
, O 0 0.031500834971666336
progression O 1 0.7404793500900269
to O 0 0.02935507707297802
S O 1 0.9999864101409912
phase O 1 0.5963194966316223
is O 0 0.018964184448122978
accompanied O 0 0.03503721207380295
by O 0 0.014430039562284946
the O 0 0.017704376950860023
aggregation O 0 0.04394685849547386
of O 0 0.023970533162355423
nuclear O 0 0.06194186583161354
BARD1 O 1 0.9994508624076843
polypeptides O 0 0.0916135385632515
into O 0 0.0463949553668499
BRCA1 O 1 0.9990108013153076
nuclear O 0 0.09142005443572998
dots O 0 0.10445834696292877
. O 0 0.04925166815519333

This O 0 0.03249713033437729
cell O 0 0.061305224895477295
cycle O 0 0.06668923795223236
- O 1 0.9972749352455139
dependent O 0 0.04721955582499504
colocalization O 1 0.9321281313896179
of O 0 0.03457250818610191
BARD1 O 1 0.9999951124191284
and O 0 0.03608299419283867
BRCA1 O 1 0.9979162812232971
indicates O 0 0.02894955687224865
a O 0 0.017981888726353645
role O 0 0.024788374081254005
for O 0 0.016592368483543396
BARD1 O 1 0.9996585845947266
in O 0 0.030759045854210854
BRCA1 O 1 0.9999983310699463
- O 1 0.9999996423721313
mediated O 1 0.9999969005584717
tumor B-Disease 1 0.9999998807907104
suppression O 1 0.9999943971633911
. O 0 0.07442733645439148

Ethnic O 0 0.061841487884521484
differences O 0 0.03611398860812187
in O 0 0.02194363623857498
the O 0 0.03617076948285103
HFE O 1 0.9999752044677734
codon O 0 0.31350579857826233
282 O 1 0.6233615875244141
( O 0 0.09063252806663513
Cys O 1 0.9999995231628418
/ O 1 0.9999955892562866
Tyr O 1 0.9999960660934448
) O 0 0.06115245074033737
polymorphism O 0 0.10617642104625702
. O 0 0.04612119495868683

Recent O 0 0.0399637445807457
studies O 0 0.019321082159876823
have O 0 0.00909881480038166
shown O 0 0.014586498029530048
that O 0 0.01948685571551323
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999998807907104
HH B-Disease 1 1.0
) O 0 0.04954881966114044
is O 0 0.015968551859259605
likely O 0 0.014134707860648632
to O 0 0.010869565419852734
be O 0 0.009938061237335205
caused O 0 0.020113883540034294
by O 0 0.01761682890355587
homozygosity O 1 0.9328858256340027
for O 0 0.017567003145813942
a O 0 0.030621124431490898
Cys282Tyr O 1 0.9989042282104492
mutation O 0 0.040549106895923615
in O 0 0.015391102060675621
the O 0 0.034996397793293
HFE O 1 0.9999979734420776
gene O 0 0.05595347285270691
located O 0 0.04870786890387535
4 O 0 0.04733389616012573
. O 0 0.0416773296892643

5 O 0 0.07957455515861511
Mb O 1 0.9898723363876343
telomeric O 1 0.992621898651123
to O 0 0.06987496465444565
HLA O 1 1.0
- O 1 0.9999802112579346
A O 0 0.08493690192699432
. O 0 0.047618161886930466

Population O 0 0.03208685666322708
studies O 0 0.020633356645703316
of O 0 0.017434945330023766
this O 0 0.014820504002273083
polymorphism O 0 0.04854103922843933
are O 0 0.008857784792780876
facilitated O 0 0.034283556044101715
by O 0 0.011224818415939808
the O 0 0.014733805321156979
fact O 0 0.013779272325336933
that O 0 0.0088048642501235
the O 0 0.02285771071910858
Cys282Tyr O 1 0.9999058246612549
mutation O 0 0.06909161061048508
creates O 0 0.053539518266916275
a O 0 0.04363701865077019
Rsal O 1 0.9988504648208618
restriction O 0 0.07457523792982101
site O 0 0.05569719895720482
. O 0 0.03501398116350174

We O 0 0.026095159351825714
have O 0 0.011146578937768936
studied O 0 0.017608152702450752
the O 0 0.01909589022397995
codon O 0 0.0698811486363411
282 O 0 0.2589930593967438
( O 0 0.0669800192117691
Cys O 1 0.9999997615814209
/ O 1 0.9999899864196777
Tyr O 1 0.9999973773956299
) O 0 0.03600850701332092
polymorphism O 0 0.045651875436306
in O 0 0.013175223022699356
different O 0 0.008797667920589447
ethnic O 0 0.029156863689422607
groups O 0 0.026770422235131264
. O 0 0.03696296736598015

In O 0 0.028387323021888733
agreement O 0 0.02542845346033573
with O 0 0.013691666536033154
previous O 0 0.021222498267889023
observations O 0 0.02517460286617279
the O 0 0.02862381935119629
Tyr O 1 0.9999980926513672
allele O 0 0.3224005103111267
appeared O 0 0.02206474356353283
to O 0 0.013836724683642387
be O 0 0.010247895494103432
rare O 0 0.020270470529794693
or O 0 0.01490867417305708
absent O 0 0.06747224181890488
in O 0 0.019807716831564903
Asiatic O 1 0.9999221563339233
( O 0 0.02643352560698986
Indian O 0 0.03134159371256828
, O 0 0.02072075568139553
Chinese O 0 0.03345324844121933
) O 0 0.024411316961050034
populations O 0 0.031058667227625847
. O 0 0.03240657597780228

The O 0 0.046441029757261276
highest O 0 0.09745831787586212
allele O 0 0.15521244704723358
frequency O 0 0.03009103052318096
( O 0 0.019800830632448196
7 O 0 0.021351821720600128
. O 0 0.011108264327049255
5 O 0 0.019604403525590897
% O 0 0.0172561127692461
) O 0 0.014251556247472763
was O 0 0.020235026255249977
found O 0 0.016202643513679504
in O 0 0.019035998731851578
Swedes O 0 0.08357299119234085
. O 0 0.045495014637708664

Saamis O 1 0.9991877675056458
( O 0 0.040383804589509964
2 O 0 0.034500595182180405
% O 0 0.02024238370358944
) O 0 0.016372136771678925
and O 0 0.019343974068760872
Mordvinians O 1 0.9996664524078369
( O 0 0.022653184831142426
1 O 0 0.022331634536385536
. O 0 0.011198852211236954
8 O 0 0.02069460041821003
% O 0 0.01588410511612892
) O 0 0.014147870242595673
had O 0 0.014701208099722862
significantly O 0 0.01865273527801037
lower O 0 0.020310087129473686
frequencies O 0 0.01676356978714466
of O 0 0.017218368127942085
the O 0 0.03935180604457855
Tyr O 1 0.9999953508377075
allele O 1 0.5999696850776672
. O 0 0.05309782922267914

Comparisons O 0 0.077849842607975
with O 0 0.03568214550614357
allele O 0 0.06775076687335968
frequencies O 0 0.02086258865892887
based O 0 0.015840871259570122
on O 0 0.016698189079761505
prevalence O 1 0.9013064503669739
estimates O 0 0.024170974269509315
of O 0 0.03577910736203194
HH B-Disease 1 0.9999998807907104
showed O 0 0.029767673462629318
some O 0 0.012644697912037373
disagreements O 0 0.036085344851017
with O 0 0.016255630180239677
the O 0 0.02746950462460518
RFLP O 1 0.9997300505638123
data O 0 0.01856994442641735
, O 0 0.01741783134639263
particularly O 0 0.02232152223587036
in O 0 0.02564333751797676
Finns O 0 0.11772175878286362
. O 0 0.04939676821231842

The O 0 0.04798685014247894
newly O 0 0.09936130046844482
described O 0 0.0816408321261406
HFE O 1 0.9999955892562866
marker O 1 0.9819504022598267
provides O 0 0.026383601129055023
a O 0 0.017885882407426834
new O 0 0.015659134835004807
approach O 0 0.015080444514751434
to O 0 0.009118380025029182
the O 0 0.013287308625876904
screening O 0 0.04709998145699501
of O 0 0.03933127224445343
HH B-Disease 1 1.0
as O 0 0.02079952321946621
well O 0 0.012239325791597366
as O 0 0.009364110417664051
studies O 0 0.008407704532146454
of O 0 0.009513629600405693
the O 0 0.014556070789694786
relationship O 0 0.022604357451200485
between O 0 0.01865553669631481
the O 0 0.035784173756837845
HFE O 1 0.9999998807907104
Tyr O 1 0.9999998807907104
allele O 1 0.825237512588501
and O 0 0.02871662564575672
different O 0 0.025534750893712044
disorders O 1 0.9999990463256836
including O 1 0.9156702160835266
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9998501539230347
dominant I-Disease 1 0.9999735355377197
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.06570056825876236
with O 0 0.02205176092684269
a O 0 0.02869141846895218
missense O 0 0.10850692540407181
mutation O 0 0.04163521155714989
encoding O 0 0.03595729544758797
Gly23 O 1 0.9993858337402344
- O 1 0.9999966621398926
- O 1 0.9999934434890747
> O 1 0.9910575151443481
Val O 1 0.9936740398406982
in O 0 0.04089885950088501
neurophysin O 1 0.9994640946388245
II O 1 0.9999823570251465
. O 0 0.06415101885795593

Autosomal B-Disease 1 0.9996998310089111
dominant I-Disease 1 0.9999654293060303
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9985584616661072
ADNDI B-Disease 1 0.9999998807907104
) O 0 0.022240182384848595
is O 0 0.015011073090136051
an O 0 0.0961136519908905
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999980926513672
by O 1 0.9959718585014343
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.9796069860458374
the O 1 0.9979780316352844
magnocellular O 1 0.9999998807907104
neurons O 0 0.05084389075636864
of O 0 0.020866254344582558
the O 0 0.04169667139649391
hypothalamus O 1 0.9998136162757874
leading O 0 0.1448117047548294
to O 0 0.021766530349850655
decreased O 0 0.03974619880318642
ability O 0 0.017616011202335358
to O 0 0.013415714725852013
produce O 0 0.016034932807087898
the O 0 0.02987581491470337
hormone O 1 0.9998618364334106
arginine O 1 0.9999011754989624
vasopressin O 1 0.9999836683273315
( O 0 0.16525140404701233
AVP O 1 0.999992847442627
) O 0 0.050416916608810425
. O 0 0.04307945817708969

Affected O 0 0.06742794811725616
individuals O 0 0.021326687186956406
are O 0 0.009040560573339462
not O 0 0.015131624415516853
symptomatic O 1 0.9999959468841553
at O 0 0.21526890993118286
birth O 1 0.9946432113647461
, O 0 0.016222570091485977
but O 0 0.012298033572733402
usually O 0 0.018080316483974457
develop O 1 0.9146422147750854
diabetes B-Disease 1 1.0
insipidus I-Disease 1 1.0
at O 0 0.19807560741901398
1 O 0 0.09552343189716339
- O 1 0.9997492432594299
6 O 0 0.05304180458188057
yr O 1 0.992201566696167
of O 0 0.03770386427640915
age O 0 0.04986470565199852
. O 0 0.04538806155323982

The O 0 0.042942337691783905
genetic O 0 0.037804313004016876
locus O 0 0.07061904668807983
of O 0 0.02190963551402092
the O 0 0.22540029883384705
disease O 1 0.9999964237213135
is O 0 0.017359323799610138
the O 0 0.02683933451771736
AVP O 1 1.0
- O 1 0.999998927116394
neurophysin O 1 0.999995231628418
II O 1 0.9999997615814209
( O 0 0.05479253828525543
NPII O 1 0.9999973773956299
) O 0 0.022886715829372406
gene O 0 0.021876808255910873
, O 0 0.013585944660007954
and O 0 0.014765194617211819
mutations O 0 0.026420699432492256
that O 0 0.014346979558467865
cause O 1 0.998594343662262
ADNDI B-Disease 1 0.9999996423721313
have O 0 0.011463812552392483
been O 0 0.010335056111216545
found O 0 0.007788005750626326
in O 0 0.006221835035830736
both O 0 0.007903177291154861
the O 0 0.015750661492347717
signal O 0 0.030052628368139267
peptide O 0 0.027502378448843956
of O 0 0.011763487942516804
the O 0 0.021090839058160782
prepro O 1 0.9999673366546631
- O 1 0.999998927116394
AVP O 1 0.9999997615814209
- O 1 0.9999964237213135
NPII O 1 0.9999924898147583
precursor O 0 0.4386371374130249
and O 0 0.020658334717154503
within O 0 0.03187338262796402
NPII O 1 0.9998470544815063
itself O 0 0.0612809881567955
. O 0 0.044840916991233826

An O 0 0.045093100517988205
affected O 0 0.05380141735076904
girl O 1 0.9438310265541077
who O 0 0.02694380283355713
presented O 0 0.026290787383913994
at O 0 0.01802343875169754
9 O 0 0.020620830357074738
months O 0 0.015204483643174171
of O 0 0.014720465056598186
age O 0 0.022268613800406456
and O 0 0.016042841598391533
her O 0 0.17352066934108734
similarly O 0 0.0861382856965065
affected O 0 0.05122171342372894
younger O 1 0.9635868072509766
brother O 1 0.9970118999481201
and O 0 0.02311418019235134
father O 0 0.47018033266067505
were O 0 0.01081179641187191
all O 0 0.009952418506145477
found O 0 0.009195683524012566
to O 0 0.00813169777393341
have O 0 0.005544440820813179
a O 0 0.01352111529558897
novel O 0 0.03135253116488457
missense O 0 0.0919446051120758
mutation O 0 0.04088163375854492
( O 0 0.02598773129284382
G1758 O 1 0.9998171925544739
- O 1 0.9999996423721313
- O 1 0.9999995231628418
> O 1 0.99981290102005
T O 1 0.9883217215538025
) O 0 0.01621350273489952
encoding O 0 0.016917800530791283
the O 0 0.016189387068152428
amino O 0 0.028427353128790855
acid O 0 0.04089350998401642
substitution O 0 0.05527685210108757
Gly23 O 1 0.9999279975891113
- O 1 0.9999988079071045
- O 1 0.9999954700469971
> O 1 0.9927079081535339
Val O 1 0.996232807636261
within O 0 0.055879659950733185
NPII O 1 0.9984343647956848
. O 0 0.0664927214384079

The O 0 0.05885637551546097
mutation O 0 0.07010302692651749
was O 0 0.03699309751391411
confirmed O 0 0.0316455103456974
by O 0 0.02876409702003002
restriction O 0 0.07134262472391129
endonuclease O 1 0.9831158518791199
analysis O 0 0.03869037702679634
. O 0 0.03753707557916641

A O 0 0.2622970938682556
T1 O 1 0.9999797344207764
- O 1 0.9992924928665161
weighted O 0 0.06783919781446457
magnetic O 0 0.0439823754131794
resonance O 0 0.04009728506207466
imaging O 0 0.029544778168201447
of O 0 0.015349061228334904
the O 0 0.02754848077893257
fathers O 1 0.9999836683273315
pituitary O 1 1.0
gland O 1 0.9999995231628418
demonstrates O 1 0.9209932088851929
an O 0 0.15452882647514343
attenuated O 1 0.9999997615814209
posterior O 1 0.999998927116394
pituitary O 1 0.9999998807907104
bright O 1 0.998542070388794
spot O 1 0.7303866744041443
. O 0 0.05615272745490074

This O 0 0.03896728903055191
mutation O 0 0.07350041717290878
may O 0 0.019625524058938026
be O 0 0.008973432704806328
valuable O 0 0.016472239047288895
for O 0 0.010501138865947723
developing O 0 0.019164875149726868
models O 0 0.01591360941529274
of O 0 0.02471209689974785
dominantly B-Disease 1 0.9999998807907104
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.03068171627819538
as O 0 0.014335406012833118
the O 0 0.011245631612837315
early O 0 0.01248972862958908
age O 0 0.01558169350028038
of O 0 0.0284279715269804
onset O 1 1.0
of O 1 0.999985933303833
symptoms O 1 1.0
suggests O 1 0.8380202054977417
that O 0 0.011548652313649654
this O 0 0.013299104757606983
mutation O 0 0.14981763064861298
may O 0 0.014453352428972721
be O 0 0.011239037849009037
particularly O 0 0.019704671576619148
deleterious O 0 0.06368737667798996
to O 0 0.02420767769217491
the O 0 0.04368354752659798
magnocellular O 1 0.9999973773956299
neuron O 1 0.9990479350090027
. O 0 0.035323210060596466
. O 0 0.03739022836089134

Frequent O 0 0.1149638295173645
inactivation O 1 0.9968340992927551
of O 0 0.07820143550634384
PTEN O 1 0.9999995231628418
/ O 1 0.9999866485595703
MMAC1 O 1 0.9999934434890747
in O 0 0.056126244366168976
primary O 1 0.9999966621398926
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.6981959342956543

Sporadic B-Disease 1 0.9999973773956299
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.04807243123650551
the O 0 0.021774059161543846
most O 0 0.01525141391903162
common O 1 0.6590245962142944
male B-Disease 1 0.999987006187439
cancer I-Disease 1 0.9999998807907104
in O 0 0.013233165256679058
the O 0 0.01612919196486473
Western O 0 0.02795657329261303
world O 0 0.027468711137771606
, O 0 0.011456601321697235
yet O 0 0.008431135676801205
many O 0 0.005363354459404945
of O 0 0.009798550046980381
the O 0 0.015643611550331116
major O 0 0.03570453077554703
genetic O 0 0.02127298153936863
events O 0 0.010804546065628529
involved O 0 0.011039888486266136
in O 0 0.009240204468369484
the O 0 0.01761692762374878
progression O 1 0.9970088601112366
of O 0 0.016751352697610855
this O 0 0.014562022872269154
often O 0 0.031983934342861176
fatal O 1 1.0
cancer B-Disease 1 1.0
remain O 0 0.07940227538347244
to O 0 0.0269403625279665
be O 0 0.02512037567794323
elucidated O 0 0.43447446823120117
. O 0 0.04807399585843086

Numerous O 0 0.07249245792627335
cytogenetic O 1 0.9979152083396912
and O 0 0.04488016664981842
allelotype O 1 0.9999434947967529
studies O 0 0.020803624764084816
have O 0 0.009684483520686626
reported O 0 0.016182323917746544
frequent O 0 0.027163347229361534
loss O 0 0.029982691630721092
of O 0 0.02755751460790634
heterozygosity O 1 0.999984622001648
on O 0 0.034044425934553146
chromosomal O 1 0.9995393753051758
arm O 1 0.9991418123245239
10q O 1 0.9998683929443359
in O 0 0.04183942452073097
sporadic B-Disease 1 0.9999990463256836
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8977667689323425

Deletion O 0 0.21621429920196533
mapping O 0 0.056443966925144196
studies O 0 0.021635767072439194
have O 0 0.01196679100394249
unambiguously O 0 0.051928482949733734
identified O 0 0.01763732358813286
a O 0 0.015570718795061111
region O 0 0.02127792313694954
of O 0 0.023581912741065025
chromosome O 1 0.6220405697822571
10q23 O 1 0.9949658513069153
to O 0 0.01592474989593029
be O 0 0.010110113769769669
the O 0 0.015195954591035843
minimal O 0 0.029822377488017082
area O 0 0.02311115153133869
of O 0 0.025531457737088203
loss O 1 0.7472878694534302
. O 0 0.045073848217725754

A O 0 0.06065801903605461
new O 0 0.06448814272880554
tumor B-Disease 1 0.9999991655349731
suppressor O 1 0.999988317489624
gene O 0 0.06092512235045433
, O 0 0.040401943027973175
PTEN O 1 0.9999988079071045
/ O 1 0.9999872446060181
MMAC1 O 1 0.999996542930603
, O 0 0.025390785187482834
was O 0 0.028167830780148506
isolated O 0 0.04092845693230629
recently O 0 0.022077608853578568
at O 0 0.012332586571574211
this O 0 0.007934615015983582
region O 0 0.017264826223254204
of O 0 0.020332759246230125
chromosome O 1 0.7927687764167786
10q23 O 1 0.9991115927696228
and O 0 0.016197331249713898
found O 0 0.010455884970724583
to O 0 0.011196455918252468
be O 0 0.009829298593103886
inactivated O 0 0.4531356394290924
by O 0 0.013701381161808968
mutation O 0 0.02493632212281227
in O 0 0.014884323813021183
three O 0 0.2741144299507141
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999909400939941
lines O 0 0.06773805618286133
. O 0 0.044615548104047775

We O 0 0.032130297273397446
screened O 0 0.09489482641220093
80 O 1 0.9225888848304749
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999997615814209
by O 0 0.05080246925354004
microsatellite O 1 0.9992817044258118
analysis O 0 0.01999109610915184
and O 0 0.015313713811337948
found O 0 0.019698066636919975
chromosome O 0 0.055720970034599304
10q23 O 1 0.7821820378303528
to O 0 0.020665250718593597
be O 0 0.014789354056119919
deleted O 0 0.03630160540342331
in O 0 0.01689489558339119
23 O 0 0.040941767394542694
cases O 0 0.041505493223667145
. O 0 0.04647110402584076

We O 0 0.035863298922777176
then O 0 0.02615492418408394
proceeded O 0 0.03781449422240257
with O 0 0.01470125000923872
sequence O 0 0.013580878265202045
analysis O 0 0.0077508557587862015
of O 0 0.009254821576178074
the O 0 0.017611954361200333
entire O 0 0.14268986880779266
PTEN O 1 0.9999998807907104
/ O 1 0.999995231628418
MMAC1 O 1 0.9999977350234985
coding O 0 0.07716194540262222
region O 0 0.031177200376987457
and O 0 0.018049266189336777
tested O 0 0.02888917364180088
for O 0 0.015333876013755798
homozygous O 0 0.05621149763464928
deletion O 0 0.05399661883711815
with O 0 0.019446847960352898
new O 0 0.032293226569890976
intragenic O 1 0.9998350143432617
markers O 0 0.049890439957380295
in O 0 0.012877245433628559
these O 0 0.008919059298932552
23 O 0 0.02370518073439598
cases O 0 0.018882915377616882
with O 0 0.02417011745274067
10q23 O 1 0.9995755553245544
loss O 1 0.603651225566864
of O 0 0.06172608956694603
heterozygosity O 1 0.999966025352478
. O 0 0.057898953557014465

The O 0 0.03780370205640793
identification O 0 0.027011649683117867
of O 0 0.016873540356755257
the O 0 0.022322198376059532
second O 0 0.04827302694320679
mutational O 1 0.9996871948242188
event O 0 0.026724910363554955
in O 0 0.01179171446710825
10 O 0 0.014788993634283543
( O 0 0.015011814422905445
43 O 0 0.024472812190651894
% O 0 0.021613989025354385
) O 0 0.03154411166906357
tumors B-Disease 1 0.9999972581863403
establishes O 1 0.9999865293502808
PTEN O 1 1.0
/ O 1 0.9999852180480957
MMAC1 O 1 0.999954104423523
as O 0 0.019590195268392563
a O 0 0.023597227409482002
main O 0 0.039953239262104034
inactivation O 1 0.9896315932273865
target O 0 0.022255541756749153
of O 0 0.019461615011096
10q O 1 0.9869005084037781
loss O 0 0.05082370340824127
in O 0 0.03530805930495262
sporadic B-Disease 1 0.9999995231628418
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.32646557688713074
. O 0 0.05225318670272827

Risk O 1 0.8412980437278748
reversals O 1 0.6791945695877075
in O 0 0.03000740334391594
predictive O 0 0.07666999101638794
testing O 0 0.05693946033716202
for O 0 0.27955886721611023
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.26236647367477417

The O 0 0.02945862151682377
first O 0 0.02353750355541706
predictive O 0 0.045000750571489334
testing O 0 0.029831884428858757
for O 0 0.04189528897404671
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9977433681488037
HD B-Disease 1 0.9999773502349854
) O 0 0.02003270573914051
was O 0 0.018747026100754738
based O 0 0.011211125180125237
on O 0 0.009481601417064667
analysis O 0 0.009831340983510017
of O 0 0.01546176802366972
linked O 0 0.054817844182252884
polymorphic O 1 0.9574073553085327
DNA O 0 0.04198380559682846
markers O 0 0.03341110423207283
to O 0 0.012792554683983326
estimate O 0 0.014075586572289467
the O 0 0.013386964797973633
likelihood O 0 0.026058712974190712
of O 0 0.022516002878546715
inheriting O 1 0.9262865781784058
the O 0 0.03943081945180893
mutation O 0 0.09603621810674667
for O 0 0.03778543695807457
HD B-Disease 1 0.9984869956970215
. O 0 0.05440046638250351

Limits O 0 0.04793037846684456
to O 0 0.020723290741443634
accuracy O 0 0.023190420120954514
included O 0 0.019353164359927177
recombination O 0 0.03948376700282097
between O 0 0.014838248491287231
the O 0 0.017926855012774467
DNA O 0 0.027561664581298828
markers O 0 0.027228862047195435
and O 0 0.01201873179525137
the O 0 0.018044449388980865
mutation O 0 0.04486078768968582
, O 0 0.021213822066783905
pedigree O 1 0.9071154594421387
structure O 0 0.027853576466441154
, O 0 0.013147872872650623
and O 0 0.011282605119049549
whether O 0 0.013088788837194443
DNA O 0 0.019271543249487877
samples O 0 0.013237587176263332
were O 0 0.008146332576870918
available O 0 0.010046477429568768
from O 0 0.014950636774301529
family O 0 0.031353652477264404
members O 0 0.033168643712997437
. O 0 0.037452418357133865

With O 0 0.03264264389872551
direct O 0 0.026930509135127068
tests O 0 0.01712699979543686
for O 0 0.014387426897883415
the O 0 0.029666384682059288
HD B-Disease 1 0.9999722242355347
mutation O 0 0.08027885109186172
, O 0 0.017513075843453407
we O 0 0.009491266682744026
have O 0 0.007044259924441576
assessed O 0 0.016869427636265755
the O 0 0.01206557359546423
accuracy O 0 0.01427389495074749
of O 0 0.011208657175302505
results O 0 0.011860272847115993
obtained O 0 0.014772617258131504
by O 0 0.01894068717956543
linkage O 0 0.15741993486881256
approaches O 0 0.034545499831438065
when O 0 0.020217545330524445
requested O 0 0.029777348041534424
to O 0 0.013637502677738667
do O 0 0.011577973142266273
so O 0 0.009453822858631611
by O 0 0.0121568962931633
the O 0 0.01970951445400715
test O 0 0.03664243966341019
individuals O 0 0.029113272204995155
. O 0 0.04053596407175064

For O 0 0.031165262684226036
six O 0 0.02525349147617817
such O 0 0.01678304187953472
individuals O 0 0.01640257053077221
, O 0 0.01578560657799244
there O 0 0.012271223589777946
was O 0 0.022426988929510117
significant O 0 0.019794316962361336
disparity O 0 0.32191202044487
between O 0 0.02253013104200363
the O 0 0.031585823744535446
tests O 0 0.03963802382349968
. O 0 0.0378354974091053

Three O 0 0.02671259641647339
went O 0 0.03247721120715141
from O 0 0.017025083303451538
a O 0 0.02684275060892105
decreased O 1 0.8764005303382874
risk O 0 0.0981782004237175
to O 0 0.014778908342123032
an O 0 0.016675468534231186
increased O 0 0.08237258344888687
risk O 1 0.9374565482139587
, O 0 0.013133600354194641
while O 0 0.00974059198051691
in O 0 0.007445193827152252
another O 0 0.01174161210656166
three O 0 0.010809281840920448
the O 0 0.02300618402659893
risk O 1 0.9537519812583923
was O 0 0.20182469487190247
decreased O 1 0.6516284942626953
. O 0 0.0445832796394825

Knowledge O 0 0.04426610842347145
of O 0 0.025404660031199455
the O 0 0.025247802957892418
potential O 0 0.0288276057690382
reasons O 0 0.017176924273371696
for O 0 0.011626937426626682
these O 0 0.007566219195723534
changes O 0 0.01015862450003624
in O 0 0.010238353163003922
results O 0 0.011590219102799892
and O 0 0.011545996181666851
impact O 0 0.01839482970535755
of O 0 0.015709253028035164
these O 0 0.012726529501378536
risk O 0 0.20951886475086212
reversals O 1 0.9821908473968506
on O 0 0.01856636442244053
both O 0 0.019092388451099396
patients O 1 0.998775064945221
and O 0 0.01710984669625759
the O 0 0.0772291049361229
counseling O 1 0.9999879598617554
team O 0 0.02470962516963482
can O 0 0.011132585816085339
assist O 0 0.022297846153378487
in O 0 0.009298408403992653
the O 0 0.01235443726181984
development O 0 0.015249967575073242
of O 0 0.012958694249391556
strategies O 0 0.024338511750102043
for O 0 0.012593300081789494
the O 0 0.029926840215921402
prevention O 1 0.9999992847442627
and O 0 0.02014772780239582
, O 0 0.01487688533961773
where O 0 0.013200131244957447
necessary O 0 0.014736137352883816
, O 0 0.01205388642847538
management O 0 0.01936822198331356
of O 0 0.014296360313892365
a O 0 0.03072800487279892
risk O 1 0.5314499735832214
reversal O 0 0.32492104172706604
in O 0 0.017402835190296173
any O 0 0.02194223739206791
predictive O 0 0.06014023348689079
testing O 0 0.03972631320357323
program O 0 0.031556636095047
. O 0 0.02164200134575367
. O 0 0.03149895742535591

A O 0 0.0684623122215271
novel O 0 0.06960833072662354
common O 0 0.04532073438167572
missense O 1 0.6469727158546448
mutation O 0 0.07405548542737961
G301C O 1 0.5666825175285339
in O 0 0.014456668868660927
the O 0 0.022259896621108055
N O 0 0.38134530186653137
- O 1 0.9965992569923401
acetylgalactosamine O 1 0.9977149963378906
- O 1 0.9994760155677795
6 O 0 0.05828879028558731
- O 1 0.9999901056289673
sulfate O 1 0.9999942779541016
sulfatase O 1 0.9999974966049194
gene O 0 0.0557844340801239
in O 0 0.03298356756567955
mucopolysaccharidosis B-Disease 1 0.999873161315918
IVA I-Disease 1 0.9999964237213135
. O 0 0.07996642589569092

Mucopolysaccharidosis B-Disease 1 0.9999043941497803
IVA I-Disease 1 0.9999994039535522
( O 0 0.08592508733272552
MPS B-Disease 1 0.9996689558029175
IVA I-Disease 1 1.0
) O 0 0.02865658327937126
is O 0 0.01668422669172287
an O 0 0.026873957365751266
autosomal B-Disease 1 0.9999988079071045
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9996222257614136
by O 0 0.02684379182755947
a O 0 0.07475414127111435
genetic B-Disease 1 0.9833074808120728
defect I-Disease 1 0.9999878406524658
in O 0 0.01900501921772957
N O 1 0.906175434589386
- O 1 0.9995429515838623
acetylgalactosamine O 1 0.9998012185096741
- O 1 0.9997770190238953
6 O 0 0.06679416447877884
- O 1 0.9999974966049194
sulfate O 1 0.9999967813491821
sulfatase O 1 0.9999995231628418
( O 0 0.14780226349830627
GALNS O 1 0.9999761581420898
) O 0 0.04667479544878006
. O 0 0.039536282420158386

In O 0 0.030520757660269737
previous O 0 0.030342217534780502
studies O 0 0.021690608933568
, O 0 0.013646177016198635
we O 0 0.008876069448888302
have O 0 0.006496382877230644
found O 0 0.007713065017014742
two O 0 0.00949694775044918
common O 0 0.020314637571573257
mutations O 0 0.02902364358305931
in O 0 0.020068049430847168
Caucasians O 1 0.9990453124046326
and O 0 0.026671724393963814
Japanese O 0 0.06952804327011108
, O 0 0.02912016026675701
respectively O 0 0.04154447466135025
. O 0 0.041091687977313995

To O 0 0.044805191457271576
characterize O 0 0.0781283974647522
the O 0 0.04185381531715393
mutational O 1 0.9993809461593628
spectrum O 0 0.05143125727772713
in O 0 0.01243165135383606
various O 0 0.010886269621551037
ethnic O 0 0.020218612626194954
groups O 0 0.015825245529413223
, O 0 0.016202764585614204
mutations O 0 0.017541034147143364
in O 0 0.009662866592407227
the O 0 0.019710281863808632
GALNS O 1 0.9999573230743408
gene O 0 0.0243636816740036
in O 0 0.012413842603564262
Colombian O 1 0.5051487684249878
MPS B-Disease 1 0.9999852180480957
IVA I-Disease 1 1.0
patients O 1 0.9999610185623169
were O 0 0.02067854255437851
investigated O 0 0.07161817699670792
, O 0 0.02231753244996071
and O 0 0.020639503374695778
genetic O 0 0.029617493972182274
backgrounds O 0 0.025227559730410576
were O 0 0.012919974513351917
extensively O 0 0.02357434295117855
analyzed O 0 0.019145991653203964
to O 0 0.01359543763101101
identify O 0 0.021578257903456688
racial O 0 0.03158846125006676
origin O 0 0.013848167844116688
, O 0 0.012216834351420403
based O 0 0.014679054729640484
on O 0 0.017981138080358505
mitochondrial O 0 0.06453597545623779
DNA O 0 0.03995104134082794
( O 0 0.03381606191396713
mtDNA O 0 0.06109423190355301
) O 0 0.035035621374845505
lineages O 0 0.06739833950996399
. O 0 0.045892030000686646

Three O 0 0.038690343499183655
novel O 0 0.08293840289115906
missense O 1 0.9760914444923401
mutations O 0 0.05010064318776131
never O 0 0.02619369700551033
identified O 0 0.01940467767417431
previously O 0 0.015648333355784416
in O 0 0.009641343727707863
other O 0 0.009887629188597202
populations O 0 0.01516153384000063
and O 0 0.011842953972518444
found O 0 0.010182841680943966
in O 0 0.008911401964724064
16 O 0 0.014588224701583385
out O 0 0.01086187269538641
of O 0 0.014705470763146877
19 O 0 0.03090500272810459
Colombian O 0 0.19323699176311493
MPS B-Disease 1 0.9991136193275452
IVA I-Disease 1 0.9999998807907104
unrelated O 0 0.3439362943172455
alleles O 0 0.07064034044742584
account O 0 0.028966212645173073
for O 0 0.026527903974056244
84 O 0 0.08689235150814056
. O 0 0.046812113374471664

2 O 0 0.04895659163594246
% O 0 0.02209128625690937
of O 0 0.020040832459926605
the O 0 0.02998386137187481
alleles O 0 0.058466073125600815
in O 0 0.01937810331583023
this O 0 0.018158210441470146
study O 0 0.0330912210047245
. O 0 0.03765362128615379

The O 0 0.08106374740600586
G301C O 1 0.9856573343276978
and O 0 0.05289061740040779
S162F O 1 0.9944842457771301
mutations O 0 0.05584625154733658
account O 0 0.028550397604703903
for O 0 0.02573293447494507
68 O 0 0.07808248698711395
. O 0 0.047719843685626984

4 O 0 0.07207024097442627
% O 0 0.03566510230302811
and O 0 0.029447635635733604
10 O 0 0.03991539776325226
. O 0 0.044803887605667114

5 O 0 0.0421442911028862
% O 0 0.02234877645969391
of O 0 0.025696896016597748
mutations O 0 0.03746684268116951
, O 0 0.018562767654657364
respectively O 0 0.021785128861665726
, O 0 0.015160060487687588
whereas O 0 0.019524527713656425
the O 0 0.017013221979141235
remaining O 0 0.03493465855717659
F69V O 1 0.999911904335022
is O 0 0.018566686660051346
limited O 0 0.016289057210087776
to O 0 0.015523025766015053
a O 0 0.026793403550982475
single O 0 0.04789246246218681
allele O 0 0.09411264955997467
. O 0 0.04225815087556839

The O 0 0.06367093324661255
skewed O 0 0.10062869638204575
prevalence O 1 0.876193642616272
of O 0 0.04089193791151047
G301C O 1 0.9883168339729309
in O 0 0.019646363332867622
only O 0 0.01961100473999977
Colombian O 1 0.8651111125946045
patients O 1 0.9981485605239868
and O 0 0.029375283047556877
haplotype O 1 0.7082723379135132
analysis O 0 0.01625194028019905
by O 0 0.01569453440606594
restriction O 0 0.0360172763466835
fragment O 0 0.04541172832250595
length O 0 0.023970237001776695
polymorphisms O 0 0.0429953970015049
in O 0 0.013468870893120766
the O 0 0.02849726192653179
GALNS O 1 0.9999063014984131
gene O 0 0.03886100649833679
suggest O 0 0.02028631791472435
that O 0 0.013977551832795143
G301C O 0 0.17659881711006165
originated O 0 0.03272402286529541
from O 0 0.01675260253250599
a O 0 0.027461474761366844
common O 0 0.03889437019824982
ancestor O 0 0.26559433341026306
. O 0 0.053363535553216934

Investigation O 0 0.05478740856051445
of O 0 0.02614491432905197
the O 0 0.02753276564180851
genetic O 0 0.02960832044482231
background O 0 0.02186564728617668
by O 0 0.01309011410921812
means O 0 0.015490612015128136
of O 0 0.017888085916638374
mtDNA O 0 0.04232116788625717
lineages O 0 0.03201073780655861
indicate O 0 0.012966198846697807
that O 0 0.007306965999305248
all O 0 0.009872650727629662
our O 0 0.02498709410429001
patients O 1 0.9767954349517822
are O 0 0.010120422579348087
probably O 0 0.018185647204518318
of O 0 0.019028473645448685
native O 0 0.03358069434762001
American O 0 0.05877811461687088
descent O 0 0.17636415362358093

Low O 0 0.06525913625955582
frequency O 0 0.03365200385451317
of O 0 0.036460716277360916
BRCA1 O 1 0.999834418296814
germline O 1 0.960635244846344
mutations O 0 0.027481354773044586
in O 0 0.012294409796595573
45 O 0 0.031067976728081703
German O 1 0.9998064637184143
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9836660623550415
. O 0 0.06712987273931503

In O 0 0.02393122762441635
this O 0 0.012734477408230305
study O 0 0.011864318512380123
we O 0 0.007807521149516106
investigated O 0 0.020635154098272324
45 O 0 0.024826617911458015
German O 1 0.9990898370742798
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.6735658645629883
for O 0 0.04035968706011772
germline O 1 0.9999091625213623
mutations O 0 0.036830835044384
in O 0 0.017950264737010002
the O 0 0.039857275784015656
BRCA1 O 1 0.9999380111694336
gene O 0 0.07067888975143433
. O 0 0.0447513684630394

We O 0 0.026353983208537102
identified O 0 0.025471311062574387
four O 0 0.021196966990828514
germline O 1 0.604565441608429
mutations O 0 0.03247937560081482
in O 0 0.014757233671844006
three O 0 0.03517119958996773
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.024842916056513786
and O 0 0.011760072782635689
in O 0 0.01138788741081953
one O 0 0.05082627758383751
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999496936798096
. O 0 0.01450310368090868
among O 0 0.01238054409623146
these O 0 0.005503461696207523
were O 0 0.007540800608694553
one O 0 0.0170845165848732
frameshift O 1 0.9982348680496216
mutation O 0 0.04366833344101906
, O 0 0.0174680408090353
one O 0 0.017541125416755676
nonsense O 0 0.3631129562854767
mutation O 0 0.034541428089141846
, O 0 0.013395597226917744
one O 0 0.014307975769042969
novel O 0 0.03961074724793434
splice O 0 0.29478219151496887
site O 0 0.041375771164894104
mutation O 0 0.03977438434958458
, O 0 0.016295529901981354
and O 0 0.016912342980504036
one O 0 0.03041866421699524
missense O 0 0.3990824222564697
mutation O 0 0.08861178904771805
. O 0 0.04526688903570175

The O 0 0.06128990277647972
missense O 1 0.8820977210998535
mutation O 0 0.11310985684394836
was O 0 0.0350458025932312
also O 0 0.019077714532613754
found O 0 0.015460127964615822
in O 0 0.016745997592806816
2 O 0 0.03833477199077606
. O 0 0.03733762726187706

8 O 0 0.042578186839818954
% O 0 0.01781124621629715
of O 0 0.015523805283010006
the O 0 0.017512246966362
general O 0 0.027721095830202103
population O 0 0.01532034669071436
, O 0 0.014257063157856464
suggesting O 0 0.016065377742052078
that O 0 0.0077912150882184505
it O 0 0.00871233083307743
is O 0 0.015733160078525543
not O 0 0.021116167306900024
disease O 1 0.9999442100524902
associated O 0 0.04860832914710045
. O 0 0.046901263296604156

The O 0 0.033388182520866394
average O 0 0.02750103361904621
age O 0 0.03241383656859398
of O 1 0.980962872505188
disease O 1 1.0
onset O 1 1.0
in O 0 0.026634423062205315
those O 0 0.018568994477391243
families O 0 0.05288708209991455
harbouring O 1 0.9999998807907104
causative O 1 0.9999997615814209
mutations O 0 0.4032193720340729
was O 0 0.03720463812351227
between O 0 0.028394261375069618
32 O 0 0.05321953445672989
. O 0 0.04152962192893028

3 O 0 0.07152450829744339
and O 0 0.04617999866604805
37 O 0 0.07980231940746307
. O 0 0.05543379858136177

4 O 0 0.049327634274959564
years O 0 0.02448771707713604
, O 0 0.019252032041549683
whereas O 0 0.022323837503790855
the O 0 0.022495953366160393
family O 0 0.04399394616484642
harbouring O 1 0.9998315572738647
the O 0 0.04152950644493103
missense O 1 0.9967549443244934
mutation O 0 0.04830851033329964
had O 0 0.01673382706940174
an O 0 0.013030310161411762
average O 0 0.017088159918785095
age O 0 0.022065410390496254
of O 0 0.026552466675639153
onset O 1 0.999993085861206
of O 0 0.0558881051838398
51 O 0 0.36516687273979187
. O 0 0.05034606531262398

2 O 0 0.08226903527975082
years O 0 0.05451754480600357
. O 0 0.05055789276957512

These O 0 0.02076401561498642
findings O 0 0.023564066737890244
show O 0 0.02082616277039051
that O 0 0.018376419320702553
BRCA1 O 1 0.9999370574951172
is O 0 0.01950620673596859
implicated O 0 0.11098486185073853
in O 0 0.009649078361690044
a O 0 0.011721964925527573
small O 0 0.011171518824994564
fraction O 0 0.02435165084898472
of O 0 0.22164031863212585
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.3806314468383789
suggesting O 0 0.027960490435361862
the O 0 0.015596548095345497
involvement O 0 0.03531321883201599
of O 0 0.02302364818751812
another O 0 0.4457623362541199
susceptibility O 1 0.9999918937683105
gene O 0 0.26968318223953247
( O 0 0.045773111283779144
s O 1 0.7787790298461914
) O 0 0.056646909564733505

Paternal O 1 0.9958409667015076
transmission O 1 0.9993695616722107
of O 1 0.9999872446060181
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.999488353729248

We O 0 0.025352075695991516
report O 0 0.020838432013988495
a O 0 0.018703598529100418
rare O 0 0.022217826917767525
case O 0 0.02322734333574772
of O 0 0.03403560817241669
paternally O 1 0.9999984502792358
transmitted O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.06963686645030975
. O 0 0.04824623838067055

The O 0 0.04995713382959366
proband O 1 0.995753288269043
is O 0 0.01819661818444729
a O 0 0.016274819150567055
23 O 0 0.019391503185033798
year O 0 0.015146524645388126
old O 0 0.23192133009433746
, O 0 0.03395838662981987
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 1 0.9999802112579346
who O 1 0.9999845027923584
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9964630007743835

He O 0 0.04366398975253105
presented O 0 0.05055105686187744
with O 1 0.6266897320747375
respiratory O 1 1.0
and O 1 0.9917193651199341
feeding O 1 0.9999210834503174
difficulties O 1 0.9998810291290283
at O 1 0.974065899848938
birth O 1 0.998332679271698
. O 0 0.049812525510787964

His O 0 0.05661524087190628
two O 0 0.04182823747396469
sibs O 1 0.9999819993972778
suffer O 1 0.999596893787384
from O 0 0.3366517722606659
childhood O 1 0.9999998807907104
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.44189023971557617

Their O 0 0.030325651168823242
late O 0 0.03832223266363144
father O 0 0.04331168159842491
had O 0 0.01657123491168022
the O 0 0.016528325155377388
adult O 0 0.031669601798057556
type O 0 0.13470372557640076
of O 1 0.8884634375572205
DM B-Disease 1 1.0
, O 0 0.037281785160303116
with O 0 0.02979331463575363
onset O 1 0.9999967813491821
around O 0 0.029690666124224663
30 O 0 0.03299013152718544
years O 0 0.030962547287344933
. O 0 0.038657475262880325

Only O 0 0.02020546980202198
six O 0 0.014927833341062069
other O 0 0.008501449599862099
cases O 0 0.012578798457980156
of O 0 0.020696617662906647
paternal O 1 0.9999052286148071
transmission O 1 0.9999094009399414
of O 1 0.9999910593032837
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.032813236117362976
been O 0 0.023563744500279427
reported O 0 0.029851119965314865
recently O 0 0.04173297807574272
. O 0 0.03856271132826805

We O 0 0.025046860799193382
review O 0 0.035008929669857025
the O 0 0.02690649777650833
sex O 0 0.047607794404029846
related O 0 0.02796832285821438
effects O 0 0.03222569078207016
on O 0 0.026686223223805428
transmission O 1 0.991826057434082
of O 1 0.9995980858802795
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9616641402244568

Decreased O 0 0.17007800936698914
fertility O 1 0.5565683245658875
of O 0 0.0259555596858263
males O 0 0.024053843691945076
with O 0 0.02496514469385147
adult O 1 0.9996811151504517
onset O 1 1.0
DM B-Disease 1 1.0
and O 1 0.7059926986694336
contraction O 1 0.8393833041191101
of O 0 0.019834639504551888
the O 0 0.021868448704481125
repeat O 0 0.27016326785087585
upon O 0 0.029427966102957726
male O 1 0.7665972113609314
transmission O 0 0.19805441796779633
contribute O 0 0.022197287529706955
to O 0 0.011481708846986294
the O 0 0.01334111113101244
almost O 0 0.013825693167746067
absent O 0 0.03313087299466133
occurrence O 0 0.031542375683784485
of O 0 0.024765217676758766
paternal O 1 0.999704897403717
transmission O 1 0.9993292093276978
of O 1 0.9999454021453857
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9845506548881531

Also O 0 0.02916983887553215
the O 0 0.022453423589468002
fathers O 0 0.03916851058602333
of O 0 0.01839100942015648
the O 0 0.026908056810498238
reported O 1 0.5161986947059631
congenitally O 1 0.999996542930603
affected O 0 0.07843565940856934
children O 0 0.03629928082227707
showed O 0 0.025506148114800453
, O 0 0.016289668157696724
on O 0 0.015351438894867897
average O 0 0.019196471199393272
, O 0 0.018908046185970306
shorter O 0 0.03865997493267059
CTG O 1 0.9997376799583435
repeat O 0 0.07401277124881744
lengths O 0 0.045097269117832184
and O 0 0.019334297627210617
hence O 0 0.03336763381958008
less O 0 0.02738053724169731
severe O 1 0.9999995231628418
clinical O 1 1.0
symptoms O 1 0.9999997615814209
than O 0 0.01676189713180065
the O 0 0.024421509355306625
mothers O 1 0.9770992398262024
of O 0 0.02702186070382595
children O 1 0.989120602607727
with O 1 0.9999395608901978
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9903462529182434

We O 0 0.025592226535081863
conclude O 0 0.036222152411937714
that O 0 0.013832072727382183
paternal O 0 0.2325122356414795
transmission O 1 0.9353365302085876
of O 1 0.9997579455375671
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9838716983795166
rare O 1 0.5730207562446594
and O 0 0.02302286960184574
preferentially O 0 0.4856925308704376
occurs O 0 0.017445288598537445
with O 0 0.01801026239991188
onset O 1 0.9999990463256836
of O 1 0.9936920404434204
DM B-Disease 1 1.0
past O 0 0.03687242045998573
30 O 0 0.020202193409204483
years O 0 0.013880124315619469
in O 0 0.012482661753892899
the O 0 0.023120339959859848
father O 1 0.8178906440734863
. O 0 0.027154086157679558
. O 0 0.0341896191239357

The O 0 0.08261674642562866
RB1 O 1 0.9999895095825195
gene O 0 0.05364083871245384
mutation O 0 0.03688535839319229
in O 0 0.013598303310573101
a O 0 0.023763885721564293
child O 1 0.9816599488258362
with O 1 0.8189331889152527
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 1 0.7795154452323914

The O 0 0.07540305703878403
RB1 O 1 0.9999970197677612
gene O 0 0.07230992615222931
mutation O 0 0.04739229753613472
was O 0 0.02548651583492756
investigated O 0 0.028997231274843216
in O 0 0.011283519677817822
a O 0 0.021165529265999794
child O 0 0.4208253026008606
with O 0 0.07876169681549072
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999998807907104
using O 0 0.025769494473934174
DNA O 0 0.02249208278954029
obtained O 0 0.011136859655380249
from O 0 0.008267128840088844
both O 0 0.009793712757527828
the O 0 0.026708804070949554
pineal B-Disease 1 0.9999996423721313
and I-Disease 1 0.8443790674209595
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 1 0.7615311741828918
the O 1 0.9841486811637878
patient O 1 0.9999985694885254
. O 0 0.05585974454879761

A O 0 0.07489892840385437
nonsense O 0 0.4405646026134491
mutation O 0 0.0531965047121048
in O 0 0.021301914006471634
exon O 0 0.09746847301721573
17 O 0 0.03706729784607887
( O 0 0.026147177442908287
codon O 0 0.06346983462572098
556 O 0 0.07188066840171814
) O 0 0.01516260951757431
of O 0 0.01613222062587738
the O 0 0.033800158649683
RB1 O 1 0.9999997615814209
gene O 0 0.04017815366387367
was O 0 0.02095113880932331
found O 0 0.010134140960872173
to O 0 0.01017871405929327
be O 0 0.009263565763831139
present O 0 0.015585258603096008
homozygously O 1 0.8943116068840027
in O 0 0.01280843187123537
both O 0 0.014228844083845615
the O 0 0.03316846862435341
retinal B-Disease 1 0.9999939203262329
and I-Disease 0 0.03937442973256111
the I-Disease 1 0.9726636409759521
pineal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 0.08288327604532242

The O 0 0.041593991219997406
same O 0 0.02578214928507805
mutation O 0 0.04414726793766022
was O 0 0.028311870992183685
present O 0 0.027010509744286537
heterozygously O 1 0.9609692096710205
in O 0 0.012940398417413235
the O 0 0.01525849848985672
DNA O 0 0.016407856717705727
from O 0 0.00873082410544157
the O 0 0.012291931547224522
constitutional O 0 0.02837493270635605
cells O 0 0.020543478429317474
of O 0 0.015726646408438683
the O 0 0.04279317706823349
patient O 1 0.9999964237213135
, O 0 0.02259930968284607
proving O 0 0.04728202894330025
it O 0 0.008902325294911861
to O 0 0.010722693055868149
be O 0 0.009989360347390175
of O 0 0.021486636251211166
germline O 1 0.8090723156929016
origin O 0 0.033848464488983154
. O 0 0.038492701947689056

The O 0 0.04900415614247322
initial O 0 0.051527511328458786
mutation O 0 0.06788269430398941
was O 0 0.02892039343714714
shown O 0 0.016100924462080002
to O 0 0.011400477029383183
have O 0 0.007810912560671568
occurred O 0 0.014668256975710392
in O 0 0.010929453186690807
the O 0 0.025700032711029053
paternally O 1 0.9674138426780701
derived O 0 0.06721841543912888
RB1 O 1 0.999977707862854
allele O 0 0.1483689248561859
. O 0 0.053971707820892334

The O 0 0.051160778850317
mutation O 0 0.06124955788254738
is O 0 0.015750084072351456
in O 0 0.009495027363300323
an O 0 0.010548209771513939
area O 0 0.01288203988224268
of O 0 0.01035945676267147
the O 0 0.013526426628232002
gene O 0 0.01363193616271019
that O 0 0.006334847304970026
encodes O 0 0.019728826358914375
the O 0 0.01461218111217022
protein O 0 0.02571798861026764
- O 1 0.9723543524742126
binding O 0 0.020900484174489975
region O 0 0.017583923414349556
known O 0 0.01626981981098652
as O 0 0.012247741222381592
the O 0 0.019803514704108238
pocket O 1 0.9936308264732361
region O 0 0.02523927018046379
and O 0 0.013381934724748135
has O 0 0.013506151735782623
been O 0 0.01191492099314928
detected O 0 0.020053114742040634
in O 0 0.009182524867355824
other O 0 0.009475387632846832
cases O 0 0.01989545114338398
of O 0 0.06938907504081726
retinoblastoma B-Disease 1 1.0
. O 0 0.04657382890582085
. O 0 0.04660053551197052

Low O 0 0.05944003909826279
levels O 0 0.025110848248004913
of O 0 0.024404441937804222
beta O 1 0.8581286072731018
hexosaminidase O 1 0.991820216178894
A O 0 0.03469773754477501
in O 0 0.016929762437939644
healthy O 0 0.04633767530322075
individuals O 0 0.015517613850533962
with O 0 0.02688037045300007
apparent O 1 0.9999995231628418
deficiency O 1 1.0
of O 1 0.9851183891296387
this O 0 0.057201020419597626
enzyme O 1 0.7311959862709045
. O 0 0.03987030312418938

Appreciable O 1 0.7669367790222168
beta O 1 0.7851110100746155
hexosaminidase O 1 0.9896550178527832
A O 0 0.058007899671792984
( O 0 0.03417137637734413
hex O 1 0.8387997150421143
A O 0 0.044387247413396835
) O 0 0.01926620677113533
activity O 0 0.014772582799196243
has O 0 0.009020297788083553
been O 0 0.009308487176895142
detected O 0 0.02017812989652157
in O 0 0.01631902903318405
cultured O 1 0.9997976422309875
skin O 1 0.9999996423721313
fibroblasts O 1 0.999998927116394
and O 1 0.9998846054077148
melanoma B-Disease 1 1.0
tissue O 1 0.9999998807907104
from O 1 0.8092007040977478
healthy O 1 0.9960891008377075
individuals O 0 0.014627830125391483
previously O 0 0.016520503908395767
reported O 0 0.016437988728284836
as O 0 0.017579535022377968
having O 0 0.21605591475963593
deficiency B-Disease 1 1.0
of I-Disease 0 0.22654202580451965
hex I-Disease 1 0.9999030828475952
A I-Disease 0 0.10742241144180298
activity O 0 0.023142751306295395
indistinguishable O 0 0.027961695566773415
from O 0 0.007934315130114555
that O 0 0.005533967632800341
of O 0 0.011338882148265839
patients O 1 0.8538732528686523
with O 1 0.9718353748321533
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9996803998947144
TSD B-Disease 1 1.0
) O 0 0.05272247642278671
. O 0 0.04461441934108734

Identification O 0 0.06474804878234863
and O 0 0.03423096239566803
quantitation O 1 0.6966120600700378
of O 0 0.04075390100479126
hex O 1 0.998561441898346
A O 0 0.11014872044324875
, O 0 0.028869062662124634
amounting O 0 0.04549549147486687
to O 0 0.026717042550444603
3 O 0 0.04317920655012131
. O 0 0.03824741020798683

5 O 0 0.06661050021648407
% O 0 0.05498174577951431
- O 1 0.9991804957389832
6 O 0 0.06811448931694031
. O 0 0.043872982263565063

9 O 0 0.04408709332346916
% O 0 0.01844446361064911
of O 0 0.016228659078478813
total O 0 0.025690101087093353
beta O 1 0.9043997526168823
hexosaminidase O 1 0.9995238780975342
activity O 0 0.032976679503917694
, O 0 0.015709612518548965
has O 0 0.011662543751299381
been O 0 0.011537346057593822
obtained O 0 0.015207618474960327
by O 0 0.022364148870110512
cellulose O 1 0.9985074400901794
acetate O 1 0.9999721050262451
gel O 1 0.9988623857498169
electrophoresis O 0 0.11454279720783234
, O 0 0.034802958369255066
DEAE O 1 0.9999459981918335
- O 1 0.9999712705612183
cellulose O 1 0.9989678859710693
ion O 1 0.9970443844795227
- O 1 0.9997579455375671
exchange O 0 0.054880186915397644
chromatography O 1 0.9966762065887451
, O 0 0.037973858416080475
radial O 1 0.9932581186294556
immunodiffusion O 1 0.9995019435882568
, O 0 0.0401914119720459
and O 0 0.04241883382201195
radioimmunoassay O 1 0.9974216222763062
. O 0 0.06052988022565842

Previous O 0 0.058361321687698364
family O 0 0.04906782507896423
studies O 0 0.022633332759141922
suggested O 0 0.018971504643559456
that O 0 0.009629281237721443
these O 0 0.008572888560593128
individuals O 0 0.012950963340699673
may O 0 0.012986415065824986
be O 0 0.011006775312125683
compound O 0 0.049734748899936676
heterozygotes O 0 0.1342592090368271
for O 0 0.012675047852098942
the O 0 0.019182972609996796
common O 0 0.029314808547496796
mutant O 1 0.9991483688354492
TSD B-Disease 1 0.9999998807907104
gene O 0 0.03747490048408508
and O 0 0.016258353367447853
a O 0 0.02341870218515396
rare O 0 0.0715775415301323
( O 0 0.032226260751485825
allelic O 1 0.9968746900558472
) O 0 0.03687197342514992
mutant O 1 0.5429604649543762
gene O 0 0.057472556829452515
. O 0 0.041063494980335236

Thus O 0 0.039410196244716644
, O 0 0.02117440290749073
the O 0 0.023336509242653847
postulated O 0 0.06390980631113052
rate O 0 0.03614174574613571
mutant O 1 0.7207916378974915
gene O 0 0.03504228964447975
appears O 0 0.022726131603121758
to O 0 0.012045605108141899
code O 0 0.014360855333507061
for O 0 0.010014786384999752
the O 0 0.014734108932316303
expression O 0 0.01972857676446438
of O 0 0.01541139930486679
low O 0 0.02971014752984047
amounts O 0 0.0178133063018322
of O 0 0.02552042156457901
hex O 1 0.9767107367515564
A O 0 0.06667068600654602
. O 0 0.04639332741498947

Heterozygotes O 0 0.38695546984672546
for O 0 0.025867486372590065
the O 0 0.027935216203331947
rare O 0 0.33352428674697876
mutant O 1 0.9994045495986938
may O 0 0.023379642516374588
be O 0 0.013761075213551521
indistinguishable O 0 0.041549019515514374
from O 0 0.020880015566945076
heterozygotes O 0 0.46620073914527893
for O 0 0.020226797088980675
the O 0 0.03290944546461105
common O 0 0.1286705732345581
TSD B-Disease 1 0.9999991655349731
mutant O 1 0.992334246635437
. O 0 0.06466873735189438

However O 0 0.03618135675787926
, O 0 0.02534850500524044
direct O 0 0.03326893225312233
visualization O 0 0.06653115898370743
and O 0 0.02330256626009941
quantitation O 1 0.996008038520813
of O 0 0.030277760699391365
hex O 1 0.9302977323532104
A O 0 0.02899799309670925
by O 0 0.013390984386205673
the O 0 0.014751452952623367
methods O 0 0.013747957535088062
described O 0 0.021539201959967613
may O 0 0.014017011038959026
prevent O 0 0.027101820334792137
false O 0 0.04336158558726311
- O 1 0.9999783039093018
positive O 0 0.07331693917512894
prenatal O 1 0.9999964237213135
diagnosis O 1 0.9999949932098389
of O 1 0.915915310382843
TSD B-Disease 1 1.0
in O 0 0.029738744720816612
fetuses O 1 0.8700214624404907
having O 0 0.01930818520486355
the O 0 0.018810119479894638
incomplete O 0 0.039540547877550125
hex B-Disease 1 0.9936599135398865
A I-Disease 1 0.9911407828330994
deficiency I-Disease 1 1.0
of O 0 0.03205600380897522
the O 0 0.4847710132598877
type O 1 0.9790948033332825
described O 0 0.025466864928603172
in O 0 0.011884337291121483
the O 0 0.01875070296227932
four O 0 0.030109526589512825
healthy O 0 0.4056626856327057
individuals O 0 0.05596771463751793

The O 0 0.0782354474067688
tumor B-Disease 1 0.999998927116394
suppressor O 1 0.9999914169311523
gene O 0 0.14344920217990875
Smad4 O 1 0.9999903440475464
/ O 1 0.9999923706054688
Dpc4 O 1 0.9998131394386292
is O 0 0.017563369125127792
required O 0 0.014298819936811924
for O 0 0.01740582101047039
gastrulation O 1 0.9999122619628906
and O 0 0.01888124644756317
later O 0 0.02175578474998474
for O 0 0.01953882724046707
anterior O 1 0.9985198378562927
development O 0 0.02444562502205372
of O 0 0.024416949599981308
the O 0 0.05340060591697693
mouse O 1 0.9755576848983765
embryo O 1 0.5046900510787964
. O 0 0.049588099122047424

Mutations O 0 0.052622780203819275
in O 0 0.018134452402591705
the O 0 0.03108152002096176
SMAD4 O 1 0.9999990463256836
/ O 1 0.9999995231628418
DPC4 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999996423721313
gene O 0 0.04307145997881889
, O 0 0.01483309268951416
a O 0 0.01706843636929989
key O 0 0.025324013084173203
signal O 0 0.03374669700860977
transducer O 0 0.05490284040570259
in O 0 0.01027270220220089
most O 0 0.014620478264987469
TGFbeta O 1 0.9999960660934448
- O 1 0.9999998807907104
related O 1 0.743899405002594
pathways O 1 0.7961835861206055
, O 0 0.012035450898110867
are O 0 0.005210823379456997
involved O 0 0.009015335701406002
in O 0 0.007876281626522541
50 O 0 0.016128897666931152
% O 0 0.021990064531564713
of O 1 0.9593893885612488
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.15501853823661804

Homozygous O 0 0.2301483005285263
Smad4 O 1 0.9998307228088379
mutant O 1 0.9992213249206543
mice O 1 0.9528539776802063
die O 1 0.7329509854316711
before O 0 0.03770642355084419
day O 0 0.04802417755126953
7 O 0 0.05789576470851898
. O 0 0.044223591685295105

5 O 0 0.06632400304079056
of O 0 0.05872484669089317
embryogenesis O 1 0.9706631898880005
. O 0 0.07203754782676697

Mutant O 1 0.6163612604141235
embryos O 0 0.04569905996322632
have O 0 0.01319045014679432
reduced O 0 0.025895699858665466
size O 0 0.021245943382382393
, O 0 0.01840367540717125
fail O 0 0.037357036024332047
to O 0 0.02117336355149746
gastrulate O 1 0.9866264462471008
or O 0 0.02098807506263256
express O 0 0.037830255925655365
a O 0 0.0319448746740818
mesodermal O 1 0.9999732971191406
marker O 1 0.9976528286933899
, O 0 0.021529844030737877
and O 0 0.020495064556598663
show O 0 0.04201951250433922
abnormal O 1 0.9999642372131348
visceral O 1 0.9999992847442627
endoderm O 1 0.9999964237213135
development O 0 0.09754268079996109
. O 0 0.05130353569984436

Growth B-Disease 1 0.961666464805603
retardation I-Disease 1 0.9999247789382935
of O 0 0.034728359431028366
the O 0 0.0866190493106842
Smad4 O 1 0.9999998807907104
- O 1 0.9999998807907104
deficient O 1 0.9999420642852783
embryos O 0 0.02681455947458744
results O 0 0.011638356372714043
from O 0 0.014188016764819622
reduced O 0 0.036245763301849365
cell O 1 0.6988288164138794
proliferation O 1 0.9519641399383545
rather O 0 0.02113930508494377
than O 0 0.019480286166071892
increased O 0 0.04396748170256615
apoptosis O 1 0.9926548004150391
. O 0 0.054484520107507706

Aggregation O 0 0.09097617864608765
of O 0 0.035375647246837616
mutant O 1 0.9882060885429382
Smad4 O 1 0.9999970197677612
ES O 1 0.9999982118606567
cells O 0 0.040472324937582016
with O 0 0.018516095355153084
wild O 0 0.041184451431035995
- O 1 0.9997602105140686
type O 0 0.07670512050390244
tetraploid O 1 0.9755183458328247
morulae O 1 0.9982757568359375
rescues O 1 0.9812361001968384
the O 0 0.07859057188034058
gastrulation B-Disease 1 0.9999884366989136
defect I-Disease 1 0.9999055862426758
. O 0 0.07087238132953644

These O 0 0.025089658796787262
results O 0 0.020009709522128105
indicate O 0 0.02220911905169487
that O 0 0.016569431871175766
Smad4 O 1 0.9983844757080078
is O 0 0.01696028746664524
initially O 0 0.017820090055465698
required O 0 0.01058028731495142
for O 0 0.008889086544513702
the O 0 0.015207920223474503
differentiation O 0 0.03668569400906563
of O 0 0.02008010819554329
the O 0 0.04494433104991913
visceral O 1 0.9999943971633911
endoderm O 1 0.9999738931655884
and O 0 0.019518548622727394
that O 0 0.010902749374508858
the O 0 0.024738671258091927
gastrulation B-Disease 1 0.999996542930603
defect I-Disease 1 0.9999651908874512
in O 0 0.01805715635418892
the O 0 0.028751738369464874
epiblast O 1 0.9999932050704956
is O 0 0.02230898104608059
secondary O 0 0.04139523580670357
and O 0 0.02139647677540779
non O 1 0.9993342757225037
- O 1 0.9999994039535522
cell O 1 0.6595393419265747
autonomous O 0 0.05670193210244179
. O 0 0.03735065832734108

Rescued O 0 0.22469137609004974
embryos O 0 0.0783815011382103
show O 0 0.05655413866043091
severe O 1 0.9999566078186035
anterior O 1 0.9999972581863403
truncations O 1 0.9999985694885254
, O 0 0.041455358266830444
indicating O 0 0.03206464275717735
a O 0 0.020703690126538277
second O 0 0.024797536432743073
important O 0 0.015740221366286278
role O 0 0.02695862017571926
for O 0 0.021724702790379524
Smad4 O 1 0.9999237060546875
in O 0 0.03880923613905907
anterior O 1 0.9999969005584717
patterning O 1 0.9999946355819702
during O 1 0.913942277431488
embryogenesis O 1 0.9995918869972229
. O 0 0.06462586671113968

Prevalence O 1 0.9939268231391907
of O 0 0.059904489666223526
p16 O 1 0.9977103471755981
and O 0 0.04526495188474655
CDK4 O 1 0.999984860420227
germline O 1 0.9966482520103455
mutations O 0 0.03677167743444443
in O 0 0.017243601381778717
48 O 0 0.3796219229698181
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9999762773513794
families O 0 0.040766991674900055
in O 0 0.02652314305305481
France O 0 0.07538259774446487
. O 0 0.043189406394958496

The O 0 0.05673711746931076
French O 1 0.9888096451759338
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 1 0.9823242425918579
Group O 1 0.8847933411598206
. O 0 0.04171665757894516

Germline O 1 0.982585072517395
mutations O 0 0.05441324785351753
in O 0 0.0195029117166996
the O 0 0.03186335787177086
p16 O 1 0.9958693385124207
and O 0 0.03720635175704956
CDK4 O 1 0.9999974966049194
genes O 0 0.023660780861973763
have O 0 0.008030243217945099
been O 0 0.009019001387059689
reported O 0 0.010474249720573425
in O 0 0.007291452493518591
a O 0 0.01621495559811592
subset O 0 0.05647146701812744
of O 0 0.09761812537908554
melanoma B-Disease 1 1.0
pedigrees O 1 0.9998698234558105
, O 0 0.021090280264616013
but O 0 0.012128610163927078
their O 0 0.015426849946379662
prevalence O 1 0.9999300241470337
is O 0 0.018371453508734703
not O 0 0.013372840359807014
well O 0 0.019124170765280724
known O 0 0.03349533677101135
. O 0 0.03295304626226425

We O 0 0.028477294370532036
searched O 0 0.04685521870851517
for O 0 0.018105564638972282
such O 0 0.017912931740283966
germline O 1 0.6954818367958069
mutations O 0 0.02861069329082966
in O 0 0.01358484011143446
48 O 0 0.03580065816640854
French O 1 0.9990666508674622
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9999752044677734
families O 0 0.028518537059426308
selected O 0 0.01876235567033291
according O 0 0.0103597491979599
to O 0 0.008744589984416962
two O 0 0.008505305275321007
major O 0 0.020541014149785042
criteria O 0 0.019964484497904778
families O 0 0.01540237944573164
with O 0 0.010362834669649601
at O 0 0.01247408241033554
least O 0 0.008234252221882343
three O 0 0.00934890192002058
affected O 0 0.01827656850218773
members O 0 0.017598923295736313
( O 0 0.023586418479681015
n O 0 0.05527413636445999
= O 0 0.04035677760839462
20 O 0 0.019414350390434265
) O 0 0.014198599383234978
or O 0 0.01051364652812481
families O 0 0.013515976257622242
with O 0 0.009198286570608616
two O 0 0.010640527121722698
affected O 0 0.01949399709701538
members O 0 0.015572823584079742
, O 0 0.01074221357703209
one O 0 0.009247230365872383
of O 0 0.010527615435421467
them O 0 0.009650025516748428
affected O 0 0.015848232433199883
before O 0 0.010905166156589985
the O 0 0.011979539878666401
age O 0 0.01600877195596695
of O 0 0.014223841950297356
50 O 0 0.02302738092839718
( O 0 0.023986347019672394
n O 0 0.05934089049696922
= O 0 0.046060577034950256
28 O 0 0.029441572725772858
) O 0 0.016742920503020287
, O 0 0.012531129643321037
and O 0 0.012079807929694653
one O 0 0.015063711442053318
additional O 0 0.023784451186656952
minor O 1 0.5163321495056152
criterion O 1 0.9991490840911865
. O 0 0.05375343933701515

Sixteen O 0 0.09090136736631393
different O 0 0.033318985253572464
p16 O 1 0.9969825148582458
germline O 1 0.9985313415527344
mutations O 0 0.04268345609307289
were O 0 0.011197401210665703
found O 0 0.01059421431273222
in O 0 0.010506615042686462
21 O 0 0.021826529875397682
families O 0 0.016567334532737732
, O 0 0.011649188585579395
while O 0 0.01181358378380537
one O 0 0.01833317242562771
germline O 1 0.9980806112289429
mutation O 0 0.06555437296628952
, O 0 0.024363169446587563
Arg24His O 1 0.9996175765991211
, O 0 0.0191202349960804
was O 0 0.023833302780985832
detected O 0 0.0270334854722023
in O 0 0.013749812729656696
the O 0 0.0298618171364069
CDK4 O 1 0.999988317489624
gene O 0 0.06305769085884094
. O 0 0.04262755811214447

The O 0 0.03870456665754318
frequency O 0 0.03241727501153946
of O 0 0.03299098461866379
p16 O 1 0.987248957157135
gene O 0 0.04074001684784889
mutation O 0 0.032430991530418396
in O 0 0.011515218764543533
our O 0 0.01991824246942997
sample O 0 0.02208733931183815
( O 0 0.01716931164264679
44 O 0 0.028248799964785576
% O 0 0.017775163054466248
) O 0 0.012647188268601894
is O 0 0.009472648613154888
among O 0 0.011947722174227238
the O 0 0.01351180113852024
highest O 0 0.03562077879905701
rates O 0 0.019255751743912697
yet O 0 0.013000967912375927
reported O 0 0.012673593126237392
and O 0 0.010474520735442638
the O 0 0.02120954357087612
CDK4 O 1 0.9999985694885254
mutation O 0 0.04457709565758705
is O 0 0.01140537392348051
the O 0 0.013292411342263222
second O 0 0.03042164072394371
mutation O 0 0.042374152690172195
detected O 0 0.026526471599936485
in O 0 0.012677984312176704
this O 0 0.014377030543982983
gene O 0 0.0335950069129467
worldwide O 0 0.03869626298546791
. O 0 0.03768644854426384

In O 0 0.035484861582517624
summary O 0 0.04626321792602539
, O 0 0.019659781828522682
our O 0 0.02124662697315216
results O 0 0.014862733893096447
show O 0 0.017697803676128387
frequent O 0 0.025329437106847763
involvement O 0 0.030873432755470276
of O 0 0.018724417313933372
the O 0 0.031802576035261154
p16 O 1 0.9998583793640137
gene O 0 0.03978554904460907
in O 0 0.029856538400053978
familial B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 0.03857753425836563
confirm O 0 0.02582571655511856
the O 0 0.013176318258047104
role O 0 0.01892285980284214
of O 0 0.013650053180754185
the O 0 0.021352391690015793
CDK4 O 1 0.999970555305481
gene O 0 0.02472827211022377
as O 0 0.015680788084864616
a O 0 0.059390027076005936
melanoma B-Disease 1 1.0
- O 1 1.0
predisposing O 1 0.9999983310699463
gene O 0 0.055944401770830154
. O 0 0.02393321692943573
. O 0 0.03357195854187012

Progression O 1 0.964487612247467
of O 0 0.07060670107603073
somatic O 1 0.9985242486000061
CTG O 1 0.9999728202819824
repeat O 0 0.18284213542938232
length O 0 0.03689422085881233
heterogeneity O 0 0.0632539764046669
in O 0 0.015266059897840023
the O 0 0.02533099427819252
blood O 1 0.9996680021286011
cells O 1 0.8960514664649963
of O 1 0.9996819496154785
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 0 0.30628353357315063

The O 0 0.039553865790367126
genetic O 0 0.027884237468242645
basis O 0 0.01932935230433941
of O 0 0.3409229815006256
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999991655349731
DM B-Disease 1 1.0
) O 0 0.02701263502240181
is O 0 0.012371962890028954
the O 0 0.012479275465011597
expansion O 0 0.02250771038234234
of O 0 0.016239190474152565
an O 0 0.02887892909348011
unstable O 1 0.999994158744812
CTG O 1 0.9999988079071045
repeat O 0 0.058296725153923035
in O 0 0.012752629816532135
the O 0 0.01703563705086708
34 O 0 0.03008652850985527
UTR O 0 0.10345378518104553
of O 0 0.022377444431185722
the O 0 0.049310073256492615
DM B-Disease 1 1.0
protein O 0 0.13761228322982788
kinase O 1 0.901637852191925
gene O 0 0.037517037242650986
on O 0 0.029980231076478958
chromosome O 0 0.06070582941174507
19 O 0 0.04886437952518463
. O 0 0.04146774485707283

One O 0 0.025350449606776237
of O 0 0.01907598040997982
the O 0 0.020431486889719963
principal O 0 0.03530256450176239
features O 0 0.017485899850726128
of O 0 0.01798023097217083
the O 1 0.5963325500488281
DM B-Disease 1 1.0
mutation O 1 0.9876019358634949
is O 0 0.016189316287636757
an O 0 0.014603545889258385
extraordinarily O 0 0.08297576010227203
high O 0 0.02557636983692646
level O 0 0.01951606757938862
of O 0 0.026819128543138504
somatic O 1 0.9999843835830688
mosaicism O 1 0.9999996423721313
, O 0 0.022013727575540543
due O 0 0.016224905848503113
to O 0 0.012179093435406685
an O 0 0.012354088947176933
extremely O 0 0.02039172500371933
high O 0 0.0240024384111166
degree O 0 0.022897973656654358
of O 0 0.07981177419424057
somatic O 1 0.9999850988388062
instability O 1 0.9992396831512451
both O 0 0.01827843487262726
within O 0 0.017979035153985023
and O 0 0.018436133861541748
between O 0 0.021163661032915115
different O 0 0.017697522416710854
tissues O 0 0.20557253062725067
. O 0 0.04089367389678955

This O 0 0.04687294363975525
instability O 1 0.9761399626731873
appears O 0 0.04583349823951721
to O 0 0.019680140540003777
be O 0 0.013732675462961197
biased O 0 0.035395894199609756
towards O 0 0.02408790960907936
further O 0 0.01698787324130535
expansion O 0 0.028273066505789757
and O 0 0.013803708367049694
continuous O 0 0.0251717958599329
throughout O 0 0.013012171722948551
the O 0 0.013387154787778854
life O 0 0.018173733726143837
of O 0 0.012705840170383453
an O 0 0.014325618743896484
individual O 0 0.013742837123572826
, O 0 0.012884471565485
features O 0 0.012782368808984756
that O 0 0.006816016044467688
could O 0 0.007881134748458862
be O 0 0.0069661736488342285
associated O 0 0.00977177545428276
with O 0 0.008698735386133194
the O 0 0.01800314523279667
progressive O 1 0.9986740350723267
nature O 0 0.02960464358329773
of O 0 0.029745886102318764
the O 1 0.9417089819908142
disease O 1 0.9999996423721313
. O 0 0.07258796691894531

Although O 0 0.0385066419839859
increasing O 0 0.03484581410884857
measured O 0 0.0352538600564003
allele O 0 0.060592737048864365
size O 0 0.025046564638614655
between O 0 0.02620731294155121
patients O 1 0.9825641512870789
clearly O 0 0.02818034403026104
correlates O 0 0.04950077086687088
with O 0 0.012304292060434818
an O 0 0.014806949533522129
increased O 0 0.02547299675643444
severity O 1 0.9999475479125977
of O 1 0.9927759170532227
symptoms O 1 0.9999998807907104
and O 0 0.020538536831736565
an O 0 0.013197125867009163
earlier O 0 0.013554954901337624
age O 0 0.020654812455177307
of O 0 0.20573335886001587
onset O 1 1.0
, O 0 0.02747398428618908
this O 0 0.013785792514681816
correlation O 0 0.030322624370455742
is O 0 0.012626784853637218
not O 0 0.00963227916508913
precise O 0 0.01660272851586342
and O 0 0.013742785900831223
measured O 0 0.0267547108232975
allele O 0 0.051654014736413956
length O 0 0.020045815035700798
cannot O 0 0.016262220218777657
be O 0 0.008074639365077019
used O 0 0.008047003298997879
as O 0 0.009731235913932323
an O 0 0.011180064640939236
accurate O 0 0.02201005257666111
predictor O 1 0.7416357398033142
of O 0 0.023619957268238068
age O 0 0.04093090072274208
of O 0 0.07206442207098007
onset O 1 0.9999997615814209
. O 0 0.08223861455917358

In O 0 0.03144657984375954
order O 0 0.02594701573252678
to O 0 0.01554907113313675
further O 0 0.018094904720783234
characterize O 0 0.03868512809276581
the O 0 0.01937766931951046
dynamics O 0 0.040395576506853104
of O 0 0.05675092339515686
DM B-Disease 1 1.0
CTG O 1 1.0
repeat O 1 0.99997878074646
somatic O 1 0.9999426603317261
instability O 1 0.9990076422691345
, O 0 0.022632744163274765
we O 0 0.011871671304106712
have O 0 0.008622564375400543
studied O 0 0.020649218931794167
repeat O 0 0.03580481931567192
length O 0 0.014410744421184063
changes O 0 0.009418148547410965
over O 0 0.009942734614014626
time O 0 0.011206390336155891
in O 0 0.017626406624913216
111 O 1 0.9999933242797852
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999997615814209
with O 0 0.16672144830226898
varying O 0 0.04957515373826027
clinical O 1 0.9999711513519287
severity O 1 0.999993085861206
and O 1 0.6117417812347412
CTG O 1 0.9999995231628418
repeat O 0 0.15419578552246094
size O 0 0.021532991901040077
over O 0 0.014050654135644436
time O 0 0.012492147274315357
intervals O 0 0.017621155828237534
of O 0 0.017372293397784233
1 O 0 0.038987793028354645
- O 1 0.9992432594299316
7 O 0 0.03959139436483383
years O 0 0.029613107442855835
. O 0 0.03397566080093384

We O 0 0.02550131268799305
have O 0 0.010529558174312115
found O 0 0.01144943293184042
a O 0 0.016966529190540314
direct O 0 0.02660219557583332
progression O 1 0.9744823575019836
of O 0 0.01983746513724327
the O 0 0.023911746218800545
size O 0 0.02447899617254734
heterogeneity O 0 0.05985530465841293
over O 0 0.016751684248447418
time O 0 0.013471703045070171
related O 0 0.014948812313377857
to O 0 0.014378841035068035
initial O 0 0.036990851163864136
CTG O 1 0.9999946355819702
repeat O 0 0.11625441908836365
size O 0 0.02086752839386463
and O 0 0.012987378984689713
the O 0 0.017076848074793816
time O 0 0.017777258530259132
interval O 0 0.04098142310976982
and O 0 0.01913401111960411
always O 0 0.024858737364411354
biased O 0 0.04386439174413681
towards O 0 0.0323030948638916
further O 0 0.028348468244075775
expansion O 0 0.05708104744553566
. O 0 0.043345727026462555

Attempts O 0 0.06290178000926971
to O 0 0.02677658572793007
mathematically O 0 0.04268869012594223
model O 0 0.02918042615056038
the O 0 0.019855905324220657
dynamics O 0 0.03336428105831146
have O 0 0.010206096805632114
proved O 0 0.02254393696784973
only O 0 0.012467282824218273
partially O 0 0.037852175533771515
successful O 0 0.025911888107657433
suggesting O 0 0.021125392988324165
that O 0 0.008481072261929512
individual O 0 0.010608903132379055
specific O 0 0.01163427159190178
genetic O 0 0.024639682844281197
and O 0 0.02823997475206852
/ O 1 0.999996542930603
or O 0 0.022196447476744652
environmental O 0 0.06032771244645119
factors O 0 0.015044090338051319
also O 0 0.008564106188714504
play O 0 0.009403088130056858
a O 0 0.01481962762773037
role O 0 0.029026944190263748
in O 0 0.02524224855005741
somatic O 1 0.9998728036880493
mosaicism O 1 0.9999951124191284
. O 0 0.040093209594488144
. O 0 0.03943246230483055

Aspartylglucosaminuria B-Disease 1 0.9998669624328613
among O 0 0.07266740500926971
Palestinian O 0 0.12115668505430222
Arabs O 0 0.11568570137023926
. O 0 0.06586646288633347

Aspartylglucosaminuria B-Disease 1 0.999998927116394
( O 1 0.9821182489395142
AGU B-Disease 1 1.0
) O 0 0.026683883741497993
is O 0 0.01569526270031929
a O 0 0.021492425352334976
rare O 1 0.7749882936477661
disorder B-Disease 1 1.0
of I-Disease 1 0.9998440742492676
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 0.9999966621398926
caused O 0 0.37794995307922363
by O 0 0.019358450546860695
the O 0 0.09474503993988037
deficiency B-Disease 1 1.0
of I-Disease 0 0.03297983482480049
the I-Disease 1 0.8109866976737976
lysosomal I-Disease 1 1.0
enzyme I-Disease 1 0.9998834133148193
aspartylglucosaminidase I-Disease 1 0.9999970197677612
( O 0 0.09079203009605408
AGA O 1 0.9999953508377075
) O 0 0.05397407338023186
. O 0 0.04600365087389946

AGU B-Disease 1 0.9999992847442627
is O 0 0.04516810178756714
inherited O 1 0.9393172264099121
as O 0 0.028977690264582634
an O 0 0.17671248316764832
autosomal O 1 1.0
recessive O 1 1.0
trait O 1 0.9999982118606567
and O 0 0.17062914371490479
occurs O 0 0.02173278108239174
with O 0 0.013842855580151081
a O 0 0.01946735940873623
high O 0 0.03467417135834694
frequency O 0 0.01790323667228222
in O 0 0.010217336006462574
Finland O 0 0.030392415821552277
because O 0 0.011811267584562302
of O 0 0.01577748917043209
a O 0 0.03517022356390953
founder O 1 0.9993280172348022
effect O 0 0.04620974138379097
. O 0 0.04190640524029732

While O 0 0.03573847562074661
very O 0 0.022612931206822395
few O 0 0.023764733225107193
patients O 1 0.995096743106842
with O 0 0.19401691854000092
AGU B-Disease 1 1.0
have O 0 0.013049125671386719
been O 0 0.011590312235057354
reported O 0 0.013500701636075974
from O 0 0.011565608903765678
non O 0 0.13730527460575104
- O 1 0.9998514652252197
Finnish O 0 0.10326224565505981
origin O 0 0.01276550255715847
, O 0 0.012237884104251862
we O 0 0.014542574994266033
diagnosed O 1 0.9999995231628418
the O 1 0.9189005494117737
disorder O 1 1.0
in O 0 0.026298491284251213
8 O 0 0.4062853455543518
patients O 1 0.994442880153656
originating O 0 0.03498325124382973
from O 0 0.01625661365687847
3 O 0 0.024762356653809547
unrelated O 0 0.031073082238435745
families O 0 0.019274111837148666
, O 0 0.012408267706632614
all O 0 0.010506723076105118
Palestinian O 0 0.03541450574994087
Arabs O 0 0.03345315903425217
from O 0 0.014596384018659592
the O 0 0.01828678324818611
region O 0 0.026012642309069633
of O 0 0.028926534578204155
Jerusalem O 1 0.8808164000511169
. O 0 0.051042668521404266

The O 0 0.05714474245905876
clinical O 1 0.999884843826294
diagnosis O 1 0.9999998807907104
of O 1 0.9999659061431885
AGU B-Disease 1 1.0
is O 0 0.27678558230400085
often O 0 0.0189764816313982
difficult O 0 0.018879221752285957
, O 0 0.01298012025654316
in O 0 0.009135749191045761
particular O 0 0.011454938910901546
early O 0 0.011673485860228539
in O 0 0.008096391335129738
the O 0 0.011913864873349667
course O 0 0.017193064093589783
of O 0 0.016615040600299835
the O 1 0.9917894601821899
disease O 1 1.0
, O 0 0.017544157803058624
and O 0 0.00996475014835596
most O 0 0.007633499801158905
of O 0 0.013171873986721039
the O 1 0.8906225562095642
patients O 1 0.9999994039535522
are O 0 0.01596939004957676
diagnosed O 1 0.9999997615814209
after O 0 0.03577037528157234
the O 0 0.021083591505885124
age O 0 0.026175379753112793
of O 0 0.023328084498643875
5 O 0 0.030216779559850693
years O 0 0.02952776849269867
. O 0 0.03768392279744148

However O 0 0.03775949403643608
, O 0 0.024078914895653725
since O 0 0.02438880316913128
these O 0 0.01866229623556137
patients O 1 0.9979463219642639
excrete O 1 0.9988571405410767
early O 0 0.026991764083504677
large O 0 0.016957562416791916
amounts O 0 0.01483264472335577
of O 0 0.019501829519867897
aspartylglucosamine O 1 0.9975200295448303
in O 0 0.02459816448390484
urine O 0 0.21417348086833954
, O 0 0.02729225717484951
biochemical O 0 0.077179454267025
screening O 0 0.157818004488945
is O 0 0.019335037097334862
easy O 0 0.0299144946038723
by O 0 0.02902851812541485
urine O 1 0.9872642755508423
chromatography O 1 0.9983962178230286
. O 0 0.0317237488925457
. O 0 0.03781286999583244

Detection O 0 0.08357443660497665
of O 0 0.03048442304134369
heterozygous O 0 0.055290475487709045
carriers O 0 0.03421434387564659
of O 0 0.02014928311109543
the O 0 0.05120784416794777
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.07367007434368134
ATM O 1 0.9650754928588867
) O 0 0.020270703360438347
gene O 0 0.02086707204580307
by O 0 0.02339046075940132
G2 O 1 0.9999940395355225
phase O 1 0.9033983945846558
chromosomal O 1 0.9993731379508972
radiosensitivity O 1 0.9999431371688843
of O 1 0.9830548763275146
peripheral O 1 1.0
blood O 1 0.9999982118606567
lymphocytes O 1 0.9999969005584717
. O 0 0.07420305907726288

In O 0 0.05233900249004364
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 0.04612799361348152
A B-Disease 1 0.9999306201934814
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.03300243988633156
patients O 1 0.9519472718238831
, O 0 0.016703763976693153
mutations O 0 0.018578948453068733
in O 0 0.008573495782911777
a O 0 0.016016313806176186
single O 0 0.026041418313980103
gene O 0 0.024564675986766815
, O 0 0.0180500615388155
ATM O 0 0.2879822254180908
, O 0 0.010683834552764893
result O 0 0.008942071348428726
in O 0 0.010204005055129528
an O 0 0.03475525602698326
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 1 0.6308314800262451
embraces O 1 0.9999202489852905
a O 0 0.02327551692724228
variety O 0 0.013841943815350533
of O 0 0.0192946195602417
clinical O 1 0.9979779124259949
features O 0 0.027744077146053314
and O 0 0.02335498295724392
manifests O 1 0.9998654127120972
extreme O 1 0.9996742010116577
radiosensitivity O 1 0.9999878406524658
and O 0 0.019430339336395264
a O 0 0.02012541890144348
strong O 0 0.030459709465503693
pre O 1 0.9980307221412659
- O 1 0.9999932050704956
disposition O 1 0.9984128475189209
to O 0 0.05196960270404816
malignancy B-Disease 1 0.9999982118606567
. O 0 0.053053807467222214

Heterozygotes O 0 0.25111091136932373
for O 0 0.028849905356764793
the O 0 0.0343770794570446
ATM O 1 0.9942958950996399
gene O 0 0.02670045755803585
have O 0 0.00843186117708683
no O 0 0.012840009294450283
clinical O 0 0.030969703570008278
expression O 0 0.017818361520767212
of O 0 0.016183797270059586
A B-Disease 1 0.9999909400939941
- I-Disease 1 1.0
T I-Disease 1 0.9999995231628418
but O 0 0.015092333778738976
may O 0 0.015131892636418343
be O 0 0.01706383004784584
cancer B-Disease 1 0.9999994039535522
prone O 1 0.999907374382019
with O 0 0.017176274210214615
a O 0 0.02417673170566559
moderate O 1 0.9112178683280945
increase O 0 0.0178367979824543
in O 0 0.015604441985487938
in O 0 0.022030899301171303
vitro O 1 0.9378954172134399
radiosensitivity O 1 0.998394787311554
. O 0 0.052037883549928665

We O 0 0.033249061554670334
performed O 0 0.04154188558459282
a O 0 0.037552621215581894
blind O 1 0.9992725253105164
chromosomal O 1 0.7992302775382996
analysis O 0 0.01737585850059986
on O 0 0.02528911456465721
G2 O 1 0.9999998807907104
- O 1 0.9999933242797852
phase O 1 0.9886562824249268
lymphocytes O 1 0.9970569610595703
from O 0 0.0136022437363863
7 O 0 0.02054135873913765
unrelated O 0 0.03203710541129112
A B-Disease 1 0.9995748400688171
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
patients O 1 0.9726938605308533
, O 0 0.014203805476427078
13 O 0 0.021313808858394623
obligate O 1 0.5463445782661438
A B-Disease 1 0.9998688697814941
- I-Disease 1 1.0
T I-Disease 1 0.9999997615814209
heterozygotes O 1 0.9992000460624695
( O 0 0.02117106132209301
parents O 0 0.020269053056836128
of O 0 0.015170827507972717
the O 0 0.09200307726860046
patients O 1 0.9999855756759644
) O 0 0.017106158658862114
, O 0 0.011835145764052868
and O 0 0.010091162286698818
14 O 0 0.016229672357439995
normal O 0 0.016063177958130836
controls O 0 0.023673847317695618
following O 0 0.022753842175006866
X O 1 0.9987851977348328
- O 1 0.999854326248169
irradiation O 0 0.09708443284034729
with O 0 0.018651671707630157
1 O 0 0.038733020424842834
Gy O 1 0.9933515191078186
in O 0 0.016373954713344574
order O 0 0.021191224455833435
to O 0 0.017680121585726738
evaluate O 0 0.03705831617116928
this O 0 0.01587117835879326
cytogenetic O 0 0.43160709738731384
method O 0 0.021681027486920357
as O 0 0.015355720184743404
a O 0 0.02185307815670967
tool O 0 0.03742297738790512
for O 0 0.019358612596988678
detection O 0 0.05323999002575874
of O 0 0.0389791838824749
ATM O 1 0.9976565837860107
carriers O 0 0.08166893571615219
. O 0 0.04265677183866501

Both O 0 0.037172213196754456
A B-Disease 1 0.9842586517333984
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999998807907104
homozygotes O 1 0.9999699592590332
and O 0 0.03373756259679794
heterozygotes O 1 0.9757769703865051
showed O 0 0.026271410286426544
significantly O 0 0.021042611449956894
increased O 0 0.015578906051814556
levels O 0 0.016864383593201637
of O 0 0.024785449728369713
radiation O 1 0.9999979734420776
- O 1 1.0
induced O 1 0.9999997615814209
chromatid O 1 0.9999997615814209
damage O 1 0.8842797875404358
relative O 0 0.03108983300626278
to O 0 0.014468841254711151
that O 0 0.009869029745459557
of O 0 0.019543267786502838
normal O 0 0.0410148911178112
controls O 0 0.0600116141140461
. O 0 0.04255245253443718

These O 0 0.0199093297123909
results O 0 0.014340789057314396
show O 0 0.014239027164876461
that O 0 0.007643511984497309
the O 0 0.02278686873614788
G2 O 1 0.9999997615814209
- O 1 0.9999948740005493
phase O 1 0.9981971383094788
chromosomal O 1 0.9999667406082153
radiosensitivity O 1 0.9999934434890747
assay O 1 0.8429538607597351
can O 0 0.012375785037875175
be O 0 0.007152744103223085
used O 0 0.006809317972511053
for O 0 0.007439374923706055
the O 0 0.012206103652715683
detection O 0 0.029453257098793983
of O 0 0.022127743810415268
A B-Disease 1 0.9999121427536011
- I-Disease 1 1.0
T I-Disease 1 0.999997615814209
heterozygotes O 1 0.9751182794570923
. O 0 0.053743768483400345

In O 0 0.03747626766562462
combination O 0 0.050048697739839554
with O 0 0.026926076039671898
molecular O 0 0.04510893300175667
genetic O 0 0.030299386009573936
analyses O 0 0.023222142830491066
, O 0 0.012807472608983517
this O 0 0.009262634441256523
test O 0 0.020825523883104324
may O 0 0.010715683922171593
be O 0 0.0058723376132547855
of O 0 0.008194359950721264
value O 0 0.007989808917045593
in O 0 0.007704785093665123
studies O 0 0.011345170438289642
of O 0 0.01953839883208275
familial B-Disease 1 0.9999997615814209
and I-Disease 1 0.8098152875900269
sporadic I-Disease 1 0.9999855756759644
cancers I-Disease 1 0.9999997615814209
aimed O 0 0.27754852175712585
at O 0 0.020463362336158752
determination O 0 0.030590903013944626
of O 0 0.011305665597319603
the O 0 0.012616035528481007
potential O 0 0.016646280884742737
involvement O 0 0.025687098503112793
of O 0 0.021656017750501633
ATM O 1 0.9998249411582947
mutations O 0 0.05227579176425934
in O 0 0.03748534247279167
tumor B-Disease 1 1.0
risk O 1 0.9999090433120728
or O 0 0.03282679617404938
development O 0 0.037219416350126266
. O 0 0.024776354432106018
. O 0 0.03310924023389816

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
telangiectasia I-Disease 1 0.999998927116394
: O 0 0.04157373309135437
identification O 0 0.029055260121822357
and O 0 0.014999665319919586
detection O 0 0.030216241255402565
of O 0 0.023458998650312424
founder O 1 0.9999805688858032
- O 1 0.999988317489624
effect O 0 0.02420203946530819
mutations O 0 0.01979736238718033
in O 0 0.010388883762061596
the O 0 0.020617825910449028
ATM O 1 0.9885278940200806
gene O 0 0.026601875200867653
in O 0 0.01691376231610775
ethnic O 0 0.036651428788900375
populations O 0 0.043495967984199524
. O 0 0.04343412443995476

To O 0 0.03605028986930847
facilitate O 0 0.04500045254826546
the O 0 0.025599928572773933
evaluation O 0 0.04465126618742943
of O 0 0.029854213818907738
ATM O 1 0.9975681900978088
heterozygotes O 1 0.9696727395057678
for O 0 0.026135873049497604
susceptibility O 1 0.9811570048332214
to O 0 0.02051394060254097
other O 0 0.020194843411445618
diseases O 1 0.9999988079071045
, O 0 0.017956504598259926
such O 0 0.013183160685002804
as O 1 0.999619722366333
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.44998231530189514
we O 0 0.010382100008428097
have O 0 0.007121856790035963
attempted O 0 0.020506974309682846
to O 0 0.010828608646988869
define O 0 0.019872106611728668
the O 0 0.013373230583965778
most O 0 0.013693032786250114
common O 0 0.019609877839684486
mutations O 0 0.018662147223949432
and O 0 0.009181591682136059
their O 0 0.008669639937579632
frequencies O 0 0.014441348612308502
in O 0 0.01676657423377037
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.036776695400476456
A B-Disease 1 0.9997977614402771
- I-Disease 1 1.0
T I-Disease 1 0.9999992847442627
) O 0 0.030127178877592087
homozygotes O 0 0.12496551126241684
from O 0 0.018176432698965073
10 O 0 0.022852515801787376
ethnic O 0 0.038096360862255096
populations O 0 0.04425552487373352
. O 0 0.04282037541270256

Both O 0 0.04885558411478996
genomic O 0 0.0936310738325119
mutations O 0 0.045607440173625946
and O 0 0.01986098289489746
their O 0 0.019443560391664505
effects O 0 0.03877243399620056
on O 0 0.030195051804184914
cDNA O 0 0.08986987173557281
were O 0 0.027312563732266426
characterized O 0 0.07036421447992325
. O 0 0.04659704864025116

Protein O 0 0.1015898734331131
- O 1 0.9824618697166443
truncation O 0 0.09326645731925964
testing O 0 0.02266319841146469
of O 0 0.014466822147369385
the O 0 0.018384715542197227
entire O 0 0.0411478616297245
ATM O 1 0.7190373539924622
cDNA O 0 0.0915285050868988
detected O 0 0.04416832700371742
92 O 0 0.05682726204395294
( O 0 0.024738291278481483
66 O 0 0.04358962923288345
% O 0 0.02280261553823948
) O 0 0.023545319214463234
truncating O 0 0.4127857983112335
mutations O 0 0.035305388271808624
in O 0 0.02039908990263939
140 O 0 0.058267977088689804
mutant O 0 0.45216700434684753
alleles O 0 0.11608979851007462
screened O 0 0.1292714625597
. O 0 0.058955077081918716

The O 0 0.055239684879779816
haplotyping O 1 0.9991187453269958
of O 0 0.042097873985767365
patients O 1 0.9960224628448486
with O 0 0.02362923137843609
identical O 0 0.03842300921678543
mutations O 0 0.03485315293073654
indicates O 0 0.02099003456532955
that O 0 0.007006418891251087
almost O 0 0.007624650839716196
all O 0 0.006926369853317738
of O 0 0.009573856368660927
these O 0 0.006274541839957237
represent O 0 0.012772317975759506
common O 0 0.017893262207508087
ancestry O 0 0.02233499102294445
and O 0 0.012242693454027176
that O 0 0.008781693875789642
very O 0 0.011719169095158577
few O 0 0.017051365226507187
spontaneously O 1 0.7813231945037842
recurring O 1 0.9999619722366333
ATM O 1 0.9999258518218994
mutations O 0 0.0658567026257515
exist O 0 0.034549519419670105
. O 0 0.04093261435627937

Assays O 0 0.10029478371143341
requiring O 0 0.046385254710912704
minimal O 0 0.04559297859668732
amounts O 0 0.020855175331234932
of O 0 0.02388572134077549
genomic O 0 0.05262235179543495
DNA O 0 0.02960824780166149
were O 0 0.011860350146889687
designed O 0 0.02404613047838211
to O 0 0.01443058904260397
allow O 0 0.023153960704803467
rapid O 0 0.06695614010095596
screening O 0 0.08353090286254883
for O 0 0.023515330627560616
common O 0 0.032989758998155594
ethnic O 0 0.052879348397254944
mutations O 0 0.06984148919582367
. O 0 0.04409763589501381

These O 0 0.03747202455997467
rapid O 0 0.09527783840894699
assays O 0 0.07129468768835068
detected O 0 0.050608087331056595
mutations O 0 0.02680595964193344
in O 0 0.012496041133999825
76 O 0 0.037083856761455536
% O 0 0.01490786112844944
of O 0 0.017274415120482445
Costa O 1 0.681766927242279
Rican O 1 0.9998623132705688
patients O 1 0.9999575614929199
( O 0 0.026370074599981308
3 O 0 0.02229408361017704
) O 0 0.012898464687168598
, O 0 0.009494748897850513
50 O 0 0.011002860963344574
% O 0 0.009148473851382732
of O 0 0.013412786647677422
Norwegian O 0 0.47670087218284607
patients O 1 0.9996297359466553
( O 0 0.02220086194574833
1 O 0 0.023271197453141212
) O 0 0.012415905483067036
, O 0 0.008563394658267498
25 O 0 0.009856331162154675
% O 0 0.008987518027424812
of O 0 0.015044556930661201
Polish O 1 0.9999918937683105
patients O 1 0.9999974966049194
( O 0 0.030528178438544273
4 O 0 0.026628663763403893
) O 0 0.013325962238013744
, O 0 0.009146139957010746
and O 0 0.007730163633823395
14 O 0 0.013245569542050362
% O 0 0.010265263728797436
of O 0 0.014626345597207546
Italian O 1 0.9998262524604797
patients O 1 0.9999960660934448
( O 0 0.032922063022851944
1 O 0 0.03152243420481682
) O 0 0.014133325777947903
, O 0 0.010370397940278053
as O 0 0.009829494170844555
well O 0 0.00875694490969181
as O 0 0.011801536194980145
in O 0 0.012595648877322674
patients O 0 0.046678539365530014
of O 0 0.030924629420042038
Amish O 1 0.9999265670776367
/ O 1 0.9998756647109985
Mennonite O 1 0.9633551836013794
and O 0 0.02984621934592724
Irish O 0 0.0654384046792984
English O 0 0.04341442510485649
backgrounds O 0 0.057763054966926575
. O 0 0.040460988879203796

Additional O 0 0.04926229640841484
mutations O 0 0.042242225259542465
were O 0 0.013237631879746914
observed O 0 0.017049280926585197
in O 0 0.012964153662323952
Japanese O 0 0.02765846997499466
, O 0 0.017570363357663155
Utah O 0 0.05008331686258316
Mormon O 0 0.13756981492042542
, O 0 0.02210487611591816
and O 0 0.019776057451963425
African O 0 0.05582104250788689
American O 0 0.26560965180397034
patients O 1 0.9973612427711487
. O 0 0.055719561874866486

These O 0 0.031547434628009796
assays O 0 0.04423458129167557
should O 0 0.018395286053419113
facilitate O 0 0.03443513810634613
screening O 0 0.03744528070092201
for O 0 0.018563220277428627
A B-Disease 1 0.9990116357803345
- I-Disease 1 1.0
T I-Disease 1 0.9999986886978149
heterozygotes O 1 0.7817096710205078
in O 0 0.018085500225424767
the O 0 0.021555131301283836
populations O 0 0.030100008472800255
studied O 0 0.031984034925699234
. O 0 0.024426180869340897
. O 0 0.03447553515434265

The O 0 0.06073634326457977
von B-Disease 1 0.8478868007659912
Hippel I-Disease 1 0.999950647354126
- I-Disease 1 0.999998927116394
Lindau I-Disease 1 0.9999998807907104
tumor I-Disease 1 1.0
suppressor O 1 0.999998927116394
gene O 0 0.048923198133707047
is O 0 0.016700318083167076
required O 0 0.012971327640116215
for O 0 0.01784520223736763
cell O 0 0.07180629670619965
cycle O 0 0.05640416219830513
exit O 0 0.0782010555267334
upon O 0 0.054085783660411835
serum O 1 0.9998296499252319
withdrawal O 1 0.7162778377532959
. O 0 0.05480649322271347

The O 0 0.052188094705343246
inactivation O 1 0.7151600122451782
of O 0 0.026922250166535378
the O 0 0.03312847390770912
von B-Disease 1 0.9932627081871033
Hippel I-Disease 1 0.9999980926513672
- I-Disease 1 0.9999991655349731
Lindau I-Disease 1 0.9999988079071045
( I-Disease 0 0.08719199895858765
VHL I-Disease 1 0.9999980926513672
) I-Disease 0 0.22816549241542816
tumor I-Disease 1 0.9999998807907104
suppressor O 1 0.9999995231628418
gene O 1 0.6490705013275146
predisposes O 1 0.999893307685852
affected O 0 0.02543514221906662
individuals O 0 0.010502016171813011
to O 0 0.011079478077590466
the O 0 0.020159896463155746
human O 1 0.9997915625572205
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.8187078833580017
is O 0 0.0198685172945261
associated O 0 0.01676996238529682
with O 0 0.01970364898443222
sporadic B-Disease 1 0.9999899864196777
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.999951958656311
RCC B-Disease 1 1.0
) O 0 0.048539772629737854
and O 0 0.04391837120056152
brain B-Disease 1 0.99967360496521
hemangioblastomas I-Disease 1 0.9999130964279175
. O 0 0.059528447687625885

VHL O 1 0.9998183846473694
- O 1 0.9982101917266846
negative O 0 0.06679846346378326
786 O 1 0.9996514320373535
- O 1 0.999992847442627
0 O 1 0.9510310888290405
RCC B-Disease 1 0.9999998807907104
cells O 0 0.04160582646727562
are O 0 0.011800841428339481
tumorigenic O 1 0.9218488335609436
in O 0 0.02293456718325615
nude O 1 0.9994186162948608
mice O 0 0.10925427824258804
which O 0 0.015502390451729298
is O 0 0.01663326658308506
suppressed O 0 0.04405715689063072
by O 0 0.014832505956292152
the O 0 0.02363426983356476
reintroduction O 1 0.596893310546875
of O 0 0.05818009376525879
VHL B-Disease 1 0.9999920129776001
. O 0 0.06971961259841919

Remarkably O 0 0.2509728968143463
, O 0 0.02471747435629368
this O 0 0.015272682532668114
occurs O 0 0.019450433552265167
without O 0 0.012490551918745041
affecting O 0 0.02207729034125805
the O 0 0.016377126798033714
growth O 0 0.024877678602933884
rate O 0 0.02037680707871914
and O 0 0.018450232222676277
cell O 0 0.1121993437409401
cycle O 0 0.04457234963774681
profile O 0 0.03892438858747482
of O 0 0.01871001161634922
these O 0 0.015079531818628311
cells O 0 0.03190956264734268
in O 0 0.02158549427986145
culture O 0 0.0489126518368721
. O 0 0.043566081672906876

The O 0 0.055546000599861145
786 O 1 0.9971367120742798
- O 1 0.9997977614402771
0 O 0 0.05458216741681099
cell O 0 0.041929587721824646
line O 0 0.02728523313999176
, O 0 0.015109753236174583
like O 0 0.0178982000797987
many O 0 0.022260788828134537
cancer B-Disease 1 1.0
cells O 1 0.8237040638923645
, O 0 0.02315511554479599
fails O 0 0.0448845811188221
to O 0 0.016559209674596786
exit O 0 0.04487376660108566
the O 0 0.02759653516113758
cell O 0 0.08930885046720505
cycle O 0 0.059467863291502
upon O 0 0.0528084859251976
serum O 1 0.9996820688247681
withdrawal O 1 0.7667838931083679
. O 0 0.05302291363477707

Here O 0 0.04032495245337486
, O 0 0.020290080457925797
it O 0 0.012216955423355103
is O 0 0.011567054316401482
shown O 0 0.010261747054755688
that O 0 0.007498516701161861
reintroduction O 0 0.04056461155414581
of O 0 0.013128669932484627
the O 0 0.01936727948486805
wild O 0 0.043388061225414276
- O 1 0.9999840259552002
type O 1 0.6601464748382568
VHL B-Disease 1 0.9999772310256958
gene O 0 0.036425016820430756
restores O 0 0.0686400905251503
the O 0 0.016381174325942993
ability O 0 0.01679343916475773
of O 0 0.027332022786140442
VHL O 1 0.9999992847442627
- O 1 0.9999997615814209
negative O 1 0.9997711777687073
RCC B-Disease 1 1.0
cancer I-Disease 1 1.0
cells O 0 0.043516483157873154
to O 0 0.018064450472593307
exit O 0 0.04669826477766037
the O 0 0.02677178382873535
cell O 0 0.04628201946616173
cycle O 0 0.0404813326895237
and O 0 0.02517274022102356
enter O 0 0.08230813592672348
G0 O 1 0.9999997615814209
/ O 1 0.999931812286377
quiescence O 1 0.9990074038505554
in O 0 0.04576585441827774
low O 1 0.7052928805351257
serum O 1 0.9988013505935669
. O 0 0.061138052493333817

Both O 0 0.059388451278209686
VHL O 1 0.9999871253967285
- O 1 0.9997128844261169
positive O 0 0.03474477678537369
and O 0 0.02838921919465065
VHL O 1 0.9999984502792358
- O 1 0.9999980926513672
negative O 1 0.893886387348175
RCC B-Disease 1 1.0
cells O 0 0.04799380898475647
exit O 0 0.050581011921167374
the O 0 0.029828134924173355
cell O 0 0.13123732805252075
cycle O 0 0.0513022318482399
by O 0 0.03308955952525139
contact O 0 0.21822206676006317
inhibition O 1 0.946733832359314
. O 0 0.047082770615816116

The O 0 0.07041388005018234
cyclin O 1 0.9999734163284302
- O 1 0.9999686479568481
dependent O 0 0.3035964071750641
kinase O 1 0.9994800686836243
inhibitor O 1 0.9999115467071533
, O 0 0.04748215153813362
p27 O 1 0.9991070628166199
, O 0 0.037201911211013794
accumulates O 0 0.3587856590747833
upon O 0 0.04539117217063904
serum O 1 0.9999858140945435
withdrawal O 1 0.6126422882080078
, O 0 0.014421978034079075
only O 0 0.007120363414287567
in O 0 0.006557710003107786
the O 0 0.011185998097062111
presence O 0 0.020281583070755005
of O 0 0.02793950028717518
VHL B-Disease 1 0.9999998807907104
, O 0 0.01754879392683506
as O 0 0.012626457959413528
a O 0 0.01402341853827238
result O 0 0.011158821173012257
of O 0 0.012682330794632435
the O 0 0.01889679953455925
stabilization O 1 0.9808217883110046
of O 0 0.027346862480044365
the O 0 0.04118599742650986
protein O 0 0.0481586791574955
. O 0 0.0322636179625988

We O 0 0.025822453200817108
propose O 0 0.028365742415189743
that O 0 0.007675830274820328
the O 0 0.010261408984661102
loss O 0 0.017857549712061882
of O 0 0.015432693995535374
wild O 0 0.07777996361255646
- O 1 0.9999998807907104
type O 1 0.9994342923164368
VHL B-Disease 1 0.999998927116394
gene O 0 0.024660790339112282
results O 0 0.008639691397547722
in O 0 0.0071493107825517654
a O 0 0.011754533275961876
specific O 0 0.01210113801062107
cellular O 0 0.044653620570898056
defect O 1 0.9991581439971924
in O 0 0.0210798978805542
serum O 1 0.9999997615814209
- O 1 0.9999996423721313
dependent O 0 0.05719954892992973
growth O 0 0.024822426959872246
control O 0 0.02334495075047016
, O 0 0.0139990309253335
which O 0 0.013234486803412437
may O 0 0.023808050900697708
initiate O 1 0.9990257024765015
tumor B-Disease 1 0.9999998807907104
formation O 1 0.991775393486023
. O 0 0.053063683211803436

This O 0 0.028221333399415016
is O 0 0.024153776466846466
corrected O 0 0.0429406575858593
by O 0 0.010905725881457329
the O 0 0.016284165903925896
reintroduction O 0 0.051001884043216705
of O 0 0.018943307921290398
wild O 0 0.04513389617204666
- O 1 0.9999957084655762
type O 1 0.9889746904373169
VHL B-Disease 1 0.9999972581863403
, O 0 0.032515112310647964
implicating O 1 0.9999927282333374
VHL B-Disease 1 0.9999955892562866
as O 0 0.016771841794252396
the O 0 0.01940201409161091
first O 1 0.5570626854896545
tumor B-Disease 1 1.0
suppressor O 1 0.9999940395355225
involved O 0 0.01760443113744259
in O 0 0.00975223071873188
the O 0 0.012922176159918308
regulation O 0 0.020976174622774124
of O 0 0.019739151000976562
cell O 1 0.9271644949913025
cycle O 0 0.2675996720790863
exit O 0 0.22706225514411926
, O 0 0.015125513076782227
which O 0 0.008876173757016659
is O 0 0.009156404994428158
consistent O 0 0.014065227471292019
with O 0 0.009945318102836609
its O 0 0.018257124349474907
gatekeeper O 1 0.999997615814209
function O 0 0.026176176965236664
in O 0 0.017589272931218147
the O 0 0.24811434745788574
kidney O 1 1.0
. O 0 0.0456589050590992
. O 0 0.04536490514874458

Piebaldism B-Disease 1 0.999980092048645
with O 1 0.7077862620353699
deafness B-Disease 1 1.0
: O 0 0.0478745698928833
molecular O 0 0.02712278813123703
evidence O 0 0.013813735917210579
for O 0 0.01510792225599289
an O 0 0.026342691853642464
expanded O 1 0.971771776676178
syndrome O 1 1.0
. O 0 0.06632749736309052

In O 0 0.025493746623396873
a O 0 0.024237973615527153
South O 0 0.03686216473579407
African O 0 0.04563123360276222
girl O 1 0.6712141036987305
of O 0 0.03514352813363075
Xhosa O 1 0.999992847442627
stock O 0 0.18259665369987488
with O 0 0.02669578418135643
severe O 1 0.9999756813049316
piebaldism B-Disease 1 0.9999992847442627
and O 1 0.9772989153862
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.3974040448665619
identified O 0 0.027148323133587837
a O 0 0.020025068894028664
novel O 0 0.036833055317401886
missense O 0 0.07685913890600204
substitution O 0 0.03954531252384186
at O 0 0.018540168181061745
a O 0 0.019392697140574455
highly O 0 0.026210851967334747
conserved O 0 0.030896605923771858
residue O 0 0.0367872528731823
in O 0 0.011640983633697033
the O 0 0.02333460934460163
intracellular O 1 0.9940985441207886
kinase O 1 0.6596037149429321
domain O 0 0.024472013115882874
of O 0 0.013912155292928219
the O 0 0.024317491799592972
KIT O 1 0.9999954700469971
proto O 1 0.999998927116394
- O 1 0.9999997615814209
oncogene O 1 0.9999942779541016
, O 0 0.051215481013059616
R796G O 1 0.9768075942993164
. O 0 0.04651274532079697

Though O 0 0.07190900295972824
auditory B-Disease 1 0.9975354671478271
anomalies I-Disease 1 0.8846595287322998
have O 0 0.01242357399314642
been O 0 0.012133216485381126
observed O 0 0.01370912790298462
in O 0 0.011250308714807034
mice O 0 0.0225694477558136
with O 0 0.013368361629545689
dominant O 1 0.902802586555481
white O 1 0.9988300204277039
spotting O 1 0.9999891519546509
( O 0 0.32218271493911743
W O 1 0.9998823404312134
) O 0 0.016900844871997833
due O 0 0.016432108357548714
to O 0 0.022454343736171722
KIT O 1 0.999995231628418
mutations O 1 0.5653749108314514
, O 0 0.27744343876838684
deafness B-Disease 1 1.0
is O 0 0.026824792847037315
not O 0 0.01426856778562069
typical O 0 0.02992948330938816
in O 0 0.018536651507019997
human O 0 0.03960946202278137
piebaldism B-Disease 1 0.9994223117828369
. O 0 0.05349123477935791

Thus O 0 0.034495770931243896
, O 0 0.01845032349228859
the O 0 0.01686895452439785
occurrence O 0 0.2807416021823883
of O 1 0.9306895136833191
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.13203686475753784
this O 0 0.023994050920009613
patient O 1 0.9999889135360718
extends O 0 0.1778179407119751
considerably O 0 0.025017352774739265
the O 0 0.015682099387049675
phenotypic O 0 0.030462412163615227
range O 0 0.013734755106270313
of O 0 0.017227496951818466
piebaldism B-Disease 1 0.9977558255195618
due O 0 0.022108929231762886
to O 0 0.02308579534292221
KIT O 1 0.9999970197677612
gene O 0 0.0458015501499176
mutation O 0 0.03702585771679878
in O 0 0.014897543005645275
humans O 0 0.019236966967582703
and O 0 0.021938316524028778
tightens O 1 0.9868068099021912
the O 0 0.026337139308452606
clinical O 1 0.5372923016548157
similarity O 0 0.03299568593502045
between O 0 0.024174656718969345
piebaldism B-Disease 1 0.9977351427078247
and O 0 0.013864572159945965
the O 0 0.01415569894015789
various O 0 0.011518942192196846
forms O 0 0.026609476655721664
of O 1 0.9995307922363281
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.6601262092590332
. O 0 0.0541115440428257

Cycloheximide O 1 0.9985415935516357
facilitates O 0 0.11247389018535614
the O 0 0.03064245916903019
identification O 0 0.03040444292128086
of O 0 0.028321854770183563
aberrant O 1 0.9960441589355469
transcripts O 0 0.04746907949447632
resulting O 0 0.02338360995054245
from O 0 0.012709219940006733
a O 0 0.020017074421048164
novel O 0 0.0416775718331337
splice O 1 0.8666669130325317
- O 1 0.998566210269928
site O 0 0.0340045765042305
mutation O 0 0.029180331155657768
in O 0 0.015633732080459595
COL17A1 O 1 0.9984272718429565
in O 0 0.016886020079255104
a O 0 0.03269756957888603
patient O 1 0.9997854828834534
with O 0 0.11830131709575653
generalized O 1 0.9999994039535522
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
. O 0 0.17339234054088593

Patients O 1 0.9978844523429871
with O 0 0.07003689557313919
generalized O 1 0.999998927116394
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.04585561901330948
show O 0 0.03019038401544094
decreased O 0 0.03617431968450546
expression O 0 0.027124159038066864
of O 0 0.028469664976000786
type O 1 0.9999850988388062
XVII O 1 1.0
collagen O 1 1.0
, O 0 0.036899134516716
a O 0 0.04150519147515297
transmembrane O 1 0.9988914132118225
hemidesmosomal O 1 0.9997076392173767
protein O 0 0.04072756692767143
encoded O 0 0.02565852925181389
by O 0 0.031171882525086403
COL17A1 O 1 0.9984697699546814
. O 0 0.052063681185245514

This O 0 0.02217753790318966
report O 0 0.017967570573091507
documents O 0 0.01599000208079815
a O 0 0.019099952653050423
novel O 0 0.046640679240226746
splice O 1 0.7788462042808533
- O 1 0.9983348250389099
site O 0 0.03350769728422165
mutation O 0 0.02990475669503212
in O 0 0.014857248403131962
COL17A1 O 1 0.9973527193069458
in O 0 0.015435933135449886
a O 0 0.028972189873456955
patient O 1 0.9988559484481812
with O 0 0.044349852949380875
generalized O 1 0.9999990463256836
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.0861017256975174
and O 0 0.02542993053793907
applies O 0 0.029499368742108345
a O 0 0.020657407119870186
new O 0 0.022313136607408524
methodology O 0 0.02767719142138958
to O 0 0.015523136593401432
define O 0 0.02949201501905918
and O 0 0.015915431082248688
characterize O 0 0.05440709367394447
the O 0 0.02812528982758522
resulting O 0 0.04900563135743141
mRNA O 0 0.07854217290878296
splice O 0 0.12798605859279633
variants O 0 0.05092291161417961
. O 0 0.03805479779839516

Mutational O 1 0.7210577130317688
analysis O 0 0.029949842020869255
of O 0 0.029479026794433594
COL17A1 O 1 0.9957088232040405
identified O 0 0.026807568967342377
a O 0 0.024094466120004654
maternally O 1 0.7489575743675232
inherited O 1 0.9997740387916565
G O 1 0.999944806098938
- O 1 0.9998602867126465
to O 0 0.02772354893386364
- O 1 0.9999964237213135
T O 1 0.9998015761375427
transversion O 1 0.9227246642112732
at O 0 0.018916763365268707
the O 0 0.020434146746993065
- O 1 0.9704259037971497
1 O 0 0.024918852373957634
position O 0 0.023131823167204857
of O 0 0.025490133091807365
exon O 0 0.12309522181749344
32 O 0 0.057357463985681534
. O 0 0.040970463305711746

This O 0 0.041503679007291794
acceptor O 1 0.8844922780990601
splice O 1 0.9578973650932312
- O 1 0.9989560842514038
site O 0 0.045038286596536636
mutation O 0 0.03528858348727226
led O 0 0.025603454560041428
to O 0 0.014380261301994324
the O 0 0.018349407240748405
formation O 0 0.034442238509655
of O 0 0.025355804711580276
aberrant O 1 0.9978805780410767
transcripts O 0 0.04780678078532219
present O 0 0.02535238116979599
at O 0 0.02945880778133869
extremely O 0 0.04564675688743591
low O 0 0.0639176145195961
levels O 0 0.045670051127672195
. O 0 0.04000319540500641

Based O 0 0.040964290499687195
on O 0 0.020049309358000755
our O 0 0.02134981006383896
recent O 0 0.020170532166957855
finding O 0 0.024299466982483864
that O 0 0.018654031679034233
cycloheximide O 1 0.99853515625
stabilized O 1 0.999082088470459
mutant O 1 0.8441915512084961
COL17A1 O 1 0.9984880685806274
transcripts O 0 0.061242666095495224
in O 0 0.024805432185530663
keratinocytes O 1 0.7791261076927185
homozygous O 0 0.05134057253599167
for O 0 0.018329432234168053
a O 0 0.035686783492565155
frameshift O 1 0.9998865127563477
mutation O 0 0.06852491199970245
, O 0 0.01516817044466734
the O 0 0.014752616174519062
effects O 0 0.01933944970369339
of O 0 0.013068250380456448
the O 0 0.023817161098122597
splice O 1 0.9987738728523254
- O 1 0.9997629523277283
site O 0 0.031032903119921684
mutation O 0 0.023609086871147156
on O 0 0.013635758310556412
splicing O 0 0.03015492670238018
of O 0 0.020861323922872543
COL17A1 O 1 0.9993531107902527
transcripts O 0 0.037208326160907745
were O 0 0.01079473551362753
determined O 0 0.01837603561580181
using O 0 0.012567108497023582
reverse O 0 0.04750553146004677
transcriptase O 1 0.9926915764808655
polymerase O 1 0.9421008229255676
chain O 0 0.05841391161084175
reaction O 0 0.02665885165333748
of O 0 0.01631120592355728
total O 0 0.02105497010052204
RNA O 0 0.046169713139534
from O 0 0.024797184392809868
keratinocytes O 1 0.9271451234817505
incubated O 0 0.11271048337221146
for O 0 0.029986508190631866
2 O 0 0.049296993762254715
. O 0 0.04039302468299866

5 O 0 0.06917433440685272
h O 0 0.0867655798792839
in O 0 0.018469585105776787
the O 0 0.022721800953149796
presence O 0 0.0322129912674427
or O 0 0.019560104236006737
absence O 0 0.036572784185409546
of O 0 0.02420578896999359
10 O 0 0.03885446861386299
microg O 1 0.9983929991722107
cycloheximide O 1 0.9990963935852051
per O 0 0.049393557012081146
ml O 1 0.9897205233573914
. O 0 0.04746754840016365

Using O 0 0.028059542179107666
this O 0 0.01592232659459114
approach O 0 0.02425956539809704
, O 0 0.015572437085211277
an O 0 0.018022097647190094
abnormally O 1 0.9929592609405518
spliced O 0 0.05746086314320564
transcript O 0 0.04052794352173805
was O 0 0.0213656984269619
identified O 0 0.016143465414643288
that O 0 0.008230206556618214
contains O 0 0.013357962481677532
an O 0 0.01348176971077919
extra O 0 0.021408705040812492
264 O 0 0.0480857789516449
bases O 0 0.027560900896787643
upstream O 0 0.03456730395555496
from O 0 0.016834508627653122
exon O 0 0.07316605001688004
32 O 0 0.0316423736512661
, O 0 0.016894260421395302
resulting O 0 0.01968655176460743
in O 0 0.013234598562121391
a O 0 0.029204102233052254
premature O 1 0.9995637536048889
termination O 1 0.9995554089546204
codon O 0 0.32686367630958557
27 O 0 0.05284484848380089
bp O 0 0.07075926661491394
downstream O 0 0.03931090980768204
from O 0 0.01815430074930191
the O 0 0.0342416912317276
cryptic O 0 0.3781273663043976
splice O 0 0.3267360031604767
site O 0 0.06357498466968536
. O 0 0.04636300355195999

Three O 0 0.030000627040863037
other O 0 0.023529110476374626
splice O 0 0.10236134380102158
variants O 0 0.0337003655731678
, O 0 0.01506426278501749
including O 0 0.013080297037959099
one O 0 0.014452117495238781
derived O 0 0.0132529241964221
from O 0 0.010756969451904297
the O 0 0.015958506613969803
skipping O 0 0.04580656439065933
of O 0 0.02532116323709488
exon O 1 0.8157064318656921
32 O 0 0.03801792860031128
, O 0 0.019977746531367302
were O 0 0.015014830976724625
also O 0 0.020028231665492058
identified O 0 0.034994401037693024
. O 0 0.033839743584394455

These O 0 0.02210608869791031
results O 0 0.01620808057487011
indicate O 0 0.015865137800574303
the O 0 0.016616864129900932
usefulness O 0 0.05152111500501633
of O 0 0.02982286922633648
cycloheximide O 1 0.9999974966049194
treatment O 1 0.9998400211334229
in O 0 0.0174002293497324
evaluating O 0 0.037693966180086136
the O 0 0.02208271622657776
abnormal O 1 0.8253617882728577
processing O 0 0.016629507765173912
of O 0 0.015126357786357403
mRNA O 0 0.02760528028011322
due O 0 0.013578343205153942
to O 0 0.014951903373003006
splice O 0 0.3182341754436493
- O 1 0.9990050196647644
site O 0 0.032755278050899506
mutations O 0 0.025240477174520493
, O 0 0.015001862309873104
because O 0 0.0159460436552763
( O 0 0.018150493502616882
i O 0 0.022709444165229797
) O 0 0.020879019051790237
aberrant O 1 0.6387543678283691
splicing O 0 0.03628217801451683
often O 0 0.011012143455445766
generates O 0 0.020349115133285522
a O 0 0.019349228590726852
premature O 1 0.9865266680717468
termination O 1 0.9984086155891418
codon O 1 0.9463596940040588
, O 0 0.023136848583817482
( O 0 0.022524775937199593
ii O 1 0.9980345368385315
) O 0 0.017902515828609467
transcripts O 0 0.03126542642712593
with O 0 0.01920922100543976
premature O 1 0.9997504353523254
termination O 1 0.9999769926071167
codons O 1 0.6080126166343689
can O 0 0.015982674434781075
occur O 0 0.014886058866977692
at O 0 0.020741144195199013
low O 0 0.05893532186746597
or O 0 0.02623775042593479
undetectable O 1 0.9999644756317139
levels O 0 0.02349678985774517
due O 0 0.01641845703125
to O 0 0.01572754792869091
nonsense O 1 0.524305522441864
- O 1 0.9995313882827759
mediated O 1 0.7480370998382568
mRNA O 0 0.04517759755253792
decay O 0 0.05822795256972313
, O 0 0.016176750883460045
and O 0 0.015173721127212048
( O 0 0.025089029222726822
iii O 1 0.9989728927612305
) O 0 0.015286789275705814
the O 0 0.013015355914831161
levels O 0 0.015256771817803383
of O 0 0.013695621863007545
these O 0 0.010529781691730022
transcripts O 0 0.02975146286189556
can O 0 0.010993965901434422
be O 0 0.011005736887454987
increased O 0 0.019811708480119705
by O 0 0.030790532007813454
cycloheximide O 1 0.998430073261261
. O 0 0.04997089505195618

A O 0 0.08580805361270905
deletion O 0 0.37425485253334045
mutation O 0 0.059992171823978424
in O 0 0.02449224703013897
COL17A1 O 1 0.9978502988815308
in O 0 0.01510793436318636
five O 0 0.018120553344488144
Austrian O 0 0.16769225895404816
families O 0 0.029936425387859344
with O 0 0.031450580805540085
generalized O 1 0.9999986886978149
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 1 0.9157854914665222
propagation O 0 0.3841334581375122
of O 0 0.029986312612891197
an O 0 0.03565988689661026
ancestral O 1 0.9907258749008179
allele O 0 0.165944904088974
. O 0 0.04577028006315231

Patients O 1 0.9958661794662476
with O 0 0.07224041223526001
generalized O 1 0.9999935626983643
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.0814519077539444
a O 0 0.03845307230949402
usually O 0 0.024483490735292435
nonlethal O 0 0.06945430487394333
form O 0 0.02455763705074787
of O 0 0.043905191123485565
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.03771997615695
have O 0 0.01666586846113205
generalized O 1 0.8827732801437378
blistering B-Disease 1 0.9999462366104126
, O 1 0.9783115983009338
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9969357252120972
patchy B-Disease 1 0.9999998807907104
alopecia I-Disease 1 1.0
, O 1 0.9653079509735107
and O 1 0.9906120896339417
dental B-Disease 1 1.0
abnormalities I-Disease 1 0.9999997615814209
. O 0 0.12171179056167603

Skin B-Disease 1 0.9999994039535522
fragility I-Disease 1 0.9999985694885254
in O 0 0.029608504846692085
most O 0 0.02076871134340763
cases O 0 0.023748207837343216
is O 0 0.016769947484135628
due O 0 0.017680907621979713
to O 0 0.014858216978609562
mutations O 0 0.019383197650313377
in O 0 0.009229588322341442
the O 0 0.015928097069263458
gene O 0 0.02742583304643631
encoding O 0 0.04065929353237152
type O 1 0.9773162007331848
XVII O 1 1.0
collagen O 1 1.0
( O 1 0.9722930192947388
COL17A1 O 1 0.9999954700469971
) O 0 0.047150447964668274
. O 0 0.03916425630450249

Recently O 0 0.07006300240755081
, O 0 0.022619877010583878
we O 0 0.011421202681958675
reported O 0 0.016023313626646996
five O 0 0.015209062024950981
Austrian O 0 0.05812475457787514
families O 0 0.029201775789260864
with O 0 0.03502959385514259
generalized O 1 0.9999978542327881
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.09291069954633713
share O 0 0.03390303626656532
the O 0 0.03068806789815426
same O 0 0.036832358688116074
COL17A1 O 1 0.9999816417694092
mutation O 0 0.12416361272335052
. O 0 0.049947820603847504

Affected O 0 0.06730954349040985
individuals O 0 0.02074768953025341
in O 0 0.013377182185649872
three O 0 0.01298921462148428
families O 0 0.01901412196457386
are O 0 0.010064823552966118
homozygous O 0 0.04302549362182617
for O 0 0.023113049566745758
4003delTC O 1 0.9996590614318848
, O 0 0.023893199861049652
whereas O 0 0.022595485672354698
those O 0 0.009477227926254272
in O 0 0.010059584863483906
two O 0 0.01183576975017786
others O 0 0.019007418304681778
are O 0 0.0157614815980196
compound O 0 0.3158455789089203
heterozygotes O 1 0.9656946659088135
. O 0 0.05363665893673897

To O 0 0.031426798552274704
determine O 0 0.020988015457987785
if O 0 0.012888547964394093
the O 0 0.015674423426389694
occurrence O 0 0.03282034024596214
of O 0 0.02410348318517208
4003delTC O 1 0.9994598031044006
in O 0 0.014466427266597748
these O 0 0.009477275423705578
unrelated O 0 0.027131693437695503
families O 0 0.02601567655801773
signifies O 1 0.8881630897521973
propagation O 0 0.0522681288421154
of O 0 0.018043700605630875
an O 0 0.0228117685765028
ancestral O 1 0.9977364540100098
allele O 0 0.07636687904596329
or O 0 0.019398575648665428
a O 0 0.03214515373110771
mutational O 1 0.9997128844261169
hot O 1 0.9926363229751587
spot O 0 0.08647993952035904
, O 0 0.02625909261405468
haplotypes O 0 0.06617993116378784
were O 0 0.012975111603736877
determined O 0 0.019766654819250107
for O 0 0.016306767240166664
polymorphisms O 0 0.045992325991392136
both O 0 0.01573888771235943
within O 0 0.022018413990736008
and O 0 0.03442863002419472
flanking O 1 0.999901294708252
COL17A1 O 1 0.9999969005584717
. O 0 0.0674380362033844

Five O 0 0.07228286564350128
intragenic O 1 0.9988394379615784
polymorphisms O 0 0.09928115457296371
were O 0 0.017903126776218414
chosen O 0 0.028471726924180984
based O 0 0.018841130658984184
on O 0 0.01906910352408886
their O 0 0.024925917387008667
informativeness O 1 0.9919801950454712
. O 0 0.04910746589303017

One O 0 0.029504258185625076
of O 0 0.020763138309121132
these O 0 0.010856980457901955
, O 0 0.012153425253927708
not O 0 0.007456957828253508
previously O 0 0.013275772333145142
reported O 0 0.014648980461061
, O 0 0.012741378508508205
was O 0 0.023901473730802536
2988 O 1 0.9977013468742371
A O 0 0.043979838490486145
or O 0 0.019604185596108437
C O 0 0.41645461320877075
that O 0 0.011352265253663063
introduces O 0 0.04145025834441185
a O 0 0.020178090780973434
new O 0 0.022891972213983536
restriction O 0 0.035318996757268906
site O 0 0.031875934451818466
for O 0 0.027195850387215614
Eco0109 O 1 0.9993849992752075
I O 0 0.1040906086564064
. O 0 0.042929477989673615

All O 0 0.03456436097621918
the O 0 0.047906890511512756
4003delTC O 1 0.9969283938407898
alleles O 0 0.06624941527843475
showed O 0 0.026767747476696968
the O 0 0.02263764850795269
same O 0 0.021987058222293854
haplotype O 0 0.08616501837968826
for O 0 0.016287444159388542
these O 0 0.013009445741772652
five O 0 0.03067365288734436
polymorphic O 1 0.9643515944480896
markers O 0 0.10553809255361557
. O 0 0.05508502200245857

Fourteen O 0 0.1407831311225891
microsatellite O 1 0.9493622183799744
polymorphisms O 0 0.08312582969665527
were O 0 0.015115544199943542
selected O 0 0.02009560540318489
based O 0 0.013709772378206253
on O 0 0.011340940371155739
their O 0 0.012578082270920277
high O 0 0.0397864393889904
heterozygosity O 1 0.9983413219451904
and O 0 0.017068028450012207
their O 0 0.012315097264945507
location O 0 0.02063351683318615
within O 0 0.022320382297039032
10q23 O 1 0.9992715716362
- O 1 0.9999697208404541
q25 O 1 0.9983035326004028
near O 0 0.10766689479351044
COL17A1 O 1 0.9994204044342041
. O 0 0.05893675237894058

Three O 0 0.033384714275598526
families O 0 0.03906351700425148
shared O 0 0.056104257702827454
microsatellite O 1 0.9971503615379333
polymorphisms O 0 0.18947379291057587
covering O 0 0.04216631129384041
at O 0 0.02214718796312809
most O 0 0.0161818228662014
19 O 0 0.03159787133336067
cM O 0 0.044398270547389984
, O 0 0.017634574323892593
whereas O 0 0.019919592887163162
the O 0 0.015481770038604736
others O 0 0.013776648789644241
shared O 0 0.020410260185599327
smaller O 0 0.016430504620075226
regions O 0 0.015016813762485981
consistent O 0 0.021215835586190224
with O 0 0.015123056247830391
cross O 1 0.5976534485816956
- O 1 0.999886155128479
over O 0 0.017632681876420975
events O 0 0.014064043760299683
during O 0 0.017689557746052742
passage O 0 0.027437925338745117
of O 0 0.018619144335389137
this O 0 0.017460471019148827
mutation O 0 0.038437262177467346
through O 0 0.0204544086009264
several O 0 0.020453931763768196
generations O 0 0.05559910461306572
. O 0 0.04589621350169182

These O 0 0.027806174010038376
results O 0 0.024195373058319092
indicate O 0 0.023189406841993332
that O 0 0.01645325869321823
4003delTC O 1 0.8806279897689819
occurs O 0 0.02328765019774437
on O 0 0.015110631473362446
a O 0 0.021420510485768318
single O 0 0.042771730571985245
ancestral O 1 0.9586492776870728
allele O 0 0.09869523346424103
. O 0 0.02720978669822216
. O 0 0.034118711948394775

The O 0 0.07137405872344971
haptoglobin O 1 0.9994631409645081
- O 1 0.9999277591705322
gene O 0 0.07233273237943649
deletion O 0 0.08324044197797775
responsible O 0 0.05270935222506523
for O 0 0.04001088812947273
anhaptoglobinemia B-Disease 1 0.9975294470787048
. O 0 0.059004299342632294

We O 0 0.028009826317429543
have O 0 0.01166023500263691
found O 0 0.012657349929213524
an O 0 0.01644199900329113
allelic O 0 0.17352943122386932
deletion O 0 0.053652323782444
of O 0 0.023233456537127495
the O 0 0.040211617946624756
haptoglobin O 1 0.9999901056289673
( O 0 0.043670833110809326
Hp O 1 0.9799764156341553
) O 0 0.023368488997220993
gene O 0 0.020019086077809334
from O 0 0.012021636590361595
an O 0 0.015531896613538265
individual O 0 0.020972639322280884
with O 0 0.029536131769418716
anhaptoglobinemia B-Disease 1 0.999445378780365
. O 0 0.05122263729572296

The O 0 0.05776858329772949
Hp O 1 0.7710111737251282
gene O 0 0.05094515159726143
cluster O 0 0.04832472652196884
consists O 0 0.02503264509141445
of O 0 0.019556649029254913
coding O 0 0.03448011353611946
regions O 0 0.013018075376749039
of O 0 0.011703196913003922
the O 0 0.022178560495376587
alpha O 1 0.9913753867149353
chain O 0 0.042343106120824814
and O 0 0.018045926466584206
beta O 0 0.051652077585458755
chain O 0 0.030426209792494774
of O 0 0.016534408554434776
the O 0 0.02686494030058384
haptoglobin O 1 0.9999732971191406
gene O 0 0.0507732518017292
( O 0 0.027594421058893204
Hp O 1 0.5265942215919495
) O 0 0.011345170438289642
and O 0 0.007337958551943302
of O 0 0.010114925913512707
the O 0 0.017884206026792526
alpha O 1 0.9595913290977478
chain O 0 0.03891071304678917
and O 0 0.017082611098885536
beta O 0 0.0510900653898716
chain O 0 0.02448100969195366
of O 0 0.012020583264529705
the O 0 0.021230855956673622
haptoglobin O 1 0.9999465942382812
- O 1 0.9999781847000122
related O 0 0.02745508775115013
gene O 0 0.034975815564394
( O 0 0.03036503866314888
Hpr O 1 0.9999358654022217
) O 0 0.0189937986433506
, O 0 0.015335540287196636
in O 0 0.013870456255972385
tandem O 0 0.052569679915905
from O 0 0.015946252271533012
the O 0 0.025060895830392838
5 O 0 0.03699987009167671
side O 0 0.047376178205013275
. O 0 0.03810447081923485

Southern O 0 0.11052195727825165
blot O 1 0.9901166558265686
and O 0 0.0490199439227581
PCR O 1 0.5760074853897095
analyses O 0 0.03062318079173565
have O 0 0.009085066616535187
indicated O 0 0.014886084944009781
that O 0 0.006571074947714806
the O 0 0.010525962337851524
individual O 0 0.010658854618668556
with O 0 0.01315018068999052
anhaptoglobinemia B-Disease 1 0.9995228052139282
was O 0 0.02706005983054638
homozygous O 0 0.03361395746469498
for O 0 0.01218330580741167
the O 0 0.01923229731619358
gene O 0 0.029655953869223595
deletion O 0 0.03649894893169403
and O 0 0.011293216608464718
that O 0 0.0075036101043224335
the O 0 0.015157682821154594
gene O 0 0.027125481516122818
deletion O 0 0.041312459856271744
was O 0 0.01883862167596817
included O 0 0.013612406328320503
at O 0 0.01185773964971304
least O 0 0.008047563023865223
from O 0 0.009251303039491177
the O 0 0.016776395961642265
promoter O 1 0.8263803124427795
region O 0 0.02371191792190075
of O 0 0.021624036133289337
Hp O 0 0.47451499104499817
to O 0 0.026263786479830742
Hpr O 1 0.9998559951782227
alpha O 0 0.06911320984363556
but O 0 0.012337872758507729
not O 0 0.010746491141617298
to O 0 0.022912554442882538
Hpr O 1 0.9993765950202942
beta O 1 0.9808900356292725
( O 0 0.05742582678794861
Hpdel O 1 0.9990147352218628
) O 0 0.04718868061900139
. O 0 0.04002910479903221

In O 0 0.03624563291668892
addition O 0 0.026772983372211456
, O 0 0.01675177924335003
we O 0 0.010201473720371723
found O 0 0.009498408995568752
seven O 0 0.013540343381464481
individuals O 0 0.013211441226303577
with O 0 0.015527931973338127
hypohaptoglobinemia B-Disease 1 0.9958764314651489
in O 0 0.012908571399748325
three O 0 0.012651563622057438
families O 0 0.018090959638357162
, O 0 0.014432298019528389
and O 0 0.01248173788189888
the O 0 0.018536359071731567
genotypes O 0 0.3866410553455353
of O 0 0.014469433575868607
six O 0 0.01498864870518446
of O 0 0.015291140414774418
the O 0 0.017558695748448372
seven O 0 0.01821189932525158
individuals O 0 0.013094007037580013
were O 0 0.009698835201561451
found O 0 0.011533116921782494
to O 0 0.015244639478623867
be O 0 0.023542454466223717
Hp2 O 1 0.999863862991333
/ O 1 0.9998047947883606
Hpdel O 1 0.9988445043563843
. O 0 0.05367729067802429

The O 0 0.06685413420200348
phenotypes O 1 0.5627027750015259
and O 0 0.03516581282019615
genotypes O 1 0.697841465473175
in O 0 0.015616092830896378
one O 0 0.012472720816731453
of O 0 0.012207845225930214
these O 0 0.007156954612582922
three O 0 0.009560517966747284
families O 0 0.01628716103732586
showed O 0 0.01582782156765461
the O 0 0.017095908522605896
father O 0 0.037200335413217545
to O 0 0.01643179915845394
be O 0 0.015787648037075996
hypohaptoglobinemic B-Disease 1 0.9961257576942444
( O 0 0.030956512317061424
Hp2 O 1 0.9901531338691711
) O 0 0.020762871950864792
and O 0 0.021296920254826546
Hp2 O 1 0.9999536275863647
/ O 1 0.9999754428863525
Hpdel O 1 0.999776303768158
, O 0 0.01821693778038025
the O 0 0.016564039513468742
mother O 0 0.037305798381567
to O 0 0.01236993633210659
be O 0 0.011457524262368679
Hp2 O 1 0.9967081546783447
- O 1 0.9979957342147827
1 O 0 0.024815233424305916
and O 0 0.02040022239089012
Hp1 O 1 0.9999810457229614
/ O 1 0.9999822378158569
Hp2 O 1 0.9995681643486023
, O 0 0.015233191661536694
one O 0 0.008553463965654373
of O 0 0.008332514204084873
the O 0 0.010600153356790543
two O 0 0.009677196852862835
children O 0 0.01771882176399231
to O 0 0.013443727977573872
be O 0 0.014590481296181679
hypohaptoglobinemic B-Disease 1 0.9988290667533875
( O 0 0.028238045051693916
Hp2 O 1 0.9948641657829285
) O 0 0.01970553584396839
and O 0 0.020971452817320824
Hp2 O 1 0.9999955892562866
/ O 1 0.999996542930603
Hpdel O 1 0.9999470710754395
, O 0 0.018699729815125465
and O 0 0.01194131188094616
the O 0 0.014675647020339966
other O 0 0.011302590370178223
child O 0 0.037268199026584625
to O 0 0.01533286739140749
be O 0 0.014519210904836655
Hp1 O 1 0.9934810400009155
and O 0 0.029384266585111618
Hp1 O 1 0.9999967813491821
/ O 1 0.9999923706054688
Hpdel O 1 0.9995205402374268
, O 0 0.02134338952600956
showing O 0 0.023099733516573906
an O 0 0.019533557817339897
anomalous O 1 0.9009366631507874
inheritance O 0 0.17752757668495178
of O 0 0.03604644536972046
Hp O 1 0.9993091821670532
phenotypes O 0 0.14667226374149323
in O 0 0.018238740041851997
the O 0 0.027496423572301865
child O 1 0.8412315845489502
with O 0 0.042315445840358734
Hp1 O 1 0.9999305009841919
. O 0 0.05642112344503403

The O 0 0.07422563433647156
Hp2 O 1 0.999987006187439
/ O 1 0.9999926090240479
Hpdel O 1 0.999813973903656
individuals O 0 0.021834036335349083
had O 0 0.016662104055285454
an O 0 0.014383858069777489
extremely O 0 0.02211972512304783
low O 0 0.023695658892393112
level O 0 0.015532299876213074
of O 0 0.01657865010201931
Hp O 1 0.9877134561538696
( O 0 0.019054489210247993
mean O 0 0.024163538590073586
+ O 1 0.8997964262962341
/ O 1 0.9995929598808289
- O 1 0.9999493360519409
SD O 1 0.9998155236244202
= O 0 0.044586583971977234
0 O 0 0.03076815977692604
. O 0 0.019163943827152252
049 O 1 0.9969319105148315
+ O 1 0.7304460406303406
/ O 1 0.9726616740226746
- O 1 0.7043492197990417
0 O 0 0.03364894539117813
. O 0 0.01988711580634117
043 O 1 0.9908457398414612
mg O 1 0.9998620748519897
/ O 1 0.9997366070747375
ml O 1 0.9991239905357361
; O 0 0.03090779483318329
n O 0 0.06014828011393547
= O 0 0.04729975759983063
6 O 0 0.02828088030219078
) O 0 0.014337650500237942
, O 0 0.009941786527633667
compared O 0 0.00872245617210865
with O 0 0.008406806737184525
the O 0 0.013351215980947018
level O 0 0.01991526409983635
( O 0 0.01363017875701189
1 O 0 0.015894312411546707
. O 0 0.009406032972037792
64 O 0 0.03253059461712837
+ O 1 0.5137040615081787
/ O 1 0.9892723560333252
- O 1 0.9629472494125366
1 O 0 0.024382315576076508
. O 0 0.01700640469789505
07 O 1 0.9799903035163879
mg O 1 0.9999933242797852
/ O 1 0.9999816417694092
ml O 1 0.9992608428001404
) O 0 0.015576142817735672
obtained O 0 0.0127990348264575
from O 0 0.011672517284750938
52 O 0 0.03786839172244072
healthy O 0 0.1221277192234993
volunteers O 0 0.05660630762577057
having O 0 0.03886360302567482
phenotype O 1 0.9921700358390808
Hp2 O 1 0.9996115565299988
, O 0 0.024764539673924446
whereas O 0 0.0265973974019289
the O 0 0.028148159384727478
serum O 1 0.9999693632125854
Hp O 1 0.8849853277206421
level O 0 0.022688407450914383
of O 0 0.014768843539059162
an O 0 0.014735416509211063
individual O 0 0.01562618277966976
with O 0 0.024461235851049423
Hp1 O 1 0.9999938011169434
/ O 1 0.9999873638153076
Hpdel O 1 0.9999217987060547
was O 0 0.05324149504303932
0 O 0 0.06488078832626343
. O 0 0.03622446954250336

50 O 0 0.07689449936151505
mg O 1 0.9999876022338867
/ O 1 0.9999973773956299
ml O 1 0.9999314546585083
, O 0 0.021871773526072502
which O 0 0.01116461493074894
was O 0 0.01507822796702385
approximately O 0 0.009936399757862091
half O 0 0.011110590770840645
the O 0 0.012161471880972385
level O 0 0.018336262553930283
of O 0 0.017538735643029213
Hp O 0 0.22491753101348877
in O 0 0.015051418915390968
control O 0 0.03172636032104492
sera O 1 0.997572124004364
from O 0 0.018085474148392677
the O 0 0.028775176033377647
Hp1 O 1 0.9999890327453613
phenotype O 1 0.9948124885559082
( O 0 0.020250368863344193
1 O 0 0.019955048337578773
. O 0 0.010591404512524605
26 O 0 0.02564551681280136
+ O 1 0.6294846534729004
/ O 1 0.9894927740097046
- O 1 0.9134660363197327
0 O 0 0.026400601491332054
. O 0 0.011800308711826801
33 O 0 0.034187786281108856
mg O 1 0.9997442364692688
/ O 1 0.9999556541442871
ml O 1 0.9998774528503418
; O 0 0.02513820491731167
n O 0 0.05463296175003052
= O 0 0.04371236264705658
9 O 0 0.02380198799073696
) O 0 0.012429460883140564
, O 0 0.010346543975174427
showing O 0 0.017558472231030464
a O 0 0.026489557698369026
gene O 0 0.06729152053594589
- O 1 0.9998975992202759
dosage O 1 0.9960411787033081
effect O 0 0.04686426371335983
. O 0 0.03645098954439163

The O 0 0.04444211348891258
other O 0 0.02620074711740017
allele O 0 0.1482822597026825
( O 0 0.036199845373630524
Hp2 O 1 0.9898772835731506
) O 0 0.016639109700918198
of O 0 0.012376287020742893
individuals O 0 0.013119467534124851
with O 0 0.0208932813256979
Hp2 O 1 0.9999992847442627
/ O 1 0.9999994039535522
Hpdel O 1 0.9999909400939941
was O 0 0.029300076887011528
found O 0 0.011856745928525925
to O 0 0.00963114108890295
have O 0 0.006543540395796299
, O 0 0.008780394680798054
in O 0 0.008126823231577873
all O 0 0.01163114607334137
exons O 0 0.04803775995969772
, O 0 0.017865881323814392
no O 0 0.020372824743390083
mutation O 0 0.03624977916479111
, O 0 0.017777010798454285
by O 0 0.021054401993751526
DNA O 0 0.03714551404118538
sequencing O 0 0.051302045583724976
. O 0 0.03660619258880615

On O 0 0.026442961767315865
the O 0 0.015633270144462585
basis O 0 0.011176660656929016
of O 0 0.013104178942739964
the O 0 0.01501474715769291
present O 0 0.016291288658976555
study O 0 0.01323606725782156
, O 0 0.010380678810179234
the O 0 0.013223737478256226
mechanism O 0 0.03005518764257431
of O 0 0.019431160762906075
anhaptoglobinemia B-Disease 1 0.9999822378158569
and O 0 0.01638173498213291
the O 0 0.018981250002980232
mechanism O 0 0.031584445387125015
of O 0 0.0224281158298254
anomalous O 1 0.9986667633056641
inheritance O 1 0.9839401245117188
of O 0 0.40745559334754944
Hp O 1 0.9999830722808838
phenotypes O 1 0.7783987522125244
were O 0 0.021021924912929535
well O 0 0.025036681443452835
explained O 0 0.04691437631845474
. O 0 0.036213066428899765

However O 0 0.03509650006890297
, O 0 0.022510265931487083
the O 0 0.02650764025747776
mechanism O 0 0.04699236527085304
of O 0 0.04175776615738869
hypohaptoglobinemia B-Disease 1 0.999713122844696
remains O 0 0.11028742045164108
unknown O 0 0.08471933752298355

ATM O 1 0.9070531725883484
mutations O 0 0.0452963151037693
and O 0 0.022933874279260635
phenotypes O 0 0.45240524411201477
in O 0 0.04251264035701752
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 0.9999998807907104
families O 0 0.030441775918006897
in O 0 0.013950815424323082
the O 0 0.016813630238175392
British O 0 0.03306952118873596
Isles O 1 0.634931206703186
: O 0 0.01789028011262417
expression O 0 0.016128739342093468
of O 0 0.01638932339847088
mutant O 1 0.9877462387084961
ATM O 1 0.600808322429657
and O 0 0.010391819290816784
the O 0 0.013724133372306824
risk O 0 0.035894669592380524
of O 1 0.8178195357322693
leukemia B-Disease 1 1.0
, O 1 0.9999994039535522
lymphoma B-Disease 1 1.0
, O 1 0.9999502897262573
and O 1 0.9999620914459229
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7058084607124329

We O 0 0.028274113312363625
report O 0 0.022146297618746758
the O 0 0.017623482272028923
spectrum O 0 0.030157074332237244
of O 0 0.021591365337371826
59 O 0 0.057993218302726746
ATM O 0 0.33324533700942993
mutations O 0 0.027251001447439194
observed O 0 0.017400698736310005
in O 0 0.020424002781510353
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.03978016600012779
A B-Disease 1 0.99992835521698
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.03140592202544212
patients O 0 0.06615150719881058
in O 0 0.014205955900251865
the O 0 0.024880487471818924
British O 0 0.05540898069739342
Isles O 1 0.5058032274246216
. O 0 0.05207115039229393

Of O 0 0.04614020511507988
51 O 0 0.0956125259399414
ATM O 1 0.9819536209106445
mutations O 0 0.043117161840200424
identified O 0 0.022711899131536484
in O 0 0.012908468022942543
families O 0 0.01788789965212345
native O 0 0.015608149580657482
to O 0 0.012095211073756218
the O 0 0.01670709066092968
British O 0 0.030346538871526718
Isles O 0 0.08123380690813065
, O 0 0.014072381891310215
11 O 0 0.016455264762043953
were O 0 0.014275451190769672
founder O 1 0.9995040893554688
mutations O 0 0.03171931207180023
, O 0 0.013135641813278198
and O 0 0.01092720590531826
2 O 0 0.0157779473811388
of O 0 0.012211237102746964
these O 0 0.007375852204859257
11 O 0 0.018360739573836327
conferred O 0 0.0537816621363163
a O 0 0.03657691925764084
milder O 1 0.9988380074501038
clinical O 1 0.9997318387031555
phenotype O 1 0.9806099534034729
with O 0 0.019107164815068245
respect O 0 0.02974633313715458
to O 0 0.02504245936870575
both O 0 0.044488921761512756
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9964264035224915
cellular O 1 0.9967190623283386
features O 0 0.05019517242908478
. O 0 0.040238309651613235

We O 0 0.025976724922657013
report O 0 0.018376825377345085
, O 0 0.010444199666380882
in O 0 0.0073046074248850346
two O 0 0.010699696838855743
A B-Disease 1 0.9803956151008606
- I-Disease 1 0.9999997615814209
T I-Disease 1 0.9999924898147583
families O 0 0.019365321844816208
, O 0 0.012410260736942291
an O 0 0.013507003895938396
ATM O 1 0.517650842666626
mutation O 0 0.03074042685329914
( O 0 0.01905297487974167
7271T O 1 0.998846173286438
- O 1 0.9999973773956299
- O 1 0.9999995231628418
> O 1 0.999962329864502
G O 1 0.9986122846603394
) O 0 0.014892324805259705
that O 0 0.008263212628662586
may O 0 0.009502083994448185
be O 0 0.006190994754433632
associated O 0 0.008681458421051502
with O 0 0.007660565432161093
an O 0 0.010582763701677322
increased O 0 0.01863345503807068
risk O 1 0.9555009007453918
of O 1 0.9992258548736572
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.025925258174538612
both O 0 0.026813294738531113
homozygotes O 1 0.9998946189880371
and O 0 0.03441547229886055
heterozygotes O 1 0.9998868703842163
( O 0 0.026165472343564034
relative O 0 0.031015001237392426
risk O 0 0.030741581693291664
12 O 0 0.016549699008464813
. O 0 0.011317344382405281
7 O 0 0.02294592745602131
; O 0 0.018778033554553986
P O 1 0.9991262555122375
= O 0 0.04913192614912987
. O 0 0.019079523161053658
0025 O 1 0.9998027682304382
) O 0 0.016214001923799515
, O 0 0.010729816742241383
although O 0 0.007602598052471876
there O 0 0.006262499839067459
is O 0 0.008142265491187572
a O 0 0.011057248339056969
less O 0 0.011766631156206131
severe O 1 0.9996440410614014
A B-Disease 1 0.9999991655349731
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 1 0.8736995458602905
in O 0 0.01091490127146244
terms O 0 0.01021686289459467
of O 0 0.01247880607843399
the O 0 0.01906304992735386
degree O 0 0.03902807459235191
of O 1 0.8647003173828125
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.8714233636856079

This O 0 0.026547329500317574
mutation O 0 0.0458010658621788
( O 0 0.030140329152345657
7271T O 1 0.9996784925460815
- O 1 0.9999980926513672
- O 1 0.9999992847442627
> O 1 0.9999185800552368
G O 1 0.9915173053741455
) O 0 0.016213754191994667
also O 0 0.01069623976945877
allows O 0 0.011246160604059696
expression O 0 0.012296673841774464
of O 0 0.012150665745139122
full O 0 0.024444758892059326
- O 1 0.9981386661529541
length O 0 0.02471710927784443
ATM O 0 0.4191136658191681
protein O 0 0.020261581987142563
at O 0 0.013140078634023666
a O 0 0.01556929387152195
level O 0 0.018364369869232178
comparable O 0 0.024067554622888565
with O 0 0.013292411342263222
that O 0 0.012622453272342682
in O 0 0.020578432828187943
unaffected O 1 0.9813939332962036
individuals O 0 0.03186165168881416
. O 0 0.04007086902856827

In O 0 0.032671570777893066
addition O 0 0.02468114346265793
, O 0 0.015429318882524967
we O 0 0.00827952940016985
have O 0 0.0052322386763989925
studied O 0 0.0116276815533638
18 O 0 0.018151093274354935
A B-Disease 1 0.9993521571159363
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9995031356811523
, O 0 0.013649026863276958
in O 0 0.00888705812394619
15 O 0 0.012841724790632725
families O 0 0.014130502939224243
, O 0 0.01154746487736702
who O 0 0.021092303097248077
developed O 1 0.9957858920097351
leukemia B-Disease 1 1.0
, O 1 0.9999619722366333
lymphoma B-Disease 1 1.0
, O 1 0.9929075241088867
preleukemic O 1 0.9999998807907104
T O 1 0.9999997615814209
- O 1 0.9999988079071045
cell O 0 0.49989551305770874
proliferation O 1 0.9335662126541138
, O 0 0.029564043506979942
or O 1 0.9991282820701599
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.9940798282623291
mostly O 0 0.03058810345828533
in O 0 0.029527612030506134
childhood O 1 0.9995323419570923
. O 0 0.05064060911536217

A O 0 0.058986227959394455
wide O 0 0.03313358128070831
variety O 0 0.021287081763148308
of O 0 0.027644922956824303
ATM O 1 0.9997369647026062
mutation O 0 0.0825563445687294
types O 0 0.018735187128186226
, O 0 0.01313965953886509
including O 0 0.01630711928009987
missense O 1 0.5374546051025391
mutations O 0 0.02638360857963562
and O 0 0.014401408843696117
in O 0 0.01912175491452217
- O 1 0.9999891519546509
frame O 1 0.7037458419799805
deletions O 0 0.05579409748315811
, O 0 0.015207404270768166
were O 0 0.010420216247439384
seen O 0 0.02024604193866253
in O 0 0.015392042696475983
these O 0 0.018458308652043343
patients O 1 0.9864426851272583
. O 0 0.04500403255224228

We O 0 0.030782803893089294
also O 0 0.016820136457681656
show O 0 0.014440915547311306
that O 0 0.006887206807732582
25 O 0 0.009998130612075329
% O 0 0.006889455020427704
of O 0 0.0075927795842289925
all O 0 0.01072255615144968
A B-Disease 1 0.9996991157531738
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9950841069221497
carried O 0 0.02014976181089878
in O 0 0.016868621110916138
- O 1 0.999902606010437
frame O 0 0.061149388551712036
deletions O 0 0.05574912577867508
or O 0 0.023444129154086113
missense O 1 0.9118725061416626
mutations O 0 0.02875829115509987
, O 0 0.010992882773280144
many O 0 0.006872992031276226
of O 0 0.010993804782629013
which O 0 0.008614481426775455
were O 0 0.007570682093501091
also O 0 0.009912214241921902
associated O 0 0.010792291723191738
with O 0 0.009984394535422325
expression O 0 0.020473122596740723
of O 0 0.0281771719455719
mutant O 1 0.9998918771743774
ATM O 1 0.9996918439865112
protein O 0 0.05632556974887848
. O 0 0.03620808944106102

The O 0 0.05114289000630379
DMPK O 1 0.9994600415229797
gene O 0 0.0414201058447361
of O 0 0.03194136545062065
severely O 1 0.9999921321868896
affected O 1 0.9999974966049194
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.9988896250724792
hypermethylated O 1 0.9999997615814209
proximal O 1 0.9999974966049194
to O 0 0.025072839111089706
the O 0 0.02523021586239338
largely O 0 0.03307611122727394
expanded O 0 0.054587192833423615
CTG O 1 0.9999016523361206
repeat O 0 0.1597517877817154
. O 0 0.051810599863529205

Using O 0 0.03741464391350746
methylation O 0 0.0971529483795166
- O 1 0.9999403953552246
sensitive O 0 0.35087841749191284
restriction O 0 0.061873048543930054
enzymes O 0 0.04204915091395378
, O 0 0.014793424867093563
we O 0 0.011850233189761639
characterized O 0 0.027904273942112923
the O 0 0.01985207386314869
methylation O 0 0.04217753931879997
pattern O 0 0.022903863340616226
on O 0 0.013188472017645836
the O 0 0.014015481807291508
5 O 0 0.016146788373589516
side O 0 0.016017967835068703
of O 0 0.012729632668197155
the O 0 0.022485928609967232
CTG O 1 0.999988317489624
repeat O 0 0.0429377481341362
in O 0 0.011659509502351284
the O 0 0.020751919597387314
DMPK O 1 0.9999887943267822
gene O 0 0.025550179183483124
of O 0 0.016387101262807846
normal O 0 0.019749142229557037
individuals O 0 0.010886553674936295
and O 0 0.011849641799926758
of O 0 0.024087032303214073
patients O 1 0.9999922513961792
affected O 1 0.9663759469985962
with O 1 0.9985326528549194
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.42700842022895813
showing O 0 0.04267336428165436
expansions O 0 0.05261310562491417
of O 0 0.02617587335407734
the O 0 0.040778569877147675
repetitive O 1 0.9948862195014954
sequence O 0 0.04538213089108467
. O 0 0.03992939740419388

The O 0 0.05284398794174194
gene O 0 0.05774557590484619
segment O 0 0.04561400040984154
analyzed O 0 0.026422303169965744
corresponds O 0 0.02564992755651474
to O 0 0.014317771419882774
the O 0 0.02228309027850628
genomic O 0 0.0674368217587471
SacI O 1 0.9995274543762207
- O 1 0.9993353486061096
HindIII O 1 0.9556301832199097
fragment O 0 0.06267088651657104
carrying O 0 0.038493379950523376
exons O 0 0.06726931780576706
11 O 0 0.046054065227508545
- O 1 0.9742051959037781
15 O 0 0.04681362584233284
. O 0 0.04018806666135788

There O 0 0.029988287016749382
is O 0 0.027765851467847824
constitutive O 0 0.12141836434602737
methylation O 0 0.05640404298901558
in O 0 0.023227520287036896
intron O 1 0.9992740750312805
12 O 0 0.024890368804335594
at O 0 0.02046801894903183
restriction O 0 0.027658311650156975
sites O 0 0.015115139074623585
of O 0 0.01953776739537716
SacII O 1 0.9982825517654419
and O 0 0.02603026293218136
HhaI O 1 0.9994596838951111
, O 0 0.024182500317692757
localized O 0 0.051709141582250595
1 O 0 0.02409687265753746
, O 0 0.016910940408706665
159 O 0 0.14267124235630035
- O 1 0.9986648559570312
1 O 0 0.02847473882138729
, O 0 0.016861040145158768
232 O 0 0.052348386496305466
bp O 0 0.04886702075600624
upstream O 0 0.02843291684985161
of O 0 0.015575236640870571
the O 0 0.030174249783158302
CTG O 1 0.9999966621398926
repeat O 1 0.8123029470443726
, O 0 0.024282129481434822
whereas O 0 0.022637933492660522
most O 0 0.01268937811255455
, O 0 0.012905155308544636
if O 0 0.009822293184697628
not O 0 0.0063306610099971294
all O 0 0.006910982076078653
, O 0 0.008676158264279366
of O 0 0.009662848897278309
the O 0 0.012494240887463093
other O 0 0.007247992791235447
sites O 0 0.012599177658557892
of O 0 0.016710132360458374
SacII O 1 0.9999533891677856
, O 0 0.029645340517163277
HhaI O 1 0.9998064637184143
, O 0 0.021194571629166603
and O 0 0.018001893535256386
HpaII O 1 0.9972791075706482
in O 0 0.012320191599428654
this O 0 0.009904991835355759
region O 0 0.02046172507107258
are O 0 0.010924017056822777
unmethylated O 1 0.999312162399292
, O 0 0.019293995574116707
in O 0 0.015235365368425846
normal O 0 0.022721050307154655
individuals O 0 0.013764149509370327
and O 0 0.013520275242626667
most O 0 0.012403720989823341
of O 0 0.022512296214699745
the O 0 0.08231649547815323
patients O 1 0.9998067021369934
. O 0 0.05499494448304176

In O 0 0.019868137314915657
a O 0 0.01591396890580654
number O 0 0.01046408899128437
of O 0 0.017909809947013855
young O 1 0.9986103773117065
and O 0 0.36342817544937134
severely O 1 0.9999998807907104
affected O 1 0.9997897744178772
patients O 1 0.9999960660934448
, O 0 0.02215692400932312
however O 0 0.013721415773034096
, O 0 0.013136852532625198
complete O 0 0.022185727953910828
methylation O 0 0.03309201821684837
of O 0 0.014262036420404911
these O 0 0.009329115971922874
restriction O 0 0.025640251114964485
sites O 0 0.01650063693523407
was O 0 0.016825096681714058
found O 0 0.010886640287935734
in O 0 0.01178741455078125
the O 0 0.0283586997538805
mutated O 0 0.3316133916378021
allele O 0 0.10690738260746002
. O 0 0.049211423844099045

In O 0 0.02221822179853916
most O 0 0.014487599954009056
of O 0 0.01655268669128418
these O 0 0.013022665865719318
patients O 1 0.9923551082611084
, O 0 0.015091078355908394
the O 0 0.021077647805213928
onset O 1 0.999998927116394
of O 1 0.5115299820899963
the O 1 0.9999574422836304
disease O 1 1.0
was O 1 0.9999996423721313
congenital O 1 1.0
. O 1 0.9823640584945679

Preliminary O 0 0.05039384961128235
in O 0 0.03486411273479462
vivo O 1 0.7297922968864441
footprinting O 1 0.9972135424613953
data O 0 0.015358664095401764
gave O 0 0.01888730190694332
evidence O 0 0.011343041434884071
for O 0 0.013597587123513222
protein O 0 0.03358738496899605
- O 1 0.9935623407363892
DNA O 0 0.026536984369158745
contact O 0 0.02394193410873413
in O 0 0.011834708973765373
normal O 0 0.02074739895761013
genes O 0 0.016938893124461174
at O 0 0.018258046358823776
an O 0 0.023363744840025902
Sp1 O 1 0.9997850060462952
consensus O 0 0.038600027561187744
binding O 0 0.028674807399511337
site O 0 0.02583671547472477
upstream O 0 0.02331058867275715
of O 0 0.01389340776950121
the O 0 0.02765667997300625
CTG O 1 0.9999963045120239
repeat O 0 0.21116070449352264
and O 0 0.015130259096622467
for O 0 0.011314256116747856
a O 0 0.015710387378931046
significant O 0 0.015189704485237598
reduction O 0 0.023417947813868523
of O 0 0.01412203535437584
this O 0 0.010800918564200401
interaction O 0 0.018713681027293205
in O 0 0.012289267964661121
cells O 0 0.02014550194144249
with O 0 0.013460040092468262
a O 0 0.03662589564919472
hypermethylated O 1 0.9999902248382568
DMPK O 1 0.9999969005584717
gene O 0 0.05997610464692116
. O 0 0.02760544791817665
. O 0 0.03596841171383858

The O 0 0.11476188153028488
hemochromatosis B-Disease 1 1.0
gene O 0 0.10509659349918365
product O 0 0.03925703465938568
complexes O 0 0.049598101526498795
with O 0 0.016126884147524834
the O 0 0.03133906424045563
transferrin O 1 0.9999986886978149
receptor O 1 0.9943602681159973
and O 0 0.026835637167096138
lowers O 1 0.9919975399971008
its O 0 0.025111723691225052
affinity O 0 0.04906958341598511
for O 0 0.028836283832788467
ligand O 1 0.8551666736602783
binding O 0 0.05378055199980736
. O 0 0.038088567554950714

We O 0 0.03054603561758995
recently O 0 0.03172169253230095
reported O 0 0.020775362849235535
the O 0 0.020762363448739052
positional O 0 0.052429500967264175
cloning O 0 0.030715642496943474
of O 0 0.01618947647511959
a O 0 0.020923640578985214
candidate O 0 0.03347093611955643
gene O 0 0.033612966537475586
for O 0 0.03606965020298958
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999961853027344
HFE O 1 0.9999995231628418
. O 0 0.08393239229917526

The O 0 0.04899340867996216
gene O 0 0.040186308324337006
product O 0 0.024126701056957245
, O 0 0.01183618325740099
a O 0 0.013039867393672466
member O 0 0.016951363533735275
of O 0 0.01240468118339777
the O 0 0.017996182665228844
major O 0 0.2639707624912262
histocompatibility O 1 1.0
complex O 0 0.35298633575439453
class O 1 0.953200101852417
I O 1 0.9826473593711853
- O 1 0.999991774559021
like O 0 0.022397441789507866
family O 0 0.024650344625115395
, O 0 0.014235621318221092
was O 0 0.016589395701885223
found O 0 0.008895957842469215
to O 0 0.007533702068030834
have O 0 0.005577126517891884
a O 0 0.013920373283326626
mutation O 0 0.02748720534145832
, O 0 0.01888124644756317
Cys O 1 0.9999935626983643
- O 1 0.9995105266571045
282 O 1 0.970618724822998
- O 1 0.9999983310699463
- O 1 0.9999974966049194
> O 1 0.9996103644371033
Tyr O 1 0.999993085861206
( O 0 0.044381678104400635
C282Y O 1 0.9990085959434509
) O 0 0.018400471657514572
, O 0 0.01285218633711338
in O 0 0.010620075277984142
85 O 0 0.03140443190932274
% O 0 0.022273428738117218
of O 0 0.03226039931178093
patient O 1 0.9999264478683472
chromosomes O 0 0.08169008046388626
. O 0 0.05069439113140106

This O 0 0.04208202660083771
mutation O 0 0.06540926545858383
eliminates O 0 0.07234997302293777
the O 0 0.02212260290980339
ability O 0 0.021256497129797935
of O 0 0.023910289630293846
HFE O 1 0.9999383687973022
to O 0 0.019819708541035652
associate O 0 0.03427562490105629
with O 0 0.020075127482414246
beta2 O 1 0.9999790191650391
- O 1 0.9999984502792358
microglobulin O 1 0.9999867677688599
( O 0 0.034636758267879486
beta2m O 1 0.9988683462142944
) O 0 0.019725406542420387
and O 0 0.018512317910790443
prevents O 1 0.9850947856903076
cell O 1 0.9979730248451233
- O 1 0.9999903440475464
surface O 0 0.048841070383787155
expression O 0 0.04564492776989937
. O 0 0.03352935239672661

A O 0 0.05940160155296326
second O 0 0.051610805094242096
mutation O 0 0.046524886041879654
that O 0 0.010572873055934906
has O 0 0.012153277173638344
no O 0 0.010991358198225498
effect O 0 0.016358396038413048
on O 0 0.018206613138318062
beta2m O 1 0.9995675683021545
association O 0 0.040009308606386185
, O 0 0.026015447452664375
H63D O 1 0.9999898672103882
, O 0 0.018279999494552612
was O 0 0.017902733758091927
found O 0 0.008748497813940048
in O 0 0.0070336489006876945
eight O 0 0.010660836473107338
out O 0 0.01065788883715868
of O 0 0.014224905520677567
nine O 0 0.0292409248650074
patients O 1 0.997600257396698
heterozygous O 0 0.053193021565675735
for O 0 0.022430352866649628
the O 0 0.038699034601449966
C282Y O 1 0.9996585845947266
mutant O 1 0.9364047646522522
. O 0 0.05520796403288841

In O 0 0.031152591109275818
this O 0 0.017110656946897507
report O 0 0.019781289622187614
, O 0 0.013963744044303894
we O 0 0.010881876572966576
demonstrate O 0 0.021168546751141548
in O 0 0.01588772051036358
cultured O 0 0.07607409358024597
293 O 0 0.4971195161342621
cells O 0 0.05097467079758644
overexpressing O 1 0.9874380230903625
wild O 0 0.05384109541773796
- O 1 0.9999746084213257
type O 0 0.06547601521015167
or O 0 0.026471635326743126
mutant O 1 0.9948856234550476
HFE O 1 0.9999936819076538
proteins O 0 0.02425736002624035
that O 0 0.0071651083417236805
both O 0 0.00680939806625247
the O 0 0.013203821144998074
wild O 0 0.030900122597813606
- O 1 0.9999047517776489
type O 0 0.03787754476070404
and O 0 0.02431984432041645
H63D O 1 0.9999990463256836
HFE O 1 0.9999997615814209
proteins O 0 0.038917217403650284
form O 0 0.02586616389453411
stable O 0 0.19229060411453247
complexes O 0 0.04839273542165756
with O 0 0.017810845747590065
the O 0 0.0383354090154171
transferrin O 1 0.9999997615814209
receptor O 1 0.9999088048934937
( O 0 0.06636063754558563
TfR O 1 0.9999501705169678
) O 0 0.04113583639264107
. O 0 0.03804619610309601

The O 0 0.06465301662683487
C282Y O 1 0.997368574142456
mutation O 0 0.06576260179281235
nearly O 0 0.02998667024075985
completely O 0 0.04061103239655495
prevents O 0 0.04421333596110344
the O 0 0.017687475308775902
association O 0 0.02135687880218029
of O 0 0.01570822112262249
the O 0 0.03191479668021202
mutant O 1 0.999879002571106
HFE O 1 0.9999986886978149
protein O 0 0.04411090165376663
with O 0 0.022746305912733078
the O 0 0.04245072603225708
TfR O 1 0.9995623230934143
. O 0 0.05789399892091751

Studies O 0 0.034119874238967896
on O 0 0.027222374454140663
cell O 1 0.7377643585205078
- O 1 0.9998902082443237
associated O 0 0.03239842876791954
transferrin O 1 0.9923960566520691
at O 0 0.02543461136519909
37 O 0 0.03406265005469322
degrees O 0 0.02995530143380165
C O 0 0.06520824134349823
suggest O 0 0.013355575501918793
that O 0 0.007262152153998613
the O 0 0.014909683726727962
overexpressed O 1 0.9672079682350159
wild O 0 0.046783123165369034
- O 1 0.9999889135360718
type O 1 0.9784018397331238
HFE O 1 0.9999991655349731
protein O 0 0.04195305332541466
decreases O 0 0.03443703055381775
the O 0 0.019455915316939354
affinity O 0 0.03486736863851547
of O 0 0.022871140390634537
the O 0 0.04240206629037857
TfR O 1 0.9999247789382935
for O 0 0.052166663110256195
transferrin O 1 0.9996330738067627
. O 0 0.06327804923057556

The O 0 0.07351590692996979
overexpressed O 1 0.9999336004257202
H63D O 1 0.9999991655349731
protein O 0 0.0477270781993866
does O 0 0.015598664060235023
not O 0 0.007888640277087688
have O 0 0.005854932125657797
this O 0 0.007548648398369551
effect O 0 0.014904586598277092
, O 0 0.010947818867862225
providing O 0 0.014180350117385387
the O 0 0.01141146756708622
first O 0 0.012897067703306675
direct O 0 0.014005554839968681
evidence O 0 0.010732803493738174
for O 0 0.009949407540261745
a O 0 0.01917385868728161
functional O 0 0.030279917642474174
consequence O 0 0.03588416054844856
of O 0 0.02320762351155281
the O 0 0.052406564354896545
H63D O 1 0.9999980926513672
mutation O 1 0.5060182809829712
. O 0 0.047043778002262115

Addition O 0 0.03221768140792847
of O 0 0.0319828987121582
soluble O 1 0.9737293124198914
wild O 0 0.05950227007269859
- O 1 0.9999970197677612
type O 1 0.9972091317176819
HFE O 1 0.9999997615814209
/ O 1 0.9999806880950928
beta2m O 1 0.999958872795105
heterodimers O 1 0.9999635219573975
to O 0 0.03829662501811981
cultured O 1 0.999488353729248
cells O 0 0.03919927030801773
also O 0 0.01686442270874977
decreased O 0 0.027176542207598686
the O 0 0.019611572846770287
apparent O 0 0.07980898767709732
affinity O 0 0.03682747483253479
of O 0 0.01743985339999199
the O 0 0.026244832202792168
TfR O 1 0.9997175335884094
for O 0 0.015127914026379585
its O 0 0.017853839322924614
ligand O 0 0.07017172873020172
under O 0 0.023289933800697327
steady O 1 0.8990033268928528
- O 1 0.9996428489685059
state O 0 0.01537823025137186
conditions O 0 0.021175695583224297
, O 0 0.010559885762631893
both O 0 0.008995565585792065
in O 0 0.014836200512945652
293 O 1 0.9983130693435669
cells O 0 0.039929136633872986
and O 0 0.02118496224284172
in O 0 0.033950984477996826
HeLa O 1 0.999998927116394
cells O 0 0.14193174242973328
. O 0 0.043470315635204315

Furthermore O 0 0.0615338571369648
, O 0 0.023658115416765213
at O 0 0.020357167348265648
4 O 0 0.026006560772657394
degrees O 0 0.02806972712278366
C O 1 0.542309045791626
, O 0 0.014207771979272366
the O 0 0.016300147399306297
added O 0 0.02301088534295559
soluble O 0 0.1851230412721634
complex O 0 0.025850260630249977
of O 0 0.03315375745296478
HFE O 1 0.9999998807907104
/ O 1 0.999997615814209
beta2m O 1 0.9999669790267944
inhibited O 1 0.8074529767036438
binding O 0 0.029159901663661003
of O 0 0.024892084300518036
transferrin O 1 0.9982872605323792
to O 0 0.038184233009815216
HeLa O 1 0.9999959468841553
cell O 0 0.2519044578075409
TfR O 1 0.993436872959137
in O 0 0.018905075266957283
a O 0 0.03161890059709549
concentration O 1 0.999634861946106
- O 1 0.9999849796295166
dependent O 0 0.060246098786592484
manner O 0 0.05001053586602211
. O 0 0.038936931639909744

Scatchard O 0 0.4239639341831207
plots O 0 0.06130487471818924
of O 0 0.023335833102464676
these O 0 0.01131047960370779
data O 0 0.011166874319314957
indicate O 0 0.01214881706982851
that O 0 0.006858887150883675
the O 0 0.014423253014683723
added O 0 0.027401765808463097
heterodimer O 1 0.9995974898338318
substantially O 0 0.03611351177096367
reduced O 0 0.023461204022169113
the O 0 0.020067201927304268
affinity O 0 0.044953420758247375
of O 0 0.037170667201280594
TfR O 1 0.9999560117721558
for O 0 0.054271381348371506
transferrin O 1 0.9998096823692322
. O 0 0.06829652190208435

These O 0 0.021736331284046173
results O 0 0.016338510438799858
establish O 0 0.03033733367919922
a O 0 0.026324963197112083
molecular O 0 0.03450946509838104
link O 0 0.04093985632061958
between O 0 0.029629843309521675
HFE O 1 0.9999921321868896
and O 0 0.018914055079221725
a O 0 0.02369574084877968
key O 0 0.03418073430657387
protein O 0 0.020035075023770332
involved O 0 0.01414634007960558
in O 0 0.014891967177391052
iron O 1 0.9991758465766907
transport O 0 0.03833606094121933
, O 0 0.01539798267185688
the O 0 0.024554774165153503
TfR O 1 0.9999988079071045
, O 0 0.017502030357718468
and O 0 0.012068995274603367
raise O 0 0.016445113345980644
the O 0 0.012460855767130852
possibility O 0 0.016938162967562675
that O 0 0.008835739456117153
alterations O 0 0.02659210003912449
in O 0 0.010751206427812576
this O 0 0.011872532777488232
regulatory O 0 0.12992915511131287
mechanism O 0 0.04598986357450485
may O 0 0.012428431771695614
play O 0 0.009496578946709633
a O 0 0.012809474021196365
role O 0 0.017253316938877106
in O 0 0.010530040599405766
the O 0 0.023423198610544205
pathogenesis O 1 0.9999992847442627
of O 1 0.9996086955070496
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9887484312057495
. O 0 0.058251332491636276

Genomic O 0 0.0823855847120285
organization O 0 0.03526249900460243
of O 0 0.021005095914006233
the O 0 0.03849131613969803
UBE3A O 1 0.9999997615814209
/ O 1 0.9999963045120239
E6 O 1 0.9999992847442627
- O 1 0.9999973773956299
AP O 1 0.9045249819755554
gene O 0 0.04271052032709122
and O 0 0.02437126636505127
related O 0 0.04190101474523544
pseudogenes O 0 0.14015944302082062
. O 0 0.05309801921248436

The O 0 0.071198470890522
UBE3A O 1 0.9997431635856628
gene O 0 0.044390857219696045
encodes O 0 0.038682714104652405
the O 0 0.025144845247268677
E6 O 1 0.9995669722557068
- O 1 0.9997574687004089
AP O 1 0.5337284803390503
ubiquitin O 1 0.9960582256317139
- O 1 0.9999576807022095
protein O 0 0.036961544305086136
ligase O 0 0.045486267656087875
and O 0 0.01288782712072134
has O 0 0.01289286743849516
recently O 0 0.01774952933192253
been O 0 0.01058855652809143
shown O 0 0.009054670110344887
to O 0 0.008855604566633701
be O 0 0.010454799979925156
mutated O 0 0.06566880643367767
in O 1 0.8491160273551941
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 1 0.99928218126297
lack O 1 0.999737560749054
15q11 O 1 0.9999996423721313
- O 1 0.999998927116394
q13 O 1 0.9997081160545349
deletions O 0 0.09644553810358047
or O 0 0.03142758086323738
chromosome O 0 0.06267236918210983
15 O 0 0.04704451560974121
paternal O 1 0.9981582760810852
uniparental B-Disease 1 0.9999964237213135
disomy I-Disease 1 0.9998676776885986
. O 0 0.0723082423210144

Previous O 0 0.09129781275987625
UBE3A O 1 0.999849796295166
cDNA O 0 0.14320603013038635
analysis O 0 0.02864633873105049
has O 0 0.01785287633538246
shown O 0 0.017811821773648262
a O 0 0.02354223094880581
coding O 0 0.04284192994236946
region O 0 0.023448223248124123
of O 0 0.020354503765702248
approximately O 0 0.027179919183254242
2 O 0 0.04872437193989754
. O 0 0.044431474059820175

6 O 0 0.07145462185144424
kb O 0 0.09834801405668259
and O 0 0.01862325705587864
a O 0 0.022649815306067467
3 O 0 0.0376153327524662
- O 1 0.9998160004615784
untranslated O 1 0.989185094833374
region O 0 0.0375581830739975
( O 0 0.031611599028110504
UTR O 1 0.9738947153091431
) O 0 0.017603088170289993
of O 0 0.020823674276471138
< O 1 0.8706995844841003
50 O 0 0.02782745473086834
bp O 0 0.05042688921093941
, O 0 0.017552001401782036
whereas O 0 0.019930889829993248
Northern O 0 0.022885499522089958
analysis O 0 0.01273441594094038
has O 0 0.012055909261107445
indicated O 0 0.01750975474715233
mRNA O 0 0.022449560463428497
sizes O 0 0.012065868824720383
of O 0 0.014697004109621048
5 O 0 0.0363895408809185
- O 1 0.9988798499107361
8 O 0 0.05716070905327797
kb O 0 0.2918180227279663
. O 0 0.052169863134622574

We O 0 0.029286084696650505
have O 0 0.012929013930261135
analyzed O 0 0.023848455399274826
additional O 0 0.02413320168852806
cDNA O 0 0.09793587028980255
clones O 0 0.10099596530199051
and O 0 0.01973678544163704
provide O 0 0.01848323456943035
evidence O 0 0.014713619835674763
for O 0 0.012586992233991623
an O 0 0.01622673310339451
additional O 0 0.02314135618507862
0 O 0 0.05495273694396019
. O 0 0.039641544222831726

5 O 0 0.05205749347805977
kb O 0 0.08514885604381561
of O 0 0.027090691030025482
5 O 0 0.044398654252290726
- O 1 0.9998477697372437
UTR O 1 0.9975765347480774
and O 0 0.02365674078464508
> O 0 0.08460927754640579
2 O 0 0.030494485050439835
kb O 0 0.07363195717334747
of O 0 0.028793031349778175
3 O 0 0.05709861218929291
- O 1 0.9998111128807068
UTR O 1 0.9865648746490479
. O 0 0.04870721697807312

We O 0 0.022493647411465645
have O 0 0.011006546206772327
established O 0 0.023034969344735146
the O 0 0.01943529210984707
genomic O 0 0.04279163479804993
organization O 0 0.028701176866889
of O 0 0.03126025199890137
UBE3A O 1 0.9999778270721436
and O 0 0.019523588940501213
the O 0 0.01812845468521118
sequence O 0 0.018675636500120163
of O 0 0.03150252252817154
intron O 1 0.9999982118606567
- O 1 0.9999892711639404
exon O 1 0.9053005576133728
borders O 0 0.06673257052898407
. O 0 0.04330752044916153

We O 0 0.027414044365286827
have O 0 0.01211390271782875
also O 0 0.013701998628675938
mapped O 0 0.02491796761751175
two O 0 0.011654839850962162
highly O 0 0.03199372813105583
homologous O 0 0.05727819725871086
processed O 0 0.037588078528642654
pseudogenes O 0 0.08311719447374344
, O 0 0.03088277392089367
UBE3AP1 O 1 0.9999669790267944
and O 0 0.032777298241853714
UBE3AP2 O 1 0.9999881982803345
, O 0 0.019059937447309494
to O 0 0.016224008053541183
chromosomes O 0 0.025926027446985245
2 O 0 0.02056642435491085
and O 0 0.013782602734863758
21 O 0 0.023334311321377754
, O 0 0.016105806455016136
respectively O 0 0.020942162722349167
, O 0 0.014738284051418304
and O 0 0.013383553363382816
determined O 0 0.02372589148581028
their O 0 0.019833680242300034
genomic O 0 0.05674581602215767
organization O 0 0.0505744069814682
. O 0 0.04169907420873642

These O 0 0.024071691557765007
results O 0 0.019196776673197746
will O 0 0.013521968387067318
form O 0 0.012492057867348194
the O 0 0.012310342863202095
basis O 0 0.011917917989194393
for O 0 0.01137431338429451
studies O 0 0.013643365353345871
of O 0 0.021029368042945862
mutation O 0 0.05506110563874245
and O 0 0.030035387724637985
imprinting O 1 0.9976515173912048
of O 0 0.0742274671792984
UBE3A O 1 0.9999983310699463
. O 0 0.06790038198232651

Mutation O 0 0.12155904620885849
spectrum O 0 0.06750687211751938
and O 0 0.03498025983572006
genotype O 1 0.9991605281829834
- O 1 0.9999470710754395
phenotype O 0 0.1907503306865692
analyses O 0 0.026768609881401062
in O 0 0.024498825892806053
Cowden B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999996423721313
and O 1 0.7476620078086853
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.040775198489427567
two O 0 0.04340073838829994
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.9962652325630188
germline O 1 0.9999998807907104
PTEN O 1 0.9999998807907104
mutation O 1 0.9513163566589355
. O 0 0.06345675140619278

The O 1 0.6244540214538574
tumour B-Disease 1 1.0
suppressor O 1 0.9999998807907104
gene O 1 0.9931555390357971
PTEN O 1 0.9999884366989136
, O 0 0.0315348356962204
which O 0 0.019010156393051147
maps O 0 0.025698937475681305
to O 0 0.02863539569079876
10q23 O 1 0.7998020648956299
. O 0 0.04727068915963173

3 O 0 0.048841290175914764
and O 0 0.025742415338754654
encodes O 0 0.047828707844018936
a O 0 0.03166584298014641
403 O 0 0.09233369678258896
amino O 0 0.0484701432287693
acid O 0 0.05686228722333908
dual O 0 0.06164030358195305
specificity O 0 0.2066505402326584
phosphatase O 1 0.9997838139533997
( O 0 0.038879912346601486
protein O 0 0.03822832927107811
tyrosine O 1 0.9159933924674988
phosphatase O 1 0.9998180270195007
; O 0 0.03032517433166504
PTPase O 1 0.9999490976333618
) O 0 0.018564322963356972
, O 0 0.014868928119540215
was O 0 0.017441431060433388
shown O 0 0.012704686261713505
recently O 0 0.01647304929792881
to O 0 0.009982872754335403
play O 0 0.011165989562869072
a O 0 0.016716016456484795
broad O 0 0.035251062363386154
role O 0 0.03901955857872963
in O 0 0.025153454393148422
human O 1 0.8665480613708496
malignancy B-Disease 1 0.9999998807907104
. O 0 0.06509730219841003

Somatic O 1 0.9998218417167664
PTEN O 1 0.9999899864196777
deletions O 0 0.14388440549373627
and O 0 0.025482134893536568
mutations O 0 0.02449052967131138
were O 0 0.007654391694813967
observed O 0 0.011578202247619629
in O 0 0.011053922586143017
sporadic B-Disease 1 0.9927970767021179
breast I-Disease 1 1.0
, I-Disease 1 0.9944515824317932
brain I-Disease 1 0.9999972581863403
, I-Disease 1 0.9925400614738464
prostate I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999982118606567
lines O 0 0.02605605497956276
and O 0 0.010712631046772003
in O 0 0.008523821830749512
several O 0 0.010624630376696587
primary O 1 0.6193662881851196
tumours B-Disease 1 0.9999998807907104
such O 0 0.019245866686105728
as O 1 0.9399961233139038
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9999992847442627
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.993339478969574

In O 0 0.03133383393287659
addition O 0 0.029537642374634743
, O 0 0.03293206915259361
PTEN O 1 0.9999798536300659
was O 0 0.028391314670443535
identified O 0 0.018533453345298767
as O 0 0.012034708634018898
the O 0 0.018569067120552063
susceptibility O 1 0.9885923862457275
gene O 0 0.01990986242890358
for O 0 0.012173425406217575
two O 0 0.02768525294959545
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.998292863368988
CD B-Disease 1 0.9999061822891235
; O 0 0.04533206298947334
MIM O 1 0.9999995231628418
158350 O 1 0.9983882904052734
) O 0 0.020079268142580986
and O 0 0.019410541281104088
Bannayan B-Disease 1 0.9996834993362427
- I-Disease 1 0.9999954700469971
Zonana I-Disease 1 0.9999897480010986
( I-Disease 0 0.04939482361078262
BZS I-Disease 1 0.9992526173591614
) I-Disease 0 0.021709557622671127
or I-Disease 0 0.01928803324699402
Ruvalcaba I-Disease 1 0.9999579191207886
- I-Disease 1 0.9999743700027466
Riley I-Disease 1 0.9998668432235718
- I-Disease 1 0.9999998807907104
Smith I-Disease 1 0.9999983310699463
syndrome I-Disease 1 1.0
( O 1 0.998986542224884
MIM O 1 1.0
153480 O 1 0.9999977350234985
) O 0 0.04925094172358513
. O 0 0.04209280386567116

Constitutive O 0 0.4671975076198578
DNA O 0 0.04996465891599655
from O 0 0.023921409621834755
37 O 0 0.051246725022792816
CD B-Disease 0 0.0841720774769783
families O 0 0.027112511917948723
and O 0 0.018443774431943893
seven O 0 0.03341469541192055
BZS B-Disease 1 0.9995092153549194
families O 0 0.037795908749103546
was O 0 0.0363791398704052
screened O 0 0.0684070885181427
for O 0 0.043299123644828796
germline O 1 0.9999817609786987
PTEN O 1 0.9999969005584717
mutations O 0 0.10938385128974915
. O 0 0.0544658862054348

PTEN O 1 0.9999758005142212
mutations O 0 0.05836281552910805
were O 0 0.015359889715909958
identified O 0 0.018807804211974144
in O 0 0.0097799776121974
30 O 0 0.013389837928116322
of O 0 0.015132994391024113
37 O 0 0.035778939723968506
( O 0 0.02142885886132717
81 O 0 0.04616083577275276
% O 0 0.02228606306016445
) O 0 0.020906962454319
CD B-Disease 0 0.04969506710767746
families O 0 0.02067922055721283
, O 0 0.01412259228527546
including O 0 0.017206082120537758
missense O 0 0.08173131197690964
and O 0 0.023805834352970123
nonsense O 0 0.4476374387741089
point O 0 0.03475506231188774
mutations O 0 0.034526243805885315
, O 0 0.019138719886541367
deletions O 0 0.052787359803915024
, O 0 0.022742994129657745
insertions O 0 0.0688864067196846
, O 0 0.01853230409324169
a O 0 0.03240777924656868
deletion O 1 0.9571202993392944
/ O 1 0.9998132586479187
insertion O 0 0.4280358850955963
and O 0 0.0374782532453537
splice O 0 0.34521833062171936
site O 0 0.06424390524625778
mutations O 0 0.059833601117134094
. O 0 0.04067787528038025

These O 0 0.035356953740119934
mutations O 0 0.03521227464079857
were O 0 0.011883536353707314
scattered O 0 0.021067101508378983
over O 0 0.014396727085113525
the O 0 0.015736261382699013
entire O 0 0.025979505851864815
length O 0 0.020450597628951073
of O 0 0.028971774503588676
PTEN O 1 0.999998927116394
, O 0 0.016380323097109795
with O 0 0.01089745294302702
the O 0 0.013397613540291786
exception O 0 0.017354583367705345
of O 0 0.011675982736051083
the O 0 0.014765861444175243
first O 0 0.018177630379796028
, O 0 0.017111890017986298
fourth O 0 0.03690473735332489
and O 0 0.02087589167058468
last O 0 0.040068428963422775
exons O 0 0.09003301709890366
. O 0 0.040079616010189056

A O 0 0.07551030814647675
hot O 0 0.11948563903570175
spot O 0 0.054912764579057693
for O 0 0.03154335543513298
PTEN O 1 0.9999887943267822
mutation O 0 0.05099063739180565
in O 0 0.01739024929702282
CD B-Disease 0 0.399750292301178
was O 0 0.020092526450753212
identified O 0 0.015695957466959953
in O 0 0.011247895658016205
exon O 0 0.0530112124979496
5 O 0 0.015023650601506233
that O 0 0.0064300973899662495
contains O 0 0.013268479146063328
the O 0 0.018433641642332077
PTPase O 1 0.9999542236328125
core O 1 0.9260358810424805
motif O 0 0.0872717872262001
, O 0 0.01173594780266285
with O 0 0.009068193845450878
13 O 0 0.013148440979421139
of O 0 0.012492646463215351
30 O 0 0.018153196200728416
( O 0 0.01680128276348114
43 O 0 0.027425678446888924
% O 0 0.019544798880815506
) O 0 0.02228517085313797
CD B-Disease 0 0.19556166231632233
mutations O 0 0.02905246429145336
identified O 0 0.023069705814123154
in O 0 0.013909859582781792
this O 0 0.020174775272607803
exon O 0 0.12441403418779373
. O 0 0.046594612300395966

Seven O 0 0.03405723720788956
of O 0 0.0266614630818367
30 O 0 0.030145099386572838
( O 0 0.023333752527832985
23 O 0 0.025678059086203575
% O 0 0.015384918078780174
) O 0 0.009677032008767128
were O 0 0.005670974962413311
within O 0 0.008508292958140373
the O 0 0.015052524395287037
core O 0 0.49967533349990845
motif O 0 0.24861246347427368
, O 0 0.011587887071073055
the O 0 0.012879342772066593
majority O 0 0.015878617763519287
( O 0 0.012190991081297398
five O 0 0.009495440870523453
of O 0 0.011686310172080994
seven O 0 0.016239052638411522
) O 0 0.013196311891078949
of O 0 0.012831490486860275
which O 0 0.011204034090042114
were O 0 0.014871479012072086
missense O 1 0.8474728465080261
mutations O 0 0.04007863625884056
, O 0 0.018849192187190056
possibly O 0 0.021500641480088234
pointing O 0 0.023725206032395363
to O 0 0.014078748412430286
the O 0 0.017746826633810997
functional O 0 0.030730079859495163
significance O 0 0.022557323798537254
of O 0 0.01989729143679142
this O 0 0.01872282288968563
region O 0 0.042997587472200394
. O 0 0.037196338176727295

Germline O 1 0.9999569654464722
PTEN O 1 0.9999923706054688
mutations O 0 0.057156018912792206
were O 0 0.013559590093791485
identified O 0 0.014380233362317085
in O 0 0.008149230852723122
four O 0 0.008117522113025188
of O 0 0.013900071382522583
seven O 0 0.022690782323479652
( O 0 0.025572875514626503
57 O 0 0.04934651404619217
% O 0 0.033138178288936615
) O 0 0.03688301891088486
BZS B-Disease 1 0.9970701932907104
families O 0 0.05190378800034523
studied O 0 0.05136462673544884
. O 0 0.04552064090967178

Interestingly O 0 0.13384120166301727
, O 0 0.025648722425103188
none O 0 0.018485011532902718
of O 0 0.016925476491451263
these O 0 0.012653565965592861
mutations O 0 0.024094274267554283
was O 0 0.019808301702141762
observed O 0 0.016550147905945778
in O 0 0.012040045112371445
the O 0 0.02773791365325451
PTPase O 1 0.9999668598175049
core O 1 0.9933134913444519
motif O 0 0.4298783838748932
. O 0 0.0446225106716156

It O 0 0.025134999305009842
is O 0 0.018494272604584694
also O 0 0.014780622906982899
worthy O 0 0.03968627750873566
of O 0 0.016830427572131157
note O 0 0.019713670015335083
that O 0 0.007195763289928436
a O 0 0.014287788420915604
single O 0 0.022580202668905258
nonsense O 0 0.05663646012544632
point O 0 0.024340547621250153
mutation O 0 0.03719037026166916
, O 0 0.01978408731520176
R233X O 1 0.9975638389587402
, O 0 0.016789400950074196
was O 0 0.017237598076462746
observed O 0 0.013062629848718643
in O 0 0.01010633073747158
the O 0 0.019786102697253227
germline O 1 0.7421427965164185
DNA O 0 0.023982111364603043
from O 0 0.013363161124289036
two O 0 0.012969421222805977
unrelated O 0 0.042017750442028046
CD B-Disease 0 0.22928549349308014
families O 0 0.03178887814283371
and O 0 0.026022177189588547
one O 0 0.040519312024116516
BZS B-Disease 1 0.9998977184295654
family O 0 0.07878293842077255
. O 0 0.052049871534109116

Genotype O 1 0.9998687505722046
- O 1 0.9999953508377075
phenotype O 1 0.9895074963569641
studies O 0 0.019735850393772125
were O 0 0.010758176445960999
not O 0 0.010141137056052685
performed O 0 0.018419239670038223
on O 0 0.01164760161191225
this O 0 0.007662842515856028
small O 0 0.014670724980533123
group O 0 0.028778240084648132
of O 0 0.034733809530735016
BZS B-Disease 1 0.99979168176651
families O 0 0.06285640597343445
. O 0 0.048058025538921356

However O 0 0.040644384920597076
, O 0 0.04104435071349144
genotype O 1 0.9902143478393555
- O 1 0.9998102784156799
phenotype O 0 0.09270194172859192
analysis O 0 0.023006781935691833
inthe O 0 0.2950373888015747
group O 0 0.03306569904088974
of O 0 0.024823881685733795
CD B-Disease 1 0.6644207835197449
families O 0 0.024925842881202698
revealed O 0 0.02236115001142025
two O 0 0.009595784358680248
possible O 0 0.01601427234709263
associations O 0 0.021175943315029144
worthy O 0 0.05028223246335983
of O 0 0.02116035483777523
follow O 0 0.03506665676832199
- O 1 0.9996017813682556
up O 0 0.023938670754432678
in O 0 0.016067594289779663
independent O 0 0.032873474061489105
analyses O 0 0.04329831153154373
. O 0 0.03609973564743996

The O 0 0.03336836025118828
first O 0 0.0246431827545166
was O 0 0.024584824219346046
an O 0 0.01524908747524023
association O 0 0.02261914126574993
noted O 0 0.01328298356384039
in O 0 0.007220899220556021
the O 0 0.011654993519186974
group O 0 0.016995038837194443
of O 0 0.016751965507864952
CD B-Disease 1 0.9252033829689026
families O 0 0.0381762869656086
with O 1 0.9040321111679077
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.5135200619697571

A O 0 0.07035147398710251
correlation O 0 0.04958242550492287
was O 0 0.027103999629616737
observed O 0 0.015459539368748665
between O 0 0.011813203804194927
the O 0 0.017009204253554344
presence O 0 0.038134705275297165
/ O 1 0.9918740391731262
absence O 0 0.03176281973719597
of O 0 0.018346032127738
a O 0 0.2672744691371918
PTEN O 1 0.9999997615814209
mutation O 0 0.03533473238348961
and O 0 0.011096512898802757
the O 0 0.014647018164396286
type O 0 0.03558381274342537
of O 0 0.059794072061777115
breast O 1 1.0
involvement O 1 0.9999862909317017
( O 1 0.5341625213623047
unaffected O 1 0.9997686743736267
versus O 1 0.9996976852416992
benign O 1 1.0
versus O 1 0.9999984502792358
malignant O 1 1.0
) O 0 0.057128529995679855
. O 0 0.04305298998951912

Specifically O 0 0.04691985249519348
and O 0 0.017085028812289238
more O 0 0.009758767671883106
directly O 0 0.01561162993311882
, O 0 0.012263393960893154
an O 0 0.012384951114654541
association O 0 0.0422656424343586
was O 0 0.02096913382411003
also O 0 0.010007484816014767
observed O 0 0.009810336865484715
between O 0 0.00781007157638669
the O 0 0.010039298795163631
presence O 0 0.014125699177384377
of O 0 0.013368588872253895
a O 0 0.035826537758111954
PTEN O 1 0.9999996423721313
mutation O 1 0.9993046522140503
and O 1 0.9997765421867371
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.977640688419342

Secondly O 1 0.9441885352134705
, O 0 0.03311821073293686
there O 0 0.01499530952423811
appeared O 0 0.020401738584041595
to O 0 0.012705733068287373
be O 0 0.01111948024481535
an O 0 0.01757591962814331
interdependent O 1 0.9572824835777283
association O 0 0.03315899521112442
between O 0 0.025363624095916748
mutations O 0 0.034708574414253235
upstream O 0 0.03273126855492592
and O 0 0.012155699543654919
within O 0 0.01261309627443552
the O 0 0.022675756365060806
PTPase O 1 0.9999611377716064
core O 1 0.9555595517158508
motif O 0 0.24706432223320007
, O 0 0.016011536121368408
the O 0 0.020203854888677597
core O 0 0.050704214721918106
motif O 0 0.04153415560722351
containing O 0 0.015157739631831646
the O 0 0.011285774409770966
majority O 0 0.018320325762033463
of O 0 0.023417333140969276
missense O 1 0.9971562623977661
mutations O 0 0.03444667533040047
, O 0 0.013913214206695557
and O 0 0.010251861996948719
the O 0 0.01165776140987873
involvement O 0 0.02184220775961876
of O 0 0.011152339167892933
all O 0 0.010043754242360592
major O 0 0.42873311042785645
organ O 1 0.9999985694885254
systems O 1 0.6622079610824585
( O 0 0.01706971600651741
central O 0 0.029871059581637383
nervous O 1 0.9947047829627991
system O 0 0.03434652462601662
, O 0 0.495779424905777
thyroid O 1 1.0
, O 1 0.99951171875
breast O 1 1.0
, O 1 0.9999263286590576
skin O 1 1.0
and O 1 0.9999977350234985
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.992893397808075
. O 0 0.048830971121788025

However O 0 0.03841428458690643
, O 0 0.022687625139951706
these O 0 0.011063694953918457
observations O 0 0.01832682266831398
would O 0 0.01200733333826065
need O 0 0.013724257238209248
to O 0 0.010326651856303215
be O 0 0.007434637285768986
confirmed O 0 0.011918014846742153
by O 0 0.0089032594114542
studying O 0 0.01232846174389124
a O 0 0.013377810828387737
larger O 0 0.013013720512390137
number O 0 0.011455873027443886
of O 0 0.024639496579766273
CD B-Disease 1 0.9343634843826294
families O 0 0.04600721597671509
. O 0 0.04166863486170769

Molecular O 1 0.8334459662437439
defects O 1 0.9958364963531494
leading O 0 0.045817404985427856
to O 0 0.02222009189426899
human O 0 0.03424603119492531
complement B-Disease 1 0.9988490343093872
component I-Disease 1 0.9999998807907104
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.020228581503033638
an O 0 0.020371409133076668
African O 1 0.8827680945396423
- O 1 0.9999728202819824
American O 0 0.04635189473628998
family O 0 0.0467827208340168
. O 0 0.03540389612317085

Complement B-Disease 1 0.9721970558166504
component I-Disease 1 0.999994158744812
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9981405735015869
C6D B-Disease 1 0.9999998807907104
) O 0 0.036256466060876846
was O 0 0.050819192081689835
diagnosed O 1 0.9998698234558105
in O 0 0.012150615453720093
a O 0 0.01656336337327957
16 O 0 0.024556441232562065
- O 1 0.9978659749031067
year O 0 0.019265227019786835
- O 1 0.9915609955787659
old O 0 0.039394672960042953
African O 0 0.04100501537322998
- O 1 0.9958511590957642
American O 0 0.034885223954916
male O 0 0.20595955848693848
with O 1 0.7455735206604004
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9565457701683044

The O 0 0.07029091566801071
patients O 1 0.9989926218986511
father O 1 0.5050283670425415
and O 0 0.017869504168629646
two O 0 0.013934236019849777
brothers O 0 0.27360138297080994
also O 0 0.01834685727953911
had O 0 0.026323264464735985
C6D B-Disease 1 0.9999926090240479
, O 0 0.01585787907242775
but O 0 0.009118224494159222
gave O 0 0.014032118022441864
no O 0 0.009192890487611294
history O 0 0.01845335029065609
of O 0 0.08420497924089432
meningitis B-Disease 1 1.0
or O 0 0.3965975046157837
other O 0 0.0467500239610672
neisserial B-Disease 1 0.9999998807907104
infection I-Disease 1 1.0
. O 0 0.0721970945596695

By O 0 0.03213753551244736
using O 0 0.0248701348900795
exon O 0 0.12065839767456055
- O 1 0.9187002778053284
specific O 0 0.02358882501721382
polymerase O 0 0.4280884563922882
chain O 0 0.06224612146615982
reaction O 0 0.0420951321721077
( O 0 0.027741117402911186
PCR O 0 0.07873173803091049
) O 0 0.02484861947596073
/ O 0 0.2515682578086853
single O 0 0.03988310322165489
- O 1 0.9980294108390808
strand O 0 0.07987336069345474
conformation O 0 0.06070048362016678
polymorphism O 0 0.04377433657646179
as O 0 0.015457929112017155
a O 0 0.02357964590191841
screening O 0 0.04615643247961998
step O 0 0.0326433964073658
and O 0 0.01622420735657215
nucleotide O 0 0.030521975830197334
sequencing O 0 0.019374344497919083
of O 0 0.013468737713992596
target O 0 0.027493594214320183
exons O 0 0.04145815968513489
, O 0 0.014291630126535892
we O 0 0.00939278956502676
determined O 0 0.013894411735236645
that O 0 0.006505412515252829
the O 0 0.014304399490356445
proband O 1 0.9904963970184326
was O 0 0.023726485669612885
a O 0 0.0230263564735651
compound O 0 0.06653675436973572
heterozygote O 0 0.2975232005119324
for O 0 0.017414653673768044
two O 0 0.029023930430412292
C6 O 1 0.9999996423721313
gene O 0 0.087244912981987
mutations O 0 0.06261209398508072
. O 0 0.039748698472976685

The O 0 0.040404271334409714
first O 0 0.03271942958235741
, O 0 0.026442350819706917
1195delC O 1 0.705734372138977
located O 0 0.029879530891776085
in O 0 0.015142244286835194
exon O 0 0.1571895182132721
7 O 0 0.028419865295290947
, O 0 0.01470958348363638
is O 0 0.012004747986793518
a O 0 0.01824684627354145
novel O 0 0.042158279567956924
mutation O 0 0.036951225250959396
, O 0 0.01243447232991457
while O 0 0.010054142214357853
the O 0 0.013196456246078014
second O 0 0.023695791140198708
, O 0 0.018913550302386284
1936delG O 1 0.93355792760849
in O 0 0.015881866216659546
exon O 0 0.10990232229232788
12 O 0 0.02034274861216545
, O 0 0.014871254563331604
has O 0 0.011992601677775383
been O 0 0.01012365147471428
described O 0 0.01602691411972046
before O 0 0.013474290259182453
to O 0 0.017693044617772102
cause O 1 0.8283945918083191
C6D B-Disease 1 0.9999649524688721
in O 0 0.014697576873004436
an O 0 0.015186859294772148
unrelated O 0 0.03485816344618797
African O 1 0.7656061053276062
- O 1 0.9999823570251465
American O 0 0.04201759025454521
individual O 0 0.02803857810795307
. O 0 0.03292696923017502

Both O 0 0.04283439368009567
mutations O 0 0.04393817484378815
result O 0 0.02287774719297886
in O 0 0.024320218712091446
premature O 1 0.9993519186973572
termination O 1 0.9999028444290161
codons O 1 0.9088247418403625
and O 0 0.06702601164579391
C6 O 1 0.9999995231628418
null O 1 0.983177125453949
alleles O 0 0.12140020728111267
. O 0 0.05264139175415039

Allele O 1 0.9013854265213013
- O 1 0.9985384941101074
specific O 0 0.027642998844385147
PCR O 0 0.06470953673124313
indicated O 0 0.020199891179800034
that O 0 0.008907224051654339
the O 0 0.015930190682411194
probands O 0 0.4182143807411194
two O 0 0.013905445113778114
brothers O 0 0.042470697313547134
also O 0 0.01788298413157463
inherited O 1 0.8642475605010986
the O 0 0.03262743353843689
1195delC O 1 0.9999707937240601
mutation O 0 0.043565914034843445
from O 0 0.014202609658241272
their O 0 0.014666278846561909
heterozygous O 0 0.05961843952536583
mother O 0 0.16240017116069794
and O 0 0.017483236268162727
the O 0 0.028179533779621124
1936delG O 1 0.9996829032897949
mutation O 0 0.04465342313051224
from O 0 0.017351817339658737
their O 0 0.018721114844083786
homozygous O 0 0.07645648717880249
father O 0 0.36330971121788025
. O 0 0.03435302525758743
. O 0 0.0410480797290802

PAX6 O 1 0.9999589920043945
mutations O 0 0.14451159536838531
reviewed O 0 0.09188617020845413
. O 0 0.05852602794766426

Mutations O 0 0.0837070420384407
in O 0 0.037174832075834274
PAX6 O 1 0.9999785423278809
are O 0 0.014162483625113964
responsible O 0 0.026695700362324715
for O 0 0.017856979742646217
human O 1 0.6240689158439636
aniridia B-Disease 1 1.0
and O 0 0.018089139834046364
have O 0 0.008465372025966644
also O 0 0.00773959094658494
been O 0 0.0076844836585223675
found O 0 0.008369659073650837
in O 0 0.011027541011571884
patients O 1 0.9127889275550842
with O 0 0.022009171545505524
Peters B-Disease 1 0.9999984502792358
anomaly I-Disease 1 0.9999980926513672
, O 0 0.0413481742143631
with O 1 0.99945467710495
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9990543723106384
with O 1 0.9977537989616394
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 1 0.8217756152153015
and O 0 0.025970907881855965
with O 0 0.04044748470187187
isolated B-Disease 1 0.9999396800994873
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.09023527801036835

No O 0 0.042381446808576584
locus O 0 0.06937061250209808
other O 0 0.013859404250979424
than O 0 0.016277728602290154
chromosome O 0 0.06067369133234024
11p13 O 1 0.9850257039070129
has O 0 0.018102094531059265
been O 0 0.0154413478448987
implicated O 1 0.5972690582275391
in O 0 0.023280179128050804
aniridia B-Disease 1 0.999998927116394
, O 0 0.02593926526606083
and O 0 0.02827988751232624
PAX6 O 1 1.0
is O 0 0.019706476479768753
clearly O 0 0.017146097496151924
the O 0 0.015189804136753082
major O 0 0.02493227645754814
, O 0 0.013249040581285954
if O 0 0.01009954884648323
not O 0 0.007588989567011595
only O 0 0.009918880648911
, O 0 0.017286701127886772
gene O 0 0.03197286278009415
responsible O 0 0.04357423260807991
. O 0 0.03780980035662651

Twenty O 0 0.08043219894170761
- O 0 0.45409145951271057
eight O 0 0.02069804072380066
percent O 0 0.016978725790977478
of O 0 0.018413959071040154
identified O 0 0.03781261667609215
PAX6 O 1 0.9999971389770508
mutations O 0 0.03305800259113312
are O 0 0.011543113738298416
C O 1 0.9998687505722046
- O 1 0.9999980926513672
T O 1 0.9991928935050964
changes O 0 0.01634988747537136
at O 0 0.02407040446996689
CpG O 1 0.9854742288589478
dinucleotides O 1 0.9884722232818604
, O 0 0.018585845828056335
20 O 0 0.016147729009389877
% O 0 0.013333878479897976
are O 0 0.008029278367757797
splicing O 0 0.035834770649671555
errors O 0 0.02416922338306904
, O 0 0.013421747833490372
and O 0 0.009528117254376411
more O 0 0.006625088397413492
than O 0 0.00950664933770895
30 O 0 0.018413420766592026
% O 0 0.017436765134334564
are O 0 0.011517961509525776
deletion O 0 0.06785689294338226
or O 0 0.032468970865011215
insertion O 0 0.24782492220401764
events O 0 0.04085041210055351
. O 0 0.04195594787597656

There O 0 0.02475525625050068
is O 0 0.019031858071684837
a O 0 0.027218621224164963
noticeably O 0 0.3218793272972107
elevated O 1 0.9994527697563171
level O 0 0.027464846149086952
of O 0 0.02173779532313347
mutation O 0 0.03475723788142204
in O 0 0.012840516865253448
the O 0 0.0202851053327322
paired O 0 0.06993331760168076
domain O 0 0.02767263539135456
compared O 0 0.014545171521604061
with O 0 0.010670185089111328
the O 0 0.014142890460789204
rest O 0 0.02157074399292469
of O 0 0.020446786656975746
the O 0 0.03207383677363396
gene O 0 0.05014274641871452
. O 0 0.03678257390856743

Increased O 0 0.06922583281993866
mutation O 0 0.05636276677250862
in O 0 0.018369492143392563
the O 0 0.033238448202610016
homeodomain O 1 0.998559296131134
is O 0 0.022370146587491035
accounted O 0 0.026162344962358475
for O 0 0.01390915922820568
by O 0 0.017245624214410782
the O 0 0.033280111849308014
hypermutable O 1 0.9998812675476074
CpG O 1 0.9987573623657227
dinucleotide O 1 0.9800646901130676
in O 0 0.03535608574748039
codon O 0 0.10661280900239944
240 O 0 0.08049832284450531
. O 0 0.0472121499478817

Very O 0 0.030373478308320045
nearly O 0 0.024777919054031372
all O 0 0.019728487357497215
mutations O 0 0.032775621861219406
appear O 0 0.018625376746058464
to O 0 0.018097637221217155
cause O 0 0.4519447684288025
loss O 0 0.03246777877211571
of O 0 0.017177321016788483
function O 0 0.015750395134091377
of O 0 0.013692949898540974
the O 0 0.02389177493751049
mutant O 1 0.9992528557777405
allele O 0 0.4141118824481964
, O 0 0.015540488064289093
and O 0 0.010113030672073364
more O 0 0.006352975498884916
than O 0 0.007984481751918793
80 O 0 0.019130732864141464
% O 0 0.015530985780060291
of O 0 0.022379163652658463
exonic O 1 0.9953579306602478
substitutions O 0 0.054173607379198074
result O 0 0.022182779386639595
in O 0 0.025059258565306664
nonsense O 1 0.5662510395050049
codons O 0 0.11218678951263428
. O 0 0.05116615071892738

In O 0 0.028068196028470993
a O 0 0.0321393683552742
gene O 0 0.027506090700626373
with O 0 0.014566360041499138
such O 0 0.014591208659112453
extraordinarily O 1 0.918766975402832
high O 0 0.0409449003636837
sequence O 0 0.019259583204984665
conservation O 0 0.0247491467744112
throughout O 0 0.014055336825549603
evolution O 0 0.019796203821897507
, O 0 0.011674651876091957
there O 0 0.00855069886893034
are O 0 0.007982993498444557
presumed O 0 0.051050588488578796
undiscovered O 1 0.9988921284675598
missense O 1 0.9970479607582092
mutations O 0 0.043666303157806396
, O 0 0.016087396070361137
these O 0 0.008703547529876232
are O 0 0.007886184379458427
hypothesized O 0 0.027541466057300568
to O 0 0.012393037788569927
exist O 0 0.011047382839024067
in O 0 0.009600217454135418
as O 0 0.0189554151147604
- O 1 0.9996386766433716
yet O 0 0.029810693114995956
unidentified O 0 0.1452687680721283
phenotypes O 0 0.11393387615680695
. O 0 0.028674455359578133
. O 0 0.035655271261930466

Genetic O 0 0.09558344632387161
heterogeneity O 0 0.1441487967967987
and O 0 0.03533150255680084
penetrance O 1 0.987622082233429
analysis O 0 0.015299398452043533
of O 0 0.01606227271258831
the O 0 0.027289606630802155
BRCA1 O 1 0.999795138835907
and O 0 0.03349965810775757
BRCA2 O 1 0.9999879598617554
genes O 0 0.04466412216424942
in O 0 0.08120822161436081
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9585326313972473
. O 0 0.05888853222131729

The O 1 0.9944508671760559
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999985694885254
Consortium O 1 0.9427547454833984
. O 0 0.06118832156062126

The O 0 0.03366977721452713
contribution O 0 0.03877812623977661
of O 0 0.03155126795172691
BRCA1 O 1 0.9999297857284546
and O 0 0.030448447912931442
BRCA2 O 1 0.9999213218688965
to O 1 0.5216411352157593
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9998582601547241
assessed O 0 0.05099642649292946
by O 0 0.022745784372091293
linkage O 1 0.967187762260437
and O 0 0.018707139417529106
mutation O 0 0.03133770078420639
analysis O 0 0.010803786106407642
in O 0 0.011119705624878407
237 O 0 0.04964186251163483
families O 0 0.020771028473973274
, O 0 0.011885842308402061
each O 0 0.00630077812820673
with O 0 0.007002004887908697
at O 0 0.009021221660077572
least O 0 0.00606490159407258
four O 0 0.006834623869508505
cases O 0 0.014699370600283146
of O 1 0.9954337477684021
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.02082958072423935
collected O 0 0.013070845976471901
by O 0 0.016278110444545746
the O 1 0.9520864486694336
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999978542327881
Consortium O 1 0.7694413661956787
. O 0 0.04961903393268585

Families O 0 0.04237835481762886
were O 0 0.016025161370635033
included O 0 0.017247674986720085
without O 0 0.012322391383349895
regard O 0 0.017908142879605293
to O 0 0.011457368731498718
the O 0 0.016319584101438522
occurrence O 0 0.15731629729270935
of O 1 0.9829199910163879
ovarian B-Disease 1 1.0
or I-Disease 1 0.9903936982154846
other I-Disease 0 0.12733475863933563
cancers I-Disease 1 0.9999977350234985
. O 0 0.06090548634529114

Overall O 0 0.37265363335609436
, O 0 0.4730861485004425
disease O 1 0.999998927116394
was O 1 0.9223299026489258
linked O 1 0.5896495580673218
to O 0 0.024777740240097046
BRCA1 O 1 0.9996391534805298
in O 0 0.011924602091312408
an O 0 0.012002542614936829
estimated O 0 0.014437520876526833
52 O 0 0.02245345152914524
% O 0 0.011356612667441368
of O 0 0.012573600746691227
families O 0 0.01714787632226944
, O 0 0.01466839574277401
to O 0 0.018110528588294983
BRCA2 O 1 0.9926924109458923
in O 0 0.012641056440770626
32 O 0 0.02191041223704815
% O 0 0.012807810679078102
of O 0 0.013198069296777248
families O 0 0.019631028175354004
, O 0 0.012926324270665646
and O 0 0.010589735582470894
to O 0 0.013266137801110744
neither O 0 0.023154370486736298
gene O 0 0.018361816182732582
in O 0 0.00957192201167345
16 O 0 0.019096586853265762
% O 0 0.015721119940280914
( O 0 0.016118671745061874
95 O 0 0.024496285244822502
% O 0 0.01748357154428959
confidence O 0 0.0400208942592144
interval O 0 0.08076941967010498
[ O 0 0.2950233221054077
CI O 1 0.999991774559021
] O 0 0.04635082557797432
6 O 0 0.027290204539895058
% O 0 0.023193184286355972
- O 1 0.9797989130020142
28 O 0 0.03172030672430992
% O 0 0.020793013274669647
) O 0 0.017501305788755417
, O 0 0.017264574766159058
suggesting O 0 0.030753986909985542
other O 0 0.0266528632491827
predisposition O 1 0.9999815225601196
genes O 0 0.05084940046072006
. O 0 0.0439203605055809

The O 0 0.03511904552578926
majority O 0 0.033180899918079376
( O 0 0.02351737953722477
81 O 0 0.038821883499622345
% O 0 0.013734824024140835
) O 0 0.008318916894495487
of O 0 0.010984927415847778
the O 0 0.038952454924583435
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.2639167010784149
were O 0 0.012682204134762287
due O 0 0.018149366602301598
to O 0 0.022280734032392502
BRCA1 O 1 0.9999797344207764
, O 0 0.012876312248408794
with O 0 0.010096938349306583
most O 0 0.011398984119296074
others O 0 0.014313895255327225
( O 0 0.01761849783360958
14 O 0 0.021233215928077698
% O 0 0.019777733832597733
) O 0 0.018654515966773033
due O 0 0.026429053395986557
to O 0 0.03924120217561722
BRCA2 O 1 0.9991760849952698
. O 0 0.054001130163669586

Conversely O 0 0.10502821207046509
, O 0 0.02276800014078617
the O 0 0.017098689451813698
majority O 0 0.017332550138235092
of O 0 0.013805331662297249
families O 0 0.016463596373796463
with O 0 0.012494588270783424
male B-Disease 0 0.1910526007413864
and I-Disease 0 0.0384988859295845
female I-Disease 1 0.9999996423721313
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.018874602392315865
due O 0 0.027796318754553795
to O 0 0.03198951110243797
BRCA2 O 1 0.9999867677688599
( O 0 0.03480241447687149
76 O 0 0.24167263507843018
% O 0 0.03237483650445938
) O 0 0.028934231027960777
. O 0 0.03099757619202137

The O 0 0.038319215178489685
largest O 0 0.056408293545246124
proportion O 0 0.042494017630815506
( O 0 0.02496858686208725
67 O 0 0.040833406150341034
% O 0 0.018864654004573822
) O 0 0.013194194063544273
of O 0 0.012333509512245655
families O 0 0.017067676410079002
due O 0 0.015875088050961494
to O 0 0.011766438372433186
other O 0 0.010573172941803932
genes O 0 0.014249131083488464
was O 0 0.014932993799448013
found O 0 0.009356262162327766
in O 0 0.008431646972894669
families O 0 0.011857337318360806
with O 0 0.0088662663474679
four O 0 0.009514860808849335
or O 0 0.009135563857853413
five O 0 0.009622340090572834
cases O 0 0.01372078899294138
of O 0 0.042079608887434006
female O 1 0.9999998807907104
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.08042578399181366
. O 0 0.04129395633935928

These O 0 0.023494470864534378
estimates O 0 0.021500077098608017
were O 0 0.012416543439030647
not O 0 0.012472866103053093
substantially O 0 0.026712505146861076
affected O 0 0.02044740691781044
either O 0 0.012009182944893837
by O 0 0.011562617495656013
changing O 0 0.01578579656779766
the O 0 0.014990043826401234
assumed O 0 0.03931987285614014
penetrance O 1 0.9982511401176453
model O 0 0.031256306916475296
for O 0 0.022410564124584198
BRCA1 O 1 0.999976396560669
or O 0 0.01531271543353796
by O 0 0.012742321006953716
including O 0 0.015221379697322845
or O 0 0.023318862542510033
excluding O 0 0.17228849232196808
BRCA1 O 1 0.9999884366989136
mutation O 0 0.10038432478904724
data O 0 0.02963166870176792
. O 0 0.034279435873031616

Among O 0 0.03491687774658203
those O 0 0.01748310588300228
families O 0 0.029759902507066727
with O 0 0.03833717107772827
disease O 1 0.9999997615814209
due O 1 0.9428222179412842
to O 1 0.5942354798316956
BRCA1 O 1 0.9999985694885254
that O 0 0.011029916815459728
were O 0 0.009513656608760357
tested O 0 0.017717277631163597
by O 0 0.008007355965673923
one O 0 0.00793828722089529
of O 0 0.010081079788506031
the O 0 0.017356272786855698
standard O 0 0.030179033055901527
screening O 0 0.05020350590348244
methods O 0 0.017008516937494278
, O 0 0.015918569639325142
mutations O 0 0.020782245323061943
were O 0 0.009985145181417465
detected O 0 0.020301103591918945
in O 0 0.00984951201826334
the O 0 0.016669636592268944
coding O 0 0.03784086927771568
sequence O 0 0.018447786569595337
or O 0 0.015632102265954018
splice O 0 0.05458535626530647
sites O 0 0.01388011034578085
in O 0 0.0072037456557154655
an O 0 0.010069740936160088
estimated O 0 0.016835298389196396
63 O 0 0.03202807903289795
% O 0 0.017470618709921837
( O 0 0.015003468841314316
95 O 0 0.027247153222560883
% O 0 0.02646944858133793
CI O 1 0.9995772242546082
51 O 0 0.04969891905784607
% O 0 0.03592079132795334
- O 1 0.9990397095680237
77 O 0 0.07208894193172455
% O 0 0.033368583768606186
) O 0 0.03147624060511589
. O 0 0.03247416391968727

The O 0 0.045753803104162216
estimated O 0 0.040911637246608734
sensitivity O 0 0.05817371979355812
was O 0 0.026441331952810287
identical O 0 0.018586628139019012
for O 0 0.014401661232113838
direct O 0 0.026135986670851707
sequencing O 0 0.034012533724308014
and O 0 0.017570585012435913
other O 0 0.016598470509052277
techniques O 0 0.030659260228276253
. O 0 0.03487062454223633

The O 0 0.05855180695652962
penetrance O 1 0.9967418313026428
of O 0 0.05544527620077133
BRCA2 O 1 0.9997743964195251
was O 0 0.03491681441664696
estimated O 0 0.020421577617526054
by O 0 0.015934038907289505
maximizing O 0 0.057902541011571884
the O 0 0.024838194251060486
LOD O 1 0.9996975660324097
score O 0 0.022192006930708885
in O 0 0.02180853858590126
BRCA2 O 1 0.9999918937683105
- O 1 0.999997615814209
mutation O 0 0.0883600115776062
families O 0 0.020021231845021248
, O 0 0.01261394564062357
over O 0 0.013946356251835823
all O 0 0.014571454375982285
possible O 0 0.02961820736527443
penetrance O 1 0.9997537732124329
functions O 0 0.04471401497721672
. O 0 0.042589474469423294

The O 0 0.03187984600663185
estimated O 0 0.02999371849000454
cumulative O 0 0.06376249343156815
risk O 1 0.7076736092567444
of O 1 0.9902417063713074
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 1 0.9068010449409485
28 O 0 0.03757063299417496
% O 0 0.017170341685414314
( O 0 0.015297165140509605
95 O 0 0.026554035022854805
% O 0 0.02367604337632656
CI O 1 0.9996567964553833
9 O 0 0.030294932425022125
% O 0 0.020335158333182335
- O 1 0.955188512802124
44 O 0 0.030618049204349518
% O 0 0.016335269436240196
) O 0 0.010711736045777798
by O 0 0.009924632497131824
age O 0 0.01678611896932125
50 O 0 0.01588968187570572
years O 0 0.013810202479362488
and O 0 0.014718015678226948
84 O 0 0.04442848637700081
% O 0 0.02022634632885456
( O 0 0.01746765710413456
95 O 0 0.02984679862856865
% O 0 0.023574069142341614
CI O 1 0.9989826083183289
43 O 0 0.03869708254933357
% O 0 0.027027077972888947
- O 1 0.9918400049209595
95 O 0 0.03376736119389534
% O 0 0.019018206745386124
) O 0 0.014093324542045593
by O 0 0.01524922251701355
age O 0 0.026406167075037956
70 O 0 0.03685273230075836
years O 0 0.0338202565908432
. O 0 0.04237491637468338

The O 0 0.07314452528953552
corresponding O 1 0.9997919201850891
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.999975323677063
were O 0 0.037682902067899704
0 O 0 0.07361625134944916
. O 0 0.04370555281639099

4 O 0 0.053001176565885544
% O 0 0.028911123052239418
( O 0 0.021619470790028572
95 O 0 0.033955346792936325
% O 0 0.027408741414546967
CI O 1 0.9999014139175415
0 O 0 0.042218826711177826
% O 0 0.026614593341946602
- O 1 0.9974644184112549
1 O 0 0.025031641125679016
% O 0 0.015159803442656994
) O 0 0.010338621214032173
by O 0 0.009562710300087929
age O 0 0.015389363281428814
50 O 0 0.014072608202695847
years O 0 0.012182461097836494
and O 0 0.012788490392267704
27 O 0 0.025924082845449448
% O 0 0.016044678166508675
( O 0 0.015747541561722755
95 O 0 0.027712248265743256
% O 0 0.02564186044037342
CI O 1 0.9999035596847534
0 O 0 0.03970271348953247
% O 0 0.023607579991221428
- O 1 0.812705397605896
47 O 0 0.03815663605928421
% O 0 0.02014058642089367
) O 0 0.0142449252307415
by O 0 0.014398383907973766
age O 0 0.027383852750062943
70 O 0 0.03885217010974884
years O 0 0.034900639206171036
. O 0 0.04060102999210358

The O 0 0.04396085813641548
lifetime O 0 0.4766324460506439
risk O 1 0.9921358823776245
of O 1 0.9996497631072998
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 1 0.7014360427856445
similar O 0 0.012747816741466522
to O 0 0.0112981041893363
the O 0 0.016458045691251755
risk O 0 0.2079382687807083
in O 0 0.020387783646583557
BRCA1 O 1 0.9999996423721313
carriers O 1 0.7501682639122009
, O 0 0.015341090969741344
but O 0 0.008947513997554779
there O 0 0.007070229388773441
was O 0 0.012238698080182076
some O 0 0.006652673706412315
suggestion O 0 0.022224033251404762
of O 0 0.013012347742915154
a O 0 0.019776878878474236
lower O 0 0.039584025740623474
risk O 0 0.21970248222351074
in O 0 0.02343628741800785
BRCA2 O 1 0.9999547004699707
carriers O 1 0.7803876996040344
< O 1 0.9605132341384888
50 O 0 0.02208781987428665
years O 0 0.01747567020356655
of O 0 0.024597730487585068
age O 0 0.04961598664522171
. O 0 0.04333299398422241

Eye B-Disease 1 0.9999732971191406
movement I-Disease 1 0.9965587258338928
abnormalities I-Disease 1 0.9998855590820312
correlate O 0 0.06712015718221664
with O 0 0.025952450931072235
genotype O 1 0.6477670669555664
in O 0 0.028866427019238472
autosomal O 1 0.999996542930603
dominant O 1 0.9999996423721313
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999988079071045
I I-Disease 1 0.999778687953949
. O 0 0.05149461328983307

We O 0 0.03368942439556122
compared O 0 0.039830658584833145
horizontal O 1 0.6904515027999878
eye O 1 0.9997987151145935
movements O 0 0.05339214950799942
( O 0 0.03363291919231415
visually O 0 0.0640217587351799
guided O 0 0.13602471351623535
saccades O 1 0.9999949932098389
, O 0 0.035453490912914276
antisaccades O 1 0.9999313354492188
, O 0 0.022405456751585007
and O 0 0.01899891160428524
smooth O 0 0.12780018150806427
pursuit O 1 0.7230390310287476
) O 0 0.015871332958340645
in O 0 0.010226399637758732
control O 0 0.02329416759312153
subjects O 0 0.026805922389030457
( O 0 0.023034939542412758
n O 0 0.05901460722088814
= O 0 0.04296528548002243
14 O 0 0.02479805424809456
) O 0 0.018421757966279984
and O 0 0.0155654801055789
patients O 0 0.043266940861940384
with O 0 0.010595233179628849
three O 0 0.011503052897751331
forms O 0 0.01820354536175728
of O 0 0.028213966637849808
autosomal O 1 0.9999916553497314
dominant O 1 0.999995231628418
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9999608993530273
I I-Disease 1 0.9996850490570068
spinocerebellar B-Disease 1 0.9999998807907104
ataxias I-Disease 1 0.9996857643127441
1 I-Disease 0 0.03182356059551239
and I-Disease 0 0.016984935849905014
2 I-Disease 0 0.026590047404170036
( O 0 0.026120146736502647
SCA1 B-Disease 1 0.9990002512931824
, O 0 0.027804819867014885
n O 0 0.056120194494724274
= O 0 0.04031435772776604
11 O 0 0.024061551317572594
; O 0 0.02463349886238575
SCA2 B-Disease 1 0.9911551475524902
, O 0 0.02585938572883606
n O 0 0.05355193838477135
= O 0 0.03668563812971115
10 O 0 0.01447676494717598
) O 0 0.014357811771333218
and O 0 0.01797572523355484
SCA3 B-Disease 1 0.999998927116394
/ O 1 0.9998331069946289
Machado B-Disease 1 0.9997625946998596
- I-Disease 1 0.999997615814209
Joseph I-Disease 1 0.9999914169311523
disease I-Disease 1 0.9999998807907104
( O 1 0.9687550663948059
MJD B-Disease 1 1.0
) O 0 0.03755318000912666
( O 0 0.03219487890601158
n O 0 0.0729881078004837
= O 0 0.05935368686914444
16 O 0 0.03663479909300804
) O 0 0.031135454773902893
. O 0 0.03384974226355553

In O 0 0.05041366070508957
SCA1 B-Disease 1 0.9998146891593933
, O 0 0.0497627817094326
saccade O 1 0.9996366500854492
amplitude O 0 0.17078344523906708
was O 0 0.040145546197891235
significantly O 0 0.029493408277630806
increased O 0 0.02680128999054432
, O 0 0.02261286973953247
resulting O 0 0.03001388907432556
in O 0 0.03021738864481449
hypermetria B-Disease 1 0.9993681311607361
. O 0 0.05026765167713165

The O 0 0.07310228794813156
smooth O 0 0.4197215437889099
pursuit O 1 0.8089231252670288
gain O 0 0.06917983293533325
was O 0 0.11404290795326233
decreased O 1 0.586758553981781
. O 0 0.04881850257515907

In O 0 0.06386840343475342
SCA2 B-Disease 1 0.999596893787384
, O 0 0.06343696266412735
saccade O 1 0.9975270628929138
velocity O 0 0.08593703806400299
was O 0 0.06455790996551514
markedly O 0 0.43706801533699036
decreased O 0 0.12153268605470657
. O 0 0.048218678683042526

The O 0 0.03587402030825615
percentage O 0 0.029492631554603577
of O 0 0.021552395075559616
errors O 0 0.036744631826877594
in O 0 0.02247604727745056
antisaccades O 1 0.9999713897705078
was O 0 0.07311529666185379
greatly O 0 0.02979719266295433
increased O 0 0.019823696464300156
and O 0 0.014736982062458992
was O 0 0.02350052073597908
significantly O 0 0.02158786915242672
correlated O 0 0.031835831701755524
with O 0 0.017507703974843025
age O 1 0.5423228740692139
at O 1 0.9994361996650696
disease O 1 1.0
onset O 1 1.0
. O 0 0.2245529592037201

In O 0 0.02881806157529354
addition O 0 0.024386737495660782
, O 0 0.018466472625732422
a O 0 0.024943988770246506
correlation O 0 0.03760012611746788
between O 0 0.02580559439957142
smooth O 0 0.4396895468235016
pursuit O 1 0.5023820400238037
gain O 0 0.026159949600696564
and O 0 0.012310744263231754
the O 0 0.012722451239824295
number O 0 0.012781262397766113
of O 0 0.029071800410747528
trinucleotide O 1 0.9999767541885376
repeats O 0 0.0899127647280693
was O 0 0.044918302446603775
found O 0 0.03333946689963341
. O 0 0.03767968714237213

In O 0 0.051945269107818604
SCA3 B-Disease 1 0.9999855756759644
, O 0 0.04702962189912796
gaze B-Disease 1 0.9998490810394287
- I-Disease 1 0.9999994039535522
evoked I-Disease 1 0.9999719858169556
nystagmus I-Disease 1 0.999998927116394
was O 0 0.04611831158399582
often O 0 0.014562501572072506
present O 0 0.015576326288282871
as O 0 0.016432376578450203
was O 0 0.041908279061317444
saccade O 1 0.9999411106109619
hypometria O 1 0.9998675584793091
and O 0 0.03051591105759144
smooth O 0 0.31974831223487854
pursuit O 0 0.3937060832977295
gain O 0 0.04634123295545578
was O 0 0.06985088437795639
markedly O 0 0.4307458698749542
decreased O 0 0.09549407660961151
. O 0 0.04731462523341179

Three O 0 0.03914117068052292
major O 0 0.049780961126089096
criteria O 0 0.04819723963737488
, O 0 0.04040156677365303
saccade O 1 0.9990983009338379
amplitude O 0 0.09144316613674164
, O 0 0.038521699607372284
saccade O 1 0.9932399988174438
velocity O 0 0.04824656620621681
, O 0 0.016871104016900063
and O 0 0.01214102003723383
presence O 0 0.020602185279130936
of O 0 0.024077359586954117
gaze B-Disease 1 0.9999809265136719
- I-Disease 1 0.9999997615814209
evoked I-Disease 1 0.9999340772628784
nystagmus I-Disease 1 0.9999958276748657
, O 0 0.024181749671697617
permitted O 0 0.02583688125014305
the O 0 0.01969454251229763
correct O 0 0.032816819846630096
assignment O 0 0.03746791183948517
of O 0 0.013660650700330734
90 O 0 0.018415428698062897
% O 0 0.011442790739238262
of O 0 0.013322790153324604
the O 0 0.02603200450539589
SCA1 B-Disease 1 0.9999974966049194
, O 0 0.01665925793349743
90 O 0 0.016148395836353302
% O 0 0.009621253237128258
of O 0 0.01274373009800911
the O 0 0.026063669472932816
SCA2 B-Disease 1 0.9999954700469971
, O 0 0.018755177035927773
and O 0 0.01342867873609066
93 O 0 0.033622659742832184
% O 0 0.012360007502138615
of O 0 0.014273491688072681
the O 0 0.02204868756234646
patients O 1 0.9948886036872864
with O 0 0.024993425235152245
SCA3 B-Disease 1 0.9999998807907104
to O 0 0.0159220602363348
their O 0 0.010791584849357605
genetically O 0 0.020643502473831177
confirmed O 0 0.024772826582193375
patient O 1 0.999904990196228
group O 0 0.057901665568351746
and O 0 0.01584744267165661
, O 0 0.015211917459964752
therefore O 0 0.014452774077653885
, O 0 0.013731428422033787
may O 0 0.013641158118844032
help O 0 0.026046164333820343
orient O 1 0.9839561581611633
diagnoses O 1 0.9993247985839844
of O 0 0.03806695342063904
SCA1 B-Disease 1 0.9999994039535522
, O 0 0.0443950891494751
SCA2 B-Disease 1 0.9999977350234985
, O 0 0.021457888185977936
and O 0 0.021862346678972244
SCA3 B-Disease 1 0.9999991655349731
at O 0 0.024166833609342575
early O 0 0.025084666907787323
clinical O 0 0.16922205686569214
stages O 0 0.037649817764759064
of O 0 0.036753542721271515
the O 1 0.9976387023925781
diseases O 1 1.0
. O 0 0.049345728009939194
. O 0 0.04346829280257225

Genetic O 0 0.05550291761755943
basis O 0 0.022632194682955742
and O 0 0.022661207243800163
molecular O 0 0.04620753973722458
mechanism O 1 0.8205299973487854
for O 1 0.9948530793190002
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.992035448551178

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.9999346733093262
more O 0 0.019422952085733414
than O 0 0.014989360235631466
300 O 0 0.025735678151249886
, O 0 0.02066916972398758
000 O 0 0.050027620047330856
sudden O 1 0.876499354839325
deaths O 0 0.03875341638922691
each O 0 0.012581855989992619
year O 0 0.015458994545042515
in O 0 0.016338765621185303
the O 0 0.031079711392521858
USA O 0 0.10067743062973022
alone O 0 0.04750487580895424
. O 0 0.04323220252990723

In O 0 0.02166987583041191
approximately O 0 0.021257268264889717
5 O 0 0.028733929619193077
- O 1 0.8990993499755859
12 O 0 0.01918255165219307
% O 0 0.01192713063210249
of O 0 0.011156894266605377
these O 0 0.007761832792311907
cases O 0 0.014552268199622631
, O 0 0.010541155003011227
there O 0 0.006635754369199276
are O 0 0.005203092470765114
no O 0 0.014674641191959381
demonstrable O 1 0.9999984502792358
cardiac O 1 1.0
or O 1 0.8199424147605896
non O 1 0.9999991655349731
- O 1 1.0
cardiac O 1 1.0
causes O 1 0.9994192123413086
to O 0 0.015639405697584152
account O 0 0.012414679862558842
for O 0 0.009114062413573265
the O 0 0.013250774703919888
episode O 0 0.02938995696604252
, O 0 0.01126000378280878
which O 0 0.007443389389663935
is O 0 0.00811468530446291
therefore O 0 0.011925720609724522
classified O 0 0.0306249987334013
as O 1 0.7700706720352173
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999973773956299
IVF B-Disease 1 1.0
) O 0 0.0592019148170948
. O 0 0.048010390251874924

A O 0 0.04429975897073746
distinct O 0 0.023734010756015778
group O 0 0.03159717097878456
of O 0 0.17985378205776215
IVF B-Disease 1 1.0
patients O 1 0.9999977350234985
has O 0 0.02352410927414894
been O 0 0.01313784159719944
found O 0 0.008987000212073326
to O 0 0.010185105726122856
present O 0 0.013334706425666809
with O 0 0.014837948605418205
a O 0 0.030758369714021683
characteristic O 1 0.9929216504096985
electrocardiographic O 1 0.9999940395355225
pattern O 0 0.4974091053009033
. O 0 0.047318343073129654

Because O 0 0.03119778446853161
of O 0 0.019665203988552094
the O 0 0.01912907138466835
small O 0 0.014905145391821861
size O 0 0.012420030310750008
of O 0 0.012313258834183216
most O 0 0.012466167099773884
pedigrees O 0 0.05323494225740433
and O 0 0.012331894598901272
the O 0 0.016745544970035553
high O 1 0.8359351754188538
incidence O 1 0.9999873638153076
of O 0 0.45933103561401367
sudden B-Disease 1 0.9999997615814209
death I-Disease 1 0.9999886751174927
, O 0 0.01974831335246563
however O 0 0.011405272409319878
, O 0 0.01328949723392725
molecular O 0 0.019770396873354912
genetic O 0 0.016171440482139587
studies O 0 0.01258634589612484
of O 0 0.025194119662046432
IVF B-Disease 1 0.9999996423721313
have O 0 0.014984924346208572
not O 0 0.012635094113647938
yet O 0 0.018069850280880928
been O 0 0.01816418021917343
done O 0 0.0272210780531168
. O 0 0.03251659497618675

Because O 0 0.32758665084838867
IVF B-Disease 1 1.0
causes O 1 0.9999998807907104
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.9999994039535522
, O 0 0.029688280075788498
we O 0 0.015559503808617592
investigated O 0 0.03367317467927933
whether O 0 0.02114972472190857
malfunction O 1 0.9956063628196716
of O 0 0.026867521926760674
ion O 1 0.9719956517219543
channels O 0 0.022803843021392822
could O 0 0.01575501635670662
cause O 0 0.050254859030246735
the O 0 0.02988387458026409
disorder O 1 0.9999964237213135
by O 0 0.02282952331006527
studying O 0 0.024271510541439056
mutations O 0 0.02431928552687168
in O 0 0.013229616917669773
the O 0 0.04430442303419113
cardiac O 1 1.0
sodium O 1 0.9998514652252197
channel O 0 0.07320084422826767
gene O 0 0.06431858241558075
SCN5A O 1 0.9954612851142883
. O 0 0.04926764592528343

We O 0 0.02651194855570793
have O 0 0.011582405306398869
now O 0 0.01629987731575966
identified O 0 0.017621515318751335
a O 0 0.021204493939876556
missense O 0 0.08782175183296204
mutation O 0 0.03629915416240692
, O 0 0.014483828097581863
a O 0 0.024347689002752304
splice O 1 0.9939249157905579
- O 1 0.9999966621398926
donor O 1 0.9984996318817139
mutation O 0 0.04591868072748184
, O 0 0.013932604342699051
and O 0 0.013389510102570057
a O 0 0.024480391293764114
frameshift O 1 0.9995143413543701
mutation O 0 0.03655917942523956
in O 0 0.010966867208480835
the O 0 0.017719415947794914
coding O 0 0.03439878299832344
region O 0 0.020395096391439438
of O 0 0.021807702258229256
SCN5A O 1 0.9999163150787354
in O 0 0.020931826904416084
three O 0 0.031693536788225174
IVF B-Disease 1 0.999996542930603
families O 0 0.061696864664554596
. O 0 0.04947780445218086

We O 0 0.030760211870074272
show O 0 0.029551636427640915
that O 0 0.015044564381241798
sodium O 0 0.038919202983379364
channels O 0 0.014531842432916164
with O 0 0.009493700228631496
the O 0 0.01948493905365467
missense O 1 0.6546294689178467
mutation O 0 0.061682309955358505
recover O 0 0.37086617946624756
from O 0 0.026244234293699265
inactivation O 1 0.9999579191207886
more O 0 0.013273075222969055
rapidly O 0 0.027679117396473885
than O 0 0.010721336118876934
normal O 0 0.018316633999347687
and O 0 0.010617995634675026
that O 0 0.00915511604398489
the O 0 0.02328009344637394
frameshift O 1 0.9998849630355835
mutation O 1 0.6899975538253784
causes O 0 0.4039320647716522
the O 0 0.029759323224425316
sodium O 0 0.4631800949573517
channel O 0 0.02192048542201519
to O 0 0.012373542413115501
be O 0 0.01274172030389309
non O 0 0.083927221596241
- O 1 0.9999043941497803
functional O 0 0.07009904831647873
. O 0 0.0410107858479023

Our O 0 0.03791596367955208
results O 0 0.018951980397105217
indicate O 0 0.016087206080555916
that O 0 0.009540248662233353
mutations O 0 0.02345402166247368
in O 0 0.020304692909121513
cardiac O 1 1.0
ion O 1 0.9999961853027344
- O 1 0.9999966621398926
channel O 0 0.04251968860626221
genes O 0 0.018229179084300995
contribute O 0 0.016461193561553955
to O 0 0.011755596846342087
the O 0 0.01798401027917862
risk O 0 0.03237021714448929
of O 0 0.02820011042058468
developing O 1 0.9985200762748718
IVF B-Disease 1 0.9999996423721313
. O 0 0.04225872457027435
. O 0 0.04119894281029701

Molecular O 0 0.08955793082714081
heterogeneity O 0 0.11031893640756607
in O 0 0.03359503298997879
mucopolysaccharidosis B-Disease 1 0.999819815158844
IVA I-Disease 1 0.9999994039535522
in O 0 0.021014759317040443
Australia O 0 0.026917971670627594
and O 0 0.014263537712395191
Northern O 0 0.022777333855628967
Ireland O 0 0.029864268377423286
: O 0 0.01639603264629841
nine O 0 0.01777019165456295
novel O 0 0.03643382340669632
mutations O 0 0.02754240110516548
including O 0 0.019587678834795952
T312S O 1 0.9997037053108215
, O 0 0.02100180834531784
a O 0 0.023269275203347206
common O 0 0.026420364156365395
allele O 0 0.05812694877386093
that O 0 0.017525706440210342
confers O 1 0.9703882932662964
a O 0 0.11750941723585129
mild O 1 0.999966025352478
phenotype O 1 0.9996992349624634
. O 0 0.05933288112282753

Mucopolysaccharidosis B-Disease 1 0.9998156428337097
IVA I-Disease 1 0.9999994039535522
( O 0 0.08741510659456253
MPS B-Disease 1 0.9996976852416992
IVA I-Disease 1 1.0
) O 0 0.02880828268826008
is O 0 0.016828810796141624
an O 0 0.02597414329648018
autosomal B-Disease 1 0.9999985694885254
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999245405197144
by O 0 0.028750918805599213
a O 0 0.27742424607276917
genetic B-Disease 1 0.9929874539375305
defect I-Disease 1 0.9999946355819702
in O 0 0.020522423088550568
N O 1 0.9888830780982971
- O 1 0.9996178150177002
acetylgalactosamine O 1 0.9977879524230957
- O 1 0.9996743202209473
6 O 0 0.0633917972445488
- O 1 0.9999924898147583
sulfate O 1 0.9999967813491821
sulfatase O 1 0.9999991655349731
( O 0 0.08817312121391296
GALNS O 1 0.999958872795105
) O 0 0.04830637574195862
. O 0 0.043278664350509644

Previous O 0 0.0414012186229229
studies O 0 0.02187327854335308
of O 0 0.022530656307935715
patients O 1 0.8909882307052612
from O 0 0.013601168058812618
a O 0 0.018642397597432137
British O 0 0.10199329257011414
- O 1 0.9998968839645386
Irish O 0 0.033914610743522644
population O 0 0.011421993374824524
showed O 0 0.011713259853422642
that O 0 0.007926302030682564
the O 0 0.017522038891911507
I113F O 1 0.9998811483383179
mutation O 0 0.035076968371868134
is O 0 0.010686591267585754
the O 0 0.009994634427130222
most O 0 0.008246340788900852
common O 0 0.013686426915228367
single O 0 0.02471458911895752
mutation O 0 0.03355391323566437
among O 0 0.029872111976146698
MPS B-Disease 1 0.9999984502792358
IVA I-Disease 1 1.0
patients O 1 0.9999996423721313
and O 0 0.07120786607265472
produces O 0 0.0560123585164547
a O 0 0.42003223299980164
severe O 1 0.9999996423721313
clinical O 1 0.9999996423721313
phenotype O 1 0.9999872446060181
. O 0 0.06552337110042572

We O 0 0.030511263757944107
studied O 0 0.034514982253313065
mutations O 0 0.024763382971286774
in O 0 0.012103031389415264
the O 0 0.023545878008008003
GALNS O 1 0.9999665021896362
gene O 0 0.026183275505900383
from O 0 0.011535302735865116
23 O 0 0.02091604471206665
additional O 0 0.02065073326230049
MPS B-Disease 1 0.9999504089355469
IVA I-Disease 1 1.0
patients O 1 0.9999988079071045
( O 0 0.027296660467982292
15 O 0 0.017894310876727104
from O 0 0.01199291180819273
Australia O 0 0.01802225038409233
, O 0 0.0117598632350564
8 O 0 0.015367837622761726
from O 0 0.00938440766185522
Northern O 0 0.021349789574742317
Ireland O 0 0.02541523426771164
) O 0 0.013149265199899673
, O 0 0.009047300554811954
with O 0 0.009669463150203228
various O 0 0.014616397209465504
clinical O 1 0.9999940395355225
phenotypes O 1 0.9999984502792358
( O 1 0.9920599460601807
severe O 1 0.9999983310699463
, O 0 0.03132987394928932
16 O 0 0.02750958316028118
cases O 0 0.023178542032837868
; O 0 0.0193910114467144
intermediate O 0 0.43020910024642944
, O 0 0.015630651265382767
4 O 0 0.023349598050117493
cases O 0 0.023416750133037567
; O 0 0.02484763227403164
mild O 1 0.9980453252792358
, O 0 0.026511862874031067
3 O 0 0.0360446535050869
cases O 0 0.030779803171753883
) O 0 0.03091486543416977
. O 0 0.03029693476855755

We O 0 0.02662896364927292
found O 0 0.017021238803863525
two O 0 0.013687367551028728
common O 0 0.024835772812366486
mutations O 0 0.025472182780504227
that O 0 0.009761790744960308
together O 0 0.013429240323603153
accounted O 0 0.022277409210801125
for O 0 0.011308017186820507
32 O 0 0.01977888122200966
% O 0 0.011306737549602985
of O 0 0.011544865556061268
the O 0 0.01847701147198677
44 O 0 0.04298216477036476
unrelated O 0 0.05183648690581322
alleles O 0 0.05506862327456474
in O 0 0.022376026958227158
these O 0 0.02317163161933422
patients O 1 0.998388409614563
. O 0 0.05118850618600845

One O 0 0.028397321701049805
is O 0 0.01783754862844944
the O 0 0.025961441919207573
T312S O 1 0.9996060729026794
mutation O 0 0.052659567445516586
, O 0 0.017389662563800812
a O 0 0.02296455018222332
novel O 0 0.04930093139410019
mutation O 0 0.043358419090509415
found O 0 0.017736773937940598
exclusively O 0 0.02912280149757862
in O 0 0.028792692348361015
milder O 1 0.9925383925437927
patients O 1 0.9974851608276367
. O 0 0.05704443156719208

The O 0 0.03885488584637642
other O 0 0.014992183074355125
is O 0 0.012474823743104935
the O 0 0.01313247624784708
previously O 0 0.020909138023853302
described O 0 0.029548220336437225
I113F O 1 0.9971107244491577
that O 0 0.017320625483989716
produces O 0 0.03460811823606491
a O 0 0.050917211920022964
severe O 1 0.999991774559021
phenotype O 1 0.9998658895492554
. O 0 0.06872274726629257

The O 0 0.061686668545007706
I113F O 1 0.9773163199424744
and O 0 0.04119892045855522
T312S O 1 0.9986327290534973
mutations O 0 0.04241295903921127
accounted O 0 0.029291806742548943
for O 0 0.015269485302269459
8 O 0 0.02601306140422821
( O 0 0.018246302381157875
18 O 0 0.019229959696531296
% O 0 0.01638256572186947
) O 0 0.013424173928797245
and O 0 0.012922382913529873
6 O 0 0.026127133518457413
( O 0 0.016658101230859756
14 O 0 0.019092155620455742
% O 0 0.01462190505117178
) O 0 0.012336181476712227
of O 0 0.016984865069389343
44 O 0 0.04424905776977539
unrelated O 0 0.07881680876016617
alleles O 0 0.09150061011314392
, O 0 0.03408117592334747
respectively O 0 0.04353579133749008
. O 0 0.04190704599022865

The O 0 0.04545329138636589
relatively O 0 0.038286466151475906
high O 0 0.1402682214975357
residual O 1 0.9998117089271545
GALNS O 1 0.999996542930603
activity O 0 0.034349534660577774
seen O 0 0.020732570439577103
when O 0 0.014566909521818161
the O 0 0.01885351911187172
T312S O 1 0.9604438543319702
mutant O 0 0.09474287927150726
cDNA O 0 0.0736989825963974
is O 0 0.02293493039906025
overexpressed O 0 0.281762033700943
in O 0 0.022165948525071144
mutant O 1 0.9922653436660767
cells O 0 0.035208430141210556
provides O 0 0.018694868311285973
an O 0 0.011763322167098522
explanation O 0 0.01756560429930687
for O 0 0.012302728369832039
the O 0 0.02647891454398632
mild O 1 0.9999933242797852
phenotype O 1 0.9999699592590332
in O 0 0.03161046281456947
patients O 1 0.9998121857643127
with O 0 0.02322123758494854
this O 0 0.024608073756098747
mutation O 0 0.09318986535072327
. O 0 0.03690299764275551

The O 0 0.046612322330474854
distribution O 0 0.03295883908867836
and O 0 0.01895676739513874
relative O 0 0.027200734242796898
frequencies O 0 0.016329126432538033
of O 0 0.014164653606712818
the O 0 0.024759674444794655
I113F O 1 0.9993818998336792
and O 0 0.030989689752459526
T312S O 1 0.9998464584350586
mutations O 0 0.03185221180319786
in O 0 0.013065876439213753
Australia O 0 0.022329287603497505
corresponded O 0 0.03021998144686222
to O 0 0.011868897825479507
those O 0 0.009165399707853794
observed O 0 0.012910380959510803
in O 0 0.009077292867004871
Northern O 0 0.01846248097717762
Ireland O 0 0.027806749567389488
and O 0 0.014353885315358639
are O 0 0.006781501695513725
unique O 0 0.010302752256393433
to O 0 0.008618835359811783
these O 0 0.005203248467296362
two O 0 0.008747827261686325
populations O 0 0.01560154277831316
, O 0 0.014049624092876911
suggesting O 0 0.01920265518128872
that O 0 0.009832195937633514
both O 0 0.012770617380738258
mutations O 0 0.023551596328616142
were O 0 0.010698934085667133
probably O 0 0.015294400975108147
introduced O 0 0.014978528022766113
to O 0 0.011910622008144855
Australia O 0 0.01678115501999855
by O 0 0.01419280655682087
Irish O 0 0.03704028204083443
migrants O 0 0.030801815912127495
during O 0 0.022341517731547356
the O 0 0.027789149433374405
19th O 0 0.060712434351444244
century O 0 0.06659805029630661
. O 0 0.04347634315490723

Haplotype O 0 0.19426053762435913
analysis O 0 0.028109928593039513
using O 0 0.019084515050053596
6 O 0 0.040111493319272995
RFLPs O 1 0.9533906579017639
provides O 0 0.023774581030011177
additional O 0 0.011326001025736332
data O 0 0.008188700303435326
that O 0 0.006404886953532696
the O 0 0.016429664567112923
I113F O 1 0.9976451992988586
mutation O 0 0.05157152935862541
originated O 0 0.02834813855588436
from O 0 0.015527566894888878
a O 0 0.02695693075656891
common O 0 0.03757413104176521
ancestor O 0 0.15532585978507996
. O 0 0.04648544266819954

The O 0 0.0348869189620018
other O 0 0.017187217250466347
9 O 0 0.03417937085032463
novel O 0 0.04586521163582802
mutations O 0 0.03360302746295929
identified O 0 0.019977279007434845
in O 0 0.01033791434019804
these O 0 0.009650508873164654
23 O 0 0.03335968032479286
patients O 1 0.8471036553382874
were O 0 0.011325580067932606
each O 0 0.007722281850874424
limited O 0 0.014307101257145405
to O 0 0.014000782743096352
a O 0 0.025203289464116096
single O 0 0.041777078062295914
family O 0 0.050089698284864426
. O 0 0.04190988466143608

These O 0 0.026455162093043327
data O 0 0.018695324659347534
provide O 0 0.01646341010928154
further O 0 0.013089262880384922
evidence O 0 0.014365906827151775
for O 0 0.014002203941345215
extensive O 0 0.03725689649581909
allelic O 1 0.9880490899085999
heterogeneity O 1 0.8432649970054626
in O 0 0.026212075725197792
MPS B-Disease 1 0.9937326312065125
IVA I-Disease 1 0.999998927116394
in O 0 0.02307688631117344
British O 0 0.20832979679107666
- O 1 0.999998927116394
Irish O 1 0.9983851909637451
patients O 1 0.9993640780448914
and O 0 0.01724623702466488
provide O 0 0.01561010628938675
evidence O 0 0.011043719947338104
for O 0 0.010132165625691414
their O 0 0.012077538296580315
transmission O 0 0.02608729898929596
to O 0 0.010840740986168385
Australia O 0 0.016511132940649986
by O 0 0.013866053894162178
British O 0 0.04655083641409874
- O 1 0.9998695850372314
Irish O 0 0.06560773402452469
migrants O 0 0.04777950048446655
. O 0 0.024526607245206833
. O 0 0.0319129079580307

Identification O 0 0.040917813777923584
of O 0 0.027372602373361588
constitutional O 0 0.389432817697525
WT1 O 1 0.9999998807907104
mutations O 0 0.07752460986375809
, O 0 0.018864046782255173
in O 0 0.016192873939871788
patients O 1 0.8461089730262756
with O 0 0.028508398681879044
isolated O 1 0.9999986886978149
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.1301412284374237
and O 0 0.02292223460972309
analysis O 0 0.017105942592024803
of O 0 0.0281886775046587
genotype O 1 0.9999762773513794
/ O 1 0.9999887943267822
phenotype O 1 0.874953031539917
correlations O 0 0.037999361753463745
by O 0 0.012419894337654114
use O 0 0.009826687164604664
of O 0 0.013810097239911556
a O 0 0.029313763603568077
computerized O 1 0.9680212736129761
mutation O 0 0.07136715203523636
database O 0 0.04192792624235153
. O 0 0.03334254026412964

Constitutional O 0 0.06842762231826782
mutations O 0 0.038739267736673355
of O 0 0.02420482225716114
the O 0 0.03938427194952965
WT1 O 1 0.9999973773956299
gene O 0 0.03583281859755516
, O 0 0.016617456451058388
encoding O 0 0.022150738164782524
a O 0 0.026388507336378098
zinc O 1 0.9999828338623047
- O 1 0.9999915361404419
finger O 1 0.995810866355896
transcription O 0 0.19256573915481567
factor O 0 0.02768952026963234
involved O 0 0.015385554172098637
in O 0 0.02604028210043907
renal O 1 1.0
and O 1 0.9996157884597778
gonadal O 1 1.0
development O 1 0.9971754550933838
, O 0 0.016667822375893593
are O 0 0.00525331636890769
found O 0 0.0063768234103918076
in O 0 0.006246922537684441
most O 0 0.009694613516330719
patients O 0 0.10864313691854477
with O 0 0.021022796630859375
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9998829364776611
DDS B-Disease 1 1.0
) O 0 0.026746202260255814
, O 0 0.019249774515628815
or O 0 0.03426292911171913
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999920129776001
DMS B-Disease 1 1.0
) O 0 0.022550290450453758
associated O 0 0.01588435098528862
with O 0 0.01597828045487404
pseudohermaphroditism B-Disease 1 0.999997615814209
and O 0 0.06974504142999649
/ O 1 0.9999991655349731
or O 1 0.9968296885490417
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.9975184202194214
WT B-Disease 1 0.9999992847442627
) O 0 0.04774138703942299
. O 0 0.03643859550356865

Most O 0 0.04469747096300125
mutations O 0 0.05963483825325966
in O 0 0.04300031065940857
DDS B-Disease 1 1.0
patients O 1 0.9999021291732788
lie O 0 0.11929889023303986
in O 0 0.024967066943645477
exon O 0 0.24923881888389587
8 O 0 0.030248422175645828
or O 0 0.01989857666194439
exon O 0 0.07233641296625137
9 O 0 0.03065124899148941
, O 0 0.019419720396399498
encoding O 0 0.04005008935928345
zinc O 1 0.9991414546966553
finger O 1 0.8069807887077332
2 O 0 0.039326246827840805
or O 0 0.031243320554494858
zinc O 1 0.9999855756759644
finger O 1 0.998288094997406
3 O 0 0.025709984824061394
, O 0 0.015524499118328094
respectively O 0 0.015086933970451355
, O 0 0.010272648185491562
with O 0 0.009661964140832424
a O 0 0.021425064653158188
hot O 1 0.9967107772827148
spot O 1 0.6325719952583313
( O 0 0.03186170384287834
R394W O 1 0.9972283244132996
) O 0 0.022864801809191704
in O 0 0.020998267456889153
exon O 0 0.1064126193523407
9 O 0 0.05698806792497635
. O 0 0.03973063826560974

We O 0 0.026873068884015083
analyzed O 0 0.026012176647782326
a O 0 0.018227344378829002
series O 0 0.018066393211483955
of O 0 0.019214659929275513
24 O 0 0.03602255880832672
patients O 1 0.5807414054870605
, O 0 0.016271352767944336
10 O 0 0.017119454219937325
with O 0 0.020451724529266357
isolated B-Disease 1 0.9991660118103027
DMS I-Disease 1 1.0
( O 1 0.8515505194664001
IDMS B-Disease 1 0.9999996423721313
) O 0 0.02286882884800434
, O 0 0.014360466040670872
10 O 0 0.016876420006155968
with O 0 0.02421509474515915
DDS B-Disease 1 0.9999997615814209
, O 0 0.020013712346553802
and O 0 0.015937725082039833
4 O 0 0.02811572514474392
with O 0 0.03251892328262329
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 0.9999998807907104
and O 1 0.9952439665794373
/ O 1 0.9999990463256836
or O 1 0.6745165586471558
WT B-Disease 1 0.9999892711639404
. O 0 0.057499345391988754

We O 0 0.03776680305600166
report O 0 0.04479721561074257
WT1 O 1 0.9998227953910828
heterozygous O 0 0.08576205372810364
mutations O 0 0.03931097686290741
in O 0 0.017877627164125443
16 O 0 0.034893617033958435
patients O 1 0.9929454922676086
, O 0 0.018971916288137436
4 O 0 0.02209348790347576
of O 0 0.02035854198038578
whom O 0 0.036622464656829834
presented O 0 0.041204776614904404
with O 0 0.04334481433033943
IDMS B-Disease 1 0.9999986886978149
. O 0 0.06314926594495773

One O 0 0.037024278193712234
male O 0 0.03818633034825325
and O 0 0.015369192697107792
two O 0 0.0183549914509058
female O 1 0.9971932768821716
IDMS B-Disease 1 1.0
patients O 1 0.9999814033508301
with O 1 0.9595472812652588
WT1 O 1 1.0
mutations O 1 0.9995368719100952
underwent O 1 0.9999982118606567
normal O 1 0.9814068078994751
puberty O 1 0.9999351501464844
. O 0 0.06378363817930222

Two O 0 0.0375712551176548
mutations O 0 0.054369352757930756
associated O 0 0.03291322663426399
with O 0 0.03030102699995041
IDMS B-Disease 1 0.9999963045120239
are O 0 0.00950397364795208
different O 0 0.005615806207060814
from O 0 0.009525850415229797
those O 0 0.011295623145997524
described O 0 0.03485561162233353
in O 0 0.051076263189315796
DDS B-Disease 1 1.0
patients O 1 0.9999881982803345
. O 0 0.06411325186491013

No O 0 0.08451542258262634
WT1 O 1 0.9999749660491943
mutations O 0 0.054182905703783035
were O 0 0.015696199610829353
detected O 0 0.024939673021435738
in O 0 0.010005452670156956
the O 0 0.012596058659255505
six O 0 0.02150055579841137
other O 0 0.02668151818215847
IDMS B-Disease 1 1.0
patients O 1 0.9998860359191895
, O 0 0.026658320799469948
suggesting O 0 0.03378007188439369
genetic O 0 0.02965797856450081
heterogeneity O 1 0.8778760433197021
of O 0 0.03449495509266853
this O 0 0.04136766865849495
disease O 1 0.9999977350234985
. O 0 0.05472562089562416

We O 0 0.03909102827310562
analyzed O 0 0.07182647287845612
genotype O 1 0.9989396929740906
/ O 1 0.9999562501907349
phenotype O 1 0.9080271124839783
correlations O 0 0.06613891571760178
, O 0 0.017298424616456032
on O 0 0.011411143466830254
the O 0 0.010259819217026234
basis O 0 0.008620268665254116
of O 0 0.010065611451864243
the O 0 0.013154210522770882
constitution O 0 0.019057316705584526
of O 0 0.018503837287425995
a O 0 0.03659021109342575
WT1 O 1 0.9999891519546509
mutation O 0 0.04017099365592003
database O 0 0.017255987972021103
of O 0 0.015751361846923828
84 O 1 0.7596256136894226
germ O 1 0.9999997615814209
- O 1 0.9999990463256836
line O 0 0.13734495639801025
mutations O 0 0.02684604935348034
, O 0 0.011423442512750626
to O 0 0.01092536747455597
compare O 0 0.018424248322844505
the O 0 0.013285684399306774
distribution O 0 0.015183058567345142
and O 0 0.013366620987653732
type O 0 0.029997648671269417
of O 0 0.0225193053483963
mutations O 0 0.031434740871191025
, O 0 0.013970731757581234
according O 0 0.011951341293752193
to O 0 0.013172345235943794
the O 0 0.022286776453256607
different O 0 0.01961997151374817
symptoms O 1 0.9999576807022095
. O 0 0.050834979861974716

This O 0 0.03264032304286957
demonstrated O 0 0.043530385941267014
( O 0 0.026485102251172066
1 O 0 0.02534577064216137
) O 0 0.014333323575556278
the O 0 0.013469137251377106
association O 0 0.020379839465022087
between O 0 0.016367657110095024
mutations O 0 0.022935573011636734
in O 0 0.013268479146063328
exons O 0 0.03954841569066048
8 O 0 0.021172216162085533
and O 0 0.013969600200653076
9 O 0 0.025633594021201134
and O 0 0.024237871170043945
DMS B-Disease 1 0.9999994039535522
; O 0 0.024858200922608376
( O 0 0.019354455173015594
2 O 0 0.022231068462133408
) O 0 0.015621882863342762
among O 0 0.021244555711746216
patients O 1 0.9730826616287231
with O 0 0.03756125271320343
DMS B-Disease 1 1.0
, O 0 0.021310999989509583
a O 0 0.016509609296917915
higher O 0 0.012349538505077362
frequency O 0 0.01346729975193739
of O 0 0.014477643184363842
exon O 0 0.07491122931241989
8 O 0 0.026010245084762573
mutations O 0 0.019708281382918358
among O 0 0.01595207490026951
46 O 0 0.036704905331134796
, O 0 0.0320352278649807
XY O 1 0.9999988079071045
patients O 1 0.9910571575164795
with O 0 0.021650029346346855
female O 1 0.8740782737731934
phenotype O 0 0.4364091157913208
than O 0 0.01077704131603241
among O 0 0.016402531415224075
46 O 0 0.03737003728747368
, O 0 0.03123238869011402
XY O 1 0.9999983310699463
patients O 1 0.9524112939834595
with O 0 0.017727620899677277
sexual O 0 0.2556121349334717
ambiguity O 1 0.9510905146598816
or O 0 0.0568314865231514
male O 1 0.999903678894043
phenotype O 1 0.9999927282333374
; O 0 0.019625073298811913
and O 0 0.015615087933838367
( O 0 0.02004382014274597
3 O 0 0.020561687648296356
) O 0 0.011984405107796192
statistically O 0 0.011983401142060757
significant O 0 0.009831443428993225
evidence O 0 0.011282221414148808
that O 0 0.009605936706066132
mutations O 0 0.01898486353456974
in O 0 0.012993603944778442
exons O 0 0.046324312686920166
8 O 0 0.024732252582907677
and O 0 0.01717420481145382
9 O 0 0.03520367667078972
preferentially O 0 0.06611661612987518
affect O 0 0.03608241304755211
amino O 0 0.03761718049645424
acids O 0 0.02478497475385666
with O 0 0.012219926342368126
different O 0 0.01011731382459402
functions O 0 0.022315233945846558
. O 0 0.02381981536746025
. O 0 0.03620942309498787

The O 0 0.0701529011130333
185delAG O 1 0.9999656677246094
BRCA1 O 1 0.9999666213989258
mutation O 0 0.06940241903066635
originated O 0 0.03407219797372818
before O 0 0.018416833132505417
the O 0 0.019383352249860764
dispersion O 0 0.0445750392973423
of O 0 0.01698393188416958
Jews O 0 0.027925532311201096
in O 0 0.013265932910144329
the O 0 0.019639737904071808
diaspora O 0 0.050635818392038345
and O 0 0.018895544111728668
is O 0 0.01694639027118683
not O 0 0.013345790095627308
limited O 0 0.022251520305871964
to O 0 0.03110915794968605
Ashkenazim O 1 0.9968018531799316
. O 0 0.054268162697553635

The O 0 0.06312628090381622
185delAG O 1 0.9940569400787354
mutation O 0 0.07193271815776825
in O 0 0.030414821580052376
BRCA1 O 1 0.9998012185096741
is O 0 0.021793026477098465
detected O 0 0.026323143392801285
in O 0 0.01278194785118103
Ashkenazi O 0 0.07224525511264801
Jews O 0 0.024685367941856384
both O 0 0.01083528995513916
in O 0 0.019615497440099716
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9644979238510132
in O 0 0.019477855414152145
the O 0 0.02314583957195282
general O 0 0.03582633659243584
population O 0 0.02463020756840706
. O 0 0.03077227808535099

All O 0 0.04252662882208824
tested O 0 0.07850248366594315
Ashkenazi O 1 0.9966893196105957
mutation O 0 0.08011486381292343
carriers O 0 0.04089837521314621
share O 0 0.01618937775492668
the O 0 0.015640471130609512
same O 0 0.017851723358035088
allelic O 1 0.527892529964447
pattern O 0 0.038025323301553726
at O 0 0.02806742489337921
the O 0 0.04677237197756767
BRCA1 O 1 0.999984860420227
locus O 1 0.9821407794952393
. O 0 0.05206312984228134

Our O 0 0.039974261075258255
previous O 0 0.024791782721877098
study O 0 0.015492770820856094
showed O 0 0.015528791584074497
that O 0 0.007944057695567608
this O 0 0.011073779314756393
Ashkenazi O 1 0.9997976422309875
mutation O 1 0.613290548324585
also O 0 0.015507927164435387
occurs O 0 0.01562459859997034
in O 0 0.010171366855502129
Iraqi O 0 0.02434602938592434
Jews O 0 0.02565169706940651
with O 0 0.014483298175036907
a O 0 0.023346856236457825
similar O 0 0.028380529955029488
allelic O 1 0.998350977897644
pattern O 0 0.2147134393453598
. O 0 0.05138419568538666

We O 0 0.03395993635058403
extended O 0 0.036508724093437195
our O 0 0.021932827308773994
analysis O 0 0.011360906064510345
to O 0 0.01013330090790987
other O 0 0.011193821206688881
non O 0 0.057075269520282745
- O 1 0.9992054104804993
Ashkenazi O 1 0.8521443009376526
subsets O 0 0.08109686523675919
354 O 0 0.07530678808689117
of O 0 0.02647758275270462
Moroccan O 0 0.07898653298616409
origin O 0 0.02076101489365101
, O 0 0.019341833889484406
200 O 0 0.03230354189872742
Yemenites O 1 0.8873420357704163
and O 0 0.024648206308484077
150 O 0 0.03710358217358589
Iranian O 0 0.049171458929777145
Jews O 0 0.060708191245794296
. O 0 0.04122661054134369

Heteroduplex O 1 0.975923478603363
analysis O 0 0.03607930988073349
complemented O 0 0.05294075980782509
by O 0 0.01710779406130314
direct O 0 0.02388572134077549
DNA O 0 0.028655756264925003
sequencing O 0 0.03123263455927372
of O 0 0.031603164970874786
abnormally O 1 0.9984750151634216
migrating O 0 0.07926824688911438
bands O 0 0.05241422355175018
were O 0 0.024543900042772293
employed O 0 0.053340692073106766
. O 0 0.041052378714084625

Four O 0 0.024732055142521858
of O 0 0.025469524785876274
Moroccan O 0 0.07495950162410736
origin O 0 0.022545142099261284
( O 0 0.019070466980338097
1 O 0 0.021034598350524902
. O 0 0.011725017800927162
1 O 0 0.021353494375944138
% O 0 0.015569827519357204
) O 0 0.012131684459745884
and O 0 0.008924996480345726
none O 0 0.011960872448980808
of O 0 0.014094537124037743
the O 0 0.026765434071421623
Yemenites O 1 0.999963641166687
or O 0 0.022529758512973785
Iranians O 0 0.03095112554728985
was O 0 0.02036343514919281
a O 0 0.018923785537481308
carrier O 0 0.05035003647208214
of O 0 0.020031461492180824
the O 0 0.03845302015542984
185delAG O 1 0.9997722506523132
mutation O 0 0.10650503635406494
. O 0 0.04847435653209686

BRCA1 O 1 0.9995101690292358
allelic O 1 0.9547269344329834
patterns O 0 0.035632502287626266
were O 0 0.013820427469909191
determined O 0 0.0167121309787035
for O 0 0.00902247428894043
four O 0 0.010145331732928753
of O 0 0.012795217335224152
these O 0 0.009122361429035664
individuals O 0 0.010367197915911674
and O 0 0.009917545132339
for O 0 0.009653106331825256
12 O 0 0.014951030723750591
additional O 0 0.013440451584756374
non O 0 0.054146282374858856
- O 1 0.9998642206192017
Ashkenazi O 1 0.9983075857162476
185delAG O 1 0.9991579055786133
mutation O 0 0.05025146156549454
carriers O 0 0.03772684931755066
who O 0 0.026903538033366203
had O 1 0.6917877197265625
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9667219519615173

Six O 0 0.04612606391310692
non O 1 0.6037698984146118
- O 1 0.9999489784240723
Ashkenazi O 1 0.9828928112983704
individuals O 0 0.018204670399427414
shared O 0 0.02319524995982647
the O 0 0.021129371598362923
common O 0 0.036467600613832474
Ashkenazi O 1 0.999988317489624
haplotype O 1 0.9994063377380371
, O 0 0.016033856198191643
four O 0 0.010612121783196926
had O 0 0.01326621975749731
a O 0 0.016151683405041695
closely O 0 0.01785263419151306
related O 0 0.01706085540354252
pattern O 0 0.027199052274227142
, O 0 0.012944838963449001
and O 0 0.00987645611166954
the O 0 0.01553343515843153
rest O 0 0.030354131013154984
( O 0 0.025977062061429024
n O 0 0.06007232517004013
= O 0 0.04574735090136528
6 O 0 0.026419105008244514
) O 0 0.014482983388006687
displayed O 0 0.02256033942103386
a O 0 0.025678925216197968
distinct O 0 0.04464447870850563
BRCA1 O 1 0.9997418522834778
allelic O 1 0.9977847933769226
pattern O 0 0.2134457379579544
. O 0 0.05868248641490936

We O 0 0.029568200930953026
conclude O 0 0.03474965691566467
that O 0 0.0115698566660285
the O 0 0.02666151523590088
185delAG O 1 0.9999539852142334
BRCA1 O 1 0.9999953508377075
mutation O 0 0.09259025752544403
occurs O 0 0.01901533268392086
in O 0 0.008793103508651257
some O 0 0.009598883800208569
non O 0 0.4254801869392395
- O 1 0.9999891519546509
Ashkenazi O 1 0.9959608912467957
populations O 0 0.026107309386134148
at O 0 0.019315103068947792
rates O 0 0.021144170314073563
comparable O 0 0.024341968819499016
with O 0 0.01216109748929739
that O 0 0.011955593712627888
of O 0 0.028968365862965584
Ashkenazim O 1 0.9995335340499878
. O 0 0.05469712242484093

The O 0 0.03298128768801689
majority O 0 0.024453654885292053
of O 0 0.023523598909378052
Jewish O 0 0.3474264442920685
185delAG O 1 0.9999945163726807
mutation O 1 0.836532473564148
carriers O 0 0.03753799945116043
have O 0 0.009295927360653877
a O 0 0.01899738982319832
common O 0 0.026601366698741913
allelic O 1 0.9957787990570068
pattern O 0 0.03860902786254883
, O 0 0.016460176557302475
supporting O 0 0.02410283125936985
the O 0 0.023084677755832672
founder O 1 0.9997313618659973
effect O 0 0.026228196918964386
notion O 0 0.028123440220952034
, O 0 0.013837648555636406
but O 0 0.009841009974479675
dating O 0 0.021172456443309784
the O 0 0.015738770365715027
mutations O 0 0.019744055345654488
origin O 0 0.00949552096426487
to O 0 0.009264484979212284
an O 0 0.010875544510781765
earlier O 0 0.013742837123572826
date O 0 0.016276903450489044
than O 0 0.01094811875373125
currently O 0 0.020043756812810898
estimated O 0 0.029514549300074577
. O 0 0.03600107505917549

However O 0 0.032394856214523315
, O 0 0.018561294302344322
the O 0 0.015731770545244217
different O 0 0.010632026940584183
allelic O 0 0.0801665261387825
pattern O 0 0.03171447291970253
at O 0 0.022264134138822556
the O 0 0.03328495845198631
BRCA1 O 1 0.999996542930603
locus O 1 0.882049560546875
even O 0 0.013865609653294086
in O 0 0.008731777779757977
some O 0 0.009522395208477974
Jewish O 0 0.05273112282156944
mutation O 1 0.5537580251693726
carriers O 0 0.06556969881057739
, O 0 0.017853768542408943
might O 0 0.012777208350598812
suggest O 0 0.012034532614052296
that O 0 0.00822393223643303
the O 0 0.018614498898386955
mutation O 0 0.04659676179289818
arose O 0 0.041897185146808624
independently O 0 0.02641398459672928
. O 0 0.023074306547641754
. O 0 0.03321271762251854

Crystal O 0 0.1127237007021904
structure O 0 0.036605846136808395
of O 0 0.027400102466344833
the O 0 0.46710607409477234
hemochromatosis B-Disease 1 1.0
protein O 1 0.9978943467140198
HFE O 1 0.9999947547912598
and O 0 0.025821436196565628
characterization O 0 0.04949996992945671
of O 0 0.019093353301286697
its O 0 0.021232977509498596
interaction O 0 0.0337262898683548
with O 0 0.03406306356191635
transferrin O 1 0.9999891519546509
receptor O 1 0.9412249326705933
. O 0 0.054269831627607346

HFE O 1 0.9998272061347961
is O 0 0.030076486989855766
an O 0 0.03262428194284439
MHC O 1 0.9999994039535522
- O 1 0.9999933242797852
related O 0 0.02746346779167652
protein O 0 0.01658821478486061
that O 0 0.006081169471144676
is O 0 0.008910263888537884
mutated O 0 0.025296127423644066
in O 0 0.008592144586145878
the O 0 0.022702623158693314
iron B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9998319149017334

HFE O 1 0.9991450309753418
binds O 0 0.13502949476242065
to O 0 0.04715733602643013
transferrin O 1 0.999990701675415
receptor O 1 0.9995654225349426
( O 0 0.058874066919088364
TfR O 1 0.999980092048645
) O 0 0.023341849446296692
and O 0 0.0170737337321043
reduces O 0 0.03508597984910011
its O 0 0.01635170541703701
affinity O 0 0.033932074904441833
for O 0 0.019565638154745102
iron O 1 0.9999737739562988
- O 1 0.9999814033508301
loaded O 0 0.06263144314289093
transferrin O 1 0.998305082321167
, O 0 0.03493314981460571
implicating O 1 0.9994671940803528
HFE O 1 0.9999958276748657
in O 0 0.06954263150691986
iron O 1 0.9999980926513672
metabolism O 1 0.999806821346283
. O 0 0.059877313673496246

The O 0 0.07688113301992416
2 O 0 0.07536507397890091
. O 0 0.052011072635650635

6 O 0 0.059851497411727905
A O 0 0.055997952818870544
crystal O 0 0.3206034302711487
structure O 0 0.03712790086865425
of O 0 0.03468679264187813
HFE O 1 0.999997615814209
reveals O 0 0.051620714366436005
the O 0 0.019699329510331154
locations O 0 0.01802614890038967
of O 0 0.03544085845351219
hemochromatosis B-Disease 1 1.0
mutations O 1 0.5743860006332397
and O 0 0.01984165795147419
a O 0 0.06420224905014038
patch O 1 0.9999854564666748
of O 0 0.0343792624771595
histidines O 1 0.9999866485595703
that O 0 0.01219541858881712
could O 0 0.009540517814457417
be O 0 0.007370777428150177
involved O 0 0.014183628372848034
in O 0 0.02227734588086605
pH O 1 0.9999934434890747
- O 1 0.9999969005584717
dependent O 0 0.07183113694190979
interactions O 0 0.047700271010398865
. O 0 0.035863280296325684

We O 0 0.030435020104050636
also O 0 0.020398814231157303
demonstrate O 0 0.030362943187355995
that O 0 0.020874792709946632
soluble O 1 0.998008668422699
TfR O 1 0.9999420642852783
and O 0 0.042813193053007126
HFE O 1 0.9999986886978149
bind O 1 0.5675125122070312
tightly O 0 0.051791559904813766
at O 0 0.016277767717838287
the O 0 0.016251247376203537
basic O 0 0.031090455129742622
pH O 1 0.9859699606895447
of O 0 0.016836507245898247
the O 0 0.029047206044197083
cell O 1 0.731046736240387
surface O 0 0.02404581382870674
, O 0 0.012012328952550888
but O 0 0.007705411873757839
not O 0 0.007649994920939207
at O 0 0.013774699531495571
the O 0 0.026717785745859146
acidic O 1 0.9996289014816284
pH O 1 0.9998691082000732
of O 0 0.05754717439413071
intracellular O 1 0.9999842643737793
vesicles O 1 0.9998291730880737
. O 0 0.05243642255663872

TfR O 1 0.999873161315918
HFE O 1 0.9999938011169434
stoichiometry O 1 0.9955482482910156
( O 0 0.04026855528354645
2 O 0 0.03444896638393402
1 O 0 0.0299322959035635
) O 0 0.017360908910632133
differs O 0 0.02314767986536026
from O 0 0.022521384060382843
TfR O 1 0.9998113512992859
transferrin O 1 0.9999655485153198
stoichiometry O 1 0.9978880286216736
( O 0 0.029587717726826668
2 O 0 0.029772154986858368
2 O 0 0.028709322214126587
) O 0 0.01869259774684906
, O 0 0.014859565533697605
implying O 0 0.030176423490047455
a O 0 0.013888095505535603
different O 0 0.006726888474076986
mode O 0 0.024604791775345802
of O 0 0.014872484840452671
binding O 0 0.027071278542280197
for O 0 0.023558586835861206
HFE O 1 0.999995231628418
and O 0 0.034488242119550705
transferrin O 1 0.9999068975448608
to O 0 0.03924648463726044
TfR O 1 0.9999586343765259
, O 0 0.020977413281798363
consistent O 0 0.02462826855480671
with O 0 0.012091964483261108
our O 0 0.020409105345606804
demonstration O 0 0.03997782990336418
that O 0 0.017549240961670876
HFE O 1 0.9999748468399048
, O 0 0.03648555651307106
transferrin O 1 0.9998621940612793
, O 0 0.026494182646274567
and O 0 0.028208879753947258
TfR O 1 0.9999270439147949
form O 0 0.03662700578570366
a O 0 0.04674701765179634
ternary O 1 0.9967470169067383
complex O 0 0.070689857006073
. O 0 0.04758979007601738

Identification O 0 0.04421736299991608
of O 0 0.02308744378387928
three O 0 0.02238273434340954
novel O 0 0.05394162982702255
mutations O 0 0.0314902625977993
and O 0 0.015201235190033913
a O 0 0.01841321401298046
high O 0 0.024879343807697296
frequency O 0 0.016412021592259407
of O 0 0.012659196741878986
the O 0 0.021846206858754158
Arg778Leu O 1 0.9999417066574097
mutation O 0 0.046398259699344635
in O 0 0.018019549548625946
Korean O 1 0.9927473664283752
patients O 1 0.9996896982192993
with O 0 0.17731888592243195
Wilson B-Disease 1 0.9999955892562866
disease I-Disease 1 0.9999995231628418
. O 0 0.06996951252222061

Four O 0 0.03851080685853958
mutations O 0 0.07134869694709778
- O 1 0.9999688863754272
- O 1 0.9999583959579468
R778L O 1 0.9986101388931274
, O 0 0.03145407512784004
A874V O 1 0.9892776012420654
, O 0 0.023896923288702965
L1083F O 1 0.8608548045158386
, O 0 0.016484782099723816
and O 0 0.01695431023836136
2304delC O 1 0.999889612197876
- O 1 0.9999935626983643
- O 1 0.9875210523605347
in O 0 0.009336556307971478
the O 0 0.014616075903177261
copper O 1 0.7171454429626465
- O 1 0.9982950091362
transporting O 0 0.043228112161159515
enzyme O 0 0.03466789424419403
, O 0 0.01827397570014
P O 1 0.9987745881080627
- O 1 0.9999879598617554
type O 1 0.9799917936325073
ATPase O 1 0.9999927282333374
( O 0 0.03718053549528122
ATP7B O 1 0.9999774694442749
) O 0 0.017106590792536736
, O 0 0.009239906445145607
were O 0 0.006510321516543627
identified O 0 0.012601787224411964
in O 0 0.013179339468479156
Korean O 1 0.9988742470741272
Patients O 1 0.9999446868896484
with O 0 0.33960434794425964
Wilson B-Disease 1 0.9999938011169434
disease I-Disease 1 0.9999996423721313
. O 0 0.06560328602790833

Arg778Leu O 1 0.9976199269294739
, O 0 0.02756394073367119
the O 0 0.019771238788962364
most O 0 0.013144297525286674
frequently O 0 0.015784434974193573
reported O 0 0.018347475677728653
mutation O 0 0.02463129721581936
of O 0 0.012924553826451302
this O 0 0.01419857144355774
enzyme O 0 0.16804148256778717
, O 0 0.013223344460129738
was O 0 0.015362144447863102
found O 0 0.008116520941257477
in O 0 0.006161626428365707
six O 0 0.009252932853996754
of O 0 0.012916775420308113
eight O 0 0.024589676409959793
unrelated O 1 0.8487806916236877
patients O 1 0.9993104934692383
studied O 0 0.03134463354945183
, O 0 0.019114933907985687
an O 0 0.021685050800442696
allele O 0 0.05866134166717529
frequency O 0 0.02344626374542713
of O 0 0.024646982550621033
37 O 0 0.058028094470500946
. O 0 0.03912041336297989

5 O 0 0.04935033246874809
% O 0 0.02585303969681263
, O 0 0.01847774162888527
which O 0 0.012489858083426952
is O 0 0.013699485920369625
considerably O 0 0.020782170817255974
higher O 0 0.013607350178062916
than O 0 0.008679809048771858
those O 0 0.01032982487231493
in O 0 0.012851891107857227
other O 0 0.015836456790566444
Asian O 0 0.04795920103788376
populations O 0 0.04325750470161438
. O 0 0.045329391956329346

The O 0 0.03673138469457626
novel O 0 0.05157150328159332
single O 0 0.03994068130850792
nucleotide O 0 0.05880844220519066
deletion O 0 0.06104294955730438
, O 0 0.026761429384350777
2304delC O 1 0.9997809529304504
, O 0 0.018721342086791992
was O 0 0.021026821807026863
found O 0 0.012537232600152493
in O 0 0.013959410600364208
one O 0 0.02614269033074379
patient O 1 0.9992526173591614
. O 0 0.045822449028491974

Since O 0 0.035679977387189865
a O 0 0.032976873219013214
mutation O 0 0.0436091385781765
at O 0 0.02940116450190544
cDNA O 0 0.10180576890707016
nucleotide O 0 0.08500999957323074
2302 O 1 0.9998704195022583
( O 0 0.03750203177332878
2302insC O 1 0.9848726987838745
) O 0 0.0177622027695179
had O 0 0.01331250835210085
been O 0 0.010035574436187744
previously O 0 0.01586982235312462
described O 0 0.019921276718378067
, O 0 0.009475245140492916
this O 0 0.006256615277379751
region O 0 0.011706308461725712
of O 0 0.011745186522603035
the O 0 0.027720369398593903
ATP7B O 1 0.9999998807907104
gene O 0 0.07043531537055969
may O 0 0.017857292667031288
be O 0 0.012218407355248928
susceptible O 0 0.04722674936056137
to O 0 0.02288949489593506
gene O 0 0.049686871469020844
rearrangements O 1 0.9981237053871155
causing O 1 0.999863862991333
Wilson B-Disease 1 0.9999957084655762
disease I-Disease 1 0.9999998807907104
. O 0 0.07843166589736938

Disruption O 0 0.11641643941402435
of O 0 0.03591568395495415
splicing O 0 0.0519491471350193
regulated O 0 0.0254356749355793
by O 0 0.012997775338590145
a O 0 0.027396490797400475
CUG O 1 0.9999969005584717
- O 1 0.9999755620956421
binding O 0 0.048477061092853546
protein O 0 0.03772026672959328
in O 0 0.04435060918331146
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.161294087767601

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999983310699463
DM B-Disease 1 1.0
) O 0 0.06735793501138687
is O 0 0.020840508863329887
caused O 0 0.02785096876323223
by O 0 0.015683334320783615
a O 0 0.029896169900894165
CTG O 1 0.9999430179595947
expansion O 0 0.032545845955610275
in O 0 0.011759769171476364
the O 0 0.015856057405471802
3 O 0 0.027638085186481476
untranslated O 0 0.08797279745340347
region O 0 0.023580556735396385
of O 0 0.023375065997242928
the O 0 0.4823399782180786
DM B-Disease 1 1.0
gene O 0 0.12289316952228546
. O 0 0.04337218031287193

One O 0 0.035618241876363754
model O 0 0.04445508122444153
of O 0 0.06192388758063316
DM B-Disease 1 1.0
pathogenesis O 1 0.9999997615814209
suggests O 0 0.0470895878970623
that O 0 0.01628728210926056
RNAs O 0 0.05326914042234421
from O 0 0.011674288660287857
the O 0 0.013554469682276249
expanded O 0 0.024940388277173042
allele O 0 0.03655429184436798
create O 0 0.014614667743444443
a O 0 0.015110829845070839
gain O 0 0.02335738204419613
- O 1 0.9958996176719666
of O 0 0.024327723309397697
- O 1 0.9999887943267822
function O 0 0.02328818291425705
mutation O 0 0.022708341479301453
by O 0 0.01064394973218441
the O 0 0.016168739646673203
inappropriate O 0 0.037524182349443436
binding O 0 0.021772151812911034
of O 0 0.016451595351099968
proteins O 0 0.01957036554813385
to O 0 0.01605098694562912
the O 0 0.03360709920525551
CUG O 1 0.9999926090240479
repeats O 0 0.09877704828977585
. O 0 0.04227231815457344

Data O 0 0.03132076933979988
presented O 0 0.028738630935549736
here O 0 0.01639915630221367
indicate O 0 0.01401408389210701
that O 0 0.007055506110191345
the O 0 0.015109424479305744
conserved O 0 0.03525913506746292
heterogeneous O 0 0.07058823853731155
nuclear O 0 0.05380673334002495
ribonucleoprotein O 1 0.996891438961029
, O 0 0.028786253184080124
CUG O 1 0.999893069267273
- O 1 0.999538779258728
binding O 0 0.033189669251441956
protein O 0 0.025049181655049324
( O 0 0.021992774680256844
CUG O 1 0.9999752044677734
- O 1 0.9999949932098389
BP O 1 0.9713580012321472
) O 0 0.01785796880722046
, O 0 0.013456080108880997
may O 0 0.013060848228633404
mediate O 0 0.04397188127040863
the O 0 0.026301439851522446
trans O 1 0.9990646243095398
- O 1 0.9999589920043945
dominant O 0 0.07397593557834625
effect O 0 0.02161054126918316
of O 0 0.020469948649406433
the O 0 0.03159894049167633
RNA O 0 0.07237192243337631
. O 0 0.035997845232486725

CUG O 1 0.9999915361404419
- O 1 0.9999947547912598
BP O 1 0.7295822501182556
was O 0 0.033915925770998
found O 0 0.014221122488379478
to O 0 0.014072085730731487
bind O 0 0.025823542848229408
to O 0 0.012861930765211582
the O 0 0.020248286426067352
human O 1 0.6488364338874817
cardiac O 1 1.0
troponin O 1 1.0
T O 1 0.9999996423721313
( O 0 0.04046252369880676
cTNT O 1 0.9814515709877014
) O 0 0.024722885340452194
pre O 0 0.2913287281990051
- O 1 0.9999444484710693
messenger O 1 0.9442021250724792
RNA O 0 0.049906909465789795
and O 0 0.017337927594780922
regulate O 0 0.03323714807629585
its O 0 0.024974798783659935
alternative O 0 0.047051381319761276
splicing O 0 0.07049988955259323
. O 0 0.039185162633657455

Splicing O 0 0.0813790112733841
of O 0 0.030943715944886208
cTNT O 1 0.9583286643028259
was O 0 0.041063908487558365
disrupted O 1 0.7899174094200134
in O 0 0.08941702544689178
DM B-Disease 1 1.0
striated O 1 1.0
muscle O 1 0.9999949932098389
and O 0 0.025158368051052094
in O 0 0.020585162565112114
normal O 0 0.04004981368780136
cells O 0 0.03481708839535713
expressing O 0 0.04521182179450989
transcripts O 0 0.046545907855033875
that O 0 0.017030080780386925
contain O 0 0.04010706767439842
CUG O 1 0.9992721676826477
repeats O 0 0.10076259821653366
. O 0 0.04605437442660332

Altered O 0 0.06892574578523636
expression O 0 0.03811957314610481
of O 0 0.025606637820601463
genes O 0 0.024639111012220383
regulated O 0 0.03405420482158661
posttranscriptionally O 0 0.10041674226522446
by O 0 0.03198239207267761
CUG O 1 0.9999990463256836
- O 1 0.9999982118606567
BP O 1 0.9174023866653442
therefore O 0 0.02369752526283264
may O 0 0.018588803708553314
contribute O 0 0.031961169093847275
to O 0 0.05471807345747948
DM B-Disease 1 1.0
pathogenesis O 1 0.9999998807907104
. O 0 0.04418257251381874
. O 0 0.043786972761154175

Identification O 0 0.04619024693965912
of O 0 0.02501414529979229
a O 0 0.03382449224591255
novel O 0 0.06289409101009369
nonsense O 1 0.8346879482269287
mutation O 0 0.044410280883312225
and O 0 0.016678735613822937
a O 0 0.024021029472351074
missense O 0 0.07691579312086105
substitution O 0 0.035083599388599396
in O 0 0.01131365168839693
the O 0 0.02151310443878174
vasopressin O 1 0.9994962215423584
- O 1 0.9999970197677612
neurophysin O 1 0.999983549118042
II O 1 0.9999961853027344
gene O 0 0.028601594269275665
in O 0 0.009559967555105686
two O 0 0.009742772206664085
Spanish O 0 0.034244246780872345
kindreds O 1 0.8770034313201904
with O 0 0.050143763422966
familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 0.32404106855392456

Familial B-Disease 1 0.9999992847442627
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9997678399085999
FNDI B-Disease 1 1.0
) O 0 0.023547114804387093
is O 0 0.014279470779001713
an O 0 0.01946275122463703
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999996423721313
by O 1 0.9999206066131592
deficiency O 1 1.0
in O 0 0.026289334520697594
the O 1 0.9170784950256348
antidiuretic O 1 1.0
hormone O 1 0.9999996423721313
arginine O 1 0.9999945163726807
vasopressin O 1 0.9999953508377075
( O 0 0.054505977779626846
AVP O 1 0.9999933242797852
) O 0 0.017357883974909782
encoded O 0 0.011685440316796303
by O 0 0.009461237117648125
the O 0 0.018237758427858353
AVP O 1 0.9999984502792358
- O 1 0.9999922513961792
neurophysin O 1 0.9999629259109497
II O 1 0.9999983310699463
( O 0 0.06706741452217102
AVP O 1 0.9999996423721313
- O 1 0.9999957084655762
NPII O 1 0.9999876022338867
) O 0 0.031168222427368164
gene O 0 0.030740488320589066
on O 0 0.029931046068668365
chromosome O 0 0.08555804938077927
20p13 O 1 0.9555407166481018
. O 0 0.05270685255527496

In O 0 0.027080945670604706
this O 0 0.0174659863114357
study O 0 0.02114856243133545
, O 0 0.014241672120988369
we O 0 0.009998506866395473
analyzed O 0 0.01403290219604969
two O 0 0.00878883246332407
families O 0 0.018999772146344185
with O 0 0.021688401699066162
FNDI B-Disease 1 0.9999825954437256
using O 0 0.019359663128852844
direct O 0 0.026477908715605736
automated O 0 0.05734112113714218
fluorescent O 0 0.09609823673963547
, O 0 0.018123820424079895
solid O 0 0.032533444464206696
phase O 0 0.04061732813715935
, O 0 0.01749851182103157
single O 0 0.03294631838798523
- O 1 0.945178747177124
stranded O 0 0.0587938092648983
DNA O 0 0.02330671437084675
sequencing O 0 0.023313812911510468
of O 0 0.02346920408308506
PCR O 0 0.2627979516983032
- O 1 0.9992129802703857
amplified O 1 0.6156697273254395
AVP O 1 0.9999755620956421
- O 1 0.9998952150344849
NPII O 1 0.9996309280395508
DNA O 0 0.07407956570386887
. O 0 0.04579366743564606

In O 0 0.02331356331706047
one O 0 0.016223246231675148
of O 0 0.01608225330710411
the O 0 0.022507501766085625
families O 0 0.02861424908041954
, O 0 0.0204273983836174
affected O 0 0.023323968052864075
individuals O 0 0.01211700588464737
presented O 0 0.019854960963129997
a O 0 0.02133520320057869
novel O 0 0.04503791779279709
nonsense O 1 0.8018510341644287
mutation O 0 0.03608403727412224
in O 0 0.01241473201662302
exon O 0 0.054751213639974594
3 O 0 0.01515207439661026
of O 0 0.011854718439280987
the O 0 0.01769736222922802
gene O 0 0.02057100087404251
, O 0 0.01089282426983118
consisting O 0 0.01561710424721241
in O 0 0.009916446171700954
a O 0 0.02232331410050392
G O 1 0.957633376121521
to O 0 0.025737997144460678
T O 1 0.9961279034614563
transition O 0 0.04046494886279106
at O 0 0.025345299392938614
nucleotide O 0 0.06069893389940262
2101 O 1 0.9986792206764221
, O 0 0.019201742485165596
which O 0 0.012225591577589512
produces O 0 0.01728763058781624
a O 0 0.017338359728455544
stop O 0 0.030917255207896233
signal O 0 0.02770812250673771
in O 0 0.014369180426001549
codon O 0 0.06277300417423248
82 O 0 0.06788188219070435
( O 0 0.048931751400232315
Glu O 1 0.9999915361404419
) O 0 0.03360458463430405
of O 0 0.04307680204510689
NPII O 1 0.9996552467346191
. O 0 0.06037071347236633

The O 0 0.06402520090341568
premature O 1 0.9994311928749084
termination O 1 0.9943788647651672
eliminates O 1 0.5255199074745178
part O 0 0.023311257362365723
of O 0 0.017053654417395592
the O 0 0.028530895709991455
C O 1 0.9999719858169556
- O 1 0.999990701675415
terminal O 1 0.7917712330818176
domain O 0 0.03211650997400284
of O 0 0.02477121353149414
NPII O 1 0.9997230172157288
, O 0 0.019000226631760597
including O 0 0.014635941945016384
a O 0 0.02467389963567257
cysteine O 0 0.0804356038570404
residue O 0 0.04803575575351715
in O 0 0.013542437925934792
position O 0 0.02399403788149357
85 O 0 0.035922419279813766
, O 0 0.015622192993760109
which O 0 0.010297387838363647
could O 0 0.0093314154073596
be O 0 0.007668595295399427
involved O 0 0.010346845723688602
in O 0 0.009567013941705227
the O 0 0.01970948837697506
correct O 0 0.04289812967181206
folding O 0 0.14214234054088593
of O 0 0.028150765225291252
the O 0 0.05785874277353287
prohormone O 1 0.9999912977218628
. O 0 0.059845659881830215

In O 0 0.025683697313070297
the O 0 0.02406419813632965
second O 0 0.035443663597106934
family O 0 0.031155336648225784
, O 0 0.018716363236308098
a O 0 0.024578390643000603
G279A O 1 0.9710112810134888
substitution O 0 0.04074637219309807
at O 0 0.01720951870083809
position O 0 0.023177191615104675
- O 1 0.9498980641365051
1 O 0 0.015022986568510532
of O 0 0.010770677588880062
the O 0 0.01661725342273712
signal O 0 0.04661800339818001
peptide O 0 0.052698757499456406
was O 0 0.01852118782699108
observed O 0 0.014532499015331268
in O 0 0.011367215774953365
all O 0 0.017147021368145943
affected O 0 0.03665995970368385
individuals O 0 0.029051320627331734
. O 0 0.03839676454663277

This O 0 0.03476034104824066
missense O 0 0.362415611743927
mutation O 0 0.050298746675252914
, O 0 0.018860584124922752
which O 0 0.019119545817375183
replaces O 1 0.9987758994102478
Ala O 1 0.9999971389770508
with O 0 0.036563530564308167
Thr O 1 0.9999992847442627
, O 0 0.02319389209151268
is O 0 0.017637737095355988
frequent O 0 0.03976567089557648
among O 0 0.35599130392074585
FNDI B-Disease 1 1.0
patients O 1 0.9999982118606567
and O 0 0.02662702463567257
is O 0 0.016492290422320366
thought O 0 0.01588648185133934
to O 0 0.011929492466151714
reduce O 0 0.021109972149133682
the O 0 0.015514533035457134
efficiency O 0 0.031881220638751984
of O 0 0.02586754411458969
cleavage O 1 0.9997206330299377
by O 0 0.032225385308265686
signal O 0 0.1313711255788803
peptidases O 1 0.9762702584266663
. O 0 0.03212614357471466
. O 0 0.039095763117074966

Genetic O 0 0.057586681097745895
heterogeneity O 0 0.08396127074956894
of O 0 0.04536813870072365
Saethre B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.04411933571100235
due O 0 0.032319553196430206
to O 0 0.029933027923107147
TWIST O 1 0.9967851638793945
and O 0 0.047967616468667984
FGFR O 1 0.9999967813491821
mutations O 0 0.08601247519254684
. O 0 0.046983733773231506

Thirty O 0 0.09452062100172043
- O 1 0.9750526547431946
two O 0 0.021660607308149338
unrelated O 0 0.04811779037117958
patients O 0 0.14993636310100555
with O 0 0.013195205479860306
features O 0 0.017160454764962196
of O 0 0.02415444515645504
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0206752922385931
a O 0 0.021542800590395927
common O 0 0.22050951421260834
autosomal B-Disease 1 0.999996542930603
dominant I-Disease 1 0.9999241828918457
condition I-Disease 1 0.9999116659164429
of O 1 0.9994434714317322
craniosynostosis B-Disease 1 1.0
and O 1 0.9999902248382568
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999988079071045
, O 0 0.01948023959994316
were O 0 0.011708680540323257
screened O 0 0.03449398651719093
for O 0 0.01338791660964489
mutations O 0 0.024047741666436195
in O 0 0.015765313059091568
TWIST O 1 0.9943882822990417
, O 0 0.03690025210380554
FGFR2 O 1 0.9999979734420776
, O 0 0.03456731513142586
and O 0 0.03549571707844734
FGFR3 O 1 0.9999474287033081
. O 0 0.05159059911966324

Nine O 0 0.04780416563153267
novel O 0 0.05492541939020157
and O 0 0.024453621357679367
three O 0 0.03362458199262619
recurrent O 1 0.9999996423721313
TWIST O 1 0.9999951124191284
mutations O 0 0.07049503922462463
were O 0 0.013363544829189777
found O 0 0.013942500576376915
in O 0 0.01447004359215498
12 O 0 0.02745605818927288
families O 0 0.03564870357513428
. O 0 0.03670775517821312

Seven O 0 0.04495931416749954
families O 0 0.03124445676803589
were O 0 0.01347450539469719
found O 0 0.011047689244151115
to O 0 0.009505320340394974
have O 0 0.007588501088321209
the O 0 0.021431367844343185
FGFR3 O 1 0.999998927116394
P250R O 1 0.9999933242797852
mutation O 0 0.25061631202697754
, O 0 0.016849335283041
and O 0 0.012648996897041798
one O 0 0.013102643191814423
individual O 0 0.013050820678472519
was O 0 0.01795467920601368
found O 0 0.009717957116663456
to O 0 0.009495915845036507
have O 0 0.0070454576052725315
an O 0 0.01818631961941719
FGFR2 O 1 0.9999556541442871
VV269 O 1 0.999842643737793
- O 1 0.9996597766876221
270 O 0 0.09294827282428741
deletion O 0 0.11075958609580994
. O 0 0.044269710779190063

To O 0 0.03498748689889908
date O 0 0.027879804372787476
, O 0 0.017114682123064995
our O 0 0.021366870030760765
detection O 0 0.0371716283261776
rate O 0 0.016821790486574173
for O 0 0.016782553866505623
TWIST O 1 0.9759206771850586
or O 0 0.030387356877326965
FGFR O 1 0.9999942779541016
mutations O 0 0.031233448535203934
is O 0 0.013137025758624077
68 O 0 0.0239157285541296
% O 0 0.009877458214759827
in O 0 0.00836180243641138
our O 0 0.021365536376833916
Saethre B-Disease 1 0.9999986886978149
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999984502792358
, O 0 0.02462218888103962
including O 0 0.015709901228547096
our O 0 0.022829914465546608
five O 0 0.025323694571852684
patients O 1 0.9993342757225037
elsewhere O 0 0.02628389000892639
reported O 0 0.028085440397262573
with O 0 0.029658937826752663
TWIST O 1 0.9983314871788025
mutations O 0 0.07063909620046616
. O 0 0.043604157865047455

More O 0 0.016977349296212196
than O 0 0.012328416109085083
35 O 0 0.021837662905454636
different O 0 0.012333810329437256
TWIST O 1 0.7227742671966553
mutations O 0 0.030571775510907173
are O 0 0.008187669329345226
now O 0 0.016978830099105835
known O 0 0.020525064319372177
in O 0 0.013016716577112675
the O 0 0.023053189739584923
literature O 0 0.03211622312664986
. O 0 0.03456034138798714

The O 0 0.04025175794959068
most O 0 0.02507133036851883
common O 0 0.030299710109829903
phenotypic O 0 0.05544546619057655
features O 0 0.02867695316672325
, O 0 0.01570780947804451
present O 0 0.01265750452876091
in O 0 0.008209723979234695
more O 0 0.005340070929378271
than O 0 0.005837355740368366
a O 0 0.011387323960661888
third O 0 0.01927480474114418
of O 0 0.015214362181723118
our O 0 0.02653656154870987
patients O 1 0.997751772403717
with O 0 0.023504089564085007
TWIST O 1 0.999950647354126
mutations O 0 0.03631843999028206
, O 0 0.01513298787176609
are O 0 0.01147766038775444
coronal B-Disease 1 0.9997225403785706
synostosis I-Disease 1 0.9998218417167664
, O 0 0.026139257475733757
brachycephaly B-Disease 1 0.9980575442314148
, O 0 0.02537803165614605
low B-Disease 1 0.9640839099884033
frontal I-Disease 1 0.9999998807907104
hairline I-Disease 1 1.0
, O 1 0.999535083770752
facial B-Disease 1 0.9999998807907104
asymmetry I-Disease 1 0.9999994039535522
, O 1 0.9994984865188599
ptosis B-Disease 1 1.0
, O 1 0.7282955050468445
hypertelorism B-Disease 1 0.9999970197677612
, O 0 0.034266069531440735
broad B-Disease 1 0.6202595829963684
great I-Disease 1 0.9843919277191162
toes I-Disease 1 0.9999643564224243
, O 0 0.03973839432001114
and O 0 0.04085510969161987
clinodactyly B-Disease 1 0.9997124075889587
. O 0 0.05403328314423561

Significant O 0 0.05867810547351837
intra O 1 0.9997561573982239
- O 1 0.999954342842102
and O 0 0.03966418653726578
interfamilial O 1 0.9997381567955017
phenotypic O 0 0.12902013957500458
variability O 0 0.05189226195216179
is O 0 0.01484580710530281
present O 0 0.014492514543235302
for O 0 0.013391121290624142
either O 0 0.02653798833489418
TWIST O 1 0.9854047894477844
mutations O 0 0.058315176516771317
or O 0 0.04133593291044235
FGFR O 1 0.9999847412109375
mutations O 0 0.0866444781422615
. O 0 0.04729835316538811

The O 0 0.04882459715008736
overlap O 0 0.04034626856446266
in O 0 0.022357122972607613
clinical O 1 0.8950904011726379
features O 0 0.025291040539741516
and O 0 0.014375396072864532
the O 0 0.017399223521351814
presence O 0 0.025563346222043037
, O 0 0.011272884905338287
in O 0 0.008111597038805485
the O 0 0.01143031008541584
same O 0 0.010804098099470139
genes O 0 0.012892637401819229
, O 0 0.010699218139052391
of O 0 0.0134947020560503
mutations O 0 0.01766778528690338
for O 0 0.00865692738443613
more O 0 0.006120468955487013
than O 0 0.00824051909148693
one O 0 0.016434868797659874
craniosynostotic B-Disease 1 0.9998013377189636
condition I-Disease 1 0.9323902726173401
- O 1 0.990884006023407
such O 0 0.011041856370866299
as O 0 0.0183878056704998
Saethre B-Disease 1 0.9999343156814575
- I-Disease 1 0.9999878406524658
Chotzen I-Disease 1 0.999758780002594
, I-Disease 0 0.025608690455555916
Crouzon I-Disease 1 0.9985955357551575
, I-Disease 0 0.019979365170001984
and I-Disease 0 0.03085245005786419
Pfeiffer I-Disease 1 1.0
syndromes I-Disease 1 1.0
- O 1 0.9999994039535522
support O 0 0.0384388230741024
the O 0 0.02040257677435875
hypothesis O 0 0.031014181673526764
that O 0 0.010470260865986347
TWIST O 0 0.27960219979286194
and O 0 0.020496651530265808
FGFRs O 1 0.9990261793136597
are O 0 0.008147667162120342
components O 0 0.01346941664814949
of O 0 0.010491099208593369
the O 0 0.014181695878505707
same O 0 0.01524442620575428
molecular O 0 0.030520092695951462
pathway O 0 0.03811667487025261
involved O 0 0.010333260521292686
in O 0 0.009041111916303635
the O 0 0.01640206202864647
modulation O 0 0.19145110249519348
of O 1 0.6328648924827576
craniofacial O 1 1.0
and O 1 0.9999833106994629
limb O 1 1.0
development O 1 0.9874663949012756
in O 0 0.03083069808781147
humans O 0 0.03286543861031532
. O 0 0.0262519009411335
. O 0 0.03668675199151039

Mutation O 0 0.08068101108074188
analysis O 0 0.023490790277719498
of O 0 0.03992605209350586
UBE3A O 1 0.9999995231628418
in O 1 0.9998865127563477
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9613335132598877

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997983574867249
AS B-Disease 1 0.9999572038650513
) O 0 0.02626977488398552
is O 0 0.0155039606615901
caused O 0 0.024685868993401527
by O 0 0.02065129205584526
chromosome O 0 0.20530427992343903
15q11 O 1 0.999895453453064
- O 1 0.9999630451202393
q13 O 1 0.9944484233856201
deletions O 0 0.05915483832359314
of O 0 0.025371339172124863
maternal O 1 0.9595082998275757
origin O 0 0.01737169921398163
, O 0 0.014280000701546669
by O 0 0.02103004977107048
paternal O 1 0.9994978904724121
uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999997615814209
( O 1 0.9220094680786133
UPD B-Disease 1 0.9999998807907104
) O 0 0.022801319137215614
15 O 0 0.018483974039554596
, O 0 0.015492341481149197
by O 0 0.025272076949477196
imprinting O 1 0.9999992847442627
defects O 1 0.9999897480010986
, O 0 0.018984757363796234
and O 0 0.01529875211417675
by O 0 0.016316095367074013
mutations O 0 0.024355415254831314
in O 0 0.015114962123334408
the O 0 0.0391872301697731
UBE3A O 1 0.9999984502792358
gene O 0 0.07529377937316895
. O 0 0.045974038541316986

UBE3A O 1 0.9988306164741516
encodes O 0 0.07952432334423065
a O 0 0.0470116063952446
ubiquitin O 1 0.9925816059112549
- O 1 0.999968409538269
protein O 0 0.038655493408441544
ligase O 0 0.053036514669656754
and O 0 0.019798848778009415
shows O 0 0.03198676556348801
brain O 1 0.999822199344635
- O 1 0.9999889135360718
specific O 0 0.034064460545778275
imprinting O 1 0.9877057671546936
. O 0 0.044854722917079926

Here O 0 0.037463121116161346
we O 0 0.022685451433062553
describe O 0 0.04978156462311745
UBE3A O 1 0.9999144077301025
coding O 0 0.22596970200538635
- O 1 0.998680055141449
region O 0 0.04213477671146393
mutations O 0 0.033122215420007706
detected O 0 0.028464000672101974
by O 0 0.02011982724070549
SSCP O 1 0.9999397993087769
analysis O 0 0.01642022840678692
in O 0 0.012742980383336544
13 O 0 0.02756095677614212
AS B-Disease 0 0.08163034170866013
individuals O 0 0.022688308730721474
or O 0 0.026220345869660378
families O 0 0.03906545415520668
. O 0 0.04300513118505478

Two O 0 0.027552222833037376
identical O 0 0.0365164577960968
de O 0 0.0828583836555481
novo O 0 0.36428749561309814
5 O 0 0.054694510996341705
- O 1 0.9965588450431824
bp O 0 0.07295346260070801
duplications O 0 0.07098527997732162
in O 0 0.023966865614056587
exon O 0 0.09392640739679337
16 O 0 0.032490622252225876
were O 0 0.019077926874160767
found O 0 0.026830019429326057
. O 0 0.037228941917419434

Among O 0 0.03946689888834953
the O 0 0.024689406156539917
other O 0 0.0146950613707304
11 O 0 0.024086562916636467
unique O 0 0.024285821244120598
mutations O 0 0.02964884601533413
, O 0 0.016430111601948738
8 O 0 0.020427780225872993
were O 0 0.010034754872322083
small O 0 0.01798550970852375
deletions O 0 0.050816915929317474
or O 0 0.02217808924615383
insertions O 0 0.18791483342647552
predicted O 0 0.03075757436454296
to O 0 0.02040279656648636
cause O 1 0.9481496214866638
frameshifts O 1 0.9999831914901733
, O 0 0.018862323835492134
1 O 0 0.021918905898928642
was O 0 0.018083281815052032
a O 0 0.01961907558143139
mutation O 0 0.027563953772187233
to O 0 0.012329746037721634
a O 0 0.01780058816075325
stop O 0 0.03145310655236244
codon O 0 0.04668368771672249
, O 0 0.013288860209286213
1 O 0 0.016297874972224236
was O 0 0.015522435307502747
a O 0 0.020987428724765778
missense O 1 0.8516783118247986
mutation O 0 0.042413130402565
, O 0 0.01372020784765482
and O 0 0.011424008756875992
1 O 0 0.020496422424912453
was O 0 0.018086334690451622
predicted O 0 0.021926023066043854
to O 0 0.016134535893797874
cause O 0 0.05074012652039528
insertion O 0 0.06615028530359268
of O 0 0.020224545150995255
an O 0 0.02262936718761921
isoleucine O 1 0.9963384866714478
in O 0 0.014929095283150673
the O 0 0.02164212055504322
hect O 1 0.9654960036277771
domain O 0 0.02697126194834709
of O 0 0.015212446451187134
the O 0 0.02932031825184822
UBE3A O 1 0.9999992847442627
protein O 0 0.034970689564943314
, O 0 0.014397180639207363
which O 0 0.010193713940680027
functions O 0 0.014917725697159767
in O 0 0.020309604704380035
E2 O 1 0.9998045563697815
binding O 0 0.046001747250556946
and O 0 0.03150974214076996
ubiquitin O 1 0.6462551951408386
transfer O 0 0.0504448264837265
. O 0 0.0401032529771328

Eight O 0 0.03142356127500534
of O 0 0.021495776250958443
the O 0 0.02360736019909382
cases O 0 0.02615269087255001
were O 0 0.02237660065293312
familial O 1 0.9999969005584717
, O 0 0.02919001691043377
and O 0 0.01846836507320404
five O 0 0.02138761803507805
were O 0 0.021471887826919556
sporadic O 0 0.07261458039283752
. O 0 0.040814612060785294

In O 0 0.029368657618761063
two O 0 0.025908032432198524
familial O 1 0.9999185800552368
cases O 0 0.03783927485346794
and O 0 0.019639618694782257
one O 0 0.018541574478149414
sporadic O 0 0.28521230816841125
case O 0 0.032087549567222595
, O 0 0.02357340417802334
mosaicism O 1 0.9999469518661499
for O 0 0.034813180565834045
UBE3A O 1 0.9999998807907104
mutations O 0 0.09983737021684647
was O 0 0.027716120705008507
detected O 0 0.021153677254915237
in O 0 0.008530659601092339
the O 0 0.012951049022376537
mother O 0 0.031301695853471756
of O 0 0.012472179718315601
three O 0 0.012951452285051346
AS B-Disease 1 0.9180470108985901
sons O 1 0.9591262936592102
, O 0 0.014275317080318928
in O 0 0.009450411424040794
the O 0 0.017216375097632408
maternal O 1 0.9995439648628235
grandfather O 1 0.9717260599136353
of O 0 0.015688465908169746
two O 0 0.011933674104511738
AS B-Disease 0 0.4166337847709656
first O 0 0.024539848789572716
cousins O 1 0.7344049215316772
, O 0 0.013913594186306
and O 0 0.009343443438410759
in O 0 0.009301875717937946
the O 0 0.013922060839831829
mother O 0 0.1189039871096611
of O 0 0.018946263939142227
an O 0 0.027776358649134636
AS B-Disease 1 0.9990523457527161
daughter O 1 0.9999510049819946
. O 0 0.05164499953389168

The O 0 0.0393139123916626
frequencies O 0 0.023566626012325287
with O 0 0.013568798080086708
which O 0 0.01007987093180418
we O 0 0.01087125763297081
detected O 0 0.02601519785821438
mutations O 0 0.01972225308418274
were O 0 0.009881101548671722
5 O 0 0.018248364329338074
( O 0 0.014604288153350353
14 O 0 0.017142634838819504
% O 0 0.012683028355240822
) O 0 0.009425077587366104
of O 0 0.010912786237895489
35 O 0 0.01925128512084484
in O 0 0.013315321877598763
sporadic O 0 0.03899950906634331
cases O 0 0.018324585631489754
and O 0 0.016468098387122154
8 O 0 0.02699384093284607
( O 0 0.018067823722958565
80 O 0 0.019864259287714958
% O 0 0.01379679050296545
) O 0 0.010264749638736248
of O 0 0.011015819385647774
10 O 0 0.016879023984074593
in O 0 0.02194572612643242
familial O 1 0.999990701675415
cases O 0 0.3227449357509613
. O 0 0.030525976791977882
. O 0 0.039846763014793396

The O 0 0.07739770412445068
hemochromatosis B-Disease 1 0.9999998807907104
845 O 1 0.9999780654907227
G O 1 0.9999908208847046
- O 1 0.9999991655349731
- O 1 0.9999806880950928
> O 0 0.27049052715301514
A O 0 0.019736463204026222
and O 0 0.011128070764243603
187 O 0 0.04288627207279205
C O 1 0.9901912212371826
- O 1 0.9999904632568359
- O 1 0.999997615814209
> O 1 0.9996992349624634
G O 1 0.9954211115837097
mutations O 0 0.03483261913061142
: O 0 0.02169053629040718
prevalence O 1 0.8703160881996155
in O 0 0.021498724818229675
non O 1 0.9988081455230713
- O 1 0.9999983310699463
Caucasian O 1 0.9995680451393127
populations O 0 0.05703974887728691
. O 0 0.04024924710392952

Hemochromatosis B-Disease 1 0.999997615814209
, O 0 0.03787337616086006
the O 1 0.7352645397186279
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.9999995231628418
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 0.17734390497207642
leads O 1 0.9700441360473633
, O 0 0.021714970469474792
if O 0 0.020298253744840622
untreated O 1 0.9999791383743286
, O 0 0.017857935279607773
to O 0 0.02362687513232231
progressive O 1 0.9999982118606567
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 1 0.8573576807975769
premature B-Disease 1 0.9999909400939941
death I-Disease 1 0.9990473389625549
. O 0 0.050843093544244766

The O 0 0.16007819771766663
hemochromatosis B-Disease 1 1.0
gene O 1 0.7233245968818665
, O 0 0.052674323320388794
HFE O 1 0.9999990463256836
, O 0 0.023753022775053978
recently O 0 0.024999195709824562
has O 0 0.012164587154984474
been O 0 0.010650841519236565
identified O 0 0.015423821285367012
, O 0 0.009717218577861786
and O 0 0.010510442778468132
characterization O 0 0.028329800814390182
of O 0 0.01385017391294241
this O 0 0.01165543869137764
gene O 0 0.020606564357876778
has O 0 0.010698167607188225
shown O 0 0.009291528724133968
that O 0 0.0061264680698513985
it O 0 0.006035835947841406
contains O 0 0.01075803954154253
two O 0 0.009582222439348698
mutations O 0 0.018812337890267372
that O 0 0.008181809447705746
result O 0 0.013507905416190624
in O 0 0.015015902929008007
amino O 0 0.031476810574531555
acid O 0 0.04362088814377785
substitutions O 0 0.04416853189468384
- O 0 0.4019894599914551
cDNA O 0 0.06712309271097183
nucleotides O 0 0.03808537870645523
845 O 0 0.3428751528263092
G O 1 0.9949304461479187
- O 1 0.9999454021453857
- O 1 0.9999762773513794
> O 1 0.8190717101097107
A O 0 0.03572702780365944
( O 0 0.024880865588784218
C282Y O 0 0.27049413323402405
) O 0 0.013325298205018044
and O 0 0.010912313126027584
187 O 0 0.04851315915584564
C O 1 0.9884536862373352
- O 1 0.9999889135360718
- O 1 0.9999979734420776
> O 1 0.9995760321617126
G O 1 0.9985443353652954
( O 0 0.05148119851946831
H63D O 1 0.9998102784156799
) O 0 0.042345549911260605
. O 0 0.037885334342718124

Although O 0 0.173613503575325
hemochromatosis B-Disease 1 1.0
is O 0 0.033348243683576584
common O 0 0.027721095830202103
in O 0 0.02047710306942463
Caucasians O 1 0.9988918900489807
, O 0 0.02726762183010578
affecting O 0 0.30563440918922424
> O 1 0.9968746900558472
= O 0 0.06831596791744232
1 O 0 0.04207492619752884
/ O 0 0.4519016146659851
300 O 0 0.019781554117798805
individuals O 0 0.009977717883884907
of O 0 0.012038740329444408
northern O 0 0.020205862820148468
European O 0 0.015967098996043205
origin O 0 0.011681420728564262
, O 0 0.01097989734262228
it O 0 0.00796408113092184
has O 0 0.009053844027221203
not O 0 0.0071317050606012344
been O 0 0.009577910415828228
recognized O 0 0.01881709136068821
in O 0 0.012671563774347305
other O 0 0.014945462346076965
populations O 0 0.032373588532209396
. O 0 0.03287225961685181

The O 0 0.04142732545733452
present O 0 0.03320266306400299
study O 0 0.023120185360312462
used O 0 0.01760859601199627
PCR O 0 0.058031391352415085
and O 0 0.01953016221523285
restriction O 0 0.08256124705076218
- O 1 0.9999966621398926
enzyme O 1 0.8676278591156006
digestion O 1 0.7278194427490234
to O 0 0.017284853383898735
analyze O 0 0.019749458879232407
the O 0 0.011583779938519001
frequency O 0 0.01083059050142765
of O 0 0.00954981055110693
the O 0 0.017764782533049583
845 O 1 0.9995953440666199
G O 1 0.9998676776885986
- O 1 0.9999929666519165
- O 1 0.9999018907546997
> O 0 0.05897786468267441
A O 0 0.020706141367554665
and O 0 0.012619218789041042
187 O 0 0.046908728778362274
C O 1 0.9906042218208313
- O 1 0.9999898672103882
- O 1 0.999983549118042
> O 1 0.9702812433242798
G O 0 0.19578413665294647
mutations O 0 0.03361812233924866
in O 0 0.02465757541358471
HLA O 1 0.9999997615814209
- O 1 0.9995054006576538
typed O 0 0.04383036866784096
samples O 0 0.01738664321601391
from O 0 0.012711176648736
non O 0 0.11062835901975632
- O 1 0.999980092048645
Caucasian O 1 0.9909274578094482
populations O 0 0.024040745571255684
, O 0 0.014150956645607948
comprising O 0 0.027878519147634506
Australian O 0 0.039850909262895584
Aboriginal O 1 0.690223217010498
, O 0 0.022061530500650406
Chinese O 0 0.0292588472366333
, O 0 0.019952962175011635
and O 0 0.021960625424981117
Pacific O 0 0.06498526781797409
Islanders O 0 0.13916510343551636
. O 0 0.042745430022478104

Results O 0 0.027780715376138687
showed O 0 0.018274180591106415
that O 0 0.00895022414624691
the O 0 0.015980606898665428
845 O 1 0.9977152347564697
G O 1 0.9999186992645264
- O 1 0.9999980926513672
- O 1 0.9999948740005493
> O 1 0.9521878361701965
A O 0 0.03307919204235077
mutation O 0 0.03329651802778244
was O 0 0.017571672797203064
present O 0 0.013274050317704678
in O 0 0.00838426686823368
these O 0 0.00789616722613573
populations O 0 0.018854781985282898
( O 0 0.02138066478073597
allele O 0 0.04722277820110321
frequency O 0 0.02037876285612583
0 O 0 0.020674768835306168
. O 0 0.009315489791333675
32 O 0 0.019193384796380997
% O 0 0.01686406508088112
) O 0 0.01354127936065197
, O 0 0.012393329292535782
and O 0 0.012268426828086376
, O 0 0.013784495182335377
furthermore O 0 0.019581809639930725
, O 0 0.010998792946338654
it O 0 0.00812400970607996
was O 0 0.015893109142780304
always O 0 0.013198789209127426
seen O 0 0.011761514469981194
in O 0 0.009117518551647663
conjunction O 0 0.03089730627834797
with O 0 0.03801341354846954
HLA O 1 1.0
haplotypes O 1 0.9975476861000061
common O 0 0.024991000071167946
in O 0 0.0169480349868536
Caucasians O 1 0.9913455247879028
, O 0 0.015112506225705147
suggesting O 0 0.016976099461317062
that O 0 0.009811410680413246
845 O 1 0.9898751378059387
G O 1 0.9999610185623169
- O 1 0.9999997615814209
- O 1 0.9999998807907104
> O 1 0.9989984631538391
A O 0 0.03543979674577713
may O 0 0.013101748190820217
have O 0 0.00635685957968235
been O 0 0.00894354097545147
introduced O 0 0.013706252910196781
into O 0 0.01085724774748087
these O 0 0.00816470105201006
populations O 0 0.01889326423406601
by O 0 0.02880169451236725
Caucasian O 1 0.9981241822242737
admixture O 1 0.9878489971160889
. O 0 0.05599857494235039

187 O 0 0.11757951974868774
C O 1 0.9955883026123047
- O 1 0.9999955892562866
- O 1 0.9999959468841553
> O 1 0.998909592628479
G O 1 0.5992742776870728
was O 0 0.022223204374313354
present O 0 0.01626064069569111
at O 0 0.015967532992362976
an O 0 0.018145490437746048
allele O 0 0.050123926252126694
frequency O 0 0.022698530927300453
of O 0 0.024154258891940117
2 O 0 0.04397206008434296
. O 0 0.03693395107984543

68 O 0 0.07841340452432632
% O 0 0.023067642003297806
in O 0 0.013138064183294773
the O 0 0.015306921675801277
two O 0 0.012808100320398808
populations O 0 0.023509161546826363
analyzed O 0 0.02787160687148571
( O 0 0.02158692106604576
Australian O 0 0.03713137283921242
Aboriginal O 0 0.10131523758172989
and O 0 0.029047120362520218
Chinese O 0 0.053566500544548035
) O 0 0.03511599451303482
. O 0 0.031831320375204086

In O 0 0.024423686787486076
the O 0 0.02331661619246006
Australian O 0 0.036405812948942184
Aboriginal O 0 0.05018576607108116
samples O 0 0.020049497485160828
, O 0 0.011843501590192318
187 O 0 0.04649434611201286
C O 1 0.9988079071044922
- O 1 0.9999979734420776
- O 1 0.9999984502792358
> O 1 0.9994669556617737
G O 1 0.9276688694953918
was O 0 0.019171858206391335
found O 0 0.008294289000332355
to O 0 0.00869099609553814
be O 0 0.007730667479336262
associated O 0 0.014167169108986855
with O 0 0.024504683911800385
HLA O 1 1.0
haplotypes O 1 0.998928964138031
common O 0 0.029856057837605476
in O 0 0.020228683948516846
Caucasians O 1 0.996941864490509
, O 0 0.02012801170349121
suggesting O 0 0.018734101206064224
that O 0 0.007906020618975163
it O 0 0.007134819868952036
was O 0 0.016175363212823868
introduced O 0 0.019331222400069237
by O 0 0.017686475068330765
recent O 0 0.03225593641400337
admixture O 1 0.7748653888702393
. O 0 0.047669436782598495

In O 0 0.027608610689640045
the O 0 0.024092206731438637
Chinese O 0 0.028539344668388367
samples O 0 0.0196116641163826
analyzed O 0 0.016207730397582054
, O 0 0.011371107771992683
187 O 0 0.046722643077373505
C O 1 0.9787395000457764
- O 1 0.9999899864196777
- O 1 0.9999916553497314
> O 1 0.9975695013999939
G O 1 0.8428184986114502
was O 0 0.02301573008298874
present O 0 0.015234366059303284
in O 0 0.011736571788787842
association O 0 0.01764063723385334
with O 0 0.010462942533195019
a O 0 0.01592695340514183
wide O 0 0.01911965385079384
variety O 0 0.016296079382300377
of O 0 0.28762713074684143
HLA O 1 1.0
haplotypes O 1 0.9998584985733032
, O 0 0.020406603813171387
showing O 0 0.020374204963445663
this O 0 0.011145716533064842
mutation O 0 0.0232977494597435
to O 0 0.010252819396555424
be O 0 0.009755578823387623
widespread O 0 0.024411311373114586
and O 0 0.013786465860903263
likely O 0 0.016730207949876785
to O 0 0.014229653403162956
predate O 0 0.039910390973091125
the O 0 0.013578169047832489
more O 0 0.007939624600112438
genetically O 0 0.01835666038095951
restricted O 0 0.025724945589900017
845 O 1 0.9953822493553162
G O 1 0.9999017715454102
- O 1 0.9999986886978149
- O 1 0.9999978542327881
> O 1 0.9853271245956421
A O 0 0.060994893312454224
mutation O 0 0.07442625612020493
. O 0 0.04131264612078667

Genotype O 1 0.9979903697967529
- O 1 0.9997989535331726
phenotype O 1 0.7567926645278931
correlations O 0 0.10698933899402618
in O 0 0.05839964374899864
attenuated B-Disease 1 0.9999986886978149
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
. O 0 0.14634326100349426

Germ O 1 0.9999673366546631
- O 1 0.9997171759605408
line O 0 0.04773576557636261
mutations O 0 0.027954386547207832
of O 0 0.01859758235514164
the O 0 0.31981122493743896
tumor B-Disease 1 1.0
suppressor O 1 1.0
APC O 1 0.9999973773956299
are O 0 0.014961990527808666
implicated O 0 0.07746076583862305
in O 0 0.029558444395661354
attenuated B-Disease 1 0.999998927116394
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999618530273438
AAPC B-Disease 1 1.0
) O 0 0.025729002431035042
, O 0 0.014299826696515083
a O 0 0.018792107701301575
variant O 0 0.03987373784184456
of O 0 0.04722892865538597
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999979734420776
FAP B-Disease 1 1.0
) O 0 0.07052917033433914
. O 0 0.04951659217476845

AAPC B-Disease 1 0.9999938011169434
is O 0 0.034436676651239395
recognized O 0 0.027210064232349396
by O 0 0.014681549742817879
the O 0 0.017574874684214592
occurrence O 0 0.03878631815314293
of O 0 0.030101532116532326
< O 1 0.999824583530426
100 O 0 0.055174119770526886
colonic B-Disease 1 0.9999997615814209
adenomas I-Disease 1 0.9999927282333374
and O 0 0.017792636528611183
a O 0 0.017864275723695755
later O 0 0.025160348042845726
onset O 1 0.9999992847442627
of O 1 0.9999958276748657
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9996180534362793
age O 1 0.9981523156166077
> O 1 0.9993855953216553
40 O 0 0.03110935539007187
years O 0 0.02669931761920452
) O 0 0.028480632230639458
. O 0 0.03403089940547943

The O 0 0.04082288593053818
aim O 0 0.0423843152821064
of O 0 0.01714211329817772
this O 0 0.011262907646596432
study O 0 0.014869256876409054
was O 0 0.017657427117228508
to O 0 0.017715053632855415
assess O 0 0.057666610926389694
genotype O 1 0.995945394039154
- O 1 0.9999516010284424
phenotype O 0 0.4608302116394043
correlations O 0 0.0788460299372673
in O 0 0.04512602463364601
AAPC B-Disease 1 0.9999974966049194
families O 0 0.07328309863805771
. O 0 0.05439586937427521

By O 0 0.044819045811891556
protein O 0 0.05626319721341133
- O 1 0.9831090569496155
truncation O 1 0.5221739411354065
test O 0 0.043583113700151443
( O 0 0.033313579857349396
PTT O 1 0.9717773199081421
) O 0 0.023383796215057373
assay O 0 0.04024749994277954
, O 0 0.01173015870153904
the O 0 0.01329480018466711
entire O 0 0.02622254565358162
coding O 0 0.029506338760256767
region O 0 0.014475513249635696
of O 0 0.013543305918574333
the O 0 0.0254910159856081
APC B-Disease 1 0.9999991655349731
gene O 0 0.03569090738892555
was O 0 0.02799065038561821
screened O 0 0.04620721936225891
in O 0 0.014323641546070576
affected O 0 0.019993634894490242
individuals O 0 0.012737474404275417
from O 0 0.020061999559402466
11 O 0 0.06270553171634674
AAPC B-Disease 1 0.9999998807907104
kindreds O 1 0.9998818635940552
, O 0 0.030155625194311142
and O 0 0.0192306786775589
their O 0 0.018069235607981682
phenotypic O 0 0.04882076755166054
differences O 0 0.029859939590096474
were O 0 0.022818706929683685
examined O 0 0.059922996908426285
. O 0 0.038580745458602905

Five O 0 0.041850198060274124
novel O 0 0.08455954492092133
germ O 1 0.999974250793457
- O 1 0.999987006187439
line O 1 0.9556556940078735
APC B-Disease 1 0.9999830722808838
mutations O 0 0.03814654424786568
were O 0 0.013628640212118626
identified O 0 0.022422995418310165
in O 0 0.018292969092726707
seven O 0 0.0407247357070446
kindreds O 1 0.9714866876602173
. O 0 0.058645717799663544

Mutations O 0 0.061176132410764694
were O 0 0.015270977281033993
located O 0 0.024493662640452385
in O 0 0.00860733725130558
three O 0 0.007330932188779116
different O 0 0.004114137962460518
regions O 0 0.007472170051187277
of O 0 0.010464921593666077
the O 0 0.03124362975358963
APC B-Disease 1 1.0
gene O 0 0.15197832882404327
( O 0 0.01677040196955204
1 O 0 0.019447706639766693
) O 0 0.010335417464375496
at O 0 0.010580318048596382
the O 0 0.011974832974374294
5 O 0 0.016216741874814034
end O 0 0.02132224850356579
spanning O 0 0.031273484230041504
exons O 0 0.043693311512470245
4 O 0 0.02245573326945305
and O 0 0.014394750818610191
5 O 0 0.019624248147010803
, O 0 0.014543874189257622
( O 0 0.014406844973564148
2 O 0 0.016358017921447754
) O 0 0.010802946984767914
within O 0 0.011490636505186558
exon O 0 0.08035602420568466
9 O 0 0.02709200419485569
, O 0 0.015744948759675026
and O 0 0.014815193600952625
( O 0 0.017403073608875275
3 O 0 0.01840171217918396
) O 0 0.01098691113293171
at O 0 0.012345445342361927
the O 0 0.014831683598458767
3 O 0 0.028222516179084778
distal O 1 0.9938218593597412
end O 0 0.03012366220355034
of O 0 0.022197052836418152
the O 0 0.037766024470329285
gene O 0 0.05191832035779953
. O 0 0.03745103254914284

Variability O 0 0.06107926741242409
in O 0 0.013311431743204594
the O 0 0.014166582375764847
number O 0 0.017437662929296494
of O 1 0.9897425770759583
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9975582361221313
most O 0 0.02011127397418022
apparent O 1 0.7887340784072876
in O 0 0.012506011873483658
individuals O 0 0.010968667455017567
with O 0 0.011498530395328999
mutations O 0 0.01768510788679123
in O 0 0.009033890441060066
region O 0 0.016920369118452072
1 O 0 0.016714520752429962
, O 0 0.01101131085306406
and O 0 0.01491768192499876
upper O 1 0.9999986886978149
- O 1 1.0
gastrointestinal O 1 1.0
manifestations O 1 0.9999997615814209
were O 0 0.02138597145676613
more O 0 0.017192404717206955
severe O 1 0.999873161315918
in O 0 0.024134300649166107
them O 0 0.024818576872348785
. O 0 0.039438966661691666

In O 0 0.030182231217622757
individuals O 0 0.019365232437849045
with O 0 0.020235227420926094
mutations O 0 0.027064453810453415
in O 0 0.012348747812211514
either O 0 0.015586301684379578
region O 0 0.021787399426102638
2 O 0 0.024145718663930893
or O 0 0.013736867345869541
region O 0 0.018665922805666924
3 O 0 0.016857877373695374
, O 0 0.010026956908404827
the O 0 0.010154789313673973
average O 0 0.012959963642060757
number O 0 0.010416150093078613
of O 0 0.02574685961008072
adenomas B-Disease 1 0.9999996423721313
tended O 0 0.04959257319569588
to O 0 0.015787553042173386
be O 0 0.01028498075902462
lower O 0 0.015143565833568573
than O 0 0.007302518468350172
those O 0 0.0066948928870260715
in O 0 0.00869073811918497
individuals O 0 0.009948580525815487
with O 0 0.01223838608711958
mutations O 0 0.022612374275922775
in O 0 0.012070131488144398
region O 0 0.02226538397371769
1 O 0 0.022898193448781967
, O 0 0.013141339644789696
although O 0 0.012105019763112068
age O 0 0.02538197487592697
at O 0 0.22201961278915405
diagnosis O 1 0.9999867677688599
was O 0 0.05268368497490883
similar O 0 0.03175154700875282
. O 0 0.040465690195560455

In O 0 0.04233328998088837
all O 0 0.046362873166799545
AAPC B-Disease 1 0.9999972581863403
kindreds O 1 0.9888172149658203
, O 0 0.02817964181303978
a O 0 0.025130607187747955
predominance O 0 0.11902891099452972
of O 0 0.02796698361635208
right O 1 0.9640884399414062
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999969005584717
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999983310699463
was O 1 0.8902259469032288
observed O 0 0.04818984493613243
. O 0 0.04014967381954193

No O 0 0.08957765996456146
desmoid B-Disease 1 0.9999958276748657
tumors I-Disease 1 0.9999978542327881
were O 0 0.024200746789574623
found O 0 0.021386239677667618
in O 0 0.019111456349492073
these O 0 0.022522136569023132
kindreds O 1 0.9836639165878296
. O 0 0.05841134488582611

Our O 0 0.04321545735001564
data O 0 0.01614348031580448
suggest O 0 0.014920773915946484
that O 0 0.007923913188278675
, O 0 0.013334824703633785
in O 0 0.01785149797797203
AAPC B-Disease 1 0.9999998807907104
families O 0 0.02175264060497284
, O 0 0.011103344149887562
the O 0 0.01114574819803238
location O 0 0.012437259778380394
of O 0 0.013143318705260754
the O 0 0.037321917712688446
APC B-Disease 1 0.9999998807907104
mutation O 1 0.9406535029411316
may O 0 0.02719665877521038
partially O 0 0.050703343003988266
predict O 0 0.03669629245996475
specific O 0 0.021942654624581337
phenotypic O 0 0.0647648423910141
expression O 0 0.053488876670598984
. O 0 0.04246171936392784

This O 0 0.02653302252292633
should O 0 0.01943921484053135
help O 0 0.020531805232167244
in O 0 0.009408233687281609
the O 0 0.013498466461896896
design O 0 0.018851451575756073
of O 0 0.019385861232876778
tailored O 1 0.9001416563987732
clinical O 1 0.9999784231185913
- O 1 0.9999998807907104
management O 1 0.673085629940033
protocols O 0 0.047492071986198425
in O 0 0.01093881856650114
this O 0 0.011247954331338406
subset O 0 0.07032890617847443
of O 1 0.5700500011444092
FAP B-Disease 1 1.0
patients O 1 0.9999986886978149
. O 0 0.03938952088356018
. O 0 0.044651906937360764

Wilms B-Disease 1 0.9999998807907104
' I-Disease 1 0.9999496936798096
tumor I-Disease 1 0.9999903440475464
1 O 0 0.04676735773682594
and O 0 0.029914584010839462
Dax O 1 0.9999966621398926
- O 1 0.9997523427009583
1 O 0 0.0323055237531662
modulate O 0 0.05606454983353615
the O 0 0.023945076391100883
orphan O 1 0.9999421834945679
nuclear O 0 0.11564843356609344
receptor O 1 0.9793816804885864
SF O 1 0.9999970197677612
- O 1 0.9958187937736511
1 O 0 0.026831427589058876
in O 0 0.014991811476647854
sex O 0 0.05199660360813141
- O 1 0.9998277425765991
specific O 0 0.025984706357121468
gene O 0 0.040277644991874695
expression O 0 0.04145357385277748
. O 0 0.037259798496961594

Products O 0 0.05001293495297432
of O 0 0.04010075330734253
steroidogenic O 1 0.9999872446060181
factor O 0 0.2832355499267578
1 O 0 0.04181038960814476
( O 0 0.036923766136169434
SF O 1 0.9999996423721313
- O 1 0.9997621178627014
1 O 0 0.02801419422030449
) O 0 0.01691070944070816
and O 0 0.021404311060905457
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
1 O 1 0.5891011357307434
( O 0 0.061709899455308914
WT1 O 1 0.9999974966049194
) O 0 0.026043590158224106
genes O 0 0.016958069056272507
are O 0 0.007119918707758188
essential O 0 0.022504542022943497
for O 0 0.01954270526766777
mammalian O 0 0.2040550708770752
gonadogenesis O 1 0.997864305973053
prior O 0 0.034050267189741135
to O 0 0.030760306864976883
sexual O 1 0.5319374203681946
differentiation O 1 0.9931758046150208
. O 0 0.058557040989398956

In O 0 0.02607860416173935
males O 0 0.030583083629608154
, O 0 0.038574229925870895
SF O 1 1.0
- O 1 0.9999927282333374
1 O 0 0.039469316601753235
participates O 0 0.04310973733663559
in O 0 0.014568524435162544
sexual O 0 0.030808625742793083
development O 0 0.022406142204999924
by O 0 0.01804010570049286
regulating O 0 0.03521715849637985
expression O 0 0.019177544862031937
of O 0 0.013833419419825077
the O 0 0.02883687987923622
polypeptide O 1 0.9999603033065796
hormone O 1 0.999951958656311
Mullerian O 1 0.9999998807907104
inhibiting O 1 0.9999966621398926
substance O 1 0.9999239444732666
( O 1 0.6683782339096069
MIS O 1 0.9999940395355225
) O 0 0.04744694381952286
. O 0 0.040291059762239456

Here O 0 0.0397515594959259
, O 0 0.01986057497560978
we O 0 0.013099173083901405
show O 0 0.01782413013279438
that O 0 0.018684551119804382
WT1 O 1 0.9999890327453613
- O 1 0.9999731779098511
KTS O 1 0.9999133348464966
isoforms O 0 0.04815913736820221
associate O 0 0.04324119910597801
and O 0 0.020997880026698112
synergize O 1 0.9996126294136047
with O 0 0.05387265607714653
SF O 1 1.0
- O 1 0.9999891519546509
1 O 0 0.03393395245075226
to O 0 0.024156449362635612
promote O 0 0.08208758383989334
MIS O 1 0.9999868869781494
expression O 0 0.06245454028248787
. O 0 0.042863454669713974

In O 0 0.0371982678771019
contrast O 0 0.05224725231528282
, O 0 0.04613914340734482
WT1 O 1 0.9999969005584717
missense O 1 0.9968335032463074
mutations O 0 0.045432884246110916
, O 0 0.018655773252248764
associated O 0 0.016789456829428673
with O 0 0.01408868096768856
male B-Disease 0 0.041825130581855774
pseudohermaphroditism I-Disease 1 0.9998859167098999
in O 0 0.030750693753361702
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.07398457080125809
fail O 0 0.11081156134605408
to O 0 0.03210611641407013
synergize O 1 0.9998575448989868
with O 0 0.056314460933208466
SF O 1 1.0
- O 1 0.9999901056289673
1 O 0 0.05958016589283943
. O 0 0.038140472024679184

Additionally O 0 0.04604965075850487
, O 0 0.019443342462182045
the O 0 0.024142703041434288
X O 1 0.9995052814483643
- O 1 0.9999569654464722
linked O 0 0.041318442672491074
, O 0 0.016611425206065178
candidate O 0 0.03275207802653313
dosage O 1 0.9968432188034058
- O 1 0.9997135996818542
sensitive O 0 0.0432870052754879
sex O 0 0.05009203031659126
- O 1 0.9995259046554565
reversal O 0 0.13773766160011292
gene O 0 0.02934972569346428
, O 0 0.023658951744437218
Dax O 1 0.9999831914901733
- O 1 0.9987362027168274
1 O 0 0.028294337913393974
, O 0 0.019884156063199043
antagonizes O 1 0.7660381197929382
synergy O 0 0.2847927510738373
between O 0 0.0357576459646225
SF O 1 1.0
- O 1 0.9999880790710449
1 O 0 0.03549604490399361
and O 0 0.02561262808740139
WT1 O 1 0.9999955892562866
, O 0 0.018059443682432175
most O 0 0.012102732434868813
likely O 0 0.013753480277955532
through O 0 0.012318392284214497
a O 0 0.016240740194916725
direct O 0 0.021891148760914803
interaction O 0 0.027661295607686043
with O 0 0.031267907470464706
SF O 1 1.0
- O 1 0.9999758005142212
1 O 0 0.054873622953891754
. O 0 0.036158520728349686

We O 0 0.029769141227006912
propose O 0 0.0439092293381691
that O 0 0.019898714497685432
WT1 O 1 0.9998010993003845
and O 0 0.03659578412771225
Dax O 1 0.9999991655349731
- O 1 0.9999887943267822
1 O 0 0.03927953913807869
functionally O 0 0.05249180644750595
oppose O 0 0.028062716126441956
each O 0 0.008261250331997871
other O 0 0.008450189605355263
in O 0 0.014459861442446709
testis O 1 0.9991017580032349
development O 0 0.025855766609311104
by O 0 0.026041580364108086
modulating O 1 0.9999790191650391
SF O 1 1.0
- O 1 0.9999933242797852
1 O 0 0.09690926969051361
- O 1 0.9999740123748779
mediated O 1 0.9915378093719482
transactivation O 1 0.9992259740829468
. O 0 0.03137631714344025
. O 0 0.03903249278664589

A O 0 0.06845176219940186
mouse O 0 0.06541270762681961
model O 0 0.032741233706474304
for O 0 0.031048687174916267
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 1.0
centre O 1 0.9998881816864014
mutations O 0 0.08112314343452454
. O 0 0.04107552021741867

Imprinting O 0 0.15613757073879242
in O 0 0.024825308471918106
the O 0 0.03325540944933891
15q11 O 1 0.9998549222946167
- O 1 0.9999839067459106
q13 O 1 0.9973183274269104
region O 0 0.03439939394593239
involves O 0 0.02676697075366974
an O 0 0.021347586065530777
imprinting O 1 0.9999114274978638
centre O 1 0.9996792078018188
( O 0 0.2896234095096588
IC O 1 0.9999947547912598
) O 0 0.023964256048202515
, O 0 0.01671653427183628
mapping O 0 0.020256882533431053
in O 0 0.009339326992630959
part O 0 0.015670061111450195
to O 0 0.012515597976744175
the O 0 0.020265016704797745
promoter O 1 0.9651520252227783
and O 0 0.016950853168964386
first O 0 0.027298245579004288
exon O 0 0.12428213655948639
of O 0 0.04683554545044899
SNRPN O 1 0.9999032020568848
. O 0 0.05828477069735527

Deletion O 0 0.10801480710506439
of O 0 0.03407268226146698
this O 0 0.02962411381304264
IC O 1 0.9998770952224731
abolishes O 1 0.9987871050834656
local O 0 0.038698162883520126
paternally O 0 0.3288653790950775
derived O 0 0.03230169788002968
gene O 0 0.026465516537427902
expression O 0 0.018021253868937492
and O 0 0.009611275978386402
results O 0 0.01061124075204134
in O 0 0.021842477843165398
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999969005584717
PWS B-Disease 1 1.0
) O 0 0.06913136690855026
. O 0 0.04670868068933487

We O 0 0.024106230586767197
have O 0 0.01074314583092928
created O 0 0.01856120489537716
two O 0 0.014363737776875496
deletion O 0 0.262518048286438
mutations O 0 0.036499183624982834
in O 0 0.01996300183236599
mice O 0 0.04374842345714569
to O 0 0.023711979389190674
understand O 0 0.08494260162115097
PWS B-Disease 1 0.9999998807907104
and O 0 0.023362072184681892
the O 0 0.02458501048386097
mechanism O 0 0.04289867728948593
of O 0 0.024133963510394096
this O 0 0.028332078829407692
IC O 1 0.9987978935241699
. O 0 0.051587704569101334

Mice O 1 0.581508994102478
harbouring O 1 0.9990586638450623
an O 0 0.044586025178432465
intragenic O 1 0.9987843632698059
deletion O 0 0.3049357533454895
in O 0 0.028437046334147453
Snrpn O 1 0.9999169111251831
are O 0 0.016304075717926025
phenotypically O 1 0.9171512126922607
normal O 0 0.030863085761666298
, O 0 0.0173112191259861
suggesting O 0 0.019888779148459435
that O 0 0.010038446635007858
mutations O 0 0.022704068571329117
of O 0 0.022676981985569
SNRPN O 1 0.9999963045120239
are O 0 0.01184284221380949
not O 0 0.013481161557137966
sufficient O 0 0.03232674300670624
to O 0 0.038470856845378876
induce O 1 0.9996850490570068
PWS B-Disease 1 0.9999997615814209
. O 0 0.08091390132904053

Mice O 0 0.07466372847557068
with O 0 0.021425757557153702
a O 0 0.024615880101919174
larger O 0 0.029927046969532967
deletion O 0 0.05799635499715805
involving O 0 0.028460586443543434
both O 0 0.019361086189746857
Snrpn O 1 0.9832628965377808
and O 0 0.01729130931198597
the O 0 0.029098542407155037
putative O 1 0.9999972581863403
PWS O 1 1.0
- O 1 1.0
IC O 1 0.9999940395355225
lack O 0 0.037566859275102615
expression O 0 0.022575922310352325
of O 0 0.015332839451730251
the O 0 0.025450455024838448
imprinted O 1 0.9990672469139099
genes O 0 0.03697721287608147
Zfp127 O 1 0.9990523457527161
( O 0 0.029491577297449112
mouse O 0 0.05023955553770065
homologue O 0 0.15863099694252014
of O 0 0.03128685802221298
ZNF127 O 1 0.999984622001648
) O 0 0.031063128262758255
, O 0 0.030187157914042473
Ndn O 1 0.9999483823776245
and O 0 0.03236708417534828
Ipw O 1 0.9984619617462158
, O 0 0.023884326219558716
and O 0 0.019696401432156563
manifest O 0 0.09873735904693604
several O 0 0.018633781000971794
phenotypes O 0 0.2799953520298004
common O 0 0.04427235201001167
to O 1 0.6183515787124634
PWS B-Disease 1 1.0
infants O 1 0.9999895095825195
. O 0 0.06994515657424927

These O 0 0.023811940103769302
data O 0 0.01793959178030491
demonstrate O 0 0.022425169125199318
that O 0 0.008544904179871082
both O 0 0.007674897089600563
the O 0 0.011638284660875797
position O 0 0.016358831897377968
of O 0 0.015933524817228317
the O 0 0.028915781527757645
IC O 1 0.9999539852142334
and O 0 0.014178975485265255
its O 0 0.012751621194183826
role O 0 0.01921048015356064
in O 0 0.009564854204654694
the O 0 0.01397527102380991
coordinate O 0 0.03373189643025398
expression O 0 0.01903690956532955
of O 0 0.014084959402680397
genes O 0 0.01431594043970108
is O 0 0.010791385546326637
conserved O 0 0.020650066435337067
between O 0 0.01607627235352993
mouse O 0 0.09322572499513626
and O 0 0.014116832055151463
human O 0 0.017924610525369644
, O 0 0.012936434708535671
and O 0 0.010754117742180824
indicate O 0 0.011211575008928776
that O 0 0.006282520480453968
the O 0 0.013464894145727158
mouse O 0 0.0349392332136631
is O 0 0.011428079567849636
a O 0 0.015234149992465973
suitable O 0 0.0321478471159935
model O 0 0.02139880508184433
system O 0 0.01570625975728035
in O 0 0.008332164026796818
which O 0 0.007863354869186878
to O 0 0.010576475411653519
investigate O 0 0.027398156002163887
the O 0 0.018459947779774666
molecular O 0 0.026856642216444016
mechanisms O 0 0.02075713872909546
of O 0 0.019510947167873383
imprinting O 1 0.9948654770851135
in O 0 0.013169785961508751
this O 0 0.01043875515460968
region O 0 0.01979232020676136
of O 0 0.01670352928340435
the O 0 0.026935258880257607
genome O 0 0.042682722210884094
. O 0 0.024464890360832214
. O 0 0.0327339842915535

Mutations O 0 0.051030997186899185
of O 0 0.02283039316534996
the O 0 0.030695529654622078
ATM O 1 0.9321604371070862
gene O 0 0.03129870072007179
detected O 0 0.023473607376217842
in O 0 0.013670509681105614
Japanese O 0 0.44847381114959717
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999749660491943
: O 0 0.02649528719484806
possible O 0 0.01971658505499363
preponderance O 1 0.7310472726821899
of O 0 0.016800589859485626
the O 0 0.01875399425625801
two O 0 0.020069438964128494
founder O 1 0.9993963241577148
mutations O 0 0.07902341336011887
4612del165 O 1 0.9995198249816895
and O 0 0.04830581322312355
7883del5 O 1 0.9982629418373108
. O 0 0.057037610560655594

The O 0 0.046766869723796844
ATM O 0 0.1846524029970169
( O 0 0.03096664510667324
A O 1 0.9485946297645569
- O 1 0.9999997615814209
T O 1 0.9999971389770508
, O 0 0.02541806735098362
mutated O 0 0.08229619264602661
) O 0 0.01840941794216633
gene O 0 0.021130429580807686
on O 0 0.019427699968218803
human O 0 0.040808677673339844
chromosome O 0 0.2983042001724243
11q22 O 1 0.9950237274169922
. O 0 0.05356520414352417

3 O 0 0.04437532648444176
has O 0 0.02332448400557041
recently O 0 0.02489349991083145
been O 0 0.012249868363142014
identified O 0 0.01401533093303442
as O 0 0.0090774642303586
the O 0 0.012138144113123417
gene O 0 0.015963023528456688
responsible O 0 0.014547333121299744
for O 0 0.00864765141159296
the O 0 0.015494327992200851
human O 1 0.7423116564750671
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9710850119590759
A B-Disease 1 0.999996542930603
- I-Disease 1 1.0
T I-Disease 1 0.9999992847442627
) O 0 0.03498753532767296
. O 0 0.031119221821427345

In O 0 0.0261997077614069
order O 0 0.0236542709171772
to O 0 0.014320139773190022
define O 0 0.021639445796608925
the O 0 0.013462966307997704
types O 0 0.015592187643051147
of O 0 0.15331155061721802
disease O 1 1.0
- O 1 1.0
causing O 1 0.9999314546585083
ATM O 1 0.998619794845581
mutations O 0 0.019766414538025856
in O 0 0.007667318917810917
Japanese O 0 0.026711400598287582
A B-Disease 1 0.9998687505722046
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9999538660049438
as O 0 0.016338733956217766
well O 0 0.011332704685628414
as O 0 0.010752971284091473
to O 0 0.010968263261020184
look O 0 0.01577494852244854
for O 0 0.011211241595447063
possible O 0 0.023425307124853134
mutational O 1 0.999718964099884
hotspots O 1 0.9927071928977966
, O 0 0.020739536732435226
reverse O 0 0.05427739396691322
- O 1 0.9997721314430237
transcribed O 0 0.048520904034376144
RNA O 0 0.03410884365439415
derived O 0 0.012662557885050774
from O 0 0.011385202407836914
ten O 0 0.024084702134132385
patients O 1 0.6619986891746521
belonging O 0 0.029602890834212303
to O 0 0.013121110387146473
eight O 0 0.014430508017539978
unrelated O 0 0.02653582952916622
Japanese O 0 0.03917445242404938
A B-Disease 1 0.9998714923858643
- I-Disease 1 1.0
T I-Disease 1 0.9999954700469971
families O 0 0.025586998090147972
was O 0 0.02411179430782795
analyzed O 0 0.020996060222387314
for O 0 0.013672632165253162
mutations O 0 0.0240799393504858
by O 0 0.01695225201547146
the O 0 0.029381679370999336
restriction O 0 0.07446951419115067
endonuclease O 1 0.9967285394668579
fingerprinting O 0 0.11205732077360153
method O 0 0.0491042360663414
. O 0 0.03808679059147835

As O 0 0.03826137259602547
has O 0 0.021491723135113716
been O 0 0.014834889210760593
reported O 0 0.017173780128359795
by O 0 0.014269051142036915
others O 0 0.017388824373483658
, O 0 0.016249410808086395
mutations O 0 0.019330210983753204
that O 0 0.009256185963749886
lead O 0 0.020578183233737946
to O 0 0.019377121701836586
exon O 1 0.9690722227096558
skipping O 0 0.21568286418914795
or O 0 0.030109064653515816
premature O 1 0.9986674785614014
protein O 0 0.041175756603479385
truncation O 0 0.06669718772172928
were O 0 0.014176457189023495
also O 0 0.018263613805174828
predominant O 0 0.04651031643152237
in O 0 0.01944665051996708
our O 0 0.03544767573475838
mutants O 1 0.6421247124671936
. O 0 0.04804804176092148

Six O 0 0.0358726903796196
different O 0 0.013809877447783947
mutations O 0 0.02560259960591793
were O 0 0.009556488133966923
identified O 0 0.015039011836051941
on O 0 0.01109323650598526
12 O 0 0.014349421486258507
of O 0 0.014674282632768154
the O 0 0.02309524454176426
16 O 0 0.04235338047146797
alleles O 0 0.08086629956960678
examined O 0 0.07406537979841232
. O 0 0.04549071565270424

Four O 0 0.029688075184822083
were O 0 0.018810993060469627
deletions O 0 0.05582112818956375
involving O 0 0.02507435902953148
a O 0 0.022601071745157242
loss O 0 0.029515869915485382
of O 0 0.01842544786632061
a O 0 0.024561360478401184
single O 0 0.03909643366932869
exon O 1 0.5103962421417236
exon O 0 0.10129020363092422
7 O 0 0.03519931435585022
, O 0 0.022996142506599426
exon O 0 0.07588925957679749
16 O 0 0.030455809086561203
, O 0 0.02461145631968975
exon O 0 0.09389573335647583
33 O 0 0.05148611217737198
or O 0 0.03542047366499901
exon O 0 0.126726895570755
35 O 0 0.05921734869480133
. O 0 0.04738609120249748

The O 0 0.04569045081734657
others O 0 0.02636285312473774
were O 0 0.01679115742444992
minute O 0 0.039547644555568695
deletions O 0 0.06383555382490158
, O 0 0.027299789711833
4649delA O 1 0.6084257364273071
in O 0 0.02383941039443016
exon O 0 0.10600592941045761
33 O 0 0.050704605877399445
and O 0 0.03146981820464134
7883del5 O 1 0.9168457984924316
in O 0 0.03661102429032326
exon O 0 0.13758644461631775
55 O 0 0.07376144826412201
. O 0 0.04649908468127251

The O 0 0.059282541275024414
mutations O 0 0.08143054693937302
4612del165 O 1 0.9942343831062317
and O 0 0.03668132796883583
7883del5 O 1 0.9973209500312805
were O 0 0.01439552940428257
found O 0 0.011222410947084427
in O 0 0.008217142894864082
more O 0 0.0058638532646000385
than O 0 0.0061930394731462
two O 0 0.008666370064020157
unrelated O 0 0.024157492443919182
families O 0 0.020746828988194466
; O 0 0.01576429046690464
44 O 0 0.026275770738720894
% O 0 0.01725407876074314
( O 0 0.014939778484404087
7 O 0 0.01713574305176735
of O 0 0.014203137718141079
16 O 0 0.018436450511217117
) O 0 0.01127641461789608
of O 0 0.013095461763441563
the O 0 0.024260491132736206
mutant O 1 0.8378322124481201
alleles O 0 0.047094039618968964
had O 0 0.018465479835867882
one O 0 0.013109526596963406
of O 0 0.016006480902433395
the O 0 0.02104034647345543
two O 0 0.02258405275642872
mutations O 0 0.053653620183467865
. O 0 0.037770651280879974

The O 0 0.07275087386369705
4612del165 O 1 0.9990969896316528
mutations O 0 0.04678091034293175
in O 0 0.014121277257800102
three O 0 0.011035671457648277
different O 0 0.007847405038774014
families O 0 0.013639901764690876
were O 0 0.00777050107717514
all O 0 0.009297390468418598
ascribed O 0 0.031087277457118034
to O 0 0.010465620085597038
the O 0 0.0122983418405056
same O 0 0.015483739785850048
T O 1 0.9999775886535645
- O 1 0.9999955892562866
- O 1 0.9999792575836182
> O 0 0.27540746331214905
A O 0 0.028263883665204048
substitution O 0 0.031766172498464584
at O 0 0.017006246373057365
the O 0 0.022237727418541908
splice O 0 0.1649639755487442
donor O 0 0.062008779495954514
site O 0 0.03760649636387825
in O 0 0.027622949331998825
intron O 1 0.997805655002594
33 O 0 0.07767850160598755
. O 0 0.045252058655023575

Microsatellite O 1 0.852203905582428
genotyping O 0 0.40464961528778076
around O 0 0.03060995414853096
the O 0 0.03667130321264267
ATM O 1 0.9985999464988708
locus O 0 0.23793037235736847
also O 0 0.015290666371583939
indicated O 0 0.016194552183151245
that O 0 0.008224651217460632
a O 0 0.016255881637334824
common O 0 0.022666944190859795
haplotype O 1 0.6188392043113708
was O 0 0.01785176433622837
shared O 0 0.016788722947239876
by O 0 0.013381588272750378
the O 0 0.021413292735815048
mutant O 1 0.954021692276001
alleles O 0 0.051011960953474045
in O 0 0.019281115382909775
both O 0 0.025896601378917694
mutations O 0 0.052989788353443146
. O 0 0.04079035297036171

This O 0 0.02629971131682396
suggests O 0 0.02510855160653591
that O 0 0.007738799788057804
these O 0 0.007067859638482332
two O 0 0.013321161270141602
founder O 1 0.9998685121536255
mutations O 0 0.051273413002491
may O 0 0.018701931461691856
be O 0 0.012807781808078289
predominant O 0 0.042758677154779434
among O 0 0.026570701971650124
Japanese O 0 0.06742791831493378
ATM O 1 0.9885148406028748
mutant O 1 0.5389832854270935
alleles O 0 0.10348564386367798
. O 0 0.051151152700185776

W474C O 1 0.9990403056144714
amino O 0 0.10717537999153137
acid O 0 0.15377283096313477
substitution O 0 0.07381396740674973
affects O 0 0.04304613173007965
early O 0 0.017341982573270798
processing O 0 0.012219305150210857
of O 0 0.009083732031285763
the O 0 0.015144512057304382
alpha O 0 0.15745319426059723
- O 1 0.6796858906745911
subunit O 0 0.03826690837740898
of O 0 0.016675185412168503
beta O 1 0.736274003982544
- O 1 0.9996606111526489
hexosaminidase O 1 0.9941155910491943
A O 0 0.030331091955304146
and O 0 0.01417804230004549
is O 0 0.013079595752060413
associated O 0 0.018487107008695602
with O 0 0.030561402440071106
subacute O 1 1.0
G B-Disease 1 0.9999998807907104
( I-Disease 1 0.8801556825637817
M2 I-Disease 1 0.9999552965164185
) I-Disease 0 0.05259190872311592
gangliosidosis I-Disease 1 0.9524278044700623
. O 0 0.052403535693883896

Mutations O 0 0.057490721344947815
in O 0 0.019654175266623497
the O 0 0.03529392182826996
HEXA O 1 0.9999997615814209
gene O 0 0.037574537098407745
, O 0 0.013385266065597534
encoding O 0 0.014990592375397682
the O 0 0.013368052430450916
alpha O 0 0.047832638025283813
- O 0 0.1449853628873825
subunit O 0 0.037587326020002365
of O 0 0.017948660999536514
beta O 0 0.1420692801475525
- O 1 0.9973702430725098
hexosaminidase O 1 0.9861311912536621
A O 0 0.04225101321935654
( O 0 0.029613202437758446
Hex O 1 0.92558753490448
A O 0 0.034701500087976456
) O 0 0.014856661669909954
, O 0 0.009881898760795593
that O 0 0.00810503400862217
abolish O 0 0.04515683278441429
Hex O 0 0.2168121635913849
A O 0 0.03320226073265076
enzyme O 0 0.04329241067171097
activity O 0 0.030967094004154205
cause O 1 0.9983869791030884
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9779970049858093
TSD B-Disease 1 0.9999998807907104
) O 0 0.02153506875038147
, O 0 0.013682628981769085
the O 0 0.021812546998262405
fatal O 1 0.9999942779541016
infantile B-Disease 1 1.0
form I-Disease 1 0.614638090133667
of I-Disease 1 0.9537807106971741
G I-Disease 1 0.9999984502792358
( I-Disease 0 0.05206513777375221
M2 I-Disease 1 0.9999042749404907
) I-Disease 0 0.03189782798290253
gangliosidosis I-Disease 1 0.9996157884597778
, I-Disease 0 0.028641220182180405
Type I-Disease 0 0.06092900037765503
1 I-Disease 0 0.04570835828781128
. O 0 0.035260215401649475

Less O 0 0.04791562259197235
severe O 1 0.999388575553894
, O 0 0.05263514444231987
subacute O 1 1.0
( O 1 0.8241804838180542
juvenile O 1 0.9999998807907104
- O 1 1.0
onset O 1 1.0
) O 0 0.18914523720741272
and O 0 0.24834734201431274
chronic O 1 1.0
( O 1 0.9305636882781982
adult O 1 0.999895453453064
- O 1 1.0
onset O 1 1.0
) O 0 0.027876734733581543
variants O 0 0.020006339997053146
are O 0 0.00633641704916954
characterized O 0 0.0202273428440094
by O 0 0.011354072019457817
a O 0 0.018266065046191216
broad O 0 0.06042158603668213
spectrum O 0 0.11905492097139359
of O 0 0.06296626478433609
clinical O 1 0.9999985694885254
manifestations O 1 0.9999998807907104
and O 0 0.11812584847211838
are O 0 0.0084441052749753
associated O 0 0.013202330097556114
with O 0 0.014173944480717182
residual O 1 0.9461061954498291
levels O 0 0.02269084006547928
of O 0 0.024021491408348083
Hex O 1 0.9998581409454346
A O 1 0.9249184727668762
enzyme O 0 0.2173755168914795
activity O 0 0.04110581800341606
. O 0 0.037510886788368225

We O 0 0.020381717011332512
identified O 0 0.021724428981542587
a O 0 0.027295473963022232
1422 O 1 0.9994021654129028
G O 1 0.999828577041626
- O 1 0.9999980926513672
- O 1 0.9999972581863403
> O 1 0.9987045526504517
C O 1 0.9592273235321045
( O 0 0.029589731246232986
amino O 0 0.04137610271573067
acid O 0 0.11881985515356064
W474C O 1 0.996199905872345
) O 0 0.019421864300966263
substitution O 0 0.027620719745755196
in O 0 0.008818046189844608
the O 0 0.011199365369975567
first O 0 0.012978898361325264
position O 0 0.01700831763446331
of O 0 0.015328571200370789
exon O 0 0.0642959251999855
13 O 0 0.021602625027298927
of O 0 0.021577440202236176
HEXA O 1 0.9999949932098389
of O 0 0.02021128498017788
a O 0 0.025167353451251984
non O 1 0.7289113998413086
- O 1 0.9999328851699829
Jewish O 0 0.06738313287496567
proband O 1 0.9959141612052917
who O 0 0.031752441078424454
manifested O 1 0.6889179944992065
a O 0 0.04779445007443428
subacute O 1 0.9999998807907104
variant O 1 0.8758983612060547
of O 0 0.15861590206623077
G B-Disease 1 0.9999934434890747
( I-Disease 0 0.08609208464622498
M2 I-Disease 1 0.9996416568756104
) I-Disease 0 0.04833697900176048
gangliosidosis I-Disease 1 0.9179193377494812
. O 0 0.04871148243546486

On O 0 0.02537885680794716
the O 0 0.023025499656796455
second O 0 0.044251907616853714
maternally O 1 0.9977083206176758
inherited O 1 0.999962329864502
allele O 1 0.8157792091369629
, O 0 0.015700481832027435
we O 0 0.008471413515508175
identified O 0 0.013273336924612522
the O 0 0.015681613236665726
common O 1 0.6417150497436523
infantile O 1 1.0
disease O 1 1.0
- O 1 1.0
causing O 1 0.9997794032096863
4 O 0 0.1713990569114685
- O 1 0.9998564720153809
bp O 0 0.06998544931411743
insertion O 0 0.06910139322280884
, O 0 0.0317135713994503
+ O 1 0.6027851700782776
TATC O 1 0.9998515844345093
1278 O 1 0.999690055847168
, O 0 0.028952790424227715
in O 0 0.02609889768064022
exon O 0 0.12485888600349426
11 O 0 0.052021730691194534
. O 0 0.04093669727444649

Pulse O 1 0.996760904788971
- O 1 0.9973975419998169
chase O 0 0.07443118095397949
analysis O 0 0.020449165254831314
using O 0 0.02023480087518692
proband O 1 0.9989410042762756
fibroblasts O 1 0.7953698039054871
revealed O 0 0.025385446846485138
that O 0 0.009202481247484684
the O 0 0.017258979380130768
W474C O 1 0.9955090284347534
- O 1 0.9842674136161804
containing O 0 0.024877838790416718
alpha O 0 0.08729467540979385
- O 1 0.9982903599739075
subunit O 0 0.08348260819911957
precursor O 0 0.05784504488110542
was O 0 0.027368301525712013
normally O 0 0.024754665791988373
synthesized O 0 0.03910602629184723
, O 0 0.013217048719525337
but O 0 0.009772978723049164
not O 0 0.012227953411638737
phosphorylated O 1 0.7670605778694153
or O 0 0.021672755479812622
secreted O 0 0.04430637136101723
, O 0 0.011589111760258675
and O 0 0.01019857544451952
the O 0 0.016925809904932976
mature O 0 0.07945812493562698
lysosomal O 1 0.9999991655349731
alpha O 1 0.9998689889907837
- O 1 0.9999747276306152
subunit O 0 0.10869944840669632
was O 0 0.034194838255643845
not O 0 0.020187625661492348
detected O 0 0.04726249724626541
. O 0 0.03442865237593651

When O 0 0.035197287797927856
the O 0 0.029282737523317337
W474C O 1 0.9355756640434265
- O 1 0.97413569688797
containing O 0 0.03124835342168808
alpha O 0 0.08975937217473984
- O 1 0.956720769405365
subunit O 0 0.057024840265512466
was O 0 0.02777295559644699
transiently O 1 0.7034937143325806
co O 1 0.8353320956230164
- O 1 0.955138087272644
expressed O 0 0.015342921018600464
with O 0 0.009532338939607143
the O 0 0.016354067251086235
beta O 1 0.9096294045448303
- O 1 0.9959686994552612
subunit O 0 0.044447772204875946
to O 0 0.01356611680239439
produce O 0 0.01650337688624859
Hex O 0 0.07785487920045853
A O 0 0.03482654318213463
( O 0 0.025550594553351402
alphabeta O 1 0.5581578612327576
) O 0 0.015118611045181751
in O 0 0.01682080514729023
COS O 1 0.9999948740005493
- O 1 0.999958872795105
7 O 0 0.03441990539431572
cells O 0 0.02063751593232155
, O 0 0.008713961578905582
the O 0 0.01190971303731203
mature O 0 0.03033089078962803
alpha O 1 0.8840888142585754
- O 1 0.9997703433036804
subunit O 0 0.06551516056060791
was O 0 0.02169926092028618
present O 0 0.01415075734257698
, O 0 0.009707197546958923
but O 0 0.0070594181306660175
its O 0 0.009727337397634983
level O 0 0.015346307307481766
was O 0 0.015221207402646542
much O 0 0.010554840788245201
lower O 0 0.013963310979306698
than O 0 0.005512801930308342
that O 0 0.004981470759958029
from O 0 0.008025527000427246
normal O 0 0.016860168427228928
alpha O 0 0.45373401045799255
- O 1 0.9998668432235718
subunit O 1 0.6273910999298096
transfections O 1 0.9939278364181519
, O 0 0.014769544824957848
although O 0 0.00908314436674118
higher O 0 0.009634452871978283
than O 0 0.006009409669786692
in O 0 0.008468025363981724
those O 0 0.011379972100257874
cells O 0 0.02933250181376934
transfected O 0 0.199410542845726
with O 0 0.013260890729725361
an O 0 0.01853460818529129
alpha O 1 0.8736757040023804
- O 1 0.9993347525596619
subunit O 0 0.07318605482578278
associated O 0 0.031165851280093193
with O 0 0.04063589870929718
infantile O 1 1.0
TSD B-Disease 1 0.9999998807907104
. O 0 0.08070038259029388

Furthermore O 0 0.05894720181822777
, O 0 0.021955830976366997
the O 0 0.021505868062376976
precursor O 0 0.04500936344265938
level O 0 0.01635626144707203
of O 0 0.011501609347760677
the O 0 0.018385613337159157
W474C O 1 0.9996359348297119
alpha O 1 0.9970173835754395
- O 1 0.9998619556427002
subunit O 0 0.06101532652974129
was O 0 0.020226161926984787
found O 0 0.01018197275698185
to O 0 0.012489423155784607
accumulate O 0 0.031881652772426605
in O 0 0.008815182372927666
comparison O 0 0.012982564978301525
to O 0 0.00963746476918459
the O 0 0.013605979271233082
normal O 0 0.028099941089749336
alpha O 1 0.527159571647644
- O 1 0.9992846846580505
subunit O 0 0.17199769616127014
precursor O 0 0.10255789756774902
levels O 0 0.04893346130847931
. O 0 0.03956516087055206

We O 0 0.027501625940203667
conclude O 0 0.03375064581632614
that O 0 0.009918084368109703
the O 0 0.02053939178586006
1422 O 1 0.9998742341995239
G O 1 0.9998297691345215
- O 1 0.9999990463256836
- O 1 0.9999992847442627
> O 1 0.9998643398284912
C O 1 0.9860187768936157
mutation O 0 0.03181033208966255
is O 0 0.010562124662101269
the O 0 0.012554256245493889
cause O 0 0.025948835536837578
of O 0 0.024292604997754097
Hex B-Disease 1 0.9999642372131348
A I-Disease 1 0.9999754428863525
enzyme I-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
in O 0 0.03296563774347305
the O 0 0.05174162983894348
proband O 1 0.9996848106384277
. O 0 0.05460193380713463

The O 0 0.05669150874018669
resulting O 0 0.057980507612228394
W474C O 1 0.986664891242981
substitution O 0 0.06319496035575867
clearly O 0 0.02958463691174984
interferes O 0 0.06012085825204849
with O 0 0.01736047863960266
alpha O 1 0.9558257460594177
- O 1 0.9999368190765381
subunit O 0 0.1531478464603424
processing O 0 0.02020401693880558
, O 0 0.011653774417936802
but O 0 0.008411005139350891
because O 0 0.00965453777462244
the O 0 0.015106404200196266
base O 0 0.03555639833211899
substitution O 0 0.04459521174430847
falls O 0 0.05828665941953659
at O 0 0.016093842685222626
the O 0 0.012759212404489517
first O 0 0.013966711238026619
position O 0 0.017484819516539574
of O 0 0.01688695326447487
exon O 0 0.07714371383190155
13 O 0 0.03011876903474331
, O 0 0.026477055624127388
aberrant O 1 0.9981445074081421
splicing O 0 0.05581722408533096
may O 0 0.016440309584140778
also O 0 0.011711284518241882
contribute O 0 0.02015990950167179
to O 0 0.020274372771382332
Hex B-Disease 1 0.9989473223686218
A I-Disease 1 0.9996237754821777
deficiency I-Disease 1 1.0
in O 0 0.027791891247034073
this O 0 0.026083363220095634
proband O 1 0.999825656414032
. O 0 0.03198625147342682
. O 0 0.03858394920825958

Two O 0 0.03953210264444351
frequent O 0 0.08274656534194946
missense O 1 0.7425601482391357
mutations O 0 0.09260794520378113
in O 0 0.07891061902046204
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.6201624870300293

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.06479868292808533
an O 1 0.9958270192146301
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999997615814209
by O 1 0.9943189024925232
early O 1 0.9999816417694092
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999996423721313
goiter B-Disease 1 1.0
. O 1 0.9751714468002319

A O 0 0.05058777332305908
century O 0 0.03835985064506531
after O 0 0.02126605249941349
its O 0 0.014718569815158844
recognition O 0 0.02142220176756382
as O 0 0.019018862396478653
a O 0 0.26832088828086853
syndrome O 1 1.0
by O 0 0.029427092522382736
Vaughan O 1 0.999975323677063
Pendred O 1 0.9999593496322632
, O 0 0.023466231301426888
the O 0 0.04346875101327896
disease O 1 0.9999998807907104
gene O 1 0.9935576319694519
( O 1 0.642900824546814
PDS O 1 0.9999997615814209
) O 0 0.021495414897799492
was O 0 0.022033626213669777
mapped O 0 0.03096841461956501
to O 0 0.021997395902872086
chromosome O 0 0.07469169795513153
7q22 O 1 0.9997429251670837
- O 1 0.9999513626098633
q31 O 1 0.9936432838439941
. O 0 0.05550342798233032

1 O 0 0.05865185335278511
and O 0 0.027082614600658417
, O 0 0.02120240032672882
recently O 0 0.025308124721050262
, O 0 0.014686670154333115
found O 0 0.01135720033198595
to O 0 0.013538629747927189
encode O 0 0.02845318801701069
a O 0 0.03827393800020218
putative O 1 0.9996993541717529
sulfate O 1 0.9999856948852539
transporter O 1 0.9996374845504761
. O 0 0.05579238757491112

We O 0 0.038230281323194504
performed O 0 0.04381973668932915
mutation O 0 0.03467569500207901
analysis O 0 0.011171096935868263
of O 0 0.013274249620735645
the O 0 0.028519460931420326
PDS B-Disease 1 0.9999996423721313
gene O 0 0.040585849434137344
in O 0 0.019674353301525116
patients O 0 0.41467994451522827
from O 0 0.020540542900562286
14 O 0 0.03553140163421631
Pendred B-Disease 1 0.9980257749557495
families O 0 0.03115888126194477
originating O 0 0.03235333040356636
from O 0 0.014897851273417473
seven O 0 0.017024829983711243
countries O 0 0.012167143635451794
and O 0 0.01577814109623432
identified O 0 0.026453936472535133
all O 0 0.023936673998832703
mutations O 0 0.05353148281574249
. O 0 0.04085433483123779

The O 0 0.05278528481721878
mutations O 0 0.045477546751499176
include O 0 0.01955711655318737
three O 0 0.01827065832912922
single O 0 0.038042645901441574
base O 0 0.04491821676492691
deletions O 0 0.05426879972219467
, O 0 0.01806236244738102
one O 0 0.021382812410593033
splice O 0 0.08633415400981903
site O 0 0.0370839461684227
mutation O 0 0.03645602613687515
and O 0 0.018318410962820053
10 O 0 0.03429214656352997
missense O 0 0.36339589953422546
mutations O 0 0.07051316648721695
. O 0 0.047093428671360016

One O 0 0.04745187610387802
missense O 0 0.4897887408733368
mutation O 0 0.4438648521900177
( O 0 0.04373963177204132
L236P O 1 0.9998699426651001
) O 0 0.02178635634481907
was O 0 0.018676938489079475
found O 0 0.01041952334344387
in O 0 0.009157470427453518
a O 0 0.016734765842556953
homozygous O 0 0.032066237181425095
state O 0 0.011303997598588467
in O 0 0.010192087851464748
two O 0 0.01563766598701477
consanguineous O 1 0.9986246824264526
families O 0 0.0262648593634367
and O 0 0.014214571565389633
in O 0 0.012504948303103447
a O 0 0.01911969855427742
heterozygous O 0 0.03212372586131096
state O 0 0.010435125790536404
in O 0 0.008741111494600773
five O 0 0.012274449691176414
additional O 0 0.01964724063873291
non O 1 0.6518310308456421
- O 1 0.9999929666519165
consanguineous O 1 0.9998089671134949
families O 0 0.06443770974874496
. O 0 0.05029424652457237

Another O 0 0.06723730266094208
missense O 1 0.704139232635498
mutation O 0 0.27684059739112854
( O 0 0.04402508959174156
T416P O 1 0.999885082244873
) O 0 0.021429209038615227
was O 0 0.018677156418561935
found O 0 0.009854605421423912
in O 0 0.008349329233169556
a O 0 0.015225155279040337
homozygous O 0 0.029670681804418564
state O 0 0.010701418854296207
in O 0 0.010457917116582394
one O 0 0.014502952806651592
family O 0 0.0217196773737669
and O 0 0.012262660078704357
in O 0 0.011382611468434334
a O 0 0.020847158506512642
heterozygous O 0 0.036402732133865356
state O 0 0.013472876511514187
in O 0 0.014564603567123413
four O 0 0.02003205008804798
families O 0 0.03964059427380562
. O 0 0.04416675120592117

Pendred B-Disease 1 0.9999579191207886
patients O 1 0.8105444312095642
in O 0 0.01769087463617325
three O 0 0.01952173188328743
non O 1 0.9942236542701721
- O 1 0.9999996423721313
consanguineous O 1 0.9998939037322998
families O 0 0.026361221447587013
were O 0 0.012701163999736309
shown O 0 0.014103061519563198
to O 0 0.013014835305511951
be O 0 0.013466501608490944
compound O 0 0.0645696222782135
heterozygotes O 0 0.4919013977050781
for O 0 0.03317832574248314
L236P O 1 0.9990866184234619
and O 0 0.04838177189230919
T416P O 1 0.9985917210578918
. O 0 0.057461272925138474

In O 0 0.024651672691106796
total O 0 0.022187093272805214
, O 0 0.015999948605895042
one O 0 0.012869603000581264
or O 0 0.010216375812888145
both O 0 0.008815906941890717
of O 0 0.01312957238405943
these O 0 0.010371151380240917
mutations O 0 0.018671182915568352
were O 0 0.007600252982228994
found O 0 0.008802331052720547
in O 0 0.007629465311765671
nine O 0 0.01284339465200901
of O 0 0.014653213322162628
the O 0 0.021134167909622192
14 O 0 0.0336533822119236
families O 0 0.035900816321372986
analyzed O 0 0.044884562492370605
. O 0 0.03581755608320236

The O 0 0.04058673232793808
identification O 0 0.029780104756355286
of O 0 0.019389307126402855
two O 0 0.02115481160581112
frequent O 1 0.9050825238227844
PDS B-Disease 1 0.9999996423721313
mutations O 0 0.04406426474452019
will O 0 0.01407723966985941
facilitate O 0 0.025717081502079964
the O 0 0.021734977141022682
molecular O 0 0.05752527341246605
diagnosis O 1 0.9999960660934448
of O 1 0.9998723268508911
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9829939603805542

Insertional O 1 0.9903529286384583
mutation O 0 0.07649675756692886
by O 0 0.03373803570866585
transposable O 1 0.9996438026428223
element O 0 0.3532768487930298
, O 0 0.02792343683540821
L1 O 1 0.9998718500137329
, O 0 0.01423779595643282
in O 0 0.01163427159190178
the O 0 0.027452124282717705
DMD B-Disease 1 1.0
gene O 0 0.02897418849170208
results O 0 0.012502620927989483
in O 0 0.01816047541797161
X B-Disease 1 0.9996495246887207
- I-Disease 1 0.9999991655349731
linked I-Disease 1 0.9999415874481201
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
. O 0 0.2751554250717163

X B-Disease 1 0.9946038126945496
- I-Disease 1 0.9999963045120239
linked I-Disease 1 0.9999237060546875
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 1 0.9997864365577698
XLDCM B-Disease 1 0.9999998807907104
) O 0 0.02311674878001213
is O 0 0.014789408072829247
a O 0 0.02170305885374546
clinical O 1 0.9139527082443237
phenotype O 1 0.8579856157302856
of O 0 0.02793128788471222
dystrophinopathy B-Disease 1 0.9999953508377075
which O 0 0.017024455592036247
is O 0 0.015118922106921673
characterized O 0 0.0345684215426445
by O 0 0.030998261645436287
preferential O 1 0.999991774559021
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.9993184804916382
without O 0 0.02347981557250023
any O 0 0.0223452877253294
overt O 1 0.9753647446632385
clinical O 1 0.9989013671875
signs O 1 0.9887582063674927
of O 1 0.9996868371963501
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.84535151720047

To O 0 0.026591595262289047
date O 0 0.020959239453077316
, O 0 0.011651983484625816
several O 0 0.007770088035613298
mutations O 0 0.01581120677292347
in O 0 0.011178633198142052
the O 0 0.06250592321157455
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999920129776001
, O 1 0.9991149306297302
DMD O 1 1.0
, O 0 0.01923234388232231
have O 0 0.0076289852149784565
been O 0 0.009287772700190544
identified O 0 0.014847501181066036
in O 0 0.01263069175183773
patients O 1 0.8925610184669495
with O 0 0.025113660842180252
XLDCM B-Disease 1 0.9999996423721313
, O 0 0.019312934949994087
but O 0 0.010805454105138779
a O 0 0.018249578773975372
pathogenic O 0 0.04627200961112976
correlation O 0 0.02361437864601612
of O 0 0.014488996006548405
these O 0 0.01178224477916956
cardiospecific O 1 0.9977200627326965
mutations O 0 0.03855813667178154
in O 0 0.02467508800327778
DMD O 1 0.9999992847442627
with O 0 0.02185593917965889
the O 0 0.19046777486801147
XLDCM B-Disease 1 1.0
phenotype O 1 0.9999727010726929
has O 0 0.0240023173391819
remained O 0 0.036806099116802216
to O 0 0.022271843627095222
be O 0 0.024341074749827385
elucidated O 0 0.2523166537284851
. O 0 0.04452165961265564

We O 0 0.0262531116604805
report O 0 0.019382961094379425
here O 0 0.012594410218298435
the O 0 0.013151053339242935
identification O 0 0.015418109484016895
of O 0 0.01136954315006733
a O 0 0.017901981249451637
unique O 0 0.020479192957282066
de O 0 0.07881329953670502
novo O 1 0.9959372282028198
L1 O 1 0.9997327923774719
insertion O 0 0.07002441585063934
in O 0 0.016280600801110268
the O 0 0.026708442717790604
muscle O 1 0.9904638528823853
exon O 1 0.8696334958076477
1 O 0 0.03611128404736519
in O 0 0.02372339740395546
DMD O 1 0.9999985694885254
in O 0 0.020549718290567398
three O 0 0.029173051938414574
XLDCM B-Disease 1 0.9999998807907104
patients O 1 0.9994773268699646
from O 0 0.018830742686986923
two O 0 0.018438439816236496
unrelated O 0 0.04631773754954338
Japanese O 0 0.05969684571027756
families O 0 0.04733014851808548
. O 0 0.041893359273672104

The O 0 0.044547583907842636
insertion O 0 0.07078007608652115
was O 0 0.026259833946824074
a O 0 0.02296842634677887
5 O 0 0.031456489115953445
- O 1 0.9950959086418152
truncated O 0 0.0572369247674942
form O 0 0.015542815439403057
of O 0 0.017720988020300865
human O 0 0.0334257148206234
L1 O 1 0.999977707862854
inversely O 0 0.09117018431425095
integrated O 0 0.037542615085840225
in O 0 0.009643156081438065
the O 0 0.014226590283215046
5 O 0 0.0272182896733284
- O 1 0.9996662139892578
untranslated O 1 0.5061601996421814
region O 0 0.019574696198105812
in O 0 0.010978157632052898
the O 0 0.021150823682546616
muscle O 1 0.9988774657249451
exon O 1 0.9980502128601074
1 O 0 0.029384158551692963
, O 0 0.014191264286637306
which O 0 0.00881809089332819
affected O 0 0.01721622236073017
the O 0 0.016297530382871628
transcription O 0 0.03883758932352066
or O 0 0.011322247795760632
the O 0 0.013572652824223042
stability O 0 0.02710709162056446
of O 0 0.015488341450691223
the O 0 0.02700318582355976
muscle O 1 0.9976193308830261
form O 0 0.022047152742743492
of O 0 0.03687690198421478
dystrophin O 1 0.9999983310699463
transcripts O 0 0.036332614719867706
but O 0 0.008258586749434471
not O 0 0.004897702485322952
that O 0 0.003973653074353933
of O 0 0.008729562163352966
the O 0 0.0200315173715353
brain O 1 0.9998525381088257
or O 0 0.26414868235588074
Purkinje O 1 1.0
cell O 1 0.9941352605819702
form O 0 0.02550632879137993
, O 0 0.01741022616624832
probably O 0 0.01448433194309473
due O 0 0.012151691131293774
to O 0 0.010340949520468712
its O 0 0.012975991703569889
unique O 0 0.016921771690249443
site O 0 0.02424469403922558
of O 0 0.02423718571662903
integration O 0 0.062208421528339386
. O 0 0.04537174478173256

We O 0 0.03391820192337036
speculate O 0 0.040905166417360306
that O 0 0.0096168527379632
this O 0 0.008957833051681519
insertion O 0 0.03228236362338066
of O 0 0.01574333757162094
an O 0 0.021035190671682358
L1 O 1 0.9999139308929443
sequence O 0 0.02789386361837387
in O 0 0.027495337650179863
DMD O 1 1.0
is O 0 0.021665943786501884
responsible O 0 0.022384515032172203
for O 0 0.009676177054643631
some O 0 0.0063683511689305305
of O 0 0.00935247354209423
the O 0 0.012198751792311668
population O 0 0.012398489750921726
of O 0 0.01709788851439953
Japanese O 1 0.7792211771011353
patients O 1 0.9994632601737976
with O 0 0.03914438188076019
XLDCM B-Disease 1 0.9999977350234985
. O 0 0.034299567341804504
. O 0 0.03787513077259064

Severe O 1 0.9906176924705505
early O 0 0.37557095289230347
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 1.0
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9997898936271667
red O 1 0.9999998807907104
hair O 1 0.9999994039535522
pigmentation O 1 1.0
caused O 1 0.999982476234436
by O 1 0.9974283576011658
POMC O 1 1.0
mutations O 1 0.6214845776557922
in O 0 0.02792995423078537
humans O 0 0.03952384740114212
. O 0 0.03754756599664688

Sequential O 0 0.10192088782787323
cleavage O 0 0.2219560444355011
of O 0 0.024350481107831
the O 0 0.02626204863190651
precursor O 0 0.1005745381116867
protein O 0 0.031674619764089584
pre O 0 0.06884045898914337
- O 1 0.9992075562477112
pro O 1 0.8996554613113403
- O 1 0.999961256980896
opiomelanocortin O 1 0.9998502731323242
( O 0 0.053500376641750336
POMC O 1 0.9999253749847412
) O 0 0.02155754528939724
generates O 0 0.024982091039419174
the O 0 0.025848833844065666
melanocortin O 1 0.9999605417251587
peptides O 0 0.3523545265197754
adrenocorticotrophin O 1 0.9999756813049316
( O 0 0.059852566570043564
ACTH O 1 0.9999836683273315
) O 0 0.023804204538464546
, O 0 0.02576442062854767
melanocyte O 1 0.9999972581863403
- O 1 0.9999996423721313
stimulating O 1 0.9999957084655762
hormones O 1 0.9992782473564148
( O 0 0.04670378193259239
MSH O 1 0.999998927116394
) O 0 0.026561370119452477
alpha O 0 0.056078407913446426
, O 0 0.021684199571609497
beta O 0 0.053975049406290054
and O 0 0.017938004806637764
gamma O 0 0.08782152086496353
as O 0 0.011903165839612484
well O 0 0.008701774291694164
as O 0 0.010093954391777515
the O 0 0.019206365570425987
opioid O 1 0.999985933303833
- O 1 0.9999915361404419
receptor O 1 0.9914291501045227
ligand O 1 0.9896613359451294
beta O 1 0.9923650026321411
- O 1 0.9998728036880493
endorphin O 1 0.9993267059326172
. O 0 0.05821242183446884

While O 0 0.02893751487135887
a O 0 0.02020142413675785
few O 0 0.012605858035385609
cases O 0 0.01649297960102558
of O 0 0.03754335641860962
isolated O 1 0.9999997615814209
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.01653934270143509
been O 0 0.01606891304254532
reported O 0 0.024825075641274452
( O 0 0.033952802419662476
OMIM O 1 0.9999982118606567
201400 O 1 0.9985867738723755
) O 0 0.019485650584101677
, O 0 0.014886434189975262
an O 0 0.02371681109070778
inherited O 1 0.9999998807907104
POMC O 1 1.0
defect O 1 0.9999998807907104
has O 0 0.02457009069621563
not O 0 0.01291639357805252
been O 0 0.014492160640656948
described O 0 0.024513589218258858
so O 0 0.01509525440633297
far O 0 0.022403186187148094
. O 0 0.030601635575294495

Recent O 0 0.0462016761302948
studies O 0 0.026434456929564476
in O 0 0.018303530290722847
animal O 0 0.030493024736642838
models O 0 0.023486977443099022
elucidated O 0 0.19920878112316132
a O 0 0.01662561669945717
central O 0 0.01858711615204811
role O 0 0.02088194526731968
of O 0 0.02282918244600296
alpha O 1 0.9995704293251038
- O 1 0.9999946355819702
MSH O 1 0.9999750852584839
in O 0 0.013371948152780533
the O 0 0.014716951176524162
regulation O 0 0.02153942361474037
of O 0 0.01754821091890335
food O 0 0.03564750403165817
intake O 0 0.1552472710609436
by O 0 0.015893282368779182
activation O 0 0.029476352035999298
of O 0 0.01387688796967268
the O 0 0.020437009632587433
brain O 1 0.9987612962722778
melanocortin O 1 0.9999991655349731
- O 1 0.9999246597290039
4 O 0 0.040248241275548935
- O 1 0.999772846698761
receptor O 0 0.10715905576944351
( O 0 0.03060002438724041
MC4 O 1 0.9999943971633911
- O 1 0.9999368190765381
R O 1 0.9071513414382935
; O 0 0.021334262564778328
refs O 0 0.06075972318649292
3 O 0 0.03396022319793701
- O 1 0.998354971408844
5 O 0 0.019768640398979187
) O 0 0.01025245152413845
and O 0 0.008424832485616207
the O 0 0.012194505892693996
linkage O 0 0.046791765838861465
of O 0 0.021302219480276108
human O 1 0.9848611354827881
obesity B-Disease 1 1.0
to O 0 0.05833384394645691
chromosome O 0 0.4651010036468506
2 O 0 0.020420394837856293
in O 0 0.010966826230287552
close O 0 0.01733238995075226
proximity O 0 0.02750551328063011
to O 0 0.01563931070268154
the O 0 0.028880130499601364
POMC O 1 0.9999995231628418
locus O 1 0.9965448975563049
, O 0 0.016682537272572517
led O 0 0.02114035189151764
to O 0 0.010937492363154888
the O 0 0.011961403302848339
proposal O 0 0.017666803672909737
of O 0 0.011008139699697495
an O 0 0.013453067280352116
association O 0 0.02546638436615467
of O 0 0.034545645117759705
POMC O 1 0.9999997615814209
with O 0 0.05749202147126198
human O 1 0.9917755126953125
obesity B-Disease 1 1.0
. O 0 0.07509949058294296

The O 0 0.040800418704748154
dual O 0 0.04552842304110527
role O 0 0.030564891174435616
of O 0 0.026484519243240356
alpha O 1 0.9995237588882446
- O 1 0.9999966621398926
MSH O 1 0.999996542930603
in O 0 0.020816711708903313
regulating O 0 0.08104509860277176
food O 0 0.053554803133010864
intake O 1 0.9596471786499023
and O 0 0.025859978049993515
influencing O 1 0.9740865230560303
hair O 1 0.9997225403785706
pigmentation O 1 0.9999973773956299
predicts O 0 0.23622964322566986
that O 0 0.014926564879715443
the O 0 0.022233061492443085
phenotype O 0 0.07481035590171814
associated O 0 0.016733316704630852
with O 0 0.013049592263996601
a O 0 0.03076554462313652
defect O 1 0.9999876022338867
in O 0 0.028104571625590324
POMC O 1 0.9999998807907104
function O 0 0.02573874220252037
would O 0 0.014484713785350323
include O 0 0.029365917667746544
obesity B-Disease 1 1.0
, O 0 0.039604298770427704
alteration O 1 0.9995088577270508
in O 0 0.20930609107017517
pigmentation O 1 1.0
and O 1 0.9999953508377075
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.30844035744667053

The O 0 0.04525294899940491
observation O 0 0.07917817682027817
of O 0 0.031341250985860825
these O 0 0.021599672734737396
symptoms O 1 0.9998879432678223
in O 0 0.019771002233028412
two O 0 0.02308213897049427
probands O 1 0.9997537732124329
prompted O 0 0.06482570618391037
us O 0 0.02596200443804264
to O 0 0.015381913632154465
search O 0 0.025604400783777237
for O 0 0.01627349853515625
mutations O 0 0.026239531114697456
within O 0 0.018469074741005898
their O 0 0.029485614970326424
POMC O 1 0.9999842643737793
genes O 0 0.06357888132333755
. O 0 0.043896324932575226

Patient O 1 0.9994407296180725
1 O 0 0.04566581919789314
was O 0 0.02867909148335457
found O 0 0.012532297521829605
to O 0 0.010097475722432137
be O 0 0.007951102219522
a O 0 0.01751416176557541
compound O 0 0.08373561501502991
heterozygote O 1 0.5251010060310364
for O 0 0.013259111903607845
two O 0 0.011345341801643372
mutations O 0 0.022199565544724464
in O 0 0.014273229986429214
exon O 0 0.17229197919368744
3 O 0 0.031992584466934204
( O 0 0.02994145266711712
G7013T O 1 0.9986421465873718
, O 0 0.029769400134682655
C7133delta O 1 0.9996542930603027
) O 0 0.019392671063542366
which O 0 0.012010655365884304
interfere O 0 0.03014083206653595
with O 0 0.013018903322517872
appropriate O 0 0.022830510511994362
synthesis O 0 0.030058274045586586
of O 0 0.026572033762931824
ACTH O 1 0.9999983310699463
and O 0 0.03815047815442085
alpha O 1 0.9990400671958923
- O 1 0.9999923706054688
MSH O 1 0.9999836683273315
. O 0 0.0626387745141983

Patient O 1 0.9960777163505554
2 O 0 0.04533270001411438
was O 0 0.036721955984830856
homozygous O 0 0.04559686779975891
for O 0 0.01521299034357071
a O 0 0.022729087620973587
mutation O 0 0.03331892564892769
in O 0 0.0168033204972744
exon O 0 0.2463284134864807
2 O 0 0.038420628756284714
( O 0 0.032809384167194366
C3804A O 1 0.9861252903938293
) O 0 0.02678612992167473
which O 0 0.028895193710923195
abolishes O 1 0.9981908202171326
POMC O 1 0.9999614953994751
translation O 0 0.0894864872097969
. O 0 0.05395220220088959

These O 0 0.024648483842611313
findings O 0 0.023225421085953712
represent O 0 0.016144273802638054
the O 0 0.015416168607771397
first O 0 0.01711905375123024
examples O 0 0.016566619277000427
of O 0 0.017677122727036476
a O 0 0.03593737632036209
genetic B-Disease 1 0.9678289294242859
defect I-Disease 1 0.9999867677688599
within O 0 0.023290209472179413
the O 0 0.04344486817717552
POMC O 1 0.9999991655349731
gene O 0 0.029714731499552727
and O 0 0.013038652949035168
define O 0 0.02063804864883423
a O 0 0.019475815817713737
new O 0 0.050840266048908234
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 0.07589919865131378
in O 0 0.015818985179066658
early O 1 0.8102210760116577
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999997615814209
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999580383300781
red O 1 1.0
hair O 1 0.9999997615814209
pigmentation O 1 0.9999998807907104
. O 0 0.04536560922861099
. O 0 0.0445236973464489

A O 0 0.06036284565925598
European O 0 0.03949492424726486
multicenter O 1 0.9787771701812744
study O 0 0.034125927835702896
of O 0 0.11303409934043884
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.05757012218236923
classification O 0 0.05164254829287529
of O 0 0.02344825118780136
105 O 0 0.42927876114845276
mutations O 0 0.029215458780527115
and O 0 0.012721809558570385
a O 0 0.015969377011060715
general O 0 0.024506546556949615
system O 0 0.020312730222940445
for O 0 0.017184719443321228
genotype O 1 0.9645329713821411
- O 1 0.9919844269752502
based O 0 0.02578004263341427
prediction O 0 0.045878637582063675
of O 0 0.04529288411140442
metabolic O 1 0.9999938011169434
phenotype O 1 0.9983904361724854
. O 0 0.057596564292907715

Phenylketonuria B-Disease 1 0.999998927116394
( O 1 0.9367042183876038
PKU B-Disease 1 0.9999998807907104
) O 0 0.04058906435966492
and O 0 0.03347669169306755
mild B-Disease 1 0.9999988079071045
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9999527931213379
MHP B-Disease 1 1.0
) O 0 0.03042398951947689
are O 0 0.01710123009979725
allelic B-Disease 1 0.999998927116394
disorders I-Disease 1 1.0
caused O 1 0.9999008178710938
by O 0 0.03243609145283699
mutations O 0 0.02495976723730564
in O 0 0.011030302383005619
the O 0 0.018938973546028137
gene O 0 0.033568236976861954
encoding O 0 0.04733828455209732
phenylalanine O 1 0.9997168183326721
hydroxylase O 1 0.9999932050704956
( O 1 0.9460651278495789
PAH O 1 1.0
) O 0 0.05612296983599663
. O 0 0.04048433527350426

Previous O 0 0.04923059046268463
studies O 0 0.02387978509068489
have O 0 0.00988044310361147
suggested O 0 0.013073737733066082
that O 0 0.00787356961518526
the O 0 0.014997965656220913
highly O 0 0.03438112884759903
variable O 0 0.04567896947264671
metabolic O 1 0.9951468110084534
phenotypes O 1 0.981823205947876
of O 1 0.9999097585678101
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9999532699584961
with O 1 0.9995406866073608
PAH O 1 1.0
genotypes O 1 0.9999074935913086
. O 0 0.05913310870528221

We O 0 0.027213439345359802
identified O 0 0.02747875452041626
both O 0 0.021839378401637077
causative O 1 0.9977692365646362
mutations O 0 0.043270453810691833
in O 0 0.027453865855932236
686 O 1 0.9999978542327881
patients O 1 0.9998016953468323
from O 0 0.022304166108369827
seven O 0 0.030988404527306557
European O 0 0.03861565515398979
centers O 0 0.0625753104686737
. O 0 0.04724103957414627

On O 0 0.028783613815903664
the O 0 0.0184926800429821
basis O 0 0.01282901968806982
of O 0 0.014143533073365688
the O 0 0.019880298525094986
phenotypic O 0 0.04126555100083351
characteristics O 0 0.024707579985260963
of O 0 0.025855612009763718
297 O 1 0.9998173117637634
functionally O 1 0.9999246597290039
hemizygous O 1 0.9999972581863403
patients O 1 0.9956953525543213
, O 0 0.018735205754637718
105 O 0 0.03566296771168709
of O 0 0.01780957728624344
the O 0 0.021086543798446655
mutations O 0 0.021775702014565468
were O 0 0.009135378524661064
assigned O 0 0.022288119420409203
to O 0 0.009768021292984486
one O 0 0.00987903494387865
of O 0 0.013360275886952877
four O 0 0.021933743730187416
arbitrary O 0 0.05084502696990967
phenotype O 1 0.8351096510887146
categories O 0 0.04793485626578331
. O 0 0.04174160212278366

We O 0 0.029546841979026794
proposed O 0 0.030665138736367226
and O 0 0.021762799471616745
tested O 0 0.034663137048482895
a O 0 0.023362724110484123
simple O 0 0.024890562519431114
model O 0 0.026209866628050804
for O 0 0.017463482916355133
correlation O 0 0.0410599522292614
between O 0 0.034239109605550766
genotype O 1 0.7066037058830261
and O 0 0.028060972690582275
phenotypic O 0 0.06867445260286331
outcome O 0 0.051233768463134766
. O 0 0.04432430490851402

The O 0 0.04784258455038071
observed O 0 0.04088626056909561
phenotype O 0 0.06690552830696106
matched O 0 0.03304516524076462
the O 0 0.02225247211754322
predicted O 0 0.040220487862825394
phenotype O 0 0.053868137300014496
in O 0 0.012909993529319763
79 O 0 0.036685504019260406
% O 0 0.01321395207196474
of O 0 0.013152649626135826
the O 0 0.017112862318754196
cases O 0 0.020159630104899406
, O 0 0.012817393988370895
and O 0 0.009413900785148144
in O 0 0.006720791570842266
only O 0 0.006927997339516878
5 O 0 0.011635323986411095
of O 0 0.013490206561982632
184 O 1 0.9887387752532959
patients O 1 0.997494101524353
was O 0 0.027933143079280853
the O 0 0.020654164254665375
observed O 0 0.02581200748682022
phenotype O 0 0.05389389768242836
more O 0 0.007369242608547211
than O 0 0.008304430171847343
one O 0 0.015183642506599426
category O 0 0.024578288197517395
away O 0 0.018859053030610085
from O 0 0.013786026276648045
that O 0 0.013736014254391193
expected O 0 0.027927616611123085
. O 0 0.034082211554050446

Among O 0 0.03867008537054062
the O 0 0.025846177712082863
seven O 0 0.026375966146588326
contributing O 0 0.04394226148724556
centers O 0 0.03179524093866348
, O 0 0.013500561937689781
the O 0 0.013988596387207508
proportion O 0 0.025684893131256104
of O 0 0.021565742790699005
patients O 1 0.9969654679298401
for O 0 0.017872963100671768
whom O 0 0.03143661841750145
the O 0 0.023746732622385025
observed O 0 0.031217897310853004
phenotype O 1 0.6706063747406006
did O 0 0.01267885509878397
not O 0 0.0070099723525345325
match O 0 0.012745294719934464
the O 0 0.014385904185473919
predicted O 0 0.029170161113142967
phenotype O 0 0.044545549899339676
was O 0 0.019424570724368095
4 O 0 0.02061065100133419
% O 0 0.016797881573438644
- O 1 0.5558106899261475
23 O 0 0.022300682961940765
% O 0 0.0183323472738266
( O 0 0.02705664187669754
P O 1 0.9997095465660095
< O 1 0.9969983100891113
. O 0 0.0238940566778183
0001 O 1 0.9992823004722595
) O 0 0.02092893421649933
, O 0 0.014169727452099323
suggesting O 0 0.017781265079975128
that O 0 0.008489247411489487
differences O 0 0.011810733005404472
in O 0 0.009308240376412868
methods O 0 0.010992633178830147
used O 0 0.009466422721743584
for O 0 0.01397798489779234
mutation O 0 0.24713212251663208
detection O 1 0.9501811861991882
or O 0 0.07497677206993103
phenotype O 1 0.9990122318267822
classification O 0 0.40789365768432617
may O 0 0.01704098843038082
account O 0 0.013595265336334705
for O 0 0.010399192571640015
a O 0 0.016064338386058807
considerable O 0 0.024194220080971718
proportion O 0 0.033110667020082474
of O 0 0.03831418603658676
genotype O 1 0.9999451637268066
- O 1 0.999995231628418
phenotype O 1 0.9778343439102173
inconsistencies O 0 0.10527056455612183
. O 0 0.052968043833971024

Our O 0 0.03949834033846855
data O 0 0.014677825383841991
indicate O 0 0.01243340689688921
that O 0 0.00850670039653778
the O 0 0.03197874128818512
PAH O 1 1.0
- O 1 0.9999984502792358
mutation O 0 0.26800304651260376
genotype O 0 0.05880407243967056
is O 0 0.011121568270027637
the O 0 0.013108434155583382
main O 0 0.030560048297047615
determinant O 1 0.9931255578994751
of O 0 0.08670540153980255
metabolic O 1 0.9999995231628418
phenotype O 1 0.9950096607208252
in O 0 0.017685115337371826
most O 0 0.025532295927405357
patients O 1 0.9999785423278809
with O 1 0.9999812841415405
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.7262306809425354

In O 0 0.02569469064474106
the O 0 0.023975566029548645
present O 0 0.019987111911177635
study O 0 0.014616549015045166
, O 0 0.010934248566627502
the O 0 0.013209016993641853
classification O 0 0.030457619577646255
of O 0 0.025210881605744362
105 O 1 0.9999896287918091
PAH O 1 1.0
mutations O 0 0.4853639006614685
may O 0 0.013661248609423637
allow O 0 0.011750999838113785
the O 0 0.01210029423236847
prediction O 0 0.02350437082350254
of O 0 0.011849518865346909
the O 0 0.020148953422904015
biochemical O 1 0.5937284827232361
phenotype O 1 0.8630905747413635
in O 0 0.018102848902344704
> O 1 0.7963210344314575
10 O 0 0.017473887652158737
, O 0 0.016476092860102654
000 O 0 0.04562408849596977
genotypes O 1 0.9543298482894897
, O 0 0.018822330981492996
which O 0 0.011642273515462875
may O 0 0.011720450595021248
be O 0 0.007507404312491417
useful O 0 0.009948528371751308
for O 0 0.007954680360853672
the O 0 0.014045079238712788
management O 0 0.03158685564994812
of O 0 0.030468666926026344
hyperphenylalaninemia B-Disease 1 0.9999996423721313
in O 0 0.048575740307569504
newborns O 1 0.999758780002594
. O 0 0.05355331301689148

Somatic O 1 0.9624547362327576
instability O 0 0.1355869174003601
of O 0 0.032807789742946625
the O 0 0.0446527935564518
CTG O 1 0.9999980926513672
repeat O 0 0.11074288934469223
in O 0 0.021635115146636963
mice O 0 0.03538407012820244
transgenic O 0 0.04211080074310303
for O 0 0.018522214144468307
the O 1 0.9002957940101624
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9998021721839905
is O 0 0.07846441119909286
age O 0 0.06421451270580292
dependent O 0 0.033084940165281296
but O 0 0.011447123251855373
not O 0 0.010324389673769474
correlated O 0 0.02573530189692974
to O 0 0.01249587070196867
the O 0 0.01848721131682396
relative O 0 0.04299430549144745
intertissue O 1 0.9996670484542847
transcription O 1 0.8378669023513794
levels O 0 0.04820258170366287
and O 0 0.047839920967817307
proliferative O 1 0.9999997615814209
capacities O 1 0.8834289312362671
. O 0 0.05925677716732025

A O 0 0.0996452122926712
( O 0 0.05957324802875519
CTG O 1 0.9999768733978271
) O 0 0.028755927458405495
nexpansion O 0 0.0791587233543396
in O 0 0.011115780100226402
the O 0 0.015515481121838093
3 O 0 0.03185778111219406
- O 1 0.9993953704833984
untranslated O 1 0.9308224320411682
region O 0 0.029591817408800125
( O 0 0.02371077612042427
UTR O 0 0.45143717527389526
) O 0 0.01017732173204422
of O 0 0.011519175954163074
the O 0 0.032187774777412415
DM O 1 1.0
protein O 0 0.35355114936828613
kinase O 1 0.9987408518791199
gene O 0 0.037448953837156296
( O 0 0.025681132450699806
DMPK O 1 0.9998612403869629
) O 0 0.01404595747590065
is O 0 0.010072327218949795
responsible O 0 0.02070496790111065
for O 0 0.024849342182278633
causing O 1 0.9999985694885254
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 0.06022251769900322
. O 0 0.042695824056863785

Major O 1 0.5120745301246643
instability O 1 0.9990153312683105
, O 0 0.02505292184650898
with O 0 0.015081522054970264
very O 0 0.01389374677091837
large O 0 0.015357328578829765
expansions O 0 0.040419355034828186
between O 0 0.01823277212679386
generations O 0 0.028164314106106758
and O 0 0.015152771957218647
high O 0 0.027683455497026443
levels O 0 0.022185759618878365
of O 0 0.029886014759540558
somatic O 1 0.9999891519546509
mosaicism O 1 0.9999992847442627
, O 0 0.033160075545310974
is O 0 0.022287026047706604
observed O 0 0.028821906074881554
in O 0 0.027377478778362274
patients O 1 0.9919873476028442
. O 0 0.049447204917669296

There O 0 0.02766251564025879
is O 0 0.018652312457561493
a O 0 0.01996735855937004
good O 0 0.023490499705076218
correlation O 0 0.02818087674677372
between O 0 0.02027684636414051
repeat O 0 0.06793560832738876
size O 0 0.02164296805858612
( O 0 0.015321352519094944
at O 0 0.013418164104223251
least O 0 0.00995421689003706
in O 0 0.014531522057950497
leucocytes O 1 0.9997664093971252
) O 0 0.02603537030518055
, O 0 0.02603723481297493
clinical O 1 0.9646571278572083
severity O 1 0.9972015619277954
and O 0 0.028921205550432205
age O 0 0.11463987082242966
of O 0 0.4603886902332306
onset O 1 0.9999997615814209
. O 0 0.07247455418109894

The O 0 0.06453832983970642
trinucleotide O 1 0.9999723434448242
repeat O 1 0.9991393089294434
instability O 1 0.9997474551200867
mechanisms O 0 0.05296734720468521
involved O 0 0.026197554543614388
in O 0 0.03215928003191948
DM B-Disease 1 1.0
and O 0 0.02259841002523899
other O 0 0.019042329862713814
human O 1 0.9822025299072266
genetic B-Disease 1 0.9999949932098389
diseases I-Disease 1 1.0
are O 0 0.023463662713766098
unknown O 0 0.05204259976744652
. O 0 0.03923468291759491

We O 0 0.03627245873212814
studied O 0 0.05033155530691147
somatic O 1 0.742867648601532
instability O 0 0.48618555068969727
by O 0 0.02677975594997406
measuring O 0 0.05577465519309044
the O 0 0.04192629083991051
CTG O 1 0.999992847442627
repeat O 0 0.08321432769298553
length O 0 0.02345046028494835
at O 0 0.018386514857411385
several O 0 0.011436901055276394
ages O 0 0.020782798528671265
in O 0 0.010645578615367413
various O 0 0.01274329237639904
tissues O 0 0.04096844047307968
of O 0 0.02606290578842163
transgenic O 1 0.9864192605018616
mice O 0 0.03945666551589966
carrying O 0 0.029057607054710388
a O 0 0.027826717123389244
( O 0 0.03531087934970856
CTG O 1 0.9999825954437256
) O 0 0.029158765450119972
55expansion O 1 0.5802507400512695
surrounded O 0 0.04125886783003807
by O 0 0.015123588033020496
45 O 0 0.02281844988465309
kb O 0 0.05760060250759125
of O 0 0.017652565613389015
the O 0 0.02675078995525837
human O 1 0.9849607348442078
DM B-Disease 1 1.0
region O 0 0.05154331400990486
, O 0 0.01992098055779934
using O 0 0.015550863929092884
small O 0 0.026620417833328247
- O 1 0.9991812109947205
pool O 0 0.23582108318805695
PCR O 0 0.13670048117637634
. O 0 0.04568072408437729

These O 0 0.038196224719285965
mice O 0 0.05087805539369583
have O 0 0.011415760964155197
been O 0 0.011990244500339031
shown O 0 0.0124947065487504
to O 0 0.013151337392628193
reproduce O 0 0.025771398097276688
the O 0 0.023461706936359406
intergenerational O 1 0.999931812286377
and O 0 0.0293111614882946
somatic O 1 0.9932841062545776
instability O 0 0.44169536232948303
of O 0 0.02132446877658367
the O 0 0.02762933075428009
55 O 0 0.0613737553358078
CTG O 1 0.9999778270721436
repeat O 0 0.10060837864875793
suggesting O 0 0.02713320218026638
that O 0 0.009799710474908352
surrounding O 0 0.022325772792100906
sequences O 0 0.013508337549865246
and O 0 0.010989305563271046
the O 0 0.020681103691458702
chromatin O 1 0.9965131878852844
environment O 0 0.028235532343387604
are O 0 0.009168241173028946
involved O 0 0.019999617710709572
in O 0 0.024332227185368538
instability O 1 0.9989179372787476
mechanisms O 0 0.27690041065216064
. O 0 0.048464082181453705

As O 0 0.032046303153038025
observed O 0 0.01873483695089817
in O 0 0.007697540335357189
some O 0 0.005966880824416876
of O 0 0.010479780845344067
the O 0 0.017950130626559258
tissues O 1 0.996941864490509
of O 1 0.9998306035995483
DM B-Disease 1 1.0
patients O 1 0.9999998807907104
, O 0 0.024852611124515533
there O 0 0.011500735767185688
is O 0 0.012091120705008507
a O 0 0.018024992197752
tendency O 0 0.036624372005462646
for O 0 0.019772198051214218
repeat O 0 0.06238233298063278
length O 0 0.02570655755698681
and O 0 0.026728440076112747
somatic O 1 0.9876842498779297
mosaicism O 1 0.9991194605827332
to O 0 0.018467403948307037
increase O 0 0.013447137549519539
with O 0 0.012056487612426281
the O 0 0.016178468242287636
age O 0 0.02008521370589733
of O 0 0.021112896502017975
the O 0 0.040250133723020554
mouse O 0 0.4304390549659729
. O 0 0.041399210691452026

Furthermore O 0 0.081455297768116
, O 0 0.02603139542043209
we O 0 0.013302309438586235
observed O 0 0.016229702159762383
no O 0 0.01333501935005188
correlation O 0 0.021521005779504776
between O 0 0.014444648288190365
the O 0 0.024739716202020645
somatic O 1 0.9990001320838928
mutation O 0 0.12920664250850677
rate O 0 0.03483414277434349
and O 0 0.03624768182635307
tissue O 1 0.9998700618743896
proliferation O 1 0.9999728202819824
capacity O 0 0.06977138668298721
. O 0 0.04346257075667381

The O 0 0.06405466049909592
somatic O 1 0.9871112704277039
mutation O 0 0.09303905069828033
rates O 0 0.02796284109354019
in O 0 0.014015243388712406
different O 0 0.009880900382995605
tissues O 0 0.05151096731424332
were O 0 0.009769067168235779
also O 0 0.01010989025235176
not O 0 0.008374788798391819
correlated O 0 0.021353473886847496
to O 0 0.008738264441490173
the O 0 0.01218455657362938
relative O 0 0.029768602922558784
inter O 1 0.9999728202819824
- O 1 0.9999996423721313
tissue O 1 0.8928055167198181
difference O 0 0.018794961273670197
in O 0 0.013190054334700108
transcriptional O 0 0.039584048092365265
levels O 0 0.013662256300449371
of O 0 0.009241203777492046
the O 0 0.012047341093420982
three O 0 0.013681123964488506
genes O 0 0.023031046614050865
( O 0 0.026471007615327835
DMAHP O 1 0.9999144077301025
, O 0 0.031247759237885475
DMPK O 1 0.9998278617858887
and O 0 0.02422182820737362
59 O 0 0.049711599946022034
) O 0 0.019184201955795288
surrounding O 0 0.03108365647494793
the O 0 0.029391514137387276
repeat O 0 0.13349397480487823
. O 0 0.029292821884155273
. O 0 0.0399949811398983

A O 0 0.06862484663724899
novel O 0 0.0756547823548317
missense O 1 0.9614899754524231
mutation O 0 0.10791025310754776
in O 0 0.02200714312493801
patients O 1 0.9690185189247131
from O 0 0.020748542621731758
a O 0 0.07644469290971756
retinoblastoma B-Disease 1 0.9999996423721313
pedigree O 1 0.9809737801551819
showing O 0 0.03445767983794212
only O 0 0.01862824708223343
mild O 1 0.7361242175102234
expression O 0 0.031401377171278
of O 0 0.027754919603466988
the O 1 0.9705631136894226
tumor B-Disease 1 1.0
phenotype O 1 0.9997028708457947
. O 0 0.05690683797001839

We O 0 0.02818961814045906
have O 0 0.013060817494988441
used O 0 0.017018526792526245
single O 0 0.03573353588581085
strand O 0 0.08874800056219101
conformation O 0 0.07031328976154327
polymorphism O 0 0.05272052064538002
analysis O 0 0.012055481784045696
to O 0 0.00949037354439497
study O 0 0.009723781608045101
the O 0 0.011755418963730335
27 O 0 0.021522749215364456
exons O 0 0.034118253737688065
of O 0 0.01610473170876503
the O 0 0.03256426379084587
RB1 O 1 0.9999996423721313
gene O 0 0.028613334521651268
in O 0 0.011446906253695488
individuals O 0 0.01010935753583908
from O 0 0.010760165750980377
a O 0 0.02018866315484047
family O 0 0.03727469965815544
showing O 0 0.0373225212097168
mild O 1 0.9959039092063904
expression O 0 0.033340778201818466
of O 0 0.02749853953719139
the O 1 0.8594196438789368
retinoblastoma B-Disease 1 1.0
phenotype O 1 0.999927282333374
. O 0 0.05547202378511429

In O 0 0.02714940346777439
this O 0 0.01853036880493164
family O 0 0.033938728272914886
affected O 0 0.02864101342856884
individuals O 0 0.019487911835312843
developed O 0 0.10303735733032227
unilateral B-Disease 1 0.9999978542327881
tumors I-Disease 1 1.0
and O 0 0.041263941675424576
, O 0 0.017622319981455803
as O 0 0.01258358545601368
a O 0 0.014117095619440079
result O 0 0.01247797254472971
of O 0 0.01787494495511055
linkage O 1 0.9249932169914246
analysis O 0 0.018320191651582718
, O 0 0.02027704380452633
unaffected O 1 0.9968133568763733
mutation O 0 0.09247639775276184
carriers O 0 0.03529971092939377
were O 0 0.011851214803755283
also O 0 0.012413878925144672
identified O 0 0.01584632135927677
within O 0 0.015112802386283875
the O 0 0.02965596877038479
pedigree O 0 0.24360515177249908
. O 0 0.043329693377017975

A O 0 0.06680214405059814
single O 0 0.05027579888701439
band O 0 0.058338556438684464
shift O 0 0.03766660764813423
using O 0 0.018780149519443512
SSCP O 1 0.9975234866142273
was O 0 0.028451213613152504
identified O 0 0.01892826333642006
in O 0 0.014224397018551826
exon O 0 0.07098156213760376
21 O 0 0.026008594781160355
which O 0 0.010938193649053574
resulted O 0 0.0184932854026556
in O 0 0.01159761380404234
a O 0 0.021144643425941467
missense O 0 0.06571321934461594
mutation O 0 0.0323982797563076
converting O 0 0.032197970896959305
a O 0 0.035913530737161636
cys O 1 0.9999997615814209
- O 1 0.9999995231628418
- O 1 0.9999977350234985
> O 1 0.998170018196106
arg O 1 0.9984229803085327
at O 0 0.02751021459698677
nucleotide O 0 0.03716684877872467
position O 0 0.02341812290251255
28 O 0 0.02165655419230461
in O 0 0.014124133624136448
the O 0 0.02901919186115265
exon O 0 0.2929776906967163
. O 0 0.0481061153113842

The O 0 0.06125538423657417
mutation O 0 0.07074376940727234
destroyed O 0 0.05713414400815964
an O 0 0.03809449076652527
NdeI O 1 0.999664306640625
restriction O 1 0.5564290285110474
enzyme O 0 0.14046096801757812
site O 0 0.056453876197338104
. O 0 0.03918533772230148

Analysis O 0 0.025318840518593788
of O 0 0.017138073220849037
all O 0 0.01402619294822216
family O 0 0.02238493785262108
members O 0 0.01616755686700344
demonstrated O 0 0.01684240810573101
that O 0 0.006757779512554407
the O 0 0.013056878000497818
missense O 0 0.09152654558420181
mutation O 0 0.05473029240965843
co O 1 0.997015118598938
- O 1 0.9999889135360718
segregated O 1 0.9985041618347168
with O 0 0.02657732553780079
patients O 1 0.9999873638153076
with O 1 0.9898735284805298
tumors B-Disease 1 1.0
or O 0 0.12465792894363403
who O 0 0.02968566119670868
, O 0 0.013263086788356304
as O 0 0.011372731067240238
a O 0 0.013939452357590199
result O 0 0.013318654149770737
of O 0 0.019175633788108826
linkage O 1 0.9732881188392639
analysis O 0 0.014956517145037651
had O 0 0.013820817694067955
been O 0 0.01153473649173975
predicted O 0 0.01816043071448803
to O 0 0.0140673303976655
carry O 0 0.02421877346932888
the O 0 0.03598065674304962
predisposing O 1 0.998964786529541
mutation O 0 0.14347222447395325
. O 0 0.04889676719903946

These O 0 0.024359488859772682
observations O 0 0.025657596066594124
point O 0 0.01793668605387211
to O 0 0.01205554511398077
another O 0 0.014941665343940258
region O 0 0.016483251005411148
of O 0 0.014892030507326126
the O 0 0.035698652267456055
RB1 O 1 0.9999996423721313
gene O 0 0.04090922325849533
where O 0 0.021823566406965256
mutations O 0 0.02136625535786152
only O 0 0.009554036892950535
modify O 0 0.02442496456205845
the O 0 0.014380516484379768
function O 0 0.014429952017962933
of O 0 0.013044273480772972
the O 0 0.019933011382818222
gene O 0 0.024560237303376198
and O 0 0.012894203886389732
raise O 0 0.01958492584526539
important O 0 0.01271940115839243
questions O 0 0.01648087054491043
for O 0 0.015361611731350422
genetic O 0 0.03267747163772583
counseling O 1 0.990903913974762
in O 0 0.015388190746307373
families O 0 0.019947029650211334
with O 0 0.015584781765937805
these O 0 0.015151639468967915
distinctive O 1 0.6836731433868408
phenotypes O 1 0.9187117218971252
. O 0 0.03337167948484421
. O 0 0.04067647084593773

Maternal B-Disease 1 0.9810983538627625
disomy I-Disease 1 0.9989816546440125
and O 1 0.6714001893997192
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9942804574966431
with O 0 0.11115435510873795
gamete O 1 0.9999951124191284
complementation O 1 0.9999985694885254
in O 0 0.019206250086426735
a O 0 0.019606636837124825
case O 0 0.022055424749851227
of O 0 0.026573317125439644
familial O 1 0.9999998807907104
translocation O 1 0.9999868869781494
( O 0 0.026515554636716843
3 O 0 0.02083427459001541
; O 0 0.013524944894015789
15 O 0 0.01841324009001255
) O 0 0.018933024257421494
( O 0 0.025303322821855545
p25 O 1 0.9975391626358032
; O 0 0.03230733796954155
q11 O 1 0.9941153526306152
. O 0 0.023621240630745888
2 O 0 0.03991870954632759
) O 0 0.02828151173889637
. O 0 0.033614106476306915

Maternal B-Disease 1 0.9999372959136963
uniparental I-Disease 1 0.9999991655349731
disomy I-Disease 1 0.9999985694885254
( I-Disease 1 0.9133208394050598
UPD I-Disease 1 1.0
) I-Disease 0 0.027863984927535057
for I-Disease 0 0.01974068023264408
chromosome I-Disease 0 0.039963968098163605
15 I-Disease 0 0.018917283043265343
is O 0 0.013036954216659069
responsible O 0 0.018755218014121056
for O 0 0.010347940027713776
an O 0 0.011689658276736736
estimated O 0 0.013094906695187092
30 O 0 0.01061155553907156
% O 0 0.007774748373776674
of O 0 0.0084881242364645
cases O 0 0.015905532985925674
of O 0 0.10992933064699173
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999992847442627
PWS B-Disease 1 1.0
) O 0 0.06867923587560654
. O 0 0.0462985634803772

We O 0 0.027146687731146812
report O 0 0.01981492154300213
on O 0 0.01245957612991333
an O 0 0.010638849809765816
unusual O 0 0.015779435634613037
case O 0 0.01814809814095497
of O 0 0.02170635759830475
maternal B-Disease 1 0.9999803304672241
disomy I-Disease 1 0.9999929666519165
15 I-Disease 0 0.03448019549250603
in O 0 0.030006635934114456
PWS B-Disease 1 1.0
that O 0 0.015035375021398067
is O 0 0.012531506828963757
most O 0 0.008982066996395588
consistent O 0 0.017788244411349297
with O 0 0.01348521001636982
adjacent O 0 0.040121957659721375
- O 1 0.989404559135437
1 O 0 0.02433352917432785
segregation O 0 0.043386060744524
of O 0 0.015003709122538567
a O 0 0.0269718449562788
paternal O 1 0.999966025352478
t O 1 0.9997956156730652
( O 0 0.020102152600884438
3 O 0 0.020339304581284523
; O 0 0.013579664751887321
15 O 0 0.018260745331645012
) O 0 0.018782557919621468
( O 0 0.026624735444784164
p25 O 1 0.9908181428909302
; O 0 0.027118271216750145
q11 O 1 0.9608949422836304
. O 0 0.016193320974707603
2 O 0 0.021211711689829826
) O 0 0.013301745988428593
with O 0 0.013449357822537422
simultaneous O 0 0.038717202842235565
maternal O 1 0.9989687204360962
meiotic O 1 0.9999909400939941
nondisjunction O 1 0.9999679327011108
for O 0 0.05049239844083786
chromosome O 0 0.09628427028656006
15 O 0 0.05063886567950249
. O 0 0.043642256408929825

The O 0 0.05943368375301361
patient O 1 0.9999725818634033
( O 0 0.28045451641082764
J O 1 0.9999997615814209
. O 0 0.027758799493312836
B O 1 0.9998986721038818
. O 0 0.013118677772581577
) O 0 0.00993689801543951
, O 0 0.00758016761392355
a O 0 0.011432918719947338
17 O 0 0.02164185792207718
- O 1 0.9632057547569275
year O 0 0.015166467987000942
- O 1 0.9888560175895691
old O 0 0.03855001926422119
white O 0 0.05175824463367462
male O 0 0.11101451516151428
with O 0 0.043900664895772934
PWS B-Disease 1 1.0
, O 0 0.028904248028993607
was O 0 0.02305259369313717
found O 0 0.009386642836034298
to O 0 0.008337190374732018
have O 0 0.0064298599027097225
47 O 0 0.020022382959723473
chromosomes O 0 0.018297353759407997
with O 0 0.011494682170450687
a O 0 0.02314835414290428
supernumerary O 1 0.9999219179153442
, O 0 0.028925690799951553
paternal O 1 0.9997794032096863
der O 1 0.9999150037765503
( O 0 0.021902872249484062
15 O 0 0.017949476838111877
) O 0 0.011863519437611103
consisting O 0 0.013109452091157436
of O 0 0.011203188449144363
the O 0 0.017682017758488655
short O 0 0.024473704397678375
arm O 1 0.6861003041267395
and O 0 0.017043529078364372
the O 0 0.027813812717795372
proximal O 1 0.9999974966049194
long O 0 0.24823254346847534
arm O 1 0.9974631071090698
of O 0 0.03138512745499611
chromosome O 0 0.15564334392547607
15 O 0 0.02634008601307869
, O 0 0.02207760512828827
and O 0 0.03011748380959034
distal O 1 0.9999980926513672
chromosome O 1 0.999413251876831
arm O 1 0.9995915293693542
3p O 1 0.9996035695075989
. O 0 0.06250854581594467

The O 0 0.06404433399438858
t O 1 0.988163411617279
( O 0 0.03064216859638691
3 O 0 0.02661489136517048
; O 0 0.016404416412115097
15 O 0 0.017779165878891945
) O 0 0.013253998011350632
was O 0 0.015108538791537285
present O 0 0.011501912027597427
in O 0 0.008354087360203266
the O 0 0.012467728927731514
balanced O 0 0.02041134610772133
state O 0 0.010119419544935226
in O 0 0.010321593843400478
the O 0 0.02343687228858471
patients O 1 0.9998273849487305
father O 1 0.9795758128166199
and O 0 0.02667669951915741
a O 0 0.04074082523584366
sister O 1 0.9766145348548889
. O 0 0.0477268360555172

Fluorescent O 1 0.7185081243515015
in O 0 0.04988698661327362
situ O 1 0.9852450489997864
hybridization O 0 0.05768146365880966
analysis O 0 0.01858816295862198
demonstrated O 0 0.021770009770989418
that O 0 0.011356429196894169
the O 0 0.0303257517516613
PWS B-Disease 1 0.9999998807907104
critical O 0 0.05388512462377548
region O 0 0.03341688960790634
resided O 0 0.04741727560758591
on O 0 0.015551486052572727
the O 0 0.021140551194548607
derivative O 1 0.7917352914810181
chromosome O 0 0.07632967829704285
3 O 0 0.01867830939590931
and O 0 0.010189433582127094
that O 0 0.006545674055814743
there O 0 0.0069199418649077415
was O 0 0.014777207747101784
no O 0 0.010576654225587845
deletion O 0 0.030016424134373665
of O 0 0.01780991069972515
the O 0 0.15523260831832886
PWS B-Disease 1 1.0
region O 0 0.03454102575778961
on O 0 0.016246499493718147
the O 0 0.01651865430176258
normal O 0 0.020787864923477173
pair O 0 0.022847892716526985
of O 0 0.02308015525341034
15s O 1 0.9998540878295898
present O 0 0.039048489183187485
in O 0 0.035358499735593796
J O 1 0.9999938011169434
. O 0 0.053562749177217484

B O 1 0.9967578053474426
. O 0 0.07875806838274002

Methylation O 0 0.09217506647109985
analysis O 0 0.023767957463860512
at O 0 0.026367807760834694
exon O 0 0.08085796982049942
alpha O 0 0.04590365290641785
of O 0 0.014941483736038208
the O 0 0.01635873317718506
small O 0 0.018325792625546455
nuclear O 0 0.04416292905807495
ribonucleoprotein O 1 0.9998927116394043
- O 1 0.9992300271987915
associated O 0 0.037242479622364044
polypeptide O 1 0.9957980513572693
N O 1 0.9684875011444092
( O 0 0.03738239035010338
SNRPN O 1 0.9999572038650513
) O 0 0.026576412841677666
gene O 0 0.02342008240520954
showed O 0 0.018332337960600853
a O 0 0.020100360736250877
pattern O 0 0.027795571833848953
characteristic O 0 0.023056501522660255
of O 0 0.012591622769832611
only O 0 0.011674828827381134
the O 0 0.023619750514626503
maternal O 1 0.9999548196792603
chromosome O 1 0.524297833442688
15 O 0 0.030224692076444626
in O 0 0.029520008713006973
J O 1 0.9999676942825317
. O 0 0.04956287518143654

B O 1 0.9733616709709167
. O 0 0.09540387988090515

Maternal B-Disease 1 0.9995235204696655
disomy I-Disease 1 0.9982191920280457
was O 0 0.0390143059194088
confirmed O 0 0.02934546023607254
by O 0 0.025364894419908524
polymerase O 1 0.9668877720832825
chain O 0 0.05313606560230255
reaction O 0 0.027692999690771103
analysis O 0 0.012469579465687275
of O 0 0.017162498086690903
microsatellite O 0 0.4660971760749817
repeats O 0 0.03289010375738144
at O 0 0.014353967271745205
the O 0 0.017259471118450165
gamma O 1 0.9910203814506531
- O 1 0.9999456405639648
aminobutyric O 1 0.9995660185813904
acid O 0 0.45963022112846375
receptor O 0 0.199543759226799
beta3 O 1 0.9942586421966553
subunit O 0 0.334486186504364
( O 0 0.05397199094295502
GABRB3 O 1 0.999903678894043
) O 0 0.05105148255825043
locus O 0 0.11765056848526001
. O 0 0.04791535809636116

A O 0 0.10370628535747528
niece O 1 0.9999626874923706
( O 0 0.062277909368276596
B O 1 0.9996581077575684
. O 0 0.02942707948386669
B O 1 0.9986542463302612
. O 0 0.015365234576165676
) O 0 0.012097444385290146
with O 0 0.00976569950580597
45 O 0 0.020183106884360313
chromosomes O 0 0.023127200081944466
and O 0 0.011263502761721611
the O 0 0.016892993822693825
derivative O 0 0.04435053467750549
3 O 0 0.016041502356529236
but O 0 0.008006647229194641
without O 0 0.009082166478037834
the O 0 0.01699238270521164
der O 1 0.9963850975036621
( O 0 0.020227625966072083
15 O 0 0.01849454827606678
) O 0 0.01581275649368763
demonstrated O 0 0.02291480451822281
a O 0 0.023944711312651634
phenotype O 0 0.18140336871147156
consistent O 0 0.02451671101152897
with O 0 0.012352942489087582
that O 0 0.008243760094046593
reported O 0 0.01479906402528286
for O 0 0.014465938322246075
haploinsufficiency O 1 0.9980053305625916
of O 0 0.040332768112421036
distal O 1 0.9999957084655762
3 O 0 0.1429223120212555
p O 1 0.6683834791183472
. O 0 0.045277491211891174

Uniparental B-Disease 1 0.9999983310699463
disomy I-Disease 1 0.9999399185180664
associated O 0 0.04259299486875534
with O 0 0.022717205807566643
unbalanced O 1 0.8694112300872803
segregation O 1 0.9331051707267761
of O 0 0.029127521440386772
non O 1 0.99974125623703
- O 1 0.9999998807907104
Robertsonian O 1 0.9999983310699463
translocations O 1 0.9779862761497498
has O 0 0.01705910451710224
been O 0 0.011840812861919403
reported O 0 0.01458889152854681
previously O 0 0.015922894701361656
but O 0 0.00945350993424654
has O 0 0.01031570229679346
not O 0 0.007552260998636484
, O 0 0.009232833981513977
to O 0 0.011431527324020863
our O 0 0.01602810248732567
knowledge O 0 0.018131794407963753
, O 0 0.01163488533347845
been O 0 0.010060181841254234
observed O 0 0.011777598410844803
in O 0 0.008615930564701557
a O 0 0.018917769193649292
case O 0 0.030425790697336197
of O 0 0.05174015462398529
PWS B-Disease 1 0.9999998807907104
. O 0 0.06577220559120178

Furthermore O 0 0.08095002174377441
, O 0 0.029199257493019104
our O 0 0.026326637715101242
findings O 0 0.020997829735279083
are O 0 0.008112912066280842
best O 0 0.016825465485453606
interpreted O 0 0.016508113592863083
as O 0 0.015889806672930717
true O 0 0.039973143488168716
gamete O 1 0.998928964138031
complementation O 1 0.9999837875366211
resulting O 0 0.05945156142115593
in O 0 0.04270376265048981
maternal B-Disease 1 0.9999918937683105
UPD I-Disease 1 0.9999998807907104
15 I-Disease 0 0.09549306333065033
and O 0 0.09606357663869858
PWS B-Disease 1 0.9999992847442627

Schwartz B-Disease 1 0.999322772026062
- I-Disease 1 0.9999997615814209
Jampel I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
type I-Disease 1 0.6639713644981384
2 I-Disease 0 0.031190814450383186
and O 0 0.02527236007153988
Stuve B-Disease 1 0.9999995231628418
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.03226212039589882
a O 0 0.024748070165514946
case O 0 0.028940867632627487
for O 0 0.022334717214107513
" O 0 0.045629289001226425
lumping O 1 0.9312349557876587
" O 0 0.0629182904958725
. O 0 0.04573681950569153

Recent O 0 0.04272497817873955
studies O 0 0.024592895060777664
demonstrated O 0 0.02425331249833107
the O 0 0.014485434629023075
existence O 0 0.018728457391262054
of O 0 0.012966137379407883
a O 0 0.02144077606499195
genetically O 0 0.02773360162973404
distinct O 0 0.017107054591178894
, O 0 0.014302288182079792
usually O 0 0.01269473321735859
lethal O 0 0.02427540346980095
form O 0 0.01123345922678709
of O 0 0.011230943724513054
the O 0 0.018534304574131966
Schwartz B-Disease 1 0.99988853931427
- I-Disease 1 0.9999998807907104
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.997798502445221
SJS B-Disease 1 1.0
) O 0 0.022212330251932144
of O 0 0.029662081971764565
myotonia B-Disease 1 1.0
and O 1 0.9993941783905029
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.03597639501094818
which O 0 0.015000890009105206
we O 0 0.015448743477463722
called O 1 0.6300559043884277
SJS B-Disease 1 1.0
type I-Disease 1 0.5172476768493652
2 I-Disease 0 0.05428590998053551
. O 0 0.038948021829128265

This O 0 0.05801236629486084
disorder O 1 0.9999964237213135
is O 0 0.028274167329072952
reminiscent O 0 0.07608161121606827
of O 0 0.021665962412953377
another O 0 0.02893349714577198
rare O 0 0.06943246722221375
condition O 1 0.5760062336921692
, O 0 0.012364588677883148
the O 0 0.01886555552482605
Stuve B-Disease 1 0.9999995231628418
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9990742206573486
SWS B-Disease 1 1.0
) O 0 0.02368946745991707
, O 0 0.01267819944769144
which O 0 0.009759357199072838
comprises O 0 0.02787581831216812
campomelia B-Disease 1 0.7980587482452393
at O 0 0.0221713799983263
birth O 1 0.7941089272499084
with O 1 0.6140774488449097
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.999902606010437
contractures B-Disease 1 1.0
, O 0 0.04087426885962486
and O 0 0.022785715758800507
early B-Disease 0 0.036874547600746155
death I-Disease 1 0.9113392233848572
. O 0 0.04604899883270264

To O 0 0.030891617760062218
test O 0 0.0259973406791687
for O 0 0.014655430801212788
possible O 0 0.02232869155704975
nosologic O 1 0.9914073348045349
identity O 0 0.03059491515159607
between O 0 0.022619478404521942
these O 0 0.021906888112425804
disorders O 1 0.9999997615814209
, O 0 0.022175602614879608
we O 0 0.012324457988142967
reviewed O 0 0.019513430073857307
the O 0 0.013835891149938107
literature O 0 0.013839678838849068
and O 0 0.00991794466972351
obtained O 0 0.010937363840639591
a O 0 0.014555823989212513
follow O 0 0.02294609136879444
- O 1 0.9925565123558044
up O 0 0.011894716881215572
of O 0 0.008903578855097294
the O 0 0.00907034520059824
only O 0 0.006365823093801737
two O 0 0.009206125512719154
surviving O 1 0.9726465940475464
patients O 1 0.9897745847702026
, O 0 0.01353734452277422
one O 0 0.013556841760873795
with O 0 0.04473470523953438
SJS B-Disease 1 1.0
type I-Disease 0 0.4295448958873749
2 I-Disease 0 0.0223498847335577
at O 0 0.015592778101563454
age O 0 0.016706231981515884
10 O 0 0.011196893639862537
years O 0 0.010441494174301624
and O 0 0.010008192621171474
another O 0 0.018232004716992378
with O 0 0.022745827212929726
SWS B-Disease 1 0.9999996423721313
at O 0 0.036367885768413544
age O 0 0.034099798649549484
7 O 0 0.037604786455631256
years O 0 0.0336698554456234
. O 0 0.03804131969809532

Patients O 1 0.9919529557228088
reported O 0 0.029249904677271843
as O 0 0.017791053280234337
having O 0 0.025002937763929367
either O 0 0.057471759617328644
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.39110270142555237
SWS B-Disease 1 0.9999909400939941
presented O 0 0.026465220376849174
a O 0 0.017998814582824707
combination O 0 0.020606746897101402
of O 0 0.01342370081692934
a O 0 0.025520017370581627
severe O 1 0.999962568283081
, O 1 0.8822516798973083
prenatal O 1 1.0
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9997596144676208
with O 1 0.999950647354126
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9999815225601196
feeding O 1 0.9999974966049194
difficulties O 1 0.9999197721481323
, O 0 0.050869591534137726
tendency O 1 0.9847646355628967
to O 0 0.16012530028820038
hyperthermia B-Disease 1 1.0
, O 0 0.0222699623554945
and O 0 0.015800422057509422
frequent O 0 0.044218823313713074
death O 1 0.9904652833938599
in O 0 0.019378531724214554
infancy O 1 0.9994902610778809
) O 0 0.013657753355801105
with O 0 0.009309889748692513
a O 0 0.016429325565695763
distinct O 0 0.025382574647665024
campomelic B-Disease 1 0.9999873638153076
- I-Disease 1 1.0
metaphyseal I-Disease 1 0.9999997615814209
skeletal I-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
. O 0 0.0829758271574974

The O 0 0.03696846589446068
similarity O 0 0.03198029100894928
of O 0 0.02041841670870781
the O 0 0.030460814014077187
clinical O 1 0.9998137354850769
and O 0 0.041856613010168076
radiographic O 1 0.9999977350234985
findings O 0 0.03667646646499634
is O 0 0.014358993619680405
so O 0 0.010109174065291882
extensive O 0 0.018170291557908058
that O 0 0.012870822101831436
these O 0 0.015684453770518303
disorders O 1 0.9999996423721313
appear O 0 0.022109128534793854
to O 0 0.016216591000556946
be O 0 0.011797805316746235
a O 0 0.021736497059464455
single O 0 0.03838559612631798
entity O 0 0.06887423992156982
. O 0 0.04054567962884903

The O 0 0.04041371867060661
follow O 0 0.04607535898685455
- O 1 0.9879952073097229
up O 0 0.02304071933031082
observation O 0 0.035478416830301285
of O 0 0.013206182979047298
an O 0 0.01118999533355236
identical O 0 0.013496712781488895
and O 0 0.009202724322676659
unique O 0 0.011720549315214157
pattern O 0 0.024572093039751053
of O 1 0.8488283157348633
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.024522565305233
the O 0 0.022789500653743744
two O 0 0.01591762714087963
patients O 1 0.9938902854919434
( O 0 0.01554361917078495
one O 0 0.014294780790805817
with O 0 0.0290055051445961
SJS B-Disease 1 1.0
type I-Disease 0 0.2500743269920349
2 I-Disease 0 0.020159320905804634
, O 0 0.010856391862034798
one O 0 0.010776817798614502
with O 0 0.01776304468512535
SWS B-Disease 1 0.9999986886978149
) O 0 0.023580292239785194
surviving O 0 0.07097359001636505
beyond O 0 0.038539301604032516
infancy O 1 0.8941189646720886
adds O 0 0.03563675656914711
to O 0 0.01254220400005579
the O 0 0.013482010923326015
evidence O 0 0.01289156824350357
in O 0 0.010403785854578018
favor O 0 0.02147787995636463
of O 0 0.024609005078673363
identity O 0 0.04888191819190979
. O 0 0.03987431898713112

The O 0 0.03801823407411575
hypothesis O 0 0.04678395390510559
that O 0 0.019983142614364624
SWS B-Disease 1 0.9999932050704956
and O 0 0.2291264683008194
SJS B-Disease 1 1.0
type I-Disease 0 0.18424977362155914
2 I-Disease 0 0.020418161526322365
are O 0 0.006804062984883785
the O 0 0.01638786680996418
same O 0 0.026670338585972786
disorder O 1 0.9999996423721313
should O 0 0.020834194496273994
be O 0 0.015848372131586075
testable O 0 0.05128028243780136
by O 0 0.024472687393426895
molecular O 0 0.036176685243844986
methods O 0 0.02440929040312767
. O 0 0.023048309609293938
. O 0 0.03203205764293671

A O 0 0.06926607340574265
mouse O 0 0.06291181594133377
model O 0 0.031151818111538887
of O 0 0.030835270881652832
severe O 1 0.9999982118606567
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999909400939941
defects O 1 0.9999998807907104
in O 1 0.9673891663551331
hemostasis O 1 1.0
and O 1 0.999897837638855
thrombosis B-Disease 1 1.0
. O 0 0.3350072205066681

von B-Disease 1 0.9985774755477905
Willebrand I-Disease 1 0.9999997615814209
factor I-Disease 1 0.9952108263969421
( I-Disease 0 0.3169119954109192
vWf I-Disease 1 0.9999935626983643
) I-Disease 1 0.9974220991134644
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9940536618232727
humans O 0 0.13593626022338867
. O 0 0.04774916172027588

We O 0 0.02585999108850956
generated O 0 0.021820809692144394
a O 0 0.025223063305020332
mouse O 0 0.045875877141952515
model O 0 0.025344036519527435
for O 0 0.015468882396817207
this O 0 0.018519327044487
disease O 1 0.9998831748962402
by O 0 0.022916650399565697
using O 0 0.023776499554514885
gene O 0 0.042798612266778946
targeting O 0 0.050676196813583374
. O 0 0.03645819053053856

vWf B-Disease 1 0.9999760389328003
- I-Disease 1 0.9999995231628418
deficient I-Disease 1 0.9999946355819702
mice O 0 0.06730246543884277
appeared O 0 0.03164730221033096
normal O 0 0.02687211148440838
at O 0 0.026250289753079414
birth O 1 0.5943397879600525
; O 0 0.014530081301927567
they O 0 0.007991336286067963
were O 0 0.012271570973098278
viable O 0 0.043335940688848495
and O 0 0.029749836772680283
fertile O 1 0.8296087384223938
. O 0 0.04803970456123352

Neither O 0 0.12566658854484558
vWf O 1 0.9794418811798096
nor O 0 0.09985332190990448
vWf O 1 0.9890326261520386
propolypeptide O 1 0.9759953618049622
( O 0 0.061060525476932526
von B-Disease 1 0.9994035959243774
Willebrand I-Disease 1 1.0
antigen O 1 1.0
II O 1 0.9999995231628418
) O 0 0.02166101522743702
were O 0 0.011715822853147984
detectable O 0 0.04268309473991394
in O 0 0.016568709164857864
plasma O 1 0.9719754457473755
, O 0 0.03301870450377464
platelets O 1 0.9999986886978149
, O 0 0.03977572172880173
or O 0 0.038275450468063354
endothelial O 1 0.9999790191650391
cells O 0 0.030522478744387627
of O 0 0.020006045699119568
the O 0 0.03579771891236305
homozygous O 0 0.458566814661026
mutant O 1 0.9633678197860718
mice O 0 0.10460083186626434
. O 0 0.053979769349098206

The O 0 0.06450137495994568
mutant O 1 0.9979185461997986
mice O 1 0.9735097289085388
exhibited O 1 0.9878247976303101
defects O 1 0.9999328851699829
in O 0 0.030361175537109375
hemostasis O 1 0.999997615814209
with O 0 0.023038849234580994
a O 0 0.040166039019823074
highly O 1 0.9981839060783386
prolonged O 1 0.9999998807907104
bleeding O 1 1.0
time O 0 0.24253620207309723
and O 1 0.7138382196426392
spontaneous O 1 0.9999969005584717
bleeding O 1 1.0
events O 0 0.01982853002846241
in O 0 0.012564149685204029
approximately O 0 0.014550436288118362
10 O 0 0.017606088891625404
% O 0 0.02139701135456562
of O 0 0.03439558297395706
neonates O 1 0.9990745782852173
. O 0 0.054195601493120193

As O 0 0.026645272970199585
in O 0 0.01415415108203888
the O 0 0.023586319759488106
human O 1 0.8724179863929749
disease O 1 0.9999979734420776
, O 0 0.019648920744657516
the O 0 0.026129530742764473
factor O 1 0.9962387084960938
VIII O 1 0.9999998807907104
level O 0 0.031353652477264404
in O 0 0.012433899566531181
these O 0 0.009902792982757092
mice O 0 0.02851955220103264
was O 0 0.018885919824242592
reduced O 0 0.018065879121422768
strongly O 0 0.015470379032194614
as O 0 0.011028876528143883
a O 0 0.012922929599881172
result O 0 0.010942904278635979
of O 0 0.01218455657362938
the O 0 0.016570815816521645
lack O 0 0.024638807401061058
of O 0 0.024845870211720467
protection O 1 0.982386589050293
provided O 0 0.03896551579236984
by O 0 0.04125544801354408
vWf O 1 0.9989751577377319
. O 0 0.053657710552215576

Defective O 1 0.9999862909317017
thrombosis B-Disease 1 0.9999998807907104
in O 0 0.06654509902000427
mutant O 1 0.99998939037323
mice O 1 0.9852607846260071
was O 0 0.033332597464323044
also O 0 0.014124359004199505
evident O 0 0.022765446454286575
in O 0 0.009677526541054249
an O 0 0.011166642419993877
in O 0 0.01355381403118372
vivo O 1 0.7096163034439087
model O 0 0.038206737488508224
of O 1 0.7993606328964233
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999998807907104
. O 0 0.44804930686950684

In O 0 0.027374494820833206
this O 0 0.01613444648683071
model O 0 0.025422440841794014
, O 0 0.014995366334915161
the O 0 0.024548010900616646
exteriorized O 1 0.9996637105941772
mesentery O 1 0.9998370409011841
was O 0 0.07734109461307526
superfused O 1 0.9997251629829407
with O 0 0.05454542115330696
ferric O 1 0.9999998807907104
chloride O 1 0.999711811542511
and O 0 0.020489349961280823
the O 0 0.025203315541148186
accumulation O 1 0.7891099452972412
of O 0 0.04078930616378784
fluorescently O 1 0.9999979734420776
labeled O 1 0.9998822212219238
platelets O 1 0.9999802112579346
was O 0 0.04665139690041542
observed O 0 0.03502842038869858
by O 0 0.03343348950147629
intravital O 1 0.9885155558586121
microscopy O 0 0.10655159503221512
. O 0 0.05062283203005791

We O 0 0.032405976206064224
conclude O 0 0.04358314350247383
that O 0 0.01406689453870058
these O 0 0.011923164129257202
mice O 0 0.02921639196574688
very O 0 0.014938677661120892
closely O 0 0.027173731476068497
mimic O 1 0.995984673500061
severe O 1 0.9999860525131226
human O 1 0.9999508857727051
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9988815188407898
will O 0 0.028447238728404045
be O 0 0.010158076882362366
very O 0 0.010406339541077614
useful O 0 0.011058968491852283
for O 0 0.008398184552788734
investigating O 0 0.01831822842359543
the O 0 0.01315055787563324
role O 0 0.024303648620843887
of O 0 0.02456122636795044
vWf O 1 0.9997476935386658
in O 0 0.018631452694535255
normal O 0 0.0577591247856617
physiology O 1 0.9954786896705627
and O 0 0.027468407526612282
in O 0 0.34750649333000183
disease O 1 1.0
models O 0 0.050209272652864456
. O 0 0.02540571615099907
. O 0 0.03596367686986923

Oral O 1 0.9917261600494385
contraceptives O 1 0.9978907704353333
and O 0 0.02368980459868908
the O 0 0.026920080184936523
risk O 1 0.9701042771339417
of O 1 0.9996182918548584
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9996387958526611

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999998807907104
Study O 1 0.9734199643135071
Group O 1 0.8971938490867615
. O 0 0.04470069333910942

BACKGROUND O 0 0.08144064992666245
Women O 0 0.03798847645521164
with O 0 0.020363377407193184
mutations O 0 0.02557171881198883
in O 0 0.010513200424611568
either O 0 0.013546413742005825
the O 0 0.021796440705657005
BRCA1 O 1 0.9999305009841919
or O 0 0.018005818128585815
the O 0 0.02906196378171444
BRCA2 O 1 0.9999921321868896
gene O 0 0.021239178255200386
have O 0 0.006275347899645567
a O 0 0.013532454147934914
high O 0 0.03118531033396721
lifetime O 1 0.8947901129722595
risk O 1 0.9998432397842407
of O 1 0.9999839067459106
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9948110580444336

Oral O 1 0.8872990012168884
contraceptives O 1 0.9994698166847229
protect O 1 0.9909652471542358
against O 1 0.999998927116394
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.8990891575813293
general O 1 0.9922347068786621
, O 0 0.016390280798077583
but O 0 0.008577246218919754
it O 0 0.006442609243094921
is O 0 0.007954728789627552
not O 0 0.006566743832081556
known O 0 0.012526269070804119
whether O 0 0.008662822656333447
they O 0 0.005476556718349457
also O 0 0.007638384122401476
protect O 0 0.020761169493198395
against O 0 0.026285914704203606
hereditary B-Disease 1 0.9999983310699463
forms I-Disease 1 0.9942541718482971
of I-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9724038243293762

METHODS O 0 0.044585052877664566
We O 0 0.01780170574784279
enrolled O 0 0.04185786470770836
207 O 0 0.06984128057956696
women O 0 0.02937992475926876
with O 0 0.36920166015625
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9975250363349915
161 O 1 0.9938402771949768
of O 0 0.021061228588223457
their O 0 0.015441251918673515
sisters O 1 0.9781835675239563
as O 0 0.015520570799708366
controls O 0 0.02071119099855423
in O 0 0.009762085974216461
a O 0 0.018226303160190582
case O 0 0.07584080100059509
- O 1 0.9999618530273438
control O 0 0.04368005320429802
study O 0 0.029757201671600342
. O 0 0.03155976161360741

All O 0 0.030205335468053818
the O 0 0.03294728696346283
patients O 1 0.5167405605316162
carried O 0 0.026461634784936905
a O 0 0.029061410576105118
pathogenic O 1 0.6923003196716309
mutation O 0 0.035923149436712265
in O 0 0.013797012157738209
either O 0 0.024677641689777374
BRCA1 O 1 0.9997100234031677
( O 0 0.024935325607657433
179 O 0 0.08702396601438522
women O 0 0.03412781283259392
) O 0 0.02633991464972496
or O 0 0.030027398839592934
BRCA2 O 1 0.9998440742492676
( O 0 0.03300507366657257
28 O 0 0.04518217220902443
women O 0 0.04744568467140198
) O 0 0.03629268333315849
. O 0 0.03540331497788429

The O 0 0.05286843702197075
control O 0 0.04909664765000343
women O 0 0.03187761455774307
were O 0 0.014766638167202473
enrolled O 0 0.046882133930921555
regardless O 0 0.024393249303102493
of O 0 0.018672429025173187
whether O 0 0.020759018138051033
or O 0 0.014870744198560715
not O 0 0.009640580043196678
they O 0 0.009107314050197601
had O 0 0.018518133088946342
either O 0 0.02683369442820549
mutation O 0 0.062156133353710175
. O 0 0.037715449929237366

Lifetime O 0 0.08700920641422272
histories O 0 0.069841168820858
of O 0 0.040302518755197525
oral O 1 0.9999575614929199
- O 1 0.9999998807907104
contraceptive O 1 0.9999980926513672
use O 0 0.015789354220032692
were O 0 0.008853993378579617
obtained O 0 0.011815630830824375
by O 0 0.011898579075932503
interview O 0 0.021931134164333344
or O 0 0.009645028039813042
by O 0 0.010083992965519428
written O 0 0.015403610654175282
questionnaire O 0 0.03131087124347687
and O 0 0.01039474830031395
were O 0 0.008602497167885303
compared O 0 0.015452202409505844
between O 0 0.022188406437635422
patients O 1 0.9994284510612488
and O 0 0.019266441464424133
control O 0 0.4208543598651886
women O 0 0.314487099647522
, O 0 0.01779819279909134
after O 0 0.026650918647646904
adjustment O 0 0.12409184128046036
for O 0 0.012183723971247673
year O 0 0.01434627827256918
of O 0 0.021681953221559525
birth O 1 0.9418613314628601
and O 0 0.030809935182332993
parity O 1 0.8809387683868408
. O 0 0.042567178606987

RESULTS O 0 0.030946116894483566
The O 0 0.022189758718013763
adjusted O 0 0.034360215067863464
odds O 0 0.04989936575293541
ratio O 0 0.18125855922698975
for O 1 0.9965718984603882
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 1 0.5757631659507751
with O 0 0.017562059685587883
any O 0 0.014474615454673767
past O 0 0.018798399716615677
use O 0 0.01278587244451046
of O 0 0.021310575306415558
oral O 1 0.9989768266677856
contraceptives O 1 0.9999881982803345
was O 0 0.09954684227705002
0 O 0 0.07093436270952225
. O 0 0.040720321238040924

5 O 0 0.055223140865564346
( O 0 0.0328080840408802
95 O 0 0.03763307258486748
percent O 0 0.025449644774198532
confidence O 0 0.043478939682245255
interval O 0 0.046456024050712585
, O 0 0.018948310986161232
0 O 0 0.027279462665319443
. O 0 0.010963928885757923
3 O 0 0.01507519744336605
to O 0 0.015626462176442146
0 O 0 0.03386152163147926
. O 0 0.01749071665108204
8 O 0 0.03440205752849579
) O 0 0.027012433856725693
. O 0 0.03147096186876297

The O 0 0.06763333082199097
risk O 0 0.43251773715019226
decreased O 0 0.049038179218769073
with O 0 0.01756954938173294
increasing O 0 0.024534286931157112
duration O 0 0.03558633103966713
of O 0 0.018694886937737465
use O 0 0.017153659835457802
( O 0 0.022479800507426262
P O 0 0.18245087563991547
for O 0 0.015371755696833134
trend O 0 0.03194062039256096
, O 0 0.022579606622457504
< O 1 0.6618713736534119
0 O 0 0.03811190649867058
. O 0 0.021242791786789894
001 O 1 0.9950839877128601
) O 0 0.02015797235071659
; O 0 0.011223607696592808
use O 0 0.008084253408014774
for O 0 0.008114186115562916
six O 0 0.011769154109060764
or O 0 0.009435402229428291
more O 0 0.006404543295502663
years O 0 0.011718545109033585
was O 0 0.017729662358760834
associated O 0 0.011694476008415222
with O 0 0.009196843951940536
a O 0 0.016016464680433273
60 O 0 0.022783221676945686
percent O 0 0.025337036699056625
reduction O 0 0.04803729057312012
in O 0 0.025209596380591393
risk O 0 0.08046894520521164
. O 0 0.042664919048547745

Oral O 1 0.9957951307296753
- O 1 0.9999815225601196
contraceptive O 1 0.9999510049819946
use O 0 0.022237882018089294
protected O 1 0.6487586498260498
against O 1 0.9999970197677612
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.022738737985491753
for O 0 0.016184207051992416
carriers O 0 0.026924973353743553
of O 0 0.014872393570840359
the O 0 0.032304033637046814
BRCA1 O 1 0.9999982118606567
mutation O 1 0.509248673915863
( O 0 0.02379729598760605
odds O 0 0.046106431633234024
ratio O 0 0.036909982562065125
, O 0 0.01640843227505684
0 O 0 0.026409275829792023
. O 0 0.0107733104377985
5 O 0 0.016400447115302086
; O 0 0.011781172826886177
95 O 0 0.020558906719088554
percent O 0 0.01737968623638153
confidence O 0 0.039210155606269836
interval O 0 0.04564879462122917
, O 0 0.017757363617420197
0 O 0 0.024880049750208855
. O 0 0.009863021783530712
3 O 0 0.013470183126628399
to O 0 0.012233343906700611
0 O 0 0.02631540596485138
. O 0 0.012651344761252403
9 O 0 0.02126903459429741
) O 0 0.012054704129695892
and O 0 0.008961571380496025
for O 0 0.010010422207415104
carriers O 0 0.024953996762633324
of O 0 0.01689148135483265
the O 0 0.03498571366071701
BRCA2 O 1 0.9999921321868896
mutation O 1 0.6902945041656494
( O 0 0.02530280128121376
odds O 0 0.05208347365260124
ratio O 0 0.03651076555252075
, O 0 0.017022721469402313
0 O 0 0.026411039754748344
. O 0 0.010651339776813984
4 O 0 0.01814088597893715
; O 0 0.011385622434318066
95 O 0 0.019758783280849457
percent O 0 0.017682531848549843
confidence O 0 0.03595535457134247
interval O 0 0.04102833941578865
, O 0 0.016437826678156853
0 O 0 0.02352975681424141
. O 0 0.00990290753543377
2 O 0 0.015459379181265831
to O 0 0.012125139124691486
1 O 0 0.023399529978632927
. O 0 0.015141617506742477
1 O 0 0.029948744922876358
) O 0 0.02564641274511814
. O 0 0.031182382255792618

CONCLUSIONS O 0 0.09012782573699951
Oral O 1 0.9994460940361023
- O 1 0.9999978542327881
contraceptive O 1 0.9999957084655762
use O 0 0.020980218425393105
may O 0 0.01391879003494978
reduce O 0 0.017928902059793472
the O 0 0.016665682196617126
risk O 1 0.8995270729064941
of O 1 0.9999797344207764
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.2389397919178009
women O 0 0.12352226674556732
with O 0 0.022041091695427895
pathogenic O 1 0.9961507320404053
mutations O 0 0.026317594572901726
in O 0 0.014955723658204079
the O 0 0.039729826152324677
BRCA1 O 1 0.9999959468841553
or O 0 0.10606040805578232
BRCA2 O 1 0.9998757839202881
gene O 0 0.10304833948612213

A O 0 0.05781041458249092
Japanese O 0 0.060177285224199295
family O 0 0.04639897495508194
with O 0 0.031974922865629196
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.02423548325896263
a O 0 0.030031519010663033
codon O 0 0.0849909633398056
291 O 0 0.2404232621192932
deletion O 0 0.10613225400447845
: O 0 0.022697629407048225
a O 0 0.025701195001602173
clinical O 1 0.9825239777565002
, O 0 0.03168504685163498
biochemical O 1 0.9473602771759033
, O 0 0.03410344198346138
pathological O 1 0.9999489784240723
, O 0 0.03309527039527893
and O 0 0.026065822690725327
genetic O 0 0.03969922289252281
report O 0 0.030150791630148888
. O 0 0.03680496662855148

We O 0 0.022234875708818436
report O 0 0.01643458753824234
a O 0 0.015571054071187973
Japanese O 0 0.028928810730576515
family O 0 0.03133874014019966
with O 0 0.05520465970039368
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999948740005493
ALD B-Disease 1 1.0
) O 0 0.0233741607517004
with O 0 0.011296633630990982
a O 0 0.013881201855838299
three O 0 0.011195932514965534
base O 0 0.02759687416255474
pair O 0 0.030547630041837692
deletion O 0 0.06687688827514648
( O 0 0.031061219051480293
delGAG O 1 0.9984878301620483
291 O 0 0.1064951941370964
) O 0 0.018935194239020348
in O 0 0.017561888322234154
the O 0 0.05002560093998909
ALD B-Disease 1 1.0
gene O 0 0.1508507877588272
. O 0 0.048764172941446304

A O 0 0.05599450320005417
variety O 0 0.028672436252236366
of O 0 0.030390137806534767
phenotypes O 1 0.6122002005577087
were O 0 0.016261382028460503
observed O 0 0.02025783061981201
within O 0 0.016732435673475266
this O 0 0.018114285543560982
family O 0 0.04478028044104576
. O 0 0.041553083807229996

While O 0 0.03172638639807701
the O 0 0.03802385926246643
proband O 1 0.9999454021453857
( O 0 0.04494648799300194
patient O 1 0.9992972612380981
1 O 0 0.032142557203769684
) O 0 0.016238702461123466
was O 0 0.01765827275812626
classified O 0 0.020007556304335594
as O 0 0.010651660151779652
having O 0 0.012534447014331818
a O 0 0.01606576144695282
rare O 0 0.027782341465353966
intermediate O 1 0.813893735408783
type O 0 0.02957574650645256
of O 0 0.020484991371631622
adult O 1 0.9794912338256836
cerebral O 1 0.9999971389770508
and O 1 0.6982583999633789
cerebello O 1 1.0
- O 1 1.0
brain O 1 0.9999978542327881
stem O 1 0.7503069043159485
forms O 0 0.017241960391402245
, O 0 0.013537712395191193
his O 0 0.024362333118915558
younger O 1 0.9921625256538391
brother O 1 0.9995710253715515
( O 0 0.030957162380218506
patient O 1 0.9968134760856628
2 O 0 0.027154460549354553
) O 0 0.015259480103850365
and O 0 0.01632799208164215
nephew O 1 0.9999933242797852
( O 0 0.04785064235329628
patient O 1 0.9997761845588684
3 O 0 0.026533382013440132
) O 0 0.01490240078419447
had O 0 0.017859406769275665
a O 0 0.04507368430495262
childhood O 1 0.9999992847442627
ALD B-Disease 1 1.0
type O 1 0.9998352527618408
. O 0 0.06143129989504814

Another O 0 0.08076279610395432
nephew O 1 0.9999619722366333
( O 0 0.04795059189200401
patient O 1 0.9975025057792664
4 O 0 0.02764473669230938
) O 0 0.015006780624389648
of O 0 0.01668025180697441
patient O 1 0.9997767806053162
1 O 0 0.030591368675231934
was O 0 0.02410322055220604
classified O 0 0.022341886535286903
as O 0 0.01429559476673603
having O 0 0.019521726295351982
an O 0 0.026029985398054123
adolescent O 1 0.9999929666519165
form O 0 0.11138522624969482
. O 0 0.05046314746141434

The O 0 0.04994970187544823
tau O 1 0.9375412464141846
level O 0 0.028998171910643578
in O 0 0.016305161640048027
the O 0 0.03603469952940941
cerebrospinal O 1 0.9999996423721313
fluid O 1 0.9999001026153564
( O 0 0.24325338006019592
CSF O 1 0.9999979734420776
) O 0 0.02114386484026909
in O 0 0.01454143412411213
patient O 1 0.9897049069404602
1 O 0 0.022556796669960022
was O 0 0.01836712844669819
as O 0 0.012041894719004631
high O 0 0.01576663739979267
as O 0 0.008710717782378197
that O 0 0.006364405620843172
of O 0 0.016470637172460556
patients O 1 0.9999725818634033
with O 1 0.9999656677246094
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9995126724243164
AD B-Disease 1 0.9996140599250793
) O 0 0.03595214709639549
. O 0 0.035632312297821045

His O 0 0.23638483881950378
brain O 1 0.9961671233177185
magnetic O 0 0.08770336210727692
resonance O 1 0.6383470296859741
image O 1 0.9170417189598083
( O 0 0.04092675819993019
MRI O 1 0.9993159770965576
) O 0 0.022429000586271286
showed O 0 0.02647743560373783
abnormalities B-Disease 1 0.9575371742248535
in I-Disease 0 0.012340550310909748
the I-Disease 0 0.02150583267211914
bilateral I-Disease 1 0.998002827167511
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9999903440475464
and O 1 0.9973546266555786
brain O 1 0.9999994039535522
stem O 1 0.9987528324127197
, O 0 0.015022358857095242
but O 0 0.0083258505910635
not O 0 0.006130437832325697
in O 0 0.008270639926195145
the O 0 0.024579493328928947
cerebral O 1 0.9999997615814209
white O 1 0.998150110244751
matter O 0 0.0197058767080307
, O 0 0.011990324594080448
where O 0 0.010693555697798729
marked O 0 0.019631844013929367
reductions O 0 0.02268303371965885
of O 0 0.016593730077147484
the O 1 0.7888220548629761
cerebral O 1 1.0
blood O 1 0.9999994039535522
flow O 1 0.969302773475647
and O 0 0.13864894211292267
oxygen O 1 0.9997033476829529
metabolism O 0 0.4365798234939575
were O 0 0.011909796856343746
clearly O 0 0.018949277698993683
demonstrated O 0 0.02402484603226185
by O 0 0.021335434168577194
positron O 1 0.9978121519088745
emission O 1 0.6403305530548096
tomography O 1 0.9825750589370728
( O 0 0.058965086936950684
PET O 1 0.9960376024246216
) O 0 0.04064253717660904
. O 0 0.03982376307249069

In O 0 0.04973642900586128
patients O 1 0.9800470471382141
2 O 0 0.036447033286094666
and O 0 0.02139558270573616
3 O 0 0.023116230964660645
, O 0 0.014156532473862171
the O 0 0.017237728461623192
autopsy O 0 0.14819204807281494
findings O 0 0.02138284035027027
showed O 0 0.02492779865860939
massive O 1 0.9897631406784058
demyelination B-Disease 1 1.0
of I-Disease 0 0.46061310172080994
the I-Disease 1 0.9979705214500427
cerebral I-Disease 1 1.0
white I-Disease 1 0.9858615398406982
matter I-Disease 0 0.020414510741829872
with O 0 0.011995555832982063
sparing O 0 0.04737699776887894
of O 0 0.016231263056397438
the O 0 0.03669142350554466
U O 1 0.9999997615814209
- O 1 0.9999998807907104
fibers O 1 0.9859384894371033
, O 0 0.01743197999894619
compatible O 0 0.028746167197823524
with O 0 0.01135967392474413
the O 0 0.01637553609907627
findings O 0 0.025265762582421303
of O 0 0.04197810962796211
childhood O 1 0.9999996423721313
ALD B-Disease 1 1.0
. O 0 0.1967286616563797

Oleic O 1 0.9975361824035645
and O 0 0.070757195353508
erucic O 1 0.9999918937683105
acids O 0 0.08955969661474228
( O 0 0.04529622942209244
Lorenzos O 1 0.997989296913147
Oil O 0 0.0349898599088192
) O 0 0.013472647406160831
were O 0 0.009658437222242355
administered O 0 0.035687778145074844
to O 0 0.02071785181760788
patients O 1 0.9967764019966125
1 O 0 0.02999240718781948
and O 0 0.017268622294068336
4 O 0 0.023836785927414894
, O 0 0.014609022997319698
but O 0 0.012459194287657738
sufficient O 0 0.026608208194375038
effectiveness O 0 0.0435648113489151
was O 0 0.028126126155257225
not O 0 0.01696769893169403
obtained O 0 0.025579815730452538
. O 0 0.0322791151702404

The O 0 0.03714550659060478
findings O 0 0.024321964010596275
in O 0 0.012400789186358452
this O 0 0.011532030068337917
family O 0 0.023260723799467087
suggest O 0 0.016390956938266754
that O 0 0.011227778159081936
delGAG291 O 1 0.9782156348228455
is O 0 0.01437894906848669
part O 0 0.015346956439316273
of O 0 0.013306842185556889
the O 0 0.019853075966238976
cause O 0 0.155184805393219
of O 0 0.03240140900015831
Japanese O 1 0.999711811542511
ALD B-Disease 1 1.0
with O 0 0.05104920268058777
phenotypic O 0 0.16560958325862885
variations O 0 0.05365562066435814
. O 0 0.043898437172174454

Moreover O 0 0.06273680180311203
, O 0 0.019716493785381317
although O 0 0.012421047315001488
the O 0 0.01290311012417078
scale O 0 0.01789940521121025
of O 0 0.01305306889116764
the O 0 0.016625462099909782
study O 0 0.016026683151721954
is O 0 0.012411737814545631
limited O 0 0.014161377213895321
, O 0 0.011052660644054413
there O 0 0.007508000824600458
is O 0 0.009448464959859848
a O 0 0.013289673253893852
possibility O 0 0.020350947976112366
that O 0 0.01463023480027914
PET O 1 0.9885940551757812
can O 0 0.014313754625618458
detect O 0 0.036884430795907974
an O 0 0.026745447888970375
insidious B-Disease 1 0.9999990463256836
lesion I-Disease 1 0.9999994039535522
which O 0 0.01822269894182682
is O 0 0.01729981228709221
undetectable O 1 0.7500319480895996
by O 0 0.01770985871553421
computed O 0 0.04332887753844261
tomogram O 1 0.9999750852584839
( O 0 0.08242858946323395
CT O 1 0.999997615814209
) O 0 0.025455964729189873
or O 0 0.020266475155949593
MRI O 1 0.9735684990882874
analysis O 0 0.014813982881605625
, O 0 0.011667600832879543
and O 0 0.008385805413126945
that O 0 0.005934286396950483
the O 0 0.009342243894934654
higher O 0 0.011319173499941826
level O 0 0.01437100488692522
of O 0 0.018895331770181656
tau O 1 0.9975034594535828
reflects O 0 0.030058659613132477
the O 0 0.0164202731102705
process O 0 0.019036727026104927
of O 0 0.03484595566987991
neuronal B-Disease 1 0.9999768733978271
degeneration I-Disease 1 1.0
in O 1 0.984580934047699
ALD B-Disease 1 1.0
. O 0 0.09032998234033585

Lorenzos O 1 0.9996858835220337
Oil O 0 0.0609004944562912
should O 0 0.02001006528735161
be O 0 0.010422986000776291
given O 0 0.011646679602563381
in O 0 0.009867408312857151
the O 0 0.01778952032327652
early O 0 0.029179541394114494
stage O 0 0.1852782964706421
. O 0 0.02764638513326645
. O 0 0.03382929414510727

Nonsense O 0 0.2524259090423584
mutation O 0 0.05884987860918045
in O 0 0.021013962104916573
exon O 0 0.078863225877285
4 O 0 0.023636655882000923
of O 0 0.017252242192626
human O 0 0.02899318002164364
complement O 1 0.9888322353363037
C9 O 1 0.9999998807907104
gene O 0 0.040499087423086166
is O 0 0.014706790447235107
the O 0 0.016897737979888916
major O 0 0.026680804789066315
cause O 0 0.04519803449511528
of O 0 0.02796449325978756
Japanese O 1 0.993240475654602
complement B-Disease 1 0.9999901056289673
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.11545385420322418

Deficiency B-Disease 1 0.9999996423721313
of I-Disease 0 0.03398497402667999
the I-Disease 0 0.03462572395801544
ninth I-Disease 1 0.9993457198143005
component I-Disease 1 0.5154244303703308
of I-Disease 0 0.021044347435235977
human I-Disease 0 0.055007342249155045
complement I-Disease 1 0.9942945837974548
( O 0 0.17058387398719788
C9 O 1 0.9999997615814209
) O 0 0.017445499077439308
is O 0 0.00937574077397585
the O 0 0.010333007201552391
most O 0 0.012500537559390068
common O 1 0.6739286780357361
complement B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
in O 0 0.04860173538327217
Japan O 0 0.25504404306411743
but O 0 0.016068067401647568
is O 0 0.015409976243972778
rare O 0 0.021524297073483467
in O 0 0.014083356596529484
other O 0 0.01387421227991581
countries O 0 0.018817143514752388
. O 0 0.03353925049304962

We O 0 0.02833862043917179
studied O 0 0.02349778451025486
the O 0 0.01890294812619686
molecular O 0 0.020304124802350998
basis O 0 0.016220904886722565
of O 0 0.042025648057460785
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.019263217225670815
four O 0 0.019778631627559662
Japanese O 1 0.8875777125358582
C9 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999998807907104
patients O 1 0.9998997449874878
who O 0 0.04006139561533928
had O 0 0.0660693570971489
suffered O 1 0.999998927116394
from O 1 0.9998550415039062
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9653392434120178

Direct O 0 0.05701780319213867
sequencing O 0 0.048108965158462524
of O 0 0.03637251257896423
amplified O 1 0.6612646579742432
C9 O 1 0.9999730587005615
cDNA O 0 0.10880130529403687
and O 0 0.024527525529265404
DNA O 0 0.027214040979743004
revealed O 0 0.02292006090283394
a O 0 0.0221160426735878
nonsense O 0 0.06297086179256439
substitution O 0 0.046665728092193604
( O 0 0.024554841220378876
CGA O 1 0.502045214176178
- O 1 0.9999692440032959
- O 1 0.9999867677688599
> O 1 0.9968640804290771
TGA O 1 0.999541163444519
) O 0 0.02160629816353321
at O 0 0.020563578233122826
codon O 0 0.04732610285282135
95 O 0 0.025014912709593773
in O 0 0.013478143140673637
exon O 0 0.05750705674290657
4 O 0 0.01862255111336708
in O 0 0.009137446992099285
the O 0 0.016567692160606384
four O 0 0.03659169748425484
C9 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
deficient I-Disease 1 0.9998401403427124
individuals O 0 0.042326249182224274
. O 0 0.04401291161775589

An O 0 0.044344186782836914
allele O 0 0.2903270721435547
- O 1 0.999143123626709
specific O 0 0.02583077736198902
polymerase O 1 0.9262522459030151
chain O 0 0.21538546681404114
reaction O 0 0.05019333213567734
system O 0 0.02881167083978653
designed O 0 0.03095998615026474
to O 0 0.01673593558371067
detect O 0 0.031992070376873016
exclusively O 0 0.015609336085617542
only O 0 0.007786973379552364
one O 0 0.0075652627274394035
of O 0 0.009842432104051113
the O 0 0.01584049127995968
normal O 0 0.023507414385676384
and O 0 0.02025170996785164
mutant O 1 0.9278920292854309
alleles O 0 0.04806330054998398
indicated O 0 0.020930737257003784
that O 0 0.006645558401942253
all O 0 0.007033295463770628
the O 0 0.013210508041083813
four O 0 0.01782410219311714
patients O 0 0.24853089451789856
were O 0 0.012355520389974117
homozygous O 0 0.033886685967445374
for O 0 0.013466431759297848
the O 0 0.020269447937607765
mutation O 0 0.03473726287484169
in O 0 0.017040668055415154
exon O 0 0.360645592212677
4 O 0 0.02196124754846096
and O 0 0.01091652363538742
that O 0 0.006407247856259346
the O 0 0.012987636961042881
parents O 0 0.02435947209596634
of O 0 0.024565208703279495
patient O 1 0.99993896484375
2 O 0 0.03911399096250534
were O 0 0.022056391462683678
heterozygous O 0 0.07118374109268188
. O 0 0.04175907373428345

The O 0 0.04794706404209137
common O 0 0.03934133052825928
mutation O 0 0.0481099933385849
at O 0 0.025848859921097755
codon O 0 0.05476079508662224
95 O 0 0.030992940068244934
in O 0 0.017506523057818413
exon O 0 0.08582256734371185
4 O 0 0.024508923292160034
might O 0 0.014383843168616295
be O 0 0.008386454544961452
responsible O 0 0.015312441624701023
for O 0 0.012120604515075684
most O 0 0.01797548308968544
Japanese O 1 0.9990999698638916
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0804210901260376
. O 0 0.04675811529159546

BRCA1 O 1 0.9469054341316223
required O 0 0.02625185064971447
for O 0 0.022891048341989517
transcription O 1 0.9981130361557007
- O 1 0.9999959468841553
coupled O 1 0.9254534244537354
repair O 1 0.9963131546974182
of O 0 0.0942145437002182
oxidative O 1 0.9999885559082031
DNA O 0 0.28585609793663025
damage O 0 0.23457536101341248
. O 0 0.043265387415885925

The O 0 0.08059374243021011
breast B-Disease 1 1.0
and I-Disease 1 0.9999773502349854
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 1 0.9999542236328125
BRCA1 O 1 0.9999954700469971
encodes O 0 0.06410817801952362
a O 0 0.04651455953717232
zinc O 1 0.9999954700469971
finger O 1 0.9974344372749329
protein O 0 0.031743355095386505
of O 0 0.024453353136777878
unknown O 0 0.04291920363903046
function O 0 0.03749735653400421
. O 0 0.035946089774370193

Association O 0 0.04332982748746872
of O 0 0.02456195466220379
the O 0 0.037495531141757965
BRCA1 O 1 0.9999642372131348
protein O 0 0.021845493465662003
with O 0 0.010592763312160969
the O 0 0.018643250688910484
DNA O 0 0.057642996311187744
repair O 1 0.9999547004699707
protein O 0 0.0560850165784359
Rad51 O 1 0.999769389629364
and O 0 0.015907593071460724
changes O 0 0.00966976024210453
in O 0 0.009714956395328045
the O 0 0.01615368388593197
phosphorylation O 0 0.041503529995679855
and O 0 0.016013458371162415
cellular O 0 0.029797634109854698
localization O 0 0.03561856970191002
of O 0 0.013388779945671558
the O 0 0.01737922988831997
protein O 0 0.02001408487558365
after O 0 0.01789185404777527
exposure O 0 0.03457696735858917
to O 0 0.01565159484744072
DNA O 0 0.039781633764505386
- O 1 0.999957799911499
damaging O 0 0.2668178379535675
agents O 0 0.019133886322379112
are O 0 0.0056375497952103615
consistent O 0 0.01466348860412836
with O 0 0.009219233877956867
a O 0 0.015444543212652206
role O 0 0.027768854051828384
for O 0 0.023221813142299652
BRCA1 O 1 0.99997878074646
in O 0 0.028133034706115723
DNA O 0 0.0666133463382721
repair O 1 0.9739693403244019
. O 0 0.04576637223362923

Here O 0 0.03989696130156517
, O 0 0.021678747609257698
it O 0 0.011126026511192322
is O 0 0.01170415710657835
shown O 0 0.012266531586647034
that O 0 0.011059021577239037
mouse O 0 0.04587799310684204
embryonic O 0 0.15129028260707855
stem O 1 0.6859835982322693
cells O 0 0.19712918996810913
deficient B-Disease 1 0.9994221925735474
in I-Disease 0 0.0275700893253088
BRCA1 I-Disease 1 0.9999749660491943
are O 0 0.01595408469438553
defective O 1 0.9940935969352722
in O 0 0.013109409250319004
the O 0 0.015532379038631916
ability O 0 0.01467381976544857
to O 0 0.009344939142465591
carry O 0 0.012469148263335228
out O 0 0.016703734174370766
transcription O 0 0.27670300006866455
- O 1 0.9998546838760376
coupled O 0 0.1589706838130951
repair O 1 0.9329479336738586
of O 0 0.034468866884708405
oxidative O 1 0.9999911785125732
DNA O 1 0.5572099685668945
damage O 1 0.5504040718078613
, O 0 0.01806012913584709
and O 0 0.014876270666718483
are O 0 0.012553109787404537
hypersensitive O 1 0.9998892545700073
to O 0 0.047002676874399185
ionizing O 1 0.9999967813491821
radiation O 1 0.9994970560073853
and O 0 0.040325265377759933
hydrogen O 0 0.1680164933204651
peroxide O 1 0.9165071845054626
. O 0 0.04935423284769058

These O 0 0.0205448716878891
results O 0 0.017528483644127846
suggest O 0 0.021231310442090034
that O 0 0.018905412405729294
BRCA1 O 1 0.9998881816864014
participates O 1 0.5541134476661682
, O 0 0.02198883704841137
directly O 0 0.01926502212882042
or O 0 0.014866366051137447
indirectly O 0 0.023513998836278915
, O 0 0.012563208118081093
in O 0 0.014551214873790741
transcription O 1 0.8559140563011169
- O 1 0.9999806880950928
coupled O 1 0.766074538230896
repair O 1 0.997177004814148
of O 0 0.05988131836056709
oxidative O 1 0.9999823570251465
DNA O 0 0.4098992943763733
damage O 0 0.189199760556221
. O 0 0.02839524857699871
. O 0 0.03634874150156975

Truncation O 1 0.8971779942512512
mutations O 0 0.05476338416337967
in O 0 0.019951345399022102
the O 0 0.03054679185152054
transactivation O 1 0.997287392616272
region O 0 0.03756611421704292
of O 0 0.03207520395517349
PAX6 O 1 0.9999994039535522
result O 0 0.026658084243535995
in O 0 0.020706266164779663
dominant O 1 0.999395489692688
- O 1 0.9999964237213135
negative O 0 0.06950691342353821
mutants O 1 0.8204605579376221
. O 0 0.043491020798683167

PAX6 O 1 0.9999796152114868
is O 0 0.032880865037441254
a O 0 0.03164361044764519
transcription O 0 0.05315057933330536
factor O 0 0.023437341675162315
with O 0 0.008724200539290905
two O 0 0.009390367195010185
DNA O 0 0.026794714853167534
- O 1 0.9966676831245422
binding O 0 0.026936989277601242
domains O 0 0.034843336790800095
( O 0 0.01982041448354721
paired O 0 0.039235468953847885
box O 0 0.059850748628377914
and O 0 0.023531891405582428
homeobox O 1 0.9999798536300659
) O 0 0.0157904215157032
and O 0 0.011610804125666618
a O 0 0.024860672652721405
proline O 1 0.9964762330055237
- O 1 0.9999234676361084
serine O 1 0.9986807703971863
- O 1 0.9999368190765381
threonine O 1 0.9846736192703247
( O 0 0.04583006352186203
PST O 1 0.9986146688461304
) O 0 0.04076578840613365
- O 1 0.9922193288803101
rich O 0 0.06562062352895737
transactivation O 1 0.9919771552085876
domain O 0 0.07930072396993637
. O 0 0.04531027376651764

PAX6 O 1 0.9999969005584717
regulates O 1 0.9994632601737976
eye O 1 0.9997164607048035
development O 0 0.041624702513217926
in O 0 0.020408038049936295
animals O 0 0.01746302656829357
ranging O 0 0.02404060959815979
from O 0 0.023403041064739227
jellyfish O 0 0.15683455765247345
to O 0 0.02846520021557808
Drosophila O 0 0.07529094815254211
to O 0 0.03081553801894188
humans O 0 0.03836388140916824
. O 0 0.03683428838849068

Heterozygous O 0 0.12835334241390228
mutations O 0 0.04141813889145851
in O 0 0.01535807829350233
the O 0 0.024170756340026855
human O 0 0.16533325612545013
PAX6 O 1 1.0
gene O 0 0.0444423072040081
result O 0 0.016920695081353188
in O 0 0.010831564664840698
various O 0 0.011788759380578995
phenotypes O 0 0.046080347150564194
, O 0 0.01689968630671501
including O 0 0.021151850000023842
aniridia B-Disease 1 0.9999992847442627
, O 0 0.05914128199219704
Peters B-Disease 1 0.9999970197677612
anomaly I-Disease 1 0.9999899864196777
, O 0 0.04342139884829521
autosomal B-Disease 1 0.9999945163726807
dominant I-Disease 1 0.9999984502792358
keratitis I-Disease 1 1.0
, O 1 0.8836068511009216
and O 1 0.8916838765144348
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.34359854459762573

It O 0 0.026231039315462112
is O 0 0.01758953370153904
believed O 0 0.016447782516479492
that O 0 0.007761586923152208
the O 0 0.016545208171010017
mutated O 0 0.05489199981093407
allele O 0 0.04910319298505783
of O 0 0.029665369540452957
PAX6 O 1 0.9999977350234985
produces O 0 0.035103995352983475
an O 0 0.02229958027601242
inactive O 1 0.998855710029602
protein O 0 0.03605888783931732
and O 0 0.024925850331783295
aniridia B-Disease 1 0.9999984502792358
is O 0 0.029543651267886162
caused O 0 0.05517443269491196
due O 0 0.03122960962355137
to O 0 0.03350310027599335
genetic O 0 0.07774488627910614
haploinsufficiency O 1 0.9995090961456299
. O 0 0.04770262911915779

However O 0 0.03222667798399925
, O 0 0.02135998010635376
several O 0 0.017762843519449234
truncation O 1 0.9897544980049133
mutations O 0 0.03671744093298912
have O 0 0.009864544495940208
been O 0 0.010272606275975704
found O 0 0.00858892872929573
to O 0 0.008675362914800644
occur O 0 0.008029544726014137
in O 0 0.007218178827315569
the O 0 0.017603754997253418
C O 1 0.9998186230659485
- O 1 0.9999799728393555
terminal O 0 0.07027027010917664
half O 0 0.016142887994647026
of O 0 0.0216240081936121
PAX6 O 1 0.9999995231628418
in O 0 0.025917217135429382
patients O 1 0.9953097701072693
with O 0 0.027270473539829254
Aniridia B-Disease 1 0.9999996423721313
resulting O 0 0.037642668932676315
in O 0 0.01878262124955654
mutant O 1 0.8664214015007019
proteins O 0 0.018119141459465027
that O 0 0.007340661715716124
retain O 0 0.020574821159243584
the O 0 0.01600748673081398
DNA O 0 0.036589980125427246
- O 1 0.9995092153549194
binding O 0 0.03208398446440697
domains O 0 0.02365485019981861
but O 0 0.008479636162519455
have O 0 0.006546480115503073
lost O 0 0.0172671340405941
most O 0 0.01041859295219183
of O 0 0.016885852441191673
the O 0 0.036861762404441833
transactivation O 1 0.9998800754547119
domain O 0 0.08988335728645325
. O 0 0.045508723706007004

It O 0 0.02648502215743065
is O 0 0.01657913252711296
not O 0 0.010127734392881393
clear O 0 0.015923501923680305
whether O 0 0.012926877476274967
such O 0 0.012636842206120491
mutants O 1 0.9626769423484802
really O 0 0.027361098676919937
behave O 0 0.022281769663095474
as O 0 0.011655488051474094
loss O 0 0.03116239793598652
- O 1 0.9995773434638977
of O 0 0.027760380879044533
- O 1 0.9999932050704956
function O 0 0.02790246158838272
mutants O 0 0.07317579537630081
as O 0 0.02060099132359028
predicted O 0 0.033831119537353516
by O 0 0.030719660222530365
haploinsufficiency O 1 0.9952735304832458
. O 0 0.052659664303064346

Contrary O 0 0.058119166642427444
to O 0 0.01999225653707981
this O 0 0.013368844985961914
theory O 0 0.018735891208052635
, O 0 0.013378920033574104
our O 0 0.014720603823661804
data O 0 0.008830227889120579
showed O 0 0.01081767212599516
that O 0 0.006280684377998114
these O 0 0.006842318922281265
mutants O 0 0.04750994220376015
are O 0 0.008682928048074245
dominant O 0 0.1956327259540558
- O 1 0.9998534917831421
negative O 0 0.02551768720149994
in O 0 0.021359307691454887
transient O 1 0.9998946189880371
transfection O 1 0.9999804496765137
assays O 0 0.04275411739945412
when O 0 0.015306597575545311
they O 0 0.0068883332423865795
are O 0 0.006746241822838783
coexpressed O 0 0.17605789005756378
with O 0 0.019676420837640762
wild O 0 0.05935797840356827
- O 1 0.9999920129776001
type O 1 0.9759252071380615
PAX6 O 1 0.9999895095825195
. O 0 0.0660010501742363

We O 0 0.022375518456101418
found O 0 0.01166190579533577
that O 0 0.007185210939496756
the O 0 0.01606922224164009
dominant O 1 0.9993602633476257
- O 1 0.9999961853027344
negative O 0 0.03709806501865387
effects O 0 0.02661844715476036
result O 0 0.012506159953773022
from O 0 0.011121027171611786
the O 0 0.018249711021780968
enhanced O 0 0.06291105598211288
DNA O 0 0.0293015968054533
binding O 0 0.022428210824728012
ability O 0 0.01663551852107048
of O 0 0.016619889065623283
these O 0 0.017799504101276398
mutants O 0 0.3412284851074219
. O 0 0.04411740228533745

Kinetic O 0 0.0941154956817627
studies O 0 0.02726856805384159
of O 0 0.02504287287592888
binding O 0 0.038077883422374725
and O 0 0.02612229995429516
dissociation O 1 0.7327912449836731
revealed O 0 0.026875576004385948
that O 0 0.009837144054472446
various O 0 0.012427084147930145
truncation O 0 0.07287301868200302
mutants O 0 0.06810150295495987
have O 0 0.011804535053670406
3 O 0 0.026767700910568237
- O 1 0.9881026148796082
5 O 0 0.0319514162838459
- O 1 0.9968922734260559
fold O 0 0.03969653695821762
higher O 0 0.015970425680279732
affinity O 0 0.022574855014681816
to O 0 0.010992810130119324
various O 0 0.009364891797304153
DNA O 0 0.029362164437770844
- O 1 0.9951068162918091
binding O 0 0.020453717559576035
sites O 0 0.011786703951656818
when O 0 0.009136966429650784
compared O 0 0.009015532210469246
with O 0 0.008243532851338387
the O 0 0.017531991004943848
wild O 0 0.051140911877155304
- O 1 0.9999971389770508
type O 1 0.9855597019195557
PAX6 O 1 0.9999967813491821
. O 0 0.05870189890265465

These O 0 0.022478338330984116
results O 0 0.01708679087460041
provide O 0 0.01597030647099018
a O 0 0.018494972959160805
new O 0 0.020609509199857712
insight O 0 0.030515365302562714
into O 0 0.01193202193826437
the O 0 0.01317380927503109
role O 0 0.02432483620941639
of O 0 0.0242733396589756
mutant O 1 0.9994804263114929
PAX6 O 1 0.9999997615814209
in O 0 0.04482036828994751
causing O 1 0.9991629123687744
aniridia B-Disease 1 0.9999998807907104
. O 0 0.040634412318468094
. O 0 0.043155573308467865

Reversal O 0 0.4537339508533478
of O 1 0.8489197492599487
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999569654464722
excellent O 1 0.9998960494995117
neuropsychologic O 1 0.9999958276748657
outcome O 0 0.023207196965813637
in O 0 0.011589503847062588
very B-Disease 0 0.01541236974298954
- I-Disease 1 0.9993194341659546
long I-Disease 0 0.034071583300828934
- I-Disease 1 0.9997716546058655
chain I-Disease 0 0.4727848768234253
acyl I-Disease 1 0.9999217987060547
- I-Disease 1 0.9999979734420776
coenzyme I-Disease 1 0.9999606609344482
A I-Disease 1 0.9999417066574097
dehydrogenase I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.080052949488163

Very B-Disease 0 0.04310888051986694
- I-Disease 1 0.9987117052078247
long I-Disease 0 0.0448492094874382
- I-Disease 1 0.9998972415924072
chain I-Disease 0 0.344184547662735
acyl I-Disease 1 0.9997288584709167
- I-Disease 1 0.9999282360076904
coenzyme I-Disease 1 0.9702999591827393
A I-Disease 1 0.5044019818305969
dehydrogenase I-Disease 1 0.9999574422836304
( I-Disease 0 0.046453289687633514
VLCAD I-Disease 1 0.9999997615814209
) I-Disease 1 0.9518889784812927
deficiency I-Disease 1 1.0
is O 0 0.019453786313533783
a O 0 0.053160056471824646
disorder O 1 1.0
of O 1 0.9993820190429688
fatty O 1 1.0
acid O 1 0.9999897480010986
beta O 1 0.9998513460159302
oxidation O 1 0.7678136229515076
that O 0 0.012572156265377998
reportedly O 0 0.025675402954220772
has O 0 0.013285034336149693
high O 0 0.026620646938681602
rates O 0 0.025692816823720932
of O 0 0.036024101078510284
morbidity O 1 0.9999986886978149
and O 0 0.18657152354717255
mortality O 1 0.9997479319572449
. O 0 0.056519050151109695

We O 0 0.02731616608798504
describe O 0 0.024625912308692932
the O 0 0.013594670221209526
outcome O 0 0.013560465537011623
of O 0 0.010474354028701782
a O 0 0.014673689380288124
5 O 0 0.02017657272517681
- O 1 0.9464503526687622
year O 0 0.01441336702555418
- O 1 0.9911578297615051
old O 0 0.05095291882753372
girl O 1 0.9403548836708069
with O 0 0.3567674458026886
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 1 0.9691340327262878
was O 0 0.0912148505449295
first O 0 0.01717221736907959
seen O 0 0.0161164328455925
at O 0 0.012132027186453342
5 O 0 0.011856433004140854
months O 0 0.009767056442797184
of O 0 0.01129007525742054
age O 0 0.021372580900788307
with O 0 0.03379371017217636
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999998807907104
encephalopathy B-Disease 1 1.0
, O 1 0.9840483665466309
and O 1 0.8729652762413025
hypotonia B-Disease 1 0.999997615814209
. O 0 0.06755011528730392

Biochemical O 0 0.13230200111865997
studies O 0 0.03986780345439911
indicated O 1 0.9906637668609619
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9999245405197144
by O 0 0.03563876822590828
a O 0 0.07654643803834915
stable O 1 0.9955615997314453
yet O 0 0.04178258404135704
inactive O 1 0.9993621706962585
enzyme O 0 0.09465422481298447
. O 0 0.04138050228357315

Molecular O 0 0.0732431411743164
genetic O 0 0.03653330355882645
analysis O 0 0.015114434994757175
of O 0 0.01809682324528694
her O 0 0.05342504009604454
VLCAD O 1 0.9999966621398926
gene O 0 0.0363287590444088
revealed O 0 0.027851663529872894
a O 0 0.03021029755473137
T1372C O 1 0.9997764229774475
( O 0 0.03621251508593559
F458L O 1 0.9977127313613892
) O 0 0.029349006712436676
missense O 0 0.0895293727517128
mutation O 0 0.038529206067323685
and O 0 0.01777007430791855
a O 0 0.04121154919266701
1668 O 1 0.999936580657959
ACAG O 1 0.9999957084655762
1669 O 1 0.9999085664749146
splice O 1 0.9616211652755737
site O 0 0.06958454847335815
mutation O 0 0.07534941285848618
. O 0 0.04200274124741554

After O 0 0.05084604024887085
initial O 0 0.05068248510360718
treatment O 1 0.9984063506126404
with O 0 0.06631343811750412
intravenous O 1 1.0
glucose O 1 0.9999980926513672
and O 1 0.8995121121406555
carnitine O 1 1.0
, O 0 0.02561827562749386
the O 0 0.027336401864886284
patient O 1 0.9998558759689331
has O 0 0.016819782555103302
thrived O 0 0.03698816895484924
on O 0 0.012636521831154823
a O 0 0.018740087747573853
low O 1 0.576594889163971
- O 1 0.9999979734420776
fat O 1 0.7504593133926392
diet O 0 0.04498370736837387
supplemented O 0 0.030726058408617973
with O 0 0.01553814671933651
medium O 0 0.06578583270311356
- O 1 0.9999614953994751
chain O 1 0.5972091555595398
triglyceride O 1 0.9967317581176758
oil O 0 0.04198077693581581
and O 0 0.03583529591560364
carnitine O 1 0.9999940395355225
and O 0 0.04008220136165619
avoidance O 1 0.9999734163284302
of O 0 0.2587699294090271
fasting O 1 0.9997398257255554
. O 0 0.060122597962617874

Her O 1 0.9998441934585571
ventricular O 1 1.0
hypertrophy O 1 1.0
resolved O 1 0.6718690991401672
significantly O 0 0.03106369636952877
over O 0 0.019968759268522263
1 O 0 0.024045681580901146
year O 0 0.015266388654708862
, O 0 0.015369785949587822
and O 0 0.0194859616458416
cognitively O 1 0.9999808073043823
, O 0 0.020164290443062782
she O 0 0.01737566478550434
is O 0 0.010878786444664001
in O 0 0.008935007266700268
the O 0 0.016158979386091232
superior O 0 0.04084915295243263
range O 0 0.023082520812749863
for O 0 0.02070705033838749
age O 0 0.04144405573606491
. O 0 0.03933585062623024

Clinical O 0 0.12519250810146332
recognition O 0 0.0525398775935173
of O 1 0.9998575448989868
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 1 0.8710739612579346
important O 0 0.02256891317665577
because O 0 0.013020011596381664
it O 0 0.00776077201589942
is O 0 0.00727722467854619
one O 0 0.006996831391006708
of O 0 0.009564642794430256
the O 0 0.013230601325631142
few O 0 0.016237659379839897
directly O 0 0.03454723581671715
treatable O 1 1.0
causes O 1 0.9999778270721436
of O 1 0.9997871518135071
cardiomyopathy B-Disease 1 1.0
in O 1 0.9848030805587769
children O 1 0.9901534914970398
. O 0 0.03018292598426342
. O 0 0.03437924385070801

Cloning O 0 0.06910848617553711
of O 0 0.025380166247487068
a O 0 0.02759191021323204
novel O 0 0.03767944127321243
member O 0 0.022726910188794136
of O 0 0.01558450236916542
the O 0 0.021413812413811684
low O 1 0.8492639660835266
- O 1 0.9999988079071045
density O 1 0.9928650856018066
lipoprotein O 1 0.9999998807907104
receptor O 1 0.9976143836975098
family O 0 0.060015056282281876
. O 0 0.042381491512060165

A O 0 0.060414597392082214
gene O 0 0.03946273773908615
encoding O 0 0.025405120104551315
a O 0 0.025746766477823257
novel O 0 0.05751356482505798
transmembrane O 1 0.9945210218429565
protein O 0 0.028087781742215157
was O 0 0.0192549005150795
identified O 0 0.016026634722948074
by O 0 0.01155070960521698
DNA O 0 0.01583724468946457
sequence O 0 0.009729118086397648
analysis O 0 0.005993908271193504
within O 0 0.00772304181009531
the O 0 0.01574843004345894
insulin B-Disease 1 0.9999637603759766
- I-Disease 1 0.9999997615814209
dependent I-Disease 1 0.9999377727508545
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9950498938560486
IDDM B-Disease 1 0.9999982118606567
) O 0 0.04348946362733841
locus O 1 0.7786071300506592
IDDM4 O 1 0.9997027516365051
on O 0 0.05044657737016678
chromosome O 0 0.36291155219078064
11q13 O 1 0.9606764912605286
. O 0 0.053935956209897995

Based O 0 0.028925195336341858
on O 0 0.017049361020326614
its O 0 0.023163367062807083
chromosomal O 1 0.8640760183334351
position O 0 0.02615170180797577
, O 0 0.01486426405608654
this O 0 0.009912289679050446
gene O 0 0.01762946881353855
is O 0 0.009925157763063908
a O 0 0.015215018764138222
candidate O 0 0.027393698692321777
for O 0 0.019411159679293633
conferring O 1 0.9829780459403992
susceptibility O 1 0.9999699592590332
to O 0 0.40340518951416016
diabetes B-Disease 1 1.0
. O 0 0.07588579505681992

The O 0 0.041930168867111206
gene O 0 0.034449249505996704
, O 0 0.018102535977959633
termed O 0 0.0433831512928009
low O 0 0.05586450919508934
- O 1 0.9999819993972778
density O 0 0.3805484473705292
lipoprotein O 1 0.9999995231628418
receptor O 1 0.8222967982292175
related O 0 0.026479260995984077
protein O 0 0.02479652315378189
5 O 0 0.022176511585712433
( O 0 0.02479746751487255
LRP5 O 1 0.9998039603233337
) O 0 0.017281822860240936
, O 0 0.013169762678444386
encodes O 0 0.02706293761730194
a O 0 0.018862904980778694
protein O 0 0.019505396485328674
of O 0 0.02045469731092453
1615 O 1 0.9447506070137024
amino O 0 0.03589915856719017
acids O 0 0.023195216432213783
that O 0 0.00852606724947691
contains O 0 0.02073628269135952
conserved O 0 0.031641390174627304
modules O 0 0.031935643404722214
which O 0 0.009017475880682468
are O 0 0.005221785511821508
characteristic O 0 0.01596684381365776
of O 0 0.01101693231612444
the O 0 0.016776222735643387
low O 0 0.2839690148830414
- O 1 0.9999905824661255
density O 1 0.9519484639167786
lipoprotein O 1 1.0
( O 1 0.9623446464538574
LDL O 1 1.0
) O 0 0.04887225106358528
receptor O 1 0.5439393520355225
family O 0 0.048229098320007324
. O 0 0.03680478781461716

These O 0 0.026228919625282288
modules O 0 0.041539840400218964
include O 0 0.01928894780576229
a O 0 0.02845493145287037
putative O 1 0.9963604807853699
signal O 0 0.056352052837610245
peptide O 0 0.05339634045958519
for O 0 0.016904760152101517
protein O 0 0.02024851366877556
export O 0 0.0166542436927557
, O 0 0.012424218468368053
four O 0 0.020074641332030296
epidermal O 1 0.9999631643295288
growth O 0 0.20087528228759766
factor O 1 0.954379677772522
( O 0 0.05419532582163811
EGF O 1 0.9999947547912598
) O 0 0.0268851425498724
repeats O 0 0.03333917260169983
with O 0 0.016227342188358307
associated O 0 0.025630520656704903
spacer O 0 0.45728248357772827
domains O 0 0.03184257820248604
, O 0 0.013984926976263523
three O 0 0.022748012095689774
LDL O 1 1.0
- O 1 0.9999998807907104
receptor O 1 0.9992864727973938
( O 0 0.030342409387230873
LDLR O 1 0.9998223185539246
) O 0 0.02032783254981041
repeats O 0 0.02898511104285717
, O 0 0.01148663368076086
a O 0 0.017097286880016327
single O 0 0.033387213945388794
transmembrane O 1 0.8634254336357117
spanning O 0 0.044539209455251694
domain O 0 0.03929683938622475
, O 0 0.01708889938890934
and O 0 0.016233548521995544
a O 0 0.03337077051401138
cytoplasmic O 1 0.9109087586402893
domain O 0 0.06346002966165543
. O 0 0.03735283389687538

The O 0 0.04734741151332855
encoded O 0 0.04423396289348602
protein O 0 0.025025909766554832
has O 0 0.012502497062087059
a O 0 0.0146646061912179
unique O 0 0.015675470232963562
organization O 0 0.024560866877436638
of O 0 0.03113676980137825
EGF O 1 0.9999970197677612
and O 0 0.04739563539624214
LDLR O 1 0.9999995231628418
repeats O 0 0.2816353142261505
; O 0 0.021901443600654602
therefore O 0 0.01964738965034485
, O 0 0.021857939660549164
LRP5 O 1 0.998907208442688
likely O 0 0.023534676060080528
represents O 0 0.02312724106013775
a O 0 0.01640339568257332
new O 0 0.017438922077417374
category O 0 0.023854967206716537
of O 0 0.01879318617284298
the O 0 0.03858345001935959
LDLR O 1 0.9999874830245972
family O 0 0.08702145516872406
. O 0 0.04808971285820007

Both O 0 0.034037768840789795
human O 0 0.03326183930039406
and O 0 0.034010857343673706
mouse O 1 0.9845954179763794
LRP5 O 1 0.9999990463256836
cDNAs O 1 0.9996250867843628
have O 0 0.012348109856247902
been O 0 0.013724728487432003
isolated O 0 0.027840835973620415
and O 0 0.011934235692024231
the O 0 0.017544567584991455
encoded O 0 0.02654953859746456
mature O 0 0.032621096819639206
proteins O 0 0.01594391278922558
are O 0 0.006165771279484034
95 O 0 0.021984944120049477
% O 0 0.017243625596165657
identical O 0 0.019340677186846733
, O 0 0.015226398594677448
indicating O 0 0.02049434930086136
a O 0 0.019087819382548332
high O 0 0.03213063254952431
degree O 0 0.028530851006507874
of O 0 0.02677842602133751
evolutionary O 0 0.04484641179442406
conservation O 0 0.05386582762002945
. O 0 0.026215078309178352
. O 0 0.03815138712525368

The O 0 0.07432379573583603
APC B-Disease 1 0.9993597865104675
variants O 0 0.058308519423007965
I1307K O 1 0.9512500166893005
and O 0 0.02367555722594261
E1317Q O 1 0.8561011552810669
are O 0 0.010739076882600784
associated O 0 0.02821473777294159
with O 1 0.9999054670333862
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9606456160545349
but O 0 0.017212606966495514
not O 0 0.010918330401182175
always O 0 0.015202222391963005
with O 0 0.010941289365291595
a O 0 0.0216826219111681
family O 0 0.0346430242061615
history O 0 0.03752267733216286
. O 0 0.03780827298760414

Classical O 0 0.18993201851844788
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999961853027344
FAP B-Disease 1 1.0
) O 0 0.027448009699583054
is O 0 0.013108248822391033
a O 0 0.01649703085422516
high O 0 0.10704822093248367
- O 1 0.9999994039535522
penetrance O 1 0.9999997615814209
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
that O 0 0.031745545566082
predisposes O 1 0.9999676942825317
to O 0 0.016278300434350967
hundreds O 0 0.015121295116841793
or O 0 0.010039175860583782
thousands O 0 0.021414395421743393
of O 1 0.9923568964004517
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
carcinoma I-Disease 1 1.0
and O 0 0.16812457144260406
that O 0 0.013109038583934307
results O 0 0.011146394535899162
from O 0 0.015452356077730656
truncating O 1 0.9965004920959473
mutations O 0 0.03079240582883358
in O 0 0.016923874616622925
the O 0 0.03550097346305847
APC B-Disease 1 0.999995231628418
gene O 0 0.06458786129951477
. O 0 0.041951216757297516

A O 0 0.06527891010046005
variant O 0 0.06335833668708801
of O 0 0.04255472496151924
FAP B-Disease 1 0.9999997615814209
is O 0 0.4255872666835785
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.03457195311784744
which O 0 0.012047483585774899
results O 0 0.011445008218288422
from O 0 0.01692979410290718
germ O 1 0.999996542930603
- O 1 0.9999903440475464
line O 0 0.03486141934990883
mutations O 0 0.018298545852303505
in O 0 0.008344423025846481
the O 0 0.01307644508779049
5 O 0 0.016258900985121727
and O 0 0.01117647159844637
3 O 0 0.015849824994802475
regions O 0 0.012347574345767498
of O 0 0.016971342265605927
the O 0 0.03938138484954834
APC B-Disease 1 0.9999953508377075
gene O 0 0.06812875717878342
. O 0 0.04138542711734772

Attenuated B-Disease 1 0.9999977350234985
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.999998927116394
have O 0 0.02024656906723976
" O 0 0.0363353006541729
multiple O 0 0.052744604647159576
" O 1 0.9999828338623047
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.2749897241592407
typically O 0 0.018360476940870285
fewer O 0 0.012872118502855301
than O 0 0.00982759054750204
100 O 0 0.01706130988895893
) O 0 0.012092647142708302
without O 0 0.0123074846342206
the O 0 0.022635478526353836
florid O 1 0.9995298385620117
phenotype O 1 0.6910923719406128
of O 0 0.045863859355449677
classical O 1 0.884931206703186
FAP B-Disease 1 0.9999996423721313
. O 0 0.07018062472343445

Another O 0 0.04205302149057388
group O 0 0.03256469964981079
of O 0 0.02610829472541809
patients O 1 0.9997053742408752
with O 0 0.029543552547693253
multiple O 1 0.9666324853897095
adenomas B-Disease 1 1.0
has O 0 0.023020001128315926
no O 0 0.017668960615992546
mutations O 0 0.019716551527380943
in O 0 0.010586434043943882
the O 0 0.026202479377388954
APC B-Disease 1 0.9999990463256836
gene O 0 0.03360499069094658
, O 0 0.01547034177929163
and O 0 0.012718995101749897
their O 0 0.016241401433944702
phenotype O 1 0.7933573722839355
probably O 0 0.01888658106327057
results O 0 0.01005261018872261
from O 0 0.01045058760792017
variation O 0 0.01744038425385952
at O 0 0.01696472428739071
a O 0 0.025815686210989952
locus O 1 0.9262426495552063
, O 0 0.024289997294545174
or O 0 0.02514910325407982
loci O 0 0.06479397416114807
, O 0 0.01936427131295204
elsewhere O 0 0.01981140300631523
in O 0 0.014800362288951874
the O 0 0.028835417702794075
genome O 0 0.05521559715270996
. O 0 0.03859148547053337

Recently O 0 0.06381744891405106
, O 0 0.02414526417851448
however O 0 0.013975447975099087
, O 0 0.012341387569904327
a O 0 0.01832328923046589
missense O 0 0.06935980170965195
variant O 0 0.04224446415901184
of O 0 0.033380843698978424
APC B-Disease 1 0.9999995231628418
( O 0 0.04816507548093796
I1307K O 1 0.9999001026153564
) O 0 0.01818009652197361
was O 0 0.018496468663215637
described O 0 0.016934731975197792
that O 0 0.008179333992302418
confers O 0 0.038778357207775116
an O 0 0.010966463945806026
increased O 0 0.020755905658006668
risk O 1 0.9709967374801636
of O 1 0.9999698400497437
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9802825450897217
including O 0 0.20292600989341736
multiple O 1 0.9977042078971863
adenomas B-Disease 1 1.0
, O 0 0.04134486988186836
in O 0 0.03607084974646568
Ashkenazim O 1 0.9987719655036926
. O 0 0.059229642152786255

We O 0 0.0228196419775486
have O 0 0.009656461887061596
studied O 0 0.01482198853045702
a O 0 0.012244665995240211
set O 0 0.013398016802966595
of O 0 0.015159021131694317
164 O 0 0.3371760845184326
patients O 1 0.9421626329421997
with O 0 0.03377673774957657
multiple O 1 0.999976396560669
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.999983549118042
/ I-Disease 1 1.0
or I-Disease 1 0.9989293217658997
carcinoma I-Disease 1 1.0
and O 0 0.029442187398672104
analyzed O 0 0.0361790806055069
codons O 0 0.07474800944328308
1263 O 1 0.9995803236961365
- O 1 0.9999828338623047
1377 O 1 0.9993366599082947
( O 0 0.04082288593053818
exon O 1 0.9019280076026917
15G O 1 0.9628074169158936
) O 0 0.015872547402977943
of O 0 0.01326954085379839
the O 0 0.02641812153160572
APC B-Disease 1 0.9999170303344727
gene O 0 0.03563016280531883
for O 0 0.0272152591496706
germ O 1 0.9999973773956299
- O 1 0.9999895095825195
line O 0 0.06613710522651672
variants O 0 0.049062665551900864
. O 0 0.03901434317231178

Three O 0 0.04199734702706337
patients O 0 0.1696532815694809
with O 0 0.021285343915224075
the O 0 0.035934995859861374
I1307K O 1 0.9999740123748779
allele O 0 0.18731680512428284
were O 0 0.017831901088356972
detected O 0 0.030053013935685158
, O 0 0.013056276366114616
each O 0 0.00901726633310318
of O 0 0.024356430396437645
Ashkenazi O 1 0.9980217218399048
descent O 0 0.11175354570150375
. O 0 0.04812231659889221

Four O 0 0.04706782475113869
patients O 1 0.6254027485847473
had O 0 0.02726183459162712
a O 0 0.03803148493170738
germ O 1 0.9999850988388062
- O 1 0.9999228715896606
line O 0 0.054892223328351974
E1317Q O 1 0.9792847633361816
missense O 0 0.18779024481773376
variant O 0 0.04619446396827698
of O 0 0.028094956651329994
APC O 1 0.9999966621398926
that O 0 0.012431064620614052
was O 0 0.01762147806584835
not O 0 0.008317950181663036
present O 0 0.011997771449387074
in O 0 0.010867966338992119
controls O 0 0.025847846642136574
; O 0 0.012377078644931316
one O 0 0.010262192226946354
of O 0 0.011532585136592388
these O 0 0.007562847342342138
individuals O 0 0.010358083061873913
had O 0 0.013435912318527699
an O 0 0.012496410869061947
unusually O 0 0.0266214981675148
large O 0 0.012129799462854862
number O 0 0.010993700474500656
of O 0 0.024210946634411812
metaplastic B-Disease 1 0.9999959468841553
polyps I-Disease 1 0.9999842643737793
of I-Disease 0 0.03918210417032242
the I-Disease 0 0.068022221326828
colorectum I-Disease 1 0.9999562501907349
. O 0 0.054594703018665314

There O 0 0.028766369447112083
is O 0 0.021112721413373947
increasing O 0 0.020620152354240417
evidence O 0 0.012844217009842396
that O 0 0.0071488372050225735
there O 0 0.010439153760671616
exist O 0 0.01825389638543129
germ O 1 0.9999362230300903
- O 1 0.9991592168807983
line O 0 0.03011060319840908
variants O 0 0.015901807695627213
of O 0 0.01309832651168108
the O 0 0.025759894400835037
APC B-Disease 1 0.9999963045120239
gene O 0 0.030494708567857742
that O 0 0.012820206582546234
predispose O 0 0.04886019602417946
to O 0 0.010127227753400803
the O 0 0.01089065708220005
development O 0 0.01530268881469965
of O 0 0.02245384082198143
multiple O 1 0.9997817873954773
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 0.11750084161758423
but O 0 0.013254241086542606
without O 0 0.011631365865468979
the O 0 0.01881500519812107
florid O 1 0.9999089241027832
phenotype O 1 0.6029587984085083
of O 0 0.027789965271949768
classical O 1 0.9858496189117432
FAP B-Disease 1 1.0
, O 0 0.020802419632673264
and O 0 0.011542394757270813
possibly O 0 0.011388735845685005
with O 0 0.008659355342388153
importance O 0 0.04837275668978691
for O 1 0.999920129776001
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9999990463256836
in O 0 0.01965605467557907
the O 0 0.022835468873381615
general O 0 0.07103441655635834
population O 0 0.021513305604457855
. O 0 0.020242959260940552
. O 0 0.03128436952829361

Genomic O 0 0.0777842178940773
structure O 0 0.027173232287168503
of O 0 0.019280357286334038
the O 0 0.03661810979247093
human O 1 0.9999974966049194
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999998807907104
CLD B-Disease 1 1.0
) O 0 0.2605629861354828
gene O 0 0.057090722024440765
. O 0 0.03692849352955818

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999998807907104
CLD B-Disease 1 1.0
) O 1 0.6020458340644836
is O 0 0.020198587328195572
caused O 0 0.03345818445086479
by O 0 0.016672862693667412
mutations O 0 0.020524684339761734
in O 0 0.010089666582643986
a O 0 0.019054366275668144
gene O 0 0.02072586491703987
which O 0 0.014334320090711117
encodes O 0 0.0502857081592083
an O 0 0.0748177021741867
intestinal O 1 1.0
anion O 1 0.9999998807907104
transporter O 1 0.9999728202819824
. O 0 0.060896310955286026

We O 0 0.026543039828538895
report O 0 0.01772821880877018
here O 0 0.011313412338495255
the O 0 0.013504627160727978
complete O 0 0.023548809811472893
genomic O 0 0.03357269614934921
organization O 0 0.021071990951895714
of O 0 0.014633383601903915
the O 0 0.02255566231906414
human O 0 0.2428228259086609
CLD B-Disease 1 1.0
gene O 0 0.04209189862012863
which O 0 0.017398083582520485
spans O 0 0.047827620059251785
approximately O 0 0.02964339591562748
39kb O 1 0.9726336002349854
, O 0 0.0251073706895113
and O 0 0.02348879538476467
comprises O 0 0.051832884550094604
21 O 0 0.05868666619062424
exons O 0 0.10664515197277069
. O 0 0.05103781074285507

All O 0 0.054856084287166595
exon O 1 0.9172020554542542
/ O 1 0.993055522441864
intron O 1 0.7156522274017334
boundaries O 0 0.03262957185506821
conform O 0 0.041344936937093735
to O 0 0.018185080960392952
the O 0 0.03517638146877289
GT O 1 0.9999892711639404
/ O 1 0.9999890327453613
AG O 1 0.9999290704727173
rule O 0 0.07498162984848022
. O 0 0.05004734545946121

An O 0 0.031073536723852158
analysis O 0 0.017113441601395607
of O 0 0.017339292913675308
the O 0 0.028911123052239418
putative O 1 0.9957543611526489
promoter O 1 0.9623164534568787
region O 0 0.029314842075109482
sequence O 0 0.01669023558497429
shows O 0 0.014952021650969982
a O 0 0.02511611580848694
putative O 1 0.9995348453521729
TATA O 1 0.9999996423721313
box O 0 0.2934812307357788
and O 0 0.024059776216745377
predicts O 0 0.06115740165114403
multiple O 0 0.03316114470362663
transcription O 0 0.11374868452548981
factor O 0 0.05913868173956871
binding O 0 0.03997233137488365
sites O 0 0.03219621255993843
. O 0 0.029977019876241684

The O 0 0.05468607693910599
genomic O 0 0.07498440891504288
structure O 0 0.03739576041698456
was O 0 0.02777601033449173
determined O 0 0.02397781051695347
using O 0 0.012344863265752792
DNA O 0 0.017376014962792397
from O 0 0.008128051646053791
several O 0 0.007057245820760727
sources O 0 0.008735332638025284
including O 0 0.009589841589331627
multiple O 0 0.016860928386449814
large O 0 0.026710931211709976
- O 1 0.9999688863754272
insert O 1 0.954910933971405
libaries O 1 0.9811029434204102
and O 0 0.02015857771039009
genomic O 0 0.041799791157245636
DNA O 0 0.027156278491020203
from O 0 0.023011310026049614
Finnish O 1 0.9998800754547119
CLD B-Disease 1 1.0
patients O 1 0.9999715089797974
and O 0 0.047653134912252426
controls O 0 0.24514910578727722
. O 0 0.04762095957994461

Exon O 1 0.9888303875923157
- O 1 0.9965381622314453
specific O 0 0.031410954892635345
primers O 0 0.18282537162303925
developed O 0 0.0286308191716671
in O 0 0.011915774084627628
this O 0 0.009568658657371998
study O 0 0.01292264461517334
will O 0 0.012314333580434322
facilitate O 0 0.03519024699926376
mutation O 0 0.04665374755859375
screening O 0 0.05572131648659706
studies O 0 0.015336698852479458
of O 0 0.021023832261562347
patients O 1 0.9997208714485168
with O 0 0.03898272290825844
the O 1 0.9975065588951111
disease O 1 1.0
. O 0 0.08146599680185318

Genomic O 0 0.08946928381919861
sequencing O 0 0.03936702758073807
of O 0 0.023696500808000565
a O 0 0.0439247190952301
BAC O 1 0.999990701675415
clone O 1 0.9999667406082153
H O 1 0.9999959468841553
_ O 0 0.042737916111946106
RG364P16 O 1 0.955917239189148
revealed O 0 0.026001011952757835
the O 0 0.013939670287072659
presence O 0 0.01843888871371746
of O 0 0.0146412942558527
another O 0 0.021418580785393715
, O 0 0.015726810321211815
highly O 0 0.02557566948235035
homologous O 0 0.043896693736314774
gene O 0 0.02013947069644928
3 O 0 0.01374959945678711
of O 0 0.0144599424675107
the O 0 0.0313248336315155
CLD B-Disease 1 0.9999998807907104
gene O 0 0.03466309234499931
, O 0 0.01250520534813404
with O 0 0.009566616266965866
a O 0 0.013994365930557251
similar O 0 0.013807118870317936
genomic O 0 0.03624317795038223
structure O 0 0.021517764776945114
, O 0 0.011013586074113846
recently O 0 0.015464648604393005
identified O 0 0.012343271635472775
as O 0 0.011736644431948662
the O 0 0.04515552148222923
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9999469518661499
( O 1 0.9767819046974182
PDS B-Disease 1 0.9999997615814209
) O 0 0.037926897406578064
. O 0 0.024118022993206978
. O 0 0.035466719418764114

The O 0 0.07078734040260315
APCI1307K O 1 0.999985933303833
allele O 1 0.9910174608230591
and O 0 0.3650187849998474
cancer B-Disease 1 1.0
risk O 1 0.971964418888092
in O 0 0.015321028418838978
a O 0 0.02394968271255493
community O 0 0.03914714604616165
- O 1 0.999530553817749
based O 0 0.01812494918704033
study O 0 0.014518623240292072
of O 0 0.022749250754714012
Ashkenazi O 1 0.9957484602928162
Jews O 0 0.08689647167921066
. O 0 0.051352616399526596

Mutations O 0 0.08136968314647675
in O 0 0.033408503979444504
APC O 1 0.9994538426399231
are O 0 0.01782003976404667
classically O 1 0.9484442472457886
associated O 0 0.027840467169880867
with O 0 0.03324037045240402
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999991655349731
FAP B-Disease 1 1.0
) O 0 0.025680692866444588
, O 0 0.013748150318861008
a O 0 0.019730569794774055
highly O 0 0.158515065908432
penetrant O 1 0.9999998807907104
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999978542327881
by O 1 0.9950191974639893
multiple O 1 0.9999938011169434
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.9913132786750793
, O 0 0.10736119002103806
without O 0 0.024248315021395683
surgical O 1 0.9999998807907104
intervention O 1 0.9981855750083923
, O 0 0.012266704812645912
the O 0 0.012416543439030647
development O 0 0.02416754886507988
of O 1 0.9995061159133911
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999954700469971
CRC B-Disease 1 0.9999998807907104
) O 0 0.04743550345301628
. O 0 0.038658395409584045

APC B-Disease 1 0.9968863129615784
is O 0 0.030907800421118736
a O 0 0.05937827005982399
tumour O 1 1.0
- O 1 1.0
suppressor O 1 0.9999982118606567
gene O 0 0.0426596999168396
, O 0 0.01873471401631832
and O 0 0.020782429724931717
somatic O 1 0.9802228808403015
loss O 1 0.9503899216651917
occurs O 0 0.05353132635354996
in O 0 0.04749741032719612
tumours B-Disease 1 0.9999998807907104
. O 0 0.0694173127412796

The O 0 0.06034526973962784
germline O 1 0.9988804459571838
T O 1 0.9998784065246582
- O 1 0.9974918365478516
to O 0 0.028476281091570854
- O 1 0.9966579675674438
A O 0 0.04251280054450035
transversion O 1 0.9617661237716675
responsible O 0 0.028489302843809128
for O 0 0.013583829626441002
the O 0 0.026230236515402794
APC O 1 0.9999772310256958
I1307K O 1 0.999053418636322
allele O 0 0.06373078376054764
converts O 0 0.03551594167947769
the O 0 0.017616450786590576
wild O 0 0.03140704333782196
- O 1 0.9981939196586609
type O 0 0.02347888983786106
sequence O 0 0.010572164319455624
to O 0 0.010067103430628777
a O 0 0.02421371452510357
homopolymer O 1 0.9999978542327881
tract O 1 1.0
( O 1 0.9762727618217468
A8 O 1 0.9999998807907104
) O 0 0.021659651771187782
that O 0 0.010810292325913906
is O 0 0.01834813691675663
genetically O 0 0.04190291091799736
unstable O 1 0.9995989203453064
and O 0 0.03244955837726593
prone O 1 0.9993107318878174
to O 0 0.04823398217558861
somatic O 1 0.9979000091552734
mutation O 0 0.15869846940040588
. O 0 0.052793845534324646

The O 0 0.06764303892850876
I1307K O 1 0.999354898929596
allele O 0 0.10465139895677567
was O 0 0.036894798278808594
found O 0 0.020964305847883224
in O 0 0.020606398582458496
6 O 0 0.045565035194158554
. O 0 0.03736327216029167

1 O 0 0.04845500364899635
% O 0 0.024849647656083107
of O 0 0.029230419546365738
unselected O 1 0.9980462789535522
Ashkenazi O 1 0.9973709583282471
Jews O 0 0.04866117984056473
and O 0 0.019713129848241806
higher O 0 0.019150562584400177
proportions O 0 0.04938999563455582
of O 0 0.026854051277041435
Ashkenazim O 1 0.999957799911499
with O 0 0.022598834708333015
family O 0 0.04210005700588226
or O 0 0.01506869401782751
personal O 0 0.022694667801260948
histories O 0 0.04369403049349785
of O 0 0.2210712730884552
CRC B-Disease 1 1.0
( O 0 0.40541550517082214
ref O 1 0.9998995065689087
. O 0 0.022280331701040268
2 O 0 0.03610589727759361
) O 0 0.027164418250322342
. O 0 0.030864292755723

To O 0 0.030974211171269417
evaluate O 0 0.03711215406656265
the O 0 0.0169196967035532
role O 0 0.026102453470230103
of O 0 0.022681083530187607
I1307K O 1 0.9999767541885376
in O 0 0.049921486526727676
cancer B-Disease 1 0.9999998807907104
, O 0 0.021690845489501953
we O 0 0.017518796026706696
genotyped O 1 0.9428113102912903
5 O 0 0.03207367658615112
, O 0 0.030000003054738045
081 O 1 0.9994358420372009
Ashkenazi O 1 0.9828361868858337
volunteers O 0 0.05131179466843605
in O 0 0.01762552186846733
a O 0 0.028920669108629227
community O 0 0.04456700384616852
survey O 0 0.048416897654533386
. O 0 0.03602629899978638

Risk O 0 0.0688975527882576
of O 0 0.04216667264699936
developing O 1 0.9999254941940308
colorectal B-Disease 1 1.0
, I-Disease 1 0.9999843835830688
breast I-Disease 1 1.0
and I-Disease 1 0.8009496331214905
other I-Disease 0 0.02811249904334545
cancers I-Disease 1 0.9999841451644897
were O 0 0.013639964163303375
compared O 0 0.01622515171766281
between O 0 0.022097934037446976
genotyped O 1 0.9996329545974731
I1307K O 1 0.9997217059135437
carriers O 0 0.04476664587855339
and O 0 0.017538907006382942
non O 1 0.9676551222801208
- O 1 0.9999885559082031
carriers O 0 0.03439205512404442
and O 0 0.0105841513723135
their O 0 0.010924768634140491
first O 0 0.02696666307747364
- O 1 0.9997908473014832
degree O 0 0.04335964843630791
relatives O 0 0.07386209070682526
. O 0 0.04253452271223068

Sperm O 0 0.08659911155700684
DNA O 0 0.03647216036915779
analysis O 0 0.016062702983617783
in O 0 0.014760631136596203
a O 0 0.04448063299059868
Friedreich B-Disease 1 0.9999997615814209
ataxia I-Disease 1 0.9999998807907104
premutation O 1 0.9999986886978149
carrier O 1 0.9994509816169739
suggests O 0 0.043239250779151917
both O 0 0.027340108528733253
meiotic O 1 0.9993522763252258
and O 0 0.03403549641370773
mitotic O 1 0.9916908740997314
expansion O 0 0.050043657422065735
in O 0 0.024120492860674858
the O 0 0.04348158836364746
FRDA B-Disease 1 0.9999725818634033
gene O 0 0.074447862803936
. O 0 0.044016458094120026

Friedreich B-Disease 1 0.9999998807907104
ataxia I-Disease 1 0.9999998807907104
is O 0 0.057720303535461426
usually O 0 0.02718941867351532
caused O 0 0.03179401531815529
by O 0 0.014083243906497955
an O 0 0.013544063083827496
expansion O 0 0.02475167252123356
of O 0 0.016824599355459213
a O 0 0.030674858018755913
GAA O 1 0.8287001848220825
trinucleotide O 1 0.9969360828399658
repeat O 0 0.06651332229375839
in O 0 0.025372132658958435
intron O 1 0.99872225522995
1 O 0 0.0303255133330822
of O 0 0.022001121193170547
the O 0 0.04142855107784271
FRDA B-Disease 1 0.9999828338623047
gene O 0 0.07276395708322525
. O 0 0.042562078684568405

Occasionally O 0 0.05169003829360008
, O 0 0.02229158952832222
a O 0 0.023342907428741455
fully O 0 0.03536355867981911
expanded O 0 0.039881348609924316
allele O 0 0.1192229688167572
has O 0 0.016195999458432198
been O 0 0.01378671359270811
found O 0 0.011082080192863941
to O 0 0.01399510819464922
arise O 0 0.024090349674224854
from O 0 0.013214575126767159
a O 0 0.022845083847641945
premutation O 1 0.9845992922782898
of O 0 0.02183220162987709
100 O 0 0.02806040272116661
or O 0 0.02204187959432602
less O 0 0.026974648237228394
triplet O 1 0.9984411597251892
repeats O 0 0.09464970976114273
. O 0 0.04867158085107803

We O 0 0.03013964369893074
have O 0 0.014496051706373692
examined O 0 0.033761508762836456
the O 0 0.021154703572392464
sperm O 0 0.035481516271829605
DNA O 0 0.022775031626224518
of O 0 0.021684397011995316
a O 0 0.04529862850904465
premutation O 1 0.9990197420120239
carrier O 1 0.9013518691062927
. O 0 0.05454714223742485

This O 0 0.03880130499601364
mans O 0 0.17633095383644104
leucocyte O 1 0.977042555809021
DNA O 0 0.0403873585164547
showed O 0 0.02570144645869732
one O 0 0.018293404951691628
normal O 0 0.026562144979834557
allele O 0 0.04314384236931801
and O 0 0.014094457030296326
one O 0 0.015845924615859985
allele O 0 0.03738123178482056
of O 0 0.017081890255212784
approximately O 0 0.021603062748908997
100 O 0 0.033358290791511536
repeats O 0 0.05973116308450699
. O 0 0.03953762724995613

His O 0 0.06042434275150299
sperm O 0 0.05424871668219566
showed O 0 0.0255720391869545
an O 0 0.018055826425552368
expanded O 0 0.03204713389277458
allele O 0 0.048353590071201324
in O 0 0.013874812982976437
a O 0 0.02442781813442707
tight O 0 0.045636821538209915
range O 0 0.025722721591591835
centering O 0 0.059773802757263184
on O 0 0.015141133219003677
a O 0 0.016957944259047508
size O 0 0.014781101606786251
of O 0 0.01640443317592144
approximately O 0 0.02686193212866783
320 O 0 0.08826693892478943
trinucleotide O 1 0.9969685673713684
repeats O 0 0.11674945056438446
. O 0 0.05384384095668793

His O 0 0.0660785362124443
affected O 0 0.07235462963581085
son O 1 0.9991264939308167
has O 0 0.03194589167833328
repeat O 0 0.07559382170438766
sizes O 0 0.028865359723567963
of O 0 0.03375217691063881
1040 O 1 0.9984697699546814
and O 0 0.04224870726466179
540 O 0 0.1774013191461563
. O 0 0.0533682182431221

These O 0 0.023003825917840004
data O 0 0.014601076953113079
suggest O 0 0.015331672504544258
that O 0 0.00869482196867466
expansion O 0 0.025142990052700043
occurs O 0 0.014235247857868671
in O 0 0.008221026510000229
two O 0 0.00955883041024208
stages O 0 0.02478288672864437
, O 0 0.012504711747169495
the O 0 0.013182105496525764
first O 0 0.021014094352722168
during O 0 0.029330551624298096
meiosis O 1 0.7442773580551147
followed O 0 0.029550811275839806
by O 0 0.018116822466254234
a O 0 0.027840396389365196
second O 0 0.05305420979857445
mitotic O 1 0.9974537491798401
expansion O 0 0.08736110478639603
. O 0 0.05166761204600334

We O 0 0.028134897351264954
also O 0 0.017346542328596115
show O 0 0.014510273933410645
that O 0 0.0064631374552845955
in O 0 0.007197146769613028
all O 0 0.00998339056968689
informative O 0 0.03574967384338379
carrier O 0 0.20709356665611267
father O 0 0.038224756717681885
to O 0 0.016086330637335777
affected O 0 0.029459776356816292
child O 1 0.9924037456512451
transmissions O 0 0.17448388040065765
, O 0 0.012059935368597507
with O 0 0.008433193899691105
the O 0 0.011962930671870708
notable O 0 0.01565883494913578
exception O 0 0.019034501165151596
of O 0 0.014336773194372654
the O 0 0.02601197548210621
premutation O 1 0.9999932050704956
carrier O 1 0.9905823469161987
, O 0 0.015488787554204464
the O 0 0.017671601846814156
expansion O 0 0.03735417127609253
size O 0 0.02783222123980522
decreases O 0 0.05048204958438873
. O 0 0.025146566331386566
. O 0 0.033414892852306366

The O 0 0.06779953837394714
R496H O 1 0.9572149515151978
mutation O 0 0.06769141554832458
of O 0 0.035223644226789474
arylsulfatase O 1 0.9996442794799805
A O 0 0.07448891550302505
does O 0 0.02710897848010063
not O 0 0.024877311661839485
cause O 1 0.9407588243484497
metachromatic B-Disease 1 0.9999990463256836
leukodystrophy I-Disease 1 0.9999998807907104
. O 0 0.08769781142473221

Deficiency B-Disease 1 0.9999990463256836
of I-Disease 0 0.05978911742568016
arylsulfatase I-Disease 1 0.9999570846557617
A I-Disease 1 0.9869896769523621
( O 0 0.15248467028141022
ARSA O 1 0.9999996423721313
) O 0 0.04006534442305565
enzyme O 0 0.0771966278553009
activity O 0 0.04445573315024376
causes O 1 0.9987039566040039
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9990823268890381
MLD B-Disease 1 1.0
) O 0 0.06081320717930794
. O 0 0.04720180481672287

A O 0 0.04070541635155678
number O 0 0.01783631183207035
of O 0 0.03382484242320061
ARSA O 1 0.9999996423721313
gene O 0 0.06434758007526398
mutations O 0 0.037204936146736145
responsible O 0 0.037045612931251526
for O 0 0.038692086935043335
MLD B-Disease 1 1.0
have O 0 0.02172544226050377
been O 0 0.024124454706907272
identified O 0 0.034182269126176834
. O 0 0.03385797515511513

Recently O 0 0.062452282756567
, O 0 0.025565166026353836
the O 0 0.029135674238204956
R496H O 1 0.9893988370895386
mutation O 0 0.05884934961795807
of O 0 0.03361826390028
ARSA O 1 0.9999960660934448
was O 0 0.02888507954776287
proposed O 0 0.017158862203359604
to O 0 0.011011083610355854
be O 0 0.007887845858931541
a O 0 0.01576189324259758
cause O 0 0.03273066505789757
of O 0 0.03859106823801994
MLD B-Disease 1 1.0
( O 0 0.05802883952856064
Draghia O 1 0.9999159574508667
et O 1 0.678585410118103
al O 1 0.8996630907058716
. O 0 0.019285157322883606
, O 0 0.021618196740746498
1997 O 0 0.041690487414598465
) O 0 0.032963208854198456
. O 0 0.0341784730553627

We O 0 0.025864627212285995
have O 0 0.012140609323978424
investigated O 0 0.03211352601647377
the O 0 0.0275182593613863
R496H O 1 0.9998776912689209
mutation O 0 0.05302968993782997
and O 0 0.01459086500108242
found O 0 0.011860400438308716
this O 0 0.010354304686188698
mutation O 0 0.02641739882528782
at O 0 0.015186003409326077
a O 0 0.015814466401934624
relatively O 0 0.015312306582927704
high O 0 0.02236068993806839
frequency O 0 0.014398370869457722
in O 0 0.008181898854672909
an O 0 0.010528434999287128
African O 0 0.021889403462409973
American O 0 0.0239387359470129
population O 0 0.0175466388463974
( O 0 0.025382017716765404
f O 0 0.06264199316501617
= O 0 0.04560429975390434
0 O 0 0.03157254680991173
. O 0 0.017416998744010925
09 O 0 0.07157763838768005
, O 0 0.027622397989034653
n O 0 0.06956800818443298
= O 0 0.0638989731669426
61 O 0 0.06041368097066879
subjects O 0 0.04921875521540642
) O 0 0.034237343817949295
. O 0 0.03716104477643967

The O 0 0.09747999161481857
ARSA O 1 0.9999996423721313
enzyme O 1 0.9463498592376709
activity O 0 0.03067951649427414
in O 0 0.015061781741678715
subjects O 0 0.022933799773454666
with O 0 0.013166266493499279
and O 0 0.013043464161455631
without O 0 0.012832590378820896
the O 0 0.023681877180933952
R496H O 1 0.9999673366546631
mutation O 0 0.1706950068473816
was O 0 0.028429444879293442
determined O 0 0.023835692554712296
and O 0 0.013857989571988583
found O 0 0.012717355042696
to O 0 0.014382220804691315
be O 0 0.015613528899848461
normal O 0 0.033662326633930206
. O 0 0.03539745882153511

It O 0 0.032005906105041504
is O 0 0.02239806018769741
therefore O 0 0.01692473329603672
concluded O 0 0.020950254052877426
that O 0 0.008569245226681232
the O 0 0.01933951862156391
R496H O 1 0.9943082928657532
mutation O 0 0.05656856670975685
of O 0 0.03722970187664032
ARSA O 1 0.9999994039535522
does O 0 0.024383777752518654
not O 0 0.012469361536204815
negatively O 0 0.023853139951825142
influence O 0 0.018685223534703255
the O 0 0.014515470713376999
activity O 0 0.01913553476333618
of O 0 0.02555803209543228
ARSA O 1 0.9999991655349731
and O 0 0.02322794310748577
is O 0 0.015651917085051537
not O 0 0.011905213817954063
a O 0 0.02597089670598507
cause O 0 0.17004580795764923
of O 0 0.0879746526479721
MLD B-Disease 1 0.9999995231628418

Down O 0 0.0870678573846817
- O 1 0.8481646776199341
regulation O 0 0.03125804290175438
of O 0 0.027355965226888657
transmembrane O 1 0.9975478053092957
carbonic O 1 0.9999288320541382
anhydrases O 1 0.9999754428863525
in O 1 0.9207010865211487
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9984386563301086
lines O 0 0.026762820780277252
by O 0 0.0177406445145607
wild O 0 0.037202898412942886
- O 1 0.9990481734275818
type O 0 0.07324200868606567
von B-Disease 1 0.9972931742668152
Hippel I-Disease 1 0.999995231628418
- I-Disease 1 0.9999978542327881
Lindau I-Disease 1 0.9999527931213379
transgenes O 1 0.9848282933235168
. O 0 0.06458801031112671

To O 0 0.04500976949930191
discover O 0 0.05854138731956482
genes O 0 0.021432561799883842
involved O 0 0.016068385913968086
in O 0 0.017918577417731285
von B-Disease 1 0.9379960894584656
Hippel I-Disease 1 0.9999905824661255
- I-Disease 1 0.9999996423721313
Lindau I-Disease 1 0.9999984502792358
( O 0 0.06262010335922241
VHL B-Disease 1 0.99997878074646
) O 0 0.041850656270980835
- O 1 0.9999387264251709
mediated O 1 0.9974104762077332
carcinogenesis O 1 0.9999445676803589
, O 0 0.020876416936516762
we O 0 0.015193799510598183
used O 0 0.02926163747906685
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9997610449790955
lines O 0 0.0518329031765461
stably O 1 0.8658263683319092
transfected O 1 0.5940697193145752
with O 0 0.022205794230103493
wild O 0 0.04807369038462639
- O 1 0.9999868869781494
type O 1 0.9793455600738525
VHL O 1 0.9999982118606567
- O 1 0.9999412298202515
expressing O 0 0.25975796580314636
transgenes O 1 0.915118932723999
. O 0 0.05591311678290367

Large O 0 0.05701373890042305
- O 1 0.9970031380653381
scale O 0 0.05977747589349747
RNA O 0 0.07191231846809387
differential O 0 0.05332094803452492
display O 0 0.03241610527038574
technology O 0 0.024416647851467133
applied O 0 0.01634182222187519
to O 0 0.01207921002060175
these O 0 0.01015917956829071
cell O 0 0.027537789195775986
lines O 0 0.019791197031736374
identified O 0 0.01650604046881199
several O 0 0.011342604644596577
differentially O 0 0.06686964631080627
expressed O 0 0.026003016158938408
genes O 0 0.01840471848845482
, O 0 0.011106087826192379
including O 0 0.01150455977767706
an O 0 0.02032177336513996
alpha O 1 0.8904644846916199
carbonic O 1 0.9996215105056763
anhydrase O 1 0.9999434947967529
gene O 0 0.061029452830553055
, O 0 0.03468165174126625
termed O 1 0.6137093901634216
CA12 O 1 0.9999233484268188
. O 0 0.06180334463715553

The O 0 0.04597925767302513
deduced O 0 0.07007555663585663
protein O 0 0.029754262417554855
sequence O 0 0.014994804747402668
was O 0 0.017779365181922913
classified O 0 0.017576752230525017
as O 0 0.00953193474560976
a O 0 0.015627993270754814
one O 0 0.02037709392607212
- O 1 0.9997370839118958
pass O 0 0.05088050290942192
transmembrane O 1 0.9946966171264648
CA O 0 0.05347856134176254
possessing O 0 0.02867870032787323
an O 0 0.017537904903292656
apparently O 0 0.030549773946404457
intact O 0 0.05737729370594025
catalytic O 0 0.1661464124917984
domain O 0 0.02867048606276512
in O 0 0.013829661533236504
the O 0 0.03154945746064186
extracellular O 1 0.9995168447494507
CA O 1 0.9825912117958069
module O 1 0.8706615567207336
. O 0 0.04283490031957626

Reintroduced O 0 0.1261916309595108
wild O 0 0.08301641792058945
- O 1 0.9999814033508301
type O 1 0.898888885974884
VHL B-Disease 1 0.9999598264694214
strongly O 0 0.049568191170692444
inhibited O 0 0.10865946114063263
the O 0 0.026543758809566498
overexpression O 0 0.15746434032917023
of O 0 0.018888365477323532
the O 0 0.02666083350777626
CA12 O 1 0.9999549388885498
gene O 0 0.021191546693444252
in O 0 0.010342258028686047
the O 0 0.024426929652690887
parental O 1 0.9999997615814209
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999973773956299
lines O 0 0.06251509487628937
. O 0 0.04060375317931175

Similar O 0 0.029304714873433113
results O 0 0.016099799424409866
were O 0 0.010629076510667801
obtained O 0 0.016528239473700523
with O 0 0.019313324242830276
CA9 O 1 0.9999812841415405
, O 0 0.022483397275209427
encoding O 0 0.032233186066150665
another O 0 0.034277983009815216
transmembrane O 1 0.9957869648933411
CA O 0 0.045934077352285385
with O 0 0.016041146591305733
an O 0 0.024519484490156174
intact O 0 0.30223822593688965
catalytic O 1 0.959604024887085
domain O 0 0.06573090702295303
. O 0 0.039511460810899734

Although O 0 0.02883155271410942
both O 0 0.018156059086322784
domains O 0 0.03172452747821808
of O 0 0.022152723744511604
the O 0 0.058121662586927414
VHL B-Disease 1 0.9999992847442627
protein O 0 0.04011959955096245
contribute O 0 0.02392098493874073
to O 0 0.014263740740716457
regulation O 0 0.02177322842180729
of O 0 0.023799428716301918
CA12 O 1 0.9999966621398926
expression O 0 0.03543635457754135
, O 0 0.016903340816497803
the O 0 0.02165979892015457
elongin O 1 0.9984299540519714
binding O 0 0.045423559844493866
domain O 0 0.03675074130296707
alone O 0 0.026614487171173096
could O 0 0.017726540565490723
effectively O 0 0.04569157958030701
regulate O 0 0.09669911116361618
CA9 O 1 0.9999717473983765
expression O 0 0.07880730926990509
. O 0 0.0497066006064415

We O 0 0.0546790286898613
mapped O 0 0.10246527194976807
CA12 O 1 0.9972726702690125
and O 0 0.060500480234622955
CA9 O 1 0.9999779462814331
loci O 0 0.15227989852428436
to O 0 0.04340818524360657
chromosome O 0 0.08497130870819092
bands O 0 0.07697079330682755
15q22 O 1 0.9950095415115356
and O 0 0.051553875207901
17q21 O 1 0.9987949132919312
. O 0 0.05690745264291763

2 O 0 0.06075878441333771
respectively O 0 0.04355570673942566
, O 0 0.028741123154759407
regions O 0 0.03305881842970848
prone O 1 0.5166234970092773
to O 0 0.027843307703733444
amplification O 0 0.07745835185050964
in O 0 0.016860248520970345
some O 0 0.020654454827308655
human O 0 0.46024397015571594
cancers B-Disease 1 0.9999912977218628
. O 0 0.05656089633703232

Additional O 0 0.048925649374723434
experiments O 0 0.03701304271817207
are O 0 0.009692415595054626
needed O 0 0.017305826768279076
to O 0 0.012113114818930626
define O 0 0.019740505144000053
the O 0 0.014580809511244297
role O 0 0.025077063590288162
of O 0 0.025170745328068733
CA O 1 0.996864378452301
IX O 1 0.9999995231628418
and O 0 0.04418114200234413
CA O 1 0.9984619617462158
XII O 1 0.9999998807907104
enzymes O 0 0.04911448433995247
in O 0 0.01271597109735012
the O 0 0.01666652411222458
regulation O 0 0.024892406538128853
of O 0 0.024031711742281914
pH O 1 0.9995129108428955
in O 0 0.01615218259394169
the O 0 0.027013739570975304
extracellular O 1 0.9970255494117737
microenvironment O 1 0.9976577758789062
and O 0 0.014845834113657475
its O 0 0.014562488533556461
potential O 0 0.022379286587238312
impact O 0 0.02846238948404789
on O 0 0.054208554327487946
cancer B-Disease 1 1.0
cell O 1 0.9972805976867676
growth O 0 0.0554194450378418
. O 0 0.04121513292193413

A O 0 0.057746537029743195
gene O 0 0.03719959035515785
encoding O 0 0.028203926980495453
a O 0 0.029667770490050316
transmembrane O 1 0.8799102902412415
protein O 0 0.026556430384516716
is O 0 0.013119733892381191
mutated O 0 0.03422529995441437
in O 0 0.014791597612202168
patients O 1 0.9981905817985535
with O 1 0.9980112314224243
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999997615814209
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.3763452172279358
. O 0 0.05162787809967995

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9990043044090271
WFS B-Disease 1 1.0
; O 0 0.12210575491189957
OMIM O 1 0.9999995231628418
222300 O 1 0.9995042085647583
) O 0 0.021640056744217873
is O 0 0.015433330088853836
an O 0 0.027294892817735672
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.8884698748588562
by O 0 0.02717016637325287
young O 1 0.9996917247772217
- O 1 0.9999997615814209
onset O 1 0.9999998807907104
non O 1 0.9999878406524658
- O 1 1.0
immune O 1 1.0
insulin B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
dependent I-Disease 1 0.9999442100524902
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999731779098511
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 0.19012592732906342

Linkage O 0 0.13434091210365295
to O 0 0.03331391140818596
markers O 0 0.053016871213912964
on O 0 0.029596272855997086
chromosome O 1 0.5338442921638489
4p O 1 0.9999759197235107
was O 0 0.030207376927137375
confirmed O 0 0.02386324666440487
in O 0 0.013221384026110172
five O 0 0.020661044865846634
families O 0 0.036562688648700714
. O 0 0.038034263998270035

On O 0 0.0236689280718565
the O 0 0.01591736637055874
basis O 0 0.013462436385452747
of O 0 0.022627484053373337
meiotic O 1 0.9999960660934448
recombinants O 1 0.9999992847442627
and O 1 0.9904487729072571
disease O 1 1.0
- O 1 0.9999998807907104
associated O 0 0.04857080802321434
haplotypes O 1 0.6934680938720703
, O 0 0.01800771988928318
the O 0 0.03038625791668892
WFS B-Disease 1 0.9999996423721313
gene O 0 0.037842828780412674
was O 0 0.025457384064793587
localized O 0 0.03823411837220192
to O 0 0.016437217593193054
a O 0 0.03854289650917053
BAC O 1 0.9999997615814209
/ O 1 0.9999891519546509
P1 O 1 0.9999215602874756
contig O 1 0.9719100594520569
of O 0 0.024264059960842133
less O 0 0.01667303591966629
than O 0 0.016712890937924385
250 O 0 0.05023731291294098
kb O 0 0.18382976949214935
. O 0 0.05563761666417122

Mutations O 0 0.053094908595085144
in O 0 0.01823132298886776
a O 0 0.02785431034862995
novel O 0 0.058709532022476196
gene O 0 0.042933035641908646
( O 0 0.030225683003664017
WFS1 O 1 0.9996904134750366
) O 0 0.018362347036600113
encoding O 0 0.020651381462812424
a O 0 0.02645309828221798
putative O 1 0.9969972372055054
transmembrane O 1 0.9962241649627686
protein O 0 0.02607101947069168
were O 0 0.008237909525632858
found O 0 0.009023967199027538
in O 0 0.00850681308656931
all O 0 0.010004696436226368
affected O 0 0.019216904416680336
individuals O 0 0.01124701090157032
in O 0 0.011795060709118843
six O 0 0.030680665746331215
WFS B-Disease 1 0.9999998807907104
families O 0 0.03510670363903046
, O 0 0.017122896388173103
and O 0 0.012890792451798916
these O 0 0.008803403936326504
mutations O 0 0.017102712765336037
were O 0 0.008541552349925041
associated O 0 0.017404507845640182
with O 0 0.02020590752363205
the O 1 0.9914690852165222
disease O 1 1.0
phenotype O 1 0.9999973773956299
. O 0 0.06459319591522217

WFS1 O 1 0.9996693134307861
appears O 0 0.05737677961587906
to O 0 0.02178115025162697
function O 0 0.01852361112833023
in O 0 0.01053516287356615
survival O 0 0.03155042603611946
of O 0 0.02282060496509075
islet O 1 0.9999966621398926
beta O 1 0.9999969005584717
- O 1 1.0
cells O 0 0.3743165135383606
and O 0 0.03033873625099659
neurons O 0 0.053181592375040054
. O 0 0.025006888434290886
. O 0 0.03671637177467346

Stable O 0 0.4558488130569458
interaction O 0 0.04000671207904816
between O 0 0.018253816291689873
the O 0 0.017703764140605927
products O 0 0.01862463168799877
of O 0 0.016529936343431473
the O 0 0.030750013887882233
BRCA1 O 1 0.9999839067459106
and O 0 0.3053176999092102
BRCA2 O 1 0.9999998807907104
tumor B-Disease 1 1.0
suppressor O 1 0.9999986886978149
genes O 0 0.03580290079116821
in O 0 0.02437490224838257
mitotic O 1 0.9976115226745605
and O 0 0.05940764769911766
meiotic O 1 0.9999971389770508
cells O 1 0.548930287361145
. O 0 0.05453616380691528

BRCA1 O 1 0.9998457431793213
and O 0 0.04961886256933212
BRCA2 O 1 0.997442364692688
account O 0 0.022228209301829338
for O 0 0.011972395703196526
most O 0 0.009975476190447807
cases O 0 0.013344181701540947
of O 0 0.02009313553571701
familial O 1 0.9999991655349731
, O 0 0.024440238252282143
early O 0 0.3988673686981201
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9995130300521851
/ I-Disease 1 1.0
or I-Disease 1 0.999998927116394
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.8900682330131531
encode O 0 0.03888760507106781
products O 0 0.02133455127477646
that O 0 0.009594534523785114
each O 0 0.012608470395207405
interact O 0 0.028366753831505775
with O 0 0.02753366529941559
hRAD51 O 1 0.9965783953666687
. O 0 0.05075635388493538

Results O 0 0.03325894847512245
presented O 0 0.03168856352567673
here O 0 0.019734647125005722
show O 0 0.0232863649725914
that O 0 0.01847763918340206
BRCA1 O 1 0.998529314994812
and O 0 0.03680359199643135
BRCA2 O 1 0.9995614886283875
coexist O 0 0.05318719893693924
in O 0 0.017186984419822693
a O 0 0.027700822800397873
biochemical O 0 0.1346711665391922
complex O 0 0.028302906081080437
and O 0 0.019418269395828247
colocalize O 1 0.983651876449585
in O 0 0.02254430577158928
subnuclear O 1 0.9997736811637878
foci O 1 0.999097466468811
in O 0 0.03332822769880295
somatic O 1 0.999708354473114
cells O 0 0.0392988845705986
and O 0 0.016104204580187798
on O 0 0.016147704795002937
the O 0 0.023239966481924057
axial O 0 0.06421412527561188
elements O 0 0.02687900885939598
of O 0 0.030705006793141365
developing O 0 0.13572564721107483
synaptonemal O 1 0.9999650716781616
complexes O 1 0.9198170304298401
. O 0 0.05381843075156212

Like O 0 0.09570082277059555
BRCA1 O 1 0.9995063543319702
and O 0 0.06003759056329727
RAD51 O 1 0.9999873638153076
, O 0 0.06682483851909637
BRCA2 O 1 0.9976356029510498
relocates O 1 0.9714104533195496
to O 0 0.05445762351155281
PCNA O 1 0.9999454021453857
+ O 1 0.8279532790184021
replication O 0 0.06407006084918976
sites O 0 0.019713759422302246
following O 0 0.018958041444420815
exposure O 0 0.042355913668870926
of O 0 0.030470527708530426
S O 1 0.9999980926513672
phase O 1 0.99434894323349
cells O 0 0.04598408564925194
to O 0 0.03741009533405304
hydroxyurea O 1 0.9999364614486694
or O 0 0.14589470624923706
UV O 1 0.9999991655349731
irradiation O 1 0.9978845715522766
. O 0 0.061820127069950104

Thus O 0 0.049001410603523254
, O 0 0.043512020260095596
BRCA1 O 1 0.9997159838676453
and O 0 0.03710563853383064
BRCA2 O 1 0.9998874664306641
participate O 0 0.03172902390360832
, O 0 0.015734856948256493
together O 0 0.012495576404035091
, O 0 0.009183504618704319
in O 0 0.009551971219480038
a O 0 0.023078391328454018
pathway O 1 0.9959062337875366
( O 0 0.027589503675699234
s O 1 0.9868626594543457
) O 0 0.014771404676139355
associated O 0 0.01106022484600544
with O 0 0.00883601326495409
the O 0 0.014103511348366737
activation O 0 0.028903048485517502
of O 0 0.017891034483909607
double O 0 0.47274860739707947
- O 1 0.9999798536300659
strand O 0 0.23723509907722473
break O 0 0.05609774589538574
repair O 1 0.9972220659255981
and O 0 0.04128430783748627
/ O 1 0.9999580383300781
or O 0 0.041968684643507004
homologous O 0 0.15080450475215912
recombination O 0 0.1324741244316101
. O 0 0.050450582057237625

Dysfunction O 1 0.9999974966049194
of O 0 0.04711580276489258
this O 0 0.032488808035850525
pathway O 1 0.9992927312850952
may O 0 0.016831785440444946
be O 0 0.008626926690340042
a O 0 0.016014616936445236
general O 0 0.023878468200564384
phenomenon O 0 0.02610849402844906
in O 0 0.00825497042387724
the O 0 0.010214712470769882
majority O 0 0.010061905719339848
of O 0 0.010148845613002777
cases O 0 0.01425124891102314
of O 0 0.06835684925317764
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999985694885254
/ I-Disease 1 1.0
or I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.40584078431129456
. O 0 0.04343441501259804

A O 0 0.07516630738973618
novel O 0 0.08519855886697769
Arg362Ser O 1 0.9958475232124329
mutation O 0 0.041704896837472916
in O 0 0.012004533782601357
the O 0 0.01983407698571682
sterol O 1 0.8761319518089294
27 O 0 0.04949357360601425
- O 1 0.9999918937683105
hydroxylase O 1 0.9999642372131348
gene O 0 0.04376167058944702
( O 0 0.03196670487523079
CYP27 O 1 0.999967098236084
) O 0 0.019421545788645744
: O 0 0.013036160729825497
its O 0 0.011535890400409698
effects O 0 0.01718595251441002
on O 0 0.014583516865968704
pre O 0 0.3392292857170105
- O 1 0.9997974038124084
mRNA O 0 0.05098343640565872
splicing O 0 0.048491910099983215
and O 0 0.02439057268202305
enzyme O 0 0.05486474558711052
activity O 0 0.040818922221660614
. O 0 0.03746727108955383

A O 0 0.06914689391851425
novel O 0 0.07553071528673172
C O 0 0.1450730860233307
to O 0 0.01990770921111107
A O 0 0.028679726645350456
mutation O 0 0.0250833909958601
in O 0 0.008703424595296383
the O 0 0.0159557294100523
sterol O 1 0.8596543073654175
27 O 0 0.04438573122024536
- O 1 0.9999914169311523
hydroxylase O 1 0.9999676942825317
gene O 0 0.042939744889736176
( O 0 0.028744207695126534
CYP27 O 1 0.9997976422309875
) O 0 0.017140425741672516
was O 0 0.017779331654310226
identified O 0 0.015519361943006516
by O 0 0.012348981574177742
sequencing O 0 0.0345044881105423
amplified O 0 0.07734769582748413
CYP27 O 1 0.9998873472213745
gene O 0 0.03414672240614891
products O 0 0.019308030605316162
from O 0 0.013026620261371136
a O 0 0.023040568456053734
patient O 1 0.9785810112953186
with O 0 0.038686033338308334
cerebrotendinous B-Disease 1 0.9999998807907104
xanthomatosis I-Disease 1 1.0
( O 1 0.9727782011032104
CTX B-Disease 1 0.9999997615814209
) O 0 0.052342429757118225
. O 0 0.04550269991159439

The O 0 0.059010427445173264
mutation O 0 0.06226827949285507
changed O 0 0.03392210602760315
the O 0 0.03749139979481697
adrenodoxin O 1 0.9995409250259399
cofactor O 1 0.9996402263641357
binding O 0 0.06363115459680557
residue O 0 0.11076919734477997
362Arg O 1 0.6406561732292175
to O 0 0.034906983375549316
362Ser O 1 0.9439692497253418
( O 0 0.044161055237054825
CGT O 1 0.9991713762283325
362Arg O 1 0.9707278609275818
to O 0 0.050958048552274704
AGT O 1 1.0
362Ser O 1 0.9999845027923584
) O 0 0.023081596940755844
, O 0 0.01308814249932766
and O 0 0.010457958094775677
was O 0 0.018021296709775925
responsible O 0 0.03212738409638405
for O 0 0.032806169241666794
deficiency O 1 1.0
in O 0 0.016019202768802643
the O 0 0.0264106597751379
sterol O 1 0.9999415874481201
27 O 0 0.4975699186325073
- O 1 0.9999996423721313
hydroxylase O 1 0.9998704195022583
activity O 0 0.023322714492678642
, O 0 0.011342400684952736
as O 0 0.009724598377943039
confirmed O 0 0.013047872111201286
by O 0 0.01090841181576252
expression O 0 0.017362773418426514
of O 0 0.015658635646104813
mutant O 0 0.06477436423301697
cDNA O 0 0.08022962510585785
into O 0 0.037053804844617844
COS O 1 0.9999971389770508
- O 1 0.9999828338623047
1 O 0 0.06983332335948944
cells O 0 0.05559050664305687
. O 0 0.03729585185647011

Quantitative O 0 0.06996209919452667
analysis O 0 0.02188473753631115
showed O 0 0.017116781324148178
that O 0 0.008805126883089542
the O 0 0.014609022997319698
expression O 0 0.022125374525785446
of O 0 0.0227004736661911
CYP27 O 1 0.9999916553497314
gene O 0 0.03688782453536987
mRNA O 0 0.03333163261413574
in O 0 0.01204023789614439
the O 0 0.023095518350601196
patient O 1 0.839921772480011
represented O 0 0.035212308168411255
52 O 0 0.06980374455451965
. O 0 0.0463404506444931

5 O 0 0.04211059957742691
% O 0 0.021916596218943596
of O 0 0.020797662436962128
the O 0 0.02972336672246456
normal O 0 0.04687858372926712
level O 0 0.049345530569553375
. O 0 0.04013853147625923

As O 0 0.037269964814186096
the O 0 0.03630809113383293
mutation O 0 0.046872835606336594
occurred O 0 0.025522001087665558
at O 0 0.01817655749619007
the O 0 0.020111752673983574
penultimate O 1 0.8428915739059448
nucleotide O 0 0.037989016622304916
of O 0 0.01931651122868061
exon O 0 0.42651769518852234
6 O 0 0.036230381578207016
( O 0 0.02398596704006195
- O 0 0.3248153030872345
2 O 0 0.019385453313589096
position O 0 0.016334688290953636
of O 0 0.016340449452400208
exon O 0 0.07513964176177979
6 O 0 0.04399722442030907
- O 1 0.9985607266426086
intron O 1 0.9985815286636353
6 O 0 0.04076831415295601
splice O 0 0.07205779105424881
site O 0 0.023087864741683006
) O 0 0.009088872000575066
of O 0 0.010087277740240097
the O 0 0.017264487221837044
gene O 0 0.02389431558549404
, O 0 0.012575234286487103
we O 0 0.009514006786048412
hypothesized O 0 0.025844959542155266
that O 0 0.008056707680225372
the O 0 0.01800188049674034
mutation O 0 0.08700218051671982
may O 0 0.017805757001042366
partially O 0 0.03009728714823723
affect O 0 0.016754040494561195
the O 0 0.015419810079038143
normal O 0 0.025810593739151955
splicing O 0 0.03631550818681717
efficiency O 0 0.02384289540350437
in O 0 0.012351435609161854
exon O 0 0.11315564811229706
6 O 0 0.02837885543704033
and O 0 0.01660018227994442
cause O 0 0.03970656543970108
alternative O 0 0.035663679242134094
splicing O 0 0.03996548056602478
elsewhere O 0 0.017310045659542084
, O 0 0.012063459493219852
which O 0 0.009202340617775917
resulted O 0 0.018796388059854507
in O 0 0.014755853451788425
decreased O 0 0.04727715253829956
transcript O 0 0.044536273926496506
in O 0 0.017291156575083733
the O 0 0.034986309707164764
patient O 1 0.9998061060905457
. O 0 0.051971979439258575

Transfection O 1 0.9505649209022522
of O 0 0.04781524837017059
constructed O 0 0.3824416995048523
minigenes O 1 0.999750554561615
, O 0 0.02268356829881668
with O 0 0.014574240893125534
or O 0 0.011450424790382385
without O 0 0.010065625421702862
the O 0 0.014264369383454323
mutation O 0 0.02456009015440941
, O 0 0.012189727276563644
into O 0 0.019473450258374214
COS O 1 0.9999998807907104
- O 1 0.9999969005584717
1 O 0 0.0329165905714035
cells O 0 0.018365133553743362
confirmed O 0 0.010948944836854935
that O 0 0.006049912888556719
the O 0 0.015342021360993385
mutant O 1 0.5070400238037109
minigene O 1 0.9988214373588562
was O 0 0.028207799419760704
responsible O 0 0.02451331354677677
for O 0 0.012622950598597527
a O 0 0.017409728839993477
mRNA O 0 0.031113630160689354
species O 0 0.009622402489185333
alternatively O 0 0.028770005330443382
spliced O 0 0.03681633993983269
at O 0 0.01697349175810814
an O 0 0.022954579442739487
activated O 1 0.933557391166687
cryptic O 0 0.08288221061229706
5 O 0 0.03289936110377312
splice O 0 0.07925904542207718
site O 0 0.0317750982940197
88 O 0 0.0506901741027832
bp O 0 0.05232376977801323
upstream O 0 0.03055610880255699
from O 0 0.012489975430071354
the O 0 0.016091885045170784
3 O 0 0.02251046895980835
end O 0 0.028550954535603523
of O 0 0.0335831418633461
exon O 1 0.5949389338493347
6 O 0 0.06702850759029388
. O 0 0.046988289803266525

Our O 0 0.0436675064265728
data O 0 0.01752612739801407
suggest O 0 0.014052853919565678
that O 0 0.007455546874552965
the O 0 0.016349902376532555
C O 0 0.0765480175614357
to O 0 0.016192181035876274
A O 0 0.029406005516648293
mutation O 0 0.02742498181760311
at O 0 0.015757102519273758
the O 0 0.019385818392038345
penultimate O 1 0.9769390225410461
nucleotide O 0 0.03282744809985161
of O 0 0.016036171466112137
exon O 0 0.055100467056035995
6 O 0 0.01911807805299759
of O 0 0.013983151875436306
the O 0 0.022882478311657906
CYP27 O 1 0.9999874830245972
gene O 0 0.025853805243968964
not O 0 0.008710350841283798
only O 0 0.010956517420709133
causes O 0 0.34520891308784485
the O 0 0.16500815749168396
deficiency B-Disease 1 1.0
in I-Disease 0 0.015529368072748184
the I-Disease 0 0.024477718397974968
sterol I-Disease 1 0.9999309778213501
27 I-Disease 1 0.5431796312332153
- I-Disease 1 0.9999996423721313
hydroxylase I-Disease 1 0.9999902248382568
activity I-Disease 0 0.02727128192782402
, O 0 0.01465662196278572
but O 0 0.011625106446444988
also O 0 0.013394462876021862
partially O 0 0.03208079934120178
leads O 0 0.02865399606525898
to O 0 0.016607625409960747
alternative O 0 0.02952692098915577
pre O 0 0.0794903114438057
- O 1 0.9864802956581116
mRNA O 0 0.04576394706964493
splicing O 0 0.03291109576821327
of O 0 0.018108144402503967
the O 0 0.030883444473147392
gene O 0 0.04668199643492699
. O 0 0.03718722611665726

To O 0 0.03089212439954281
our O 0 0.030045660212635994
knowledge O 0 0.026186054572463036
, O 0 0.013822436332702637
this O 0 0.007958794012665749
is O 0 0.00898347981274128
the O 0 0.01046193577349186
first O 0 0.013767172582447529
report O 0 0.013151486404240131
regarding O 0 0.01771099865436554
effects O 0 0.01953171379864216
on O 0 0.016164271160960197
pre O 0 0.22476591169834137
- O 1 0.9944199919700623
mRNA O 0 0.03256222978234291
splicing O 0 0.022748028859496117
of O 0 0.010132917203009129
a O 0 0.016880756244063377
mutation O 0 0.026575105264782906
at O 0 0.013834258541464806
the O 0 0.020359886810183525
- O 1 0.9913724660873413
2 O 0 0.020568612962961197
position O 0 0.016534866765141487
of O 0 0.013174118474125862
a O 0 0.02347685396671295
5 O 0 0.040370408445596695
splice O 0 0.13345062732696533
site O 0 0.05111648514866829
. O 0 0.0360570028424263

ATM O 1 0.9057134985923767
germline O 1 0.6776366233825684
mutations O 0 0.04187840223312378
in O 0 0.021915623918175697
classical O 0 0.4600870907306671
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999059438705444
in O 0 0.02151372656226158
the O 0 0.029397593811154366
Dutch O 0 0.08054432272911072
population O 0 0.03201626241207123
. O 0 0.03512775897979736

Germline O 1 0.991961658000946
mutations O 0 0.05287408083677292
in O 0 0.01926332712173462
the O 0 0.03060777299106121
ATM O 1 0.9454626441001892
gene O 0 0.021206041797995567
are O 0 0.0058665950782597065
responsible O 0 0.015497018583118916
for O 0 0.0123292226344347
the O 0 0.039596304297447205
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.994968831539154
A B-Disease 1 0.9999985694885254
- I-Disease 1 1.0
T I-Disease 1 0.9999996423721313
) O 0 0.037575237452983856
. O 0 0.033837612718343735

In O 0 0.033447254449129105
our O 0 0.03171991929411888
study O 0 0.023453541100025177
, O 0 0.016161050647497177
we O 0 0.009222771972417831
have O 0 0.006855642888695002
determined O 0 0.01519827265292406
the O 0 0.018795235082507133
ATM O 1 0.7017751932144165
mutation O 0 0.03488074243068695
spectrum O 0 0.024080706760287285
in O 0 0.009087798185646534
19 O 0 0.015476029366254807
classical O 0 0.022205142304301262
A B-Disease 1 0.9992343187332153
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9990577101707458
, O 0 0.012705900706350803
including O 0 0.009223878383636475
some O 0 0.008694223128259182
immigrant O 0 0.048243019729852676
populations O 0 0.019889703020453453
, O 0 0.013344382867217064
as O 0 0.011375905945897102
well O 0 0.010002600029110909
as O 0 0.01155515294522047
12 O 0 0.01684778742492199
of O 0 0.018697384744882584
Dutch O 0 0.049496691673994064
ethnic O 0 0.03933394327759743
origin O 0 0.030489901080727577
. O 0 0.03694615140557289

Both O 0 0.030334213748574257
the O 0 0.03757157176733017
protein O 0 0.048399847000837326
truncation O 0 0.13383840024471283
test O 0 0.044649332761764526
( O 0 0.03521452099084854
PTT O 1 0.8805010914802551
) O 0 0.018506783992052078
and O 0 0.01201530173420906
the O 0 0.019417859613895416
restriction O 0 0.04836549609899521
endonuclease O 1 0.9949517250061035
fingerprinting O 1 0.8459521532058716
( O 0 0.04490206018090248
REF O 1 0.9998984336853027
) O 0 0.019240494817495346
method O 0 0.014098434709012508
were O 0 0.008136852644383907
used O 0 0.009432163089513779
and O 0 0.009480110369622707
compared O 0 0.01165656466037035
for O 0 0.010394292883574963
their O 0 0.013172358274459839
detection O 0 0.04439900070428848
efficiency O 0 0.03601083904504776
, O 0 0.017920538783073425
identifying O 0 0.028281530365347862
76 O 0 0.04357783496379852
% O 0 0.015831811353564262
and O 0 0.011296389624476433
60 O 0 0.015374072827398777
% O 0 0.01182618085294962
of O 0 0.01572621986269951
the O 0 0.027778346091508865
mutations O 0 0.04509599879384041
, O 0 0.02670571208000183
respectively O 0 0.040174007415771484
. O 0 0.037147339433431625

Most O 0 0.05386067181825638
patients O 1 0.9857287406921387
were O 0 0.016733920201659203
found O 0 0.015735751017928123
to O 0 0.01879737712442875
be O 0 0.022305410355329514
compound O 0 0.12017082422971725
heterozygote O 1 0.9081571102142334
. O 0 0.053283851593732834

Seventeen O 0 0.11886435002088547
mutations O 0 0.05135172978043556
were O 0 0.015352246351540089
distinct O 0 0.018476396799087524
, O 0 0.013819440267980099
of O 0 0.014036597684025764
which O 0 0.01103002205491066
10 O 0 0.012925996445119381
were O 0 0.00916763860732317
not O 0 0.010563519783318043
reported O 0 0.022768372669816017
previously O 0 0.03244126960635185
. O 0 0.03553245961666107

Mutations O 0 0.07647652924060822
are O 0 0.016606954857707024
small O 0 0.027175357565283775
deletions O 0 0.06574010848999023
or O 0 0.027752311900258064
point O 0 0.0398811474442482
mutations O 0 0.049445848912000656
frequently O 0 0.03699638694524765
affecting O 0 0.06642502546310425
splice O 0 0.15115806460380554
sites O 0 0.05027027055621147
. O 0 0.04009592533111572

Moreover O 0 0.09085743874311447
, O 0 0.03588351979851723
a O 0 0.040708236396312714
16 O 0 0.055723898112773895
. O 0 0.04797811806201935

7 O 0 0.0888851061463356
- O 1 0.999554455280304
kb O 1 0.8595774173736572
genomic O 0 0.06536924839019775
deletion O 0 0.051171913743019104
of O 0 0.017489111050963402
the O 0 0.018500924110412598
3 O 0 0.019002892076969147
end O 0 0.0175691619515419
of O 0 0.015474664978682995
the O 0 0.02294965274631977
gene O 0 0.0261988528072834
, O 0 0.012261413969099522
most O 0 0.009308231063187122
likely O 0 0.012712828814983368
a O 0 0.01320347934961319
result O 0 0.012010439299046993
of O 0 0.014828898012638092
recombination O 0 0.04190809652209282
between O 0 0.014637778513133526
two O 0 0.013006776571273804
LINE O 0 0.048781994730234146
elements O 0 0.02485291101038456
, O 0 0.018504280596971512
was O 0 0.030287355184555054
identified O 0 0.03606593608856201
. O 0 0.033922936767339706

The O 0 0.04029299318790436
most O 0 0.02265525981783867
frequently O 0 0.02440946362912655
found O 0 0.020601291209459305
mutation O 0 0.03244122490286827
, O 0 0.012947039678692818
identified O 0 0.011756017804145813
in O 0 0.006126418709754944
three O 0 0.007424629759043455
unrelated O 0 0.019584720954298973
Turkish O 0 0.03286605700850487
A B-Disease 1 0.999945878982544
- I-Disease 1 1.0
T I-Disease 1 0.9999996423721313
individuals O 0 0.016436276957392693
, O 0 0.01341501995921135
was O 0 0.017617687582969666
previously O 0 0.015561621636152267
described O 0 0.01515920553356409
to O 0 0.00901938509196043
be O 0 0.005968322977423668
a O 0 0.010961686260998249
Turkish O 0 0.027754180133342743
A B-Disease 1 0.9984562397003174
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999997615814209
founder O 1 0.999828577041626
mutation O 0 0.09614111483097076
. O 0 0.04146121069788933

The O 0 0.0337086021900177
presence O 0 0.028351960703730583
of O 0 0.018066691234707832
a O 0 0.030725602060556412
founder O 1 0.9999790191650391
mutation O 0 0.3584279716014862
among O 0 0.022109195590019226
relatively O 0 0.019093822687864304
small O 0 0.014363515190780163
ethnic O 0 0.019430311396718025
population O 0 0.014409282244741917
groups O 0 0.011372189968824387
in O 0 0.01107254158705473
Western O 0 0.024593448266386986
Europe O 0 0.021409569308161736
could O 0 0.01088894996792078
indicate O 0 0.01252677571028471
a O 0 0.01697481796145439
high O 0 0.04224960505962372
carrier O 1 0.9764037728309631
frequency O 0 0.02289029210805893
in O 0 0.01314252708107233
such O 0 0.015048959292471409
communities O 0 0.03383387252688408
. O 0 0.037401121109724045

In O 0 0.035379160195589066
patients O 0 0.09531321376562119
of O 0 0.022894494235515594
Dutch O 0 0.1012515276670456
ethnic O 0 0.029092825949192047
origin O 0 0.014450106769800186
, O 0 0.011958494782447815
however O 0 0.009347254410386086
, O 0 0.010637867264449596
no O 0 0.011383883655071259
significant O 0 0.017301812767982483
founder O 1 0.9992497563362122
effect O 0 0.026873907074332237
could O 0 0.017859624698758125
be O 0 0.01554938405752182
identified O 0 0.03387821465730667
. O 0 0.030077291652560234

The O 0 0.04919634386897087
observed O 0 0.03945664316415787
genetic O 0 0.03756514936685562
heterogeneity O 0 0.06431417167186737
including O 0 0.014715713448822498
the O 0 0.01773795299232006
relative O 0 0.024581067264080048
high O 0 0.021697329357266426
percentage O 0 0.017392180860042572
of O 0 0.01889176107943058
splice O 1 0.9937374591827393
- O 1 0.9999371767044067
site O 0 0.037035830318927765
mutations O 0 0.022440267726778984
had O 0 0.0145559748634696
no O 0 0.014310557395219803
reflection O 0 0.04106980189681053
on O 0 0.02114017866551876
the O 0 0.034035734832286835
phenotype O 1 0.932884156703949
. O 0 0.04394698143005371

All O 0 0.04447739198803902
patients O 1 0.5659116506576538
manifested O 1 0.5888903737068176
classical O 0 0.06096383556723595
A B-Disease 1 0.9999598264694214
- I-Disease 1 1.0
T I-Disease 1 0.9999971389770508
and O 0 0.02379477210342884
increased O 0 0.037011224776506424
cellular O 0 0.37313321232795715
radioresistant O 1 0.9984782338142395
DNA O 0 0.064964659512043
synthesis O 0 0.06823746114969254
. O 0 0.042248256504535675

Determination O 0 0.07049879431724548
of O 0 0.027198726311326027
the O 0 0.029407719150185585
genomic O 0 0.046615056693553925
structure O 0 0.02200532890856266
of O 0 0.015595179982483387
the O 0 0.027620529755949974
COL4A4 O 1 0.9999988079071045
gene O 0 0.027815409004688263
and O 0 0.012029727920889854
of O 0 0.020319467410445213
novel O 0 0.08088134229183197
mutations O 1 0.5504574775695801
causing O 1 0.999672532081604
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9988320469856262

Autosomal B-Disease 1 0.9999992847442627
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.8872315883636475
a O 1 0.9699414968490601
progressive O 1 0.9999998807907104
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.999538779258728
by O 1 0.7325043678283691
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999992847442627
abnormalities I-Disease 1 0.999983549118042
and O 0 0.022725453600287437
associated O 0 0.02137639746069908
with O 0 0.015638042241334915
mutations O 0 0.022099951282143593
in O 0 0.009763624519109726
either O 0 0.012120955623686314
the O 0 0.019047005102038383
COL4A3 O 1 0.9999716281890869
or O 0 0.017510171979665756
the O 0 0.02734103798866272
COL4A4 O 1 0.9999988079071045
gene O 0 0.02892756462097168
, O 0 0.012052536010742188
which O 0 0.008585745468735695
encode O 0 0.01587069407105446
the O 0 0.01583337038755417
alpha3 O 0 0.4965764880180359
and O 0 0.027857035398483276
alpha4 O 1 0.9999434947967529
type O 1 0.9999712705612183
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.996768593788147
, O 0 0.04168352857232094
respectively O 0 0.04794443026185036
. O 0 0.04041670635342598

To O 0 0.03203923627734184
date O 0 0.030461104586720467
, O 0 0.022604385390877724
mutation O 0 0.040281977504491806
screening O 0 0.03344067186117172
in O 0 0.009774991311132908
the O 0 0.013110702857375145
two O 0 0.011533845216035843
genes O 0 0.016047675162553787
has O 0 0.012388434261083603
been O 0 0.012952780351042747
hampered O 0 0.11030035465955734
by O 0 0.014034155756235123
the O 0 0.01651495136320591
lack O 0 0.025418823584914207
of O 0 0.02658814564347267
genomic O 0 0.21885202825069427
structure O 0 0.04142419621348381
information O 0 0.02540704235434532
. O 0 0.030711835250258446

We O 0 0.026596402749419212
report O 0 0.018589194864034653
here O 0 0.013192083686590195
the O 0 0.014175951480865479
complete O 0 0.024714473634958267
characterization O 0 0.03715955838561058
of O 0 0.015286257490515709
the O 0 0.01819184608757496
48 O 0 0.02889540232717991
exons O 0 0.03650135174393654
of O 0 0.015008830465376377
the O 0 0.02640952542424202
COL4A4 O 1 0.9999915361404419
gene O 0 0.03196687251329422
, O 0 0.014305958524346352
a O 0 0.019142162054777145
comprehensive O 0 0.2415328025817871
gene O 0 0.03149436414241791
screen O 0 0.02807878889143467
, O 0 0.013124876655638218
and O 0 0.010169350542128086
the O 0 0.014192192815244198
subsequent O 0 0.024083200842142105
detection O 0 0.029659032821655273
of O 0 0.015237211249768734
10 O 0 0.018326079472899437
novel O 0 0.031900227069854736
mutations O 0 0.021259620785713196
in O 0 0.011908050626516342
eight O 0 0.03129462152719498
patients O 1 0.9999947547912598
diagnosed O 1 1.0
with O 1 0.999860405921936
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9996833801269531

Furthermore O 0 0.0753735676407814
, O 0 0.026536131277680397
we O 0 0.01464049518108368
identified O 0 0.021127725020051003
a O 0 0.02498730830848217
glycine O 0 0.06837102770805359
to O 0 0.025386225432157516
alanine O 0 0.1274811327457428
substitution O 0 0.042854323983192444
in O 0 0.015670083463191986
the O 0 0.031193366274237633
collagenous O 1 0.9999957084655762
domain O 0 0.04345371574163437
that O 0 0.014119340106844902
is O 0 0.014803394675254822
apparently O 0 0.024784579873085022
silent O 0 0.04319297894835472
in O 0 0.012946819886565208
the O 0 0.021840238943696022
heterozygous O 0 0.07572440803050995
carriers O 0 0.05745594948530197
, O 0 0.02341393753886223
in O 0 0.019774509593844414
11 O 0 0.039470575749874115
. O 0 0.0382562056183815

5 O 0 0.03474467620253563
% O 0 0.017854992300271988
of O 0 0.014681937173008919
all O 0 0.013458737172186375
control O 0 0.03173346072435379
individuals O 0 0.014141673222184181
, O 0 0.013209328055381775
and O 0 0.010913309641182423
in O 0 0.010326826013624668
one O 0 0.01483964268118143
control O 0 0.025111211463809013
individual O 0 0.017963651567697525
homozygous O 0 0.04039333015680313
for O 0 0.01941913180053234
this O 0 0.023611271753907204
glycine O 1 0.8106930255889893
substitution O 0 0.0861709862947464
. O 0 0.04572499915957451

There O 0 0.029138732701539993
has O 0 0.019330337643623352
been O 0 0.012591765262186527
no O 0 0.010734847746789455
previous O 0 0.01347975991666317
finding O 0 0.0155964819714427
of O 0 0.014357988722622395
a O 0 0.024650802835822105
glycine O 1 0.8775847554206848
substitution O 0 0.03898997604846954
that O 0 0.009863818064332008
is O 0 0.010752149857580662
not O 0 0.0077408691868186
associated O 0 0.011407960206270218
with O 0 0.011419689282774925
any O 0 0.01652057282626629
obvious O 0 0.10531099885702133
phenotype O 1 0.9360610246658325
in O 0 0.027506114915013313
homozygous O 0 0.09141647070646286
individuals O 0 0.036044783890247345
. O 0 0.04507901519536972

Founder O 1 0.9997169375419617
BRCA1 O 1 0.9997649788856506
and O 0 0.05347207188606262
BRCA2 O 1 0.9992620348930359
mutations O 0 0.031352803111076355
in O 0 0.014011952094733715
French O 0 0.048502691090106964
Canadian O 1 0.9975183010101318
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9996427297592163
. O 0 0.06848204880952835

We O 0 0.025121554732322693
have O 0 0.010804408229887486
identified O 0 0.017004581168293953
four O 0 0.012088957242667675
mutations O 0 0.015888167545199394
in O 0 0.007035539951175451
each O 0 0.005024791229516268
of O 0 0.01146142091602087
the O 0 0.15363305807113647
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 1.0
susceptibility O 1 0.9999998807907104
genes O 0 0.032295290380716324
, O 0 0.022070206701755524
BRCA1 O 1 0.9997674822807312
and O 0 0.022584358230233192
BRCA2 O 1 0.9979550838470459
, O 0 0.01192669291049242
in O 0 0.00884877610951662
French O 0 0.0360909029841423
Canadian O 1 0.9984802603721619
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999984502792358
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9426499605178833
from O 0 0.041354384273290634
Quebec O 0 0.49948638677597046
. O 0 0.05095696076750755

To O 0 0.043348416686058044
identify O 0 0.05853217467665672
founder O 1 0.9993752837181091
effects O 0 0.06428505480289459
, O 0 0.022588500753045082
we O 0 0.014347424730658531
examined O 0 0.030179057270288467
independently O 0 0.017604127526283264
ascertained O 0 0.045617956668138504
French O 0 0.045308154076337814
Canadian O 1 0.7509729862213135
cancer B-Disease 1 0.999996542930603
families O 0 0.02083303965628147
for O 0 0.013229741714894772
the O 0 0.016220135614275932
distribution O 0 0.01784447580575943
of O 0 0.015325008891522884
these O 0 0.011638264171779156
eight O 0 0.03148267790675163
mutations O 0 0.052704114466905594
. O 0 0.03684963285923004

Mutations O 0 0.061481330543756485
were O 0 0.016805129125714302
found O 0 0.014193606562912464
in O 0 0.012178738601505756
41 O 0 0.03504312410950661
of O 0 0.028239887207746506
97 O 0 0.13158421218395233
families O 0 0.0527505986392498
. O 0 0.04860721528530121

Six O 0 0.03161877766251564
of O 0 0.025658270344138145
eight O 0 0.03087272122502327
mutations O 0 0.034955400973558426
were O 0 0.014033508487045765
observed O 0 0.019359974190592766
at O 0 0.021140554919838905
least O 0 0.019729213789105415
twice O 0 0.038972727954387665
. O 0 0.03763149306178093

The O 0 0.07135158032178879
BRCA1 O 1 0.9999649524688721
C4446T O 1 0.9999479055404663
mutation O 0 0.3490665853023529
was O 0 0.024856308475136757
the O 0 0.017938634380698204
most O 0 0.0148425018414855
common O 0 0.02443614788353443
mutation O 0 0.03691809996962547
found O 0 0.013532263226807117
, O 0 0.012686283327639103
followed O 0 0.01874668337404728
by O 0 0.018598712980747223
the O 0 0.03970198333263397
BRCA2 O 1 0.9999535083770752
8765delAG O 1 0.9998602867126465
mutation O 0 0.24393127858638763
. O 0 0.051826633512973785

Together O 0 0.04730314761400223
, O 0 0.026200447231531143
these O 0 0.01345837116241455
mutations O 0 0.02217097021639347
were O 0 0.008670204319059849
found O 0 0.009943852201104164
in O 0 0.008403134532272816
28 O 0 0.018982991576194763
of O 0 0.016422400251030922
41 O 0 0.034966934472322464
families O 0 0.022275205701589584
identified O 0 0.020463410764932632
to O 0 0.012686021625995636
have O 0 0.010939952917397022
a O 0 0.029771413654088974
mutation O 0 0.06535080075263977
. O 0 0.0373915396630764

The O 0 0.045860059559345245
odds O 0 0.06494177132844925
of O 0 0.02633136883378029
detection O 0 0.037452373653650284
of O 0 0.014378657564520836
any O 0 0.010072089731693268
of O 0 0.012400556355714798
the O 0 0.01616370491683483
four O 0 0.028834737837314606
BRCA1 O 1 0.9999836683273315
mutations O 0 0.05631181597709656
was O 0 0.04044896364212036
18 O 0 0.043393272906541824
. O 0 0.03783873841166496

7x O 1 0.9996904134750366
greater O 0 0.040565889328718185
if O 0 0.01817331835627556
one O 0 0.012674558907747269
or O 0 0.008124043233692646
more O 0 0.0061956970021128654
cases O 0 0.018191037699580193
of O 1 0.9999710321426392
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.028063537552952766
also O 0 0.015075079165399075
present O 0 0.014640013687312603
in O 0 0.01285167969763279
the O 0 0.0248565636575222
family O 0 0.04928279295563698
. O 0 0.04140596464276314

The O 0 0.04515917971730232
odds O 0 0.06146682798862457
of O 0 0.026706518605351448
detection O 0 0.04126812145113945
of O 0 0.014446454122662544
any O 0 0.010868088342249393
of O 0 0.012293609790503979
the O 0 0.018662963062524796
four O 0 0.02775864489376545
BRCA2 O 1 0.9999842643737793
mutations O 0 0.057685066014528275
was O 0 0.04130380228161812
5 O 0 0.041797515004873276
. O 0 0.037683505564928055

3x O 1 0.9973135590553284
greater O 0 0.04681316018104553
if O 0 0.01824568398296833
there O 0 0.009353632107377052
were O 0 0.00724174315109849
at O 0 0.011127378791570663
least O 0 0.007135630585253239
five O 0 0.008867893368005753
cases O 0 0.017482278868556023
of O 1 0.9033765196800232
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0423552542924881
the O 0 0.22332322597503662
family O 0 0.31513774394989014
. O 0 0.04442950710654259

Interestingly O 0 0.08839903026819229
, O 0 0.018872572109103203
the O 0 0.014094267040491104
presence O 0 0.020117372274398804
of O 0 0.020169483497738838
a O 1 0.9835817813873291
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 1 0.9992528557777405
< O 1 0.9998332262039185
36 O 0 0.023428453132510185
years O 0 0.014107092283666134
of O 0 0.015671972185373306
age O 0 0.023245107382535934
was O 0 0.02422058768570423
strongly O 0 0.023009756579995155
predictive O 0 0.027545055374503136
of O 0 0.011280710808932781
the O 0 0.012543999589979649
presence O 0 0.016507867723703384
of O 0 0.01026855781674385
any O 0 0.009235555306077003
of O 0 0.012954657897353172
the O 0 0.01779768615961075
eight O 0 0.0351896770298481
mutations O 0 0.05868147686123848
screened O 0 0.14492996037006378
. O 0 0.04638371616601944

Carriers O 0 0.06542780250310898
of O 0 0.021091394126415253
the O 0 0.02347882278263569
same O 0 0.02234119549393654
mutation O 0 0.04035405442118645
, O 0 0.013513674959540367
from O 0 0.009753406047821045
different O 0 0.006127817556262016
families O 0 0.01611783169209957
, O 0 0.014003744348883629
shared O 0 0.0241397712379694
similar O 0 0.01826968416571617
haplotypes O 1 0.501196026802063
, O 0 0.015606410801410675
indicating O 0 0.017490806058049202
that O 0 0.00797312892973423
the O 0 0.018618499860167503
mutant O 1 0.8315707445144653
alleles O 0 0.04249175265431404
were O 0 0.0121160252019763
likely O 0 0.014861059375107288
to O 0 0.01065891981124878
be O 0 0.007900778204202652
identical O 0 0.012284905649721622
by O 0 0.011947305873036385
descent O 0 0.027232548221945763
for O 0 0.0126964645460248
a O 0 0.02166900411248207
mutation O 0 0.03221689909696579
in O 0 0.014261915348470211
the O 0 0.02539309673011303
founder O 1 0.986703634262085
population O 0 0.0329684317111969
. O 0 0.03776564076542854

The O 0 0.034053903073072433
identification O 0 0.02946082502603531
of O 0 0.022985750809311867
common O 0 0.21544578671455383
BRCA1 O 1 0.9999983310699463
and O 1 0.5305778384208679
BRCA2 O 1 0.9999984502792358
mutations O 0 0.049084387719631195
will O 0 0.018503250554203987
facilitate O 0 0.03926072269678116
carrier O 0 0.4076102375984192
detection O 0 0.030287552624940872
in O 0 0.010333963669836521
French O 0 0.03494074195623398
Canadian O 1 0.9058488607406616
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999979734420776
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9979185461997986
. O 0 0.06347280740737915

Are O 0 0.028886111453175545
Dp71 O 1 0.8143883347511292
and O 0 0.04627735912799835
Dp140 O 1 0.9999916553497314
brain O 1 0.999984860420227
dystrophin O 1 0.9999932050704956
isoforms O 0 0.054008983075618744
related O 0 0.024459565058350563
to O 0 0.02521962672472
cognitive B-Disease 1 0.9928185939788818
impairment I-Disease 1 0.9999994039535522
in O 1 0.9995658993721008
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9997190833091736

Molecular O 0 0.08845194429159164
study O 0 0.03422282636165619
and O 0 0.027134982869029045
neuropsychological O 1 0.9014610648155212
analysis O 0 0.016549725085496902
were O 0 0.009912107139825821
performed O 0 0.02102680131793022
concurrently O 0 0.02552962303161621
on O 0 0.014655133709311485
49 O 0 0.03734641149640083
patients O 1 0.9817920327186584
with O 1 0.8181865215301514
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
DMD B-Disease 1 1.0
) O 0 0.025694331154227257
in O 0 0.012560931034386158
order O 0 0.016028184443712234
to O 0 0.01304975152015686
find O 0 0.017317356541752815
a O 0 0.01553899422287941
molecular O 0 0.020054640248417854
explanation O 0 0.01831202767789364
for O 0 0.012516552582383156
the O 0 0.025151235982775688
cognitive B-Disease 1 0.9901042580604553
impairment I-Disease 1 0.9999938011169434
observed O 0 0.03210679814219475
in O 0 0.02539409138262272
most O 0 0.389609158039093
DMD B-Disease 1 1.0
patients O 1 0.9999946355819702
. O 0 0.06787055730819702

Complete O 0 0.04948931559920311
analysis O 0 0.018151521682739258
of O 0 0.017586197704076767
the O 0 0.03352390602231026
dystrophin O 1 0.9999628067016602
gene O 0 0.043720539659261703
was O 0 0.02764136902987957
performed O 0 0.027288194745779037
to O 0 0.012880591675639153
define O 0 0.023965775966644287
the O 0 0.018674436956644058
localization O 0 0.05263340845704079
of O 0 0.02560310810804367
deletions O 0 0.06047603487968445
and O 0 0.0235576331615448
duplications O 0 0.07213856279850006
in O 0 0.017137140035629272
relation O 0 0.027982262894511223
to O 0 0.019319893792271614
the O 0 0.025107650086283684
different O 0 0.02748842164874077
DMD B-Disease 1 0.9999992847442627
promoters O 1 0.9893607497215271
. O 0 0.05230710655450821

Qualitative O 0 0.061864521354436874
analysis O 0 0.01932971365749836
of O 0 0.01750541664659977
the O 0 0.029106367379426956
Dp71 O 1 0.9995379447937012
transcript O 0 0.052781615406274796
and O 0 0.017506785690784454
testing O 0 0.01923694834113121
for O 0 0.010251639410853386
the O 0 0.012456953525543213
specific O 0 0.009262734092772007
first O 0 0.017389412969350815
exon O 0 0.0782318264245987
of O 0 0.025881115347146988
Dp140 O 1 0.9928186535835266
were O 0 0.016654470935463905
also O 0 0.016805341467261314
carried O 0 0.025676675140857697
out O 0 0.03077017515897751
. O 0 0.037167005240917206

Neuropsychological O 1 0.9101422429084778
analysis O 0 0.043519020080566406
assessed O 0 0.05040271580219269
verbal O 0 0.061968039721250534
and O 0 0.037152890115976334
visuospatial O 1 0.9999967813491821
intelligence O 0 0.04543955251574516
, O 0 0.02780781500041485
verbal O 1 0.9197012782096863
memory O 1 0.9995930790901184
, O 0 0.026792623102664948
and O 0 0.02430693991482258
reading O 0 0.047700121998786926
skills O 0 0.05336884409189224
. O 0 0.04233398288488388

Comparison O 0 0.054866254329681396
of O 0 0.03434215486049652
molecular O 0 0.042784009128808975
and O 0 0.027204545214772224
psychometric O 1 0.9919410943984985
findings O 0 0.028787212446331978
demonstrated O 0 0.026207808405160904
that O 0 0.013605985790491104
deletions O 0 0.04350398853421211
and O 0 0.018715815618634224
duplications O 0 0.054354917258024216
that O 0 0.010457147844135761
were O 0 0.010852946899831295
localized O 0 0.036440409719944
in O 0 0.011496189050376415
the O 0 0.02127753756940365
distal O 1 0.9998058676719666
part O 0 0.02438802272081375
of O 0 0.01760275848209858
the O 0 0.023417338728904724
gene O 0 0.026227233931422234
seemed O 0 0.019477134570479393
to O 0 0.012567562982439995
be O 0 0.011485421098768711
preferentially O 0 0.04902094230055809
associated O 0 0.026414969936013222
with O 0 0.031980302184820175
cognitive B-Disease 1 0.9990894794464111
impairment I-Disease 1 0.9999974966049194
. O 0 0.06916654109954834

Two O 0 0.03398879989981651
altered O 0 0.0569305419921875
Dp71 O 1 0.6432778239250183
transcripts O 0 0.04560906067490578
and O 0 0.016896868124604225
two O 0 0.014637565240263939
deleted O 0 0.05230460688471794
Dp140 O 1 0.953331708908081
DNA O 0 0.02723948284983635
sequences O 0 0.011565015651285648
were O 0 0.006202529184520245
found O 0 0.007004684302955866
in O 0 0.008155670017004013
four O 0 0.01675216108560562
patients O 1 0.9998505115509033
with O 1 0.9984462857246399
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9987087249755859

These O 0 0.02450759895145893
findings O 0 0.026272490620613098
suggest O 0 0.01607685349881649
that O 0 0.007832079194486141
some O 0 0.007183130364865065
sequences O 0 0.010088861919939518
located O 0 0.016314581036567688
in O 0 0.008887032978236675
the O 0 0.01870719902217388
distal O 1 0.999345600605011
part O 0 0.0209414791315794
of O 0 0.01725258119404316
the O 0 0.02560521848499775
gene O 0 0.024072803556919098
and O 0 0.011751032434403896
, O 0 0.010522047989070415
in O 0 0.008316203951835632
particular O 0 0.011110402643680573
, O 0 0.01199156790971756
some O 0 0.014012900181114674
DMD B-Disease 1 0.9999998807907104
isoforms O 0 0.026459643617272377
expressed O 0 0.01771838776767254
in O 0 0.01502147689461708
the O 1 0.7675564885139465
brain O 1 0.9999524354934692
may O 0 0.015603834763169289
be O 0 0.008079979568719864
related O 0 0.010622801259160042
to O 0 0.011136428453028202
the O 0 0.026763541623950005
cognitive B-Disease 1 0.999405026435852
impairment I-Disease 1 0.9999997615814209
associated O 1 0.8972599506378174
with O 1 0.983194887638092
DMD B-Disease 1 1.0
. O 0 0.04322182014584541
. O 0 0.040917232632637024

I1307K O 1 0.9995763897895813
APC O 1 0.9998831748962402
and O 0 0.048084065318107605
hMLH1 O 1 0.9969053864479065
mutations O 0 0.034380339086055756
in O 0 0.012006496079266071
a O 0 0.019092587754130363
non O 0 0.3405691385269165
- O 1 0.9985485672950745
Jewish O 0 0.03227827697992325
family O 0 0.02183173969388008
with O 0 0.015735439956188202
hereditary B-Disease 1 0.9999990463256836
non I-Disease 1 0.9999998807907104
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9957398176193237

We O 0 0.02702128328382969
describe O 0 0.024024343118071556
a O 0 0.01738843321800232
French O 0 0.031018966808915138
Canadian O 0 0.03665086627006531
hereditary B-Disease 1 0.9999614953994751
non I-Disease 1 0.9999884366989136
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 1.0
HNPCC B-Disease 1 1.0
) O 1 0.8161680698394775
kindred O 1 0.9999301433563232
which O 0 0.017230119556188583
carries O 0 0.026528751477599144
a O 0 0.027884678915143013
novel O 0 0.058448951691389084
truncating O 1 0.9982497096061707
mutation O 0 0.08271293342113495
in O 0 0.038666777312755585
hMLH1 O 1 0.9873071908950806
. O 0 0.05841013416647911

Interestingly O 0 0.09079667925834656
, O 0 0.026763740926980972
the O 0 0.03489883616566658
I1307K O 1 0.9998230338096619
APC O 1 0.9999953508377075
polymorphism O 0 0.31503012776374817
, O 0 0.01961941458284855
associated O 0 0.013629473745822906
with O 0 0.00782031286507845
an O 0 0.009547633118927479
increased O 0 0.016566695645451546
risk O 1 0.9974567294120789
of O 1 0.9999990463256836
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9999387264251709
is O 0 0.022382589057087898
also O 0 0.011101855896413326
present O 0 0.011852344498038292
in O 0 0.011356985196471214
this O 0 0.014506850391626358
family O 0 0.03991331532597542
. O 0 0.037266749888658524

The O 0 0.06478527933359146
I1307K O 1 0.9969685673713684
polymorphism O 0 0.09393563121557236
has O 0 0.01953684538602829
previously O 0 0.017887482419610023
only O 0 0.009614473208785057
been O 0 0.009242706000804901
identified O 0 0.011921221390366554
in O 0 0.007349756080657244
individuals O 0 0.008068160153925419
of O 0 0.01643885113298893
self O 1 0.9996830224990845
- O 1 0.9999948740005493
reported O 0 0.03686165809631348
Ashkenazi O 1 0.8376901149749756
Jewish O 0 0.06525455415248871
origins O 0 0.06389552354812622
. O 0 0.043092675507068634

In O 0 0.026951191946864128
addition O 0 0.022074727341532707
, O 0 0.014525583013892174
in O 0 0.00970865972340107
this O 0 0.010195129550993443
family O 0 0.023515239357948303
, O 0 0.014048269018530846
there O 0 0.010636331513524055
appears O 0 0.018012844026088715
to O 0 0.010370446369051933
be O 0 0.00850894395262003
no O 0 0.011008231900632381
relationship O 0 0.01995094120502472
between O 0 0.014699428342282772
the O 0 0.024805910885334015
I1307K O 1 0.9998770952224731
polymorphism O 0 0.05309954658150673
and O 0 0.013541711494326591
the O 0 0.014290226623415947
presence O 0 0.024591291323304176
or O 0 0.01589762419462204
absence O 1 0.6408287882804871
of O 1 0.969641923904419
cancer B-Disease 1 1.0
. O 0 0.036246344447135925
. O 0 0.03960879519581795

Identification O 0 0.04354138672351837
of O 0 0.021762607619166374
a O 0 0.026797082275152206
novel O 0 0.04508635401725769
mutation O 0 0.03478752076625824
of O 0 0.01816379837691784
the O 0 0.030091816559433937
CPO O 1 0.9998495578765869
gene O 0 0.024545367807149887
in O 0 0.012222089804708958
a O 0 0.02357698790729046
Japanese O 0 0.08147356659173965
hereditary B-Disease 1 0.9999995231628418
coproporphyria I-Disease 1 0.9999967813491821
family O 1 0.5547983646392822
. O 0 0.051398564130067825

Hereditary B-Disease 1 0.9999946355819702
coproporphyria I-Disease 1 0.9999991655349731
( O 1 0.9312278032302856
HCP B-Disease 1 0.9999990463256836
) O 0 0.023095285519957542
is O 0 0.015143879689276218
an O 0 0.022512493655085564
autosomal B-Disease 1 0.9999978542327881
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
characterized O 1 0.9989056587219238
by O 0 0.030402448028326035
a O 1 0.9965399503707886
deficiency B-Disease 1 1.0
of I-Disease 1 0.9989468455314636
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 1.0
( O 1 0.5214177966117859
CPO O 1 0.9999414682388306
) O 0 0.022953232750296593
caused O 0 0.02320348285138607
by O 0 0.01515160407871008
a O 0 0.022741243243217468
mutation O 0 0.03387976065278053
in O 0 0.0162576362490654
the O 0 0.03468269482254982
CPO O 1 0.999854326248169
gene O 0 0.06226613372564316
. O 0 0.04224753752350807

Only O 0 0.0267826896160841
11 O 0 0.028902692720294
mutations O 0 0.02406051754951477
of O 0 0.015933187678456306
the O 0 0.022427817806601524
gene O 0 0.024676213040947914
have O 0 0.007784840650856495
been O 0 0.013237349689006805
reported O 0 0.026117870584130287
in O 0 0.03585639223456383
HCP B-Disease 1 0.9999997615814209
patients O 1 0.9997966885566711
. O 0 0.058153945952653885

We O 0 0.02798594906926155
report O 0 0.024829741567373276
another O 0 0.03167252615094185
mutation O 0 0.040118228644132614
in O 0 0.016437310725450516
a O 0 0.02753223478794098
Japanese O 0 0.06027448922395706
family O 0 0.0586317703127861
. O 0 0.04358174279332161

Polymerase O 1 0.863688051700592
chain O 0 0.10669377446174622
reaction O 0 0.07496581226587296
- O 1 0.9991127848625183
single O 0 0.05342927202582359
strand O 0 0.09429526329040527
conformational O 0 0.07398191839456558
polymorphism O 0 0.05948567017912865
and O 0 0.018635688349604607
direct O 0 0.022298449650406837
sequence O 0 0.015844186767935753
analyses O 0 0.01832304149866104
demonstrated O 0 0.020853668451309204
a O 0 0.023225173354148865
C O 0 0.28451523184776306
to O 0 0.023161819204688072
T O 1 0.9597732424736023
substitution O 0 0.032691776752471924
in O 0 0.013458865694701672
exon O 0 0.0554937869310379
1 O 0 0.01856793649494648
of O 0 0.014188816770911217
the O 0 0.02287665195763111
CPO O 1 0.9983729124069214
gene O 0 0.02873840369284153
at O 0 0.01807810738682747
nucleotide O 0 0.031406935304403305
position O 0 0.0220574252307415
85 O 0 0.0323210209608078
, O 0 0.014935714192688465
which O 0 0.010409075766801834
lies O 0 0.024059316143393517
in O 0 0.011436562053859234
the O 0 0.022064754739403725
putative O 1 0.9665588736534119
presequence O 1 0.9903432130813599
for O 0 0.02840062975883484
targeting O 0 0.04867840185761452
to O 0 0.03638651967048645
mitochondria O 0 0.10625740140676498
. O 0 0.05019745975732803

This O 0 0.03814803808927536
mutation O 0 0.052122682332992554
changes O 0 0.01997430995106697
the O 0 0.025055836886167526
codon O 0 0.06378135830163956
for O 0 0.018996788188815117
glutamine O 0 0.05735281482338905
to O 0 0.01932397484779358
a O 0 0.0283101387321949
termination O 1 0.7877408862113953
codon O 0 0.10214773565530777
at O 0 0.03828069195151329
amino O 0 0.0491928830742836
acid O 0 0.05674401670694351
position O 0 0.04019917547702789
29 O 0 0.05408411845564842
. O 0 0.0393991619348526

MaeI O 1 0.994612455368042
restriction O 0 0.07783056795597076
analysis O 0 0.02322508580982685
showed O 0 0.018072962760925293
two O 0 0.011295707896351814
other O 0 0.012824074365198612
carriers O 0 0.03600739687681198
in O 0 0.01649501919746399
the O 0 0.027724293991923332
family O 0 0.04994669929146767
. O 0 0.04576268419623375

The O 0 0.05787990242242813
C O 1 0.9998537302017212
- O 1 0.9999997615814209
T O 1 0.9999979734420776
mutation O 0 0.05840827524662018
is O 0 0.015480099245905876
located O 0 0.020418738946318626
within O 0 0.010973872616887093
a O 0 0.015625089406967163
recently O 0 0.023021331056952477
proposed O 0 0.020595412701368332
putative O 0 0.06360556930303574
alternative O 0 0.026693105697631836
translation O 0 0.02880636230111122
initiation O 0 0.23448577523231506
codon O 0 0.12767909467220306
( O 0 0.04104573652148247
TIC O 1 0.9999994039535522
- O 1 0.9999747276306152
1 O 0 0.030138641595840454
) O 0 0.013832923024892807
, O 0 0.010955442674458027
supporting O 0 0.02228832058608532
that O 0 0.016675787046551704
TIC O 1 0.999998927116394
- O 1 0.9998849630355835
1 O 0 0.023798145353794098
is O 0 0.012479082681238651
the O 0 0.017043422907590866
real O 0 0.03810537979006767
TIC O 1 0.999902606010437
rather O 0 0.01823570765554905
than O 0 0.02140764519572258
TIC O 1 0.9999970197677612
- O 1 0.9999550580978394
2 O 0 0.040467679500579834
. O 0 0.02165324054658413
. O 0 0.03040245547890663

Human B-Disease 0 0.05463454872369766
complement I-Disease 1 0.6139727234840393
factor I-Disease 1 0.9998250603675842
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.998241662979126
with O 1 0.9999984502792358
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999697208404541

This O 0 0.023171665146946907
study O 0 0.018717681989073753
reports O 0 0.013164835050702095
on O 0 0.009954000823199749
six O 0 0.012268797494471073
cases O 0 0.017811497673392296
of O 1 0.8200231194496155
deficiency B-Disease 1 1.0
in I-Disease 0 0.018290117383003235
the I-Disease 0 0.019334016367793083
human I-Disease 0 0.021527081727981567
complement I-Disease 0 0.04346279054880142
regulatory I-Disease 0 0.04739359766244888
protein I-Disease 0 0.03430008143186569
Factor I-Disease 1 0.9256406426429749
H I-Disease 1 0.9999997615814209
( O 0 0.11774573475122452
FH O 1 0.999998927116394
) O 0 0.01239998359233141
in O 0 0.0070154680870473385
the O 0 0.010609269142150879
context O 0 0.015936320647597313
of O 0 0.021735327318310738
an O 1 0.9999721050262451
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.999962568283081

Five O 0 0.02565891295671463
of O 0 0.02136215753853321
the O 0 0.022098377346992493
cases O 0 0.018252627924084663
were O 0 0.010178359225392342
observed O 0 0.012139967642724514
in O 0 0.008469547145068645
children O 0 0.018684230744838715
presenting O 0 0.05414450168609619
with O 1 0.9982210993766785
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9693340063095093
. O 0 0.056804727762937546

Two O 0 0.018499387428164482
of O 0 0.017964182421565056
the O 0 0.02327774278819561
children O 0 0.03837812319397926
exhibited O 0 0.172793909907341
a O 1 0.7990906238555908
homozygous O 1 0.9999982118606567
deficiency O 1 1.0
characterized O 1 0.9992384910583496
by O 0 0.022144092246890068
the O 0 0.019721560180187225
absence O 0 0.03145753964781761
of O 0 0.014092893339693546
the O 0 0.016222089529037476
150 O 0 0.029524199664592743
- O 1 0.9998363256454468
kD O 1 0.998837411403656
form O 0 0.015584823675453663
of O 0 0.02083163894712925
Factor O 1 0.9995425939559937
H O 1 0.9999988079071045
and O 0 0.0134812630712986
the O 0 0.014929347671568394
presence O 0 0.022287661209702492
, O 0 0.013562748208642006
upon O 0 0.0181156937032938
immunoblotting O 1 0.7138426899909973
, O 0 0.010661630891263485
of O 0 0.00962322112172842
the O 0 0.014169222675263882
42 O 0 0.03507464379072189
- O 1 0.9996674060821533
kD O 1 0.9999160766601562
Factor O 1 0.8289914727210999
H O 1 0.9999974966049194
- O 1 0.9995500445365906
like O 0 0.018348446115851402
protein O 0 0.016795746982097626
1 O 0 0.01750996708869934
( O 0 0.021940413862466812
FHL O 1 0.9999760389328003
- O 1 0.9996435642242432
1 O 0 0.022238461300730705
) O 0 0.009987926110625267
and O 0 0.00841390062123537
other O 0 0.012710651382803917
FH O 1 0.9999998807907104
- O 1 0.9999934434890747
related O 0 0.06544145196676254
protein O 0 0.04180687293410301
( O 0 0.037577707320451736
FHR O 1 0.999887228012085
) O 0 0.037802986800670624
bands O 0 0.05769107863306999
. O 0 0.03871070593595505

Southern O 0 0.11014413833618164
blot O 1 0.9672753214836121
and O 0 0.035339053720235825
PCR O 0 0.06820438802242279
analysis O 0 0.01243379432708025
of O 0 0.011961515061557293
DNA O 0 0.01580222323536873
of O 0 0.013098136521875858
one O 0 0.017092807218432426
patient O 1 0.9876807928085327
with O 0 0.028610313311219215
homozygous O 1 0.9999243021011353
deficiency O 1 1.0
ruled O 1 0.7457194924354553
out O 0 0.018129227682948112
the O 0 0.013936767354607582
presence O 0 0.016411850228905678
of O 0 0.010147055611014366
a O 0 0.013322402723133564
large O 0 0.01346703339368105
deletion O 0 0.02900676615536213
of O 0 0.014646770432591438
the O 0 0.036268506199121475
FH O 1 0.9999998807907104
gene O 0 0.02761242724955082
as O 0 0.014420080929994583
the O 0 0.024171188473701477
underlying O 1 0.9850232601165771
defect O 1 0.9999908208847046
for O 0 0.03549904748797417
the O 1 0.9972471594810486
deficiency O 1 1.0
. O 0 0.15663745999336243

The O 0 0.03129089996218681
other O 0 0.012546314857900143
four O 0 0.014001689851284027
children O 0 0.023812703788280487
presented O 0 0.027448322623968124
with O 0 0.03197905793786049
heterozygous O 1 0.9999655485153198
deficiency O 1 1.0
and O 0 0.03750287741422653
exhibited O 1 0.7517831921577454
a O 0 0.03481800854206085
normal O 0 0.08080355077981949
immunoblotting O 1 0.9998204112052917
pattern O 0 0.03221531957387924
of O 0 0.018872637301683426
proteins O 0 0.0182933546602726
of O 0 0.019210906699299812
the O 0 0.0492212176322937
FH O 1 0.9999997615814209
family O 0 0.09616731107234955
. O 0 0.042373623698949814

Factor B-Disease 1 0.9999897480010986
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.02416384033858776
the O 0 0.02405836246907711
only O 0 0.029643654823303223
complement B-Disease 1 0.9999988079071045
deficiency I-Disease 1 1.0
associated O 1 0.9868893623352051
with O 1 0.9716008305549622
HUS B-Disease 1 1.0
. O 0 0.11792431026697159

These O 0 0.024026991799473763
observations O 0 0.025490950793027878
suggest O 0 0.015392989851534367
a O 0 0.016159458085894585
role O 0 0.02741263248026371
for O 0 0.024036655202507973
FH O 1 0.9999994039535522
and O 0 0.04639843478798866
/ O 1 0.9999918937683105
or O 0 0.06220696121454239
FH O 1 0.9999992847442627
receptors O 0 0.04513580724596977
in O 0 0.015132063999772072
the O 0 0.028657415881752968
pathogenesis O 1 0.9999985694885254
of O 1 0.9997373223304749
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.9049532413482666
. O 0 0.056540653109550476

Further O 0 0.03434423357248306
evidence O 0 0.020001955330371857
for O 0 0.013673300854861736
a O 0 0.020529717206954956
major O 0 0.032994601875543594
ancient O 0 0.05601254478096962
mutation O 1 0.9946107864379883
underlying O 1 0.9999967813491821
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9978660941123962
linkage O 1 0.9999973773956299
disequilibrium O 1 0.9999892711639404
studies O 0 0.025256332010030746
in O 0 0.015758061781525612
the O 0 0.024328138679265976
Japanese O 0 0.047093864530324936
population O 0 0.02972705289721489
. O 0 0.03546842560172081

The O 1 0.8390254378318787
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999887943267822
DM B-Disease 1 1.0
) O 0 0.03907100111246109
mutation O 0 0.03615129366517067
is O 0 0.014198464341461658
an O 0 0.019907597452402115
unstable O 1 0.999976396560669
( O 0 0.04097010940313339
CTG O 1 0.9999963045120239
) O 0 0.025079427286982536
n O 0 0.048117153346538544
repeat O 0 0.038387395441532135
, O 0 0.013369381427764893
present O 0 0.012609266676008701
at O 0 0.0129965515807271
a O 0 0.013562454842031002
copy O 0 0.0205079335719347
number O 0 0.0067069209180772305
of O 0 0.012056499719619751
5 O 0 0.026324888691306114
- O 1 0.9889515042304993
37 O 0 0.03467044606804848
repeats O 0 0.03749652951955795
on O 0 0.017177021130919456
normal O 0 0.024277113378047943
chromosomes O 0 0.027213020250201225
but O 0 0.01269497163593769
amplified O 0 0.0335765965282917
to O 0 0.01307791005820036
50 O 0 0.024575596675276756
- O 1 0.8929494023323059
3000 O 0 0.051990825682878494
copies O 0 0.026550589129328728
on O 0 0.04083434119820595
DM B-Disease 1 0.9999998807907104
chromosomes O 0 0.0901714563369751
. O 0 0.045888084918260574

Previous O 0 0.041875749826431274
findings O 0 0.029093045741319656
in O 0 0.017021382227540016
Caucasian O 0 0.11717803031206131
populations O 0 0.019414091482758522
of O 0 0.020938754081726074
a O 1 0.9606616497039795
DM B-Disease 1 1.0
founder O 1 0.9999996423721313
chromosome O 1 0.8686420917510986
raise O 0 0.02923184260725975
a O 0 0.017800338566303253
question O 0 0.014621522277593613
about O 0 0.009380030445754528
the O 0 0.015827331691980362
molecular O 0 0.02112755924463272
events O 0 0.012428426183760166
involved O 0 0.012814890593290329
in O 0 0.011567718349397182
the O 0 0.023197075352072716
expansion O 0 0.08174700289964676
mutation O 0 0.08744634687900543
. O 0 0.04758418723940849

To O 0 0.03151087462902069
investigate O 0 0.04108442738652229
whether O 0 0.017084220424294472
a O 0 0.02285481058061123
founder O 1 0.9898667335510254
chromosome O 0 0.03883923590183258
for O 0 0.017574124038219452
the O 0 0.4656408131122589
DM B-Disease 1 1.0
mutation O 1 0.7137080430984497
exists O 0 0.022215377539396286
in O 0 0.01014744769781828
the O 0 0.014105062931776047
Japanese O 0 0.029310954734683037
population O 0 0.013957074843347073
, O 0 0.013693534769117832
we O 0 0.012406479567289352
genotyped O 0 0.14093518257141113
families O 0 0.02154424600303173
using O 0 0.01581987552344799
polymorphic O 0 0.08866623789072037
markers O 0 0.037450604140758514
near O 0 0.030414536595344543
the O 0 0.02221754379570484
( O 0 0.03409477323293686
CTG O 1 0.9999898672103882
) O 0 0.032142095267772675
n O 0 0.06358052045106888
repeat O 0 0.05629388242959976
region O 0 0.038816921412944794
and O 0 0.031247274950146675
constructed O 0 0.07981327176094055
haplotypes O 0 0.19418367743492126
. O 0 0.05526410788297653

Six O 0 0.03658794239163399
different O 0 0.016473930329084396
haplotypes O 0 0.06865845620632172
were O 0 0.014812592417001724
found O 0 0.019773177802562714
and O 0 0.037160277366638184
DM B-Disease 1 1.0
alleles O 0 0.4105885624885559
were O 0 0.024599766358733177
always O 0 0.038435108959674835
haplotype O 1 0.689071774482727
A O 0 0.06276079267263412
. O 0 0.0465368889272213

To O 0 0.03196287155151367
find O 0 0.024303726851940155
an O 0 0.010885070078074932
origin O 0 0.009296736679971218
of O 0 0.012127410620450974
the O 0 0.020227545872330666
( O 0 0.03380146995186806
CTG O 1 0.9999935626983643
) O 0 0.02749698981642723
n O 0 0.0575641430914402
repeat O 0 0.06374786049127579
mutation O 0 0.03524865210056305
and O 0 0.011590782552957535
to O 0 0.013149457983672619
investigate O 0 0.027571240440011024
the O 0 0.015745650976896286
mechanism O 0 0.02222437597811222
of O 0 0.012778591364622116
the O 0 0.016636215150356293
expansion O 0 0.03881743550300598
mutation O 0 0.027683697640895844
in O 0 0.009728756733238697
the O 0 0.01325968001037836
Japanese O 0 0.028654513880610466
population O 0 0.01197071559727192
we O 0 0.00783981941640377
have O 0 0.005699491128325462
studied O 0 0.014082655310630798
90 O 0 0.024302754551172256
Japanese O 0 0.08168137818574905
DM B-Disease 1 1.0
families O 0 0.037552427500486374
comprising O 0 0.043143898248672485
190 O 0 0.05639510974287987
affected O 0 0.03499237075448036
and O 0 0.024181867018342018
130 O 0 0.0576447956264019
unaffected O 1 0.6740058660507202
members O 0 0.04265261068940163
. O 0 0.04145408794283867

The O 0 0.04146980121731758
results O 0 0.02120351605117321
suggest O 0 0.017166858538985252
that O 0 0.008703782223165035
a O 0 0.015233592130243778
few O 0 0.0155491279438138
common O 0 0.024722211062908173
ancestral O 1 0.775287389755249
mutations O 0 0.03140806779265404
in O 0 0.013935469090938568
both O 0 0.017141977325081825
Caucasian O 1 0.9992828965187073
and O 0 0.02020421251654625
Japanese O 0 0.04281136766076088
populations O 0 0.018354013562202454
have O 0 0.00884508527815342
originated O 0 0.015957122668623924
by O 0 0.0097963847219944
expansion O 0 0.01862943544983864
of O 0 0.013612699694931507
an O 0 0.019553380087018013
ancestral O 1 0.983856201171875
n O 0 0.08622971177101135
= O 0 0.04066978767514229
5 O 0 0.020136268809437752
repeat O 0 0.03439852595329285
to O 0 0.019411496818065643
n O 0 0.056932516396045685
= O 0 0.04838474094867706
19 O 0 0.042667970061302185
- O 1 0.7471117973327637
37 O 0 0.04846307262778282
copies O 0 0.03896785154938698
. O 0 0.03770794719457626

These O 0 0.02338496781885624
data O 0 0.018528901040554047
support O 0 0.028297824785113335
multistep O 0 0.08417027443647385
models O 0 0.026645777747035027
of O 0 0.02799072675406933
triplet O 1 0.999795138835907
repeat O 0 0.3361837863922119
expansion O 0 0.039016857743263245
that O 0 0.010610819794237614
have O 0 0.007013787981122732
been O 0 0.008465535938739777
proposed O 0 0.012286676093935966
for O 0 0.014088217169046402
both O 0 0.02839411050081253
DM B-Disease 1 1.0
and O 1 0.830601155757904
Friedreichs B-Disease 1 0.9999998807907104
ataxia I-Disease 1 0.9999998807907104
. O 0 0.044555455446243286
. O 0 0.04829094931483269

The O 0 0.03552551940083504
molecular O 0 0.029611891135573387
basis O 0 0.02145751379430294
of O 1 0.9919494390487671
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.028219539672136307
the O 0 0.02742823213338852
western O 0 0.038019079715013504
Cape O 1 0.6080724596977234
, O 0 0.02828364074230194
South O 0 0.05111860856413841
Africa O 0 0.06281796097755432
. O 0 0.044503167271614075

Deficiency B-Disease 1 0.999998927116394
of I-Disease 0 0.031917817890644073
the I-Disease 0 0.03254695609211922
sixth I-Disease 1 0.999411940574646
component I-Disease 0 0.10028427094221115
of I-Disease 0 0.01939752884209156
human I-Disease 0 0.03192778676748276
complement I-Disease 1 0.9987983703613281
( O 1 0.9520037770271301
C6 O 1 1.0
) O 0 0.019244544208049774
has O 0 0.011291484348475933
been O 0 0.008894936181604862
reported O 0 0.0107360128313303
in O 0 0.006943160202354193
a O 0 0.009930317290127277
number O 0 0.007556379772722721
of O 0 0.011835290119051933
families O 0 0.015868568792939186
from O 0 0.010991688817739487
the O 0 0.01721595600247383
western O 0 0.03272411227226257
Cape O 1 0.7409637570381165
, O 0 0.026390492916107178
South O 0 0.04751552268862724
Africa O 0 0.060568638145923615
. O 0 0.04340403527021408

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 1 0.8350450396537781
endemic O 1 0.9994969367980957
in O 0 0.018991714343428612
the O 0 0.02500774897634983
Cape O 1 0.6145468354225159
and O 0 0.011807405389845371
almost O 0 0.008659055456519127
all O 0 0.008174850605428219
pedigrees O 0 0.03406433388590813
of O 0 0.019377557560801506
total O 1 0.9710880517959595
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9999618530273438
C6Q0 O 1 1.0
) O 0 0.018796417862176895
have O 0 0.00799049623310566
been O 0 0.011394727043807507
ascertained O 0 0.039967164397239685
because O 0 0.017614586278796196
of O 0 0.10778984427452087
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.7736575603485107

We O 0 0.027152985334396362
have O 0 0.01359474752098322
sequenced O 0 0.03003736585378647
the O 0 0.014467270113527775
expressed O 0 0.01928543485701084
exons O 0 0.03374234214425087
of O 0 0.017380930483341217
the O 0 0.03558098152279854
C6 O 1 1.0
gene O 0 0.031161775812506676
from O 0 0.01444285549223423
selected O 0 0.018076082691550255
cases O 0 0.01564541831612587
and O 0 0.010325521230697632
have O 0 0.006957509554922581
found O 0 0.008984423242509365
three O 0 0.012280566617846489
molecular O 0 0.03940866142511368
defects O 1 0.9788011908531189
leading O 0 0.03520653769373894
to O 0 0.021020079031586647
total O 1 0.837311327457428
deficiency O 1 1.0
879delG O 1 0.9999998807907104
, O 0 0.0239045899361372
which O 0 0.010925916954874992
is O 0 0.010675712488591671
the O 0 0.0169075895100832
common O 0 0.03060373291373253
defect O 1 0.9996998310089111
in O 0 0.01417580433189869
the O 0 0.020231271162629128
Cape O 1 0.6175951361656189
and O 0 0.02341732196509838
hitherto O 1 0.6561422348022461
unreported O 0 0.07503271102905273
, O 0 0.019104456529021263
and O 0 0.019859803840517998
1195delC O 1 0.9998383522033691
and O 0 0.03064902126789093
1936delG O 1 0.9999865293502808
, O 0 0.016693569719791412
which O 0 0.008666574954986572
have O 0 0.005525066051632166
been O 0 0.0080810422077775
previously O 0 0.012471769005060196
reported O 0 0.01411912776529789
in O 0 0.01341769564896822
African O 0 0.18495319783687592
- O 1 0.9999364614486694
Americans O 0 0.04734335467219353
. O 0 0.036511003971099854

We O 0 0.027925753965973854
also O 0 0.016357198357582092
show O 0 0.01395957637578249
that O 0 0.007528964895755053
the O 0 0.016450420022010803
879delG O 1 0.9981133937835693
and O 0 0.03414686396718025
1195delC O 1 0.9999996423721313
defects O 1 0.9999680519104004
are O 0 0.009587309323251247
associated O 0 0.016133984550833702
with O 0 0.019337685778737068
characteristic O 1 0.9998942613601685
C6 O 1 1.0
/ O 1 0.9999997615814209
C7 O 1 0.9999995231628418
region O 0 0.05993841215968132
DNA O 0 0.053478918969631195
marker O 1 0.9418703317642212
haplotypes O 0 0.22049398720264435
, O 0 0.020947976037859917
although O 0 0.01579926535487175
small O 0 0.01928338035941124
variations O 0 0.024067701771855354
were O 0 0.01742255501449108
observed O 0 0.033068619668483734
. O 0 0.03556576371192932

The O 0 0.07719653844833374
1936delG O 1 0.9999915361404419
defect O 1 0.999994158744812
was O 0 0.04186965152621269
observed O 0 0.01705111935734749
only O 0 0.00940193422138691
once O 0 0.015077880583703518
in O 0 0.008951997384428978
the O 0 0.01505496259778738
Cape O 0 0.16168642044067383
, O 0 0.01285418402403593
but O 0 0.008751979097723961
its O 0 0.014424988068640232
associated O 0 0.02898736484348774
haplotype O 1 0.9463049173355103
could O 0 0.021502355113625526
be O 0 0.019373102113604546
deduced O 0 0.060699354857206345
. O 0 0.03507152944803238

The O 0 0.0360846072435379
data O 0 0.0167852696031332
from O 0 0.015047334134578705
the O 0 0.024205267429351807
haplotypes O 0 0.19476141035556793
indicate O 0 0.018160846084356308
that O 0 0.006904210429638624
these O 0 0.00580974668264389
three O 0 0.013876366429030895
molecular O 0 0.04451363906264305
defects O 1 0.9894591569900513
account O 0 0.01724148727953434
for O 0 0.01618235372006893
the O 0 0.040984462946653366
defects O 1 0.9996126294136047
in O 0 0.011917414143681526
all O 0 0.01018444262444973
the O 0 0.016895171254873276
38 O 0 0.04277615249156952
unrelated O 0 0.3487429618835449
C6Q0 O 1 0.9999958276748657
individuals O 0 0.021534433588385582
we O 0 0.0126823540776968
have O 0 0.0089957220479846
studied O 0 0.016712890937924385
from O 0 0.014363076537847519
the O 0 0.028840841725468636
Cape O 0 0.4908396303653717
. O 0 0.041285254061222076

We O 0 0.02687772922217846
have O 0 0.012099051848053932
also O 0 0.013166707009077072
observed O 0 0.017031477764248848
the O 0 0.024719245731830597
879delG O 1 0.9996691942214966
defect O 1 0.9464207887649536
in O 0 0.012805422767996788
two O 0 0.01468705665320158
Dutch O 1 0.9722055792808533
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999991655349731
kindreds O 1 0.9994804263114929
, O 0 0.01967884972691536
but O 0 0.011264150030910969
the O 0 0.02130696177482605
879delG O 1 0.9999855756759644
defect O 1 0.9998897314071655
in O 0 0.015267794951796532
the O 0 0.02208646386861801
Cape O 1 0.9868619441986084
probably O 0 0.022723183035850525
did O 0 0.013278558850288391
not O 0 0.009125210344791412
come O 0 0.011831547133624554
from O 0 0.011967096477746964
The O 0 0.024520669132471085
Netherlands O 0 0.06245148181915283
. O 0 0.027144048362970352
. O 0 0.036023400723934174

Complement B-Disease 1 0.999946117401123
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.04759657755494118
seven O 0 0.03110652230679989
further O 0 0.036308933049440384
molecular O 1 0.9720327854156494
defects O 1 0.9997875094413757
and O 0 0.022630849853157997
their O 0 0.02535352297127247
associated O 0 0.04964159056544304
marker O 1 0.9986376166343689
haplotypes O 1 0.9718919992446899
. O 0 0.051327094435691833

Seven O 0 0.03643403947353363
further O 0 0.028681335970759392
molecular O 0 0.035323549062013626
bases O 0 0.04389035701751709
of O 1 0.9960206151008606
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.03594914823770523
described O 0 0.06761342287063599
. O 0 0.04525173082947731

All O 0 0.02266686037182808
these O 0 0.011358371935784817
new O 0 0.0267794206738472
molecular O 0 0.050058502703905106
defects O 1 0.9974406957626343
involve O 0 0.029289785772562027
single O 0 0.18428026139736176
- O 1 0.99998939037323
nucleotide O 0 0.04277155548334122
events O 0 0.017488380894064903
, O 0 0.0184201430529356
deletions O 0 0.04333646595478058
and O 0 0.01687263883650303
substitutions O 0 0.03184070065617561
, O 0 0.011657047085464
some O 0 0.007073919754475355
of O 0 0.014025448821485043
which O 0 0.015722574666142464
alter O 0 0.045135680586099625
splice O 0 0.11714061349630356
sites O 0 0.025595376268029213
, O 0 0.018224826082587242
and O 0 0.01946713589131832
others O 0 0.02990228682756424
codons O 0 0.08403510600328445
. O 0 0.04808361828327179

They O 0 0.019900647923350334
are O 0 0.010052254423499107
distributed O 0 0.017250526696443558
along O 0 0.020784476771950722
the O 0 0.035236798226833344
C7 O 1 1.0
gene O 0 0.04740293696522713
, O 0 0.015910623595118523
but O 0 0.011252366937696934
predominantly O 0 0.02274945378303528
towards O 0 0.025951849296689034
the O 0 0.02398482896387577
3 O 0 0.03711513802409172
end O 0 0.05031203851103783
. O 0 0.04211297631263733

All O 0 0.02663404494524002
were O 0 0.014908134937286377
found O 0 0.017736556008458138
in O 0 0.02114785835146904
compound O 1 0.5840643048286438
heterozygous O 0 0.08625607192516327
individuals O 0 0.03736286982893944
. O 0 0.0439775250852108

The O 0 0.11673613637685776
C6 O 1 0.9999997615814209
/ O 1 0.9999955892562866
C7 O 1 0.9999995231628418
marker O 1 0.9993143081665039
haplotypes O 1 0.7621756196022034
associated O 0 0.025131577625870705
with O 0 0.01921708695590496
most O 0 0.09037565439939499
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999947547912598
are O 0 0.019540635868906975
tabulated O 0 0.04542446509003639
. O 0 0.025739479809999466
. O 0 0.03369113802909851

A O 0 0.07602337747812271
genome O 0 0.06400720030069351
- O 1 0.6231749653816223
wide O 0 0.027367373928427696
search O 0 0.0280026625841856
for O 0 0.021407462656497955
chromosomal O 1 0.9985587000846863
loci O 1 0.6917092204093933
linked O 0 0.07561524957418442
to O 0 0.0326605848968029
mental O 1 0.9999998807907104
health O 1 0.9999980926513672
wellness O 1 0.9999995231628418
in O 0 0.02082475833594799
relatives O 0 0.08896269649267197
at O 0 0.02142019011080265
high O 1 0.5075691342353821
risk O 1 0.9988207221031189
for O 1 0.9990037083625793
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9541833996772766
the O 0 0.2617567181587219
Old O 1 0.9872635006904602
Order O 0 0.05675628408789635
Amish O 1 0.5311957597732544
. O 0 0.04347480833530426

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9998233914375305
BPAD B-Disease 1 1.0
; O 1 0.9994240999221802
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.10931196808815002
is O 0 0.01758245937526226
characterized O 0 0.028731511905789375
by O 0 0.013568197377026081
episodes O 0 0.02844650112092495
of O 0 0.03578033298254013
mania B-Disease 1 1.0
and O 1 0.94694983959198
/ O 1 0.9999992847442627
or O 0 0.2531347870826721
hypomania B-Disease 1 0.9999996423721313
interspersed O 0 0.21101172268390656
with O 0 0.02243766374886036
periods O 0 0.04762975499033928
of O 0 0.27019819617271423
depression B-Disease 1 0.9999998807907104
. O 0 0.07849132269620895

Compelling O 0 0.06993872672319412
evidence O 0 0.028773164376616478
supports O 0 0.0347989983856678
a O 0 0.021768756210803986
significant O 0 0.022325843572616577
genetic O 0 0.030878135934472084
component O 0 0.04155223071575165
in O 0 0.01605956070125103
the O 0 0.03030441887676716
susceptibility O 1 0.9981535077095032
to O 0 0.03724554926156998
develop O 1 0.6787807941436768
BPAD B-Disease 1 0.9999985694885254
. O 0 0.06282847374677658

To O 0 0.03323659300804138
date O 0 0.030880602076649666
, O 0 0.019435618072748184
however O 0 0.015998050570487976
, O 0 0.021204456686973572
linkage O 0 0.46520230174064636
studies O 0 0.014554688706994057
have O 0 0.00739293685182929
attempted O 0 0.021186694502830505
only O 0 0.008677692152559757
to O 0 0.014192672446370125
identify O 0 0.032165780663490295
chromosomal O 1 0.9958176016807556
loci O 0 0.25902509689331055
that O 0 0.016441859304904938
cause O 1 0.6424424648284912
or O 0 0.016299763694405556
increase O 0 0.016293473541736603
the O 0 0.02289278246462345
risk O 0 0.1578103005886078
of O 0 0.03745272010564804
developing O 1 0.9285163879394531
BPAD B-Disease 1 0.9999988079071045
. O 0 0.06578360497951508

To O 0 0.03219735622406006
determine O 0 0.01921396702528
whether O 0 0.013552557677030563
there O 0 0.009401564486324787
could O 0 0.011316000483930111
be O 0 0.012544412165880203
protective O 1 0.9974974989891052
alleles O 0 0.04452555254101753
that O 0 0.013162222690880299
prevent O 0 0.06772713363170624
or O 0 0.017461765557527542
reduce O 0 0.027322864159941673
the O 0 0.018803441897034645
risk O 0 0.028968993574380875
of O 0 0.02152140624821186
developing O 1 0.9766079187393188
BPAD B-Disease 1 1.0
, O 0 0.02004716545343399
similar O 0 0.010466674342751503
to O 0 0.009587503969669342
what O 0 0.007810048293322325
is O 0 0.007441684603691101
observed O 0 0.008399797603487968
in O 0 0.008689546957612038
other O 0 0.015073413960635662
genetic B-Disease 1 0.9999918937683105
disorders I-Disease 1 1.0
, O 0 0.11713474988937378
we O 0 0.014098779298365116
used O 0 0.019028864800930023
mental O 1 0.9999998807907104
health O 1 0.9999996423721313
wellness O 1 1.0
( O 0 0.026266809552907944
absence O 0 0.036787424236536026
of O 0 0.023616105318069458
any O 1 0.982954204082489
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.3324755132198334
as O 0 0.017237598076462746
the O 0 0.019732849672436714
phenotype O 0 0.04995465278625488
in O 0 0.011669228784739971
our O 0 0.021436454728245735
genome O 0 0.04148469865322113
- O 1 0.9976102113723755
wide O 0 0.03792057931423187
linkage O 0 0.388509601354599
scan O 0 0.03896418586373329
of O 0 0.014704070053994656
several O 0 0.010840269736945629
large O 0 0.01879034750163555
multigeneration O 1 0.7524856925010681
Old O 0 0.05709858983755112
Order O 0 0.03903632238507271
Amish O 1 0.9065317511558533
pedigrees O 0 0.1945718228816986
exhibiting O 0 0.05606730282306671
an O 0 0.02310253493487835
extremely O 0 0.04803720861673355
high O 1 0.9124164581298828
incidence O 1 0.9999914169311523
of O 1 0.9795050024986267
BPAD B-Disease 1 0.9999998807907104
. O 0 0.0759648010134697

We O 0 0.030163269490003586
have O 0 0.013593101873993874
found O 0 0.01377210021018982
strong O 0 0.016967253759503365
evidence O 0 0.012663882225751877
for O 0 0.01225097756832838
a O 0 0.021580776199698448
locus O 0 0.07395559549331665
on O 0 0.024870669469237328
chromosome O 0 0.06904984265565872
4p O 1 0.9998764991760254
at O 0 0.03894653916358948
D4S2949 O 1 0.9569876194000244
( O 0 0.025601476430892944
maximum O 0 0.03864140436053276
GENEHUNTER O 1 0.9999457597732544
- O 1 0.9991357922554016
PLUS O 0 0.06577479839324951
nonparametric O 0 0.145050048828125
linkage O 0 0.0722455382347107
score O 0 0.029627695679664612
= O 0 0.03722091391682625
4 O 0 0.021256159991025925
. O 0 0.014327781274914742
05 O 0 0.07539104670286179
, O 0 0.024224793538451195
P O 1 0.959801197052002
= O 0 0.03591101989150047
5 O 0 0.015724824741482735
. O 0 0.008893785066902637
22 O 0 0.017385225743055344
x O 0 0.030110327526926994
10 O 0 0.015970874577760696
( O 0 0.02345260977745056
- O 1 0.9973438382148743
4 O 0 0.024350345134735107
) O 0 0.0159444659948349
; O 0 0.016991160809993744
SIBPAL O 1 0.9925967454910278
Pempirical O 1 0.9624643325805664
value O 0 0.022524332627654076
< O 0 0.09150578081607819
3 O 0 0.021602004766464233
x O 0 0.030443793162703514
10 O 0 0.016896812245249748
( O 0 0.022580169141292572
- O 1 0.9989302754402161
5 O 0 0.02626221626996994
) O 0 0.017052900046110153
) O 0 0.012826683931052685
and O 0 0.012336854822933674
suggestive O 0 0.04069780930876732
evidence O 0 0.012344305403530598
for O 0 0.011388810351490974
a O 0 0.02322041429579258
locus O 0 0.16949306428432465
on O 0 0.029852094128727913
chromosome O 0 0.09960313141345978
4q O 1 0.9988034963607788
at O 0 0.03841166943311691
D4S397 O 1 0.9919792413711548
( O 0 0.029536643996834755
maximum O 0 0.04142642021179199
GENEHUNTER O 1 0.9998431205749512
- O 1 0.9985802173614502
PLUS O 0 0.07088611274957657
nonparametric O 0 0.1189860850572586
linkage O 0 0.07035595178604126
score O 0 0.027811063453555107
= O 0 0.03759656846523285
3 O 0 0.017545778304338455
. O 0 0.009880210272967815
29 O 0 0.023351497948169708
, O 0 0.019678404554724693
P O 1 0.9955337047576904
= O 0 0.034088876098394394
2 O 0 0.015282152220606804
. O 0 0.008659560233354568
57 O 0 0.028829168528318405
x O 0 0.03361108899116516
10 O 0 0.018302522599697113
( O 0 0.02320386841893196
- O 1 0.9420360922813416
3 O 0 0.024474147707223892
) O 0 0.016475388780236244
; O 0 0.018021853640675545
SIBPAL O 1 0.995515763759613
Pempirical O 1 0.9381633400917053
value O 0 0.023327378556132317
< O 0 0.13186848163604736
1 O 0 0.023143479600548744
x O 0 0.03129764273762703
10 O 0 0.0168314166367054
( O 0 0.022895468398928642
- O 1 0.9994065761566162
3 O 0 0.024166833609342575
) O 0 0.014954311773180962
) O 0 0.009797994047403336
that O 0 0.006235386244952679
are O 0 0.006974536459892988
linked O 0 0.03205016627907753
to O 0 0.0324367880821228
mental O 1 1.0
health O 1 0.9999992847442627
wellness O 1 0.9999997615814209
. O 0 0.0886726900935173

These O 0 0.0254230760037899
findings O 0 0.02649468556046486
are O 0 0.009106659330427647
consistent O 0 0.020281106233596802
with O 0 0.01254656445235014
the O 0 0.017390811815857887
hypothesis O 0 0.02782619744539261
that O 0 0.00983739085495472
certain O 0 0.013163683004677296
alleles O 0 0.03645426779985428
could O 0 0.016970841214060783
prevent O 0 0.03651895374059677
or O 0 0.016667015850543976
modify O 0 0.03558247908949852
the O 0 0.02283225581049919
clinical O 1 0.9484943151473999
manifestations O 1 0.9999363422393799
of O 1 0.993365466594696
BPAD B-Disease 1 1.0
and O 0 0.16648849844932556
perhaps O 0 0.030592981725931168
other O 0 0.021252240985631943
related O 1 0.9991255402565002
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.8727838397026062

Segregation O 1 0.9982829093933105
distortion O 1 0.9991868138313293
in O 1 0.7573932409286499
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.6400052905082703

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999990701675415
DM B-Disease 1 1.0
) O 0 0.028781292960047722
is O 0 0.016568785533308983
an O 0 0.023294722661376
autosomal B-Disease 1 0.9999995231628418
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 0.01831960119307041
, O 0 0.012956847436726093
in O 0 0.009753948077559471
the O 0 0.015603688545525074
typical O 0 0.04730664938688278
pedigree O 1 0.5915013551712036
, O 0 0.014203691855072975
shows O 0 0.012447033077478409
a O 0 0.01564675383269787
three O 0 0.020497947931289673
generation O 0 0.3370906412601471
anticipation O 0 0.36192721128463745
cascade O 1 0.9971008896827698
. O 0 0.05275759845972061

This O 0 0.019904935732483864
results O 0 0.015205548144876957
in O 0 0.02345849573612213
infertility B-Disease 1 1.0
and O 1 0.9999971389770508
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
CDM B-Disease 1 1.0
) O 0 0.019656116142868996
with O 0 0.010738696902990341
the O 0 0.015889979898929596
disappearance O 0 0.2519860863685608
of O 0 0.15988801419734955
DM B-Disease 1 1.0
in O 0 0.03141041100025177
that O 0 0.025284545496106148
pedigree O 0 0.1478525847196579
. O 0 0.04189867526292801

The O 0 0.03611581027507782
concept O 0 0.032912012189626694
of O 0 0.03166503831744194
segregation O 1 0.9999831914901733
distortion O 1 0.9998687505722046
, O 0 0.022936848923563957
where O 0 0.01579514890909195
there O 0 0.009269988164305687
is O 0 0.013055379502475262
preferential O 0 0.07143591344356537
transmission O 0 0.02534531056880951
of O 0 0.011473949067294598
the O 0 0.01391634251922369
larger O 0 0.016203776001930237
allele O 0 0.03575844690203667
at O 0 0.01797725073993206
the O 0 0.04335915669798851
DM B-Disease 1 1.0
locus O 1 0.9999738931655884
, O 0 0.021517781540751457
has O 0 0.013799425214529037
been O 0 0.010543090291321278
put O 0 0.018456917256116867
forward O 0 0.015500294044613838
to O 0 0.011940613389015198
explain O 0 0.019617507234215736
partially O 0 0.028116324916481972
the O 0 0.017419306561350822
maintenance O 1 0.9708192944526672
of O 0 0.4945005476474762
DM B-Disease 1 1.0
in O 0 0.02379392273724079
the O 0 0.029089106246829033
population O 0 0.02617694064974785
. O 0 0.03464268147945404

In O 0 0.024816755205392838
a O 0 0.024779334664344788
survey O 0 0.026969654485583305
of O 0 0.038764286786317825
DM B-Disease 1 1.0
in O 0 0.025725767016410828
Northern O 0 0.03890125826001167
Ireland O 0 0.04469870775938034
, O 0 0.030621521174907684
59 O 0 0.06801487505435944
pedigrees O 0 0.10545232892036438
were O 0 0.03243347257375717
ascertained O 0 0.10781465470790863
. O 0 0.046245988458395004

Sibships O 1 0.9088022112846375
where O 0 0.02926533669233322
the O 0 0.020310677587985992
status O 0 0.027422044426202774
of O 0 0.013842490501701832
all O 0 0.009634125977754593
the O 0 0.013819895684719086
members O 0 0.013600912876427174
had O 0 0.013414883054792881
been O 0 0.010315642692148685
identified O 0 0.013462592847645283
were O 0 0.00800797063857317
examined O 0 0.020432855933904648
to O 0 0.00983746163547039
determine O 0 0.010548100806772709
the O 0 0.012988614849746227
transmission O 0 0.02405920997262001
of O 0 0.016531772911548615
the O 0 0.19827643036842346
DM B-Disease 1 1.0
expansion O 0 0.29114264249801636
from O 0 0.02296123281121254
affected O 0 0.03164197877049446
parents O 0 0.026980774477124214
to O 0 0.018806155771017075
their O 0 0.02297530509531498
offspring O 0 0.12255247682332993
. O 0 0.04275892302393913

Where O 0 0.03640381991863251
the O 0 0.03279963135719299
transmitting O 1 0.9369011521339417
parent O 1 0.9398664832115173
was O 0 0.0452938973903656
male O 0 0.06571733206510544
, O 0 0.030090641230344772
58 O 0 0.06901653856039047
. O 0 0.04571648687124252

3 O 0 0.03458832949399948
% O 0 0.017636209726333618
of O 0 0.016096189618110657
the O 0 0.023059306666254997
offspring O 0 0.3892250955104828
were O 0 0.01465537492185831
affected O 0 0.026918409392237663
, O 0 0.013714770786464214
and O 0 0.010065853595733643
in O 0 0.007802389096468687
the O 0 0.01136100199073553
case O 0 0.014347235672175884
of O 0 0.012581892311573029
a O 0 0.023475930094718933
female O 1 0.9491602182388306
transmitting O 1 0.9993330836296082
parent O 1 0.939079225063324
, O 0 0.03031456470489502
68 O 0 0.06864137947559357
. O 0 0.04428781196475029

7 O 0 0.0752887949347496
% O 0 0.035750675946474075
were O 0 0.024410594254732132
affected O 0 0.05093371868133545
. O 0 0.045309316366910934

Studies O 0 0.037140391767024994
on O 0 0.031787045300006866
meiotic O 1 0.9993157386779785
drive O 0 0.2162843644618988
in O 0 0.04515866935253143
DM B-Disease 1 1.0
have O 0 0.015784086659550667
shown O 0 0.016263898462057114
increased O 0 0.018542591482400894
transmission O 0 0.02620578743517399
of O 0 0.014049049466848373
the O 0 0.016785254701972008
larger O 0 0.018701782450079918
allele O 0 0.038983482867479324
at O 0 0.019361421465873718
the O 0 0.03305751085281372
DM B-Disease 1 1.0
locus O 0 0.3825224041938782
in O 0 0.022243646904826164
non O 1 0.9932979941368103
- O 1 0.9999998807907104
DM O 1 1.0
heterozygotes O 1 0.999347984790802
for O 0 0.047408271580934525
CTGn O 1 0.9984288811683655
. O 0 0.06007388234138489

This O 0 0.026052964851260185
study O 0 0.023509781807661057
provides O 0 0.020378677174448967
further O 0 0.01269840169698
evidence O 0 0.012759728357195854
that O 0 0.010685043409466743
the O 0 0.03412585332989693
DM B-Disease 1 1.0
expansion O 1 0.5980521440505981
tends O 0 0.0567719042301178
to O 0 0.02563505806028843
be O 0 0.024632053449749947
transmitted O 0 0.07551734894514084
preferentially O 0 0.0938904657959938
. O 0 0.04419727623462677

Diagnosis O 1 0.9999680519104004
of O 1 0.9773181676864624
hemochromatosis B-Disease 1 1.0
. O 0 0.4193831980228424

If O 0 0.06802191585302353
untreated O 1 0.9999991655349731
, O 1 0.9993534684181213
hemochromatosis B-Disease 1 1.0
can O 1 0.7132613658905029
cause O 1 0.9999974966049194
serious O 1 0.9999996423721313
illness O 1 1.0
and O 0 0.19976291060447693
early B-Disease 1 0.6011279821395874
death I-Disease 1 0.9993820190429688
, O 0 0.014704829081892967
but O 0 0.010026970878243446
the O 0 0.1270267814397812
disease O 1 0.9999994039535522
is O 0 0.01582465134561062
still O 0 0.01589798927307129
substantially O 0 0.0339396670460701
under O 1 0.758469820022583
- O 1 1.0
diagnosed O 1 0.9999998807907104
. O 0 0.05663687363266945

The O 0 0.043615952134132385
cornerstone O 1 0.999038815498352
of O 0 0.038181014358997345
screening O 1 0.8785489797592163
and O 0 0.020973607897758484
case O 0 0.034106794744729996
detection O 0 0.05195997655391693
is O 0 0.012715151533484459
the O 0 0.014547871425747871
measurement O 0 0.03113378770649433
of O 0 0.029930971562862396
serum O 1 0.9999969005584717
transferrin O 1 0.9999927282333374
saturation O 1 0.9434181451797485
and O 0 0.03007587231695652
the O 0 0.04796692356467247
serum O 1 0.9999895095825195
ferritin O 1 0.9999508857727051
level O 0 0.06640706211328506
. O 0 0.048298995941877365

Once O 0 0.06035773083567619
the O 0 0.04767315834760666
diagnosis O 1 0.9999986886978149
is O 0 0.028862932696938515
suspected O 0 0.45829376578330994
, O 0 0.022488193586468697
physicians O 0 0.11903905868530273
must O 0 0.022730156779289246
use O 0 0.026341205462813377
serum O 1 0.9999810457229614
ferritin O 1 0.9999929666519165
levels O 0 0.049907080829143524
and O 0 0.04544077441096306
hepatic O 1 1.0
iron O 1 0.9999984502792358
stores O 0 0.089893639087677
on O 1 0.7432348728179932
liver O 1 1.0
biopsy O 1 0.9999985694885254
specimens O 0 0.03732476383447647
to O 0 0.021526949480175972
assess O 0 0.4251624047756195
patients O 1 0.527406632900238
for O 0 0.012568432837724686
the O 0 0.018440978601574898
presence O 0 0.047239966690540314
of O 0 0.28349339962005615
iron B-Disease 1 0.9999998807907104
overload I-Disease 1 0.9999992847442627
. O 0 0.06262651830911636

Liver O 1 1.0
biopsy O 1 0.9999997615814209
is O 0 0.03667892888188362
also O 0 0.017717717215418816
used O 0 0.009478950873017311
to O 0 0.010139313526451588
establish O 0 0.018781503662467003
the O 0 0.014371666125953197
presence O 0 0.021409621462225914
or O 0 0.012987184338271618
absence O 0 0.1578371822834015
of O 1 0.9850152134895325
cirrhosis B-Disease 1 1.0
, O 1 0.5730308890342712
which O 0 0.018551118671894073
can O 0 0.016034381464123726
affect O 0 0.050126537680625916
prognosis O 1 0.9999994039535522
and O 0 0.0409105122089386
management O 1 0.6966007947921753
. O 0 0.04459449276328087

A O 0 0.06723608821630478
DNA O 0 0.05741022527217865
- O 1 0.9035898447036743
based O 0 0.017983833327889442
test O 0 0.015617471188306808
for O 0 0.012012279592454433
the O 0 0.025975873693823814
HFE O 1 0.9999990463256836
gene O 0 0.04261818528175354
is O 0 0.017097510397434235
commercially O 0 0.0284286942332983
available O 0 0.01019281055778265
, O 0 0.00879413541406393
but O 0 0.005616247653961182
its O 0 0.008014889433979988
place O 0 0.011438838206231594
in O 0 0.008270299062132835
the O 0 0.0176673736423254
diagnosis O 1 0.9999957084655762
of O 1 0.9998043179512024
hemochromatosis B-Disease 1 1.0
is O 1 0.6049379706382751
still O 0 0.031675029546022415
being O 0 0.029206104576587677
evaluated O 0 0.058188796043395996
. O 0 0.03501657769083977

Currently O 0 0.04417873173952103
, O 0 0.02287125773727894
the O 0 0.01914815790951252
most O 0 0.013755394145846367
useful O 0 0.017379652708768845
role O 0 0.020683113485574722
for O 0 0.01202974934130907
this O 0 0.009688756428658962
test O 0 0.0168139711022377
is O 0 0.00901409238576889
in O 0 0.007750305812805891
the O 0 0.013602550141513348
detection O 0 0.044184666126966476
of O 0 0.03922770544886589
hemochromatosis B-Disease 1 1.0
in O 0 0.016128255054354668
the O 0 0.0168039221316576
family O 0 0.0220154020935297
members O 0 0.014632477425038815
of O 0 0.01780671626329422
patients O 1 0.9841712117195129
with O 0 0.01326700672507286
a O 0 0.022896869108080864
proven O 0 0.05577115714550018
case O 0 0.021367063745856285
of O 0 0.022270582616329193
the O 1 0.6373352408409119
disease O 1 0.9999997615814209
. O 0 0.061813950538635254

It O 0 0.02201690897345543
is O 0 0.017100905999541283
crucial O 0 0.028800787404179573
to O 0 0.032254062592983246
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999903440475464
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999998807907104
because O 1 0.9993941783905029
phlebotomy O 1 1.0
therapy O 1 0.9999996423721313
can O 0 0.03197504207491875
avert O 1 0.9999998807907104
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9999183416366577
can O 0 0.02274498902261257
even O 0 0.015419418923556805
lead O 0 0.025258196517825127
to O 0 0.018784616142511368
normal O 0 0.030383998528122902
life O 0 0.04521748051047325
expectancy O 1 0.8794180750846863
. O 0 0.03053673356771469
. O 0 0.037150971591472626

Prevalence O 1 0.9010978937149048
of O 0 0.036128491163253784
the O 0 0.0525827631354332
I1307K O 1 0.9999948740005493
APC B-Disease 1 0.9999951124191284
gene O 0 0.049363091588020325
variant O 0 0.03461206704378128
in O 0 0.012009093537926674
Israeli O 0 0.025266582146286964
Jews O 0 0.026203952729701996
of O 0 0.013412496075034142
differing O 0 0.014368937350809574
ethnic O 0 0.018823588266968727
origin O 0 0.01456040795892477
and O 0 0.01914518140256405
risk O 1 0.9956203103065491
for O 1 0.9997445940971375
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9929454922676086

BACKGROUND O 0 0.32501646876335144
& O 1 0.6260069012641907
AIMS O 0 0.07651876658201218
Israeli O 0 0.0374511294066906
Jews O 0 0.027535321190953255
of O 0 0.01664663292467594
European O 0 0.02445998415350914
birth O 1 0.9570658802986145
, O 0 0.020319867879152298
i O 0 0.023320849984884262
. O 0 0.013526585884392262
e O 0 0.03455736115574837
. O 0 0.010586204007267952
, O 0 0.014356658793985844
Ashkenazim O 1 0.7720492482185364
, O 0 0.011305701918900013
have O 0 0.006709444336593151
the O 0 0.020830616354942322
highest O 1 0.9999988079071045
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 1.0
of O 0 0.29397282004356384
any O 0 0.026791956275701523
Israeli O 0 0.04916283115744591
ethnic O 0 0.04383683204650879
group O 0 0.053499408066272736
. O 0 0.03534580394625664

The O 0 0.06335846334695816
I1307K O 1 0.9999223947525024
APC B-Disease 1 0.9999946355819702
gene O 0 0.06478987634181976
variant O 0 0.057057853788137436
was O 0 0.030964775010943413
found O 0 0.016682928428053856
in O 0 0.018339097499847412
6 O 0 0.048519331961870193
. O 0 0.040037404745817184

1 O 0 0.04106074199080467
% O 0 0.018130211159586906
of O 0 0.015680331736803055
American O 0 0.02633359469473362
Jews O 0 0.029815781861543655
, O 0 0.01373463124036789
28 O 0 0.016381043940782547
% O 0 0.009023976512253284
of O 0 0.011986535042524338
their O 0 0.03467435762286186
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9999899864196777
, O 0 0.19136488437652588
but O 0 0.010973970405757427
not O 0 0.008244023658335209
in O 0 0.012553606182336807
non O 0 0.1534913182258606
- O 1 0.9995573163032532
Jews O 0 0.0629367083311081
. O 0 0.041482750326395035

We O 0 0.036293875426054
assessed O 0 0.044799018651247025
the O 0 0.037793565541505814
I1307K O 1 0.9988183379173279
prevalence O 1 0.9940809607505798
in O 0 0.020237218588590622
Israeli O 0 0.035207897424697876
Jews O 0 0.03172862529754639
of O 0 0.0164778009057045
differing O 0 0.016067344695329666
ethnic O 0 0.022276001051068306
origin O 0 0.01661643572151661
and O 0 0.020640458911657333
risk O 1 0.9839094281196594
for O 1 0.9994522929191589
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9613589644432068

METHODS O 0 0.05848611891269684
DNA O 0 0.03864877671003342
samples O 0 0.02443372830748558
from O 0 0.014673089608550072
500 O 0 0.029284512624144554
unrelated O 0 0.026622915640473366
Jews O 0 0.02568141743540764
of O 0 0.015355669893324375
European O 0 0.019058378413319588
or O 0 0.01713758148252964
non O 1 0.951011061668396
- O 1 0.9999189376831055
European O 0 0.016728373244404793
origin O 0 0.011037899181246758
, O 0 0.009924408048391342
with O 0 0.008430490270256996
or O 0 0.010011802427470684
without O 0 0.009178617037832737
a O 0 0.01573270931839943
personal O 0 0.03692386671900749
and O 0 0.02311733551323414
/ O 1 0.9998669624328613
or O 0 0.014139905571937561
family O 0 0.02003820613026619
history O 0 0.019385235384106636
of O 0 0.033581800758838654
neoplasia B-Disease 1 0.9999998807907104
, O 0 0.019627155736088753
were O 0 0.010615496896207333
examined O 0 0.022389378398656845
for O 0 0.011810142546892166
the O 0 0.020061032846570015
I1307K O 1 0.9956150054931641
variant O 0 0.03265450894832611
by O 0 0.012745631858706474
the O 0 0.021174119785428047
allele O 0 0.23005041480064392
- O 1 0.9957728981971741
specific O 0 0.026019100099802017
oligonucleotide O 1 0.9744462370872498
( O 0 0.04804753139615059
ASO O 1 0.9999791383743286
) O 0 0.04158351570367813
method O 0 0.038599539548158646
. O 0 0.03654173016548157

RESULTS O 0 0.03299742564558983
In O 0 0.015484866686165333
persons O 0 0.019555872306227684
at O 0 0.016928620636463165
average O 0 0.021699171513319016
risk O 0 0.3466276526451111
for O 1 0.9979154467582703
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9992890357971191
I1307K O 1 0.9999985694885254
was O 0 0.05094078555703163
found O 0 0.01645768992602825
in O 0 0.01637824811041355
5 O 0 0.03491600975394249
. O 0 0.035229459404945374

0 O 0 0.06521929055452347
% O 0 0.023485183715820312
of O 0 0.02014019899070263
120 O 0 0.03365015983581543
European O 0 0.027370864525437355
and O 0 0.02572638913989067
1 O 0 0.04761214181780815
. O 0 0.03851677104830742

6 O 0 0.050899725407361984
% O 0 0.019472062587738037
of O 0 0.018466776236891747
188 O 0 0.06386850029230118
non O 0 0.08140464872121811
- O 1 0.9965603947639465
European O 0 0.024493440985679626
Jews O 0 0.04604359716176987
( O 0 0.034879665821790695
P O 1 0.9951679706573486
= O 0 0.05692547187209129
0 O 0 0.04034409299492836
. O 0 0.024614129215478897
08 O 0 0.11792246997356415
) O 0 0.035215042531490326
. O 0 0.0354141965508461

It O 0 0.03179460018873215
occurred O 0 0.03850797563791275
in O 0 0.02314860001206398
15 O 0 0.04204828664660454
. O 0 0.04203486815094948

4 O 0 0.044943325221538544
% O 0 0.02044181153178215
of O 0 0.0170900821685791
52 O 0 0.04377858713269234
Ashkenazi O 0 0.2252468764781952
Israelis O 0 0.04618356376886368
with O 0 0.03630116581916809
familial O 1 1.0
cancer B-Disease 1 1.0
( O 1 0.9567751884460449
P O 1 0.9999706745147705
= O 0 0.05544068291783333
0 O 0 0.03377017378807068
. O 0 0.019595526158809662
02 O 1 0.9992027878761292
) O 0 0.01575137861073017
and O 0 0.011923828162252903
was O 0 0.01706577278673649
not O 0 0.008318861946463585
detected O 0 0.01646079309284687
in O 0 0.008283324539661407
51 O 0 0.031137067824602127
non O 0 0.0459224097430706
- O 1 0.8818825483322144
European O 0 0.019845351576805115
Jews O 0 0.036392778158187866
at O 0 0.03594351187348366
increased O 1 0.8241892457008362
cancer B-Disease 1 0.9999998807907104
risk O 1 0.9995501637458801
. O 0 0.054053306579589844

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999998807907104
occurred O 1 0.7089604139328003
personally O 1 0.8689463138580322
or O 0 0.01692698337137699
in O 0 0.011001304723322392
the O 0 0.013251347467303276
families O 0 0.014379151165485382
of O 0 0.012034929357469082
13 O 0 0.016859671100974083
of O 0 0.014886869117617607
20 O 0 0.025685707107186317
Ashkenazi O 1 0.9996387958526611
I1307K O 1 0.9997469782829285
carriers O 0 0.05278409272432327
, O 0 0.015146867372095585
8 O 0 0.018287787213921547
of O 0 0.014310033060610294
whom O 0 0.023920515552163124
also O 0 0.012666434049606323
had O 0 0.014661875553429127
a O 0 0.01963658072054386
personal O 0 0.030872443690896034
or O 0 0.016450652852654457
family O 0 0.027272388339042664
history O 0 0.02946523018181324
of O 0 0.05116948485374451
noncolonic O 1 0.9999972581863403
neoplasia B-Disease 1 0.9999984502792358
. O 0 0.0719035267829895

CONCLUSIONS O 0 0.06392139941453934
The O 0 0.047604020684957504
I1307K O 1 0.999977707862854
APC O 1 0.9999969005584717
variant O 0 0.06579435616731644
may O 0 0.018479105085134506
represent O 0 0.015153595246374607
a O 0 0.022321006283164024
susceptibility O 1 0.9951276779174805
gene O 0 0.04006241261959076
for O 0 0.07420789450407028
colorectal B-Disease 1 1.0
, I-Disease 0 0.11706694215536118
or I-Disease 0 0.017918897792696953
other I-Disease 0 0.012487399391829967
, I-Disease 0 0.02265629731118679
cancers I-Disease 1 0.9989239573478699
in O 0 0.018069449812173843
Ashkenazi O 1 0.998611330986023
Jews O 0 0.0521550327539444
, O 0 0.020225342363119125
and O 0 0.01658122055232525
partially O 0 0.0409984365105629
explains O 0 0.023124879226088524
the O 0 0.013949785381555557
higher O 0 0.021751469001173973
incidence O 1 0.9999910593032837
of O 1 0.9999977350234985
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.4702046513557434
European O 0 0.04852830991148949
Israelis O 0 0.07361441105604172
. O 0 0.04297276958823204

Systematic O 0 0.08429992944002151
analysis O 0 0.025201603770256042
of O 0 0.03250060975551605
coproporphyrinogen O 1 0.9999891519546509
oxidase O 1 0.9999980926513672
gene O 1 0.7137174606323242
defects O 1 0.9983112812042236
in O 0 0.03327668458223343
hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999995231628418
and O 0 0.3215799033641815
mutation O 1 0.9508894681930542
update O 0 0.153667613863945
. O 0 0.04660429432988167

Hereditary B-Disease 1 0.9999966621398926
coproporphyria I-Disease 1 0.9999979734420776
( O 1 0.8356432318687439
HC B-Disease 1 0.9999998807907104
) O 0 0.028686121106147766
is O 0 0.01955895684659481
an O 0 0.07480016350746155
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.999859094619751
autosomal O 1 1.0
dominant O 1 0.9999995231628418
inheritance O 1 0.9999983310699463
caused O 1 0.9998316764831543
by O 0 0.05102868750691414
deficient B-Disease 1 0.9998170733451843
activity I-Disease 0 0.02357747033238411
of I-Disease 0 0.030060550197958946
coproporphyrinogen I-Disease 1 0.9999992847442627
III I-Disease 1 1.0
oxidase I-Disease 1 0.9999997615814209
( O 0 0.10524142533540726
CPO O 1 0.9984573125839233
) O 0 0.04494038596749306
. O 0 0.038108475506305695

Clinical O 1 0.989849328994751
manifestations O 1 0.9994956254959106
of O 0 0.11626150459051132
the O 1 0.9995947480201721
disease O 1 1.0
are O 0 0.012583485804498196
characterized O 1 0.9931656718254089
by O 0 0.249795064330101
acute O 1 1.0
attacks O 1 0.9997482895851135
of O 1 0.9999979734420776
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9437513947486877
precipitated O 1 0.9999985694885254
by O 0 0.06713045388460159
drugs O 1 0.9964320659637451
, O 0 0.029425133019685745
fasting O 1 0.9985619187355042
, O 0 0.05451890453696251
cyclical O 1 0.9999940395355225
hormonal O 1 0.999997615814209
changes O 0 0.03289315477013588
, O 0 0.058241184800863266
or O 1 0.9924716949462891
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 1 0.7798936367034912

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.3433195650577545
also O 0 0.028311897069215775
be O 0 0.019761748611927032
present O 0 0.033263955265283585
. O 0 0.03735131397843361

The O 0 0.03609795868396759
seven O 0 0.03419835865497589
exons O 0 0.0648937001824379
, O 0 0.020217517390847206
the O 0 0.02797696366906166
exon O 1 0.9972668886184692
/ O 1 0.9995443224906921
intron O 1 0.9963016510009766
boundaries O 0 0.02290024235844612
and O 0 0.013263946399092674
part O 0 0.01818605698645115
of O 0 0.017940768972039223
3 O 0 0.02850504405796528
noncoding O 0 0.057954780757427216
sequence O 0 0.01397732924669981
of O 0 0.014376908540725708
the O 0 0.025842949748039246
CPO O 1 0.9990118741989136
gene O 0 0.025231188163161278
were O 0 0.010204097256064415
systematically O 0 0.026440396904945374
analyzed O 0 0.015144120901823044
by O 0 0.009934420697391033
an O 0 0.014232957735657692
exon O 0 0.422625869512558
- O 1 0.950962245464325
by O 0 0.02307066321372986
- O 1 0.9967865943908691
exon O 1 0.5573300719261169
denaturing O 1 0.9991834759712219
gradient O 1 0.9976968169212341
gel O 1 0.9999617338180542
electrophoresis O 1 0.9968504309654236
( O 0 0.05362669378519058
DGGE O 1 0.9999879598617554
) O 0 0.02652869187295437
strategy O 0 0.02778841368854046
followed O 0 0.01911664940416813
by O 0 0.01326378621160984
direct O 0 0.019531523808836937
sequencing O 0 0.022133585065603256
in O 0 0.010306116193532944
seven O 0 0.019754167646169662
unrelated O 0 0.05288592353463173
heterozygous O 1 0.8738354444503784
HC B-Disease 1 1.0
patients O 1 0.9998959302902222
from O 0 0.029690532013773918
France O 1 0.50520920753479
, O 0 0.030993524938821793
Holland O 1 0.8549343347549438
, O 0 0.02362838387489319
and O 0 0.021036021411418915
Czech O 0 0.3025071322917938
Republic O 0 0.08004859834909439
. O 0 0.046684250235557556

Seven O 0 0.05974163860082626
novel O 0 0.07840658724308014
mutations O 0 0.04067596048116684
and O 0 0.018059726804494858
two O 0 0.0153242452070117
new O 0 0.03137059137225151
polymorphisms O 0 0.07584273815155029
were O 0 0.025972360745072365
detected O 0 0.05669272691011429
. O 0 0.036744553595781326

Among O 0 0.047794751822948456
these O 0 0.015964670106768608
mutations O 0 0.024872034788131714
two O 0 0.011076380498707294
are O 0 0.011761892586946487
missense O 0 0.13028816878795624
( O 0 0.03620807081460953
G197W O 1 0.9983118772506714
, O 0 0.033923644572496414
W427R O 1 0.9989166259765625
) O 0 0.020034512504935265
, O 0 0.012351621873676777
two O 0 0.008003062568604946
are O 0 0.008692795410752296
nonsense O 0 0.07029303163290024
( O 0 0.03001292422413826
Q306X O 1 0.9980325102806091
, O 0 0.0325397327542305
Q385X O 1 0.9997801184654236
) O 0 0.0182583536952734
, O 0 0.010144627653062344
two O 0 0.007018571719527245
are O 0 0.006191604305058718
small O 0 0.01565718837082386
deletions O 0 0.05890364944934845
( O 0 0.0319577194750309
662de14bp O 1 0.9986843466758728
; O 0 0.02581435814499855
1168del3bp O 1 0.9394278526306152
removing O 0 0.05585075169801712
a O 0 0.028204167261719704
glycine O 0 0.06971133500337601
at O 0 0.01901054009795189
position O 0 0.02591896802186966
390 O 0 0.22472785413265228
) O 0 0.01678209938108921
, O 0 0.011704024858772755
and O 0 0.009077591821551323
one O 0 0.009100439958274364
is O 0 0.010501625016331673
a O 0 0.017781507223844528
splicing O 0 0.039603203535079956
mutation O 0 0.03266271948814392
( O 0 0.02232804335653782
IVS1 O 1 0.9989098310470581
- O 1 0.9997194409370422
15c O 1 0.99977046251297
- O 1 0.9999985694885254
- O 1 0.9999985694885254
> O 1 0.9991446733474731
g O 0 0.15736684203147888
) O 0 0.0166066512465477
which O 0 0.01108844205737114
creates O 0 0.02562461979687214
a O 0 0.0233579371124506
new O 0 0.03707903251051903
acceptor O 1 0.9929763078689575
splice O 1 0.5036364793777466
site O 0 0.06099366024136543
. O 0 0.03760474920272827

The O 0 0.055401913821697235
pathological O 0 0.28749561309814453
significance O 0 0.028283482417464256
of O 0 0.017219118773937225
the O 0 0.020286697894334793
point O 0 0.029938995838165283
mutations O 0 0.044640377163887024
G197W O 1 0.99934321641922
, O 0 0.027393391355872154
W427R O 1 0.9971116781234741
, O 0 0.015950720757246017
and O 0 0.010412362404167652
the O 0 0.01377328671514988
in O 0 0.019075632095336914
- O 1 0.9999387264251709
frame O 0 0.22374816238880157
deletion O 0 0.24376916885375977
390delGly O 1 0.9594218730926514
were O 0 0.013551175594329834
assessed O 0 0.020568354055285454
by O 0 0.01030871830880642
their O 0 0.009946748614311218
respective O 0 0.023425446823239326
expression O 0 0.019496656954288483
in O 0 0.01047432329505682
a O 0 0.01900278404355049
prokaryotic O 0 0.05678426846861839
system O 0 0.024379942566156387
using O 0 0.016106130555272102
site O 0 0.03946532681584358
- O 1 0.9906957149505615
directed O 0 0.05211381986737251
mutagenesis O 0 0.11661803722381592
. O 0 0.048143696039915085

These O 0 0.027567442506551743
mutations O 0 0.03765099495649338
resulted O 0 0.029571114107966423
in O 0 0.01503265555948019
the O 0 0.022414248436689377
absence O 1 0.6286990642547607
or O 0 0.020418278872966766
a O 0 0.023234058171510696
dramatic O 0 0.04107939079403877
decrease O 0 0.04892518371343613
of O 0 0.04826934263110161
CPO O 1 0.9999192953109741
activity O 0 0.05925397947430611
. O 0 0.0423615388572216

The O 0 0.04036468267440796
two O 0 0.02495677024126053
polymorphisms O 0 0.06294931471347809
were O 0 0.018447505310177803
localized O 0 0.04529149830341339
in O 0 0.016987938433885574
noncoding O 0 0.060746487230062485
part O 0 0.017470242455601692
of O 0 0.01332124974578619
the O 0 0.016960032284259796
gene O 0 0.0217033252120018
1 O 0 0.01879105716943741
) O 0 0.012812452390789986
a O 0 0.02374757081270218
C O 1 0.9994516968727112
/ O 1 0.9996020197868347
G O 1 0.7446203827857971
polymorphism O 0 0.04856906086206436
in O 0 0.014233146794140339
the O 0 0.027372846379876137
promotor O 1 0.9999842643737793
region O 0 0.04434015229344368
, O 0 0.024276021867990494
142 O 0 0.06564167141914368
bp O 0 0.05592058226466179
upstream O 0 0.029524406418204308
from O 0 0.010575007647275925
the O 0 0.015938766300678253
transcriptional O 0 0.05382700264453888
initiation O 0 0.09434284269809723
site O 0 0.02913851849734783
( O 0 0.023644208908081055
- O 1 0.9999016523361206
142C O 1 0.9999810457229614
/ O 1 0.9999878406524658
G O 1 0.9987999200820923
) O 0 0.017617465928196907
, O 0 0.011381055228412151
and O 0 0.0109988609328866
2 O 0 0.019573718309402466
) O 0 0.01179199106991291
a O 0 0.015538462437689304
6 O 0 0.030352167785167694
bp O 0 0.05566702038049698
deletion O 0 0.051503539085388184
polymorphism O 0 0.039080020040273666
in O 0 0.01167377270758152
the O 0 0.016722368076443672
3 O 0 0.026670213788747787
noncoding O 0 0.05637868121266365
part O 0 0.01852656714618206
of O 0 0.015053709968924522
the O 0 0.027761802077293396
CPO O 1 0.9998968839645386
gene O 0 0.03733081370592117
, O 0 0.023440850898623466
574 O 1 0.9228944182395935
bp O 0 0.05896182730793953
downstream O 0 0.028290336951613426
of O 0 0.012086404487490654
the O 0 0.013889193534851074
last O 0 0.015650391578674316
base O 0 0.01992902159690857
of O 0 0.011629780754446983
the O 0 0.01723172701895237
normal O 0 0.030392609536647797
termination O 1 0.9967196583747864
codon O 1 0.7769754528999329
( O 0 0.046374112367630005
+ O 0 0.48255306482315063
574 O 1 0.9972261786460876
delATTCTT O 1 0.9994783997535706
) O 0 0.04798489063978195
. O 0 0.0450112484395504

Five O 0 0.06251052021980286
intragenic O 1 0.9998605251312256
dimorphisms O 1 0.9994876384735107
are O 0 0.016301339492201805
now O 0 0.019868869334459305
well O 0 0.01740274764597416
characterized O 0 0.031290456652641296
and O 0 0.013488386757671833
the O 0 0.01589943654835224
high O 0 0.02648993395268917
degree O 0 0.022438880056142807
of O 0 0.02584238164126873
allelic O 1 0.9996157884597778
heterogeneity O 1 0.9980923533439636
in O 0 0.03405676409602165
HC B-Disease 1 1.0
is O 0 0.024117428809404373
demonstrated O 0 0.021816620603203773
with O 0 0.009577126242220402
seven O 0 0.014447520487010479
new O 0 0.015765786170959473
different O 0 0.007668733596801758
mutations O 0 0.016852345317602158
making O 0 0.010249931365251541
a O 0 0.011921468190848827
total O 0 0.01114672515541315
of O 0 0.017336895689368248
nineteen O 1 0.8270784616470337
CPO O 1 0.9999982118606567
gene B-Disease 1 0.9791391491889954
defects I-Disease 1 0.9997995495796204
reported O 0 0.033345289528369904
so O 0 0.019228259101510048
far O 0 0.021384676918387413
. O 0 0.019835231825709343
. O 0 0.02972809039056301

Coincidence O 0 0.07319512218236923
of O 0 0.026365118101239204
two O 0 0.018387598916888237
novel O 0 0.05114305391907692
arylsulfatase O 1 0.9653528332710266
A O 0 0.05218392610549927
alleles O 0 0.05481609329581261
and O 0 0.02657211758196354
mutation O 0 0.09104952216148376
459 O 1 0.9999364614486694
+ O 1 0.9998213648796082
1G O 1 0.9999916553497314
> O 0 0.2854817509651184
A O 0 0.025801440700888634
within O 0 0.014515524730086327
a O 0 0.019636891782283783
family O 0 0.031166238710284233
with O 0 0.0316547229886055
metachromatic B-Disease 1 0.9999997615814209
leukodystrophy I-Disease 1 1.0
: O 0 0.04912130907177925
molecular O 0 0.0314662829041481
basis O 0 0.018993010744452477
of O 0 0.029260599985718727
phenotypic O 0 0.09774935990571976
heterogeneity O 1 0.7043567895889282
. O 0 0.06009906530380249

In O 0 0.028326774016022682
a O 0 0.02871662564575672
family O 0 0.027920782566070557
with O 0 0.014320219866931438
three O 0 0.017163962125778198
siblings O 0 0.12170690298080444
, O 0 0.01714882254600525
one O 0 0.014123136177659035
developed O 0 0.020541461184620857
classical O 0 0.029285600408911705
late O 0 0.06166732311248779
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9996883869171143
MLD B-Disease 1 1.0
) O 0 0.032811351120471954
, O 0 0.02358834259212017
fatal O 1 0.9979155659675598
at O 0 0.02209065668284893
age O 0 0.02033345401287079
5 O 0 0.015741489827632904
years O 0 0.012010869570076466
, O 0 0.012320260517299175
with O 0 0.01718956045806408
deficient O 1 0.9998648166656494
arylsulfatase O 1 0.9999605417251587
A O 1 0.9257790446281433
( O 0 0.08177940547466278
ARSA O 1 0.9999980926513672
) O 0 0.02542300708591938
activity O 0 0.019959650933742523
and O 0 0.015567634254693985
increased O 0 0.033820800483226776
galactosylsulfatide O 1 0.9999836683273315
( O 1 0.8359580039978027
GS O 1 1.0
) O 0 0.057439789175987244
excretion O 1 0.9904502034187317
. O 0 0.053719453513622284

The O 0 0.031242966651916504
two O 0 0.015041159465909004
other O 0 0.014674737118184566
siblings O 0 0.056607600301504135
, O 0 0.018672296777367592
apparently O 0 0.02440023235976696
healthy O 0 0.03546610474586487
at O 0 0.015539146028459072
12 O 0 0.01883329637348652
( O 0 0.01749929040670395
1 O 0 0.031945597380399704
/ O 1 0.9961840510368347
2 O 0 0.023776255548000336
) O 0 0.011986161582171917
and O 0 0.008791333064436913
15 O 0 0.01480232272297144
years O 0 0.014536549337208271
, O 0 0.013442931696772575
respectively O 0 0.017026998102664948
, O 0 0.011851495131850243
and O 0 0.00982997752726078
their O 0 0.010762526653707027
father O 1 0.921816349029541
, O 0 0.017986740916967392
apparently O 0 0.0250750370323658
healthy O 0 0.05148671939969063
as O 0 0.013100923039019108
well O 0 0.012295451015233994
, O 0 0.015539598651230335
presented O 0 0.03505774959921837
ARSA O 1 0.999998927116394
and O 0 0.043032459914684296
GS O 1 0.9999990463256836
values O 0 0.023091796785593033
within O 0 0.0131632499396801
the O 0 0.01818522997200489
range O 0 0.026970943436026573
of O 0 0.06880173832178116
MLD B-Disease 1 1.0
patients O 1 0.9999892711639404
. O 0 0.06516468524932861

Mutation O 0 0.1823219209909439
screening O 0 0.0782262533903122
and O 0 0.021369386464357376
sequence O 0 0.02083868905901909
analysis O 0 0.012979290448129177
disclosed O 0 0.023586278781294823
the O 0 0.013949110172688961
involvement O 0 0.028183192014694214
of O 0 0.014135637320578098
three O 0 0.013917939737439156
different O 0 0.01479564979672432
ARSA O 1 0.9999979734420776
mutations O 0 0.035771287977695465
being O 0 0.017694180831313133
the O 0 0.017084406688809395
molecular O 0 0.02240428328514099
basis O 0 0.014430820010602474
of O 0 0.029682662338018417
intrafamilial O 1 0.9990562796592712
phenotypic O 0 0.4057755172252655
heterogeneity O 1 0.9863604307174683
. O 0 0.06097053736448288

The O 0 0.0485355518758297
late O 0 0.1743197739124298
infantile O 1 1.0
patient O 1 0.9999990463256836
inherited O 1 0.9999849796295166
from O 0 0.025761665776371956
his O 0 0.06852678209543228
mother O 1 0.9617530107498169
the O 0 0.02022358402609825
frequent O 0 0.03885457664728165
0 O 0 0.05019538477063179
- O 1 0.9994534850120544
type O 0 0.03937288001179695
mutation O 0 0.047613032162189484
459 O 1 0.9987106323242188
+ O 1 0.999543309211731
1G O 1 0.9999949932098389
> O 1 0.9219616055488586
A O 0 0.03439175337553024
, O 0 0.01364557258784771
and O 0 0.01059375423938036
from O 0 0.00998572539538145
his O 0 0.02096903696656227
father O 0 0.09634240716695786
a O 0 0.023074865341186523
novel O 0 0.03400880843400955
, O 0 0.01915162429213524
single O 0 0.03579927980899811
basepair O 1 0.9939807653427124
microdeletion O 1 0.9815903306007385
of O 0 0.029115872457623482
guanine O 0 0.07549228519201279
at O 0 0.021659836173057556
nucleotide O 0 0.029062191024422646
7 O 0 0.019105395302176476
in O 0 0.015307741239666939
exon O 0 0.10145606845617294
1 O 0 0.04583520442247391
( O 0 0.04191531613469124
7delG O 1 0.9594036340713501
) O 0 0.04030067101120949
. O 0 0.03902123495936394

The O 0 0.03943397477269173
two O 0 0.030418582260608673
clinically O 1 0.998499870300293
unaffected O 1 0.949524998664856
siblings O 0 0.06202578544616699
carried O 0 0.025169674307107925
the O 0 0.026550080627202988
maternal O 1 0.9995158910751343
mutation O 1 0.966541051864624
459 O 1 0.9999905824661255
+ O 1 0.9999808073043823
1G O 1 0.9999982118606567
> O 1 0.9633174538612366
A O 0 0.03505965694785118
and O 0 0.015850700438022614
, O 0 0.012080861255526543
on O 0 0.011094613932073116
their O 0 0.01403643935918808
paternal O 1 0.9831978678703308
allele O 0 0.07472468167543411
, O 0 0.018038814887404442
a O 0 0.021819720044732094
novel O 0 0.043188612908124924
cytosine O 0 0.07241644710302353
to O 0 0.025425778701901436
thymidine O 0 0.1809089034795761
transition O 0 0.04306584596633911
at O 0 0.026875391602516174
nucleotide O 0 0.050582047551870346
2435 O 1 0.9622926115989685
in O 0 0.021866178140044212
exon O 0 0.24054671823978424
8 O 0 0.032103024423122406
, O 0 0.017409728839993477
resulting O 0 0.021120566874742508
in O 0 0.015112066641449928
substitution O 0 0.04260961711406708
of O 0 0.03144240379333496
alanine O 1 0.8516098856925964
464 O 1 0.9833514094352722
by O 0 0.05938186123967171
valine O 1 0.9998335838317871
( O 0 0.07370566576719284
A464V O 1 0.9995917677879333
) O 0 0.04631468281149864
. O 0 0.039097581058740616

The O 0 0.06555195152759552
fathers O 0 0.12982001900672913
genotype O 0 0.23514482378959656
thus O 0 0.040770888328552246
was O 0 0.06773361563682556
7delG O 1 0.9999072551727295
/ O 1 0.9998375177383423
A464V O 1 0.9944056272506714
. O 0 0.06116967275738716

Mutation O 1 0.6896477937698364
A464V O 1 0.9987784028053284
was O 0 0.03257574141025543
not O 0 0.01069929264485836
found O 0 0.010663160122931004
in O 0 0.011641270481050014
18 O 0 0.032513655722141266
unrelated O 1 0.9948634505271912
MLD B-Disease 1 1.0
patients O 1 0.9999785423278809
and O 0 0.03919278830289841
50 O 0 0.04408570006489754
controls O 0 0.06966515630483627
. O 0 0.04422358423471451

A464V O 1 0.9663729071617126
, O 0 0.03168526664376259
although O 0 0.018569204956293106
clearly O 0 0.03166620805859566
modifying O 0 0.09999735653400421
ARSA O 1 0.9999994039535522
and O 1 0.6738881468772888
GS O 1 1.0
levels O 0 0.05351770296692848
, O 0 0.022176481783390045
apparently O 0 0.027371173724532127
bears O 0 0.027295367792248726
little O 0 0.020460018888115883
significance O 0 0.024017568677663803
for O 0 0.01788129098713398
clinical O 1 0.9818316698074341
manifestation O 1 0.9999957084655762
of O 1 0.9846398830413818
MLD B-Disease 1 1.0
, O 0 0.04714567959308624
mimicking O 1 0.5554512739181519
the O 0 0.042504362761974335
frequent O 1 0.7538142204284668
ARSA O 1 0.9999990463256836
pseudodeficiency O 1 0.9999624490737915
allele O 0 0.3727377653121948
. O 0 0.05682048946619034

Our O 0 0.04600472003221512
results O 0 0.02086278423666954
demonstrate O 0 0.024462882429361343
that O 0 0.00803808681666851
in O 0 0.00925991591066122
certain O 0 0.013789890334010124
genetic O 0 0.02747921459376812
conditions O 1 0.8067615628242493
MLD B-Disease 1 1.0
- O 1 0.9999995231628418
like O 0 0.07753948122262955
ARSA O 1 0.999998927116394
and O 0 0.05437318608164787
GS O 1 0.9999998807907104
values O 0 0.026039840653538704
need O 0 0.016021283343434334
not O 0 0.007984179072082043
be O 0 0.007853489369153976
paralleled O 0 0.03923717513680458
by O 0 0.02614627778530121
clinical O 1 0.9999982118606567
disease O 1 0.9999998807907104
, O 0 0.02404741942882538
a O 0 0.02277236245572567
finding O 0 0.024658164009451866
with O 0 0.022784192115068436
serious O 1 0.9999213218688965
diagnostic O 1 0.9999920129776001
and O 1 0.7423135042190552
prognostic O 1 0.9999995231628418
implications O 1 0.8181028962135315
. O 0 0.0537373311817646

Moreover O 0 0.07036935538053513
, O 0 0.0333239808678627
further O 0 0.03891932964324951
ARSA O 1 0.9999904632568359
alleles O 0 0.2988331913948059
functionally O 0 0.08735960721969604
similar O 0 0.02022663503885269
to O 0 0.02550307661294937
A464V O 1 0.9994750618934631
might O 0 0.021588658913969994
exist O 0 0.012700839899480343
which O 0 0.007778475526720285
, O 0 0.008183294907212257
together O 0 0.008285307325422764
with O 0 0.010769453831017017
0 O 0 0.064577117562294
- O 1 0.9999935626983643
type O 0 0.48965445160865784
mutations O 0 0.029917141422629356
, O 0 0.017201721668243408
may O 0 0.019565219059586525
cause O 1 0.8106541633605957
pathological O 1 0.999997615814209
ARSA O 1 1.0
and O 1 0.9984405636787415
GS O 1 1.0
levels O 0 0.04005571827292442
, O 0 0.014417072758078575
but O 0 0.008674346841871738
not O 0 0.01093992218375206
clinical O 1 0.6771021485328674
outbreak O 1 0.9999192953109741
of O 0 0.4291301965713501
the O 1 0.9998520612716675
disease O 1 1.0
. O 0 0.045027147978544235
. O 0 0.04411112144589424

Human O 1 0.9720878601074219
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999978542327881
to O 1 0.9520692825317383
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 1 0.999964714050293
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9998910427093506
1 I-Disease 0 0.07454171031713486
. O 0 0.0453018955886364

Heterozygous O 0 0.4575832188129425
germ O 1 0.9999885559082031
- O 1 0.9998866319656372
line O 0 0.05390036478638649
mutations O 0 0.02742835134267807
in O 0 0.012507396750152111
the O 0 0.02090287208557129
DNA O 0 0.046439677476882935
mismatch O 1 0.9996911287307739
repair O 1 0.9970721006393433
genes O 0 0.022657660767436028
lead O 0 0.026935001835227013
to O 0 0.031865205615758896
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9911812543869019

The O 1 0.9314593076705933
disease O 1 0.9999998807907104
susceptibility O 1 0.9999505281448364
of O 0 0.04937054589390755
individuals O 0 0.028275050222873688
who O 0 0.04128801077604294
constitutionally O 1 0.9050384759902954
lack O 0 0.02831786684691906
both O 0 0.01924234814941883
wild O 0 0.06099937856197357
- O 1 0.9999986886978149
type O 1 0.9149470925331116
alleles O 0 0.06554840505123138
is O 0 0.026998281478881836
unknown O 0 0.04113462567329407
. O 0 0.03301394358277321

We O 0 0.025770612061023712
have O 0 0.01091589406132698
identified O 0 0.015204370021820068
three O 0 0.009518789127469063
offspring O 0 0.026109794154763222
in O 0 0.011062433011829853
a O 0 0.02925071306526661
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999854564666748
who O 1 0.9927833080291748
developed O 1 0.993908166885376
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 0.05208318307995796
a O 0 0.01975390687584877
very O 0 0.012666291557252407
early O 0 0.01794750802218914
age O 0 0.019642727449536324
, O 0 0.012111881747841835
and O 0 0.010081522166728973
at O 0 0.011219469830393791
least O 0 0.00654803728684783
two O 0 0.005786854308098555
of O 0 0.008999562822282314
them O 0 0.008901029825210571
displayed O 0 0.02113935723900795
signs O 0 0.031674824655056
of O 0 0.12144479900598526
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.999763548374176
1 I-Disease 1 0.5411447286605835
( O 0 0.05063914135098457
NF1 B-Disease 1 0.9998705387115479
) O 0 0.040836263447999954
. O 0 0.03798750415444374

DNA O 0 0.0529119037091732
sequence O 0 0.02261878363788128
analysis O 0 0.01573782041668892
and O 0 0.019621483981609344
allele O 0 0.0741892084479332
- O 1 0.9757232666015625
specific O 0 0.01990198716521263
amplification O 0 0.038971953094005585
in O 0 0.010529369115829468
two O 0 0.011972182430326939
siblings O 0 0.04419330134987831
revealed O 0 0.02982701174914837
a O 0 0.029827911406755447
homozygous O 0 0.17668592929840088
MLH1 O 1 0.9999879598617554
mutation O 0 0.08716816455125809
( O 0 0.03677831590175629
C676T O 1 0.9999129772186279
- O 1 0.9999991655349731
- O 1 0.999997615814209
> O 1 0.9988135099411011
Arg226Stop O 1 0.9967514276504517
) O 0 0.041690926998853683
. O 0 0.03732486814260483

Thus O 0 0.035910770297050476
, O 0 0.019111301749944687
a O 0 0.028785131871700287
homozygous O 0 0.11801527440547943
germ O 1 0.9999935626983643
- O 1 0.9999895095825195
line O 0 0.32957687973976135
MLH1 O 1 0.9999954700469971
mutation O 0 0.06927331537008286
and O 0 0.03349562734365463
consequent O 1 0.9999980926513672
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.023945044726133347
in O 0 0.016659624874591827
a O 0 0.0370977446436882
mutator O 1 0.9999994039535522
phenotype O 1 0.9978057742118835
characterized O 1 0.693852424621582
by O 0 0.06865162402391434
leukemia B-Disease 1 1.0
and O 1 0.9978531002998352
/ O 1 1.0
or O 1 0.9996961355209351
lymphoma B-Disease 1 1.0
associated O 1 0.9731157422065735
with O 1 0.9933722019195557
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999324083328247
1 I-Disease 0 0.06642759591341019
. O 0 0.023356975987553596
. O 0 0.03192858397960663

Missense O 1 0.9057653546333313
mutations O 0 0.053106945008039474
in O 0 0.01760927401483059
the O 0 0.0194840170443058
most O 0 0.013996832072734833
ancient O 0 0.02429758943617344
residues O 0 0.026935001835227013
of O 0 0.01726808026432991
the O 0 0.03347235545516014
PAX6 O 1 0.9999996423721313
paired O 0 0.49494174122810364
domain O 0 0.04523302614688873
underlie O 0 0.07148106396198273
a O 0 0.022637449204921722
spectrum O 0 0.04462559148669243
of O 1 0.7464511394500732
human O 1 0.9999992847442627
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9665038585662842

Mutations O 0 0.053629275411367416
of O 0 0.022486714646220207
the O 0 0.02699129283428192
human O 0 0.042735207825899124
PAX6 O 1 0.9999996423721313
gene O 1 0.751429557800293
underlie O 1 0.9999918937683105
aniridia B-Disease 1 1.0
( O 1 0.9997977614402771
congenital B-Disease 1 1.0
absence I-Disease 1 0.9994538426399231
of I-Disease 1 0.6275507807731628
the I-Disease 1 0.9986180067062378
iris I-Disease 1 0.9999997615814209
) O 0 0.01848975010216236
, O 0 0.0121300732716918
a O 0 0.01696198061108589
rare O 0 0.03575451672077179
dominant O 1 0.9995549321174622
malformation B-Disease 1 0.9999998807907104
of I-Disease 0 0.3154173493385315
the I-Disease 1 0.9563086032867432
eye I-Disease 1 0.9999924898147583
. O 0 0.058134086430072784

The O 0 0.03961463272571564
spectrum O 0 0.04792602360248566
of O 0 0.03924068063497543
PAX6 O 1 0.9999996423721313
mutations O 0 0.1714525818824768
in O 0 0.04106008633971214
aniridia B-Disease 1 1.0
patients O 1 0.999994158744812
is O 0 0.02390160597860813
highly O 0 0.03417458012700081
biased O 0 0.03866693377494812
, O 0 0.013229579664766788
with O 0 0.011554456315934658
92 O 0 0.03477032482624054
% O 0 0.012663392350077629
of O 0 0.011389239691197872
all O 0 0.01165100559592247
reported O 0 0.022495418787002563
mutations O 0 0.024058109149336815
leading O 0 0.02795625664293766
to O 0 0.019449617713689804
premature O 1 0.9864675998687744
truncation O 1 0.5873985290527344
of O 0 0.019423699006438255
the O 0 0.029248861595988274
protein O 0 0.032219063490629196
( O 0 0.020916368812322617
nonsense O 0 0.056816086173057556
, O 0 0.019972650334239006
splicing O 0 0.04042969271540642
, O 0 0.02045031264424324
insertions O 0 0.06843827664852142
and O 0 0.021917957812547684
deletions O 0 0.06385113298892975
) O 0 0.017878104001283646
and O 0 0.01285292487591505
just O 0 0.015270058996975422
2 O 0 0.019992053508758545
% O 0 0.014045100659132004
leading O 0 0.023439424112439156
to O 0 0.014032842591404915
substitution O 0 0.02791006676852703
of O 0 0.015934493392705917
one O 0 0.01891765557229519
amino O 0 0.031242115423083305
acid O 0 0.03724155202507973
by O 0 0.017422964796423912
another O 0 0.03432423621416092
( O 0 0.03780200704932213
missense O 0 0.157304048538208
) O 0 0.04090166836977005
. O 0 0.041117679327726364

The O 0 0.03636150434613228
extraordinary O 0 0.048027295619249344
conservation O 0 0.031674180179834366
of O 0 0.019508669152855873
the O 0 0.034970857203006744
PAX6 O 1 1.0
protein O 0 0.03294685110449791
at O 0 0.01855514943599701
the O 0 0.022022124379873276
amino O 0 0.035675227642059326
acid O 0 0.0395020917057991
level O 0 0.023338865488767624
amongst O 0 0.037791430950164795
vertebrates O 0 0.05325453355908394
predicts O 0 0.052223917096853256
that O 0 0.01729932613670826
pathological O 1 0.9989098310470581
missense O 1 0.99956876039505
mutations O 0 0.042047299444675446
should O 0 0.013405273668467999
in O 0 0.011325563304126263
fact O 0 0.013918626122176647
be O 0 0.009789134375751019
common O 0 0.014467589557170868
even O 0 0.011308341287076473
though O 0 0.009749868884682655
they O 0 0.0068788654170930386
are O 0 0.006410041358321905
hardly O 0 0.0243813656270504
ever O 0 0.021592579782009125
seen O 0 0.028682725504040718
in O 0 0.033575963228940964
aniridia B-Disease 1 0.9999996423721313
patients O 1 0.9998883008956909
. O 0 0.057031840085983276

This O 0 0.028087712824344635
indicates O 0 0.030597588047385216
that O 0 0.009883549995720387
there O 0 0.008591997437179089
is O 0 0.01114258449524641
a O 0 0.01989874057471752
heavy O 1 0.7057931423187256
ascertainment O 1 0.999994158744812
bias O 0 0.06692949682474136
in O 0 0.013071179389953613
the O 0 0.014172579161822796
selection O 0 0.021229401230812073
of O 0 0.021303391084074974
patients O 1 0.999122679233551
for O 0 0.06285016983747482
PAX6 O 1 1.0
mutation O 1 0.8392621278762817
analysis O 0 0.015357264317572117
and O 0 0.009874138981103897
that O 0 0.007892917841672897
the O 0 0.01760130561888218
missing O 0 0.058419883251190186
PAX6 O 1 0.9999982118606567
missense O 1 0.9978122711181641
mutations O 0 0.0743679627776146
frequently O 0 0.04046710580587387
may O 0 0.03755732998251915
underlie O 1 0.9888930916786194
phenotypes O 0 0.39048144221305847
distinct O 0 0.03788283094763756
from O 0 0.04004890099167824
textbook O 1 0.9995423555374146
aniridia B-Disease 1 0.9999886751174927
. O 0 0.06725403666496277

Here O 0 0.03246122971177101
we O 0 0.01434673648327589
present O 0 0.017124222591519356
four O 0 0.018374204635620117
novel O 0 0.06708204001188278
PAX6 O 1 0.9999984502792358
missense O 1 0.9996622800827026
mutations O 0 0.04489002004265785
, O 0 0.01561118196696043
two O 0 0.010196954011917114
in O 0 0.012045843526721
association O 0 0.02481824904680252
with O 0 0.02402261085808277
atypical O 1 0.9999973773956299
phenotypes O 1 0.9998952150344849
ectopia B-Disease 1 0.9999992847442627
pupillae I-Disease 1 0.9999984502792358
( O 0 0.04313512146472931
displaced B-Disease 1 0.7926845550537109
pupils I-Disease 1 0.9161840677261353
) O 0 0.034885942935943604
and O 1 0.8366725444793701
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 0 0.34917446970939636
searching B-Disease 0 0.1936202198266983
gaze I-Disease 1 0.999154806137085
) O 0 0.020943883806467056
, O 0 0.012763609178364277
and O 0 0.009774511680006981
two O 0 0.008994570933282375
in O 0 0.01108529418706894
association O 0 0.019910112023353577
with O 0 0.014986155554652214
more O 0 0.01891500875353813
recognizable O 1 0.9970388412475586
aniridia B-Disease 1 0.9999971389770508
phenotypes O 1 0.9652020931243896
. O 0 0.05802076309919357

Strikingly O 0 0.09908730536699295
, O 0 0.02493388019502163
all O 0 0.01322229951620102
four O 0 0.01873338222503662
mutations O 0 0.026351720094680786
are O 0 0.006866577081382275
located O 0 0.018908921629190445
within O 0 0.014476819895207882
the O 0 0.028774917125701904
PAX6 O 1 0.999998927116394
paired O 0 0.3545120060443878
domain O 0 0.038867801427841187
and O 0 0.01973528228700161
affect O 0 0.030467621982097626
amino O 0 0.03607888147234917
acids O 0 0.022511014714837074
which O 0 0.008299530483782291
are O 0 0.0062161944806575775
highly O 0 0.01904360204935074
conserved O 0 0.020392142236232758
in O 0 0.009469357319176197
all O 0 0.01327843964099884
known O 0 0.035017479211091995
paired O 0 0.0828181654214859
domain O 0 0.06626161932945251
proteins O 0 0.04214165359735489
. O 0 0.032530467957258224

Our O 0 0.043961603194475174
results O 0 0.018834521993994713
support O 0 0.021655473858118057
the O 0 0.018927810713648796
hypothesis O 0 0.024048343300819397
that O 0 0.006792749743908644
the O 0 0.010162747465074062
under O 0 0.0202195905148983
- O 1 0.9647358655929565
representation O 0 0.019773852080106735
of O 0 0.020031001418828964
missense O 1 0.9810613393783569
mutations O 0 0.037242114543914795
is O 0 0.018441669642925262
caused O 0 0.03593406826257706
by O 0 0.03006676211953163
ascertainment O 1 0.9999990463256836
bias O 1 0.9925572872161865
and O 0 0.018694119527935982
suggest O 0 0.013366550207138062
that O 0 0.006694778800010681
a O 0 0.01185865793377161
substantial O 0 0.017255274578928947
burden O 0 0.13507677614688873
of O 0 0.1046973392367363
PAX6 B-Disease 1 1.0
- I-Disease 1 1.0
related I-Disease 1 0.9999327659606934
disease I-Disease 1 0.9999998807907104
remains O 1 0.9463148713111877
to O 0 0.01964869163930416
be O 0 0.015763700008392334
uncovered O 0 0.047254372388124466
. O 0 0.01997183822095394
. O 0 0.030109064653515816

The O 0 0.055854666978120804
chromosomal O 0 0.123516745865345
order O 0 0.027996007353067398
of O 0 0.02325553074479103
genes O 0 0.02416364662349224
controlling O 0 0.03914614021778107
the O 0 0.023699520155787468
major O 1 0.905371367931366
histocompatibility O 1 1.0
complex O 0 0.3873581886291504
, O 0 0.025431880727410316
properdin O 1 0.9997369647026062
factor O 1 0.9753900170326233
B O 1 0.9999780654907227
, O 0 0.02705996111035347
and O 0 0.03509031608700752
deficiency B-Disease 1 1.0
of I-Disease 0 0.02565159648656845
the I-Disease 0 0.030724313110113144
second I-Disease 0 0.4389117956161499
component I-Disease 1 0.5156688690185547
of I-Disease 0 0.03064604289829731
complement I-Disease 0 0.0783139169216156
. O 0 0.04324476793408394

The O 0 0.038227006793022156
relationship O 0 0.035287920385599136
of O 0 0.01952550932765007
the O 0 0.024779560044407845
genes O 0 0.027289176359772682
coding O 0 0.0426119789481163
for O 0 0.023386182263493538
HLA O 1 0.9999991655349731
to O 0 0.01803283579647541
those O 0 0.013038567267358303
coding O 0 0.031486935913562775
for O 0 0.01514182984828949
properdin O 1 0.9979775547981262
Factor O 1 0.6706063151359558
B O 1 0.9999209642410278
allotypes O 1 0.9989770650863647
and O 0 0.022915881127119064
for O 0 0.03193178027868271
deficiency B-Disease 1 1.0
of I-Disease 0 0.022227982059121132
the I-Disease 0 0.02215958759188652
second I-Disease 0 0.033241115510463715
component I-Disease 0 0.0362885482609272
of I-Disease 0 0.02304549515247345
complement I-Disease 1 0.9908336997032166
( O 0 0.12450586259365082
C2 O 1 0.9999996423721313
) O 0 0.017919711768627167
was O 0 0.016887422651052475
studied O 0 0.012836745008826256
in O 0 0.007779869716614485
families O 0 0.015033503994345665
of O 0 0.02206445299088955
patients O 1 0.9999902248382568
with O 1 0.9998637437820435
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9851653575897217

Patients O 1 0.9844244122505188
were O 0 0.020506974309682846
selected O 0 0.02771523781120777
because O 0 0.013188830576837063
they O 0 0.007447512354701757
were O 0 0.010174396447837353
heterozygous O 0 0.040793392807245255
or O 0 0.022481005638837814
homozygous O 1 0.6222448945045471
for O 1 0.9480872750282288
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.7262519598007202

12 O 0 0.0404229499399662
families O 0 0.025980748236179352
with O 0 0.016238993033766747
15 O 0 0.027851153165102005
matings O 0 0.3168172240257263
informative O 0 0.15638336539268494
for O 1 0.9927740097045898
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.045518532395362854
found O 0 0.03557886928319931
. O 0 0.03981699049472809

Of O 0 0.04964722320437431
57 O 0 0.07807336002588272
informative O 0 0.07850411534309387
meioses O 1 0.9870899319648743
, O 0 0.017761563882231712
two O 0 0.010730261914432049
crossovers O 0 0.0332692451775074
were O 0 0.007647230289876461
noted O 0 0.010636250488460064
between O 0 0.014475601725280285
the O 1 0.8006055355072021
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.04460568353533745
and O 0 0.01728060096502304
the O 0 0.3226720094680786
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999938011169434
gene O 0 0.026195276528596878
, O 0 0.010654018260538578
with O 0 0.01068823505192995
a O 0 0.02043990232050419
recombinant O 0 0.08008114248514175
fraction O 0 0.03705696761608124
of O 0 0.02785148099064827
0 O 0 0.06414409726858139
. O 0 0.040067195892333984

035 O 1 0.9765207171440125
. O 0 0.09751021862030029

A O 0 0.08859588950872421
lod O 1 0.9940833449363708
score O 0 0.028185218572616577
of O 0 0.01960182934999466
13 O 0 0.021480616182088852
was O 0 0.017636869102716446
calculated O 0 0.015137743204832077
for O 0 0.01257600449025631
linkage O 0 0.3338660001754761
between O 0 0.4724735617637634
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9999841451644897
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999511241912842
at O 0 0.021149074658751488
a O 0 0.018041864037513733
maximum O 0 0.019988372921943665
likelihood O 0 0.021945325657725334
value O 0 0.00947715062648058
of O 0 0.012109450995922089
the O 0 0.021049173548817635
recombinant O 0 0.1278865933418274
fraction O 0 0.03641321510076523
of O 0 0.029361272230744362
0 O 0 0.06216386333107948
. O 0 0.040842071175575256

04 O 1 0.7473279237747192
. O 0 0.08859363943338394

18 O 0 0.05064336955547333
families O 0 0.03408922255039215
with O 0 0.023657668381929398
21 O 0 0.03900814428925514
informative O 0 0.058154378086328506
matings O 0 0.06968259811401367
for O 0 0.017400244250893593
both O 0 0.01949736289680004
properdin O 1 0.9982628226280212
Factor O 0 0.12190838903188705
B O 1 0.9987943172454834
allotype O 1 0.9995790123939514
and O 0 0.16671782732009888
HLA O 1 1.0
- O 1 0.9999998807907104
B O 1 0.9998642206192017
were O 0 0.02017679065465927
found O 0 0.02541845664381981
. O 0 0.0322081595659256

Of O 0 0.05427844449877739
72 O 0 0.0799143984913826
informative O 0 0.08819552510976791
meioses O 1 0.9957385063171387
, O 0 0.021377593278884888
three O 0 0.0192507803440094
recombinants O 1 0.9512266516685486
were O 0 0.013437777757644653
found O 0 0.012873547151684761
, O 0 0.01266289222985506
giving O 0 0.01782323606312275
a O 0 0.0242879930883646
recombinant O 0 0.07000765949487686
fraction O 0 0.03864758461713791
of O 0 0.029075123369693756
0 O 0 0.062322039157152176
. O 0 0.03956173360347748

042 O 1 0.9603898525238037
. O 0 0.08951573818922043

A O 0 0.09055935591459274
lod O 1 0.8902246952056885
score O 0 0.023574605584144592
of O 0 0.01626780442893505
16 O 0 0.023159559816122055
between O 0 0.032733768224716187
HLA O 1 1.0
- O 1 0.9999995231628418
B O 1 0.9996633529663086
and O 0 0.02612321823835373
Factor O 1 0.7826130390167236
B O 1 0.9999431371688843
allotypes O 1 0.9986658096313477
was O 0 0.02435658872127533
calculated O 0 0.017167188227176666
at O 0 0.012922651134431362
a O 0 0.013921517878770828
maximum O 0 0.01728886365890503
likelihood O 0 0.02064690552651882
value O 0 0.009238270111382008
of O 0 0.01164611428976059
the O 0 0.019552094861865044
recombinant O 0 0.060820091515779495
fraction O 0 0.03475809469819069
of O 0 0.028246067464351654
0 O 0 0.059469833970069885
. O 0 0.03881816193461418

04 O 1 0.9505937695503235
. O 0 0.08703728765249252

A O 0 0.07245007157325745
crossover O 0 0.11328934133052826
was O 0 0.03619424253702164
shown O 0 0.017239287495613098
to O 0 0.011429965496063232
have O 0 0.007673510350286961
occurred O 0 0.014624462462961674
between O 0 0.010593104176223278
genes O 0 0.011184790171682835
for O 0 0.0107655581086874
Factor O 0 0.08000227063894272
B O 1 0.9996148347854614
and O 0 0.10244665294885635
HLA O 1 1.0
- O 1 0.9999998807907104
D O 1 0.9998579025268555
, O 0 0.012009997852146626
in O 0 0.009528635069727898
which O 0 0.017587194219231606
HLA O 1 1.0
- O 1 0.9999958276748657
D O 1 0.9998983144760132
segregared O 1 0.9961850047111511
with O 0 0.04430990666151047
HLA O 1 1.0
- O 1 0.9999946355819702
A O 0 0.1634102612733841
and O 0 0.03873436897993088
B O 1 0.995482325553894
. O 0 0.048330869525671005

These O 0 0.026649685576558113
studies O 0 0.019127998501062393
suggest O 0 0.015197467058897018
that O 0 0.008188428357243538
the O 0 0.01168843638151884
genes O 0 0.011775757186114788
for O 0 0.01218990609049797
Factor O 1 0.5181376934051514
B O 1 0.9999974966049194
and O 1 0.9999196529388428
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.01404647994786501
located O 0 0.024149874225258827
outside O 0 0.016489775851368904
those O 0 0.010087775997817516
for O 0 0.02202797122299671
HLA O 1 1.0
, O 0 0.015168875455856323
that O 0 0.005989135708659887
the O 0 0.00855829007923603
order O 0 0.01141485758125782
of O 0 0.014671096578240395
genese O 1 0.9992278814315796
is O 0 0.027016552165150642
HLA O 1 1.0
- O 1 0.9988718628883362
A O 0 0.02713712304830551
, O 0 0.017020121216773987
- O 1 0.9998148083686829
B O 1 0.999138355255127
, O 0 0.02098071202635765
- O 1 0.9999654293060303
D O 1 0.9979810118675232
, O 0 0.01634610816836357
Factor O 0 0.044438086450099945
B O 1 0.9994725584983826
allotype O 1 0.9999914169311523
, O 1 0.999643087387085
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.025784382596611977
that O 0 0.010216052643954754
the O 0 0.015332392416894436
genes O 0 0.01871401257812977
coding O 0 0.03980233520269394
for O 0 0.07091541588306427
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.8756048679351807
Factor O 1 0.9997820258140564
B O 1 0.9999173879623413
allotypes O 1 0.9814396500587463
are O 0 0.006579615641385317
approximately O 0 0.009955242276191711
3 O 0 0.022766297683119774
- O 1 0.9981065988540649
- O 1 0.984228253364563
5 O 0 0.020207243040204048
centimorgans O 0 0.05989755690097809
from O 0 0.011508951894938946
the O 0 0.022148849442601204
HLA O 1 1.0
- O 1 0.9992170333862305
A O 0 0.03450150042772293
and O 0 0.03318645432591438
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999995231628418
loci O 1 0.7318084836006165
, O 0 0.015167665667831898
and O 0 0.009991480968892574
that O 0 0.006979729980230331
the O 0 0.013397757895290852
apparent O 0 0.03552721440792084
lack O 0 0.021008851006627083
of O 0 0.017628328874707222
recombinants O 1 0.9813450574874878
between O 0 0.015463493764400482
the O 0 0.017594538629055023
Factor O 1 0.5733585953712463
B O 1 0.9999642372131348
gene O 0 0.06369099020957947
and O 1 0.983669638633728
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 1 0.9479120969772339
suggests O 0 0.02537274919450283
that O 0 0.008771957829594612
these O 0 0.006883913651108742
two O 0 0.009791122749447823
genes O 0 0.018816255033016205
lie O 0 0.031208466738462448
in O 0 0.014264632016420364
close O 0 0.02648066356778145
proximity O 0 0.03670726716518402
to O 0 0.016808800399303436
one O 0 0.02111155353486538
another O 0 0.03387083485722542
. O 0 0.035263024270534515

Distribution O 0 0.05253336951136589
of O 0 0.04080349579453468
emerin O 1 0.9982958436012268
and O 0 0.036639731377363205
lamins O 1 0.9997106194496155
in O 0 0.02072189562022686
the O 0 0.032000038772821426
heart O 1 0.9999706745147705
and O 0 0.019836585968732834
implications O 0 0.03555985540151596
for O 0 0.025767158716917038
Emery B-Disease 1 0.9999986886978149
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.5852480530738831

Emerin O 1 0.990864098072052
is O 0 0.02686750888824463
a O 0 0.029131047427654266
nuclear O 0 0.0937170758843422
membrane O 1 0.5683815479278564
protein O 0 0.023512255400419235
which O 0 0.00951368361711502
is O 0 0.011736897751688957
missing O 0 0.02179432287812233
or O 0 0.016222912818193436
defective O 1 0.5522635579109192
in O 0 0.020976945757865906
Emery B-Disease 1 0.9999936819076538
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999479055404663
EDMD B-Disease 1 1.0
) O 0 0.057716257870197296
. O 0 0.043954383581876755

It O 0 0.02275216020643711
is O 0 0.014929522760212421
one O 0 0.011345748789608479
member O 0 0.01596241630613804
of O 0 0.011714652180671692
a O 0 0.015289372764527798
family O 0 0.024377085268497467
of O 0 0.030612202361226082
lamina O 1 1.0
- O 1 0.9999995231628418
associated O 0 0.027137940749526024
proteins O 0 0.01764938049018383
which O 0 0.009546829387545586
includes O 0 0.01957962103188038
LAP1 O 1 0.9993195533752441
, O 0 0.028026750311255455
LAP2 O 1 0.9997977614402771
and O 0 0.03920501098036766
lamin O 1 0.9999988079071045
B O 1 0.9999991655349731
receptor O 1 0.9998608827590942
( O 0 0.06783801317214966
LBR O 1 0.9998618364334106
) O 0 0.04411856457591057
. O 0 0.04167069122195244

A O 0 0.05100012198090553
panel O 0 0.04194751754403114
of O 0 0.026540428400039673
16 O 0 0.05059974640607834
monoclonal O 1 0.9999810457229614
antibodies O 1 0.999506950378418
( O 0 0.06523001939058304
mAbs O 1 0.9995658993721008
) O 0 0.025658948346972466
has O 0 0.016918998211622238
been O 0 0.012771571055054665
mapped O 0 0.0239623561501503
to O 0 0.011568634770810604
six O 0 0.012493222951889038
specific O 0 0.010686853900551796
sites O 0 0.013244989328086376
throughout O 0 0.011899386532604694
the O 0 0.018826359882950783
emerin O 1 0.9768358469009399
molecule O 0 0.04203147441148758
using O 0 0.01847172901034355
phage O 1 0.9993294477462769
- O 1 0.9992557168006897
displayed O 0 0.04614881053566933
peptide O 0 0.08039502054452896
libraries O 0 0.02889423258602619
and O 0 0.015181276947259903
has O 0 0.01241033524274826
been O 0 0.01111783366650343
used O 0 0.010596903041005135
to O 0 0.017182065173983574
localize O 1 0.8122631907463074
emerin O 1 0.990812361240387
in O 0 0.02212938480079174
human O 0 0.0337306447327137
and O 0 0.044314537197351456
rabbit O 1 0.9999896287918091
heart O 1 0.9999945163726807
. O 0 0.05943543091416359

Several O 0 0.04646608978509903
mAbs O 1 0.8419358730316162
against O 0 0.03955945372581482
different O 0 0.021693967282772064
emerin O 1 0.9988710284233093
epitopes O 1 0.9652432799339294
did O 0 0.02033279836177826
not O 0 0.012832787819206715
recognize O 0 0.035753894597291946
intercalated O 1 0.9997169375419617
discs O 0 0.051009006798267365
in O 0 0.016231263056397438
the O 0 0.03374849259853363
heart O 1 0.9999988079071045
, O 0 0.018062420189380646
though O 0 0.011117551475763321
they O 0 0.007725001312792301
recognized O 0 0.027438858523964882
cardiomyocyte O 1 0.9999480247497559
nuclei O 1 0.5066363215446472
strongly O 0 0.02456163614988327
, O 0 0.013584456406533718
both O 0 0.009750070981681347
at O 0 0.01715102419257164
the O 0 0.021352697163820267
rim O 0 0.3219555914402008
and O 0 0.017208363860845566
in O 0 0.020360277965664864
intranuclear O 1 0.9998606443405151
spots O 0 0.11177301406860352
or O 0 0.030516721308231354
channels O 0 0.03689945861697197
. O 0 0.03298629820346832

A O 0 0.13041400909423828
polyclonal O 1 0.99972003698349
rabbit O 1 0.9980138540267944
antiserum O 1 0.99874347448349
against O 0 0.09393345564603806
emerin O 1 0.9995438456535339
did O 0 0.025545833632349968
recognize O 0 0.02888827957212925
both O 0 0.01745888590812683
nuclear O 0 0.05789292976260185
membrane O 0 0.1323772817850113
and O 0 0.026622574776411057
intercalated O 1 0.9997987151145935
discs O 0 0.05707661062479019
but O 0 0.013992114923894405
, O 0 0.013438927941024303
after O 0 0.021795155480504036
affinity O 0 0.041320040822029114
purification O 0 0.16157881915569305
against O 0 0.022347865626215935
a O 0 0.024090658873319626
pure O 0 0.335153192281723
- O 1 0.9999701976776123
emerin O 1 0.9979839324951172
band O 0 0.033375293016433716
on O 0 0.013039929792284966
a O 0 0.015759853646159172
western O 0 0.028025658801198006
blot O 1 0.9972237348556519
, O 0 0.019971445202827454
it O 0 0.014080733992159367
stained O 1 0.9992647767066956
only O 0 0.014945778995752335
the O 0 0.02586382068693638
nuclear O 0 0.06562129408121109
membrane O 0 0.07995353639125824
. O 0 0.03562995791435242

These O 0 0.02318369597196579
results O 0 0.017248304560780525
would O 0 0.011737960390746593
not O 0 0.008473556488752365
be O 0 0.0076919374987483025
expected O 0 0.012686415575444698
if O 0 0.015617175959050655
immunostaining O 1 0.9981100559234619
at O 0 0.0648617297410965
intercalated O 1 0.9999761581420898
discs O 0 0.05505415424704552
were O 0 0.01096629723906517
due O 0 0.013271438889205456
to O 0 0.010638348758220673
a O 0 0.013436874374747276
product O 0 0.012911750003695488
of O 0 0.012075233273208141
the O 0 0.023630507290363312
emerin O 1 0.999987006187439
gene O 0 0.03907459229230881
and O 0 0.01660647988319397
, O 0 0.017084244638681412
therefore O 0 0.014012293890118599
, O 0 0.011621009558439255
cast O 0 0.01518181711435318
some O 0 0.007655322551727295
doubt O 0 0.018198397010564804
upon O 0 0.013442905619740486
the O 0 0.016545431688427925
hypothesis O 0 0.04242321476340294
that O 0 0.024329958483576775
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999991655349731
in O 0 0.18546612560749054
EDMD B-Disease 1 1.0
are O 0 0.01562519185245037
caused O 0 0.03284987807273865
by O 0 0.017210889607667923
absence O 0 0.05000346526503563
of O 0 0.03368346020579338
emerin O 1 0.9999850988388062
from O 0 0.06059553474187851
intercalated O 1 0.9999626874923706
discs O 0 0.26778918504714966
. O 0 0.04930701479315758

Although O 0 0.04874645918607712
emerin O 1 0.9947403073310852
was O 0 0.03681868314743042
abundant O 0 0.02552214451134205
in O 0 0.012144463136792183
the O 0 0.01989356242120266
membranes O 0 0.1213533878326416
of O 0 0.034186165779829025
cardiomyocyte O 1 0.9999990463256836
nuclei O 1 0.9921243786811829
, O 0 0.016892336308956146
it O 0 0.009140999056398869
was O 0 0.017473608255386353
absent O 0 0.026387469843029976
from O 0 0.009740767069160938
many O 0 0.011025985702872276
non O 1 0.8561509251594543
- O 1 0.9999996423721313
myocyte O 1 0.9999995231628418
cells O 0 0.054056499153375626
in O 0 0.022452469915151596
the O 0 0.04467364400625229
heart O 1 0.9999852180480957
. O 0 0.05390676483511925

This O 0 0.021245356649160385
distribution O 0 0.025999736040830612
of O 0 0.024953214451670647
emerin O 1 0.9990785121917725
was O 0 0.02622518129646778
similar O 0 0.011101096868515015
to O 0 0.00888129323720932
that O 0 0.007121684495359659
of O 0 0.016291676089167595
lamin O 1 0.9999921321868896
A O 0 0.037403400987386703
, O 0 0.013300193473696709
a O 0 0.01644979603588581
candidate O 0 0.028328310698270798
gene O 0 0.021497873589396477
for O 0 0.012827147729694843
an O 0 0.02031337469816208
autosomal O 1 0.9956653714179993
form O 0 0.039329927414655685
of O 1 0.5412530303001404
EDMD B-Disease 1 0.9999998807907104
. O 0 0.07316982746124268

In O 0 0.03571620583534241
contrast O 0 0.053309135138988495
, O 0 0.050435442477464676
lamin O 1 0.9999972581863403
B1 O 1 0.9999998807907104
was O 0 0.05170082300901413
absent O 0 0.06679879873991013
from O 0 0.028003405779600143
cardiomyocyte O 1 0.9996742010116577
nuclei O 0 0.0737876445055008
, O 0 0.016377601772546768
showing O 0 0.025474756956100464
that O 0 0.02345496229827404
lamin O 1 0.9999985694885254
B1 O 1 0.9999998807907104
is O 0 0.021312166005373
not O 0 0.010286460630595684
essential O 0 0.019564202055335045
for O 0 0.012950708158314228
localization O 0 0.04887158423662186
of O 0 0.025373823940753937
emerin O 1 0.9990148544311523
to O 0 0.02611217088997364
the O 0 0.035121239721775055
nuclear O 0 0.14070875942707062
lamina O 1 0.9998077750205994
. O 0 0.05714220926165581

Lamin O 1 0.9999978542327881
B1 O 1 0.9999996423721313
is O 0 0.03340945765376091
also O 0 0.01798115484416485
almost O 0 0.01747106947004795
completely O 0 0.03630537912249565
absent O 0 0.4861278235912323
from O 0 0.059426259249448776
skeletal O 1 0.9999995231628418
muscle O 1 0.9999971389770508
nuclei O 1 0.9983986020088196
. O 0 0.06324977427721024

In O 0 0.059552717953920364
EDMD B-Disease 1 0.999984622001648
, O 0 0.023892438039183617
the O 0 0.01705392263829708
additional O 0 0.014156052842736244
absence O 0 0.03372519090771675
of O 0 0.036898065358400345
lamin O 1 1.0
B1 O 1 1.0
from O 0 0.1857614368200302
heart O 1 0.9999998807907104
and O 1 0.9992006421089172
skeletal O 1 1.0
muscle O 1 1.0
nuclei O 1 0.9994939565658569
which O 0 0.017670318484306335
already O 0 0.02262336015701294
lack O 0 0.038229700177907944
emerin O 1 0.9996147155761719
may O 0 0.018703032284975052
offer O 0 0.015838224440813065
an O 0 0.011669580824673176
alternative O 0 0.019665515050292015
explanation O 0 0.018467294052243233
of O 0 0.0148148313164711
why O 0 0.023559212684631348
these O 0 0.014462430030107498
tissues O 1 0.9198246598243713
are O 0 0.012745620682835579
particularly O 0 0.031403787434101105
affected O 0 0.044120561331510544
. O 0 0.02724565379321575
. O 0 0.037859510630369186

Genetic O 0 0.06038164347410202
mapping O 0 0.03917301818728447
of O 0 0.023304134607315063
the O 0 0.03781769052147865
copper B-Disease 1 0.9998021721839905
toxicosis I-Disease 1 0.9999979734420776
locus O 1 0.7524374723434448
in O 0 0.03098766878247261
Bedlington O 1 0.9996825456619263
terriers O 1 0.5750688910484314
to O 0 0.0321916788816452
dog O 1 0.9494105577468872
chromosome O 0 0.050345323979854584
10 O 0 0.016886139288544655
, O 0 0.011574218980967999
in O 0 0.009422864764928818
a O 0 0.017525848001241684
region O 0 0.030384164303541183
syntenic O 1 0.8621606826782227
to O 0 0.019624119624495506
human O 0 0.028849519789218903
chromosome O 0 0.07250750064849854
region O 0 0.051148973405361176
2p13 O 1 0.9999855756759644
- O 1 0.9999982118606567
p16 O 1 0.9959872364997864
. O 0 0.04991267994046211

Abnormal O 1 0.9999990463256836
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999986886978149
accumulation I-Disease 1 0.9999475479125977
is O 0 0.016594719141721725
recognized O 0 0.017594274133443832
as O 0 0.014567908830940723
an O 0 0.2888595163822174
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.8922692537307739
man O 1 0.999937891960144
, O 0 0.04465499892830849
mouse O 1 0.9192656874656677
, O 0 0.0360284224152565
rat O 1 0.9997208714485168
and O 0 0.03367898613214493
dog O 1 0.5033358335494995
. O 0 0.04639742150902748

The O 0 0.04059148207306862
major O 0 0.05448184162378311
cause O 1 0.9920652508735657
of O 1 0.9987238049507141
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999997615814209
accumulation I-Disease 1 0.9998730421066284
in O 0 0.017116984352469444
man O 0 0.034618645906448364
is O 0 0.01253511942923069
a O 0 0.021080825477838516
dysfunctional O 1 0.999871015548706
ATP7B O 1 0.9999992847442627
gene O 0 0.04454494267702103
, O 0 0.026657763868570328
causing O 1 0.9986660480499268
Wilson B-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
( O 1 0.9997991919517517
WD B-Disease 1 1.0
) O 0 0.04836997017264366
. O 0 0.041996944695711136

Mutations O 0 0.05982458218932152
in O 0 0.01986774243414402
the O 0 0.033353760838508606
ATP7B O 1 0.9999980926513672
genes O 0 0.02648901753127575
have O 0 0.009459316730499268
also O 0 0.010308887809515
been O 0 0.011739138513803482
demonstrated O 0 0.0246745478361845
in O 0 0.020733406767249107
mouse O 0 0.402220755815506
and O 0 0.0406426265835762
rat O 1 0.9994233846664429
. O 0 0.04696328192949295

The O 0 0.06887541711330414
ATP7B O 1 0.9999955892562866
gene O 0 0.04370589554309845
has O 0 0.01645122468471527
been O 0 0.012246418744325638
excluded O 0 0.022776983678340912
in O 0 0.008515254594385624
the O 0 0.012030044570565224
much O 0 0.01525446493178606
rarer O 1 0.6227945685386658
human O 0 0.17217014729976654
copper B-Disease 1 0.9999977350234985
overload I-Disease 1 1.0
disease O 1 0.9999998807907104
non B-Disease 1 0.9999788999557495
- I-Disease 1 0.9999996423721313
Indian I-Disease 1 0.9880010485649109
childhood I-Disease 1 0.9999998807907104
cirrhosis I-Disease 1 1.0
, O 1 0.8367521166801453
indicating O 0 0.433022141456604
genetic O 0 0.06848382949829102
heterogeneity O 1 0.9710108041763306
. O 0 0.05293882265686989

By O 0 0.028040822595357895
investigating O 0 0.03571556881070137
the O 0 0.026588505133986473
common O 0 0.33258071541786194
autosomal O 1 0.9999994039535522
recessive O 1 0.9999998807907104
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.999414324760437
CT B-Disease 1 0.9999988079071045
) O 0 0.022010797634720802
in O 0 0.020925186574459076
Bedlington O 1 0.9999628067016602
terriers O 1 0.9918415546417236
, O 0 0.018565349280834198
we O 0 0.00880336668342352
have O 0 0.005809666123241186
identified O 0 0.01044833566993475
a O 0 0.01162152923643589
new O 0 0.018250493332743645
locus O 0 0.06284192949533463
involved O 0 0.022317538037896156
in O 0 0.053081709891557693
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9945070147514343

We O 0 0.02682044915854931
examined O 0 0.03533541038632393
whether O 0 0.017126847058534622
the O 0 0.029536167159676552
WD B-Disease 1 0.9999986886978149
gene O 0 0.062055863440036774
ATP7B O 1 0.9998780488967896
was O 0 0.036243680864572525
also O 0 0.021874673664569855
causative O 1 0.9799363613128662
for O 0 0.021651744842529297
CT B-Disease 1 0.9997095465660095
by O 0 0.015698468312621117
investigating O 0 0.024866411462426186
the O 0 0.023134572431445122
chromosomal O 1 0.9919588565826416
co O 1 0.9897777438163757
- O 1 0.9995259046554565
localization O 0 0.07079280912876129
of O 0 0.03216526284813881
ATP7B O 1 0.9999812841415405
and O 0 0.031014662235975266
C04107 O 1 0.9958350658416748
, O 0 0.01966770552098751
using O 0 0.014952942728996277
fluorescence O 0 0.046738337725400925
in O 0 0.02407405897974968
situ O 1 0.9979922771453857
hybridization O 0 0.07239905744791031
( O 0 0.03585686907172203
FISH O 0 0.04645807296037674
) O 0 0.031438637524843216
. O 0 0.031972166150808334

C04107 O 1 0.9464935064315796
is O 0 0.037079956382513046
an O 0 0.033431440591812134
anonymous O 0 0.08409550040960312
microsatellite O 1 0.955207884311676
marker O 0 0.21640481054782867
closely O 0 0.046902649104595184
linked O 0 0.06322363018989563
to O 0 0.04526776447892189
CT B-Disease 1 0.9999388456344604
. O 0 0.05895916745066643

However O 0 0.039181485772132874
, O 0 0.04119432345032692
BAC O 1 0.9999641180038452
clones O 1 0.8562802672386169
containing O 0 0.058715660125017166
ATP7B O 1 0.9998218417167664
and O 0 0.0358848012983799
C04107 O 1 0.8885526657104492
mapped O 0 0.04035268351435661
to O 0 0.016214756295084953
the O 0 0.025735264644026756
canine O 1 0.9999332427978516
chromosome O 0 0.08972261101007462
regions O 0 0.03225667402148247
CFA22q11 O 1 0.9998290538787842
and O 0 0.030033433809876442
CFA10q26 O 1 0.999863862991333
, O 0 0.020199861377477646
respectively O 0 0.021555142477154732
, O 0 0.014711220748722553
demonstrating O 0 0.029957110062241554
that O 0 0.018292754888534546
WD B-Disease 1 0.999997615814209
cannot O 0 0.027262097224593163
be O 0 0.016989409923553467
homologous O 0 0.06437451392412186
to O 0 0.044208087027072906
CT B-Disease 1 0.9998480081558228
. O 0 0.058710142970085144

The O 0 0.05662073194980621
copper O 1 0.8957797288894653
transport O 0 0.09314490109682083
genes O 0 0.04676046222448349
CTR1 O 1 0.9998816251754761
and O 0 0.034617867320775986
CTR2 O 1 0.9998410940170288
were O 0 0.015104856342077255
also O 0 0.013736712746322155
excluded O 0 0.028593983501195908
as O 0 0.01640211045742035
candidate O 0 0.031019771471619606
genes O 0 0.021350985392928123
for O 0 0.023476451635360718
CT B-Disease 1 0.9999884366989136
since O 0 0.01907525025308132
they O 0 0.00938712153583765
both O 0 0.012709376402199268
mapped O 0 0.038909897208213806
to O 0 0.029706304892897606
canine O 1 0.999414324760437
chromosome O 0 0.15438899397850037
region O 0 0.0705956295132637
CFA11q22 O 1 0.9973118305206299
. O 0 0.05728768929839134

2 O 0 0.10007503628730774
- O 1 0.9982913136482239
22 O 0 0.06687981635332108
. O 0 0.04874590039253235

5 O 0 0.10105855762958527
. O 0 0.06596540659666061

A O 0 0.06812738627195358
transcribed O 0 0.05545813962817192
sequence O 0 0.018297450616955757
identified O 0 0.014042194932699203
from O 0 0.008897034451365471
the O 0 0.018916577100753784
C04107 O 1 0.9998440742492676
- O 1 0.999985933303833
containing O 0 0.04620255157351494
BAC O 1 0.9999879598617554
was O 0 0.024215195327997208
found O 0 0.010087981820106506
to O 0 0.0098958108574152
be O 0 0.009096535854041576
homologous O 0 0.027436520904302597
to O 0 0.012374206446111202
a O 0 0.017622260376811028
gene O 0 0.016783341765403748
expressed O 0 0.01514989510178566
from O 0 0.012062896974384785
human O 0 0.0246127936989069
chromosome O 1 0.5026842355728149
2p13 O 1 0.9999903440475464
- O 1 0.9999985694885254
p16 O 1 0.9963856935501099
, O 0 0.018015660345554352
a O 0 0.019388001412153244
region O 0 0.028298452496528625
devoid O 0 0.04681923985481262
of O 0 0.019742542877793312
any O 0 0.023041069507598877
positional O 0 0.17647875845432281
candidate O 0 0.062489740550518036
genes O 0 0.0422540046274662
. O 0 0.03940548375248909

Molecular O 0 0.05023558437824249
analysis O 0 0.015630541369318962
of O 0 0.015036370605230331
the O 0 0.027875803411006927
APC B-Disease 1 0.9999895095825195
gene O 0 0.025539333000779152
in O 0 0.012271108105778694
205 O 0 0.04240725561976433
families O 0 0.021587025374174118
: O 0 0.01994726061820984
extended O 0 0.03630134090781212
genotype O 1 0.9985707998275757
- O 1 0.999991774559021
phenotype O 1 0.8625314235687256
correlations O 0 0.060097865760326385
in O 0 0.028857385739684105
FAP B-Disease 1 0.9999996423721313
and O 0 0.019594719633460045
evidence O 0 0.01176088210195303
for O 0 0.008659440092742443
the O 0 0.012797299772500992
role O 0 0.024146568030118942
of O 0 0.027387164533138275
APC B-Disease 1 0.9999990463256836
amino O 0 0.04996296018362045
acid O 0 0.10868148505687714
changes O 0 0.02571379579603672
in O 1 0.8159762620925903
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 1 0.6064009666442871

BACKGROUND O 0 0.16218948364257812
/ O 1 0.9640165567398071
AIMS O 0 0.0491635762155056
The O 0 0.019780665636062622
development O 0 0.032979559153318405
of O 1 0.999836802482605
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.886141300201416
a O 0 0.05110175162553787
variable O 0 0.02439947985112667
range O 0 0.01273331418633461
of O 0 0.018528250977396965
extracolonic O 1 0.9987503290176392
manifestations O 1 0.9995262622833252
in O 0 0.06589796394109726
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999998807907104
FAP B-Disease 1 1.0
) O 0 0.027613410726189613
is O 0 0.011733071878552437
the O 0 0.010667748749256134
result O 0 0.00923048797994852
of O 0 0.010148165747523308
the O 0 0.016268590465188026
dominant O 0 0.04793127626180649
inheritance O 0 0.2076292335987091
of O 1 0.971407413482666
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999575614929199
APC B-Disease 1 0.9999998807907104
) O 0 0.05341897904872894
gene O 0 0.051427196711301804
mutations O 0 0.04830349609255791
. O 0 0.037878938019275665

In O 0 0.02523714303970337
this O 0 0.014556597918272018
study O 0 0.018636412918567657
, O 0 0.01515264343470335
direct O 0 0.020549187436699867
mutation O 0 0.02612505666911602
analysis O 0 0.008629096671938896
of O 0 0.01261584460735321
the O 0 0.02462497353553772
APC B-Disease 1 0.9999974966049194
gene O 0 0.02902919054031372
was O 0 0.021666862070560455
performed O 0 0.021359650418162346
to O 0 0.015201807953417301
determine O 0 0.022165447473526
genotype O 1 0.9775488972663879
- O 1 0.9999104738235474
phenotype O 0 0.07824604958295822
correlations O 0 0.03835728392004967
for O 0 0.014745437540113926
nine O 0 0.031973376870155334
extracolonic O 1 0.9999637603759766
manifestations O 1 0.9995563626289368
and O 0 0.01802236959338188
to O 0 0.015996014699339867
investigate O 0 0.027922801673412323
the O 0 0.020793942734599113
incidence O 1 0.9994114637374878
of O 0 0.034761156886816025
APC B-Disease 1 0.9999986886978149
mutations O 0 0.028511982411146164
in O 0 0.01592199131846428
non O 1 0.999833345413208
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.914397120475769

METHODS O 0 0.05718573182821274
The O 0 0.049161091446876526
APC B-Disease 1 0.9998717308044434
gene O 0 0.04298171028494835
was O 0 0.02924160100519657
analysed O 0 0.03590505197644234
in O 0 0.014859928749501705
190 O 0 0.0474846214056015
unrelated O 0 0.0516875721514225
FAP B-Disease 1 0.9999817609786987
and O 0 0.018936825916171074
15 O 0 0.02836550399661064
non O 1 0.9991580247879028
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
using O 0 0.059064917266368866
denaturing O 1 0.9999978542327881
gradient O 1 0.999953031539917
gel O 1 0.9999616146087646
electrophoresis O 1 0.8571035861968994
, O 0 0.01896059885621071
the O 0 0.02333802543580532
protein O 0 0.03167260065674782
truncation O 0 0.11371518671512604
test O 0 0.030591756105422974
, O 0 0.018962230533361435
and O 0 0.017615122720599174
direct O 0 0.03225592151284218
sequencing O 0 0.050098076462745667
. O 0 0.03579195588827133

RESULTS O 0 0.0668034479022026
Chain O 0 0.15437093377113342
terminating O 1 0.595265805721283
signals O 0 0.02605000138282776
were O 0 0.009928747080266476
only O 0 0.009399687871336937
identified O 0 0.01726522110402584
in O 0 0.013425374403595924
patients O 0 0.19412942230701447
belonging O 0 0.029255231842398643
to O 0 0.01779068633913994
the O 0 0.03457849472761154
FAP B-Disease 1 1.0
group O 1 0.8987922668457031
( O 0 0.03745868429541588
105 O 1 0.5395135283470154
patients O 1 0.9988862872123718
) O 0 0.041376743465662
. O 0 0.04199439287185669

Amino O 0 0.11771167069673538
acid O 0 0.06950727105140686
changes O 0 0.015079234726727009
were O 0 0.010494012385606766
identified O 0 0.01516732294112444
in O 0 0.009409678168594837
four O 0 0.016705267131328583
patients O 1 0.9905890226364136
, O 0 0.01215435191988945
three O 0 0.009560267440974712
of O 0 0.013481752015650272
whom O 0 0.024752788245677948
belonged O 0 0.030108453705906868
to O 0 0.010329516604542732
the O 0 0.01371348649263382
non O 0 0.18930701911449432
- O 1 0.9999935626983643
FAP O 1 0.9999998807907104
group O 1 0.9377930164337158
of O 1 0.9999445676803589
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 1 0.867061197757721

Genotype O 1 0.9995957016944885
- O 1 0.999984860420227
phenotype O 1 0.9729226231575012
correlations O 0 0.07277153432369232
identified O 0 0.02799268066883087
significant O 0 0.015073477290570736
differences O 0 0.015068890526890755
in O 0 0.010018516331911087
the O 0 0.014009625650942326
nature O 0 0.018283849582076073
of O 0 0.014229144901037216
certain O 0 0.021407121792435646
extracolonic O 1 0.9999508857727051
manifestations O 1 0.9999916553497314
in O 1 0.6264438033103943
FAP B-Disease 1 1.0
patients O 1 0.999985933303833
belonging O 0 0.050025735050439835
to O 0 0.021799320355057716
three O 0 0.027521228417754173
mutation O 0 0.08649216592311859
subgroups O 0 0.1387375295162201
. O 0 0.04962757229804993

CONCLUSIONS O 0 0.07700586318969727
Extended O 0 0.07610735297203064
genotype O 1 0.9985318183898926
- O 1 0.999992847442627
phenotype O 1 0.9028631448745728
correlations O 0 0.04680013656616211
made O 0 0.016132129356265068
in O 0 0.011939646676182747
this O 0 0.010046903043985367
study O 0 0.015928171575069427
may O 0 0.011185022071003914
have O 0 0.006377554964274168
the O 0 0.012178520672023296
potential O 0 0.01591476798057556
to O 0 0.010147195309400558
determine O 0 0.010224263183772564
the O 0 0.01078263483941555
most O 0 0.010586188174784184
appropriate O 0 0.018005050718784332
surveillance O 0 0.03798791021108627
and O 0 0.025492258369922638
prophylactic O 1 0.9999998807907104
treatment O 1 1.0
regimens O 1 0.9999988079071045
for O 0 0.021786993369460106
those O 0 0.0192812941968441
patients O 1 0.9996651411056519
with O 0 0.024065935984253883
mutations O 0 0.08105422556400299
associated O 0 0.02159823477268219
with O 0 0.02357274293899536
life O 1 0.514857828617096
threatening O 1 0.9995408058166504
conditions O 1 0.5985438227653503
. O 0 0.05004681646823883

This O 0 0.026466062292456627
study O 0 0.023175161331892014
also O 0 0.013893112540245056
provided O 0 0.014822015538811684
evidence O 0 0.010477910749614239
for O 0 0.01069992408156395
the O 0 0.019346261397004128
pathological O 1 0.997283935546875
nature O 0 0.028940413147211075
of O 0 0.02643643133342266
amino O 0 0.04146216809749603
acid O 0 0.04337626323103905
changes O 0 0.013893498107790947
in O 0 0.017433620989322662
APC O 1 0.9996896982192993
associated O 0 0.017480313777923584
with O 0 0.010957839898765087
both O 0 0.014911819249391556
FAP B-Disease 1 0.9999990463256836
and O 0 0.02516704611480236
non O 1 0.999982476234436
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.13048256933689117
. O 0 0.04779980331659317

Inherited B-Disease 1 0.9999997615814209
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999990463256836
cancer B-Disease 1 1.0
risk O 1 0.9999897480010986
of O 1 0.7760862112045288
the O 1 0.994889497756958
APC O 1 0.9999997615814209
I1307K O 1 0.9999693632125854
polymorphism O 1 0.7127026915550232
. O 0 0.05274233967065811

Germ O 1 0.9999932050704956
- O 1 0.9996415376663208
line O 0 0.05475905165076256
and O 0 0.028176655992865562
somatic O 1 0.7753663659095764
truncating O 1 0.9893736243247986
mutations O 0 0.030544131994247437
of O 0 0.017570115625858307
the O 0 0.03433690592646599
APC B-Disease 1 0.9999971389770508
gene O 0 0.024599120020866394
are O 0 0.005823226645588875
thought O 0 0.011996584013104439
to O 0 0.01628742925822735
initiate O 1 0.9998905658721924
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 1 0.9998076558113098
in O 1 0.7266885638237
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999982118606567
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.9884734749794006
respectively O 0 0.06172848120331764
. O 0 0.0422474630177021

Recently O 0 0.058319225907325745
, O 0 0.024552995339035988
an O 0 0.030302386730909348
isoleucine O 1 0.9999754428863525
- O 1 0.9999990463256836
- O 1 0.9999978542327881
> O 1 0.9904719591140747
lysine O 0 0.10264865309000015
polymorphism O 0 0.05864366143941879
at O 0 0.03065463900566101
codon O 0 0.09175422042608261
1307 O 1 0.9906608462333679
( O 0 0.0321376696228981
I1307K O 1 0.6089708805084229
) O 0 0.012437377125024796
of O 0 0.012645984999835491
the O 0 0.02342008799314499
APC B-Disease 1 0.9999992847442627
gene O 0 0.028961997479200363
has O 0 0.011382187716662884
been O 0 0.008673862554132938
identified O 0 0.011701056733727455
in O 0 0.00844312272965908
6 O 0 0.022621318697929382
% O 0 0.01886334829032421
- O 1 0.927737832069397
7 O 0 0.021652547642588615
% O 0 0.010426915250718594
of O 0 0.012796878814697266
the O 0 0.02335985004901886
Ashkenazi O 1 0.9855571389198303
Jewish O 0 0.06452985107898712
population O 0 0.03788997232913971
. O 0 0.042646948248147964

To O 0 0.03957218676805496
assess O 0 0.05540629103779793
the O 0 0.025959419086575508
risk O 0 0.030707603320479393
of O 0 0.015614465810358524
this O 0 0.014010238461196423
common O 0 0.029847316443920135
APC B-Disease 1 0.9999901056289673
allelic O 1 0.9994423985481262
variant O 1 0.7176307439804077
in O 0 0.23046109080314636
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.03649643063545227
we O 0 0.012286525219678879
have O 0 0.006761397235095501
analyzed O 0 0.012709219940006733
a O 0 0.012189182452857494
large O 0 0.014352845959365368
cohort O 0 0.09038809686899185
of O 0 0.027693839743733406
unselected O 1 0.9980111122131348
Ashkenazi O 1 0.9895148277282715
Jewish O 0 0.05649122595787048
subjects O 0 0.03659873455762863
with O 0 0.03779185190796852
adenomatous B-Disease 1 1.0
polyps I-Disease 1 1.0
and O 0 0.0634290874004364
. O 0 0.041290972381830215
or O 1 0.9999469518661499
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.18137887120246887
for O 0 0.024551408365368843
the O 0 0.05090770125389099
APC O 1 0.9999971389770508
I1307K O 1 0.9997109770774841
polymorphism O 0 0.13773763179779053
. O 0 0.05385313183069229

The O 0 0.06710122525691986
APC O 1 0.9999467134475708
I1307K O 1 0.9998766183853149
allele O 0 0.09003855288028717
was O 0 0.025981754064559937
identified O 0 0.018576238304376602
in O 0 0.012127085588872433
48 O 0 0.0256044901907444
( O 0 0.01590658351778984
10 O 0 0.012333229184150696
. O 0 0.009519418701529503
1 O 0 0.01895459182560444
% O 0 0.0148669658228755
) O 0 0.016065649688243866
of O 0 0.027739379554986954
476 O 1 0.9994126558303833
patients O 1 0.9995481371879578
. O 0 0.0596463605761528

Compared O 0 0.03927411139011383
with O 0 0.019892381504178047
the O 0 0.02081255242228508
frequency O 0 0.019381651654839516
in O 0 0.0095150675624609
two O 0 0.007929721847176552
separate O 0 0.012148520909249783
population O 0 0.013528737239539623
control O 0 0.01995224319398403
groups O 0 0.012849368155002594
, O 0 0.01249712985008955
the O 0 0.023737384006381035
APC O 1 0.9999932050704956
I1307K O 1 0.9999833106994629
allele O 0 0.12821777164936066
is O 0 0.0166623517870903
associated O 0 0.01345219835639
with O 0 0.01073797419667244
an O 0 0.014872203581035137
estimated O 0 0.022061914205551147
relative O 0 0.037118349224328995
risk O 0 0.03939545899629593
of O 0 0.029740532860159874
1 O 0 0.05344244837760925
. O 0 0.04180975630879402

5 O 0 0.0888175517320633
- O 1 0.9968506693840027
1 O 0 0.0670027956366539
. O 0 0.04775862768292427

7 O 0 0.06237924471497536
for O 0 0.06841018050909042
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 0.05706633999943733
both O 0 0.034456077963113785
P O 1 0.9999555349349976
= O 0 0.18399959802627563
. O 0 0.03202838450670242
01 O 1 0.9970906972885132
) O 0 0.043272532522678375
. O 0 0.03675413504242897

Furthermore O 0 0.062325213104486465
, O 0 0.023646103218197823
compared O 0 0.020667092874646187
with O 0 0.021280352026224136
noncarriers O 1 0.9996688365936279
, O 0 0.044344596564769745
APC O 1 0.9999966621398926
I1307K O 1 0.9998875856399536
carriers O 0 0.04267146810889244
had O 0 0.01561710424721241
increased O 0 0.014163347892463207
numbers O 0 0.011808562092483044
of O 0 0.027135008946061134
adenomas B-Disease 1 0.9999988079071045
and O 1 0.9615039825439453
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
per O 0 0.041645970195531845
patient O 1 0.9999860525131226
( O 0 0.10634709894657135
P O 1 0.9999468326568604
= O 0 0.1302374303340912
. O 0 0.0198428425937891
03 O 1 0.9896984696388245
) O 0 0.016911914572119713
, O 0 0.012218257412314415
as O 0 0.009977246634662151
well O 0 0.008758153766393661
as O 0 0.011102316901087761
a O 0 0.02138795703649521
younger O 0 0.37586328387260437
age O 0 0.0970759317278862
at O 1 0.6757883429527283
diagnosis O 1 0.9999954700469971
. O 0 0.05267731845378876

We O 0 0.029597053304314613
conclude O 0 0.03617517277598381
that O 0 0.012607390061020851
the O 0 0.02886081486940384
APC O 1 0.9999634027481079
I1307K O 1 0.9993898868560791
variant O 0 0.06147754564881325
leads O 0 0.042802441865205765
to O 0 0.025122443214058876
increased O 1 0.6458818912506104
adenoma B-Disease 1 1.0
formation O 1 0.9964131712913513
and O 0 0.025797013193368912
directly O 0 0.021163199096918106
contributes O 0 0.030553091317415237
to O 0 0.013966652564704418
3 O 0 0.019224854186177254
% O 0 0.01764906756579876
- O 1 0.8019147515296936
4 O 0 0.01677008904516697
% O 0 0.00878708716481924
of O 0 0.010445913299918175
all O 0 0.015974463894963264
Ashkenazi O 1 0.999936580657959
Jewish O 1 0.9999960660934448
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8713943362236023

The O 0 0.046939581632614136
estimated O 0 0.038280654698610306
relative O 0 0.04857933148741722
risk O 0 0.07646352797746658
for O 0 0.025361819192767143
carriers O 0 0.12119249999523163
may O 0 0.023593105375766754
justify O 0 0.03558674082159996
specific O 0 0.018447522073984146
clinical O 1 0.958158552646637
screening O 0 0.48476141691207886
for O 0 0.013049283996224403
the O 0 0.019186364486813545
360 O 0 0.04349309578537941
, O 0 0.01765199564397335
000 O 0 0.030202878639101982
Americans O 0 0.016713188961148262
expected O 0 0.014965084381401539
to O 0 0.016131410375237465
harbor O 0 0.22476603090763092
this O 0 0.018170516937971115
allele O 0 0.05655666068196297
, O 0 0.01726980321109295
and O 0 0.015467365272343159
genetic O 0 0.01993703655898571
testing O 0 0.016864098608493805
in O 0 0.00817555096000433
the O 0 0.01083424687385559
setting O 0 0.015638317912817
of O 0 0.012957512401044369
long O 0 0.02894553355872631
- O 1 0.9999476671218872
term O 0 0.0522749088704586
- O 1 0.9995829463005066
outcome O 0 0.018842294812202454
studies O 0 0.011450640857219696
may O 0 0.00983284879475832
impact O 0 0.015179079957306385
significantly O 0 0.023946130648255348
on O 1 0.9661353230476379
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 1.0
in O 0 0.04863682761788368
this O 0 0.02047126367688179
population O 0 0.02712247520685196
. O 0 0.03242482990026474

Localization O 0 0.11869203299283981
of O 0 0.04020514711737633
human O 0 0.10985647141933441
BRCA1 O 1 0.9997431635856628
and O 0 0.016943728551268578
its O 0 0.014495989307761192
loss O 0 0.021746758371591568
in O 0 0.011991363018751144
high O 0 0.27451491355895996
- O 1 0.9999728202819824
grade O 1 0.5882691144943237
, O 0 0.017027128487825394
non B-Disease 1 0.9894659519195557
- I-Disease 1 1.0
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.20216023921966553

Although O 0 0.026928992941975594
the O 0 0.02112351916730404
link O 0 0.028196685016155243
between O 0 0.016196860000491142
the O 0 0.03007868304848671
BRCA1 O 1 0.9999998807907104
tumour B-Disease 1 1.0
- O 1 0.9999998807907104
suppressor O 1 0.9999972581863403
gene O 0 0.0295100100338459
and O 0 0.020428868010640144
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.9940251708030701
established O 1 0.5128974914550781
, O 0 0.01192187238484621
the O 0 0.01245043333619833
role O 0 0.025254687294363976
, O 0 0.010791695676743984
if O 0 0.00754126813262701
any O 0 0.006338182371109724
, O 0 0.008948206901550293
of O 0 0.015124731697142124
BRCA1 O 1 0.9974468946456909
in O 0 0.01790185272693634
non B-Disease 1 0.9998192191123962
- I-Disease 1 1.0
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 0.05721078813076019
unclear O 0 0.04796487092971802
. O 0 0.036819443106651306

BRCA1 O 1 0.9999452829360962
mutations O 0 0.05714886263012886
are O 0 0.012181205675005913
rare O 0 0.024635419249534607
in O 0 0.0196601040661335
sporadic B-Disease 1 0.9997642636299133
cancers I-Disease 1 0.9999998807907104
, O 0 0.02194232866168022
but O 0 0.012081964872777462
loss O 0 0.02683090604841709
of O 0 0.03426145389676094
BRCA1 O 1 0.9999978542327881
resulting O 0 0.030537007376551628
from O 0 0.016764098778367043
reduced O 0 0.029609356075525284
expression O 0 0.026868345215916634
or O 0 0.017581181600689888
incorrect O 0 0.04030180722475052
subcellular O 1 0.5521060228347778
localization O 0 0.09479963034391403
is O 0 0.018484069034457207
postulated O 0 0.03705079108476639
to O 0 0.011149405501782894
be O 0 0.006869159638881683
important O 0 0.007522191386669874
in O 0 0.009812948293983936
non B-Disease 1 0.7740852236747742
- I-Disease 1 0.9999997615814209
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9782590866088867

Epigenetic O 1 0.9298238158226013
loss O 1 0.6426863670349121
, O 0 0.02577662467956543
however O 0 0.016638999804854393
, O 0 0.016008898615837097
has O 0 0.013118022121489048
not O 0 0.008702663704752922
received O 0 0.017756739631295204
general O 0 0.02591777965426445
acceptance O 0 0.1161617562174797
due O 0 0.022170811891555786
to O 0 0.015550712123513222
controversy O 0 0.02984676882624626
regarding O 0 0.01895204745233059
the O 0 0.020467525348067284
subcellular O 0 0.07570748776197433
localization O 0 0.07166564464569092
of O 0 0.036015018820762634
BRCA1 O 1 0.999993085861206
proteins O 0 0.027202360332012177
, O 0 0.01343520637601614
reports O 0 0.012266230769455433
of O 0 0.012109131552278996
which O 0 0.00978037528693676
have O 0 0.008057455532252789
ranged O 0 0.02223781868815422
from O 0 0.013893353752791882
exclusively O 0 0.022864801809191704
nuclear O 0 0.02731059305369854
, O 0 0.011749870143830776
to O 0 0.013456685468554497
conditionally O 0 0.07217343896627426
nuclear O 0 0.028044188395142555
, O 0 0.010828893631696701
to O 0 0.01245073787868023
the O 0 0.03193330392241478
ER O 1 0.9999998807907104
/ O 1 0.9999960660934448
golgi O 1 0.9999666213989258
, O 0 0.028531000018119812
to O 0 0.028985217213630676
cytoplasmic O 0 0.3164825737476349
invaginations O 1 0.7305716872215271
into O 0 0.028732480481266975
the O 0 0.03728663548827171
nucleus O 0 0.12011919170618057
. O 0 0.044185616075992584

In O 0 0.0279122032225132
an O 0 0.02052018605172634
attempt O 0 0.032903894782066345
to O 0 0.018854139372706413
resolve O 0 0.04438088834285736
this O 0 0.011636453680694103
issue O 0 0.019292110577225685
, O 0 0.011827067472040653
we O 0 0.008298110216856003
have O 0 0.007625509984791279
comprehensively O 0 0.06018686667084694
characterized O 0 0.04037190601229668
19 O 0 0.043761275708675385
anti O 1 0.9999786615371704
- O 1 1.0
BRCA1 O 1 0.9999980926513672
antibodies O 1 0.9638189673423767
. O 0 0.05048012360930443

These O 0 0.033070892095565796
reagents O 0 0.08105352520942688
detect O 0 0.04367939755320549
a O 0 0.02558288350701332
220 O 0 0.05950350686907768
- O 1 0.9999858140945435
kD O 1 0.999975323677063
protein O 0 0.037776682525873184
localized O 0 0.04283364862203598
in O 0 0.01502834353595972
discrete O 0 0.03117464855313301
nuclear O 0 0.040901754051446915
foci O 0 0.1067826971411705
in O 0 0.016634227707982063
all O 0 0.025819262489676476
epithelial O 1 0.9999985694885254
cell O 1 0.9318972229957581
lines O 0 0.025896746665239334
, O 0 0.013598252087831497
including O 0 0.011811016127467155
those O 0 0.013443083502352238
derived O 0 0.029365381225943565
from O 0 0.0433722585439682
breast B-Disease 1 0.9999998807907104
malignancies I-Disease 1 0.9999990463256836
. O 0 0.08263764530420303

Immunohistochemical O 1 0.9994264841079712
staining O 1 0.9714718461036682
of O 0 0.05538095161318779
human O 1 0.9201599955558777
breast O 1 0.9999998807907104
specimens O 0 0.04583216458559036
also O 0 0.02180473320186138
revealed O 0 0.04389939457178116
BRCA1 O 1 0.9987496137619019
nuclear O 0 0.05149957910180092
foci O 1 0.9964052438735962
in O 0 0.031489647924900055
benign O 1 1.0
breast O 1 1.0
, O 1 0.999211311340332
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.406223863363266
low B-Disease 1 0.9998276233673096
- I-Disease 1 0.9999998807907104
grade I-Disease 1 0.9999990463256836
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.08498472720384598

Conversely O 0 0.35185763239860535
, O 0 0.05242706462740898
BRCA1 O 1 0.9999265670776367
expression O 0 0.04328463226556778
was O 0 0.03316959738731384
reduced O 0 0.03202540799975395
or O 0 0.02151760645210743
undetectable O 1 0.9872543215751648
in O 0 0.009599192999303341
the O 0 0.009957446716725826
majority O 0 0.01093211304396391
of O 0 0.012603307142853737
high O 1 0.9306845664978027
- O 1 0.9999994039535522
grade O 1 0.9998636245727539
, O 1 0.8772542476654053
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.03109091706573963
suggesting O 0 0.02241816185414791
that O 0 0.008438537828624249
absence O 0 0.03086450882256031
of O 0 0.049832653254270554
BRCA1 O 1 0.9999994039535522
may O 0 0.021564386785030365
contribute O 0 0.020789971575140953
to O 0 0.013449345715343952
the O 0 0.019654929637908936
pathogenesis O 1 0.9997771382331848
of O 0 0.013733644038438797
a O 0 0.014668879099190235
significant O 0 0.011351585388183594
percentage O 0 0.018911460414528847
of O 0 0.028457067906856537
sporadic B-Disease 1 0.9999990463256836
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.07594046741724014
. O 0 0.048988401889801025

